concept,cuis,hasMesh,number
heart failure ( class l - lll ),C0018801;C0456387;C1261077;C1518526;C1705943;C0018802;C4554158,true;false;false;false;false;true;false,0/10465
duration of hypertension  n ( % ),C0449238;C0020538;C1963138;C2926735,false;true;false;false,1/10465
type nmbr diabetes 一 no . ( % ),C1320657;C0053917;C1334884,false;true;false,2/10465
tofacitinib nmbr mg bid [n = nmbr |,C2930696;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3/10465
high - density lipoprotein cholesterol mean ( mg / dl ± sd ),C0023822;C0444504;C0439269;C2699239;C2347634;C2348143,true;false;false;false;false;false,4/10465
temporary discontinuation of study drug,C0205374;C0457454;C0013175;C1444662;C4552847;C1548539;C3245481,false;false;true;false;false;false;false,5/10465
death  mi  idr  st  or any timi bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,6/10465
race and ss at baseline,C0034510;C1706779;C3853635,true;false;false,7/10465
high intensity,C4081854,false,8/10465
prior percutaneous coronary intervention  n ( % ),C0332152;C1532338;C2826257,false;true;false,9/10465
pre - randomization pci,C0332152;C0034656;C4049621;C0740175;C2257086;C3669034,false;true;false;false;false;false,10/10465
p  subgroup *,C0369773;C1079230;C1515021;C2603361,false;false;false;false,11/10465
hosji fcrhypoglycemia,,,12/10465
apixaban vs . placebo,C1831808,true,13/10465
medication use — no . ( % ),C0013227;C3244316;C4284232,true;false;false,14/10465
second prior mi,C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false;false,15/10465
subarachnoid hemorrhage,C0038525,true,16/10465
total invasive cancer,C0439175;C0677898;C0439810,false;false;false,17/10465
acute stent thrombosis,C0205178;C3897493,false;false,18/10465
alteplase ( n = nmbr ),C0032143;C0053917;C1334884,true;true;false,19/10465
relative decrease > nmbr %,C0080103;C0392756;C0053917;C1334884;C0547047;C0205345;C1547039,true;false;true;false;false;false;false,20/10465
nmbrth - nmbrth percentiles,C1264641,false,21/10465
number of ( % ) females,C0237753;C0086287;C0449788,false;true;false,22/10465
emphysema ( % ),C0013990;C0034067,true;true,23/10465
argentina,C0003761;C1504311,true;false,24/10465
ccq score § §,,,25/10465
vents / patients,C0030705,true,26/10465
number of patients with,C2360800,false,27/10465
concomitant mtx —,C0521115;C0025677;C1417487,false;true;false,28/10465
europe / lsrael,C0015176,true,29/10465
thromboaspiration — no . ( % ),,,30/10465
cardiac - biomarker status — no . / total no . ( % ) $,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,31/10465
receiving insulin therapy,C1514756;C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,false;true;true;true;false;false;false;false,32/10465
pulmonary embolism ± deep vein thrombosis,C0852030;C0226514;C0034065;C0149871,false;false;true;true,33/10465
abdominal or perianal fistula at baseline  n ( % ),C0000726,true,34/10465
cyclosporine ( n = nmbr ),C0010592;C0053917;C1334884;C0010594,true;true;false;true,35/10465
geographic region - europe,C0017446;C0015176,true;true,36/10465
indian ( indian subcontinent ),C0454693,false,37/10465
percutaneous coronary intervention,C1532338,true,38/10465
antiplatelet or anticoagulant therapy,,,39/10465
lesion length  mean ( sd )  mm,C0221198;C1444754;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143;C1706316;C1546698,false;false;false;false;false;false;false;false;false;false,40/10465
non - q wave,C1518422;C0429089;C1305738,false;false;false,41/10465
continued thienopyridine n = nmbr subjects,C0549178;C1120149;C0053917;C1334884,false;true;true;false,42/10465
weight ( kg / mnmbr ) [median ( nmbrth to nmbrth percentile ) ],C0552346;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209,false;true;false;false;false;false;false;false;false,43/10465
left ventricular ejection fraction  % af history,C0428772;C0344434;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049859;C0488728,false;false;true;true;false;false;false;false;false;false,44/10465
single - vessel disease  n ( % ),C0037179;C0042373;C0087136;C0205171,true;true;true;false,45/10465
geographic region — no . ( % ),C0017446,true,46/10465
pad lower extremities,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,47/10465
bmi > nmbr kg / mnmbr ( % ),C0578022;C0053917;C0022718;C0439209;C4054209;C1334884,false;true;true;false;false;false,48/10465
total gadolinium - enhancing lesion count  no . ( % ),C0439175;C1333400;C0439810,false;false;false,49/10465
fatigue,C0015672;C3463815;C4050243;C4554645,true;false;false;false,50/10465
nmbr to < nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,51/10465
st - elevation mi,C0520886;C3810814,false;false,52/10465
azathioprine ( n = nmbr ),C0004482;C0053917;C1334884,true;true;false,53/10465
serum uric acid ( mg / dl ),C0455272;C0439269;C0700634,false;false;false,54/10465
baseline mean ( sd )  % [mmol / mol],C0168634;C0444504;C2699239;C3829066;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,55/10465
cv death  ml  or stroke,C3538987;C0011065;C0439526;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;false;true;false,56/10465
atenolol ( « = nmbr nmbr ),C0004147;C0053917;C1334884,true;true;false,57/10465
previous antiarrhythmic treatment — no . ( % ),C0205156;C0003195;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3537142;C1552607,false;true;true;true;false;false;false;false;false;false;false,58/10465
drugs used in diabetes  n ( % ),C0013227;C3687832,true;false,59/10465
after pci,C4049621,false,60/10465
secukinumab,C3179547,true,61/10465
mean a ± sem ( % ),C0444504;C2347634;C2348143,false;false;false,62/10465
ppi but no aspirin,C0358591;C0871125;C3811894,true;true;false,63/10465
nmbr mg / kg ( n = nmbr ),C0053917;C0439272;C1334884,true;false;false,64/10465
family history of cad ( diagnosed at < nmbr yr of age ) — no . ( % ) cigarette smoker — no . ( % ),C0241889;C1504769;C2239547;C3813548;C4284121,true;true;false;false;false,65/10465
trend / het . test,C1521798;C4554533,false;false,66/10465
cv death + hf hospitalization,C3538987;C0011065;C0018488;C0019993;C1313497;C1538440;C3273279;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;true;true;true;false;false;false;false;false;true;false,67/10465
mepolizumab  nmbr mg ( n = nmbr ),C0969324;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,68/10465
medical therapy only ( n = nmbr ),C0418981;C0205171;C0053917;C1334884;C1720467,false;false;true;false;false,69/10465
caucasian ethnicity,C0007457;C0015031;C0243103;C0043157,true;true;true;true,70/10465
crcl at baseline < nmbr ml / min,C1846718;C0168634;C0053917;C0439445;C1334884;C1442488,false;true;true;false;false;false,71/10465
elevated hscrp > nmbr mg / l  n ( % ),C0205250;C0053917;C0439268;C1334884;C3163633,false;true;false;false;false,72/10465
seizure types reported during baseline  n ( % ) a,C0036572;C0332307;C1959629;C4553401,true;false;false;false,73/10465
median total cholesterol  mmol / l,C0549183;C0201950;C1532563;C0543421;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,74/10465
mean ± sd bmi  kg / mnmbr,C0444504;C2699239;C0578022;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;false;true;false;false;false;false,75/10465
first mace,C0205435;C0349381;C0949745;C1445339;C1279901,false;false;true;false;false,76/10465
disease duration nmbr to bnmbr years ( n = nmbr ),C0872146;C0053917;C0439234;C1334884,false;true;false;false,77/10465
history of amputation — no . ( % ),C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,78/10465
lipid - lowering medication ( % ),C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,79/10465
previous hf hospitalization  n ( % ),C0205156;C0018488;C0019993;C1313497;C1538440;C3273279;C1552607,false;true;true;true;false;false;false,80/10465
mean lipid values  mg / dl,C0444504;C0023779;C0042295;C0439269;C2347634;C2348143,false;true;false;false;false;false,81/10465
prior years taking warfarin,C0332152;C0439234;C2826257,false;false;false,82/10465
bnp  median ( iqr )  pg / ml,C0054015;C0549183;C0439297;C0876920;C2347635;C2348144;C2939193;C1095989;C1417808;C2982014,true;false;false;false;false;false;false;false;false;false,83/10465
hbanmbrca  % ( mmol / mol ),C3829066,false,84/10465
latin america hr ( nmbr % cl ),C0023122;C0053917;C0596019;C1334884,true;true;false;false,85/10465
current atrial fibrillation or flutter on ecg,C0521116;C0004238;C0344434;C1963067;C1705970,false;true;false;false;false,86/10465
invasive,C0205281;C1334278,false;false,87/10465
estimated glomerular filtration,C0750572;C0232809,false;false,88/10465
pasi score ! * *,C4528685;C0449820;C4050231,false;false;false,89/10465
amiodarone  n ( % ),C0002598,true,90/10465
american indian or alaska,C0002460,true,91/10465
pooled simvastatin factorial studies,C1709595;C0074554;C2826344;C2349200;C4522255,false;true;false;false;false,92/10465
implantable cardioverter - defibrillator,C0162589;C2825184,true;false,93/10465
varespladib ( n = nmbr ),C2713485;C0053917;C1334884,true;true;false,94/10465
acute coronary event,C0205178;C0741923,false;false,95/10465
ntpro - cnp ( ng / ml ),C3889729;C0439275,false;false,96/10465
useofmedical therapyathospitaldischarge,,,97/10465
coenzyme qnmbr  ^g / ml #,C0009235;C1300565,true;false,98/10465
dyspnoea - mmrc grade  n ( % ),C0013404;C3826977;C0441800;C0919553;C3244287;C1963100,true;false;false;false;false;false,99/10465
triglycerides — mmol / liter,C0041004;C0439190;C0475211,true;false;false,100/10465
baseline ecrcl,C0168634;C1442488,true;false,101/10465
cardiovascular history,C1880008,false,102/10465
with placebo ( n nmbr nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,103/10465
cardiovascular medications,C0007220,true,104/10465
after bronchodilation,C1371299;C3537072,false;false,105/10465
mean nmbrmwd *  m ( sd ),C0444504;C0369637;C2699239;C0441923;C2347634;C2348143,false;false;false;false;false;false,106/10465
angiotensin - converting enzyme inhibitors / angiotensin receptor blockers,C0003015;C0597357;C2757044,true;false;false,107/10465
medication taken alone or in combination,C0013227;C3244316;C4284232,true;false;false,108/10465
etoricoxib dose,C0972314;C0178602;C0869039;C1114758,true;false;false;false,109/10465
ischemic cerebrovascular disease  n ( % ),C0475224;C0007820,false;true,110/10465
bare metal stent  n ( % ),C2825200,false,111/10465
mean age ( years ) ( s . d . ),C0444504;C1510829;C2347634;C2348143,false;false;false;false,112/10465
dasnmbr ( esr )  mean ( sd ),C3811131;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,113/10465
absolute  litres,C0205344;C0475211,false;false,114/10465
wml load at follow - up mri,C1550025;C0589120;C0024485;C1824234;C3890166;C1522577;C1704685;C3274571;C1704782;C1708715,false;false;true;false;false;false;false;false;false;false,115/10465
clopidogrel ( n = nmbr  nmbr ),C0070166;C0053917;C1334884,true;true;false,116/10465
ancestry ( % ) f,C0016327,true,117/10465
no p - blocker intake at randomisation ( n = nmbr ),C0369773;C1512806;C0034656;C0053917;C1334884;C2603361,false;false;true;true;false;false,118/10465
valsartan / hctz  n / n ( % ),C0216784;C0020261,true;true,119/10465
> nmbr oral agents,C0053917;C0442027;C0450442;C1254351;C1521826;C4521986;C1334884,true;false;false;false;false;false;false,120/10465
total chol  mg / dl,C0439175;C0201950;C0439269;C0439810,false;false;false;false,121/10465
calcium channel blockers  n ( % ),C0006684;C2757014,true;false,122/10465
bsa > nmbr %  n ( % ) t,C0053917;C1334884,true;false,123/10465
benralizumab nmbr mg qnmbrw ( n = nmbr ),C2982078;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,124/10465
blood pressure  mean ( sd ) [range]  mm hg,C0428886;C2699239;C1514721;C0439475;C2348147;C3542016,true;false;false;false;false;false,125/10465
atenolol n = nmbr,C0004147;C0053917;C1334884,true;true;false,126/10465
type of mi ( % ),C0332307;C3810814;C1547052,false;false;false,127/10465
mtx + non - mtx,C0025677;C1518422;C1417487,true;false;false,128/10465
concomitant corticosteroid use  n ( % ),C0521115;C0239126,false;false,129/10465
estimated glomerular filtration rate ( mdrd )  ml / min / nmbr . nmbrmnmbr,C3811844;C3839656;C0439445;C0053917;C1334884,false;false;false;true;false,130/10465
mild impairment ( nmbr to < nmbr ),C2945599;C0221099;C0053917;C1334884;C0684336,false;false;true;false;false,131/10465
years since menopause,C0439234,false,132/10465
major cvd /,C0205082;C0007222;C0205164;C4318856;C4521762,false;true;false;false;false,133/10465
medical therapy ( n = nmbr ),C0418981;C0053917;C1334884,false;true;false,134/10465
no . of tnfi among non - tnfi naive,,,135/10465
use of ace inhibitor,C1524063;C0003015;C4541021,false;true;false,136/10465
haemorrhagic,C0333275,false,137/10465
stroke ( vs tia ),C0038454;C4554100,true;false,138/10465
detemir / insulin glargine  %,C0537270;C0907402,true;true,139/10465
screening prebronchodilator fevnmbr  l,C0220908;C2599602;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;false;false;false;false;false,140/10465
stent plus placebo,C0038257;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,141/10465
coronary revascularization nmbr days after randomization,C0877341;C0053917;C0439228;C0034656;C1334884,false;true;false;true;false,142/10465
sacubitril / valsartan,C4033631,true,143/10465
no . of prior bdmards,C0332152;C2826257,false;false,144/10465
mean prebronchodilator fevnmbr ( sd )  % predicted,C0444504;C2599602;C2699239;C2347634;C2348143,false;false;false;false;false,145/10465
paracetamol,C0000970,true,146/10465
aspirin / other antiplatelet agents  n ( % ),C0004057,true,147/10465
randomized to receive beta carotene,C0034656;C3815594,true;false,148/10465
bsa  % *,,,149/10465
erosion score,C0333307;C0449820;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false,150/10465
peripheral arterial disease  n ( % ),C0085096;C1704436,true;true,151/10465
primary end point  no . of events / total no . ( % ),C2986535,false,152/10465
lvdd ( mm ),C4330985;C4554674,false;false,153/10465
draining cutaneous fistula at baseline  n ( % ),C0013103;C0180499;C4265177,true;false;false,154/10465
tg < nmbr  hdl > nmbr ( n = nmbr ),C0337445;C0053917;C3715113;C1334884,false;true;false;false,155/10465
comorbidities other than diabetes,C0009488;C0011847;C0011849,true;false;true,156/10465
toast classification of qualifying stroke,C1710306;C1514624;C0038454;C4554100;C4521230,false;false;true;false;false,157/10465
rasagiline  nmbr mg / day,C0525678;C0053917;C0439422;C1334884,true;true;false;false,158/10465
metabolic syndromenmbr baseline lipids  mg / dl,C0311400;C0168634;C0023779;C0439269;C1442488;C1524026;C2707259,false;true;true;false;false;false;false,159/10465
crude analysis  n ( % ),C0002778;C0936012;C1524024,false;false;true,160/10465
bypass surgery,C1536078,false,161/10465
missing — number / n ( % ),C1551393;C0237753;C0449788;C1705492;C3272743,false;false;false;false;false,162/10465
cholesterol  ( . nmbr . nmbr mmol / l )  n ( % ),C0008377;C0053917;C1532563;C1334884,true;true;false;false,163/10465
right coronary,C0225808,false,164/10465
health habits,C0679786,false,165/10465
blood pressure,C0005823;C1271104;C1272641,true;false;true,166/10465
homa . % b  median ( ql  qnmbr )  %,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,167/10465
severity of copd  ( gold nmbr )  %,C0439793;C0024117;C0018026;C0053917;C1334884;C1304897;C1412502;C3714496;C0522510,false;true;true;true;false;false;false;false;false,168/10465
prior myocardial infarction,C0155668,false,169/10465
both ptca and cabg,C2936173,true,170/10465
major cerebrovascular,C0205082;C1880018;C0205164;C4318856;C4521762,false;false;false;false;false,171/10465
hazard ratio ( nmbr % cl ) nmbr . nmbr ( nmbr . nmbr  nmbr . nmbr ),C2985465;C0053917;C0596019;C1334884,false;true;false;false,172/10465
diastolic blood pressure ( mm hg ) medications,C0428883;C0439475;C0013227;C0802604;C2598133;C4284232;C1305849,true;false;true;false;false;false;false,173/10465
iglar dose at randomization ( u / day ),C0178602;C0034656;C0456683;C0869039;C1114758,false;true;false;false;false,174/10465
prior cv event at randomization !,C0332152;C3538987;C0441471;C0034656;C4019010;C4048877;C4318503;C2826257,false;false;false;true;false;true;false;false,175/10465
mean ± sd waist circumference  cm,C0444504;C2699239;C0455829;C2347634;C2348143,false;false;true;false;false,176/10465
risk of bleeding,C3251812,false,177/10465
cv medication  % of patients,C3538987;C0013227;C0030705;C3244316;C4284232;C4048877;C4318503,false;true;true;false;false;true;false,178/10465
total updrs score ( range  nmbr - nmbr ) 卞,C0439175;C3639721;C0439810,false;true;false,179/10465
atrial fibrillation  duration — no . ( % ),C0004238;C0449238;C2926735;C0344434;C1963067,true;false;false;false;false,180/10465
known duration of diabetes  yr,C0205309;C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;false;true;false,181/10465
nmbr % < hbanmbrc < = nmbr %,C0053917;C1334884,true;false,182/10465
dactylitis count,C0239161;C0750480;C1705566,false;false;false,183/10465
previous disease :,C0205156;C0012634;C1552607,false;true;false,184/10465
previous dmards use  n ( % ),C0205156;C0242708;C1552607,false;true;false,185/10465
gly nmbr . nmbr gg b . i . d n / n ( % ),C1415124;C0053917;C0017454;C0152277;C0018370;C1334884,false;true;true;false;true;false,186/10465
previous percutaneous coronary intervention,C0205156;C1532338;C1552607,false;true;false,187/10465
unfractionated heparin before randomisation,C0019134;C0034656;C2825026,true;true;false,188/10465
oad plus insulin,C0021641;C1533581;C1579433;C3714501,true;false;false;false,189/10465
diabetes with target organ disease *,C0011847;C1521840;C0178784;C0012634;C2986546;C0011849,false;false;false;true;false;true,190/10465
unknown type,C0439673;C0332307;C1547052;C3541433;C4050014,false;false;false;false;false,191/10465
beta - blocker — no . ( % ),C0001645,true,192/10465
cognitive functioning,C0392334;C0392335,false;false,193/10465
( % ) nmbr - nmbr,C0053917;C1334884,true;false,194/10465
history of hyperlipidemia ( % ),C4695788,false,195/10465
evenls per nmbr  nmbr palienl - years,C0053917;C0439234;C1334884,true;false;false,196/10465
fasting free fatty acids ( ^mol / liter ),C0015663,true,197/10465
treatment after admission,C0039798;C0184666;C0809949;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,198/10465
rarertd antocagibtcn before andorrtzafon,,,199/10465
intestinal area involved  n ( % ) $,C0021853;C0017446;C0205146,true;true;false,200/10465
ethnicity ( % ),C0015031;C0243103,true;true,201/10465
all cardiovascular,C0007226;C3887460,true;false,202/10465
smoking in the past year,C0037369;C4086728;C0453996;C1881674,true;false;true;false,203/10465
diskus only  n,C1553480;C0205171;C1720467,false;false;false,204/10465
jsn score  mean nmbr sd,C0449820;C0444504;C0053917;C2699239;C1334884;C2347634;C2348143;C4050231,false;false;true;false;false;false;false;false,205/10465
number omega - nmbr number placeb fatty acid,C0237753;C1719844;C0053917;C0015684;C1334884;C0449788,false;false;true;true;false;false,206/10465
high - intensity statin vs medium - or low - intensity statin at randomization,C4081854;C0360714,false;true,207/10465
score on nih stroke scale — median ( iqr ),C0449820;C1697238;C0549183;C0876920;C2347635;C2348144;C2939193;C3484372;C4050231,false;false;false;false;false;false;false;false;false,208/10465
initiation of insulin,C0589507;C0021641;C1533581;C1579433;C3714501;C1158830;C1704686,false;true;false;false;false;false;false,209/10465
nmbrnd > nmbr . nmbr / < nmbr . nmbr,C0053917;C1334884,true;false,210/10465
cad and abi < nmbr - nmbr §,C1504769;C2239547;C3813548;C4284121,true;false;false;false,211/10465
pioglitazone events / n ( % ),C0071097;C0441471;C3541888,true;false;false,212/10465
acecoumarol  no . ( % ),,,213/10465
cigarette users,C0677453;C1706077;C1704760;C3890423,true;false;false;false,214/10465
gfr ( mdrd ) ( ml / min / nmbr - nmbr mnmbr ),C0017654;C3839656;C0439445;C0053917;C1334884;C1424601,true;false;false;true;false;false,215/10465
bmi ( kg / mnmbr ) cardiac parameters,C0578022;C0022718;C0018787;C0449381;C1522601;C0439209;C4054209,false;true;true;false;false;false;false,216/10465
ace inhibitor or arb at last follow - up,C0003015;C4541021,true;false,217/10465
blood urea nitrogen ( mg / dl ),C0005845;C0439269;C0600137,true;false;false,218/10465
grip strength ( kg ),C0429271;C0022718;C0439209;C4054209;C2598165,false;true;false;false;false,219/10465
current smoker — no . of patients ( % ),C3173209;C3241966,false;false,220/10465
one - third radius,C0205447;C0205437;C0034627;C1306504,false;false;true;false,221/10465
psychosocial risk factors,C0033963;C0035647;C4552904;C0542298;C0035648;C1553898;C1458132,true;true;false;false;true;false;false,222/10465
bursitis,C0006444,true,223/10465
non - hdl - c in nmbr classes,C1518422;C3715113;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884,false;false;true;false;false;false;false;false,224/10465
family history ol diabetes ?,C1313937,false,225/10465
age ( years ) : nmbr - < nmbr,C1510829;C0053917;C1334884,false;true;false,226/10465
digital clubbing  n ( % ),C0009080;C0149651,true;false,227/10465
death or myocardial infarction,C0011065;C1306577;C4082313;C4552775,true;false;false;false,228/10465
risk reduction  %,C1137094,true,229/10465
a mini - mental state examination  omega - nmbr fatty acids vs placebo,C0451306;C1719844;C0053917;C0015684;C1334884,true;false;true;true;false,230/10465
pain vas  nmbr - nmbr mm,C0042815;C0053917;C4330985;C4554674;C1334884,true;true;false;false;false,231/10465
smoking : ex - smoker,C0037369;C0453996;C1881674,true;true;false,232/10465
statin treatment,C0360714;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,233/10465
pre - bronchodilator fevnmbr / fvc ratio *,C2599602;C3714541;C0456603;C1547037,false;true;false;false,234/10465
prior stroke or transient ischemic attack,C0332152;C0038454;C4554100;C2826257,false;true;false;false,235/10465
czp nmbr mg ( n nmbr nmbr ),C0054841;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1861828;C1872109,true;true;true;true;false;false;false;false;false;false;true;true,236/10465
microvascular eye diseased,C0443258;C0015392;C0700042,false;true;false,237/10465
extent of disease  %,C0449279;C4553144,false;false,238/10465
mean ( nmbr % ci ) difference vs saxa + dapa + met,C0444504;C0053917;C0008107;C1705241;C1705242;C3259781;C1334884;C2347634;C2348143,false;true;true;false;false;false;false;false;false,239/10465
urgent coronary revascularization,C0439609;C0877341;C3272275,false;false;false,240/10465
caucasian simva,C0007457;C0043157,true;true,241/10465
full analysis set,C0443225;C0002778;C0036849;C1442518;C1705195;C0936012;C1524024,false;false;true;false;false;false;true,242/10465
serious ae,C0205404;C3887670,false;false,243/10465
smoking history ( ever ),C1519384;C3887636,false;false,244/10465
uncodable,,,245/10465
no pah therapy,C0030123;C0039798;C0087111;C1363945;C3203102;C4284467,true;true;true;false;true;false,246/10465
standard ( n = nmbr ),C1442989;C0053917;C1334884;C2828392,false;true;false;false,247/10465
patent foramen ovale,C0016522;C0344724,true;true,248/10465
laboratory values,C0022877;C0042295;C3244292;C4283904,true;false;false;false,249/10465
years  mean ( sd ),C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,250/10465
hscrp < nmbr . nmbr mga . nmbr ( nmbr . nmbrxnmbr ( nmbr . nmbr ),C0053917;C0065879;C1334884,true;true;false,251/10465
physician ' s judgment that vka,C0031831;C0022423;C0804815,true;true;false,252/10465
calcium - channel blocker ( ratelowering ),C0006684;C3536851;C4521885,true;false;false,253/10465
left ventricular hypertrophy ( % ),C0149721;C3484363,true;false,254/10465
randomized to aspirin use,C0034656;C0004057;C0042153;C0457083;C1947944;C3815594,true;true;true;false;false;false,255/10465
antihypertensive  antianginal  and other cardiovascular medications,C0003364;C1874267;C3537168,true;false;false,256/10465
glp - nmbr receptor agonist ( other than study drug ),C0018301;C0053917;C4543206;C0013175;C1334884;C1422069;C1425391;C1539338;C2350813,true;true;false;true;false;false;false;false;true,257/10465
primary renal endpoint or death,C2986535;C0022646,false;true,258/10465
metabolic syndrome characteristics  n ( % ),C0524620;C1521970,true;false,259/10465
mean duration of disease  years,C0444504;C0872146;C0439234;C2347634;C2348143,false;false;false;false;false,260/10465
other oral hypoglycemic drug ( s ),C0359086,false,261/10465
> nmbr additional cv risk factorsnmbr,C0053917;C1524062;C3538987;C0035647;C4552904;C4048877;C4318503;C1334884,true;false;false;true;false;true;false;false,262/10465
pancolitis,C0868908,false,263/10465
death from any cause,C0007465,true,264/10465
high - density lipoprotein cholesterol  mg / l,C0023822;C0439268,true;false,265/10465
diabetes mellitus status,C1317301,false,266/10465
fibrinolysis primary pci ( n = nmbr ) ( n = nmbr ) no . of patients / total no . ( % ),C0016017;C0205225;C4049621;C0053917;C1334884;C0439612;C0439631;C1305868,true;false;false;true;false;false;false;false,267/10465
stool frequency subscore,C0015733;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0183622,true;true;false;false;false;false;false;false;false,268/10465
psap - b ( ng / ml ),C1418975;C0439275;C1420002;C1425004,false;false;false;false,269/10465
no use of nmbr - asa compounds,C1524063;C0053917;C0004057;C0205198;C1706082;C3853627;C1334884,false;true;true;false;false;false;false,270/10465
visit nmbr ldl cholesterol strata,C0545082;C0053917;C0023824;C0202117;C1334884;C1512346;C2826704,false;true;true;false;false;false;false,271/10465
endothelin nmbr ( pg / ml ),C0079284;C0053917;C0439297;C1334884,true;true;false;false,272/10465
normal ( egfr > nmbr ),C0205307;C1739039;C0053917;C1334884;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;true;false;false;false;false;false;false;false,273/10465
py = nmbr . nmbr ),C0030428;C0053917;C1334884;C3538810,true;true;false;false,274/10465
fibrinogen,C0016006;C1167394;C2587184;C3540039,true;false;false;false,275/10465
total haq  nmbr - nmbr,C0439175;C0102923;C0053917;C1334884;C0451208;C0439810,false;true;true;false;false;false,276/10465
mean baseline ibdq score ( sd ) § crp concentration  mg / l,C3533236;C0168634;C2699239;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285;C1442488,false;true;false;false;true;false;false;false;false;false,277/10465
dipyridamole,C0012582,true,278/10465
aspirin and other antiplatelet,C0004057,true,279/10465
positive,C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,280/10465
age [years] ( interaction : p = nmbr . nmbr ),C1510829;C1704675;C0053917;C1334884,false;false;true;false,281/10465
decreased appetite,C0232462,false,282/10465
beta - blocker ( except sotalol ),C0001645;C0037707,true;true,283/10465
geometric mean crp concentration ( mg / l ),C2986759;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285,false;false;true;false;false;false;false,284/10465
duration of morning,C0449238;C0332170;C2926735,false;false;false,285/10465
hr ( enl vs lcz ) ( nmbr % cl ),,,286/10465
rf positive — number ( % ),C0035448;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false,287/10465
selected medications — no . ( % ),C1707391;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,288/10465
no peripheral revascularization ( n = nmbr  nmbr ),C0205100;C0581603;C0053917;C1334884,false;false;true;false,289/10465
white / european,C0007457;C0239307;C1535514;C0043157;C0220938,true;false;false;true;false,290/10465
at least nmbr flare,C0053917;C1517205;C3540542;C1334884,true;false;false;false,291/10465
time to admission  min,C3854258;C0702093;C1524029;C3813700;C3854259,false;false;false;false;false,292/10465
octave sustain,,,293/10465
lm bifurcation not treated,C1261082;C0184906;C3146289;C1551056,false;false;false;false,294/10465
radial access,C0442038;C0444454;C1554204;C0920847,false;false;false;false,295/10465
history of peripheral artery disease,C0683519;C0489868;C0730226;C0850708;C0944983,false;false;false;false;false,296/10465
baseline fev  ( l ),C0168634;C3714541;C1442488,true;true;false,297/10465
combined trials,C0205195;C0008976,false;true,298/10465
negative,C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,299/10465
severe dysfunction,C3274777,false,300/10465
fasting c - peptide  ng / ml,C0015663;C0006558;C0439275,true;true;false,301/10465
aggressive ( n = nmbr ),C0001807;C0053917;C1334884;C0580822,true;true;false;false,302/10465
aldosterone blocker  %,C0002006,true,303/10465
management of event — no . ( % ),C0001554;C0441471;C4019010;C0376636;C1273870;C3273539,true;false;false;true;false;false,304/10465
> nmbrmg / dl chd status,C3642216;C0280604;C0449438;C3542407,false;false;false;false,305/10465
serum albumin  g nmbr nmbr,C0036773;C0439267;C0053917;C1334884;C0728877,true;false;true;false;false,306/10465
intraperitoneal,C0442120,false,307/10465
headache,C0018681;C4553197,true;false,308/10465
left main artery,C0205091;C0205225;C0003842;C0226004;C1542147;C0443246;C1552822,false;false;true;false;false;false;false,309/10465
> nmbr to < nmbr egfr  ml / min / nmbr . nmbr mnmbr a,C0053917;C1739039;C0439445;C3811844;C3812682;C1334884,true;true;false;false;false;false,310/10465
established,C0443211;C1272684,false;false,311/10465
gender ( % ) male / female,C0079399;C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1522384,true;true;true;true;false;false;false;false;false;true,312/10465
chondroitin sulfate ( n = nmbr ),C0008466;C0053917;C1334884,true;true;false,313/10465
unstable angina ( biomarker negative ),C0002965;C0005516;C0205160;C1513916;C2825415;C2825491;C3853545,true;true;false;false;false;false;false,314/10465
american indian or native alaskan,C0002460,true,315/10465
symptom onset to start of reperfusion treatment : tenecteplase or arterial sheath insertion !,C4086878,false,316/10465
age ( years ) [median ( nmbrth to nmbrth percentile ) ],C1510829;C0549183;C1264641;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,317/10465
formoterol nmbr gg bid,C0060657;C0053917;C0017454;C0018370;C1334884,true;true;true;true;false,318/10465
race or ethnic group ( % ),C0034510;C1706779;C3853635,true;false;false,319/10465
dihydropyridine,C0012315;C0220821,true;true,320/10465
canakinumab,C2718773,true,321/10465
lev status  n ( % ),C0023556;C0449438,true;false,322/10465
steroids § §,C0038317,true,323/10465
normal / mild ckd,C0205307;C2945599;C1561643;C0231683;C0439166;C2347086;C4553972,false;false;true;false;false;false;false,324/10465
number of stent = nmbr,C0237753;C0038257;C0053917;C1334884;C0449788,false;true;true;false;false,325/10465
previous medications  n ( % ),C0205156;C0013227;C0802604;C2598133;C4284232;C1552607,false;true;false;false;false;false,326/10465
nyha class nmbr - nmbr : no { n = llll ),C1882083;C0053917;C1334884,false;true;false,327/10465
tofacitinib nmbr mg twice daily n = nmbr,C2930696;C0053917;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,328/10465
verapamil sr n = nmbr no . ( % ),C1527129;C0053917;C1334884,false;true;false,329/10465
no prior ml or stroke,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,330/10465
stent length per lesion  mm,C0038257;C1444754;C0221198;C4330985;C4554674;C1546698;C1706316,true;false;false;false;false;false;false,331/10465
chf history,C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,332/10465
anti - ccp antibody positive,C4318437;C0741132,true;false,333/10465
oral medications,C0304289,false,334/10465
no antidiabetic drug,C0935929,true,335/10465
tofacitinib nmbr mg two times a day,C2930696;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,336/10465
no . of nmbr - mg acetaminophen tablets / day,C0053917;C0439422;C1243102;C1334884,true;false;false;false,337/10465
acpa positive  %,C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,338/10465
timi major / minor,C4441842,false,339/10465
severity of airflow limitation ( gold nmbr - nmbr )  n ( % ),C0439793;C0231999;C0443288;C0018026;C0053917;C1334884;C1304897;C0449295;C0522510,false;false;false;true;true;false;false;false;false,340/10465
pooled simva,C1709595;C2349200;C4522255,false;false;false,341/10465
timi risk score — no . ( % ) : t,C0035647;C0449820;C4050231;C4552904,true;false;false;false,342/10465
baseline dyspnea index  mean total score,C1511069;C3533236;C0439175;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,343/10465
number ( % ) of patients with event,C2360800,false,344/10465
atrial fibrillation onset,C0004238;C0206132;C0332162;C0344434;C1963067,true;true;false;false;false,345/10465
infarct characteristics,C0021308;C1521970,true;false,346/10465
caucasian simva ( „ = nmbr },C0007457;C0053917;C1334884;C0043157,true;true;false;true,347/10465
ticagrelor nmbr mg nmbr yr km %,C1999375;C0053917;C0024671;C0439234;C3887676;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;true;false;false;false;false;false;false,348/10465
galectin - nmbr ( ng / ml ),C0607430;C0053917;C0439275;C1334884,true;true;false;false,349/10465
hctz = hydrochlorothiazide . * based on wilcoxon nmbr - sample rank - sum tests for age and body mass index  t tests for systolic and diastolic blood and ' / nmbr tests for categorical variables . t data were missing for some patients .,C0020261,true,350/10465
nmbr mg clopidogrel load,C0053917;C0024671;C0070166;C1550025;C1704782;C1708715;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;true;false;false;false;false;false;false,351/10465
intravenous dobutamine,C0348016;C0012963,false;true,352/10465
family history of diabetes — no . ( % ),C1313937,false,353/10465
primary prevention subgroup,C0033144;C1079230;C1515021,true;false;false,354/10465
telmisartan ( n = nmbr  nmbr ),C0248719;C0053917;C1334884,true;true;false,355/10465
ppi use ( p = nmbr - nmbrt ),C0358591;C0871125;C3811894,true;true;false,356/10465
large mi,C0549177;C3810814,false;false,357/10465
never / rarely,C2003901;C0522498,false;false,358/10465
medication adherence,C2364172,true,359/10465
no concomitant cortcosteroid use,C0521115;C0042153;C0457083;C1947944,false;true;false;false,360/10465
severity of hypertensionb,C0439793;C0522510,false;false,361/10465
clopidogrel  %,C0070166,true,362/10465
fevnmbr percent predicted ( sd ),C0439165,false,363/10465
antidiabetic medication | |,C0935929,true,364/10465
gad positive — no . ( % ) ^,C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false,365/10465
intravenous vasodilators ( % ),C0443081,false,366/10465
european trial,C0239307;C0008976;C1535514,false;true;false,367/10465
systemic corticosteroid use,C4053960;C0042153;C0457083;C1947944;C0205373;C0239126,false;true;false;false;false;false,368/10465
weight  median ( interquartile range )  kg,C0005910;C0549183;C1711350;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;false;false;true;false;false,369/10465
indacaterol nmbr ug versus placebo,C1722260;C0053917;C0041573;C0439211;C1334884,true;true;true;false;false,370/10465
crohn ’ s disease related surgery,C0010346,true,371/10465
peripheral arterial disease — no . ( % ) §,C0085096;C1704436,true;true,372/10465
mases ( nmbr - nmbr )  mean ( sd ),C0053917;C0444504;C2699239;C2347634;C2348143;C1334884,true;false;false;false;false;false,373/10465
duration of coronary artery disease — yr,C0449238;C0018787;C0852949;C0439234;C2926735,false;true;false;false;false,374/10465
hbanmbrc  mean ( sd )  % [mmol / mol],C0444504;C2699239;C3829066;C2347634;C2348143,false;false;false;false;false,375/10465
total cholesterol ( week nmbr ),C0201950;C0332174;C0053917;C1334884;C0439230;C0543421,false;false;true;false;false;false,376/10465
at least nmbr severe flare,C0053917;C0205082;C1517205;C3540542;C4050465;C4050466;C1334884,true;false;false;false;false;false;false,377/10465
baseline / concomitant therapies,C0168634;C1707479;C1442488,true;false;false,378/10465
chd eze / simva ( n = nmbr],C0280604;C0053917;C1334884;C3542407,false;true;false;false,379/10465
heart failure criteria met,C0018801;C0243161;C0018802;C4554158,true;true;true;false,380/10465
left atrial diameter,C0225860;C1301886;C0225861,true;false;false,381/10465
pulmonary function tests  % of predicted,C0024119;C0681842;C1882327;C2598152,true;false;false;false,382/10465
other nsaids,C0003211,true,383/10465
rheumatic heart disease,C0035439,true,384/10465
coronary angiography and intervention,C0085532;C1548829,true;false,385/10465
time of qualifying ecg to balloon inflation ( hrs ),C0040223;C1514624;C1623258;C3541383,true;false;true;false,386/10465
time from symptoms to treatment,C0040223;C0683368;C1457887;C3541383,true;true;false;false,387/10465
ratio fp / sal : sal ( nmbr % ci ),C0456603;C0016704;C0036140;C0053917;C0008107;C3259781;C1334884;C0037494;C0206136;C1419068;C1419906;C3541238;C3541412;C1547037,false;true;true;true;true;false;false;true;true;false;false;false;false;false,388/10465
coexisting conditions — no . ( % ),,,389/10465
clopidogrel  ticlopidine  or prasugrel,C0070166;C0040207,true;true,390/10465
crp ( mg / dl ) < nmbr . nmbr,C3890735;C0439269;C0053917;C1334884;C4048285,false;false;true;false;false,391/10465
mean ± s . d . duration of diabetes  years,C0444504;C0449238;C0011847;C0439234;C0011849;C2926735;C2347634;C2348143,false;false;false;false;true;false;false;false,392/10465
russia / georgia ( n = nmbr ),C0035970;C0017452;C0053917;C1334884;C0017454,true;true;true;false;true,393/10465
fatal and nonfatal ml,C1302234;C1705232,false;false,394/10465
hypertension ( n 二 nmbr ),C0020538;C0053917;C1334884;C1963138,true;true;false;false,395/10465
cv event  years,C3538987;C0441471;C0439234;C4019010;C4048877;C4318503,false;false;false;false;true;false,396/10465
oxidative stress,C0242606,true,397/10465
age ( yrs ) < nmbr,C0001779;C0053917;C1334884,false;true;false,398/10465
no . of previous anti - tnf drugs — no . ( % ),C0205156;C1448177;C0013227;C3687832;C1552607,false;true;true;false;false,399/10465
< nmbr . nmbr mmol / liter apob : apoa - l ratio,C0053917;C1532563;C0475211;C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643;C1334884,true;false;false;true;true;false;false;false;false;false;true;false,400/10465
former smoker  n ( % ),C0337671,false,401/10465
less than nmbr %,C0439092;C0053917;C1334884,false;true;false,402/10465
hispanic ( n = nmbr ),C0086409;C0053917;C1334884,true;true;false,403/10465
ischemic tvr,C0475224,false,404/10465
any albuminuria — no . ( % ),C0001925,true,405/10465
baseline ics use  n ( % ),C0168634;C0815320;C4551720;C1442488,true;false;true;false,406/10465
bosentan ( n = nmbr ),C0252643;C0053917;C1334884,true;true;false,407/10465
nitrates ( oral or topical ),C0028125;C0699857;C3848573,true;false;false,408/10465
left - sided disease only,C3842976;C0012634,false;true,409/10465
third heart sound  n ( % ),C0232237;C0232278,false;false,410/10465
other antiarrhythmics^,C0003195,true,411/10465
psa duration  years,C3810537;C0449238;C0439234;C2926735;C3813209,false;false;false;false;false,412/10465
low molecular weight ( lmw ) heparin before randomisation,C0019139;C0034656;C3536766,true;true;false,413/10465
interval study drug to pci,C1272706;C0013175;C4049621;C1552654;C1552713,false;true;false;false;false,414/10465
atrial fibrillation / atrial flutter  %,C0155709,false,415/10465
anmbr + ez n = nmbr,C0206578;C0053917;C1334884,true;true;false,416/10465
initial aspirin — no . ( % ),C0205265;C0004057;C1279901;C1555582;C1705685,false;true;false;false;false,417/10465
symbol digit score,C0679214;C0582802;C0449820;C4050231;C3241971;C1698987,false;false;false;false;false;false,418/10465
time from qualifying event to randomization,C0040223;C1514624;C0441471;C4019010;C3541383,true;false;false;false;false,419/10465
serum hdl cholesterol ( mmol / l )  mean ( sd ),C0428472;C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,420/10465
pav  mean ( nmbr % ci ),C0058890;C0444504;C0053917;C0008107;C3259781;C1334884;C2347634;C2348143,true;false;true;true;false;false;false;false,421/10465
events treatment ( nmbr ),C0441471;C0039798;C0053917;C1334884;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3541888,false;true;true;false;true;false;false;false;false;false;false,422/10465
annt or bnnh ( nmbr % ci ),,,423/10465
geographic region  %,C0017446,true,424/10465
drug - related teaesnmbr,C0013227;C0439849;C0445223;C1254351,true;false;false;false,425/10465
atorvastatin dose,C0286651;C0178602;C0869039;C1114758,true;false;false;false,426/10465
ldl - cihdl - c  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,427/10465
prior biologic therapy ( including anti - tnfs ),C0278947,false,428/10465
left ventricular ejection fraction within previous nmbr mo |,C0428772;C0205156;C0053917;C0026544;C0332177;C1334884;C1552607;C0488728,false;false;true;true;false;false;false;false,429/10465
cabg or pci,C0010055,true,430/10465
ace inhibitor monotherapy,C0003015;C4541021,true;false,431/10465
treated with cabg — no . / total no . ( % ),C0332293;C0010055,false;true,432/10465
psoriatic arthritis pain],C4317006;C0003872;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;true;false;false;false;false;false;false;false;false,433/10465
erythrocyte sedimentation rate — mm / hr | |,C1176468;C4330985;C4554674;C1619634,false;false;false;true,434/10465
dose of aspirin,C4696290,false,435/10465
p - val . ( nmbr ),C0369773;C0042285;C0053917;C1334884;C0523975;C2603361,false;true;true;false;false;false,436/10465
small - artery occlusion ( lacune ),C0226001;C0001168;C0241970;C0011382;C0028778;C0441597;C1110554;C1947917;C0700321;C0264995,false;false;false;true;false;false;false;false;false;false,437/10465
atorvastatin  n ( % ),C0286651,true,438/10465
baseline heart rate,C0168634;C0018810;C1442488,true;true;false,439/10465
apo b ( mg / dl ) - mean ± sd,C0003593;C0439269;C0444504;C2699239;C2347634;C2348143;C3252643,true;false;false;false;false;false;true,440/10465
peak procedural act — sec,C0444505;C0025664;C0184661;C2700391;C3274430;C3538935;C3539779,false;true;true;false;false;false;false,441/10465
extended - duration enoxaparin  n / n ( % ),C0231448;C0449238;C0206460;C2926735;C0231449;C0439792,false;false;true;false;false;false,442/10465
total stent length,C0439175;C0038257;C1444754;C1706316;C0439810,false;true;false;false;false,443/10465
triglycerides  median ( range ),C0041004;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false;false;false,444/10465
efficacy,C1280519;C1707887,false;false,445/10465
non - stemi,C3537184,false,446/10465
mri substudy ( n = nmbr ),C0024485;C0053917;C1334884;C1824234;C3890166,true;true;false;false;false,447/10465
lv mass index ( g / mnmbr - nmbr ),C0455825;C0600653;C0439267;C0053917;C1334884;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;true;false;false;false,448/10465
all with coenzyme qnmbr ( n = nmbr  nmbr ),C0009235;C0053917;C1334884,true;true;false,449/10465
serum total cholesterol  mmol / l ( sd ),C0587184;C1532563;C2699239;C1287371,false;false;false;false,450/10465
visits nmbrenmbr,C0545082;C1512346,false;false,451/10465
week nmbr ( itt population ),C0332174;C0053917;C0032659;C1257890;C1334884;C0439230,false;true;true;true;false;false,452/10465
puerperium,C0034042;C0086839;C1879329,true;true;false,453/10465
gold group d — no . ( % ) | |,C0018026;C0441838;C1304897,true;false;false,454/10465
atv nmbr mg study protocol,C0210243;C0053917;C0024671;C1507394;C2348563;C2599718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0674679;C1145759;C1334862,true;true;true;false;false;true;true;false;false;false;false;false;false;true;true;false,455/10465
aml / val nmbr / nmbr mg,C0023465;C0042285;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0523975;C0023467,true;true;true;true;true;false;false;false;false;false;false;false;true,456/10465
median albumin / creatinine ratio ( g / mg ),C0549183;C0486293;C0439267;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1318293;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false;false;false;false,457/10465
smoking ( a ),C0037369;C0453996;C1881674,true;true;false,458/10465
tirofiban ( n = nmbr ),C0247025;C0053917;C1334884,true;true;false,459/10465
time from acs to randomization ( median  iqr ),C0040223;C0742343;C4318612;C3541383,true;true;false;false,460/10465
smoking pack - years,C0037369;C1277691;C0453996;C1881674,true;false;true;false,461/10465
serum creatinine > nmbr mmol / l  n ( % ),C0201976;C0053917;C1532563;C1334884;C0600061,false;true;false;false;false,462/10465
nonaspirin antiplatelet agent,C0722138;C0085826,false;true,463/10465
use of concomitant lipid - modifying therapy,C1524063;C1707479;C0023779;C0392747,false;false;true;false,464/10465
% stenosis  as assessed by investigator,C0678234;C1261287;C2632116,false;true;false,465/10465
parenteral anticoagulalion before randomization,C0030547;C0034656;C4522267,true;true;false,466/10465
lesions bnmbr / c,C0221198,false,467/10465
median fasting insulin ( iqr ) — pu per milliliter,C0549183;C0015663;C0021641;C0018387;C0439242;C1533581;C1579433;C3714501;C0876920;C2347635;C2348144;C2939193,false;true;true;true;false;false;false;false;false;false;false;false,468/10465
death or stent thrombosis,C0011065;C1306577;C4082313;C4552775,true;false;false;false,469/10465
measured at home with automated device,C0444706;C3541902,false;false,470/10465
atenolol *,C0004147,true,471/10465
neuropilin ( ng / ml ),C0287275;C0439275,true;false,472/10465
individuals with diabetes  n = nmbr,C0027361;C0011847;C0053917;C1334884;C0011849;C0237401,true;false;true;false;true;false,473/10465
basal insulin analogue : insulin,C0650607;C0243071;C0205112;C2825028,false;false;false;false,474/10465
mean pulse pressure  mmhg ( s . d . ) “,C0445074;C0232117;C2347155;C0391850;C1947910;C0444504;C0949236;C2347634;C2348143,false;true;false;false;false;false;true;false;false,475/10465
oral hypoglycemic drug,C0359086,false,476/10465
antihypertensive treatment,C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,477/10465
patients with > nmbr exacerbations resulting in hospital admission,C0030705;C0053917;C4086268;C1334884,true;true;false;false,478/10465
ranolazine ( n = nmbr  nmbr ),C0073633;C0053917;C1334884,true;true;false,479/10465
final timi flow grade post - ppci,C0205088;C3272266;C0441800;C0687676;C1704687;C3469826;C0919553;C3244287;C1546485;C3853528,false;false;false;false;false;false;false;false;false;false,480/10465
duration of disease  median,C0872146;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,481/10465
ace inhibitor or arb at enrollment,C0003015;C4541021,true;false,482/10465
psoriasis duration  yrs *,C0033860;C0449238;C2926735,true;false;false,483/10465
nmbr to < nmbr . nmbr %,C0053917;C1334884,true;false,484/10465
simvastatin monotherapy ( n = nmbr  nmbr * ),C0074554;C0053917;C1334884,true;true;false,485/10465
timi major bleeding,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,486/10465
small - artery occlusion,C0226001;C0001168;C0011382;C0028778;C0441597;C1110554;C1947917;C0700321;C0264995,false;false;true;false;false;false;false;false;false,487/10465
left ventricular hypertrophy — no . ( % ),C0149721;C3484363,true;false,488/10465
laboratory findings,C0587081,false,489/10465
crp  nmol / l  median ( range ),C3890735;C0439282;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false;false;false,490/10465
bivariate frailty model ( statin users vs non - users ),C0424594;C3161035;C0360714;C1706077;C3274659;C3714583;C3853906,true;false;true;false;false;false;false,491/10465
resection performed  %,C0015252;C0728940,false;false,492/10465
liraglutide nmbr . nmbr mg ls means ( n ),C1456408;C0053917;C0024671;C0023668;C1704970;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;true;false;false;false;false;false;false,493/10465
ada ifg,C1060325;C1334085;C1708411;C3811629,false;false;false;false,494/10465
median change  %,C0549183;C0392747;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,495/10465
sita nmbr + pio nmbr,C0053917;C0030800;C2347712;C1334884,true;true;false;false,496/10465
combined estimated gfr and albuminuria status,C0205195,false,497/10465
neoplasia,C0027651;C1882062,true;false,498/10465
venous graft,C0042449;C0181074;C0332835;C1961139;C0348013,true;false;true;false;false,499/10465
mean age  y  median ( range ),C0444504;C0001779;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false,500/10465
body - mass index ( kg / mj ) previous diagnosis,C0005893;C0022718;C0439254;C0332132;C4284025;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;true,501/10465
antihyperglycemic,C0020616,true,502/10465
duration of ra ( time from symptom onset )  years,C0449238;C3538806;C0040223;C3541383;C4048756;C2926735,false;false;true;false;false;false,503/10465
grouped region,C0439745;C0017446;C0205147;C4319846,false;true;false;false,504/10465
nitrate — no . ( % ),C0028125;C0699857;C3848573,true;false;false,505/10465
shs  mean nmbr sd,C0444504;C0053917;C2699239;C1334884;C2347634;C2348143,false;true;false;false;false;false,506/10465
oral antidiabetes monotherapya  n ( % ),C0442027;C4521986,false;false,507/10465
patients without ra  as  or psa ( n = nmbr  nmbr ),C0030705;C3538806;C4048756,true;false;false,508/10465
treatmentofpulmonary embolismpriorto randomization,C0034656,true,509/10465
renin - angiotensin inhibitors,C2917241;C0003018;C4521302;C3653375,false;true;false;false,510/10465
fevnmbr  litres ( post - salbutamol )  mean ( sd ),C0475211;C0687676;C0001927;C0444504;C2699239;C2347634;C2348143;C1704687;C3469826,false;false;true;false;false;false;false;false;false,511/10465
upper respiratory tract infection nmbr ( nmbr . nmbr ),C0041912;C0053917;C1334884,true;true;false,512/10465
age at diagnosis  y,C1828181;C3173302,false;false,513/10465
change in mtss ( mean ),C0392747;C0444504;C2347634;C2348143;C0443172;C1705241;C4319952,false;false;false;false;false;false;false,514/10465
aliskiren ( n = nmbr ),C1120110;C0053917;C1334884,true;true;false,515/10465
number of exacerbations in last nmbr months ,C0237753;C4086268;C0449788,false;false;false,516/10465
p  all vs all,C0369773;C2603361,false;false,517/10465
fasting plasma insulin — mu / liter,C0015663;C0857690;C0028971;C0475211;C0347978;C3714918,true;false;true;false;false;false,518/10465
baseline albumin / creatinine ratio in nmbr classes,C0168634;C0486293;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1318293;C1442488,true;false;true;false;false;false;false;false;false;false,519/10465
cvd risk factors ( age > nmbr ),C0007222;C0035648;C0001779;C0053917;C1334884;C1553898;C0035647;C0001783;C4552904,true;true;false;true;false;false;true;true;false,520/10465
former smoker ( n = nmbr ),C0337671;C0053917;C1334884,false;true;false,521/10465
prior use of biologics  n ( % ),C0332152;C1524063;C0005515;C0005522;C4553887;C2826257,false;false;true;true;true;false,522/10465
amlodipine nmbrmg / v = nmbr,C0051696;C0053917;C1334884,true;true;false,523/10465
moderate or less airflow limitation,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,524/10465
ethnic group — no . ( % ) ',C0015031;C1879937,true;false,525/10465
any event,C0441471;C4019010,false;false,526/10465
pain in extremity,C0030196;C4553007,false;false,527/10465
hospitalized for asthma  n ( % ) *,C0701159;C0004096;C2984299,false;true;false,528/10465
sex : male ( n = nmbr ),C0086582;C0053917;C1334884,true;true;false,529/10465
apolipoprotein b^,C0003593,true,530/10465
abnormal angiogram,C0205161;C0002978;C1548816;C3891555;C4255126;C2347472;C2699333,false;true;false;false;true;false;false,531/10465
three or more drugs,C0205449,false,532/10465
data missing,C1511726;C3245479;C3714741,false;false;false,533/10465
heart failure nyha ii - iii,C0018801;C1275491;C1710602;C0439070;C1705160;C4082587;C0018802;C4554158,true;false;false;false;false;false;true;false,534/10465
cerebrovascular disease  n ( % ),C0007820,true,535/10465
western europe hr ( nmbr % cl ),C0043129;C0053917;C0596019;C1334884,true;true;false;false,536/10465
biologic agents,C0005515,true,537/10465
ls mean difference ± seb,C0023668;C0444504;C1705241;C0059386;C1309881;C1423585;C3815268;C1705242;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false,538/10465
factor xa inhibitor,C2825027;C4553708,false;false,539/10465
mean bmi  kg / mnmbr ( s . d . ),C0444504;C0578022;C1275571;C2347634;C2348143,false;false;false;false;false,540/10465
anti - ischaemia agents *,C0040616;C0022116;C4321499,true;true;false,541/10465
exposure,C0274281;C0332157,false;false,542/10465
mycophenolate mofetil,C0209368,true,543/10465
age when diabetes first diagnosed — yr,C0001779,false,544/10465
randomization to placebo or telmisartan,C0034656;C0032042;C1696465;C1706408,true;true;false;false,545/10465
aspirin nmbr clopidogrel,C0004057;C0053917;C0070166;C1334884,true;true;true;false,546/10465
chd risk equivalents  n ( % ),C1282512;C0439185;C4049980,false;false;false,547/10465
systolic blood pressure [mmhg] ( interaction : p = nmbr . nmbr ),C0488055;C0439475;C1704675;C0053917;C1334884;C0871470;C1306620,false;false;false;true;false;true;false,548/10465
clinical history,C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,549/10465
ezetimibe + simvastatin ( n = nmbr * ),C1532737;C0053917;C1334884,true;true;false,550/10465
duration of psoriasis  years,C0449238;C0033860;C0439234;C2926735,false;true;false;false,551/10465
procedures for index event,C0025664;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C0184661;C2700391;C3538935,true;true;false;false;true;false;false;false;true;false;false,552/10465
killip class at admission — no . / total no . ( % ),C1881332;C0184666;C0809949,false;false;false,553/10465
other lipid parameters,C0023779;C0449381,true;false,554/10465
tc / hdl - c ratio,C0039411;C3715113;C0456603;C1547037;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;true;true;true;false;false;false,555/10465
ct or mr scan of the brain *,C0007673;C3540513;C3813556;C3888140,true;false;false;false,556/10465
peri - or postmenopausal,C0347985,false,557/10465
indeterminate or unknown,C0205258,false,558/10465
ratet ( nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,559/10465
> nmbr % stenosis of coronary  carotid  or lower extremity arteries,C0053917;C0242231;C0741968;C0018787;C0007282;C1334884,true;true;false;true;true;false,560/10465
atrial fibrillation / flutter  n ( % ),C0155709,false,561/10465
hypertension — no . ( % ) hypercholesterolemia — no . ( % ),C0020538;C1963138,true;false,562/10465
pulmonary disease,C0024115,true,563/10465
region of enrollment  n ( % ) +,C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,564/10465
baseline bmi nmbr to < nmbr kg / mnmbr  n = nmbr,C0168634;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false,565/10465
statin + ezetimibe  n ( % ),C0360714;C1142985,true;true,566/10465
ldl - c ( calculated ) *,,,567/10465
evaluable for acrnmbr at week nmbr  n,C1516986,false,568/10465
tertile nmbr ( nmbr . nmbr - nmbr . nmbr pg / ml ) n = nmbr,C0053917;C0439297;C1334884,true;false;false,569/10465
ez / simva n = nmbr n ( % ),C0206578;C0053917;C1334884,true;true;false,570/10465
event rates  %,C0441471;C0871208;C1521828;C4019010,false;false;false;false,571/10465
baseline nmbr - h ppg ,C0168634;C0053917;C0033727;C1418888;C0369286;C0441932;C0564385;C4528284;C1334884;C1442488,true;true;true;false;false;false;false;false;false;false,572/10465
nontrial ppi,C0358591;C0871125;C3811894,true;true;false,573/10465
cardiac resynchronization therapy,C1167956,true,574/10465
nyha class iii or iv ( n = nmbr ),C1882086,false,575/10465
oral agents use,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,576/10465
recurrent ischemia - urgent revascularization,C1455761;C0022116;C0439609;C0581603;C3272275;C4321499;C2945760,false;true;false;false;false;false;false,577/10465
rheumatoid factor positive §  n ( % ),C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,578/10465
serum pnmbrnp ( ^g / liter ),C0229671;C0439267;C0475211;C1546774;C1550100,true;false;false;false;false,579/10465
investigator - reported hypoglycaemia *,C0035173,true,580/10465
diuretic — no . / total no . ( % ),C0012798,true,581/10465
interleukin - nmbr ( ng / l ),C0021764;C0053917;C0439297;C1334884;C1527200,true;true;false;false;false,582/10465
non - caucasian eze / simva ( „ = nmbr },C1518422;C0007457;C0053917;C1334884;C0043157,false;true;true;false;true,583/10465
median ( qnmbr : qnmbr ) tgs,C0549183;C1156212;C1537574;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,584/10465
indacaterol nmbr ug versus indacaterol nmbr ug,C1722260;C0053917;C0041573;C0439211;C1334884,true;true;true;false;false,585/10465
score of > nmbr . nmbr — %,C0449820;C0053917;C1334884;C4050231,false;true;false;false,586/10465
weight  median ( nmbrth — nmbrth percentiles )  kg,C0552346;C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false,587/10465
nmbr - nmbr ( n = nmbr  nmbr ),C0053917;C1334884,true;false,588/10465
anti - cholinergics ( short - acting ) a,C0242896,true,589/10465
north america n z nmbr,C0028405;C0053917;C1334884,true;true;false,590/10465
diabetes durationa < median,C0011847;C0549183;C0876920;C2347635;C2348144;C2939193;C0011849,false;false;false;false;false;false;true,591/10465
discontinuations,C0457454,false,592/10465
available baseline blood specimen n,C0470187;C0168634;C0178913;C1442488,false;true;false;false,593/10465
quicki,,,594/10465
ratio of women to men — %,C0456603;C0043210;C1547037,false;true;false,595/10465
randomization to arterial sheath insertion,C0034656;C0003842;C0227952;C0021107;C0441587;C1512796;C1883719;C0221464,true;true;true;false;false;true;false;false,596/10465
p value versus placebo,C1709380,false,597/10465
history of cardiac arrhythmia,C3494593,false,598/10465
n analysed,C0369718;C0441922,false;false,599/10465
body mass  kg,C0518010;C0022718;C0439209;C4054209,false;true;false;false,600/10465
mean cdai score,C0444504;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false,601/10465
placebo plus aspirin,C0032042;C0332287;C0004057;C1696465;C1706408,true;false;true;false;false,602/10465
ii - iv ( % ),C1710602;C0022326;C4265176;C4082587,false;true;false;false,603/10465
previous bowel resection performed — no . of patients ( % ),C0205156;C0741614;C1552607,false;false;false,604/10465
left anterior descending  n ( % ),C0441998;C0205386;C1547177,false;false;false,605/10465
postmenopausal hormone use,C0232970;C0019932;C0042153;C0457083;C1947944;C4521914,false;true;true;false;false;false,606/10465
femoral neck,C0015815,true,607/10465
standard control ( n = nmbr ) no . of patients ( percent ),C1442989;C0243148;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389;C2828392,false;true;true;false;false;false;false;false;false;false,608/10465
other asian,C0078988,true,609/10465
measurements,C0242485,false,610/10465
antithrombotic / coagulant,C0009117,true,611/10465
myocardial infarction within the previous nmbr yr,C0027051;C0205156;C0053917;C0439234;C1334884;C1552607;C0428953;C2926063;C3810814;C4552959,true;false;true;false;false;false;false;false;false;false,612/10465
receiving concomitant nsaids and / or cox - nmbr inhibitors,C1514756,false,613/10465
b digit symbol substitution  omega - nmbr fatty acids vs placebo,C0582802;C0679214;C1555721;C1719844;C0053917;C0015684;C1334884;C1706204;C1698987;C3241971,false;false;false;false;true;true;false;false;false;false,614/10465
post - bronchodilator ratio of fevnmbr to fvc — %,C2599594;C0456603;C1547037,false;false;false,615/10465
statin with niacin,C0360714;C0027996;C1142562,true;true;false,616/10465
neither glucocorticoids nor immunosuppressive agents,C0017710;C3540777;C3540778,true;false;false,617/10465
anti - inflammatory drugs,C0003209,true,618/10465
i & ii : fevnmbr > nmbr % predicted,C0021966;C1710602;C0053917;C1334884;C4082587;C0221138,true;false;true;false;false;false,619/10465
interval clopidogrel to pci,C1272706;C0070166;C4049621;C1552654;C1552713,false;true;false;false;false,620/10465
procedure,C0184661;C2700391;C3274430;C3539779,true;false;false;false,621/10465
electrophysiological study — no . ( % ) weight — ibj,C0850293,false,622/10465
montelukast ( n = nmbr ),C0298130;C0053917;C1334884,true;true;false,623/10465
nmbr - h pmg ( mg / dl ),C0053917;C0033727;C0439269;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false;false,624/10465
phenytoin,C0031507;C0202454,true;false,625/10465
enact - nmbr trial rerandomization to natalizumab ( n = nmbr ),,,626/10465
nmbr bmi  kg / m,C0053917;C0578022;C1532718;C1334884,true;false;false;false,627/10465
baseline ldl cholesterol,C0168634;C0023824;C0202117;C1442488,true;true;false;false,628/10465
iglar ( insulin glargine lnmbr u ),C0907402;C0439148,true;false,629/10465
llv wlalil nmbr statin,C0053917;C0360714;C1334884,true;true;false,630/10465
number of prior csdmards  n ( % ),C0237753;C0332152;C2826257;C0449788,false;false;false;false,631/10465
efficacy and safety : net adverse clinical events *,C1280519;C1707887,false;false,632/10465
glucocorticoids and immunosuppressants,C0017710;C3540777;C3540778,true;false;false,633/10465
heart disease risk factors,C0741920,false,634/10465
statin use at baseline,C0360714;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,635/10465
current smoker : ex - smoker ( % ),C3173209;C3241966,false;false,636/10465
aspirin but no ppi,C0004057,true,637/10465
nsaid use — no . / total no . ( % ),C0003211;C3536840,true;false,638/10465
dx at presentation  n ( % ),C3538936;C0449450,false;false,639/10465
recent surgery or trauma,C0332185;C0038894;C0038895;C0543467;C1274039,false;false;true;true;true,640/10465
left anterior descending,C0441998;C0205386;C1547177,false;false;false,641/10465
ezetimibe nmbr mg + statin ( n = nmbr  nmbr ),C1142985;C0053917;C0024671;C0360714;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;true;false;false;false;false;false;false,642/10465
coumadin,C0699129,true,643/10465
device group,C1706365,false,644/10465
glargine,C0907402,true,645/10465
safety population  n ( % ),C0036043;C0032659;C1257890;C1705187,true;true;true;false,646/10465
pef  post - bronchodilator  % predicted normal,C0030771;C1518922;C1542834,true;false;false,647/10465
all randomized patients ( range ),C0034656;C0030705;C1514721;C2348147;C3542016;C3815594,true;true;false;false;false;false,648/10465
permanent,C0205355,false,649/10465
tocilizumab,C1609165,true,650/10465
nmbr = help needed  still independent,C0053917;C1334884,true;false,651/10465
non - metsyn,C1518422,false,652/10465
hemoglobin  g nmbr nmbr,C1319312;C0053917;C1334884,false;true;false,653/10465
level of renal impairment,C0441889;C1565489;C0456079;C1547707;C2946261,false;true;false;false;false,654/10465
soe or sue,,,655/10465
previous stroke ortransient ischaemic attack ( % ),C0205156;C0038454;C0745413;C4554100;C1552607,false;true;false;false;false,656/10465
clopidogrel / ticlopidine,C0070166;C0040207,true;true,657/10465
selexipag,C2000145,true,658/10465
mi type unknown ( % ),C3810814;C0332307;C1547052,false;false;false,659/10465
crohn ' s disease,C0010346,true,660/10465
high - sensitivity crp — mg / liter | |,C1441604;C3890735;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;false;true;false;true;false;false;false;false;false;false,661/10465
prior coronary revascularization,C0332152;C0877341;C2826257,false;false;false,662/10465
severe teaes,C0205082;C4050465;C4050466,false;false;false,663/10465
any statin + other llt,C0360714,true,664/10465
arb at last follow - up,C3888198;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,665/10465
ml without st - segment elevation !,C0439526;C0520886;C1705224;C3887665,false;false;false;false,666/10465
hydralazine,C0020223,true,667/10465
multivessel pci,C4049621,false,668/10465
oral anticoagulant — no . / total no . ( % ),C0354604,false,669/10465
notable abnormalities,C4288581;C0000768;C0000769,false;true;true,670/10465
contrast nephropathy risk score,C0009924;C0022658;C0035647;C0449820;C4050231;C4552904;C1979874,true;true;true;false;false;false;false,671/10465
aspirin at last follow - up,C0004057;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,672/10465
physical component,C0031809;C0449432;C1705248;C0205485;C1509143,true;false;false;false;false,673/10465
indacaterol nmbr gg qd,C1722260;C0053917;C0017454;C0332173;C0018370;C1334884,true;true;true;false;true;false,674/10465
elderly ( > nmbr years ),C0001792;C0053917;C0439234;C1334884;C1999167,true;true;false;false;false,675/10465
odds ratio versus placebo ( nmbr % ci ),C0028873,true,676/10465
geographic region - north america,C0017446;C0028405,true;true,677/10465
all patients with fistulas ( n = nmbr ),C0030705;C0016169;C0053917;C1334884,true;true;true;false,678/10465
fevnmbr / fvc ( post - albuterol ),C3714541,true,679/10465
prior medications,C0332152;C0013227;C0802604;C2598133;C4284232;C2826257,false;true;false;false;false;false,680/10465
location of ml,C0450429;C0439526;C1705224;C3887665;C1515974;C4284930;C4284931,false;false;false;false;false;false;false,681/10465
use of hormone replacement therapy ( a ),C1524063;C0282402,false;true,682/10465
versus tiotropium nmbr . nmbr pg,,,683/10465
prior coronary revascularization  n ( % ),C0332152;C0877341;C2826257,false;false;false,684/10465
duration of infusion — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,685/10465
beta - blocker at last follow - up |,C0001645;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,686/10465
rentrop score,C0449820;C4050231,false;false,687/10465
randomisation visit ( baseline ),C0034656;C0545082;C0168634;C1442488;C1512346;C2826704,true;false;true;false;false;false,688/10465
gastrointestinal area involved — no . / total no . ( % ),C0521362;C0017446;C0205146,false;true;false,689/10465
baseline pulmonary medication  n ( % ),C0168634;C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false,690/10465
median serum periostin  ng / mla,C0549183;C0229671;C0219433;C0017887;C0599973;C0028074;C1424662;C3812270;C1546774;C1550100;C0876920;C2347635;C2348144;C2939193,false;true;true;true;true;true;false;false;false;false;false;false;false;false,691/10465
multiple tnfi *,C0439064,false,692/10465
diet + pravastatin ( n = nmbr ),C0012155;C0085542;C0053917;C1334884;C0012159;C1519433;C2983588;C3668949,true;true;true;false;true;false;false;false,693/10465
prior coronary artery bypass graft surgery,C0332152;C0010055;C2826257,false;true;false,694/10465
c - peptide  median ( ql  qnmbr )  nmol / l,C0006558;C0549183;C0439282;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,695/10465
enoxaparin,C0206460,true,696/10465
vorapaxar placebo nmbr - yr %,C2974521;C0032042;C0053917;C0439234;C1334884;C1696465;C1706408,true;true;true;false;false;false;false,697/10465
missing data,C4684714,false,698/10465
risk reduction ( %  nmbr % ci ),C1137094;C0053917;C0008107;C3259781;C1334884,true;true;true;false;false,699/10465
fastest third,C0015663;C0205437;C0456962;C2985769,true;false;false;false,700/10465
gemfibrozil,C0017245,true,701/10465
chanmbrdsnmbr - vasc,,,702/10465
ezetimibe / simvastatin nmbr / nmbr mg ( n = nmbr ),C1532737;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,703/10465
( nmbr % ci] nmbr,C0053917;C0008107;C3259781;C1334884,true;true;false;false,704/10465
triglycerides mean ( mg / dl ± sd ),C0041004;C0444504;C0439269;C2699239;C2347634;C2348143,true;false;false;false;false;false,705/10465
incidence rate,C1708485,false,706/10465
urinary albumin / creatinine ratio  median mg / g ( range ),C0455271;C0549183;C1300563;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1318330,false;false;false;false;false;false;false;false;false;false;false,707/10465
minimum stent diameter,C4054490;C0038257,false;true,708/10465
nt - probnp pg / mla ( iqr ),C0669479;C0030827;C0599973;C0072225;C1266240;C0754710,true;true;true;true;false;true,709/10465
body mass index ( bmi )  kg / mnmbr,C0005893;C0578022;C0022718;C0439209;C4054209;C1305855,false;false;true;false;false;true,710/10465
diet plus pravastatin group ( n = nmbr ),C0012155;C0332287;C0085542;C0441848;C0053917;C1334884;C0012159;C1519433;C2983588;C3668949,true;false;true;false;true;false;true;false;false;false,711/10465
duration of clopidogrel pretreatment 一 hr median,C0449238;C0070166;C1550147;C0549183;C0876920;C2347635;C2348144;C2939193;C2709094;C3539075;C3539076;C2926735,false;true;false;false;false;false;false;false;false;false;false;false,712/10465
family history of coronary artery disease,C2317524,false,713/10465
sex  n ( % ) male,C0086582,true,714/10465
cv risk factor - no . ( % ),C3538987;C0035648;C4048877;C4318503,false;true;true;false,715/10465
valvular disease ( % ),C3258293,false,716/10465
no corticosteroid + no imm  n,C0001617;C3536709,true;false,717/10465
antimalarials only,C0003374;C0205171;C1720467,true;false;false,718/10465
tnl ultrapositive > nmbr . nmbr pg / l  nmbr = nmbr,C1540071;C0053917;C0439278;C1334884,false;true;false;false,719/10465
dactylitis count ( nmbr - nmbr )  mean ( sd ),C0239161;C0750480;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C1705566,false;false;true;false;false;false;false;false;false,720/10465
nasal polyps,C0027430,true,721/10465
verapamil sr n = nmbr,C1527129;C0053917;C1334884,false;true;false,722/10465
continued thienopyridine n ( % ),C0549178;C1120149,false;true,723/10465
disease - progression composite outcome !,C0679250;C0242656;C0205199;C1547335;C0449258;C3542417;C1274040;C1335499;C1947900;C4552808,false;true;false;false;false;false;false;false;false;false,724/10465
egfrmdrd < nmbr ml - min - nmbr - nmbr . nmbr m - nmbr  n ( % ),C0053917;C0439445;C0369637;C0441923;C1334884,true;false;false;false;false,725/10465
diarrhea,C0011991;C1963091;C3641756;C4084784;C4084802;C4085317,true;false;false;false;false;false,726/10465
uric acid ( mg / dl ),C0041980;C0439269,true;false,727/10465
pasi score  mean ± sd,C4528685;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,728/10465
theophylline compound,C0039771;C0205198;C1706082,true;false;false,729/10465
heterogeneity / trend test,C0019409;C1521798;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4554533;C0242960,false;false;false;false;false;false;false;false;false;false;true,730/10465
disease,C0012634,true,731/10465
hispanic / latin american,C0019576,true,732/10465
isolated pulmonary embolism,C0205409;C0034065;C1548221,false;true;false,733/10465
middle tertile ( range  nmbr . nmbr - nmbr . nmbr mg / dl  mean ± sd  nmbr . nmbr ± nmbr . nmbr mg / dl ),C0444598;C1514721;C0053917;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C2348147;C3542016;C0549183;C1552826,false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false,734/10465
total cholesterol ( mg / dl )  mean + sd  available for nmbr patients,C0201950;C0439269;C0444504;C2699239;C2347634;C2348143;C0543421,false;false;false;false;false;false;false,735/10465
geometric mean of baseline,C2986759;C0168634;C1442488,false;true;false,736/10465
baseline fvc  l,C0168634;C3714541;C1442488,true;true;false,737/10465
csf nmbrs - hydroxy -,C3540512;C0053917;C1334884;C3889436,false;true;false;false,738/10465
mean annualized exacerbation rate,C0444504;C4086268;C0871208;C1521828;C2347634;C2348143,false;false;false;false;false;false,739/10465
placebo no . / total ( % ),C0032042;C1696465;C1706408,true;false;false,740/10465
not reported / unknown,C1518422,false,741/10465
prior therapy with tnf antagonist  n ( % ),C1514463;C1448177;C0231491;C0332152;C0279936;C2826257,false;true;false;false;false;false,742/10465
difference from baselinea,C1705241;C1705242,false;false,743/10465
age at randomization ( years ),C1510829;C0034656,false;true,744/10465
never used lev,C2003901;C1273517;C0023556,false;false;true,745/10465
single vessel coronary artery disease *,C0581374,false,746/10465
non - sulfonylurea secretagogues,C1518422;C0038766;C4704833;C3536898,false;true;true;false,747/10465
index event asymptomatic or unconfirmed,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,748/10465
baseline medical therapy,C0168634;C0418981;C1442488,true;false;false,749/10465
prior corticosteroid failure only,C0332152;C0001617;C0231174;C0205171;C1720467;C0680095;C3536709;C2826257,false;true;false;false;false;false;false;false,750/10465
one or more blood pressure medications  n ( % ),C0205447,false,751/10465
evomab ( n = nmbr ),C0053917;C1334884,true;false,752/10465
baseline post - bronchodilator % predicted fev  < nmbr %,C0168634;C1442488,true;false,753/10465
cardiovascular hospitalization,C0007226;C0019993;C3887460,true;true;false,754/10465
crohn ' s disease activity index score],C0451071;C0449820;C4050231,false;false;false,755/10465
prior use of biologic agents,C0332152;C1524063;C0005515;C2826257,false;false;true;false,756/10465
relative risk reduction ( nmbr % cl ),C0242492;C0301630;C0053917;C0596019;C1334884;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039,true;false;true;false;false;false;false;false;true;true;false;false,757/10465
hbanmbrc distribution,C0520511;C1704711,false;true,758/10465
diuretic agent,C0012798;C0450442;C1254351;C1521826,true;false;false;false,759/10465
patients treated with insulin,C0030705,true,760/10465
estimated gfr ( ml / min / nmbr . nmbr mnmbr ) ^ |,C0750572;C0017654;C0439445;C0053917;C1334884;C1424601,false;true;false;true;false;false,761/10465
nmbr - aminosalicylic compounds — no . ( % ),C0053917;C0205198;C1706082;C1334884,true;false;false;false,762/10465
iwqol - lite physical score ( arbitrary units ),C4483112;C0439183,false;false,763/10465
bdi total score ( baseline ),C0006448;C2964552;C0168634;C1442488;C0451022;C3714938;C3889415,true;false;true;false;false;false;false,764/10465
estimated * creatinine clearance < nmbr mlvmin  %,C0750572;C0812399;C0053917;C1334884,false;false;true;false,765/10465
low - density lipoprotein cholesterol  %,C0023824,true,766/10465
education  high school or higher,C0683862,false,767/10465
partial mayo clinic scored,C0728938;C0454788;C0002424;C0442592;C1077578;C1550516,false;false;true;false;false;false,768/10465
prior lipid - modifying therapy,C1514463;C0023779;C0392747,false;true;false,769/10465
cv risk factor,C3538987;C0035648;C4048877;C4318503,false;true;true;false,770/10465
mets w / o tnmbrdm,C0812270;C1705694;C2939420,false;false;false,771/10465
other countries,C0454664,false,772/10465
smoking history — no . ( % ),C1519384,false,773/10465
other vascular disease — no . ( % ),C0042373,true,774/10465
mean — g / dl,C0444504;C0439267;C2347634;C2348143,false;false;false;false,775/10465
outcome,C1274040,false,776/10465
ccbs  ( % ),C0006684,true,777/10465
sfc nmbr / nmbr | ig bid n = nmbr,C4521536;C0053917;C0021027;C0305052;C0360506;C1334884,false;true;true;false;false;false,778/10465
cangrelor  %,C1121991,true,779/10465
losartan n = nmbr,C0126174;C0053917;C1334884,true;true;false,780/10465
laba + ics,C0815320;C4551720,false;true,781/10465
short - acting anticholinergics,C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;true;false;false;false;true;false;false;false;false,782/10465
> nmbr vessels with > nmbr % stenosis,C0053917;C0679403;C1334884,true;false;false,783/10465
concomitant antihyperglycaemic drugs  n ( % ),C0521115;C0020616;C0013227;C3687832,false;true;true;false,784/10465
losmapimod,C3272847,true,785/10465
history of myocardial infarction ( % ),C1275835,false,786/10465
nmbr - nmbr with cv disease ( n = nmbr ),C0053917;C0007222;C1334884,true;true;false,787/10465
severely impaired,C0205082,false,788/10465
estimated creatinine clearance < nmbr ml / min *,C0750572;C0812399;C0053917;C0439445;C1334884,false;false;true;false;false,789/10465
anticyclic citrullinated peptide positive^  n ( % ),C1320283;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,790/10465
wrist fracture,C0435630;C4553927,false;false,791/10465
mtx exposure ( mg / week ),C0025677;C0274281;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0332157;C1417487,true;false;true;false;false;true;false;false;false;false;false;false;false,792/10465
ischaemic  n ( % ),C0475224,false,793/10465
atenolol n = nmbr no . ( % ),C0004147;C0053917;C1334884,true;true;false,794/10465
vascular disordersb,C0005847;C1558950;C1801960,true;false;false,795/10465
adjusted mean change from baseline ( nmbr % ci )  % [mmol / mol],C0456081;C0444504;C0392747;C0168634;C0053917;C0008107;C3829066;C3259781;C1334884;C1442488;C0443172;C1705241;C4319952;C0439190;C0948922;C2347634;C2348143,false;false;false;true;true;true;false;false;false;false;false;false;false;false;false;false;false,796/10465
< nmbr . nmbr mmol / liter triglyceride level,C0053917;C0439190;C0475211;C0428475;C1334884,true;false;false;false;false,797/10465
previous myocardial infarction — no . ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,798/10465
time since diagnosis of diabetesa  n ( % ),C0040223;C3541383,true;false,799/10465
fevnmbr / fvc  %  mean ( sd ) nmbr,C3714541;C0444504;C2699239;C0053917;C1334884;C2347634;C2348143,true;false;false;true;false;false;false,800/10465
> nmbr . nmbrmmol / l ( n = nmbr ),C0053917;C1334884,true;false,801/10465
serum albumin  g / dl,C0036773;C0439267;C0728877,true;false;false,802/10465
classification of af  no . ( % ),C0008902;C0344434;C4049859;C0008903;C0678229,true;false;false;true;false,803/10465
age at screening,C0001779;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,804/10465
change in sbp ( nmbr months ),C0392747;C0085805;C0053917;C0439231;C1334884;C0443172;C1705241;C4319952,false;true;true;false;false;false;false;false,805/10465
bronchitis,C0006277,true,806/10465
left ventricular ef  mean ( sd )  %,C0225897;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,807/10465
pdenmbr inhibitor monotherapy,C1999216,false,808/10465
ischemic heart disease  %,C0010054;C0151744,true;true,809/10465
neither pbo + statin eze + statin,C0031962;C0360714,true;true,810/10465
impaired fasting glucose level ( n = nmbr ),C1272092;C0441889;C0053917;C1334884;C0456079;C1547707;C2946261;C0221099;C0202045,false;false;true;false;false;false;false;false;false,811/10465
cancer ( n = nmbr ),C0006826;C0053917;C1334884;C0998265;C1306459,true;true;false;false;false,812/10465
selected clinical characteristics  n ( % ),C1707391;C0683325,false;false,813/10465
lumbar spine,C0024091;C3887615,true;false,814/10465
reversibility of fevnmbr ( % ),C0449261,false,815/10465
missing data — no . / total no . ( % ),C4684714,false,816/10465
insulin ( pmol / l ) t vital signs,C0021641;C0439284;C0150404;C0518766;C1533581;C1579433;C3714501,true;false;false;true;false;false;false,817/10465
glucose - lowering therapies,C0017725;C0441994;C0087111;C2003888,true;false;true;false,818/10465
baseline heart failure severity nyha class i,C0168634;C0018801;C0439793;C1882084;C0522510;C0018802;C4554158;C1442488,true;true;false;false;false;true;false;false,819/10465
selected baseline medications,C1707391;C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,false;true;true;false;false;false;false,820/10465
endovascular — no . ( % ),C0524425,false,821/10465
aspirin - erdp ( n = nmbr  nmbr ),C0004057;C0053917;C1334884,true;true;false,822/10465
previous treatment with tnf antagonist — no . ( % ) §,C0205156;C0039798;C1448177;C0231491;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;true;false;false;false;false;false;false,823/10465
zotarolimus - eluting,C1700035,true,824/10465
change in nt - probnp at nmbr months ( log - transformed ),C0392747;C0669479;C0754710;C0443172;C1705241;C4319952,false;true;true;false;false;false,825/10465
low - molecular - weight,C0041667;C1521991;C0205251;C0026385;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;true;false;false;false;false;false,826/10465
heart rate ( b . p . m . )  mean ± sd,C0018810;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923,true;false;false;false;false;false;false,827/10465
vorapaxar group ( n = nmbr ),C2974521;C0441848;C0053917;C1334884,true;false;true;false,828/10465
glucose test,C0337438;C0595310,false;false,829/10465
number of concomitant aeds  n ( % ),C0237753;C0521115;C0180309;C0449788,false;false;true;false,830/10465
mean number of exacerbations ( per patient - year [nmbr % ci] ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,831/10465
use nmbr - asa compounds,C0042153;C0053917;C0004057;C0205198;C1706082;C3853627;C1334884;C0457083;C1947944,true;true;true;false;false;false;false;false;false,832/10465
glycemic drugs,C0005802;C0013227;C3687832,true;true;false,833/10465
balloon angioplasty — no . ( % ),C0002996;C0002997,true;true,834/10465
prior history of cardiovascular disease  n ( % ),C0332152;C0455539;C2826257,false;false;false,835/10465
accp bleeding risk at inclusion  no . ( % ) f,C3251812;C0007637;C1512693,false;true;false,836/10465
angina pectoris — no . ( % ),C0002962,true,837/10465
history of systemic hypertension,C0455527;C0205373,false;false,838/10465
angiography — no . ( % ),C0002978,true,839/10465
prasugrel,C1620287,true,840/10465
cardiovascular disease,C0007222,true,841/10465
prior congestive heart failure,C0332152;C0018802;C2826257,false;true;false,842/10465
post - bronchodilator reversibility fevnmbr ( % ) mean ( sd ),C2599594;C0449261;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,843/10465
diabetes therapy  n ( % ),C3274787;C3539002,false;false,844/10465
low - dose aspirin use at baseline yes,C2608320;C0042153;C0168634;C1549445;C1705108;C1710701;C1442488;C0457083;C1947944,false;true;true;false;false;false;false;false;false,845/10465
medication at enrollment — no . ( % ),C0013227;C1516879;C1696073;C3888021;C3244316;C4284232,true;false;false;false;false;false,846/10465
age  yrs  median ( nmbrth  nmbrth ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,847/10465
no . of predictors of cardiovascular risk,C2698872;C0007226;C0035647;C4552904;C3887460,false;true;true;false;false,848/10465
mean ( s . d . ) free pcsknmbr  ng / ml,C0444504;C0332296;C0439275;C1880497;C1996904;C2347634;C2348143,false;false;false;false;false;false;false,849/10465
enrollment in lmwh,C1516879;C0019139;C3536766;C1696073;C3888021,false;true;false;false;false,850/10465
coronary angiography during the index hospital stay,C0085532;C0600653;C3489408;C0918012;C1552854;C1637833;C2986546;C1548829;C0428776;C0002978,true;true;true;true;false;false;false;false;false;true,851/10465
primary pci ( n = nmbr ),C0205225;C4049621;C0053917;C1334884;C0439612;C0439631,false;false;true;false;false;false,852/10465
versus tiotropium + olodaterol nmbr . nmbr / nmbr pg,,,853/10465
long - acting or short - acting nitrates,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,854/10465
cardiovascular and respiratory,C0007226;C3887460,true;false,855/10465
hispanic ethnic group — no . ( % ) f,C0086409;C0015031;C1879937,true;true;false,856/10465
placebo  n ( rate ),C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,857/10465
calcium antagonists  n ( % ),C0006684,true,858/10465
egfr  ml / min / mnmbr,C1739039;C0439445;C3811844;C3812682,true;false;false;false,859/10465
lipid lowering medication use,C0023779;C0441994;C0240320;C2003888,true;false;false;false,860/10465
opg  ( ng / ml ),C1262886;C0439275;C1336645;C1412836;C1710303,false;false;false;false;false,861/10465
final timi flow,C0205088;C3272266;C1546485;C3853528,false;false;false;false,862/10465
patient ' s global assessment of disease activity  mean ( sd ),C4054228;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,863/10465
with revascularisation,C0581603,false,864/10465
antihypertensive medication or,C0003364,true,865/10465
level nmbr immobility § | |,C0441889;C0053917;C0231441;C1334884;C0456079;C1547707;C2946261,false;true;false;false;false;false;false,866/10465
serum creatinine  limo nmbr nmbr,C0201976;C0053917;C1334884;C0600061,false;true;false;false,867/10465
central / eastern europe / russia,C0682369;C1707877;C0035970;C0205099;C0015177;C1879652,false;false;true;false;true;false,868/10465
role physical,C0035820;C0031809;C0205485;C1509143;C1705810;C3871154,true;true;false;false;false;false,869/10465
hbanmbrc category  n ( % ),C0683312;C3889287,false;false,870/10465
not reported in ecrf,C1518422,false,871/10465
beta - blockers ( all )  n ( % ),C0001645,true,872/10465
laba users,C1706077,false,873/10465
creatinine clearance at admission ( ml / min ),C0184666;C0151280;C0809949,false;false;false,874/10465
egfr nmbr - nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr  nmbr ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,875/10465
other anticoagulant,C0003280;C0848112;C3536711,true;false;false,876/10465
severe impairment ( < nmbr ),C0205082;C0221099;C0053917;C1334884;C0684336;C4050465;C4050466,false;false;true;false;false;false;false,877/10465
pre - bronchodilator fevnmbr ( % predicted normal ),C2599602,false,878/10465
insulin + oad,C0021641;C1533581;C1579433;C3714501,true;false;false;false,879/10465
clopidogrel ( n = nmbr ),C0070166;C0053917;C1334884,true;true;false,880/10465
first - generation stentt,C0205435;C0079411;C3146294;C1279901,false;true;false;false,881/10465
crp  mg / l : median ( range ),C3890735;C0439268;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false;false;false,882/10465
least square mean ( se ),C0023189;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,883/10465
preoperative heart rate ( beats per minute ),C0445204;C0018810,false;true,884/10465
angiography during index hospitalization,C0002978;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,885/10465
allhat - llt,C2347090,false,886/10465
prior cardiovascular event — no . ( % ) - j -,C0332152;C1320716;C2826257,false;false;false,887/10465
baseline killip class,C0168634;C1881332;C1442488,true;false;false,888/10465
score on modified rankin scale — no . ( % ) §,C0449820;C2984908;C3854213;C4050231,false;false;false;false,889/10465
energy / fatigue,C0424589;C0015672;C3463815;C4050243;C4554645;C0542479;C1442080;C4330907,false;true;false;false;false;false;false;false,890/10465
atrial flutter,C0004239;C0344423;C1963068,true;false;false,891/10465
subjects randomized,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,892/10465
active a,C0205177;C3853793;C3888249,false;false;false,893/10465
rec . ischemia leading to hasp,C1424025;C0022116;C4321499;C2606415,false;true;false;true,894/10465
history of cabg surgery  n ( % ),C0455610;C0010055,false;true,895/10465
western europe and other,C0043129,true,896/10465
qualifying mi type,C1514624;C3810814;C0332307;C1547052,false;false;false;false,897/10465
potassium - sparing at last follow - up,C0032821;C0589120;C1522577;C1704685;C3274571;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false,898/10465
congestive heart failure  n ( % ),C0018802,true,899/10465
score distribution : < nmbr,C0449820;C0520511;C0053917;C1334884;C1704711;C4050231,false;false;true;false;true;false,900/10465
candesartan nmbr / nmbr,C0717550;C0053917;C1334884,true;true;false,901/10465
planned treatment strategy,C0599880;C0679199,false;false,902/10465
/ ’ - valuenmbr ’,,,903/10465
parental history of myocardial infarction before nmbr yr of age ( % ),C0030551;C1275835,true;false,904/10465
hbanmbrc distribution at baseline  n ( % ),C0520511;C0168634;C1442488;C1704711,false;true;false;true,905/10465
change in haq - di ( mean ) t,C0392747;C3826998;C0444504;C2347634;C2348143;C4321476;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false;false,906/10465
normoalbuminuria at baseline ( nmbr % of patients treated ),C0168634;C0053917;C0030705;C1334884;C1442488,true;true;true;false;false,907/10465
previous deep - vein thrombosis or pulmonary embolism,C0205156;C0149871;C1552607,false;true;false,908/10465
placebo mean ( n ),C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false,909/10465
previous coronary revascularization — no . ( % ),C0205156;C0877341;C1552607,false;false;false,910/10465
medical history and risk factors — no . ( % ),C0262926;C1704706,false;false,911/10465
rankin grade,C0441800;C0919553;C3244287,false;false;false,912/10465
previous heart failure,C0205156;C0018801;C0018802;C4554158;C1552607,false;true;true;false;false,913/10465
ptca or pci,C2936173,true,914/10465
inflammatory disease,C1290884,false,915/10465
exacerbations,C4086268,false,916/10465
statin ( open ),C0360714,true,917/10465
glyburide ( n = nmbr ),C0017628;C0053917;C1334884,true;true;false,918/10465
history of cardiovascular disease — no . ( % ) ^ |,C0455539,false,919/10465
heart failure — no . ( % ),C0018801;C0018802;C4554158,true;true;false,920/10465
normoglycemicnmbr,,,921/10465
fevi  % predicted  mean ( sd ) nmbr,C0849974;C1561566;C4528367,false;false;false,922/10465
cardiac failure  n ( % ),C0018801;C0018802,true;true,923/10465
previous vascular disease,C0205156;C0042373;C1552607,false;true;false,924/10465
ethnic origin  n ( % ),C0015031,true,925/10465
abatacept monotherapy ( n = nmbr ),C1619966;C0053917;C1334884,true;true;false,926/10465
calcium channel antagonists  n ( % ),C0006684;C2757014,true;false,927/10465
high potencyc,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,928/10465
ra symptom duration — year,C3538806;C1457887;C0449238;C0439234;C0439508;C2926735;C3854129;C4048756,false;false;false;false;false;false;false;false,929/10465
previous myocardial infarction ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,930/10465
post - bronchodilator fvc ( l ) a,C2599594;C3714541,false;true,931/10465
moderate risk,C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,932/10465
< nmbr . nmbr mm hg diastolic blood pressure,C0053917;C0439475;C0428883;C1305849;C1334884,true;false;true;false;false,933/10465
nmbr mg cohort,C0053917;C0024671;C0009247;C0599755;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,934/10465
exercise times per week  ( minimum,C0015259;C0456698;C1524031;C1552614;C2826545;C1522704,true;false;false;false;false;false,935/10465
other ( nmbr . nmbr % ) t,C0053917;C1334884,true;false,936/10465
medical conditions  no . ( % ),C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,937/10465
smoking status at screening  n ( % ),C1519386;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0037369;C0421330;C0453996;C1881674,false;true;true;false;false;false;false;false;true;false;true;false,938/10465
low - dose rivaroxaban + aspirin ( n / n ),C2608320;C1739768,false;true,939/10465
revascularization,C0581603,false,940/10465
hoehn and yahr stage ( range  nmbr - nmbr ),C0205390;C1514721;C0053917;C1334884;C2348147;C3542016;C1300072;C1306673,false;false;true;false;false;false;false;false,941/10465
blood leukocyte count ( nmbr cells per l ),C0023508;C0053917;C0347983;C1334884;C0023516;C0427512,true;true;false;false;true;false,942/10465
low risk and fewer symptoms ( group a ),C3272281;C3538919,false;false,943/10465
alt and / or ast > nmbr times uln consecutive #,C1266129;C4553172,false;false,944/10465
nmbr yr km % ( n ),C0053917;C0439234;C3887676;C1334884,true;false;false;false,945/10465
history of symptomatic,C0019664;C0231220;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,946/10465
time of symptom onset to balloon inflation ( hrs ),C1320528,false,947/10465
statin potency stratum  n ( % ),C0360714;C3245505,true;false,948/10465
no dysglycaemia or mets,C1960636,false,949/10465
weight $ nmbr . nmbr kg  < nmbr . nmbr kg  n,C0005910;C0053917;C1319635;C1334884;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,950/10465
race or ethnic group,C0034510;C1706779;C3853635,true;false;false,951/10465
moderate impairment ( nmbr to < nmbr ),C0205081;C0221099;C0053917;C1334884;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false,952/10465
ascvd including tia,C3665365,false,953/10465
receiving concomitant corticosteroids,C1514756,false,954/10465
laba + ics ( free or fixed - dose combination ),C0815320;C4551720,false;true,955/10465
fc - ldl - c  friedewald - calculated,C2983605,false,956/10465
egfr nmbr - nmbr ml / min / nmbr . nmbrmnmbr n = nmbr ( nmbr . nmbr % ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,957/10465
receptor blockers  n ( % ) baseline lipid and apolipoprotein levels,C0597357;C0168634;C0023779;C1442488,false;true;true;false,958/10465
hyperkalemia ( > nmbr . nmbr meq / l ),C0020461;C0053917;C0439375;C1334884;C4552983,true;true;false;false;false,959/10465
region of enrollment  no . ( % ),C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,960/10465
mean score on haq - di §,C3533236;C3826998;C4321476,false;false;false,961/10465
medications at randomization,C0013227;C0034656;C0802604;C2598133;C4284232,true;true;false;false;false,962/10465
nmbr  nmbr / nmbr  nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,963/10465
history of cardiovascular disease,C0455539,false,964/10465
> nmbr yr warfarin experience,C0053917;C0439234;C0043031;C0237607;C0596545;C1334884,true;false;true;false;false;false,965/10465
intervention in complex lesions,C1292781;C0221198,false;false,966/10465
peak creatine kinase - mb  u / l,C0444505;C0010290;C0439339;C0523584,false;true;false;false,967/10465
secondary ( change in total updrs score from baseline to final visit in phase nmbr ),C0027627;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0175668;C0205436,true;false;false;true;false;false;false;false;false;false,968/10465
leflunomide ( mean dose : nmbr . nmbr mg / day ),C0063041;C0444504;C0178602;C0053917;C0439422;C1334884;C0869039;C1114758;C2347634;C2348143,true;false;false;true;false;false;false;false;false;false,969/10465
antithrombotic agents  n ( % ),C1704311,true,970/10465
leisure,C0086542,true,971/10465
angiotensin receptor blocker and / or ace,C0034787;C1622222,true;true,972/10465
type of treatment  n ( % ),C0455708,false,973/10465
pancreatic cancer,C0235974;C0346647;C2984259,true;true;false,974/10465
mean iglar dose ± sd ( u / day ),C0444504;C0178602;C2699239;C0456683;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false;false;false,975/10465
int . p *,C3272375,false,976/10465
hawaiian / pacific,C0337920,true,977/10465
aspirin at any dose,C4696290,false,978/10465
baseline fpg ,C0168634;C1442488,true;false,979/10465
crp ( mg / l ) : < nmbr,C3890735;C0439268;C0053917;C1334884;C4048285,false;false;true;false;false,980/10465
large - artery atherosclerosis,C0226003;C0003850;C0004153,false;true;true,981/10465
antihyperglycemic medication usage,C0020616;C0013227;C0457083;C3244316;C4284232,true;true;false;false;false,982/10465
carotid,C0741968,false,983/10465
western european includinq australia  israel  and south africa,C0043128;C0239307;C0022271;C1535514;C0239312;C0004340,true;false;true;false;false;true,984/10465
low density lipoprotein cholesterol  mg / dl * *,C0023824;C0439269,true;false,985/10465
blood eosinophil count ( nmbr cells per l ),C0200638;C0053917;C1334884,false;true;false,986/10465
egfr < nmbr ml / min / nmbr . nmbr mnmbr ( mdrd ),C1739039;C0053917;C0439445;C3839656;C1334884;C3811844;C3812682,true;true;false;false;false;false;false,987/10465
placebo n = nmbr subjects,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,988/10465
treatment with candesartan,C0039798;C0717550;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,989/10465
hbanmbrc nmbr - < = nmbr %,C0053917;C1334884,true;false,990/10465
eze / simva nmbr / nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,991/10465
pulmonary rales,C0034642,true,992/10465
loop at last follow - up,C0445022;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,993/10465
modified rankin scale score,C2984908;C0449820;C4050231;C3854213,false;false;false;false,994/10465
qualifying event — no . ( % ),C1514624;C0441471;C4019010,false;false;false,995/10465
claudication ( fontaine class > nmbr ),C0021775;C0456387;C0053917;C1334884;C1518526;C1705943;C0311395;C1456822,true;false;true;false;false;false;false;false,996/10465
steroid use at baseline  n ( % ),C0281991;C0168634;C1442488,false;true;false,997/10465
metabolic syndrome ( > nmbr of nmbr characteristics ),C0524620;C0053917;C1521970;C1334884,true;true;false;false,998/10465
killip class,C1881332,false,999/10465
respiratory medication ( % ),C0418986,false,1000/10465
concomitant lipid - lowering therapy  n ( % ),C0521115;C0585943,false;false,1001/10465
duration of tnmbrdm,C0449238;C2926735,false;false,1002/10465
egfr  ml min nmbr nmbr . nmbr m nmbr,C1739039;C0439445;C0053917;C0369637;C0441923;C1334884;C3811844;C3812682,true;false;true;false;false;false;false;false,1003/10465
smoking status ( % ),C1519386,false,1004/10465
bare - metal stent — no . ( % ),C2825200,false,1005/10465
rate / nmbr patient - years,C0871208;C0053917;C0030705;C0439234;C1334884;C1521828,false;true;true;false;false;false,1006/10465
> nmbr servings / wk ( n = nmbr ),C0053917;C1519269;C0332174;C0439230;C1334884,true;false;false;false;false,1007/10465
key secondary end point : st,C4528314;C0036056;C3272372,false;true;false,1008/10465
no . of risk factors ( % ) | |,C0035648;C1553898,true;false,1009/10465
prior antihypertensive medication  n ( % ),C0332152;C0003364;C2826257,false;true;false,1010/10465
mean yearly decline,C0444504;C2347634;C2348143,false;false;false,1011/10465
standard therapy,C2936643,true,1012/10465
phosphorus  mmol nmbr nmbr,C0031705;C0439190;C0053917;C1334884;C0080014;C3714498,true;false;true;false;true;false,1013/10465
lipid levels — mg / dl,C0428460;C0439269,false;false,1014/10465
smoking habit  n ( % ),C4505437,true,1015/10465
open triple ( n = nmbr ),C0175566,false,1016/10465
no prior hf hospitalization ( n = nmbr  nmbr ),C0332152;C0018488;C0019993;C0053917;C1334884;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;true;false;false;false,1017/10465
glyburide,C0017628,true,1018/10465
mean ( sd ) extent of exposure  days,C0444504;C2699239;C0439792;C0274281;C0439228;C0332157;C2347634;C2348143,false;false;false;false;false;false;false;false,1019/10465
triple therapy use at screening  n ( % ),C2121434;C0039798;C0042153;C0457083;C1947944;C0087111;C1363945,false;true;true;false;false;true;false,1020/10465
europe nmbr ( n = nmbr ),C0015176;C0053917;C1334884,true;true;false,1021/10465
ankle - brachial index < nmbr . nmbr — no . ( % ),C1328319;C0053917;C1334884;C3888326,true;true;false;false,1022/10465
number of subjects,C0237753;C0681850;C1550501;C1706203;C2349001;C2697811;C0449788,false;false;false;false;false;false;false,1023/10465
fasting insulin,C0015663;C0021641;C1533581;C1579433;C3714501,true;true;false;false;false,1024/10465
ace - i or arb use,C1452534;C0021966;C0221138;C4284014,true;true;false;false,1025/10465
pfo closure group ( n = nmbr ),C0185003;C0441848;C0053917;C1334884;C1521802,false;false;true;false;false,1026/10465
median ( qnmbr : qnmbr ) duration of insulin use  years,C0549183;C1881378;C0021641;C0439234;C1533581;C1579433;C3714501;C2826775;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false;false,1027/10465
control group ( n = nmbr ),C0243148;C0441848;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;true;false;false;false;false;false;false,1028/10465
normal troponin,C0205307;C0041199;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false,1029/10465
ind / glynmbr / nmbr pg o . d . n = nmbr,C4049864;C0053917;C2827928;C1334884,false;true;false;false,1030/10465
traditional chinese medicine for respiratory disease — no . ( % ),C0025124;C0035204;C0035242;C1515884,true;true;true;false,1031/10465
baseline copd exacerbation history  * n ( % ),C0168634;C0740304;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1442488,true;false;true;true;false;false;false;false;false,1032/10465
european union,C0015179,true,1033/10465
blood pressure - lowering treatment,C0596197;C0033095;C0441994;C2003888;C0460139;C1306345;C4284008;C0005823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1271104;C1272641,false;true;false;false;false;false;false;true;true;true;false;false;false;false;false;false;true,1034/10465
ezetimibe,C1142985,true,1035/10465
fish oil,C0016157,true,1036/10465
cardiovascular inclusion criteriat,C0007226;C0007637;C1512693;C3887460,true;true;false;false,1037/10465
median duration of study - drug administration,C0549183;C2348354;C0013175;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false,1038/10465
psoriasis body surface area > nmbr %,C0033860;C0005902;C0053917;C1334884,true;true;true;false,1039/10465
exenatide,C0167117,true,1040/10465
cardiovascular risk factors — no . / total no . ( % ),C0850624,false,1041/10465
( nmbr % ci ) p value,C0053917;C0008107;C1709380;C3259781;C1334884,true;true;false;false;false,1042/10465
time from symptom onset to randomization,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,1043/10465
percentage difference ( nmbr % cl ),C0439165;C1705241;C0053917;C0596019;C1334884;C1705242;C1549488;C1561533,false;false;true;false;false;false;false;false,1044/10465
fpg ( mmol / l )  mean ( sd ) 、,C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,1045/10465
apo anmbr ( g / l ),C0439294;C0456615,false;false,1046/10465
fibrinolysis ( n = nmbr ),C0016017;C0053917;C1334884;C1305868,true;true;false;false,1047/10465
ticagrelor nmbr mg vs . placebo hr ( nmbr % ci ),C1999375;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1048/10465
combined n = nmbr,C0205195;C0053917;C1334884,false;true;false,1049/10465
simplified disease activity index,C3869582,false,1050/10465
ratio of ldl to hdl,C0456603;C1547037,false;false,1051/10465
st ( arc definite only ),C0036056;C0439544;C0205171;C1720467;C1704787;C3272372,true;false;false;false;false;false,1052/10465
duration of diabetes mellitus  y,C0449238;C0011849;C2926735,false;true;false,1053/10465
sex  male / female  %,C0086287;C0086582;C1706180;C1706428;C1706429;C0043210;C1705497;C1705498,true;true;false;false;false;true;false;false,1054/10465
total study population ( n = nmbr  nmbr ),C3258257;C0557651;C0053917;C1334884;C2603343;C0439175;C2348561;C0439810,false;false;true;false;false;false;false;false,1055/10465
sita / pio nmbr / nmbr,C0030800;C0053917;C1334884;C2347712,true;true;false;false,1056/10465
blood eosinophils count,C0014467,true,1057/10465
who / idf ifg,C1334085;C1708411,false;false,1058/10465
cardiovascular history 一 no . ( % ),C1880008,false,1059/10465
ace inhibitor at last follow - up,C0003015;C0589120;C1522577;C1704685;C3274571;C4541021,true;false;false;false;false;false,1060/10465
prior cardiac surgery  n ( % ),C0455610;C0018787;C1522601;C0332152;C0018821;C0524727;C2826257,false;true;false;false;true;true;false,1061/10465
ischemic aetiology  n ( % ),C0475224;C0015127;C1314792;C1524003,false;true;true;false,1062/10465
placebo nmbr year km ( % ),C0032042;C0053917;C0439234;C3887676;C0439508;C1334884;C1696465;C1706408,true;true;false;false;false;false;false;false,1063/10465
vorapaxar n = nmbr,C2974521;C0053917;C1334884,true;true;false,1064/10465
postmenopausal  never or past hormone therapy use,C0232970;C2003901,false;false,1065/10465
difference vs placebo  % [nmbr % cl]  p,C1705241;C1705242,false;false,1066/10465
urinary albumin - to - creatinine ratio^,C0455271;C1318330,false;false,1067/10465
percent change,C0439165;C0392747;C0443172;C1705241;C4319952,false;false;false;false;false,1068/10465
standard care ( n = nmbr ),C1442989;C1947933;C0053917;C1334884;C2828392,false;false;true;false;false,1069/10465
cerebrovascular disorders  n ( % ),C0007820,true,1070/10465
ace inhibitor — no . ( % ),C0003015;C4541021,true;false,1071/10465
location of treatment center,C0039798;C0205099;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,1072/10465
indacaterol nmbr ug ( n = nmbr ),C1722260;C0053917;C0041573;C0439211;C1334884,true;true;true;false;false,1073/10465
history of peripheral arterial disease ( % ),C0683519;C0205100;C0003842;C0221464;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,1074/10465
creatinine  mean ( sd )  mg / dl,C0010294;C0444504;C2699239;C0439269;C2347634;C2348143;C1561535,true;false;false;false;false;false;false,1075/10465
sfnmbr - pcs,C1864389;C1882368,false;true,1076/10465
randomization groups nmbr and nmbr,C0034656,true,1077/10465
presence of honeycombing  nmbr n ( % ),C0150312;C0332468;C0053917;C1334884;C0349384;C0392148;C3854307,false;false;true;false;false;false;false,1078/10465
very severe n z nmbr,C3641272;C0053917;C1334884;C4050419,false;true;false;false,1079/10465
years since pah diagnosis,C0439234,false,1080/10465
partial mayo score $ | |,C0728938;C0454788;C0449820;C4050231;C1077578;C1550516,false;false;false;false;false;false,1081/10465
rosuvastain + fenofibric acid nmbr = nmbr,C0060179;C0053917;C1334884,true;true;false,1082/10465
severity n ( % ),C0439793;C0522510,false;false,1083/10465
history of hypercholesterolemia,C1533076,false,1084/10465
> nmbr years education,C0053917;C0439234;C0013621;C0013622;C0013658;C0039401;C1334884,true;false;true;true;true;true;false,1085/10465
angiographic complications  site - reported — no . / total no . ( % ),C0002978;C0009566;C0205145;C1515974;C2825164;C1171258,true;false;false;false;false;true,1086/10465
acute coronary syndrome nmbr,C0948089;C0053917;C1334884,true;true;false,1087/10465
asastoppedat randomization  n,C0034656,true,1088/10465
mean blood pressure  mmhg ( s . d . j,C0428886;C2347155;C0488053,true;false;false,1089/10465
baseline lipids  mean ± sd ( mmol / l ),C0168634;C0023779;C0444504;C2699239;C1532563;C2347634;C2348143;C1442488,true;true;false;false;false;false;false;false,1090/10465
philippines,C0031529,true,1091/10465
active cancer at randomization  n ( % ),C0205177;C0006826;C0034656;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false,1092/10465
current (  nmbr cigs / day ),C0521116;C0053917;C1570610;C0332173;C0439228;C0439505;C1334884;C1705970,false;true;true;false;false;false;false;false,1093/10465
aspirin and ppi,C0004057,true,1094/10465
screening % reversibility fevnmbr,C0220908;C0449261;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;false;false;false;false;false,1095/10465
prior pci or cabg surgery,C0332152;C4049621;C2826257,false;false;false,1096/10465
lower - limb arterial — no . ( % ),C0023216,true,1097/10465
baseline disease and quality - of - life scores,C0168634;C0012634;C1442488,true;true;false,1098/10465
index event  %,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,1099/10465
endoscopy subscore,C0014245,true,1100/10465
intended clopidogrel dose nmbr mg,C1283828;C0070166;C0178602;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0869039;C1114758;C1551357,false;true;false;true;true;true;false;false;false;false;false;false;false;false;false,1101/10465
placebo + mtx,C0032042;C0025677;C1417487;C1696465;C1706408,true;true;false;false;false,1102/10465
celecoxib ( n = nmbr ),C0538927;C0053917;C1334884,true;true;false,1103/10465
oral hypoglycemic agent,C0359086,false,1104/10465
death  mi  idr  or st,C0011065;C3810814;C1306577;C4082313;C4552775,true;false;false;false;false,1105/10465
unacceptable adverse events,C1883420;C0877248;C1705413,false;false;false,1106/10465
tolal choleslerol - lo - hdl choleslerol ralio,C0206579;C3715113;C1232424,true;false;false,1107/10465
median ( days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1108/10465
ldl particle size ( week nmbr ),C3641256;C0332174;C0053917;C1334884;C0439230,false;false;true;false;false,1109/10465
gold nmbr groups,C0018026;C0053917;C1334884;C1304897,true;true;false;false,1110/10465
parameter,C0549193;C1704769;C2350001,false;false;false,1111/10465
vascular intervention,C0005847;C0184661;C0886296;C1273869;C1558950;C1801960,true;true;false;false;false;false,1112/10465
anmbr + ezio anmbr ( n = nmbr ) ( n = nmbr ),C0053917;C1334884,true;false,1113/10465
amlodipine / vaisartan ( n = nmbr ),C0051696;C0053917;C1334884,true;true;false,1114/10465
ldl cholesterol — mg / dl | |,C0023824;C0439269;C0202117,true;false;false,1115/10465
week nmbr ( geometric mean  cv ),C0332174;C0053917;C2986759;C3538987;C4048877;C4318503;C1334884;C0439230,false;true;false;false;true;false;false;false,1116/10465
triglycerides ( week nmbr ) a,C0041004;C0332174;C0053917;C1334884;C0439230,true;false;true;false;false,1117/10465
cause of heart failure,C0015127;C0018801;C0018802;C4554158;C1524003,true;true;true;false;false,1118/10465
copd or asthma,C0024117;C1412502;C3714496,true;false;false,1119/10465
latin and north america,,,1120/10465
comorbid diseasesa diabetesb,C0009488,true,1121/10465
cardiac rhythm,C0232187,false,1122/10465
proactive intervention ( n = nmbra ),C0184661;C0886296;C1273869,true;false;false,1123/10465
nmbr = minor symptoms  no limitations,C0053917;C0026193;C0683368;C1457887;C0205165;C1334884,true;true;true;false;false;false,1124/10465
patients ' characteristics age ( years )  mean + sd,C0815172;C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,1125/10465
history of hypercholesterolemia  n ( % ),C1533076,false,1126/10465
acc / aha lesion class bnmbr or c  n ( % ),C4072694;C0221198;C0456387;C1518526;C1705943;C1546698,false;false;false;false;false;false,1127/10465
enact - nmbr trial,,,1128/10465
fasting insulin — / tiu / ml §,C0015663;C0021641;C0439526;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false,1129/10465
biomarker low ( periostin < nmbr ng / ml or blood eosinophils < nmbr cells per pl )  na,C0005516;C0205251;C0219433;C0053917;C0439275;C1334884;C1424662;C3812270;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;true;true;false;false;false;false;false;false;false;false;false,1130/10465
age  mean years  [sd],C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,1131/10465
lipoprotein ( a ) ( mg / dl ),C0065058;C0439269;C0125953;C1096202;C1439335,true;false;true;false;false,1132/10465
any pulmonary medication,C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268,true;true;false;false;false;false;false,1133/10465
non - study ppi use,C1518422;C0557651;C0358591;C0871125;C3811894;C2603343,false;false;true;true;false;false,1134/10465
> nmbr : obese class iii,C0053917;C1319441;C1334884,true;false;false,1135/10465
acute dvt study,C0205178;C0149871;C0557651;C2603343;C2926618;C3899446,false;true;false;false;false;false,1136/10465
high subgroup,C0205250;C1079230;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,1137/10465
mean ( sd ) body mass index  kg / mnmbr,C0444504;C2699239;C0005893;C0022718;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;false;true;false;false;false;true;false;false,1138/10465
diuretic drugs,C0012798;C0013227;C3687832,true;true;false,1139/10465
gallbladder - related aes,C0016976;C0439849;C1412268;C2699274;C0445223,true;false;false;false;false,1140/10465
rivastigmine ( n = nmbr ),C0649350;C0053917;C1334884,true;true;false,1141/10465
vitamin e,C0042874;C3714803,true;false,1142/10465
jvp > nmbrcm,,,1143/10465
family history of venous thromboembolism ( % ),C0241889;C1997614;C0015576;C0455533;C0042449;C0348013;C1704727,true;false;true;false;true;false;false,1144/10465
post - bronchodilator fevnmbr ( % predicted * ),C2599594,false,1145/10465
creatinine clearance by c - g ( ml / min ),C0439267;C0151280,false;false,1146/10465
associated with hiv infection,C0332281;C0019693,false;true,1147/10465
muscle spasms,C0037763,true,1148/10465
copd severity ( gold stage ),C0024117;C0439793;C0018026;C0205390;C1300072;C1306673;C1304897;C0522510;C1412502;C3714496,true;false;true;false;false;false;false;false;false;false,1149/10465
rivaroxaban nmbr mg,C1739768;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1150/10465
baseline cardiac biomarkers elevated,C0168634;C2735101;C2735102;C1442488,true;false;false;false,1151/10465
mental component score ( mcs ),C0229992;C0449432;C0449820;C4050231;C1705248,false;false;false;false;false,1152/10465
combined end points,C0205195;C2349179,false;false,1153/10465
death  large mi,C0011065;C0549177;C3810814;C1306577;C4082313;C4552775,true;false;false;false;false;false,1154/10465
race  white  n ( % ),C0034510;C1706779;C3853635,true;false;false,1155/10465
elevated tg,C0205250;C0337445;C3163633,false;false;false,1156/10465
baseline scales  median ( range ),C0168634;C1442488,true;false,1157/10465
formal education  years,C0681344;C0439234,false;false,1158/10465
tiotropium nmbr gg qd,C0213771;C0053917;C0017454;C0332173;C0018370;C1334884,true;true;true;false;true;false,1159/10465
thrombocytopenia,C0040034;C0392386,true;false,1160/10465
presence of mets,C0150312;C0812270;C1705694;C2939420;C0392148;C3854307,false;false;false;false;false;false,1161/10465
treatment at randomization — no . ( % ),C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,1162/10465
other biologic agent,C0005515,true,1163/10465
hdl < nmbr / nmbr mg / dl ( nmbr . nmbr / nmbr . nmbr mmol / l ) for men / women,C3715113;C0053917;C3642216;C3898312;C0025266;C0043210;C1334884,false;true;false;false;true;true;false,1164/10465
baseline systolic bp,C0168634;C0871470;C1442488,true;true;false,1165/10465
angina class iii or iv prior myocardial infarction,C0264677,false,1166/10465
mucolytic agent,C0026698,true,1167/10465
acenocoumaroi,,,1168/10465
multiple,C0439064,false,1169/10465
emotional well - being,C2984554;C3641833,false;false,1170/10465
nmbr ( fevnmbr < nmbr % pred ),C0053917;C1334884,true;false,1171/10465
rec . ischemia due worsening angina,C1424025;C0022116;C0678226;C0002965;C3146286;C4321499;C2606415,false;true;false;true;false;false;true,1172/10465
current ( nmbr + cigs / day ),C0521116;C0053917;C1570610;C0332173;C0439228;C0439505;C1334884;C1705970,false;true;true;false;false;false;false;false,1173/10465
prior surgery : no,C0455610,false,1174/10465
carotid stenosis,C0007282,true,1175/10465
smoking history  pack - years  mean ( sd ),C1519384;C1277691;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,1176/10465
ever smoked ( current / former ),,,1177/10465
estimated gfr  ml min - nmbr nmbr . nmbr m - nmbr ( sd ) a,C0750572;C0017654;C0439445;C0053917;C0369637;C2699239;C0441923;C1334884;C1424601,false;true;false;true;false;false;false;false;false,1178/10465
isolated systolic hypertension  n ( % ) “,C0745133,false,1179/10465
feno placebo ( lsm ),C0032042;C1696465;C1706408,true;false;false,1180/10465
no . of prior tnfi,C0332152;C2826257,false;false,1181/10465
non - fatal myocardial infarction,C1518422;C1302234;C0027051;C0428953;C2926063;C3810814;C4552959;C1705232,false;false;true;false;false;false;false;false,1182/10465
involved intestinal area  n ( % ),C1879646;C0021853,false;true,1183/10465
normal fasting glucose level ( n = nmbr ),C0522082;C0015663;C0053917;C1334884;C0205307;C0202045;C0231683;C0439166;C2347086;C4553972,false;true;true;false;false;false;false;false;false;false,1184/10465
saxa + dapa + met n = nmbr,,,1185/10465
joint damage outcomes ( mitt population ),C0022417;C0010957;C1274040;C0032659;C1257890;C1883709;C0392905;C1706309,true;false;false;true;true;false;false;false,1186/10465
discontinuations teaes,C0457454,false,1187/10465
aldosterone inhibitor,C0002007,true,1188/10465
adverse outcome,C1274040,false,1189/10465
etoricoxib nmbr mg n = nmbr n ( % ),C0972314;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1190/10465
asia - pacific hr ( nmbr % cl ),C0003980;C0053917;C0596019;C1334884,true;true;false;false,1191/10465
left bundle - branch block,C0023211;C0344420;C2828132,true;false;false,1192/10465
any prior anti - tnf treatment failure,C1514463;C1448177;C0231174;C0680095;C0332152;C0162643;C0235828;C0521983;C1547544;C2826257,false;true;false;false;false;true;false;false;false;false,1193/10465
pioglitazone pts / n ( % ),C0071097;C1419129;C2698747,true;false;false,1194/10465
central / eastern europe and russia hr ( nmbr % cl ),C0682369;C1707877;C0205099;C0015177;C1879652,false;false;false;true;false,1195/10465
copd - rosuvastatin ( n = nmbr ),C0024117;C0965129;C0053917;C1334884;C1412502;C3714496,true;true;true;false;false;false,1196/10465
abatacept / open - label abatacept,C1619966;C1709323,true;false,1197/10465
nonblack race — no . ( % ) - j -,,,1198/10465
prior ischemic stroke,C0332152;C0948008;C2826257,false;false;false,1199/10465
ff / vi nmbr / nmbr gg ( n = nmbr  nmbr ),C4554348;C0205999;C0053917;C0017454;C0018370;C1334884,false;true;true;true;true;false,1200/10465
baseline nihss score ( % ) #,C0168634;C1697238;C1442488,true;false;false,1201/10465
free fatty acids ( mmol / l ),C0015688;C1532563,true;false,1202/10465
laba or lama ’ versus ind / gly lsm difference ( nmbr % cl ),,,1203/10465
change from baseline in hbanmbrc ( % ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1204/10465
aspirin group ( n = nmbr nmbr ) ( nmbr nmbr person years ),C0004057;C0441848;C0053917;C0027361;C0439234;C2347489;C1334884,true;false;true;true;false;false;false,1205/10465
angiogenin ( ng / ml ),C0051844;C0439275;C1367482,true;false;false,1206/10465
weight  mean ± sd ( kg ),C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,1207/10465
race / ethnicity  %,C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,1208/10465
etanercept ( n = nmbr ),C0717758;C0053917;C1334884,true;true;false,1209/10465
serum creatinine — pmol / liter,C0201976;C0439192;C0475211;C0600061,false;false;false;false,1210/10465
prior carotid intervention,C0332152;C0741968;C0184661;C0886296;C1273869;C2826257,false;false;true;false;false;false,1211/10465
abx - facil . pci,C4049621,false,1212/10465
antiplatelet — no . / total no . ( % ),,,1213/10465
other lipid - modifying drug use at study entry  n ( % ),C0023779;C0392747;C0242510;C0557651;C1705654;C2603343;C0042153;C0013175;C0457083;C1947944;C0013227;C0869040;C1254351,true;false;false;false;false;false;true;true;false;false;true;false;false,1214/10465
without dm ( n = nmbrinmbr * ),C0011816;C3250443,true;false,1215/10465
potassium,C0032821;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false,1216/10465
difference ( tiotropium - placebo ) ml ( nmbr % ci ),C1705241;C0213771;C0032042;C0439526;C0053917;C0008107;C3259781;C1334884;C1705224;C3887665;C1696465;C1706408;C1705242,false;true;true;false;true;true;false;false;false;false;false;false;false,1217/10465
any relevant infarct,C2347946;C0021308,false;true,1218/10465
baricitinib  nmbr mg daily ( n = nmbr ),C4044947;C0053917;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,1219/10465
ls mean % change from baseline _ se,C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,1220/10465
established ascvd or > nmbr cv risk factors,C0443211;C3665365;C1272684,false;false;false,1221/10465
fasting plasma glucose  mg / dl  mean ( sd ) b,C0015663;C0202042;C0439269;C0444504;C2699239;C2347634;C2348143;C0455280,true;false;false;false;false;false;false;false,1222/10465
enmbr + anmbr -,,,1223/10465
filtration rate nmbr - nmbr,C0016107;C0871208;C0053917;C1334884;C1521828,true;false;true;false;false,1224/10465
placebo secukinumab nmbr mg,C0032042;C3179547;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1696465;C1706408,true;true;true;true;true;false;false;false;false;false;false;false;false,1225/10465
sf - nmbr physical component summaryjj,C0037712;C0053917;C0031809;C0449432;C1705248;C0205485;C1509143;C1334884,true;true;true;false;false;false;false;false,1226/10465
angiographic data,C0002978;C1511726;C3245479;C3714741,true;false;false;false,1227/10465
community hospital ( % ),C0020003,true,1228/10465
death or absolute fvc decrease > nmbr %,C0011065;C1306577;C4082313;C4552775,true;false;false;false,1229/10465
indacaterol nmbr mg[n z nmbr],C1722260;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1230/10465
other statin,C0360714,true,1231/10465
median ( iqr ) age  years,C0549183;C1510829;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1232/10465
estimated glomerular filtration rate < nmbr ml / min / nmbr . nmbr mnmbr : i : §,C3811844;C0053917;C0023806;C0702093;C1524029;C3813700;C0439445;C0021966;C0221138;C1334884,false;true;true;false;false;false;false;true;false;false,1233/10465
homa_ % b tx difference vs pbo  median change from baseline ( se ) nmbr,C0041403;C1705241;C1705242,true;false;false,1234/10465
tim nmbr nsk score,C1313407;C0053917;C0449820;C4050231;C1334884;C3541335;C3711667;C3827754;C3890185;C4319633,true;true;false;false;false;false;true;false;false;false,1235/10465
indication for pci,C0392360;C4049621;C3146298,false;false;false,1236/10465
percutaneous coronary intervention or coronary artery bypass graft surgery  n ( % ),C1532338,true,1237/10465
nmbr - aminosalicylates ’ i " i ‘,C0053917;C0368663;C0021966;C0221138;C1334884,true;false;true;false;false,1238/10465
native latin,C0302891,false,1239/10465
left atrial diameter  mm ( sd ),C0225860;C1301886;C4330985;C2699239;C4554674;C0225861,true;false;false;false;false;false,1240/10465
patient history of disease,C0030705;C0683519;C0730226;C0850708;C0944983,true;false;false;false;false,1241/10465
copd severity : severe / very severe,C0024117;C0439793;C0442824;C2984081;C0522510;C1412502;C3714496,true;false;false;false;false;false;false,1242/10465
mean platelet volume  fl,C0200665;C1300812;C1708024;C0344388,true;false;false;false,1243/10465
in ibdq total score at week nmbr  mean [se],C2964552;C0332174;C0053917;C0444504;C0036919;C2347634;C2348143;C1334884;C0439230;C0439175;C3533236;C0439810,false;false;true;false;true;false;false;false;false;false;false;false,1244/10465
baseline ezetimibe usec,C0168634;C1142985;C0439224;C1442488,true;true;false;false,1245/10465
ics use at screening  n ( % ),C0815320;C4551720,false;true,1246/10465
mdi / hfa  n,C0993596;C0015458;C1839839;C4049613,true;true;true;false,1247/10465
moderate or severe exacerbations in the previous year ( range ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,1248/10465
mixed chronic bronchitis and emphysema,C0205430;C0008677;C3160715,false;true;false,1249/10465
triple - vessel disease  n ( % ),C0856738,false,1250/10465
mean ( sd ) crp  mg / l *,C0444504;C2699239;C3890735;C0439268;C4048285;C2347634;C2348143,false;false;false;false;false;false;false,1251/10465
epa / aa ratio,C0282379;C0456603;C1547037;C1235746;C1882141;C4554792,true;false;false;false;false;false,1252/10465
one or more requiring hospitalization in nmbr mo before screening — no . ( % ) nmbr,C0205447,false,1253/10465
health state index score  uk algorithm,C0683314;C0600653;C0449820;C0041700;C0002045;C1553907;C4050231;C0918012;C1552854;C1637833;C2986546,false;true;false;true;true;false;false;true;false;false;false,1254/10465
time from onset of pain to randomization  median ( iqr )  h,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,1255/10465
homajr tx difference vs pbo  median change from baseline ( se ) nmbr lipid parameters,C0041403;C1705241;C1705242,true;false;false,1256/10465
ticagrelor  nmbr mg ( n = nmbr ),C1999375;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1257/10465
dpp - nmbr inhibitor therapy,C1414174;C0053917;C1999216;C0039798;C0087111;C1363945;C1334884,false;true;false;true;true;false;false,1258/10465
median cardiac troponin t ( iqr ) — pg / ml,C0549183;C3538889;C0439297;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1259/10465
> nmbr ( ml ) additional angiography,C0053917;C0439526;C1524062;C0002978;C1705224;C3887665;C1334884,true;false;false;true;false;false;false,1260/10465
sbp < nmbr mmhg and dbp < nmbr mmhg,C0085805;C0053917;C0439475;C1334884,true;true;false;false,1261/10465
insulin and oral hypoglycemic drugs,C0021641;C1533581;C1579433;C3714501,true;false;false;false,1262/10465
other antiplatelet,,,1263/10465
use of ics,C1524063;C0815320;C4551720,false;false;true,1264/10465
mean hscrp  mg / l ( sd ),C0444504;C0439268;C2699239;C2347634;C2348143,false;false;false;false;false,1265/10465
carotid revascularization,C0741968;C0581603,false;false,1266/10465
time from onset to randomization  h  mean ± sd,C0449244,false,1267/10465
beta - adrenergic blocker,C0001645;C2757061;C3536830,true;false;false,1268/10465
class l / ll heart failure,C0456387;C1518526;C1705943,false;false;false,1269/10465
rerandomization to placebo ( n = nmbr ) f,C0032042;C0053917;C0016327;C1334884;C1696465;C1706408,true;true;true;false;false;false,1270/10465
triglycerides > nmbr mg / dl,C0041004;C0053917;C0439269;C1334884,true;true;false;false,1271/10465
history of cabg surgery,C0455610;C0010055,false;true,1272/10465
vomiting,C0042963;C1963281;C3898969;C4084766;C4084767;C4084768;C4084769,true;false;false;false;false;false;false,1273/10465
thoracic cage fractures,C0222762,true,1274/10465
baseline sgrq score,C0168634;C1442488,true;false,1275/10465
usa and canada,C0041703,true,1276/10465
obesity ( body mass index > nmbr kg / mnmbr ),C0028754;C0005893;C0053917;C0022718;C0439209;C4054209;C1334884;C0578022;C1305855;C1963185,true;false;true;true;false;false;false;false;true;false,1277/10465
clopidogrel plus aspirin ( n = nmbr ),C0070166;C0332287;C0004057;C0053917;C1334884,true;false;true;true;false,1278/10465
intent of early invasive strategy  %,C0162425;C1279919;C0205281;C0679199;C1334278;C1283828;C1550453,true;false;false;false;false;false;false,1279/10465
mean fevnmbr  l ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,1280/10465
heavy calcification,C0439539;C0006660;C0006663;C0175895;C1533591;C1879982;C2242558,false;true;true;false;false;false;false,1281/10465
cardiovascular medications  %,C0007220,true,1282/10465
only peripheral artery disease,C0205171;C1704436;C4025272;C1720467,false;true;false;false,1283/10465
inhaled anticholinergic §,C0004048;C0242896;C3537004,true;true;false,1284/10465
nmbr - h plasma glucose during ogtt ( mmol / l ),C0053917;C2827804;C0202042;C0029161;C0455280;C1334884,true;false;false;true;false;false,1285/10465
uacra  mg / g  n ( % ),C1300563,false,1286/10465
western europe and israel,C0043129,true,1287/10465
sglt - nmbr inhibitors^,C3665045;C0053917;C1334884,false;true;false,1288/10465
myocardial infarction — no . ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,1289/10465
united states,C0041703,true,1290/10465
number of antidiabetes drugs at screening  n ( % ),C0237753;C0013227;C3687832;C0449788,false;true;false;false,1291/10465
any type  according to daily dose * *,C0332307;C0680240;C2348070;C1547052,false;false;false;false,1292/10465
glucocorticoids plus immunosuppressive agents,C0017710;C0021081;C3540777;C3540778,true;true;false;false,1293/10465
left anterior descending artery  n ( % ),C0226032,false,1294/10465
albuterol reversibility  %,C0001927;C0449261,true;false,1295/10465
rivaroxaban + aspirin,C1739768;C0004057,true;true,1296/10465
anyantianginal agent,C0450442;C1254351;C1521826,false;false;false,1297/10465
patients with diabetic nephropathy,C0030705;C0011881;C1442864,true;true;false,1298/10465
hbanmbrc in patients with baseline hbanmbrc > nmbr % to < nmbr % ( > nmbr to < nmbr mmol / mol )  % [mmol / mol]  la  n baseline ( sd ) adjusted mean change ( nmbr % ci ) placebo subtracted change ( se ),C0030705,true,1299/10465
health - related quality of life,C4279947,true,1300/10465
risk factors  %,C0035648;C1553898,true;false,1301/10465
concomitant therapy  no . ( % ),C1707479,false,1302/10465
any cardiovascular disease history  n ( % ),C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,1303/10465
cardiac history  %,C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1522601,true;true;true;false;false;false;false;false,1304/10465
subgroup by treatment interaction p - value,C1079230;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021,false;true;false;false;true;false;false;false;false;false;false,1305/10465
anmbr + eznmbr anmbr ( n = nmbr ) ( n = nmbr ),C0053917;C1334884,true;false,1306/10465
dpi ( other than diskus )  n,C1553480,false,1307/10465
previous copd treatment  n ( % ) *,C0205156;C0024117;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1412502;C3714496;C1552607,false;true;true;true;false;false;false;false;false;false;false;false,1308/10465
body mass index ( kg / mnmbr ) - mean ± sd,C0005893;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;true,1309/10465
positive for anti - cyclic citrullinated peptide antibody — no . ( % ) f,C0741132;C1320283,false;false,1310/10465
psoriasis duration  mean ± sd  years,C0033860;C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735,true;false;false;false;false;false;false;false,1311/10465
fevi  l *,C0429706;C0849974;C1561566;C4528367,false;false;false;false,1312/10465
ldl cholesterol at baseline ( mmol / l ) * ldl cholesterol at screening,C0023824;C0168634;C1532563;C1442488;C0202117,true;true;false;false;false,1313/10465
black race,C0005680,true,1314/10465
lp ( a )  mean ( sd ),C0065058;C0444504;C2699239;C2347634;C2348143;C1439335;C4553379,true;false;false;false;false;false;false,1315/10465
previous transient ischaemic attack / ischaemic stroke previous warfarin use,C0205156;C0007787;C0038454;C0043031;C0042153;C0457083;C1947944;C4554100;C0917805;C1552607,false;true;true;true;true;false;false;false;true;false,1316/10465
calculated ldl - c in nmbr classes,C0444686;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1441506,false;true;false;false;false;false;false;false,1317/10465
rosiglitazone,C0289313,true,1318/10465
without revascularsation,,,1319/10465
odds ratio,C0028873,true,1320/10465
body mass index  kg / mnmbr  median ( qnmbr  qnmbr ),C0005893;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;false;true,1321/10465
exenatide n = nmbr,C0167117;C0053917;C1334884,true;true;false,1322/10465
total score on the sgrq - c  i ,C2964552;C3826872;C0021966;C0221138,false;false;true;false,1323/10465
elevated creatinine ( > nmbr pmol / l ),C0151578;C0053917;C0439284;C1334884;C0700225,false;true;false;false;false,1324/10465
valsartan / hctz,C0216784;C0020261,true;true,1325/10465
baseline : < nmbr . nmbr meq / l eos : > nmbr . nmbr or < nmbr . nmbr meq / l,C0168634;C0053917;C0439375;C1623465;C1861303;C1334884;C1442488,true;true;false;false;true;false;false,1326/10465
history of currently treated hypertension  n ( % ),C0455527;C0521116;C1522326,false;false;false,1327/10465
tg  mmol / l [mg / dl],C0337445;C3898312;C3642216,false;false;false,1328/10465
terminal ileum,C0227327,false,1329/10465
dasnmbr - esr lda,C3811131;C4553195,false;false,1330/10465
prior tnfi  n ( % ),C0332152;C2826257,false;false,1331/10465
liraglutide nmbr . nmbr mg / day ( n = nmbr ),C1456408;C0053917;C0439422;C1334884,true;true;false;false,1332/10465
established ascvd,C0443211;C3665365;C1272684,false;false;false,1333/10465
depressed and low perceived social support,C0344315;C0549249,false;true,1334/10465
limb ( sd ),C0015385;C2699239,true;false,1335/10465
emergent / urgent surgery,C0750573;C2188405,false;false,1336/10465
laboratory measurements,C0681902,false,1337/10465
simva n = nmbr n ( % ),C0053917;C1334884,true;false,1338/10465
czp nmbr mg  % ( n / n ),C0054841;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1861828;C1872109,true;true;true;true;false;false;false;false;false;false;true;true,1339/10465
fibrinogen ( pmol / l ) c,C0016006;C0439284;C1167394;C2587184;C3540039,true;false;false;false;false,1340/10465
frailty status,C0424594;C0449438,true;false,1341/10465
basal insulin dose at run - in ( u / day ),C0650607;C0178602;C3274438;C0456683;C0869039;C1114758;C0205112;C0366513,false;false;false;false;false;false;false;false,1342/10465
worsening angina,C0002965,true,1343/10465
use of parenteral antithrombotic,C1524063;C0030547;C4522267,false;true;false,1344/10465
cvd or mi,C0007222,true,1345/10465
screening bmi ( kg / mnmbr ),C0220908;C0578022;C0022718;C0439209;C4054209;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;false;false;true;false;false;false;false;false,1346/10465
atherosclerosis^  n ( % ),C0003850;C0004153,true;true,1347/10465
none ( cdmard - naive or past use at baseline ),,,1348/10465
tender joint count ( nmbr - nmbr ),C0451530;C0053917;C1334884,false;true;false,1349/10465
hbanmbrc  %  n ( % ) b,,,1350/10465
ldl - c < nmbr . nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,1351/10465
duration of last qualifying episode of atrial fibrillation > nmbr days,C0449238;C1514624;C0332189;C0004238;C0053917;C0439228;C1334884;C0344434;C1963067;C2926735,false;false;false;true;true;false;false;false;false;false,1352/10465
saxagliptin nmbr . nmbr mg ( n = nmbr  nmbr ),C1611934;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1353/10465
years [range],C0439234;C1514721;C2348147;C3542016,false;false;false;false,1354/10465
potassium - sparing at enrollment,C0032821;C1516879;C1696073;C3888021;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false,1355/10465
body mass index > nmbr kg / mnmbr  n ( % ),C0005893;C0053917;C0022718;C0439209;C4054209;C1334884;C0578022;C1305855,false;true;true;false;false;false;false;true,1356/10465
modmy al randcnxzaton,C0202311,false,1357/10465
additional investigations,C2359834,false,1358/10465
peri - op amiodarone : no ( n = nmbr ),C0347985;C0002598,false;true,1359/10465
ejection fraction  % nyha class  n ( % ),C0489482;C1882083;C2700378,false;false;false,1360/10465
class i or iii aad use in nmbr months before enrollment,C0441885;C1319793;C2698967,false;false;false,1361/10465
intravenous anticoagulant during hospitalization,C0348016;C0003280;C0019993;C0848112;C3536711,false;true;true;false;false,1362/10465
high density lipoprotein cholesterol  mg / dl^,C0023822;C0439269,true;false,1363/10465
functional assessment of chronic illness,C0278372;C0008679,false;true,1364/10465
hormonal status,C0458083;C0449438,false;false,1365/10465
postmenopausal  current hormone,C0232970;C0521116;C0019932;C4521914;C1705970,false;false;true;false;false,1366/10465
spironolactone ( n = nmbr ),C0037982;C0053917;C1334884,true;true;false,1367/10465
any disease,C0012634,true,1368/10465
endothelin - receptor antagonists plus phosphodiesterase type nmbr inhibitors,C1134681;C0031638;C0332307;C0053917;C1334884;C1547052;C1656262;C3539996;C2266875,true;true;false;true;false;false;false;false;false,1369/10465
bolus administered — no . ( % ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,1370/10465
tofacitinib  nmbr mg ( n = nmbr ),C2930696;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1371/10465
medical history — no . / total no . ( % ),C0262926;C1704706,false;false,1372/10465
tobacco use ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,1373/10465
infliximab - naive ( n = nmbr ),C0666743;C0053917;C1334884,true;true;false,1374/10465
week nmbr mean 士 sd,C0332174;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C0439230,false;true;false;false;false;false;false;false,1375/10465
hr ( nmbr % ci ) p value for interaction *,C0053917;C0008107;C1709380;C1704675;C3259781;C1334884,true;true;false;false;false;false,1376/10465
history of congestive heart failure,C0455531;C0742742,false;false,1377/10465
events  no .,C0441471;C3541888,false;false,1378/10465
event / total,C0441471;C0439175;C0439810;C4019010,false;false;false;false,1379/10465
serum cholesterol — mmol / liter,C0587184;C0439190;C0475211,false;false;false,1380/10465
pooled empagliflozin ( n = nmbr ),C1709595;C3490348;C0053917;C1334884;C2349200;C4522255,false;true;true;false;false;false,1381/10465
statin monotherapy,C0360714,true,1382/10465
total comparators  patients with events / total patients,C0439175;C1707454;C0030705;C0441471;C3541888;C4553389;C4553390;C0439810,false;false;true;false;false;false;false;false,1383/10465
( % ) control ( nmbr ),C0243148;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false;false,1384/10465
hypertension : no ( n = nmbr ),C0020538;C1963138,true;false,1385/10465
angiotensin - converting enzyme inhibitor or angiotensin receptor blocker,C0003015;C2757044;C3536837;C4541021,true;false;false;false,1386/10465
bdmard - ir,C0022065;C0022071;C1448132,true;true;true,1387/10465
estimated glomerular filtration rate,C3811844,false,1388/10465
periprocedural medications — no . / total no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,1389/10465
proportion of predicted normal fevnmbr value   §,C1709707;C0681842;C0086715;C1882327,false;false;true;false,1390/10465
mellitus,,,1391/10465
amiodarone,C0002598,true,1392/10465
permanently stopped study drug because of adverse events,C1272691;C0557651;C0041755;C2603343,false;false;true;false,1393/10465
median ( qnmbr : qnmbr ) tg - rich lipoprotein cholesterol,C0549183;C0337445;C0699759;C0065055;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false,1394/10465
apolipoproiein anmbr ( tng / nmbr ),C0053917;C1334884,true;false,1395/10465
metformin dose  mg,C0025598;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,true;false;true;true;false;false;false;false;false;false;false,1396/10465
placebo no . of events / total no . ( % ),C0032042;C1696465;C1706408,true;false;false,1397/10465
hbanmbrc nmbr % - < nmbr % ( n - nmbr ),C0053917;C1334884,true;false,1398/10465
hypoglycaemic agents,C0020616,true,1399/10465
apremilast nmbr mg bid n = nmbr,C1678805;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1400/10465
duration  mean ( sd )  years,C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735,false;false;false;false;false;false;false,1401/10465
patient global assessment of disease activity ( vas nmbr - nmbr mm ),C4054228;C0042815;C0053917;C4330985;C4554674;C1334884;C3536884;C3827561,false;true;true;false;false;false;true;false,1402/10465
intermittent claudication,C0021775,true,1403/10465
myocardial ischaemia,C0010054;C0151744,true;true,1404/10465
arb at enrollment,C3888198;C1516879;C1696073;C3888021,false;false;false;false,1405/10465
rosuvastatin of patients ( rate ),C0965129;C0030705;C0871208;C1521828,true;true;false;false,1406/10465
recent cardioversion ( within nmbr days before randomization ) —,C0332185;C0013778;C0053917;C0439228;C1334884,false;true;true;false;false,1407/10465
denosumab ( n = nmbr ),C1690432;C0053917;C1334884,true;true;false,1408/10465
genotyping,C1285573,false,1409/10465
remission  n ( % ),C0544452;C0687702,false;false,1410/10465
radius fracture,C0034628,true,1411/10465
clopidogrel dose on / before pci,C0070166;C0178602;C4049621;C0869039;C1114758,true;false;false;false;false,1412/10465
enoxaparin / vka,C0206460,true,1413/10465
sf - nmbr score,C0037712;C0053917;C0449820;C4050231;C1334884,true;true;false;false;false,1414/10465
seropositivity,C0521143,false,1415/10465
interval pain onset to admission,C1272706;C1507009;C0184666;C0809949;C1552654;C1552713,false;false;false;false;false;false,1416/10465
metrex modified intention - to - treat population with an eosinophilic phenotypey,,,1417/10465
number of previous anti - tnf treatments for psoriatic arthritis,C0237753;C0205156;C1448177;C0087111;C1552607;C0449788,false;false;true;true;false;false,1418/10465
serum creatinine  mean ( sd )  pmol / l,C0201976;C0444504;C2699239;C0439284;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,1419/10465
coronary heart disease ( % ),C0010054;C0010068;C1956346,true;true;true,1420/10465
bmi ( kg / mnmbr ) < nmbr,C0578022;C0022718;C0053917;C1334884;C0439209;C4054209,false;true;true;false;false;false,1421/10465
abdominal aortic — no . ( % ),C0003484,true,1422/10465
mean weight  kg ( sd ),C0444504;C0005910;C0022718;C2699239;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false;false,1423/10465
severe hyperkalemiac,C0205082;C4050465;C4050466,false;false;false,1424/10465
history of bone disease ( predefined )  n ( % ),C0683519;C0262950;C0730226;C0850708;C0944983;C0019664;C0005940;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;false;false;true;true;true;false;false;false;false,1425/10465
abrupt vessel closure,C1276802;C0005847;C0185003;C1521802,false;true;false;false,1426/10465
/ j - valuc ! l,,,1427/10465
> nmbr days warfarin,C0053917;C0439228;C0043031;C1334884,true;false;true;false,1428/10465
non - hdl - c ( mmol / l  mean ),C1518422;C3715113;C1532563;C0444504;C2347634;C2348143,false;false;false;false;false;false,1429/10465
yes  non - insulin - treated,C1549445;C1705108;C1710701,false;false;false,1430/10465
nmbr - nmbr . nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,1431/10465
baseline lp ( a ) in nmbr classes,C0168634;C0065058;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1439335;C4553379;C1442488,true;true;true;false;false;false;false;false;false;false;false,1432/10465
primary + gusto moderate or severe bleeding,C0205225;C0439612;C0439631,false;false;false,1433/10465
dyspepsia,C0013395;C4552968,true;false,1434/10465
south asian,C1519427,false,1435/10465
claudication,C0021775;C0311395;C1456822,true;false;false,1436/10465
anticoagulant therapy,C0150457,false,1437/10465
dactylitis  n ( % ),C0239161,false,1438/10465
prior immunnosupressive failure but no anti - tnf failure,C0332152;C0231174;C0680095;C2826257,false;false;false;false,1439/10465
sf - nmbrvnmbr domain scores  mean [sd],C0037712;C1880389;C1883221;C3541951,true;false;false;false,1440/10465
reversibility ( bnmbr - agonist )  %  mean ( sd ) nmbr,C0449261;C2987634;C0444504;C2699239;C0053917;C1334884;C2347634;C2348143,false;false;false;false;true;false;false;false,1441/10465
icd therapy vs . placebo no . hazard ratio ( nmbr . nmbr % cl ),C0021122;C0039798;C0087111;C1363945,true;true;true;false,1442/10465
fev  at baseline,C3714541;C0168634;C1442488,true;true;false,1443/10465
low - density lipoprotein cholesterol  mg / dl,C0023824;C0439269,true;false,1444/10465
qualifying type of atherosclerosis — no . ( % ),C1514624;C0332307;C0003850;C0004153;C1547052,false;false;true;true;false,1445/10465
white : black : other,C0007457;C0005680;C0027567;C0085756;C0439541;C0043157;C0220938,true;true;true;true;false;true;false,1446/10465
placebo estimated mean,C0032042;C1696465;C1706408,true;false;false,1447/10465
salmeterol - fluticasone group,C0939232;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1448/10465
impaired glucose tolerance or impaired fasting glucose — no . ( % ),C0271650,true,1449/10465
duration of tnmbrdm ( % ),C0449238;C2926735,false;false,1450/10465
therapy ( asa nmbr  nmbr / placebo nmbr ),C0039798;C0004057;C0053917;C0032042;C1696465;C1706408;C1334884;C3853627;C0087111;C1363945,true;true;true;true;false;false;false;false;true;false,1451/10465
antihyperglycemic oral agent therapy,C0020616;C0442027;C0450442;C0039798;C0087111;C1363945;C1254351;C1521826;C4521986,true;false;false;true;true;false;false;false;false,1452/10465
gender  % of patients,C0079399;C0030705;C1522384,true;true;true,1453/10465
planned thienopyridine at baseline,C1301732;C1120149;C0168634;C1442488,false;true;true;false,1454/10465
medical history,C0262926;C1704706,false;false,1455/10465
medium - or low - intensity statin,C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false,1456/10465
current / past,C0521116;C1444637;C4284302;C1705970,false;false;false;false,1457/10465
rosuvastatin n = nmbr,C0965129;C0053917;C1334884,true;true;false,1458/10465
pulse rate ( bpm ),C0232117,true,1459/10465
anti - cholinergics ( long - acting ),C0242896,true,1460/10465
primary + gusto severe bleeding,C0205225;C0205082;C0019080;C4050465;C4050466;C0439612;C0439631,false;false;true;false;false;false;false,1461/10465
mean age  years ( nmbr % ci ),C0444504;C1510829;C0053917;C0008107;C3259781;C1334884;C2347634;C2348143,false;false;true;true;false;false;false;false,1462/10465
vertebrobasilar infarct,C0545733;C0021308,false;true,1463/10465
alathosterol ( % ),,,1464/10465
blood oxygenation  mean ± sd,C0005767;C0231940;C0444504;C2699239;C2347634;C2348143;C0282636;C0005768;C0229664,true;false;false;false;false;false;true;true;false,1465/10465
rf positive  %,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,1466/10465
sf - nmbr ( health transition score ),C0037712;C0053917;C0376627;C0449820;C4050231;C1334884,true;true;true;false;false;false,1467/10465
time since diagnosis of osteoarthritis — yr,C0040223;C3541383,true;false,1468/10465
no . of days to homa - ir testing — median ( iqr ),C0439228,false,1469/10465
certolizumab group ( n = nmbr ),C1872109;C0441848;C0053917;C1334884,true;false;true;false,1470/10465
nmbr - nmbr / week,C0053917;C0332174;C0439230;C1334884,true;false;false;false,1471/10465
pnmbrynmbr inhibitor,C1999216,false,1472/10465
previous cardiovascular disease !,C0205156;C0007222;C1552607,false;true;false,1473/10465
acute and delayed reaction,C0205178,false,1474/10465
atenolol strategy,C0004147;C0679199,true;false,1475/10465
nationality,C0027473,true,1476/10465
bl updrs : high,C0005918;C3639721;C0006413;C1552663;C2827109,true;true;true;false;false,1477/10465
history of paroxysmal atrial fibrillation  n ( % ),C0729790;C0205311,false;false,1478/10465
biomarker status,C0449442,false,1479/10465
nicotine pack - years,C0028040;C1277691,true;false,1480/10465
congestive heart failure — no . ( % ) | |,C0018802,true,1481/10465
fibrin - specific,C0015982,true,1482/10465
≥ nmbr . nmbr to < nmbr . nmbr years,C0053917;C0439234;C1334884,true;false;false,1483/10465
duration of hypertension ( years ),C0449238;C0020538;C0439234;C1963138;C2926735,false;true;false;false;false,1484/10465
therapy ( asa nmbr / placebo nmbr ),C0039798;C0004057;C0053917;C0032042;C1696465;C1706408;C1334884;C3853627;C0087111;C1363945,true;true;true;true;false;false;false;false;true;false,1485/10465
nmbr prolonged antithrombotic pretreatment ( n = nmbr ),C0053917;C1334884,true;false,1486/10465
isolated igt,C0205409;C1548221,false;false,1487/10465
pasi < nmbr *,C4528685;C0053917;C1334884,false;true;false,1488/10465
nmbr locf ),C0053917;C2825507;C1334884,true;false;false,1489/10465
uacr ( mgg - nmbr ),C0053917;C1334884,true;false,1490/10465
vorapaxar placebo nmbr - yr . km % rate,C2974521;C0032042;C0053917;C0439234;C3887676;C0871208;C1521828;C1334884;C1696465;C1706408,true;true;true;false;false;false;false;false;false;false,1491/10465
change from baseline  adjusted mean ( nmbr % ci )  %,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1492/10465
paclitaxel - eluting,C0144576,true,1493/10465
distal anastomosis ( % ),C0448964,false,1494/10465
< nmbr ml / min / nmbr . nmbr mnmbr — no . ( % ),C0053917;C0439445;C1334884,true;false;false,1495/10465
atrial fibrillation  n ( % ),C0004238;C0344434;C1963067,true;false;false,1496/10465
uacr  mg / mmol ( interquartile range ) b,C0567349;C1711350;C2348885,false;false;false,1497/10465
fasting glucose  mmol / l  mean ± sd,C0015663;C0017725;C1532563;C0444504;C2699239;C2347634;C2348143,true;true;false;false;false;false;false,1498/10465
coronary artery bypass surgery,C0010055,true,1499/10465
prior cardiovascular event — no . ( % ),C0332152;C1320716;C2826257,false;false;false,1500/10465
concomitant atorvastatin dose  mg,C0521115;C0286651;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,false;true;false;true;true;false;false;false;false;false;false;false,1501/10465
n ( indacaterol nmbr ug / indacaterol nmbr ug / placebo ),C0369718;C1722260;C0053917;C1319635;C0032042;C1696465;C1706408;C1334884;C0441922,false;true;true;false;true;false;false;false;false,1502/10465
etanercept,C0717758,true,1503/10465
aortic stenosis  n ( % ),C0003507,true,1504/10465
pretreatment / concomitant treatment,C1550147;C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2709094;C3539075;C3539076,false;false;true;true;false;false;false;false;false;false;false;false,1505/10465
circumflex,C1880089,false,1506/10465
diuretic drugs  n ( % ),C0012798;C0013227;C3687832,true;true;false,1507/10465
baseline median ( iq range ),C0168634;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false;false;false,1508/10465
serum sodium — meq / liter,C0523891;C0439152;C0475211,false;false;false,1509/10465
pacific islander,C0242191,true,1510/10465
hbalc > = nmbr % ( n - nmbr ),C0053917;C1334884,true;false,1511/10465
hbanmbrc ( % ) all countries,,,1512/10465
prior diabetes,C0332152;C0011847;C0011849;C2826257,false;false;true;false,1513/10465
number of events / patients,C4330837;C0030705;C2360800;C0441471;C3541888,false;true;false;false;false,1514/10465
coronary heart disease,C0010054;C0010068;C1956346,true;true;true,1515/10465
mean sgrq total score ( sd ),C3533236;C0439175;C2699239;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,1516/10465
managed medically — no . / total no . ( % ),C1273870,false,1517/10465
postoperative glucocorticoid use,C0032790;C0017710;C0042153;C0457083;C1947944,true;true;true;false;false,1518/10465
losartan + placebo,C0126174;C0032042;C1696465;C1706408,true;true;false;false,1519/10465
geographical region ( % ),C0017446,true,1520/10465
serum haemoglobin anmbrc concentration ( % )  mean ( sd ),C0683149;C0019046;C0444504;C2699239;C2347634;C2348143;C0229671;C0019029;C1314664;C1318517;C1546774;C1550100,false;true;false;false;false;false;true;false;false;false;false;false,1521/10465
creatinine ≥ nmbr . nmbr mg / dl,C0010294;C0053917;C0439269;C1334884;C1561535,true;true;false;false;false,1522/10465
previous balloon angioplasty  n ( % ),C0205156;C0002996;C0002997;C1552607,false;true;true;false,1523/10465
thrombolytic treatment before randomization,C0016018;C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0520997,true;true;true;true;false;false;false;false;false;false,1524/10465
apixaban,C1831808,true,1525/10465
urgent cor revasc,C0439609;C0018787;C0378365;C0056331;C3272275,false;true;true;true;false,1526/10465
diabetic treatments !,C0241863;C0087111,false;true,1527/10465
primary ep ( cvd / mi / ri ),C0205225;C1880476;C0007222;C3810814;C0035487;C1826843;C4321526;C0439612;C0439631,false;false;true;false;true;false;false;false;false,1528/10465
cv death / mi / stroke,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,1529/10465
ticlopidine ( n = nmbr ),C0040207;C0053917;C1334884,true;true;false,1530/10465
alt  ast  or both > nmbrx uln,C3831581,false,1531/10465
qualifying nstemi  n ( % ),C1514624;C3537184;C4255010,false;false;true,1532/10465
baseline nihss score  median ( range ),C0168634;C1697238;C1442488,true;false;false,1533/10465
scr  gmol / l,C1539487;C4050416,false;false,1534/10465
baseline cardiovascular medication  c n ( % ),C0168634;C0007220;C1442488,true;true;false,1535/10465
thienopyridine drug at start of open - label period,C1120149;C2348346;C1709323;C0439531;C1948053,true;false;false;false;false,1536/10465
egfr ( mumin / nmbr . nmbr mnmbr ),C1739039;C0053917;C1334884;C3811844;C3812682,true;true;false;false;false,1537/10465
median ( sd )  mg / mmol,C0549183;C2699239;C0567349;C2348885;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,1538/10465
double - vessel disease  n ( % ),C0205173;C0042373;C1705764;C1705765,false;true;false;false,1539/10465
lipid profile,C0023779;C1979963;C2003903,true;false;false,1540/10465
chronic obstructive pulmonary disease,C0024117,true,1541/10465
treatment difference  ml,C0039798;C1705241;C0439526;C1705224;C3887665;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;false;false;true;false;false;false;false;false,1542/10465
homa - ir  median ( qnmbr  qnmbr ),C0022065;C0549183;C0876920;C2347635;C2348144;C2939193;C0022071;C1448132,true;false;false;false;false;false;true;true,1543/10465
nmbr placebo n = nmbr,C0053917;C0032042;C1696465;C1706408;C1334884,true;true;false;false;false,1544/10465
concomitant mtx use  n ( % ),C0521115;C0025677;C0042153;C0457083;C1947944;C1417487,false;true;true;false;false;false,1545/10465
atorvastatin ls means difference nmbr mg ( nmbr % ci ) a ( n = nmbr ),C0286651;C0023668;C1704970;C1705241;C0053917;C0024671;C0008107;C3259781;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1705242,true;true;false;false;true;true;true;false;true;false;false;false;false;false;false;false,1546/10465
dmard | |,C0242708,true,1547/10465
calculated ldl cholesterol ( week nmbr ),C0444686;C0023824;C0332174;C0053917;C1334884;C0439230;C0202117;C1441506,false;true;false;true;false;false;false;false,1548/10465
median ( qnmbr : qnmbr ) total daily insulin dosenmbr,C0549183;C0439175;C0332173;C0021641;C1533581;C1579433;C3714501;C0439810;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false,1549/10465
hematologic,C0018943;C0205488,true;false,1550/10465
physician global assessment ( nmbr - nmbr mm vas ),C4050369;C0053917;C4330985;C0042815;C3536884;C3827561;C4554674;C1334884,false;true;false;true;true;false;false;false,1551/10465
ipf - related,C0034069;C1800706,true;true,1552/10465
history of major bleeding,C0019664;C0205082;C0019080;C0205164;C4318856;C4521762;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;true;false;false;false;false,1553/10465
fpg  mean ( sd )  mmol / l,C0444504;C2699239;C1532563;C2347634;C2348143,false;false;false;false;false,1554/10465
ldl - c ( bq ) ( mg / dl ) - mean ± sd,C2346983;C3642216;C0444504;C2699239;C2347634;C2348143;C0560038;C0439269;C3541236,false;false;false;false;false;false;false;false;false,1555/10465
body - mass index  !  waist - to - hip ratio,C0005893;C0205682;C0578022;C1305855,false;true;false;true,1556/10465
hba  % nmbrc,C0019016;C1825777;C3538758,true;false;false,1557/10465
current tobacco abuse  n ( % ),C0521116;C0040336;C1705970,false;true;false,1558/10465
hormone therapy,C0279025,false,1559/10465
total group ( n = nmbr ),C0439175;C0441848;C0053917;C1334884;C0439810,false;false;true;false;false,1560/10465
smoking pack year ( years ) fl,C0037369;C1277691;C0439234;C1300812;C1708024;C0439508;C0453996;C1881674,true;false;false;false;false;false;true;false,1561/10465
( nmbr % ell ' ll  * non - hdl - c,C0053917;C1427925;C3273466;C1334884,true;false;false;false,1562/10465
terol  hdl - c  high - density lipoprotein cholesterol ,C0023822,true,1563/10465
age at first seizure  years  mean ( sd ),C1510829;C0205435;C0036572;C0444504;C2699239;C2347634;C2348143;C1959629;C4553401;C1279901,false;false;true;false;false;false;false;false;false;false,1564/10465
glomerular,C0022663;C0268731,true;false,1565/10465
median blood eosinophil count  cells per pla,C0549183;C0200638;C0456170;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1566/10465
cv death or first hhf,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,1567/10465
balloon angioplasty plus abciximab,C0002996;C0332287;C0288672;C0002997,true;false;true;true,1568/10465
lipoprotein ( a )  median ( ql  qnmbr )  nmol / l,C0065058;C0549183;C0439282;C0876920;C2347635;C2348144;C2939193;C0125953;C1096202;C1439335,true;false;false;false;false;false;false;true;false;false,1569/10465
osteoporosis,C0029456;C4554622,true;false,1570/10465
acute rheumatic disorders,C0001314,true,1571/10465
intensive control,C0162425;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false,1572/10465
treatment duration  days,C0444921;C0439228;C3259042,false;false;false,1573/10465
warfarin ( n = nmbr ),C0043031;C0053917;C1334884,true;true;false,1574/10465
reported hypertension *,C0684224;C0020538;C1963138;C0700287;C4319718,true;true;false;false;false,1575/10465
before bronchodilation,C1371299;C3537072,false;false,1576/10465
ccv history / condition at baseline,C0683519;C0168634;C1442488,false;true;false,1577/10465
ivabradine ( n = nmbr ),C0257190;C0053917;C1334884,true;true;false,1578/10465
bmi ( nmbr . nmbr  nmbr . nmbr ),C0578022;C0053917;C1334884,false;true;false,1579/10465
physical function ( nmbr - nmbr  short form - nmbr subscale ),C0597240;C0031843;C0053917;C1282927;C1806781;C2350002;C1334884;C0542341;C0700205;C1705273;C0700329;C0516981;C0348078;C0376315;C1522492;C4255237;C4049916,false;true;true;false;false;false;false;false;false;false;false;false;false;true;false;false;false,1580/10465
prior cerebrovascular disease,C0332152;C0007820;C2826257,false;true;false,1581/10465
reason for enrollment in active a — no . ( % ),C0392360;C1516879;C1696073;C3888021,false;false;false;false,1582/10465
medical characteristics,C0199168;C1521970;C0205476,false;false;false,1583/10465
medication use at baseline — no . ( % ),C0240320;C0168634;C1442488,false;true;false,1584/10465
age < nmbr years — no . ( % ),C1510829;C0053917;C1334884,false;true;false,1585/10465
planned valve surgery  n ( % ),C1301732;C0184252;C0038894;C0038895;C0543467;C1274039;C1186983;C1704414;C3888056,false;false;false;true;true;true;false;false;false,1586/10465
time from randomization to pci ( st - elevation mi )  min,C0040223;C0034656;C3541383,true;true;false,1587/10465
haq - di score ( nmbr - nmbr ),C3826998;C0449820;C0053917;C1334884;C4050231;C4321476,false;false;true;false;false;false,1588/10465
mean ( sd ) dasnmbr - nmbr ( esr ) *,C0444504;C2699239;C0053917;C3811131;C1334884;C2347634;C2348143,false;false;true;false;false;false;false,1589/10465
randomised treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,1590/10465
v alsartan / hctz  n ( % ),C0020261,true,1591/10465
nmbr year or more,C0053917;C0439234;C0439508;C1334884,true;false;false;false,1592/10465
crcb - ( ml / min )  mean ( s . e . ),C0439390;C0702093;C0444504;C2347634;C2348143;C1524029;C3813700;C0439445,false;false;false;false;false;false;false;false,1593/10465
three - vessel disease,C3272265,false,1594/10465
st - segment depression > nmbr . nmbr mv on admission  %,C0520887;C0053917;C1454484;C1705503;C4281602;C1334884,false;true;true;false;false;false,1595/10465
planned treatment duration  n ( % ),C4528394,false,1596/10465
z\tonastaiin,,,1597/10465
inadequate response / intolerance to prior therapy  %,C0205412;C0871261;C0231199;C0332152;C0039798;C0087111;C1363945;C1744706;C2355652;C1704632;C1706817;C2911692;C0439856,false;false;false;false;true;true;false;false;false;false;false;false;false,1598/10465
change from baseline in dasnmbr - esr  meannmbr sd,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1599/10465
cause of heart failure — no . ( % ),C0015127;C0018801;C0018802;C4554158;C1524003,true;true;true;false;false,1600/10465
predominant type of heparin,C1542147;C0332307;C0019134;C0770546;C1547052,false;false;true;false;false,1601/10465
western europe / australia / israel,C0043128;C0015176;C0022271;C0043129;C0004340,true;true;true;true;true,1602/10465
preoperative blood pressure ( mm hg ) patients fulfilling eligibility criteria,C0445204;C0005823;C0439475;C0030705;C1271104;C1272641,false;true;false;true;false;true,1603/10465
glucose  mmol / l,C0017725;C1532563,true;false,1604/10465
aspirin + clopidogrel ( n = nmbr ) nmbr . nmbr,C0004057;C0070166;C0053917;C1334884,true;true;true;false,1605/10465
retinopathy — %,C0035309;C1962966,true;false,1606/10465
pulmonary embolism,C0034065,true,1607/10465
mild or moderate copd,C2945599,false,1608/10465
prior ml ( before index acs ),C0332152;C0439526;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1705224;C3887665;C2826257,false;false;true;true;false;true;false;false;false;false;false;false,1609/10465
diabetes duration ( known )  % of patients,C0011847;C0449238;C2926735;C0011849,false;false;false;true,1610/10465
creatinine clearance ， : : nmbr ml / min  %,C0812399;C0053917;C0439445;C1334884,false;true;false;false,1611/10465
baseline hb < nmbr g nmbr nmbr n = nmbr,C0168634;C0062408;C0053917;C0439267;C1334884;C1442488,true;true;true;false;false;false,1612/10465
joint swelling,C0152031,false,1613/10465
nmbrmwd decrease > nmbr m,C0392756;C0053917;C0369637;C0441923;C1334884;C0547047,false;true;false;false;false;false,1614/10465
profound thrombocytopenia ( < nmbrxnmbr / l ),C0439808;C0040034;C0392386,false;true;false,1615/10465
body mass index  median  ( nmbrth — nmbrth percentiles )  kg / mnmbr,C0005893;C0549183;C1264641;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;true;false;false;false;false;false;false;false;true,1616/10465
associated with connective tissue disease,C0332281;C0009782,false;true,1617/10465
postbronchodilator lung function at screening,C2599594;C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,1618/10465
non – small - cell lung cancer,C0007131;C2984258;C3539721,true;false;false,1619/10465
prior anti - tnf therapy — no . ( % ),C0332152;C0281481;C2826257,false;false;false,1620/10465
all rosuva,,,1621/10465
peripheral edema,C0085649,false,1622/10465
insulin - na ' ive,C0021641;C0597484;C3435805;C4554334;C1272460;C1546968;C1879645;C4049872;C4552882;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false;false;false,1623/10465
gender  women n  % ),C0079399;C0043210;C1522384,true;true;true,1624/10465
mean ( sd ) swollen joint count *,C0444504;C2699239;C0451521;C2347634;C2348143,false;false;false;false;false,1625/10465
diuretic drugs ( excluding antialdosterone ),C0012798;C0013227;C3687832,true;true;false,1626/10465
hfpef ( ef n nmbr )  ( % ),C0053917;C1334884,true;false,1627/10465
extent of disease  n ( % ),C0449279;C4553144,false;false,1628/10465
tendonitis,C0039503,true,1629/10465
previous hypertension,C0205156;C0020538;C1963138;C1552607,false;true;false;false,1630/10465
oral contraceptives,C0009905,true,1631/10465
syncope — no . ( % ),C0039070;C3541349;C4554644,true;false;false,1632/10465
anatomic complexity characteristics,C0502371;C0439855;C1704241,false;false;false,1633/10465
conventional treatment,C2945704,false,1634/10465
left circumflex,C0205091;C1880089;C0443246;C1552822,false;false;false;false,1635/10465
amiodarone vs . placebo no . hazard ratio ( nmbr . nmbr % cl ),C0002598,true,1636/10465
number of pack - years,C0237753;C1277691;C0449788,false;false;false,1637/10465
baseline cardiac biomarkers,C0168634;C2735101;C2735102;C1442488,true;false;false;false,1638/10465
type nmbr diabetes duration  mean ( sd )  years,C1320657;C0053917;C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735;C1334884,false;true;false;false;false;false;false;false;false;false,1639/10465
oral study drug administered — no . / total no . ( % ),C0442027;C0013175;C4521986,false;true;false,1640/10465
diltiazem or verapamil,C0012373,true,1641/10465
major bleeding ( statin use vs non - use ),C0205082;C0019080;C0360714;C0042153;C0457083;C1947944;C0205164;C4318856;C4521762,false;true;true;true;false;false;false;false;false,1642/10465
placebo secukinumab pooled,C0032042;C3179547;C1696465;C1706408,true;true;false;false,1643/10465
bilateral disease ( % ) ' j ' ' j ',C1511113,false,1644/10465
pathological q waves,C0429090,false,1645/10465
leukocytes  nmbr / nl,C0023516;C0053917;C0027778;C0560008;C3892223;C1334884,true;true;true;false;false;false,1646/10465
lipid - lowering agents ( % ),C0086440,true,1647/10465
history of second prior mi,C0019664;C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;false;false;true;false;false;false;false,1648/10465
study medication — no . ( % ),C0557651;C0013227;C3244316;C4284232;C2603343,false;true;false;false;false,1649/10465
laboratory data  mean ( sd ),C0022877;C1511726;C0444504;C2699239;C2347634;C2348143;C3245479;C3714741;C3244292;C4283904,true;false;false;false;false;false;false;false;false;false,1650/10465
p value ( men versus women ),C1709380;C0025266,false;true,1651/10465
former n z nmbr,C0205156;C0053917;C1334884;C0750523,false;true;false;false,1652/10465
insulin : glucose ratio,C0021641;C0017725;C0456603;C1547037;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,1653/10465
tnmbrdm duration ( years ),C0449238;C0439234;C2926735,false;false;false,1654/10465
serum creatinine > nmbr pmol / l . n ( % ) |,C0201976;C0053917;C0439284;C1334884;C0600061,false;true;false;false;false,1655/10465
kellgren and lawrence radiographic reading grade nmbr — no . ( % ),,,1656/10465
data missing or no drug given,C1511726;C1551393;C1705492;C3272743;C3245479;C3714741,false;false;false;false;false;false,1657/10465
gpiib / iiia receptor inhibitor,C0016011;C0597357;C1999216,true;false;false,1658/10465
ethnic origin,C0015031,true,1659/10465
supine after nmbr minutes change from baseline,C0038846;C0053917;C0439232;C0700321;C0702093;C1282918;C2347166;C1334884,true;true;false;false;false;false;false;false,1660/10465
omega - nmbr fatty acid ( n = nmbr ),C1719844;C0053917;C0015684;C1334884,false;true;true;false,1661/10465
pulmonary rales  n ( % ),C0034642,true,1662/10465
< nmbr months  n ( % ),C0053917;C0439231;C1334884,true;false;false,1663/10465
fibrinogen  g / l,C0016006;C0439294;C0456615;C1167394;C2587184;C3540039,true;false;false;false;false;false,1664/10465
right ventriculardysfunction atinclusion,C0205090;C0444532,false;false,1665/10465
nace ( primary endpoint ),C2986535,false,1666/10465
micro - / macro - albuminuria  ckd and / or retinopathy,C0085672;C2984010;C0001925;C1561643;C1553035;C3811161;C4049106,false;false;true;true;false;false;false,1667/10465
interaction : treatment by psoriasis p valuenmbr,C1704675;C3258078,false;false,1668/10465
score > nmbr %  % of patients,C0449820;C0053917;C0030705;C1334884;C4050231,false;true;true;false;false,1669/10465
any aes  n ( % ),C1412268;C2699274,false;false,1670/10465
ace inhibitors or angiotensin ii,C0003015,true,1671/10465
des ( % previous stenting ),C0011702;C0205156;C0038257;C2348535;C1552607;C4551552,true;false;true;false;false;true,1672/10465
comparison with placebo ( mean,C1707455;C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,false;true;false;false;false;false;false,1673/10465
mean ( s . d . ) hbalc  %,C0444504;C2347634;C2348143,false;false;false,1674/10465
exercise,C0015259;C1522704,true;false,1675/10465
vascular territory # nmbr,C0005847;C1301808;C0053917;C1334884;C2983136;C1558950;C1801960,true;false;true;false;false;false;false,1676/10465
native hawaiian or other pacific islander,C0337920,true,1677/10465
control baseline ( n - nmbr ),C0243148;C0168634;C0053917;C1334884;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;true;false;false;false;false;false;false;false,1678/10465
rando . in na * *,C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false,1679/10465
estimated glomerular filtration rate - ml / min  median ( iqr ) ',C3811844;C0439445;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1680/10465
nyha class within past month — no . / total no . ( % ),C1882083;C4331910,false;false,1681/10465
aspirin group,C0004057;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1682/10465
non - hdl - c ( mg / dl ) - mean ± sd,C1518422;C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false;false,1683/10465
fibrinolytic for qualifying event,C0040044;C1514624;C0441471;C4019010,true;false;false;false,1684/10465
nmbr degree of ica stenosis 丰,C0053917;C0201519;C4034225;C1334884,true;false;false;false,1685/10465
calcium - channel blockers ( % ),C0006684;C2757014,true;false,1686/10465
duration of ra ( years ),C0449238;C3538806;C0439234;C4048756;C2926735,false;false;false;false;false,1687/10465
min  max,C0702093;C1524029;C3813700,false;false;false,1688/10465
estimated gfr  < nmbr ml min - nmbr nmbr . nmbr m - nmbr  n ( % ) a,C0750572;C0017654;C0053917;C0439445;C0369637;C0441923;C1334884;C1424601,false;true;true;false;false;false;false;false,1689/10465
ctn - l  ng / ml,C0917591;C0439275,true;false,1690/10465
chd + cerebral infarction,C0280604;C0007785;C3542407,false;true;false,1691/10465
fenofibric acid + moderate - dose statin,C0060179;C1709056;C0360714,true;false;true,1692/10465
highest tg tertile,C1522410;C0337445,false;false,1693/10465
days of study - drug administration ( % ) * * nmbr day,C2826182;C0150270;C0053917;C1334884;C3469597,false;false;true;false;false,1694/10465
emotional role,C0013987;C0035820;C1705810;C3871154;C0849912,true;true;false;false;false,1695/10465
antithrombotic therapy,C0039798;C0087111;C1363945,true;true;false,1696/10465
periprocedural medications — no . / total no .,C0013227;C0802604;C2598133;C4284232,true;false;false;false,1697/10465
kim nmbr ( pg / ml ),C0053917;C0439297;C1334884,true;false;false,1698/10465
mi or cad,C3810814,false,1699/10465
d - dimer levelsatinclusion,C0060323,true,1700/10465
any immunosuppressive agent,C0021081,true,1701/10465
tender joint count  of nmbr,C0451530;C0053917;C1334884,false;true;false,1702/10465
increased waist circumference,C0205217;C0455829;C0442805,false;true;false,1703/10465
cross - damp time : < l : llhrs : min ( n = nmbr ),C2828360;C0205381;C0040223;C0702093;C0053917;C1334884;C1524029;C3813700;C3541383;C3891560,false;false;true;false;true;false;false;false;false;true,1704/10465
aspirin only ( n = nmbr  nmbr ),C0004057;C0205171;C0053917;C1334884;C1720467,true;false;true;false;false,1705/10465
high risk with atherosclerotic vascular disease *,C0332167;C0004153;C3272283;C4050568;C4319571,false;true;false;false;false,1706/10465
metrex overall modified intention - to - treat population ? :,C0282416;C0392747;C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C3889737;C1561607,true;false;true;true;true;true;false;false;false;false;false,1707/10465
basmi ( linear )  mean ( sd ),C0205132;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,1708/10465
cor revasc,C0018787;C0378365;C0056331,true;true;true,1709/10465
high ( > nmbr ) ( n = nmbr  nmbr  nmbr % ),C0205250;C0053917;C1334884;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false,1710/10465
adl subscale ( range  nmbr - nmbr ) *,C0001288;C1514721;C0053917;C1334884;C2348147;C3542016;C1420005,true;false;true;false;false;false;false,1711/10465
baseline statin usec,C0168634;C0360714;C0439224;C1442488,true;true;false;false,1712/10465
unbound pcsknmbr ( nmol / l ),C0439282,false,1713/10465
months from mi — median ( iqr ),C0439231;C3810814;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1714/10465
enthesitis count,C1282952;C0750480;C1705566,false;false;false,1715/10465
enalapril,C0014025,true,1716/10465
history of alcohol use,C0551571;C0552479,false;false,1717/10465
initiation of dialysis  renal transplantation  or creatinine . nmbr . nmbr mg / dl ( nmbr mmol / l ),C0589507;C0011946;C0040732;C0040733;C0019004;C4551529;C0011945;C0022671;C1059964;C1158830;C1704686,false;false;true;true;true;true;true;true;false;false;false,1718/10465
female race / ethnicity,C0043210;C0034510;C0015031;C0243103;C1706779;C3853635;C0086287;C1705497;C1705498,true;true;true;true;false;false;true;false;false,1719/10465
bsa affected  mean ± sd  %,,,1720/10465
timing of clopidogrel loading dose,C0449243;C0070166;C3714444;C1704250,false;true;false;false,1721/10465
week nmbr fpg  mean ( s . e . ),C0332174;C0053917;C0444504;C2347634;C2348143;C1334884;C0439230,false;true;false;false;false;false;false,1722/10465
crohn ' s disease - related medication at baseline  n ( % ),C0010346,true,1723/10465
post - menopausal ( a ),C0232970,false,1724/10465
saxagliptin nmbrmg ( n z nmbr ),C1611934;C0053917;C1334884,true;true;false,1725/10465
weight ( range ) ( kg ),C0005910;C1514721;C0022718;C0439209;C4054209;C2348147;C3542016;C0043100;C1305866;C1705104,true;false;true;false;false;false;false;true;false;false,1726/10465
monotherapy,,,1727/10465
small vessel,C0225988,false,1728/10465
history of microvascular disease — no . ( % ),C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,1729/10465
baseline sitosterol,C0168634;C0037215;C0220914;C1442488,true;true;true;false,1730/10465
hypertension and left ventricular hypertrophy,C0020538;C1963138,true;false,1731/10465
ls mean ( s . e . ) primary endpoint : % change from baseline to week nmbr,C0023668;C0444504;C2986535;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;true;false;false;false;false;false;false,1732/10465
severe n z nmbr,C0205082;C0053917;C1334884;C4050465;C4050466,false;true;false;false;false,1733/10465
arthritis,C0003864;C4552845,true;false,1734/10465
concurrent treatment of crohn ' s disease at study entry — no . of patients ( % ) ff,C0205420;C0039798;C0010346;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;false;false;false;false;false,1735/10465
extensive,C0205231,false,1736/10465
baseline corticosteroids *,C0168634;C0001617;C3539185;C3540725;C3540726;C3540727;C1442488,true;true;false;false;false;false;false,1737/10465
lv hypertrophy  n ( % ),C0149721,true,1738/10465
sex ( interaction : p = nmbr . nmbr ),C0009253;C1704675;C0053917;C1334884;C0036864;C0079399;C0804628;C1314687;C1522384,true;false;true;false;true;true;false;false;true,1739/10465
native hawaiian / other,C0337920,true,1740/10465
pain ( nmbr - nmbr mm vas ),C0042815;C0053917;C4330985;C4554674;C1334884,true;true;false;false;false,1741/10465
randomized,C0034656;C3815594,true;false,1742/10465
nmbrbaseline mean,C0444504;C2347634;C2348143,false;false;false,1743/10465
fc - ldl - c  mg / dl,C2983605;C0439269,false;false,1744/10465
patients with previous loss of response to and intolerance of infliximab *,C0030705;C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,true;false;false;false;false;false;false;false,1745/10465
other glp - nmbr receptor agonist,C0018301;C0053917;C4543206;C1334884;C1422069;C1425391;C1539338;C2350813,true;true;false;false;false;false;false;true,1746/10465
baseline hematocrit  median ( iqr ),C0168634;C0018935;C0549183;C0876920;C2347635;C2348144;C2939193;C0518014;C1442488,true;true;false;false;false;false;false;false;false,1747/10465
placebo event rate ( n = nmbr )  %,C0032042;C0441471;C0871208;C0053917;C1334884;C1521828;C4019010;C1696465;C1706408,true;false;false;true;false;false;false;false;false,1748/10465
history of amputation,C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,1749/10465
low - dose rivaroxaban + aspirin group,C2608320;C1739768;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;true;false;false;true;false;false;false,1750/10465
documented asymptomatic cardiac ischemiac,C1301725;C0231221;C0018787;C1522601;C1609436,false;false;true;false;false,1751/10465
seropositive ( rf + ve and / or acpa + ve ) subgroup,C0521143;C0035448;C0042469;C3714652;C4321495;C0201660;C0748398;C1547111,false;true;true;false;false;false;false;false,1752/10465
| ? ) - blocker  %,,,1753/10465
metabolizer phenotype ( % ) §,C0031437;C1285572,true;false,1754/10465
disease location / type : terminal ileum,C0457464;C0450429;C0227327;C1515974;C4284930;C4284931,false;false;false;false;false;false,1755/10465
selexipag ( n = nmbr ),C2000145;C0053917;C1334884,true;true;false,1756/10465
clinical presentation,C2708283,false,1757/10465
patients not receiving corticosteroids at baseline,C0030705,true,1758/10465
alteplase group ( n = nmbr ),C0032143;C0441848;C0053917;C1334884,true;false;true;false,1759/10465
obesity  % *,C0028754;C1963185,true;false,1760/10465
cardiovascular history — no . / total no . ( % ),C1880008,false,1761/10465
cardiac therapy  n ( % ) d,C3654025,false,1762/10465
femoral access — no . / total no . ( % ),C0015811,true,1763/10465
laboratory data,C0022877;C1511726;C3245479;C3714741;C3244292;C4283904,true;false;false;false;false;false,1764/10465
other drugs,C0013227;C3687832,true;false,1765/10465
apob : apoa - nmbr ratio,C0003593;C0003592;C0053917;C0456603;C1547037;C1334884;C0523508;C4553344;C4553379;C3252643,true;true;true;false;false;false;false;false;false;true,1766/10465
length of stay ( randomization to discharge  h ),C0023303;C0034656,true;true,1767/10465
nmbr - aminosalicylates | | | |,C0053917;C0368663;C1334884,true;false;false,1768/10465
peripheral - artery disease ( % ),C1704436;C4025272,true;false,1769/10465
severity of the disease ( gold nmbr )  n ( % ),C0521117;C0018026;C0053917;C1334884;C1304897,false;true;true;false;false,1770/10465
apixaban  nmbr . nmbr mg,C1831808;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,1771/10465
coronary bypass graft,C1260596,false,1772/10465
vascular disease indicator no ( n = nmbr ),C0042373;C0021212;C1235732;C1522602,true;true;false;false,1773/10465
laboratory values at randomization ( median and iqr ),C0022877;C0042295;C0034656;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904,true;false;true;false;false;false;false;false;false;false,1774/10465
acr  mg / mmol,C1412134;C0567349;C2348885;C1515941,false;false;false;false,1775/10465
tc / hdl - c,C0039411;C3715113;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,1776/10465
hbanmbrc at baseline  %,C0168634;C1442488,true;false,1777/10465
indication for stent,C0392360;C0038257;C3146298,false;true;false,1778/10465
history of intermittent claudication and abi < nmbr - nmbr or substantial peripheral arterial stenosis > nmbr %,C2315493;C0205267,false;false,1779/10465
months since ra was first diagnosed  mean ( sd ),C0439231,false,1780/10465
hemorrhagic stroke ( n = nmbr ),C0553692;C0053917;C1334884,true;true;false,1781/10465
mini - mental state examination,C0451306,true,1782/10465
number of stents implanted,C0237753;C0038257;C0449788,false;true;false,1783/10465
risk score category ( points ),C0035647;C0449820;C0683312;C3889287;C4050231;C4552904,true;false;false;false;false;false,1784/10465
microvascular complications  n ( % ) ’,C0443258;C0009566;C1171258,false;false;true,1785/10465
erosion score  median ( min  max ),C0333307;C0449820;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false;false;false;false;false;false;false;false;false,1786/10465
fevnmbr / fvc ( post salbutamol ),C3714541;C0687676;C0001927;C1704687;C3469826,true;false;true;false;false,1787/10465
type nmbr diabetes,C1320657;C0053917;C1334884,false;true;false,1788/10465
% predicted pre - bronchodilator fevnmbr  % *,C0681842;C2599602;C1882327,false;false;false,1789/10465
patients receiving corticosteroids at baseline,C0030705,true,1790/10465
odds ratio adj ( nmbr % cl ),C0028873;C0001552;C0053917;C0596019;C1334884;C2826286,true;true;true;false;false;false,1791/10465
no statin vs statin alone vs any statin plus other llt,C0360714,true,1792/10465
general and lumbar epidural,C0205246;C3812897;C3891294;C4521767,false;false;false;false,1793/10465
rf and acpa negativenmbr,C0035448;C0201660;C0748398;C1547111,true;false;false;false,1794/10465
hispanic,C0086409,true,1795/10465
onsetofaf  no . ( % ),,,1796/10465
percentage with disease duration < nmbr years,C0439165;C0872146;C0053917;C0439234;C1334884;C1549488;C1561533,false;false;true;false;false;false;false,1797/10465
doubling of creatinine †,C0205173;C0010294;C1561535;C1705764,false;true;false;false,1798/10465
diameter stenosis  mean ( sd )  %,C0552409;C0678234;C2699239;C1261287;C2632116,false;false;false;true;false,1799/10465
biologic naive,C0005515;C0205460,true;false,1800/10465
systemic corticosteroids  n ( % ) a,C4053960,false,1801/10465
europe ( non - eu ),C0015176;C1518422;C0015179;C3665627,true;false;true;false,1802/10465
fasting blood glucose ( mg / dl ),C0428568;C0439269;C1261430,false;false;false,1803/10465
fevnmbr reversibilityz ( pre / post ipratropium )  %,C0332152;C0687676;C0027235;C1704687;C3469826;C0740175;C2257086;C3669034,false;false;true;false;false;false;false;false,1804/10465
mean eosinophil count  per ml,C0444504;C0200638;C0439526;C1705224;C3887665;C0750879;C2347634;C2348143,false;false;false;false;false;false;false;false,1805/10465
men  total ( n 二 nmbr ),C0025266;C0439175;C0053917;C1334884;C0439810,true;false;true;false;false,1806/10465
rhabdomyolysis  myopathy  or myalgia with ck elevation > nmbrx uln,C0035410;C0026848;C4552660,true;true;false,1807/10465
rf positive  n ( % ),C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,1808/10465
without insulin or insulin - modifying therapy,C0021641;C1533581;C1579433;C3714501,true;false;false;false,1809/10465
hospitalized for heart failure during that time period,C0701159;C0018801;C0018802;C4554158,false;true;true;false,1810/10465
phospholipid omega - nmbr levels : < nmbr % ( n = nmbr ),C0031676;C1719844;C0053917;C0441889;C1334884;C0202177,true;false;true;false;false;false,1811/10465
clinical and laboratory measurements,C0205210,false,1812/10465
current medication — no . ( % ),C0746467,false,1813/10465
infliximab nmbr mg / kg,C0666743;C0053917;C0439272;C1334884,true;true;false;false,1814/10465
randomization - to -,C0034656,true,1815/10465
low hdl cholesterol,C0151691,false,1816/10465
history of chronic hf,C0019664;C0205191;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;true;false;false;false;false,1817/10465
race - non - white ( n = nmbr  nmbr ),C0034510;C1706779;C3853635,true;false;false,1818/10465
moderate teaes,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,1819/10465
sfc nmbr / nmbr mg twice daily ( n = nmbr ),C4521536;C0053917;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;false;true;false;false;false;false;false;false,1820/10465
time since diagnosis of type nmbr diabetes,C0040223;C3541383,true;false,1821/10465
riva roxa ban n / n { % ) nmbr ( nmbr . nmbr ),C0683610;C0053917;C1334884;C4553947,false;true;false;false,1822/10465
disease and quality - of - life scores,C0012634,true,1823/10465
laba / ics use at screening  n ( % ),C0815320;C4551720,false;true,1824/10465
mean change in radiographic end points,C0444504;C0392747;C0444708;C2349179;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,1825/10465
screening % predicted fevnmbr,C0220908;C0681842;C1882327;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;true;false;false;false;false;false,1826/10465
lntensityd,,,1827/10465
steroid use at baseline,C0281991;C0168634;C1442488,false;true;false,1828/10465
angina class at baseline,C0002962;C0456387;C0168634;C1442488;C1518526;C1705943,true;false;true;false;false;false,1829/10465
emotional status,C0013987;C0449438;C0849912,true;false;false,1830/10465
albuminuria ( g / g ),C0001925;C1319635,true;false,1831/10465
concomitant therapy,C1707479,false,1832/10465
thrombophilia,C0398623,true,1833/10465
mean — mg / dl level — no . ( % ),C0444504;C0439269;C0441889;C0456079;C1547707;C2946261;C2347634;C2348143,false;false;false;false;false;false;false;false,1834/10465
urine albumin - to - creatinine ratio - no . ( % ) § §,C0455271;C1318330,false;false,1835/10465
mean a ± sd ( mmhg ),C0444504;C2347634;C2348143,false;false;false,1836/10465
hdl cholesterol ( week nmbr ) a,C0023822;C0332174;C0053917;C1334884;C0439230;C0392885,true;false;true;false;false;false,1837/10465
low - dose rivaroxaban plus aspirin ( n = nmbr ),C2608320;C1739768;C0332287;C0053917;C1334884,false;true;false;true;false,1838/10465
clinical criterianmbr,C0205210,false,1839/10465
abatacept ( n = nmbr * ),C1619966;C0053917;C1334884,true;true;false,1840/10465
ind nmbr gg q . d . n / n ( % ),C4049864;C0053917;C0017454;C0018370;C1334884,false;true;true;true;false,1841/10465
lvef ( % )  mean ± sd,C0428772;C0444504;C2699239;C2347634;C2348143;C0488728,false;false;false;false;false;false,1842/10465
menopausal status and use of hrt ( % ) y,C1513126,false,1843/10465
renin inhibitor ( e . g . aliskerin ),C1960108;C3537174;C4521920,false;false;false,1844/10465
urine albumin - to - creatinine ratio,C0455271;C1318330,false;false,1845/10465
total n = nmbr n ( % ),C0439175;C0053917;C1334884;C0439810,false;true;false;false,1846/10465
chronic heart failure,C0018802;C0264716,true;false,1847/10465
type nmbr diabetes mellitus ’,C1320657;C0053917;C1334884,false;true;false,1848/10465
mean score on dasnmbr - nmbr ( crp ) ^,C3533236;C0053917;C3890735;C4048285;C1334884,false;true;false;false;false,1849/10465
orthostatic hypotension,C0020651,true,1850/10465
previous oral glucose - lowering agents  % of patients,C0205156;C1955477;C0441994;C0600419;C2003888;C1552607,false;false;false;true;false;false,1851/10465
aortic stenosis,C0003507,true,1852/10465
no . of patients / total no . ( % ),C0030705,true,1853/10465
any dose reduction,C0178602;C0301630;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;false;false;false;false;false,1854/10465
hazard ratio for event ( nmbr % ci ),C2985465;C0441471;C0053917;C0008107;C3259781;C1334884;C4019010,false;false;true;true;false;false;false,1855/10465
prior implantable cardiodefibrillator  n ( % ),C0332152;C0021102;C2826257,false;false;false,1856/10465
crp ( mg / l )  median ( min  max ),C3890735;C0439268;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false;false;false,1857/10465
gold nmbr groups  n ( % ),C0018026;C0053917;C1334884;C1304897,true;true;false;false,1858/10465
enalapril + aliskiren dm = nmbr non - dm = nmbr,C0014025;C1120110;C0011816;C0053917;C1518422;C1334884;C3250443,true;true;true;true;false;false;false,1859/10465
ics  mg / day,C0815320;C0439422;C4551720,false;false;true,1860/10465
psoriasis covering > nmbr % bsa  n ( % ) §,C0033860;C0180153;C0053917;C1334884;C0439844,true;false;true;false;false,1861/10465
antihypertensive drug  %,C0003364,true,1862/10465
mean ( sd ) post - bronchodilator fevnmbr reversibility  %,C0444504;C2699239;C2599594;C0449261;C2347634;C2348143,false;false;false;false;false;false,1863/10465
nmbr - nmbr ( severe ),C0053917;C1334884,true;false,1864/10465
stroke or pvd  ( % ),C0038454;C4554100,true;false,1865/10465
cabg > nmbr month ago,C0010055;C0053917;C0332177;C0439231;C1334884,true;true;false;false;false,1866/10465
history of percutaneous coronary intervention,C1320647;C4554713,false;false,1867/10465
current or previous atrial fibrillation,C0521116;C1705970,false;false,1868/10465
ace - inhibitor use,C0003015;C0042153;C0457083;C1947944;C4541021,true;true;false;false;false,1869/10465
anemia — no . ( % ) | |,C0002871;C1000483;C4554633,true;false;false,1870/10465
low - dose corticosteroid user,C0445550;C0001617;C1548600;C1706077;C3536709;C1708745,false;true;false;false;false;false,1871/10465
upper gastrointestinal,C3203348,true,1872/10465
cad history and risk factors  n ( % ),C1504769;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C2239547;C3813548;C4284121,true;true;true;false;false;false;false;false;false;false,1873/10465
das - nmbr ( crp ) < nmbr . nmbr  n ( % ),C0051767;C0053917;C3890735;C4048285;C1334884;C0057671,true;true;false;false;false;true,1874/10465
repaired chd,C0205340;C0280604;C3542407,false;false;false,1875/10465
gusto - defined bleeding,,,1876/10465
peripheral vasodilators,C0724804,false,1877/10465
mean ( sd ) number of albuterol per day  puff,C0444504;C2699239;C0237753;C0001927;C0449788;C2347634;C2348143,false;false;false;true;false;false;false,1878/10465
liraglutide ( n = nmbr  nmbr ),C1456408;C0053917;C1334884,true;true;false,1879/10465
angiotensin - converting enzyme or angiotensin receptor blocker,C0022709;C1452534,true;true,1880/10465
perianal or anus,C0442158,false,1881/10465
framingham nmbr - year cv risk score,C3166866;C0053917;C0439234;C3538987;C0035647;C0449820;C4050231;C4552904;C4048877;C4318503;C0439508;C1334884,false;true;false;false;true;false;false;false;true;false;false;false,1882/10465
native coronary - artery lesions,C0302891;C0205042;C0221198,false;true;false,1883/10465
current drinker,C0556297,false,1884/10465
placebo ls means ( n ),C0032042;C0023668;C1704970;C1696465;C1706408,true;true;false;false;false,1885/10465
( %  nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,1886/10465
duration of disease  years,C0872146;C0439234,false;false,1887/10465
musculoskeletal,C0497254;C2707260,false;false,1888/10465
severe ( gold nmbr ),C0205082;C0018026;C0053917;C1334884;C1304897;C4050465;C4050466,false;true;true;false;false;false;false,1889/10465
moderate thrombocytopenia ( < nmbrxnmbr / l ),C0205081;C0040034;C0392386;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,1890/10465
st change > nmbr mm,C0036056;C0392747;C0053917;C4330985;C4554674;C1334884;C0443172;C1705241;C4319952;C3272372,true;false;true;false;false;false;false;false;false;false,1891/10465
received an oral aha within nmbr weeks prior to screening,C1514756,false,1892/10465
stiffness subscale,C0427008,false,1893/10465
egfr < nmbr  n ( % ),C1739039;C0053917;C1334884;C3811844;C3812682,true;true;false;false;false,1894/10465
rec . ischemia requiring revasc,C1424025;C0022116;C0378365;C4321499;C2606415,false;true;true;false;true,1895/10465
type of concomitant statin,C0332307;C0521115;C0360714;C1547052,false;false;true;false,1896/10465
bmi ( kg / mnmbr ) [median ( nmbrth to nmbrth percentile ) ],C2923536;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209,false;true;false;false;false;false;false;false;false,1897/10465
moderate ( nmbr risk factor ),C0205081;C0053917;C0035648;C1334884;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false,1898/10465
timi risk score nmbr - nmbr,C0035647;C0449820;C0053917;C1334884;C4050231;C4552904,true;false;true;false;false;false,1899/10465
chronic obstructive pulmonary disease  n ( % ),C0024117,true,1900/10465
glycopyrronium nmbr mg ( n = nmbr ),C3814772;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,1901/10465
history of microvascular eye disease 本  n ( % ),C0683519;C0443258;C0015392;C0700042;C0730226;C0850708;C0944983;C0019664;C0015397;C0019665;C0262512;C0262926;C1705255;C2004062,false;false;true;false;false;false;false;true;true;true;false;false;false;false,1902/10465
oral aminosalicylates,C0442027;C0368663;C4521986,false;false;false,1903/10465
bmi kg - m - nmbr,C0578022;C1532718;C0053917;C1334884,false;false;true;false,1904/10465
mean ± sd triglycerides  mg / dl,C0444504;C2699239;C0041004;C0439269;C2347634;C2348143,false;false;true;false;false;false,1905/10465
type of des,C0332307;C0011702;C4551552;C1547052,false;true;true;false,1906/10465
white  n ( % ),C0007457;C0043157;C0220938,true;true;false,1907/10465
aspirin / antiplatelet,C0004057,true,1908/10465
any peripheral arterial disease,C0085096;C1704436,true;true,1909/10465
ldl cholesterol mean ( mg / dl ± sd ),C0023824;C0444504;C0439269;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,1910/10465
index event — no . ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,1911/10465
hospital factor # nmbr,C0019994;C1521761;C0053917;C1334884;C2827422;C1510665,true;false;true;false;false;false,1912/10465
baseline tobacco use,C0168634;C0040335;C0543414;C0841002;C3853727;C1442488,true;false;true;false;false;false,1913/10465
persistent anemia bsl hb < nmbrg i - nmbr  yr nmbr < nmbrg i nmbr,C0741008;C1549954;C0019046;C0021966;C0053917;C0439234;C1334884;C0221138,false;false;true;true;true;false;false;false,1914/10465
previously taken tnfi  %,,,1915/10465
troponin t,C0077404;C1420827,true;false,1916/10465
exacerbations in the previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,1917/10465
omega - nmbr fatty acid,C1719844;C0053917;C0015684;C1334884,false;true;true;false,1918/10465
stroke risk score,C1277291;C0449820;C4050231,false;false;false,1919/10465
daily insulin dose  mean ( sd )  iu,C2348070;C0021641;C0444504;C2699239;C0049272;C0439453;C0694756;C2347634;C2348143;C1533581;C1579433;C3714501;C0332173;C0366513,false;true;false;false;true;false;false;false;false;false;false;false;false;false,1920/10465
former or never,C0205156;C0750523,false;false,1921/10465
type nmbr diabetes duration  years,C1320657;C0053917;C0449238;C0439234;C2926735;C1334884,false;true;false;false;false;false,1922/10465
ccv history / condition,C0683519,false,1923/10465
microalbuminuria or proteinuria,C0730345,false,1924/10465
absolute risk difference ( ci )  % *,C1549031;C0035647;C0008107;C3259781;C4552904;C1519101;C1705241;C1705242,false;true;true;false;false;false;false;false,1925/10465
elevated at wk nmbr — no . ( % ) nmbr,C0205250;C0332174;C0053917;C1334884;C0439230;C3163633,false;false;true;false;false;false,1926/10465
proctosigmoiditis,C0033252,true,1927/10465
mean age ( years ) race,C0444504;C1510829;C2347634;C2348143,false;false;false;false,1928/10465
cat total score,C0007450;C2964552;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;true;false;false;false;false,1929/10465
nmbr no . of events,C0053917;C1334884,true;false,1930/10465
intervention group ( n = nmbr ),C0184661;C0441848;C0053917;C1334884;C0886296;C1273869,true;false;true;false;false;false,1931/10465
( nmbr % cl ) interaction,C0053917;C0596019;C1704675;C1334884,true;false;false;false,1932/10465
apoa - nmbr  g / l,C0003592;C0053917;C0439294;C0456615;C1334884;C0523508;C4553344;C4553379,true;true;false;false;false;false;false;false,1933/10465
yes  insulin - treated,C1549445;C0021641;C1533581;C1579433;C3714501;C1705108;C1710701,false;true;false;false;false;false;false,1934/10465
epa treatment ( n = nmbr ),C0039798;C0053917;C1334884;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,1935/10465
responders of three - item end point at nmbr weeks *,C0205449;C1551338;C2349179;C2826544;C4554251,false;false;false;false;false,1936/10465
systemic glucocorticoid use at randomisation,C0205373;C0017710;C0042153;C0034656;C0457083;C1947944,false;true;true;true;false;false,1937/10465
duration of tnmbrdm  y,C0449238;C2926735,false;false,1938/10465
ace inhibitors or angiotensin ii blockers,C0003015,true,1939/10465
physician ' s global assessment of dis -,C4050369;C0451119;C1444662;C1970187,false;false;false;true,1940/10465
clopidogrel no . of patients % ),C0070166,true,1941/10465
duration of crohn ' s disease ( yrs ),C0449238;C0010346;C2926735,false;true;false,1942/10465
multivessel intervention  n ( % ),C0184661;C0886296;C1273869,true;false;false,1943/10465
tertile nmbr,C0053917;C1334884,true;false,1944/10465
cabg surgery,C0010055;C0038894;C0038895;C0543467;C1274039,true;false;true;true;true,1945/10465
crp concentration > nmbr . nmbr mg / dl ( nmbr mg / l )  n ( % ),C3890735;C0086045;C0053917;C2827881;C3642216;C1334884;C1446561;C3827302;C4048285,false;true;true;false;false;false;false;false;false,1946/10465
fatal and nonfatal stroke,C1302234;C1705232,false;false,1947/10465
angiotensin - converting - enzyme inhibitor or angiotensin - receptor blocker §,C0003015;C2757044;C3536837;C4541021,true;false;false;false,1948/10465
ace - i / arb  ( % ),C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,1949/10465
gliclazide ( modified release ) 一 no . ( % ) ^,C0017631,true,1950/10465
conventional treatment ( n = nmbr ),C2945704;C0053917;C1334884,false;true;false,1951/10465
currentother ( notpredefined ) medical conditions,C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,1952/10465
history of coronary revascularization,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,1953/10465
concomitant conventional dmard use,C0521115;C0439858;C0242708;C0042153;C0457083;C1947944,false;false;true;true;false;false,1954/10465
dual antiplatelet,C0205173;C1554184,false;false,1955/10465
digitalis,C0012252;C0304520,true;false,1956/10465
active or previous cancer,C0205177;C3853793;C3888249,false;false;false,1957/10465
therapy at discharge,C0039798;C0012621;C0030685;C2926602;C0087111;C1363945,true;false;true;false;true;false,1958/10465
north america hr ( nmbr % cl ),C0028405;C0053917;C0596019;C1334884,true;true;false;false,1959/10465
intermediate ( nmbr ) ( n = nmbr  nmbr  nmbr % ),C0205103;C0053917;C1334884;C1550465;C2827755;C3889971,false;true;false;false;false;false,1960/10465
male sex — no . ( % ) race — no . ( % ) ) :,C0086582,true,1961/10465
primary end point kaplan - meier rate  %,C2986535;C0871208;C1521828,false;false;false,1962/10465
all ~ cause mort / hf hosp .,C0015127;C3815322;C0018488;C1313497;C1538440;C3273279;C1524003,true;false;true;true;false;false;false,1963/10465
haemodynamics and lv function,C0019010;C4281788,true;false,1964/10465
duration of study - drug infusion,C0449238;C0557651;C0392877;C2603343;C2926735,false;false;false;false;false,1965/10465
salmeterol nmbr gg bid,C0073992;C0053917;C0017454;C0018370;C1334884,true;true;true;true;false,1966/10465
p value for adjusted hr,C1709380;C0456081,false;false,1967/10465
vitamin k antagonist ( e . g . warfarin / coumarol ),C1096489;C2267235,false;false,1968/10465
a / v ( n = nmbr ),C1272460;C0053917;C1334884,false;true;false,1969/10465
unknown,C0439673;C3541433;C4050014,false;false;false,1970/10465
ff / vi nmbr / nmbr pg od,C4554348;C0205999;C0053917;C0030827;C0229089;C0439164;C1512019;C3273373;C3665488;C0072225;C1266240;C1334884,false;true;true;true;false;false;false;true;true;true;false;false,1971/10465
ivabradine group,C0257190;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1972/10465
comparison with baseline ( mean,C1707455;C0168634;C0444504;C2347634;C2348143;C1442488,false;true;false;false;false;false,1973/10465
irofiban,,,1974/10465
laba / lama,C0999593;C1416775,false;false,1975/10465
< nmbr years eze / simva,C0053917;C0439234;C1334884,true;false;false,1976/10465
placebo ( dm - vs . dm + ),C0032042;C0011816;C3250443;C1696465;C1706408,true;true;false;false;false,1977/10465
o total randomized,C0483204;C0439175;C0439810,false;false;false,1978/10465
cabgorptca,,,1979/10465
total patients n = nmbr,C0439175;C0030705;C0053917;C1334884;C0439810,false;true;true;false;false,1980/10465
left circumflex artery,C0226037,false,1981/10465
lebrikizumab ( n = nmbr ),C2981360;C0053917;C1334884,true;true;false,1982/10465
disease duration  median ( range ) years,C0872146;C0549183;C1514721;C0439234;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,1983/10465
bl updrs : low,C0005918;C3639721;C0006413;C1552663;C2827109,true;true;true;false;false,1984/10465
fevnmbr % reversibility,C0449261,false,1985/10465
lipoprotein ( a ) tx difference vs pbo  ls mean % change from baseline ( se ),C0065058;C0041403;C1705241;C1705242;C0125953;C1096202;C1439335,true;true;false;false;true;false;false,1986/10465
( $ nmbr mg / dl [nmbr . nmbr mmol / l] ),C0053917;C0439269;C1532563;C1334884,true;false;false;false,1987/10465
very high risk,C0442804;C0035647;C4552904;C4321397;C0442824;C0332167;C3272283;C4050568;C4319571;C2984081,false;true;false;false;false;false;false;false;false;false,1988/10465
location of crohn ' s disease  %,C0450429;C0010346;C1515974;C4284930;C4284931,false;true;false;false;false,1989/10465
baseline diabetes,C0168634;C0011847;C0011849;C1442488,true;false;true;false,1990/10465
number of vessels disease,C0237753;C0042373;C0449788,false;true;false,1991/10465
patient history of disease n ( % ),C0030705;C0683519;C0730226;C0850708;C0944983,true;false;false;false;false,1992/10465
tocilizumab ( n = nmbr ),C1609165;C0053917;C1334884,true;true;false,1993/10465
mean ( sd ) duration of smoking  pack years,C0444504;C2699239;C0449238;C0037369;C1277691;C0453996;C1881674;C2926735;C2347634;C2348143,false;false;false;true;false;true;false;false;false;false,1994/10465
difference ( a ) vs placebo ( nmbr % cl ),C1705241;C1705242,false;false,1995/10465
nmbr . nmbr - nmbr . nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,1996/10465
demographic characteristics,C0683970,false,1997/10465
ezetimibe use,C1142985;C0042153;C0457083;C1947944,true;true;false;false,1998/10465
subset of patients on metformin,C1515021;C0030705,false;true,1999/10465
nmbr vessels or left main,C0053917;C0005847;C1334884,true;true;false,2000/10465
congenital shunts,C0009678;C0232180;C0542331;C1442858;C1744681,true;false;false;false;false,2001/10465
eze / simva gender,C0079399;C1522384,true;true,2002/10465
methotrexate dose at baseline,C0025677;C0178602;C0168634;C1442488;C0869039;C1114758,true;false;true;false;false;false,2003/10465
neoplasia  n ( % ),C0027651;C1882062,true;false,2004/10465
mesothelin ( ng / ml ),C0380162;C0439275;C1334533,true;false;false,2005/10465
non - smoker ( n = nmbr  nmbr ),C0337672;C0053917;C1334884;C0425293;C4554605,false;true;false;false;true,2006/10465
amlodipine / valsartan nmbr / nmbr mg / v = nmbr,C1962523;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2007/10465
> nmbr . nmbr hdl cholesterol level,C0053917;C0023822;C0441889;C0456079;C1547707;C2946261;C0392885;C3715113;C0201950;C0428466;C1334884,true;true;false;false;false;false;false;false;false;false;false,2008/10465
past or current angina pectoris,C1444637;C4284302,false;false,2009/10465
history of peripheral vascular disease,C1881056,false,2010/10465
group — no . ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,2011/10465
number of treated vessels ( per patient ),C0237753;C1522326;C0005847;C0449788,false;false;true;false,2012/10465
ranolazine  n = inmbrinmbr,C0073633,true,2013/10465
prior failure of anti - tnf therapy — no . ( % ),C0332152;C0231174;C0281481;C0680095;C2826257,false;false;false;false;false,2014/10465
concomitant medications for ulcerative colitis — no . ( % ),C0521115;C0013227;C0009324;C0802604;C2598133;C4284232,false;true;true;false;false;false,2015/10465
lipid - lowering therapy,C0585943,false,2016/10465
dlqi  nmbr - nmbr *,C3899393;C0053917;C1334884,false;true;false,2017/10465
patients treated for > nmbr weeks ( % ),C0030705,true,2018/10465
immunomodulatory agents,C0005525,true,2019/10465
endothelin - receptor antagonists,C1134681;C2266875,true;false,2020/10465
nt - probnp  median ( iqr )  pg / ml,C0669479;C0549183;C0439297;C0876920;C2347635;C2348144;C2939193;C0754710,true;false;false;false;false;false;false;true,2021/10465
hosp . for hf,C0018488;C1313497;C1538440;C3273279,true;true;false;false,2022/10465
alcohol use ( > nmbr drink / wk ),C0556297;C0042153;C0053917;C0332174;C0439230;C1334884;C0457083;C1947944;C0001948;C0452428,false;true;true;false;false;false;false;false;true;false,2023/10465
st - segment elevation mi,C0520886;C3810814,false;false,2024/10465
history of dyspepsia,C0019664;C0013395;C4552968;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,2025/10465
ncep risk category at study entry  n ( % ),C0035647;C2983287;C1705654;C2983669;C4552904,true;false;false;false;false,2026/10465
treated hypertension :,C1522326;C0020538;C1963138,false;true;false,2027/10465
presence of dactylitis  n ( % ),C0150312;C0239161;C0392148;C3854307,false;false;false;false,2028/10465
placebo every nmbr weeks ( n = nmbr ),C0032042;C1696465;C1706408,true;false;false,2029/10465
heart rate  mean ± sd ( b . p . m . ),C0018810;C0444504;C2699239;C0369637;C0441923;C2347634;C2348143,true;false;false;false;false;false;false,2030/10465
post - bronchodilator fevnmbr  reversibility percentage of baseline value,C2599594;C0449261;C0439165;C0168634;C1522609;C1442488;C1549488;C1561533,false;false;false;true;false;false;false;false,2031/10465
intense physical activity,C0522510;C0015259;C0026606,false;true;true,2032/10465
concomitant drugs,C0521115;C0013227;C3687832,false;true;false,2033/10465
cholesterol absorption inhibitor ( ezetimibe ),C0003277;C0000854;C1142985;C2347023;C2347080;C2698776;C2825050;C2945742;C1999216,true;false;true;true;false;false;false;false;false,2034/10465
chanmbrdsnmbr - vasc score ( median  iqr ),C0449820;C0549183;C0876920;C2347635;C2348144;C2939193;C4050231,false;false;false;false;false;false;false,2035/10465
serum potassium — mmol / liter,C0302353;C0439190;C0475211;C0543465,false;false;false;false,2036/10465
nadroparin vs control,C0206232,true,2037/10465
type of event — no . ( % ),C1561488,false,2038/10465
stroke or tia — no . ( % ),C0038454;C4554100,true;false,2039/10465
previous major bleeding,C0205156;C0205082;C0019080;C0205164;C4318856;C4521762;C1552607,false;false;true;false;false;false;false,2040/10465
coexisting conditions,C0679225,false,2041/10465
characteristics of pulmonary embolism at inclusion,C1521970;C0034065,false;true,2042/10465
time of symptom onset to randomization ( hrs ),C1320528,false,2043/10465
recurrent heart failure,C1455761;C0018801;C0018802;C4554158;C2945760,false;true;true;false;false,2044/10465
all completers ( n nmbr nmbr ),C0053917;C1334884,true;false,2045/10465
qualifying hbanmbrc ( % ),C1514624,false,2046/10465
medically important infectionsa,C3898777;C4084912,false;false,2047/10465
three arm,C0205449;C0446516;C3715044;C4553528,false;true;false;false,2048/10465
after nmbr h,C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,2049/10465
fevnmbr % pred,,,2050/10465
copd assessment test ( cat ) score,C4284282;C0007450;C0449820;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461,false;true;false;false;false;true;false;false;false,2051/10465
aspirin use ( > nmbr mg ),C0004057;C0042153;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0457083;C1947944,true;true;true;true;true;false;false;false;false;false;false;false;false,2052/10465
moderate ( gold nmbr ),C0205081;C0018026;C0053917;C1334884;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false;false,2053/10465
no ascvd + additional cv risk factors  n ( % ),C3665365;C1524062;C3538987;C0035648;C1553898;C4048877;C4318503,false;false;false;true;false;true;false,2054/10465
arb / ace,C3888198;C1452534;C4284014,false;true;false,2055/10465
hypertension serum lipid values,C0020538;C0428462;C0042295;C1963138,true;false;false;false,2056/10465
measured at clinic visit with usual device,C0444706;C0008952;C3541902,false;true;false,2057/10465
average maximum cimt ( mm ),C1510992;C0806909;C4330985;C4554674;C1552615;C2826546;C2825518,false;false;false;false;false;false;false,2058/10465
thrombophilia  no . ( % ) e,C0398623,true,2059/10465
health assessment questionnaire - disability index,C4321476,false,2060/10465
median ( qnmbr : qnmbr ) lp ( a )  mg / dl,C0549183;C0065058;C0439269;C1439335;C4553379;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,2061/10465
any clinical ae,C0205210;C3887670,false;false,2062/10465
mean ( sd ) feno  ppb,C0444504;C2699239;C1415800;C2347634;C2348143,false;false;false;false;false,2063/10465
cdai score §,C0683448;C1413248;C3273706,false;false;false,2064/10465
unfractionated,,,2065/10465
physical and cognitive examination : ! :,C0031809;C0205485;C1509143,true;false;false,2066/10465
syst . bp ( mmhg ),C0037623;C0439475;C1415692;C1708288;C4318478,true;false;false;false;false,2067/10465
medications at discharge or day nmbr  if earlier ( % ),C0806915,false,2068/10465
drug discontinuation not due to death,C0013227;C0457454;C1444662;C4552847;C1254351,true;false;false;false;false,2069/10465
congestive heart failure ( < nmbr wk ),C0018802;C0053917;C0332174;C0439230;C1334884,true;true;false;false;false,2070/10465
aliskiren,C1120110,true,2071/10465
physician global assessment of disease activity ( vas nmbr - nmbr mm ),C4050369;C0042815;C0053917;C4330985;C4554674;C1334884;C3536884;C3827561,false;true;true;false;false;false;true;false,2072/10465
baseline dlco . mmol kpa - ’ -,C0168634;C1516251;C0439190;C0263428;C0439474;C1442488,true;false;false;true;false;false,2073/10465
role emotional,C0035820;C0013987;C0849912;C1705810;C3871154,true;true;false;false;false,2074/10465
baseline ( geometric mean  cv ),C0168634;C2986759;C3538987;C4048877;C4318503;C1442488,true;false;false;true;false;false,2075/10465
pah classification,C0030123;C0008902;C0008903;C0678229;C3203102;C4284467,true;true;true;false;true;false,2076/10465
days without albuterol use  * %,C0439228;C0001927;C0042153;C0457083;C1947944,false;true;true;false;false,2077/10465
simva ( % ),,,2078/10465
treatment with open - label perindopril,C3640652;C0136123,false;true,2079/10465
new diabetes — no . ( % ),C0205314;C0011847;C0011849,false;false;true,2080/10465
adjusted change from baseline mean ( s . e . ),C0456081;C0392747;C0168634;C0444504;C2347634;C2348143;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false;false;false;false,2081/10465
$ nmbrand  nmbr years,C0053917;C0439234;C1334884,true;false;false,2082/10465
fpg ( range ) ( mmol / l ),C1514721;C1532563;C2348147;C3542016,false;false;false;false,2083/10465
arterial graft,C0450140,false,2084/10465
any established coronary artery disease,C0443211;C0010054;C0010068;C1956346;C1272684,false;true;true;true;false,2085/10465
time to treatment ( min ) t,C3494202;C0702093;C1524029;C3813700,true;false;false;false,2086/10465
serum potassium : < nmbr . nmbrmmol / l ( n = nmbr ),C0302353;C0053917;C1334884;C0543465,false;true;false;false,2087/10465
hemoglobin concentration — g / liter,C1319312;C0086045;C0475211;C1446561;C3827302;C0019029;C0439267;C1314664;C1318517,false;true;false;false;false;false;false;false;false,2088/10465
clopidogrel + aspirin ( n = nmbr ),C0070166;C0004057;C0053917;C1334884,true;true;true;false,2089/10465
previous metformin use  %,C0205156;C0025598;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,2090/10465
current ( % ),C0521116;C1705970,false;false,2091/10465
ecg findings at baseline — no . ( % ),C0438154;C0168634;C1442488,false;true;false,2092/10465
concomitant therapies n ( % ),C1707479,false,2093/10465
baseline therapy,C0168634;C0039798;C0087111;C1363945;C1442488,true;true;true;false;false,2094/10465
hbanmbrc nmbr . nmbr to < nmbr . nmbr % ( nmbr - nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,2095/10465
history of recurrent venous thromboembolism,C0455533;C1455761;C0042449;C0348013;C2945760,false;false;true;false;false,2096/10465
magnetic resonance angiography,C0243032,true,2097/10465
free fatty acids — mmol / liter,C0015688;C0439190;C0475211,true;false;false,2098/10465
baseline post - bronchodilator % predicted fev  > nmbr % and no concurrent tiotropium,C0168634;C1442488,true;false,2099/10465
id genotype,C0009450;C0017431;C0600091;C1441613,true;true;false;false,2100/10465
major coronary,C0205082;C0018787;C0205164;C4318856;C4521762,false;true;false;false;false,2101/10465
cardiac rhythm disorders,C0264886,true,2102/10465
previous ischemic stroke  n ( % ),C0205156;C0948008;C1552607,false;false;false,2103/10465
apolipoprotein b tx difference vs pbo  ls mean % change from baseline ( se ),C0003593;C0041403;C1705241;C1705242,true;true;false;false,2104/10465
history of macroalbuminuriat  n ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,2105/10465
high ( > nmbr risk factor ),C0332167;C0053917;C1521761;C2827422;C1334884;C3272283;C4050568;C4319571;C0205250;C0035648;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false,2106/10465
psoriasis affecting > nmbr % of body - surface,C0033860;C0392760;C0053917;C0489451;C1334884;C1314939,true;false;true;false;false;false,2107/10465
asthma duration ( sd )  years,C0004096;C0449238;C2699239;C0439234;C2926735;C2984299,true;false;false;false;false;false,2108/10465
glucose metabolism,C0596620,false,2109/10465
glycated hemoglobin  median ( iqr ),C0017853;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,2110/10465
blood pressure  mean ± sd mm hg,C0428886;C2699239;C0439475,true;false;false,2111/10465
fpi  mean ( sd )  pu / mlt,C0444504;C2699239;C0018387;C4553833;C2347634;C2348143,false;false;true;false;false;false,2112/10465
secondary # nmbr,C0027627;C0053917;C1334884;C0175668;C0205436,true;true;false;false;false,2113/10465
nmbr . nmbr - nmbr . nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,2114/10465
primary pci no .,C0205225;C4049621;C0439612;C0439631,false;false;false;false,2115/10465
rectum and sigmoid colon only,C0034896,true,2116/10465
radial access — no . / total no . ( % ),C0442038;C0920847,false;false,2117/10465
oral blood glucose - lowering,C0442027;C0005802;C0441994;C2003888;C4521986,false;true;false;false;false,2118/10465
age nmbr + yrs,C0001779;C0053917;C1334884,false;true;false,2119/10465
> nmbr . nmbr pmol / liter hscrp level,C0053917;C0439192;C0475211;C0441889;C0456079;C1547707;C2946261;C1334884,true;false;false;false;false;false;false;false,2120/10465
other ischaemic heart disease ( non - infarction ),C0010054;C1518422;C0021308;C0151744,true;false;true;true,2121/10465
calcium supplements,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,2122/10465
a mini - mental state examination  insulin glargine vs standard care,C0451306;C0907402,true;true,2123/10465
country : argentina ( n = nmbr ),C0454664;C0003761;C0053917;C1334884;C1504311;C1511538,false;true;true;false;false;false,2124/10465
estimated gfr — no . ( % ) nmbr,C0750572;C0017654;C1424601,false;true;false,2125/10465
received > nmbr prior anti - tnf therapies  n,C1514756;C0053917;C0332152;C0432633;C0279936;C2826257;C1334884,false;true;false;false;false;false;false,2126/10465
nmbr placebo ( n = nmbr nmbr ),C0053917;C0032042;C1696465;C1706408;C1334884,true;true;false;false;false,2127/10465
standard care n ( % ),C1442989;C1947933;C2828392,false;false;false,2128/10465
interval from clopidogrel loading  h,C1272706;C0070166;C1708715;C0033727;C0369286;C0441932;C0564385;C4528284;C1552654;C1552713,false;true;false;true;false;false;false;false;false;false,2129/10465
severity of copd *  n ( % ),C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,2130/10465
acr deciles,C1412134;C1515941,false;false,2131/10465
change at week nmbr,C0392747;C0332174;C0053917;C1334884;C0439230;C0443172;C1705241;C4319952,false;false;true;false;false;false;false;false,2132/10465
europe  israel  or australia,C0015176;C0022271,true;true,2133/10465
low density lipoprotein cholesterol - mg / dltt,C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2134/10465
other dmard use,C0242708;C0042153;C0457083;C1947944,true;true;false;false,2135/10465
duration of hypercholesterolemia ( yr ),C0449238;C0020443;C0439234;C1522133;C2926735,false;true;false;false;false,2136/10465
personal relationships,C1552027,false,2137/10465
heart failure or lvef < nmbr % associated with index acs event,C0018801;C0018802;C4554158,true;true;false,2138/10465
previous venous thromboembolism — no . ( % ),C0205156;C1861172;C1552607,false;true;false,2139/10465
prior biologic exposure,C0332152;C0005515;C0274281;C0332157;C0205460;C2826257,false;true;false;false;false;false,2140/10465
need for urgent coronary - artery bypass grafting,C0027552;C0439609;C0010055;C3272275;C0686904,true;false;true;false;false,2141/10465
egfr ( ml / min / nmbr - nmbr mz ),C1739039;C0439445;C0053917;C0026655;C1705291;C1334884;C3811844;C3812682,true;false;true;true;false;false;false;false,2142/10465
egfr ( mdrd )  ml / min / nmbr . nmbr mnmbr,C1739039;C3839656;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;false;true;false;false;false,2143/10465
previous stroke  n ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,2144/10465
alpha nmbr blockers,C0001641;C0053917;C1334884,true;true;false,2145/10465
moderate dysfunction,C3274776,false,2146/10465
tnf - rnmbra ( ng / ml ),C1448177;C0439275,true;false,2147/10465
jejunum,C0022378,true,2148/10465
neither ace - i nor arb use,C1452534;C0021966;C0221138;C4284014,true;true;false;false,2149/10465
history of vte * *,C0019664;C0630906;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2150/10465
d - dimer level  mean ( sd )  ng / mld,C0060323;C0441889;C0444504;C2699239;C0017887;C0023522;C1539265;C3539688;C3539689;C0028074;C2347634;C2348143;C0456079;C1547707;C2946261,true;false;false;false;true;true;false;false;false;true;false;false;false;false;false,2151/10465
gfr ( ml / min per nmbr . nmbr nr ),C0017654;C0439445;C0053917;C0027496;C3844738;C1334884;C1424601,true;false;true;true;false;false;false,2152/10465
diastolic fmmhff ' ),C0012000,true,2153/10465
diabetes duration  median ( iqr )  years,C0011847;C0449238;C0549183;C0439234;C0876920;C2347635;C2348144;C2939193;C2926735;C0011849,false;false;false;false;false;false;false;false;false;true,2154/10465
nmbr . nmbr ( nmbr nmbr . nmbr ),C0053917;C1334884,true;false,2155/10465
plaque score ( nmbr - nmbr ),C0429153;C0053917;C1334884,false;true;false,2156/10465
prior disease,C0332152;C0012634;C2826257,false;true;false,2157/10465
mean sd fpg  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,2158/10465
serum ctx ( ng / ml ),C0229671;C0010377;C0439275;C0631180;C3539598;C1546774;C1550100,true;true;false;true;false;false;false,2159/10465
baseline triglycerides in nmbr classes,C0168634;C0041004;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1442488,true;true;true;false;false;false;false;false;false,2160/10465
ff / vi nmbr mg / nmbr mg ( n = nmbr ),C4554348;C0205999;C0053917;C1319635;C1334884,false;true;true;false;false,2161/10465
previous anti - tnf therapy  n [ % ],C0205156;C0432633;C0279936;C1552607,false;false;false;false,2162/10465
dronedarone ( n = nmbr ),C0766326;C0053917;C1334884,true;true;false,2163/10465
standard ( nmbr ),C1442989;C0053917;C1334884;C2828392,false;true;false;false,2164/10465
age  median ( interquartile range )  y,C0001779;C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2165/10465
one or more copd exacerbations ( n / n [ % ] ),C0205447,false,2166/10465
peripheral embolism,C0205100;C0013922;C1704212,false;true;true,2167/10465
arterial blood pressure  mm hg,C1272641;C0439475,true;false,2168/10465
co - morbidities  a n ( % ),C0009488,true,2169/10465
oral hypoglycemic drugs only,C0359086;C0205171;C1720467,false;false;false,2170/10465
p value ( on vs off omt ),C1709380,false,2171/10465
mucocutaneous,,,2172/10465
any new anti - hyperglycemic rx,C0205314;C1425688;C1521941;C2709207,false;false;false;false,2173/10465
metsyn with ldl > nmbr . nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,2174/10465
severe or worse airflow limitation,C0205082;C4050465;C4050466,false;false;false,2175/10465
periprocedural anticoagulant,C0003280;C0848112;C3536711,true;false;false,2176/10465
lsms difference ( nmbr % ci ) nmbr,C1705241;C0053917;C0008107;C3259781;C1334884;C1705242,false;true;true;false;false;false,2177/10465
age  y sex  no . ( % ),C0001779;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,false;true;true;true;false;false;true,2178/10465
blood eosinophil,C0014467,true,2179/10465
pah classification — no . ( % ),C0030123;C0008902;C0008903;C0678229;C3203102;C4284467,true;true;true;false;true;false,2180/10465
short - acting bnmbr - agonists,C1282927;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;true;false;false;true;false;false;false;false,2181/10465
fevnmbr reversibility  pre - / post - albuterol  %,C0449261;C0332152;C0687676;C0001927;C1704687;C3469826;C0740175;C2257086;C3669034,false;false;false;true;false;false;false;false;false,2182/10465
ischemia on cecg ( n = nmbr  nmbr ),C0022116;C0053917;C1334884;C4321499,true;true;false;false,2183/10465
ularitide n / n ( % ),C0077910,true,2184/10465
three of seven risk factors,C0205449;C0205453;C0035648;C1553898,false;false;true;false,2185/10465
moderately high risk without atherosclerotic vascular disease *,C0205081;C0332167;C0004153;C3272283;C4050568;C4319571;C1881878;C4085643;C4321491,false;false;true;false;false;false;false;false;false,2186/10465
randomised to canakinumab nmbr mg,,,2187/10465
ff nmbr pgod,C4554348;C0053917;C1334884,false;true;false,2188/10465
fevnmbr post - bronchodilator  % predicted normal,,,2189/10465
migraine — no . ( % ) $,C0149931,true,2190/10465
hypertension — no . / total no . ( % ),C0020538;C1963138,true;false,2191/10465
randomized to active yitamin e,C0034656;C0205177;C3853793;C3888249;C3815594,true;false;false;false;false,2192/10465
low risk and more symptoms ( group b ),C3272281;C3538919,false;false,2193/10465
high risk,C0332167;C3272283;C4050568;C4319571,false;false;false;false,2194/10465
carotid artery diseaset,C0007272;C0162859,true;true,2195/10465
cholesterol — mmol / liter,C0008377;C0439190;C0475211,true;false;false,2196/10465
fasting plasma glucose,C0015663;C0202042;C0455280,true;false;false,2197/10465
daily activities,C0871707,false,2198/10465
extended - duration enoxaparin ( n = nmbr ),C0231448;C0449238;C0206460;C0053917;C1334884;C2926735;C0231449;C0439792,false;false;true;true;false;false;false;false,2199/10465
dasnmbr - nmbr ( esr ),C0053917;C3811131;C1334884,true;false;false,2200/10465
associated with corrected - congenital shunts,C0332281;C0205202;C0009678;C0232180;C0542331;C1442858;C1744681,false;false;true;false;false;false;false,2201/10465
traditional nsaid use,C3897349;C0003211;C3536840,false;true;false,2202/10465
baseline albumin : < nmbr,C0168634;C0001924;C0053917;C1334884;C1442488,true;true;true;false;false,2203/10465
high - risk cvd  n ( % ),C0332167;C0007222;C3272283;C4050568;C4319571,false;true;false;false;false,2204/10465
pro / pro homozygotes,C1120626;C0019904,true;true,2205/10465
sulfasalazine ( mean dose : nmbr . nmbr g / day ),C0036078;C0444504;C0178602;C0053917;C0439417;C1334884;C0869039;C1114758;C2347634;C2348143,true;false;false;true;false;false;false;false;false;false,2206/10465
> nmbr years eze / simva baseline ldl - c,C0053917;C0439234;C0168634;C1442488;C1334884,true;false;true;false;false,2207/10465
< nmbr % predicted arr ( n = nmbr  nmbr ),C0053917;C0681842;C2170357;C4084934;C1882327;C1334884,true;false;false;false;false;false,2208/10465
pe associated with dvt at diagnosis,C0070939;C1880476;C4284304,true;false;false,2209/10465
baseline hbanmbrc,C0168634;C1442488,true;false,2210/10465
renal function < nmbr egfr  ml / min / nmbr . nmbr mnmbr,C0232804;C0053917;C1739039;C0439445;C3811844;C3812682;C1334884,false;true;true;false;false;false;false,2211/10465
blood eosinophil concentration  nmbr cells per l,C0014467;C0086045;C0053917;C0347983;C1334884;C1446561;C3827302;C0427728;C0699870;C1313904,true;true;true;false;false;false;false;false;false;false,2212/10465
less severenmbr,C0439092;C0547044,false;false,2213/10465
cardiovascular risk,C0007226;C0035647;C4552904;C3887460,true;true;false;false,2214/10465
prehospital ticagrelor ( n = nmbr ),C1999375;C0053917;C1334884,true;true;false,2215/10465
symptoms of atrial fibrillation in the nmbr months before randomiza -,C0683368;C0004238;C0344434;C1963067;C1457887,true;true;false;false;false,2216/10465
perindopril,C0136123,true,2217/10465
tiotropium / olodaterol nmbr / nmbr mg ( n = nmbr ),C4032878;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2218/10465
symptom onset to hospital admission,C4086878;C0184666,false;false,2219/10465
ldl - c ( measured ) *,,,2220/10465
rerapamil - sr strategy ( n = nmbr ),C0753208;C0679199;C0053917;C1334884;C1709991;C3813610;C3890900;C3891546,true;false;true;false;false;false;false;false,2221/10465
erosion score  mean nmbr sd,C0333307;C0449820;C0444504;C0053917;C2699239;C1334884;C2347634;C2348143;C4050231;C1880549;C1959609;C3887524,false;false;false;true;false;false;false;false;false;false;false;false,2222/10465
valve surgery  n ( % ),C0184252;C0038894;C0038895;C0543467;C1274039;C1186983;C1704414;C3888056,false;false;true;true;true;false;false;false,2223/10465
ticagrelor nmbr mg nmbr year km ( % ),C1999375;C0053917;C0024671;C0439234;C3887676;C0439508;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;true;false;false;false;false;false;false,2224/10465
north america ( plus australia and new zealand ),C0028405;C0332287;C0004340,true;false;true,2225/10465
calcium antagonist — no . ( % ),C0006684,true,2226/10465
penetrating disease  %,C0205321;C0012634,false;true,2227/10465
non - drug - eluting stent,C1518422;C1322815,false;true,2228/10465
number of exacerbations in the past nmbr months,C0237753;C4086268;C0449788,false;false;false,2229/10465
potassium supplement,C0304475,false,2230/10465
age group,C0027362;C2348001,true;false,2231/10465
congestive heart failure ( chf ) ( in past nmbr weeks ),C0018802;C2987125;C0053917;C1334884,true;false;true;false,2232/10465
platelet count  x nmbr mmnmbr,C0032181;C0053917;C1334884;C1287267,true;true;false;false,2233/10465
other supraventricular tachycardia,C0039240;C1963244;C3815188,true;false;false,2234/10465
egfr ( ml / min / nmbr . nmbr mnmbr [mdrdequation] ),C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,2235/10465
mean bmi  kg / mnmbr,C0444504;C0578022;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;true;false;false;false;false,2236/10465
* * * unstable angina,C0002965,true,2237/10465
rate ratio,C0871208;C0456603;C1547037;C1521828,false;false;false;false,2238/10465
recurrent vte ( statin use vs non - use ),C1455761;C0630906;C0360714;C0042153;C0457083;C1947944;C2945760,false;true;true;true;false;false;false,2239/10465
saxagliptin nmbr mg ( n = nmbr  nmbr ),C1611934;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2240/10465
irregular or ulcerated ica p ) laque : [ :,C0205271,false,2241/10465
extreme tortuosity,C0205403;C0333076;C3641272;C4085555,false;false;false;false,2242/10465
angina status — no . ( % ),C0002962;C0449438,true;false,2243/10465
p value nmbr . nmbr,C1709380;C0053917;C1334884,false;true;false,2244/10465
nonaspirin antiplatelet,C0722138,false,2245/10465
antihyperglycemictherapies  %,,,2246/10465
geographic distribution - no . ( % ),C0681686,false,2247/10465
conventional synthetic dmard use at baseline,C0439858;C1883254;C0242708;C0042153;C0168634;C1442488;C0457083;C1947944,false;false;true;true;true;false;false;false,2248/10465
statins 一 no . ( % ),C0360714,true,2249/10465
at six weeks,C0205452;C0439230,false;false,2250/10465
angiographic data and treatment :,C0002978;C1511726;C3245479;C3714741,true;false;false;false,2251/10465
clinical indication at the index procedure  n ( % ),C0205210;C2315323;C0600653;C0918012;C1552854;C1637833;C2986546;C2347896,false;false;true;true;false;false;false;false,2252/10465
mean bdi focal score ( sd ),C3533236;C0006448;C0205234;C2699239;C0451022;C3714938;C3889415,false;true;false;false;false;false;false,2253/10465
cabg during index hospitalization,C0010055;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,2254/10465
pci for index event,C4049621;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,2255/10465
concomitant drug treatment,C0521115;C0150270;C3469597,false;false;false,2256/10465
third primary ( change in updrs score / wk  wk nmbr - nmbr ),C0205437;C0205225;C0392747;C3639721;C0443172;C1705241;C4319952;C0439612;C0439631,false;false;false;true;false;false;false;false;false,2257/10465
implanted pacemaker,C0848753,false,2258/10465
concomitant asthma medications  n ( % ),C0521115;C0004096;C0013227;C0802604;C2598133;C4284232;C2984299,false;true;true;false;false;false;false,2259/10465
hbanmbrc $ nmbr . nmbr % ( nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,2260/10465
uacr not available,,,2261/10465
ret / abx - facil . pci,C0389252;C4049621,true;false,2262/10465
severity of copd  airflow limitation  n ( % ),C0439793;C0024117;C0231999;C0443288;C0449295;C1412502;C3714496;C0522510,false;true;false;false;false;false;false;false,2263/10465
claudication only,C0021775;C0205171;C1720467;C0311395;C1456822,true;false;false;false;false,2264/10465
mean % predicted dlco * ( sd ),C0444504;C2347634;C2348143,false;false;false,2265/10465
titre ( u / ml ) t,C0475208;C0439340;C1880521;C2945590,false;false;false;false,2266/10465
treatment before admission ( % ),C0039798;C0184666;C0809949;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,2267/10465
overall quality of life,C3641830,false,2268/10465
no baseline corticosteroids,C0168634;C0001617;C3539185;C3540725;C3540726;C3540727;C1442488,true;true;false;false;false;false;false,2269/10465
high on - treatment platelet reactivity *,C0205250;C0039798;C0005821;C0443286;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,2270/10465
potassium ( meql )  mean + sd  available for nmbr patients,C0032821;C0444504;C2699239;C2347634;C2348143;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false,2271/10465
all patients with opg n - nmbr,C0030705;C1262886;C0053917;C1334884;C1336645;C1412836;C1710303,true;false;true;false;false;false;false,2272/10465
urinary albumin : creatinine ratio ( pg / mg )  median ( iqr ),C0455271;C1627892;C0549183;C0876920;C2347635;C2348144;C2939193;C1318330,false;false;false;false;false;false;false;false,2273/10465
cardiac rhythm disorder at baseline yes,C0264886;C0168634;C1549445;C1705108;C1710701;C1442488,true;true;false;false;false;false,2274/10465
islander,,,2275/10465
left circumflex coronary artery,C0226037,false,2276/10465
risk category ( points ),C0035647;C0683312;C3889287;C4552904,true;false;false;false,2277/10465
nihss at randomization  nmbr - nmbr,C1697238;C0034656;C0053917;C1334884,false;true;true;false,2278/10465
cilostazol,C0055729,true,2279/10465
creatinine clearance category  ml / min  no . ( % ) b,C0812399;C0683312;C0439445;C3889287,false;false;false;false,2280/10465
tg > nmbr mg / dl  n ( ° / o ),C0337445;C0053917;C0439269;C1334884,false;true;false;false,2281/10465
chf on losartan ( % ),C0018802;C0126174,true;true,2282/10465
comorbidities  %,C0009488,true,2283/10465
prior lipid - lowering agent use,C0332152;C0086440;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,2284/10465
iwqol - lite total score ( arbitrary units ) #,C2964552;C0439183,false;false,2285/10465
absolute change,C1549031,false,2286/10465
gusto moderate / severe,,,2287/10465
ls mean difference ( se ) vs placebo,C0023668;C0444504;C1705241;C0036919;C1705242;C2347634;C2348143,true;false;false;true;false;false;false,2288/10465
stent implanted — no . ( % ),C0522776,false,2289/10465
eze / simva ( „ = nmbr },C0053917;C1334884,true;false,2290/10465
low eosinophil subgroup (  nmbr / ml ) ( n = nmbr ),C0205251;C0014467;C1079230;C0053917;C0439526;C1705224;C3887665;C1334884;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;true;false;false;false;false;false;false;false;false;false;false,2291/10465
alaska native,C0682125,true,2292/10465
| interactior nmbr p,C0053917;C1334884,true;false,2293/10465
number ( s ) of features present,C0237753;C1521970;C1706388;C2346469;C2348519;C0449788,false;false;false;false;false;false,2294/10465
extent of disease — no . / total no . ( % ) § ^ |,C0449279;C4553144,false;false,2295/10465
eze / simva nmbr / nmbr mg n = nmbr,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,2296/10465
bivalirudin,C0168273,true,2297/10465
two arm,C0205448;C0446516;C3715044;C4553528,false;true;false;false,2298/10465
metreo modified intention - to - treat population §,C0392747;C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C3889737,false;true;true;true;true;false;false;false;false,2299/10465
any blood pressure medications ( % ),C0849164;C0033095;C0460139;C1306345;C4284008;C0005823;C0013227;C0802604;C2598133;C4284232;C1271104;C1272641,false;true;false;false;false;true;true;false;false;false;false;true,2300/10465
p  net difference,C0369773;C1456447;C1705241;C1705242;C3853572;C3887809;C3890893;C2603361,false;true;false;false;false;false;false;false,2301/10465
statin users ( n = nmbr ),C0360714;C1706077;C0053917;C1334884,true;false;true;false,2302/10465
simplified disease activity index score ( nmbr - nmbr ),C3869582;C0449820;C0053917;C1334884;C4050231,false;false;true;false;false,2303/10465
calcium channel,C0006685,true,2304/10465
level — no . ( % ),C0441889;C0456079;C1547707;C2946261,false;false;false;false,2305/10465
no regular consumption,C0205272;C0009830;C1947907,false;true;false,2306/10465
nmbr / nmbr  nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,2307/10465
time from randomization to pci ( non - st - elevation mi )  h,C0040223;C0034656;C3541383,true;true;false,2308/10465
nmbre < nmbr %  n ( % ),C0053917;C1334884,true;false,2309/10465
prior pacemaker  n ( % ),C0332152;C0030163;C0810633;C1546728;C3275122;C3853703;C2826257,false;true;false;false;false;false;false,2310/10465
non - detectable / unknown  n ( % ),C1518422;C3830527;C0439673;C3541433;C4050014,false;false;false;false;false,2311/10465
individuals without diabetes  n = nmbr  nmbr,C0027361;C0011847;C0053917;C1334884;C0011849;C0237401,true;false;true;false;true;false,2312/10465
post - fibrinolysis angioplasty ( n = nmbr ),C0687676;C0016017;C0162577;C0053917;C1334884;C1548817;C1305868;C1704687;C3469826,false;true;true;true;false;false;false;false;false,2313/10465
aerobic activity,C0001701,true,2314/10465
pulse pressure,C0949236,true,2315/10465
laboratory measures,C0022877;C3244292;C4283904,true;false;false,2316/10465
deep - vein thrombosis ( % ),C0149871,true,2317/10465
cardiovascu lar subg roup,C1419115;C0276828;C3814448,false;false;false,2318/10465
greater than or equal to nmbr ml / min / nmbr . nmbrmnmbr,C0439093,false,2319/10465
statin  n ( % ),C0360714,true,2320/10465
location of infarction,C0450429;C0021308;C1515974;C4284930;C4284931,false;true;false;false;false,2321/10465
infliximab - experienced ( n = nmbr ),C0666743;C0053917;C1334884,true;true;false,2322/10465
time since first copd diagnosis ( years ),C0040223;C3541383,true;false,2323/10465
potassium — mmol / liter,C0032821;C0439190;C0475211;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false,2324/10465
rivaroxaban ( n = nmbr ),C1739768;C0053917;C1334884,true;true;false,2325/10465
investigator - determined myocardial infarction,C0035173,true,2326/10465
time from first eval,C0040223;C0205435;C1707957;C2698624;C1279901;C3541383,true;false;false;false;false;false,2327/10465
diagnosis of heterozygous familial hypercholester,C0011900;C0019425;C0015576;C0241888;C1704338;C1704656,true;true;true;false;true;false,2328/10465
baseline crp ( mg / dl ),C0168634;C3890735;C0439269;C4048285;C1442488,true;false;false;false;false,2329/10465
average of maximum far wall cimt ( mm ),C1510992;C0806909;C0205108;C0677535;C4330985;C4554674;C1552615;C2826546;C2825518,false;false;false;false;false;false;false;false;false,2330/10465
hispanic ethnicity,C0086409;C0015031;C0243103,true;true;true,2331/10465
other vasodilator,C0042402;C3537240,true;false,2332/10465
maintenance dose,C3714445,false,2333/10465
thienopyridine type,C1120149;C0332307;C1547052,true;false;false,2334/10465
perfusion defectsatinclusion,C0031001;C4281794,true;false,2335/10465
dasnmbr - esr remission,C3811131;C0544452;C0687702,false;false;false,2336/10465
no . of panents . total no . nmbr % ),C0439175;C0439810,false;false,2337/10465
disease activity outcomes ( itt population ) week nmbr,C1292728;C1274040;C0032659;C0332174;C0053917;C1334884;C0439230;C1257890;C0679250;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939;C3542417,false;false;true;false;true;false;false;true;false;false;false;false;false;false;false;false;false,2338/10465
fluticasone furoate and vilanterol ( n = nmbr ),C1948374,true,2339/10465
any infarct,C0021308,true,2340/10465
apolipoprotein a - i *,C0085201;C1677784,true;true,2341/10465
current smoking — no . / total no . ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,2342/10465
miami k antagonist received,C1551421;C0597277;C0231491;C1708601,false;false;false;false,2343/10465
rivastigmine,C0649350,true,2344/10465
europa ( n = nmbrlnmbr ),C0242751,true,2345/10465
lung function  mean,C0035245;C0444504;C2347634;C2348143,true;false;false;false,2346/10465
physician ' s global assessment of disease activity ( nmbr - nmbr mm vas )  mean ( sd ),C4050369;C0053917;C4330985;C0042815;C0444504;C2699239;C2347634;C2348143;C3536884;C3827561;C4554674;C1334884,false;true;false;true;false;false;false;false;true;false;false;false,2347/10465
nmbr - nmbr ( very severe ),C0053917;C1334884,true;false,2348/10465
high - risk clinical features,C0332167;C0683325;C3272283;C4050568;C4319571,false;false;false;false;false,2349/10465
second primary composite outcome,C0205436;C0205225;C0205199;C1274040;C1547335;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false;false;false;false;false,2350/10465
baseline % predicted fevnmbr,C0168634;C1442488,true;false,2351/10465
treatment characteristics,C0039798;C1521970;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,2352/10465
digoxin at last follow - up,C0012265;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,2353/10465
both impaired glucose tolerance and impaired fasting glucose tolerance — no .,C0271650,true,2354/10465
ez / simva < % >,C0206578,true,2355/10465
sbp indicates systolic blood pressure  dbp  diastolic blood pressure  aa  arachidonic acid  epa  eicosapentaenoic acid . values for age  bmi  total cholesterol  ldl cholesterol  hdl cholesterol  sbp  dbp  aa  epa  and epa / aa ratio represent the mean values represent the median ( interquartile range ) . p values are for the differences between the no epa and epa groups .,C0085805,true,2356/10465
# of prior bdmards,C0332152;C2826257,false;false,2357/10465
acute reaction,C0205178;C0443286,false;false,2358/10465
ulcers / gangrene,C0041582;C0017086,true;true,2359/10465
fasting plasma glucose ( mmol / l ),C0015663;C0202042;C1532563;C0455280,true;false;false;false,2360/10465
other teaes,,,2361/10465
alcohol intake,C0001948,true,2362/10465
change from baseline ( % ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,2363/10465
ileum only,C0020885;C0205171;C1720467,true;false;false,2364/10465
anti - tnf - ir patients,C1448177;C0022065;C0030705;C0022071;C1448132,true;true;true;true;true,2365/10465
north america plus australia and new zealand,C0028405;C0332287;C0004340,true;false;true,2366/10465
medial - distal - diag,C0205098;C0205108;C0348026;C4522154,false;false;false;false,2367/10465
bw at nmbr weeks  kg +,C0005910;C0053917;C0439230;C0022718;C0439209;C4054209;C1334884;C0006041;C2986891,true;true;false;true;false;false;false;true;false,2368/10465
haemoglobin ( mmol / l ),C0635222;C0439190;C0019046;C1532563,true;false;true;false,2369/10465
severity ofcopd ( goldnmbr )  n ( % ),C0439793;C0522510,false;false,2370/10465
prior stroke — no . ( % ),C0332152;C2826257,false;false,2371/10465
adalimumab ( n = nmbr ),C1122087;C0053917;C1334884,true;true;false,2372/10465
aliskiren dm = nmbr non - dm = nmbr,C1120110;C0011816;C0053917;C1518422;C1334884;C3250443,true;true;true;false;false;false,2373/10465
previous cabg ( before index acs ) *,C0205156;C0010055;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1552607,false;true;true;true;false;true;false;false;false;false,2374/10465
number of patients ( % ) or mean 士 sd,C2360800,false,2375/10465
severity of copd  n ( % ) ( gold nmbr ) : moderate,C0439793;C0024117;C0018026;C0053917;C1334884;C1304897;C1412502;C3714496;C0522510,false;true;true;true;false;false;false;false;false,2376/10465
western friroce,C1705493,false,2377/10465
baseline lipids  mean ± sd ( mmol / nmbr ),C0168634;C0023779;C0444504;C2699239;C0439190;C0053917;C1334884;C2347634;C2348143;C1442488,true;true;false;false;false;true;false;false;false;false,2378/10465
baseline calcium yes,C0168634;C0006675;C1549445;C1705108;C1710701;C0006726;C2936886;C3540037;C3714611;C1442488,true;true;false;false;false;true;false;false;false;false,2379/10465
cardiac mediations,C0018787;C0680727;C1522601,true;true;false,2380/10465
large vessel,C0225990,false,2381/10465
no . of treated vessels,C1522326;C0005847,false;true,2382/10465
sinus rhythm at baseline,C0232201;C0168634;C1442488,false;true;false,2383/10465
ipah / hpah,C0152171;C0340543;C0637939;C1150929,false;true;true;false,2384/10465
ccs class §,C1879987,false,2385/10465
antithrombotic and anticoagulant medications,,,2386/10465
ixeqnmbrw  n = nmbr,C0053917;C1334884,true;false,2387/10465
warfarin group ( n = nmbr ),C0043031;C0441848;C0053917;C1334884,true;false;true;false,2388/10465
white - cell count — xnmbr_nmbr / liter,C0023508;C0053917;C0475211;C1334884;C0427512,true;true;false;false;false,2389/10465
mean % predicted fvc ( sd ),C0444504;C2347634;C2348143,false;false;false,2390/10465
only cerebrovascular disease,C0205171;C0007820;C1720467,false;true;false,2391/10465
three or more agents,C0205449,false,2392/10465
msfc timed nmbr - foot walk test  median seconds,,,2393/10465
mean ( sd ) baseline scores,C0444504;C2699239;C0168634;C1442488;C2347634;C2348143,false;false;true;false;false;false,2394/10465
patients with > nmbr % ■ nmbr ml increase in fevnmbr post - bronchodilator ( % ),C0030705;C0053917;C0439526;C0442805;C1705224;C3887665;C1334884,true;true;false;false;false;false;false,2395/10465
meglitinide,C0065880,true,2396/10465
prior tobacco use  n ( % ),C0332152;C0040335;C0543414;C0841002;C3853727;C2826257,false;false;true;false;false;false,2397/10465
graft occlusionsa,C0181074;C0332835;C1961139,false;true;false,2398/10465
ascot - lla,C0718674,false,2399/10465
cortical only,C0001613;C0205171;C1720467;C0007776;C0022655,true;false;false;true;true,2400/10465
key : tc = triglyceride  hs - crp = ldl - c = low - density lipoprotein fc = fasting glucose  ncep atp * this category did not include ar to have > _ nmbr of the indicated char least - square means  except tc an note : all treatment by subgroup,C0039411;C0041004;C3890735;C0023823;C2983605;C0015663;C0017725;C2744579;C4552600;C4048285;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;false;true;false;true;true;true;false;false;true;true;true;false;false;false,2401/10465
prior disease - modifying drugs resulting in inadequate response — mean no . / patient,C0332152;C0012634;C0392747;C0013227;C3687832;C2826257,false;true;false;true;false;false,2402/10465
extent of disease,C0449279;C4553144,false;false,2403/10465
candesartan group ( n = nmbr ),C0717550;C0441848;C0053917;C1334884,true;false;true;false,2404/10465
rivaroxaban alone ( n = nmbr ),C1739768;C0205171;C0053917;C1334884;C0439044;C0679994,true;false;true;false;false;false,2405/10465
body mass index  mean ( sd ) [range]a,C0005893;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;false;false;true,2406/10465
baseline antihyperglycemic medications  n ( % ),C0168634;C0020616;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;true;false;false;false;false,2407/10465
fasting lipid levels  mmol / l,C0015663;C0428460;C1532563,true;false;false,2408/10465
proximal gastrointestinal tract,C0205107;C0017189;C0521362;C4489236,false;true;false;false,2409/10465
diabetes mellitus ( type nmbr or nmbr ),C1320657;C0053917;C1334884,false;true;false,2410/10465
heart failure ( hf )  ( % ),C0018801;C0018488;C1313497;C1538440;C3273279;C0018802;C4554158,true;true;true;false;false;true;false,2411/10465
platelet  nmbr / l,C0456525;C0053917;C1334884,false;true;false,2412/10465
hbanmbrc < nmbr % ( n - nmbr ),C0053917;C1334884,true;false,2413/10465
spironolactone  n ( % ),C0037982,true,2414/10465
b digit symbol substitution  insulin glargine vs standard care,C0291665;C0582802;C0679214;C1555721;C0907402;C1706204;C1698987;C3241971,true;false;false;false;true;false;false;false,2415/10465
proteinurianmbr ( g / day ),C0439417,false,2416/10465
elevated blood pressure,C0020538;C0497247,true;false,2417/10465
ldl - c ( mg / dl ) < nmbr,C0439269;C0053917;C1334884,false;true;false,2418/10465
laser or vitrectomy,C0023089;C0458142;C1023865;C1706315,true;false;false;false,2419/10465
total study population ( n = nmbr ),C3258257;C0557651;C0053917;C1334884;C2603343;C0439175;C2348561;C0439810,false;false;true;false;false;false;false;false,2420/10465
presenting diagnosis,C0449450;C0011900;C1704338;C1704656,false;true;true;false,2421/10465
duration of type nmbr diabetes ( years ),C0449238;C1320657;C0053917;C0439234;C1334884;C2926735,false;false;true;false;false;false,2422/10465
alt ( units / l ),C1266129;C0439339;C4553172,false;false;false,2423/10465
severity of airflow limitation,C0439793;C0231999;C0443288;C0449295;C0522510,false;false;false;false;false,2424/10465
patient ' s global assessment of disease,C4054229;C0012634,false;true,2425/10465
daily dose nmbr - nmbr mg n = nmbr,C2348070;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,2426/10465
in - stent restenosis of des,C3272317;C0011702;C4551552,false;true;true,2427/10465
baseline hbanmbrc  mean ( s . e . ),C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,2428/10465
predicted normal ( % ),C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327,false;false;false;false;false;false;false,2429/10465
killip class — no . ( % ) i,C1881332,false,2430/10465
prior ml or abnormal angiogram,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,2431/10465
placebo + mtx ( n = nmbr ),C0032042;C0025677;C0053917;C1334884;C1417487;C1696465;C1706408,true;true;true;false;false;false;false,2432/10465
baseline corticosteroid use ( mg ),C0168634;C0239126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;false;true;true;false;false;false;false;false;false,2433/10465
ind / gly nmbr / nmbr mg once daily ( n = nmbr  nmbr ),C4049864;C0017890;C0053917;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0523677,false;true;true;true;false;true;false;false;false;false;false;false;false,2434/10465
patients who received positive results on test for antibodies to infliximabt,C0030705,true,2435/10465
ptca < nmbr h,C2936173;C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;true;false;false;false;false;false,2436/10465
verapamil - sr ( « = nmbr nmbr ),C1527129;C0053917;C1334884,false;true;false,2437/10465
simvastatin ( nmbr / nmbr mg / d ),C0074554;C0053917;C0439422;C1334884,true;true;false;false,2438/10465
insulin 一 no . ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,2439/10465
duration of type nmbr diabetes mellitus ( years ),C0449238;C1320657;C0053917;C0439234;C1334884;C2926735,false;false;true;false;false;false,2440/10465
central america and south america,C0007674,true,2441/10465
hip circumference — cm,C0562350,false,2442/10465
rnmbr + ezio ( n = nmbr ),C0053917;C1334884,true;false,2443/10465
male sex — no . of patients ( % ),C0086582,true,2444/10465
stents per lesion  n,C0038257;C0221198;C1546698,true;false;false,2445/10465
infliximab ( n = nmbr ),C0666743;C0053917;C1334884,true;true;false,2446/10465
dose of rosuvastatin,C0178602;C0965129;C0869039;C1114758,false;true;false;false,2447/10465
lvef < nmbr %  n = nmbr nmbr ) “,C0428772;C0053917;C1334884;C0488728,false;true;false;false,2448/10465
n - terminal pro - brain natriuretic peptide  pg / ml,C3272900;C0439297,false;false,2449/10465
bmi — mean ( sd ) ( kg / mnmbr ),C0578022;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;false;true;false;false;false;false,2450/10465
vorapaxar event rate ( n = nmbr )  %,C2974521;C0441471;C0871208;C0053917;C1334884;C1521828;C4019010,true;false;false;true;false;false;false,2451/10465
death or nmbrmwd decrease > nmbr m,C0011065;C1306577;C4082313;C4552775,true;false;false;false,2452/10465
associated with transient or reversible risk factor,C0332281;C0040704;C0205374,false;true;false,2453/10465
europe and australia,C0015176,true,2454/10465
all countries,C0454664,false,2455/10465
urinary protein : creatinine ratioa ( mg / mg ),C0042027;C0369901;C1319635;C0428627;C1524119,true;false;false;false;false,2456/10465
serum cholesterol  median ( iqr )  mg / dl,C0587184;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2457/10465
intermediate risk ( ri = nmbr ),C3640764;C0035487;C0053917;C1334884;C1826843,false;true;true;false;false,2458/10465
cangrelor,C1121991,true,2459/10465
baseline cdai score  mean ( s . d . ),C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,2460/10465
major bleeding events *,C0205082;C0019080;C0441471;C3541888;C0205164;C4318856;C4521762,false;true;false;false;false;false;false,2461/10465
baseline  mm hg,C0168634;C0439475;C1442488,true;false;false,2462/10465
white / caucasian,C0043157,true,2463/10465
body mass index  mean ± sd ( kg / mnmbr ),C0005893;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0578022;C1305855,false;false;false;true;false;false;false;false;false;true,2464/10465
recurrent ischemia,C1455761;C0022116;C4321499;C2945760,false;true;false;false,2465/10465
index event not confirmed,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,2466/10465
non - hdl cholesterol ( mg / dl ),C0729627;C0439269;C1535899,false;false;false,2467/10465
comparison with placebo,C1707455;C0032042;C1696465;C1706408,false;true;false;false,2468/10465
current use of an ace inhibitor,C0521116;C1524063;C0003015;C4541021;C1705970,false;false;true;false;false,2469/10465
mean total serum ige ( sd )  iu / ml,C0444504;C0439175;C0229671;C2699239;C0439458;C1546774;C1550100;C0439810;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,2470/10465
af or atrial flutter 卞,C0344434;C4049859,false;false,2471/10465
pain subscale,C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false,2472/10465
ejection fraction based on local reading,C0489482;C2700378,false;false,2473/10465
cardiac and echocardiography parameters,C0018787;C1522601,true;false,2474/10465
albuterol use ( sd )  puffs / day,C0001927;C0042153;C2699239;C1533107;C0332173;C0439228;C0439505;C0457083;C1947944,true;true;false;false;false;false;false;false;false,2475/10465
white race — number ( % ),C0007457;C0237753;C0449788;C0043157,true;false;false;true,2476/10465
stable angina ( n - nmbr  nmbr ),C0340288;C0053917;C1334884,true;true;false,2477/10465
weight  kg  median ( nmbrth  nmbrth ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,2478/10465
long - term aspirin,C0443252;C0004057,false;true,2479/10465
moderately impaired,C0205081;C1881878;C4085643;C4321491,false;false;false;false,2480/10465
left side only,C3842976,false,2481/10465
past or never,C1444637;C4284302,false;false,2482/10465
gastroesophageal reflux disease,C0017168;C4553201,true;false,2483/10465
anticoagulant — no . ( % ),C0003280;C0848112;C3536711,true;false;false,2484/10465
region  asia / paafic,C0017446;C0003980;C0205147,true;true;false,2485/10465
arteriosclerosis,C0003850,true,2486/10465
fasting plasma glucose nmbr medan,C0015663;C0202042;C0053917;C1334884;C0455280,true;false;true;false;false,2487/10465
age mean ( yrs ± sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,2488/10465
chronic renal failure,C0022661;C1561643;C2316810,true;true;false,2489/10465
peripheral artery,C0489868,false,2490/10465
neither tnmbrdm nor mets,,,2491/10465
time since first af diagnosis  yrs,C0040223;C3541383,true;false,2492/10465
anti - hypertensive therapy - no . ( % ),C0585941,false,2493/10465
pacemaker,C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,2494/10465
infarct ion w ithin previous nmbr day s,C0021308;C0022023;C0205156;C0053917;C0332173;C0439228;C0439505;C1334884;C1552607;C1700702,true;true;false;true;false;false;false;false;false;false,2495/10465
cardiac death,C0376297,true,2496/10465
interval between clinical evaluation and initiation oftreatment — no . ( % ),C1272706;C1261322;C4084924;C1552654;C1552713;C0205210;C2826267,false;false;false;false;false;false;false,2497/10465
apolipoprotein b  mean ( sd )  g / l,C0003593;C0444504;C2699239;C0439294;C0456615;C2347634;C2348143,true;false;false;false;false;false;false,2498/10465
no . of participants with events ( % ),C0679646,false,2499/10465
mean a ± sd  mg / dl ( mmol / nmbr ),C0444504;C2347634;C2348143,false;false;false,2500/10465
homa - ir ( mu / l^mmol / l ),C0022065;C0439342;C0439190;C0022071;C1448132,true;false;false;true;true,2501/10465
> nmbr months ( n = nmbr  nmbr ),C0053917;C0439231;C1334884,true;false;false,2502/10465
elevated troponin ( > nmbr . nmbr mg / l )  %,C0205250;C0041199;C0053917;C0439268;C1334884;C3163633,false;true;true;false;false;false,2503/10465
mean weight ( sd )  kg,C0444504;C0005910;C2699239;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;false;true;false;false;true;false;false;false;false,2504/10465
europe ( zone nmbr ),C0015176;C1710706;C0053917;C1334884,true;false;true;false,2505/10465
cox bsl onlyc,C1565830;C1549954,true;false,2506/10465
number resulting in ed visit,C0237753;C0449788,false;false,2507/10465
left ventricular systolic or diastolic dysfunction,C0225897;C0039155,true;true,2508/10465
any other llts ( other than statin ),,,2509/10465
other blood - pressure drug,C0003364,true,2510/10465
both ace inhibitor and arb,C0003015;C4541021,true;false,2511/10465
tg  median ( sdy rng / cjl,C0337445;C0549183;C1424906;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2512/10465
statin at last follow - up,C0360714;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,2513/10465
p - value ( lnteraction ),C1709380,false,2514/10465
mild dysfunction or normal,C3274775,false,2515/10465
recurrent infections ( > nmbr per year ),C0239998;C0053917;C0439234;C0439508;C1334884,false;true;false;false;false,2516/10465
estimated glomerular filtration rate < nmbr ml / min per nmbr . nmbr mnmbr,C3811844;C0053917;C0439445;C1334884,false;true;false;false,2517/10465
median ( qnmbr : qnmbr ) duration of diabetes  years,C0549183;C0449238;C0011847;C0439234;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false,2518/10465
nmbrlnmbrmmhg,,,2519/10465
chronic non - steroidal antiinflammatory drugs,C0205191;C0003211,false;true,2520/10465
european subcategories,C0239307;C1515010;C1535514,false;false;false,2521/10465
placebo + nmbr mg / d of simvastatin ( n = nmbr ),C0032042;C0053917;C0439422;C0074554;C1334884;C1696465;C1706408,true;true;false;true;false;false;false,2522/10465
median c - reactive protein — mg / dl^,C0549183;C0006560;C0439269;C1413716;C4048285;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,2523/10465
use of other medications — no . ( % ),C0240320,false,2524/10465
total - c : hdl - c,C0439175;C3715113;C0439810,false;false;false,2525/10465
pre - bronchodilator fevnmbr / fvc ( % ),C2599602;C3714541,false;true,2526/10465
reversibility ( % predicted fevnmbr ) *,C0449261,false,2527/10465
conversion to sinus rhythm in < nmbr days,C1321500,false,2528/10465
stent implanted,C0522776,false,2529/10465
median weight  kg ( iqr ),C0549183;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false,2530/10465
saxagliptin ( % ),C1611934,true,2531/10465
salmeterol - fluticasone group ( n = nmbr ),C0939232;C0441848;C0053917;C1334884,true;false;true;false,2532/10465
abciximab,C0288672,true,2533/10465
vein bypass graft stented,C0398147,false,2534/10465
mean age ( sd )  years,C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,2535/10465
prior treatment,C1514463,false,2536/10465
bivalirudin used during pci,C0168273,true,2537/10465
mean ( s . d . ) ldl particle number  nmol / l,C0444504;C2612459;C0237753;C0439282;C0449788;C2347634;C2348143,false;false;false;false;false;false;false,2538/10465
pad symptoms ( % ),C0182158;C0683368;C1457887;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,2539/10465
number of treated lesions,C0449791;C1522326,false;false,2540/10465
infliximab ( combined nmbr mg / kg and nmbr mg / kg )  n ( % ),C0666743;C0205195;C0053917;C0439272;C1334884,true;false;true;false;false,2541/10465
high dose statin ( n = nmbr  nmbr ),C0444956;C0360714;C0053917;C1334884,false;true;true;false,2542/10465
any recurrent stroke,C2242682,false,2543/10465
distal one - third of radius,C0450168;C0205447;C0034627;C1306504;C0588207;C0205437,false;false;true;false;false;false,2544/10465
mean mayo score ( sd ),C3533236;C0454788;C2699239;C1077578,false;false;false;false,2545/10465
diagnosis at presentation,C0011900;C0449450;C1704338;C1704656,true;false;true;false,2546/10465
median disease duration — yr,C0549183;C0872146;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2547/10465
events / control group,C0441471;C0009932;C3541888,false;true;false,2548/10465
lowest tg tertile,C1708760;C0337445,false;false,2549/10465
other antihyperglycemic agents  not listed,C0020616,true,2550/10465
index stroke > nmbr days before randomization — no . ( % ),C0456712;C0053917;C0439228;C0034656;C1334884,false;true;false;true;false,2551/10465
renal fmclicn : creatntoe clearance,C0232813;C0699829,false;false,2552/10465
prior mi ( n - nmbr  nmbr ),C0332152;C3810814;C0053917;C1334884;C2826257,false;false;true;false;false,2553/10465
losartan plus placebo ( n = nmbr ),C0126174;C0332287;C0032042;C0053917;C1334884;C1696465;C1706408,true;false;true;true;false;false;false,2554/10465
anti - ccp positive ( > nmbr u / ml )  n ( % ),C0432633;C1525410;C0439178;C0053917;C0439340;C1880521;C2945590;C1334884;C1446409;C1514241;C2825490;C3812269;C1704514,false;false;false;true;false;false;false;false;false;false;false;false;false,2555/10465
total occlusion  n ( % ),C0439175;C0001168;C0011382;C0028778;C0441597;C1110554;C1947917;C0439810,false;false;true;false;false;false;false;false,2556/10465
male sex — no . ( % ) risk factors,C0086582,true,2557/10465
multiple tnfi and other bdmards §,C0439064,false,2558/10465
stiffness ( min ),C0427008;C0702093;C1524029;C3813700,false;false;false;false,2559/10465
rosuvastatin nmbr - nmbr mg ( n = nmbr ),C0965129;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2560/10465
randomization to angiography,C0034656;C0002978,true;true,2561/10465
thienopyridine n = nmbr,C1120149;C0053917;C1334884,true;true;false,2562/10465
treatment difference,C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,2563/10465
absolute reversibility in fevnmbr  ml *,C0205344;C0449261;C0439526;C1705224;C3887665,false;false;false;false;false,2564/10465
time to treatment,C3494202,true,2565/10465
duration of initial anticoagulation  mean ( sd )  mo,C0449238;C0205265;C0003281;C0444504;C2699239;C0026544;C0332177;C2347634;C2348143;C2917212;C2919015;C3537050;C1279901;C1555582;C1705685;C2926735,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false,2566/10465
undetermined etiology,C0478157,false,2567/10465
ace inhibitors through hospital discharge or day nmbr — %,C0003015;C0586003,true;false,2568/10465
patient ' s global assessment ( vas ),C4054229;C0042815;C3536884;C3827561,false;true;true;false,2569/10465
triglycerides ( mg / dl )  mean + sd  available for nmbr patients,C0041004;C0439269;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,2570/10465
qualifying type of atherosclerosis  n ( % ),C1514624;C0332307;C0003850;C0004153;C1547052,false;false;true;true;false,2571/10465
patient ' s preference not to take vka  only reason,C0376409,true,2572/10465
probable,C0033204;C0332148,true;false,2573/10465
at least two cardiovascular risk factors,C0205448;C0850624,false;false,2574/10465
surgical technique post - randomisation characteristic * *,C0683469;C0687676;C0034656;C1521970;C1704687;C3469826,false;false;true;false;false;false,2575/10465
age group  no . ( % )  y,C0027362;C2348001,true;false,2576/10465
disease location ( % ) *,C0012634;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,2577/10465
previous oad ( % ),C0205156;C1552607,false;false,2578/10465
hdl cholesterol — mg / dl triglycerides — mg / dl,C0023822;C0024671;C3539687;C0041004;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0392885,true;true;false;true;true;false;false;false;false;false;false,2579/10465
< nmbr months in - nmbr kill,C0053917;C0439231;C0162388;C0681205;C1550555;C1334884,true;false;true;false;false;false,2580/10465
antialdosterone agents,C0450442;C1254351;C1521826,false;false;false,2581/10465
risk factors bmi ( kg / mnmbr )  mean + sd,C0035648;C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C1553898,true;false;true;false;false;false;false;false;false;false,2582/10465
ex - smoker / current,C0337671;C0521116;C1705970;C4555205,false;false;false;true,2583/10465
at goal,C0018017;C1571704,true;false,2584/10465
history of heart failure — no . ( % ),C0455531,false,2585/10465
diabetes duration subgroups,C0011847;C0449238;C1079230;C2926735;C0011849,false;false;false;false;true,2586/10465
western europe ( including south africa ),C0043129,true,2587/10465
randomization stratum,C0034656,true,2588/10465
death  mi  idr  st or gusto severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,2589/10465
clopidogrel / total no . of patients % %,C0070166;C0439175;C0439810,true;false;false,2590/10465
corticosteroid ( without imm ),C0001617;C0205470;C3536709,true;false;false,2591/10465
creatinine ratio nmbr - nmbr,C0010294;C0456603;C0053917;C1334884;C1547037;C1561535,true;false;true;false;false;false,2592/10465
overall pad,C0282416;C1561607,true;false,2593/10465
steroids ( other ),C0038317,true,2594/10465
mean ± s . d . weight  kg,C0444504;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;true;false;false;false;false,2595/10465
amlodipine ( n = nmbr ),C0051696;C0053917;C1334884,true;true;false,2596/10465
previous infliximab therapy — no . of patients ( % ) * *,C0205156;C4076075;C1552607,false;false;false,2597/10465
anti - tnf - naive  n ( % ),C0432633;C1448177,false;true,2598/10465
previous acute hypersensitivity reaction to infliximab — no . of patients ( % ),C0205156;C0413234;C0666743;C1552607,false;false;true;false,2599/10465
non - elderly ( < nmbr years ),C1518422;C0001792;C0053917;C0439234;C1334884;C1999167,false;true;true;false;false;false,2600/10465
pravastatin ( n = nmbr >,C0085542;C0053917;C1334884,true;true;false,2601/10465
week nmbr ( mean  sd ),C0332174;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C0439230,false;true;false;false;false;false;false;false,2602/10465
factor v leiden ( % ),C0380964;C0584960;C1414509;C3542419,true;false;false;false,2603/10465
tender joint count ( nmbr - nmbr possible joints ),C0451530;C0053917;C0332149;C1705910;C2362652;C1334884,false;true;false;false;false;false,2604/10465
male sex — no . / total no . ( % ),C0086582,true,2605/10465
insulin glargine n ( x ),C0907402,true,2606/10465
time since randomization,C0040223;C3541383,true;false,2607/10465
post - bronchodilator fevnmbr ( % predicted normal ) a,C2599594,false,2608/10465
vessel size  mean ( sd )  mm,C0005847;C0456389;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143,true;false;false;false;false;false;false;false,2609/10465
hs - crp ( median  iqr )  mg / l,C3890735;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,2610/10465
insulin - requiring,C0021641;C1533581;C1579433;C3714501,true;false;false;false,2611/10465
homa . ir  median ( ql  qnmbr )  % / nmbr,C0022065;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C0022071;C1448132,true;false;true;false;false;false;false;false;true;true,2612/10465
baseline short - acting anticholinergics,C0168634;C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002;C1442488,true;false;true;true;false;false;false;true;false;false;false;false;false,2613/10465
multivitamin use ( current ),C0301532;C0042153;C0521116;C1705970;C0457083;C1947944,false;true;false;false;false;false,2614/10465
apob : apoal,C0003593;C3252643,true;true,2615/10465
cardiac stretch,C0018787;C0600080;C1522601,true;false;false,2616/10465
hospitalization for heart failure within nmbr mo,C3898876,false,2617/10465
lv ejection fraction  mean ( sd ) [range]  %,C0023128;C0489482;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C2700378;C0731033;C1881413,true;false;false;false;false;false;false;false;false;false;true;false,2618/10465
pasi score  nmbr - nmbr *,C4528685;C0449820;C0053917;C1334884;C4050231,false;false;true;false;false,2619/10465
patients with event / patients analyzed,C0030705;C0441471;C4019010,true;false;false,2620/10465
mean ( sd ) periostin  ng / ml,C0444504;C2699239;C0219433;C0439275;C1424662;C3812270;C2347634;C2348143,false;false;true;false;false;false;false;false,2621/10465
any blood transfusion,C0005841;C0281867,true;false,2622/10465
low molecular weight heparin,C0019139;C3536766,true;false,2623/10465
yes ( stopped for trial ),C1549445;C1705108;C1710701,false;false;false,2624/10465
previous chronic use of antiplatelet drugs,C0205156;C0205191;C1524063;C0085826;C2963157;C1552607,false;false;false;true;false;false,2625/10465
aspirin - erdp clopidogrel no . of patients / total no .,C0004057;C0070166,true;true,2626/10465
denosumab,C1690432,true,2627/10465
patients randomized,C0030705,true,2628/10465
days with asthma symptoms / week,C0677547;C0004096;C0683368;C1457887;C2984299,false;true;true;false;false,2629/10465
statin with fibrate,C0360714,true,2630/10465
delayed - start group ( n = nmbr ),C0205421;C0439659;C0441848;C0053917;C1334884;C1545665;C3272602,false;false;false;true;false;false;false,2631/10465
fevnmbr % predicted ( post salbutamol ),,,2632/10465
intended durat - sm of antccagubficn,C1283828;C0036154;C4553627;C1551357,false;true;false;false,2633/10465
baseline dmard use  n ( % ),C0168634;C0242708;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,2634/10465
creatinine — mg / dl urinary albumin - to - creatinine ratio §,C0010294;C0439269;C2362049;C0456603;C1547037;C1561535,true;false;false;false;false;false,2635/10465
companion : wake - up stroke,C0031268;C1170730;C0038454;C4554100;C0335343;C0682323,true;false;true;false;true;false,2636/10465
placebo events / n ( % ),C0032042;C0441471;C3541888;C1696465;C1706408,true;false;false;false;false,2637/10465
cdai score < nmbr,C0683448;C1413248;C3273706,false;false;false,2638/10465
baseline ibdq total score  mean,C0168634;C2964552;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false;false,2639/10465
positive for rheumatoid factor  anti - cyclic citrullinated peptide antibodies  or both — % ff,C0741132;C0035448;C1320283;C0201660;C0439178;C0003241;C4505301;C0439596;C1511572;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;true;true;false;false;false;false;false;false,2640/10465
current alcohol use  n ( % ),C0521116;C0001948;C1705970,false;true;false,2641/10465
cardiac medications at discharge  %,C0018787;C0806915;C1522601,true;false;false,2642/10465
medical management only,C0199168;C0001554;C0205171;C1720467;C0376636;C1273870;C3273539;C0205476,false;true;false;false;true;false;false;false,2643/10465
shoulder pain,C0037011,true,2644/10465
hbalc  mean ( s . d . ),C0444504;C2347634;C2348143,false;false;false,2645/10465
nmbr . nmbr mg bid,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,2646/10465
pci during index hospitalization,C4049621;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,2647/10465
history of cv disease,C0683519;C3538987;C4048877;C4318503;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,2648/10465
complex lesions^,C0439855;C0221198;C1704241,false;false;false,2649/10465
level nmbr immobility^,C0441889;C0053917;C0231441;C1334884;C0456079;C1547707;C2946261,false;true;false;false;false;false;false,2650/10465
asia / pacific / other,C0003980,true,2651/10465
calcium  mmol nmbr nmbr,C0006675;C0439190;C0053917;C1334884;C0006726;C2936886;C3540037;C3714611,true;false;true;false;true;false;false;false,2652/10465
race  % caucasian,C0034510;C1706779;C3853635,true;false;false,2653/10465
mtss cfb mean ± sd,C0009002;C0444504;C2699239;C2347634;C2348143;C1824728,true;false;false;false;false;false,2654/10465
study end concentration,C0557651;C0444930;C0086045;C1446561;C3827302;C2746065;C2603343,false;false;true;false;false;false;false,2655/10465
potassium  mean ( sd )  meq / l,C0032821;C0444504;C2699239;C0439375;C2347634;C2348143;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false;false,2656/10465
naive to antihyperglycemic agent therapy,C0020616;C0450442;C0039798;C0087111;C1363945;C1254351;C1521826,true;false;true;true;false;false;false,2657/10465
swollen joint count  of nmbr,C0451521;C0053917;C1334884,false;true;false,2658/10465
hemispheric tia n = nmbr,C0205139;C0007787;C0053917;C1334884;C0917805;C1054154,false;true;true;false;true;false,2659/10465
c - peptide tx difference vs pbo  median change from baseline ( se ) nmbr,C0006558;C0041403;C1705241;C1705242,true;true;false;false,2660/10465
severity of airflow limitation ( gold nmbr )  n ( % ),C0439793;C0231999;C0443288;C0018026;C0053917;C1334884;C1304897;C0449295;C0522510,false;false;false;true;true;false;false;false;false,2661/10465
other atherosclerotic event,C0333482;C0441471;C4019010,false;false;false,2662/10465
retinopathy ( stage nmbr / nmbr / nmbr / nmbr ),C0035309;C0205390;C0053917;C1334884;C1300072;C1306673;C1962966,true;false;true;false;false;false;false,2663/10465
mean — ml / min / nmbr . nmbrmnmbr,C0444504;C0439445;C0053917;C1334884;C2347634;C2348143,false;false;true;false;false;false,2664/10465
fevnmbr ( % predicted normal ),,,2665/10465
baseline total cholesterol,C0168634;C0201950;C0543421;C1442488,true;false;false;false,2666/10465
egfr category  n ( % ),C1739039;C0683312;C3889287;C3811844;C3812682,true;false;false;false;false,2667/10465
rhabdomyolysis,C0035410;C4552660,true;false,2668/10465
any other antihyperglycaemic drugs,,,2669/10465
any risk factor for stent thrombosis,C0035648;C3897493,true;false,2670/10465
copd severity : mild / moderate,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,2671/10465
medications taken at time of randomization statins,C0013227;C0802604;C2598133;C4284232,true;false;false;false,2672/10465
neither n = nmbr  nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,2673/10465
exercise at least weekly ( a ),C0015259;C1522704,true;false,2674/10465
patients with previous intolerance of infliximab,C0030705;C0205156;C0231199;C0666743;C1744706;C2355652;C1552607,true;false;false;true;false;false;false,2675/10465
mayo clinic score §,C0454788;C0002424;C0449820;C4050231;C0442592;C1077578,false;true;false;false;false;false,2676/10465
nob systolic blood pressure ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,2677/10465
geographic region - other,C0017446,true,2678/10465
months since first ra symptom  mean ( sd ) f,C0439231,false,2679/10465
continuation ( n = nmbr ),C0053917;C1334884,true;false,2680/10465
timi - defined bleeding,,,2681/10465
glycosylated hemoglobin  %,C0017853,true,2682/10465
omeprazole,C0028978,true,2683/10465
in - hospital ticagrelor ( n = nmbr ),C0019994;C1999375;C0053917;C1334884;C1510665,true;true;true;false;false,2684/10465
mean bmi ( nmbr % ci ),C0444504;C0578022;C0053917;C0008107;C3259781;C1334884;C2347634;C2348143,false;false;true;true;false;false;false;false,2685/10465
physiological measures,C0205463;C0079809;C1879489,false;true;false,2686/10465
atrial fibrillation pattern,C0004238;C0449774;C0344434;C1963067,true;false;false;false,2687/10465
corticosteroid + imm,C0001617;C0205470;C3536709,true;false;false,2688/10465
thiazide at enrollment,C0541746;C1516879;C1696073;C3888021,true;false;false;false,2689/10465
nasopharyngitis,C0027441,true,2690/10465
established atherosclerotic,C0443211;C0333482;C1272684,false;false;false,2691/10465
overall effect,C0282416;C1280500;C1518681;C2348382;C1561607,true;false;false;false;false,2692/10465
omega - nmbr fa,C1719844;C0053917;C1334884,false;true;false,2693/10465
ejection fraction : < nmbr % ( n = nmbr ),C0489482;C0053917;C1334884;C2700378,false;true;false;false,2694/10465
< nmbr mm hg heart rate,C0053917;C0439475;C0018810;C1334884,true;false;true;false,2695/10465
lv ejection fraction ( % ),C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,2696/10465
cangrelor clopidogrel no . of events / total no . ( % ),C1121991;C0070166,true;true,2697/10465
killip at baseline,C0168634;C1442488,true;false,2698/10465
time since asthma diagnosis ( years ),C0040223;C3541383,true;false,2699/10465
nmbr placebo,C0053917;C0032042;C1696465;C1706408;C1334884,true;true;false;false;false,2700/10465
carbamazepine,C0006949;C0006950;C0682993,true;false;false,2701/10465
postmenopausal  current hormone therapy use,C0232970;C2827774;C0019932;C0042153;C0457083;C1947944;C4521914;C0521116;C0279025;C1705970,false;false;true;true;false;false;false;false;false;false,2702/10465
known duration of type nmbr diabetes ( years ),C0205309;C0449238;C1320657;C0053917;C0439234;C1334884;C2926735,false;false;false;true;false;false;false,2703/10465
beta - blocker at enrollment,C0001645;C1516879;C1696073;C3888021,true;false;false;false,2704/10465
number of exacerbations nmbr months before randomisation,C0237753;C4086268;C0053917;C0439231;C1334884;C0449788,false;false;true;false;false;false,2705/10465
week nmbr hbanmbrc  mean ( s . e . ),C0332174;C0053917;C0444504;C2347634;C2348143;C1334884;C0439230,false;true;false;false;false;false;false,2706/10465
tertile nmbr ( n = nmbr ),C0053917;C1334884,true;false,2707/10465
mean ( sd ) duration of copd  years,C0444504;C2699239;C0449238;C0024117;C0439234;C1412502;C3714496;C2926735;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,2708/10465
ci - aki risk score,C0008107;C0022660;C0035647;C0449820;C4050231;C4552904;C0330978;C3259781,true;true;true;false;false;false;true;false,2709/10465
risk factors for stroke  no . ( % ),C0035648;C1553898,true;false,2710/10465
esr ( mm / h )  median ( min  max ),C3811131;C3642211;C0033727;C0549183;C0876920;C2347635;C2348144;C2939193;C0369286;C0441932;C0564385;C4528284;C0456680;C0702093;C1524029;C3813700,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false,2711/10465
units per week  mean ( sd ),C0560588;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,2712/10465
c - reactive protein — mg / literj,C0006560;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,true;true;true;false;false;false;false;false;false;false,2713/10465
non - u . s .,C1518422,false,2714/10465
acuity - defined bleeding,C0750509,false,2715/10465
vedolizumab,C2742797,true,2716/10465
other / multiracial,C1881928,false,2717/10465
time since qualifying event,C0040223;C3541383,true;false,2718/10465
> nmbr vessels treated,C0053917;C0005847;C1334884,true;true;false,2719/10465
statin use  n ( % ),C0360714;C0042153;C0457083;C1947944,true;true;false;false,2720/10465
previous coronary - artery bypass grafting,C2144990,false,2721/10465
median ( min  max ),C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,2722/10465
intensive control ( n = nmbr ) no . of patients ( percent ),C0162425;C0243148;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389;C0522510;C1283828;C1550453,true;true;true;false;false;false;false;false;false;false;false;false,2723/10465
arterial hypertension  n ( % ),C0020538,true,2724/10465
ranolazine ( n = nmbr ) placebo ( n = nmbr ),C0073633;C0053917;C0032042;C1696465;C1706408;C1334884,true;true;true;false;false;false,2725/10465
large shunt,C0549177;C0232180;C0542331;C1442858,false;false;false;false,2726/10465
history of hypertension  n ( % ),C0455527,false,2727/10465
age y  median ( range ),C0001779;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,2728/10465
companion : nmbr - nmbr hours,C0031268;C0053917;C0439227;C1334884;C0335343;C0682323,true;true;false;false;true;false,2729/10465
nt - pro bnp,C0669479;C0754710,true;true,2730/10465
lipid difference ( mg / dl ),C0023779;C1705241;C0439269;C1705242,true;false;false;false,2731/10465
other determined etiology,C0521095;C0015127;C1314792;C1524003,false;true;true;false,2732/10465
baseline pasi score,C0168634;C4528685;C0449820;C4050231;C1442488,true;false;false;false;false,2733/10465
mean ( sd ) total asthma symptom scores,C0444504;C2699239;C3533163;C0004096;C2984299;C2347634;C2348143,false;false;false;true;false;false;false,2734/10465
time since pah diagnosisc ( years ),C0040223;C3541383,true;false,2735/10465
alpha receptor antagonist,C0439095;C4543207;C2003941;C2350010,false;false;false;false,2736/10465
esrd on losartan ( % ),C0022661;C0126174;C0035078;C2316810,true;true;true;false,2737/10465
stroke at entry ( vs transient ischemic attack ),C0038454;C1705654;C4554100,true;false;false,2738/10465
medical history and risk factors ( % ),C0262926;C1704706,false;false,2739/10465
placebo monthly ( n = nmbr ),C0032042;C0332177;C0053917;C1334884;C1696465;C1706408,true;false;true;false;false;false,2740/10465
intravenous inotropes or vasopressors ( % ),C0348016;C1258199,false;true,2741/10465
overall a phase population,C0282416;C1561607,true;false,2742/10465
symptom onset to first medical contact : ambulance or emergency department,C4086878;C0205435;C0199168;C0332158;C0002422;C3846685;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;false;true;false;false;false;false;false;false,2743/10465
any glucocorticoid *,C0017710,true,2744/10465
mean ( sd ) post - bronchodilator fevnmbr percentage predicted,C0444504;C2699239;C2599594;C0439165;C1549488;C1561533;C2347634;C2348143,false;false;false;false;false;false;false;false,2745/10465
insulin ( mu / ml ),C0021641;C0439339;C1533581;C1579433;C3714501,true;false;false;false;false,2746/10465
creatinine clearance < nmbr ml / min,C0812399;C0053917;C0439445;C1334884,false;true;false;false,2747/10465
nihss at randomization,C1697238;C0034656,false;true,2748/10465
elevated serum potassium  > nmbr . nmbr mmol / l,C0553704;C0053917;C1532563;C1334884,false;true;false;false,2749/10465
concordant stress test abnormalities,C4553529;C0015260;C0000768;C0000769;C3494508,false;true;true;true;true,2750/10465
eos serum k +  meq / l,C1623465;C0302353;C0439375;C1861303,false;false;false;true,2751/10465
duration of diabetes,C0449238;C0011847;C0011849;C2926735,false;false;true;false,2752/10465
arterial revascularization,C0003842;C0581603;C0221464,true;false;false,2753/10465
endpoint rate,C2349179;C0871208;C1521828;C2826544,false;false;false;false,2754/10465
highest tertile ( range  nmbr . nmbr - nmbr . nmbr mg / dl  mean ± sd  nmbr . nmbr ± nmbr . nmbr mg / dl ),C1522410;C1514721;C0053917;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C2348147;C3542016,false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false;false,2755/10465
p interaction women vs men,C0369773;C1704675;C0043210;C2603361,false;false;true;false,2756/10465
malaysia,C0024552,true,2757/10465
populations :,C0032659;C1257890,true;true,2758/10465
serum creatinine  弘 mol 儿 | |,C0201976;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C0600061,false;true;true;false;false;false;false;false,2759/10465
index pci performed,C0600653;C4049621;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,2760/10465
retinopathy,C0035309;C1962966,true;false,2761/10465
history of nicotine use,C0019664;C0028040;C1524063;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,2762/10465
insulin glargine n ( % ) / nmbrpy,C0907402,true,2763/10465
no chd simva ( n = nmbr],C0280604;C0053917;C1334884;C3542407,false;true;false;false,2764/10465
treated with insulin,C0332293;C0021641;C1533581;C1579433;C3714501,false;true;false;false;false,2765/10465
previous ischemic stroke ortia,C0205156;C0948008;C1552607,false;false;false,2766/10465
iglarlixi,,,2767/10465
previous cabg surgery,C0205156;C0010055;C0038894;C0038895;C0543467;C1274039;C1552607,false;true;false;true;true;true;false,2768/10465
statin alone,C0360714,true,2769/10465
study drug loading days ( actual ) : nmbr ( n = nmbr ),C0013175;C1708715;C0439228;C0237400;C0053917;C1334884,true;false;false;false;true;false,2770/10465
lumbar epidural,C0581283,false,2771/10465
periprocedural medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,2772/10465
mean age  y  mean = sd,C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,2773/10465
group dif . ( nmbr ),C0441833;C0812246;C0053917;C1334884;C1710304;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false;true;false;false;false,2774/10465
prior cardiac resynchronization therapy  n ( % ),C0332152;C1167956;C2826257,false;true;false,2775/10465
cardiac risk,C0018787;C0035647;C4552904;C1522601,true;true;false;false,2776/10465
albuterol use,C0001927;C0042153;C0457083;C1947944,true;true;false;false,2777/10465
no . of events / total,C0441471;C3541888,false;false,2778/10465
no . of participants per nmbr patient - yr,C0679646,false,2779/10465
estimated glomerular filtration rate < nmbr ml / min / nmbr . nmbr mnmbr — no . / total no . ( % ) §,C3811844;C0053917;C0439445;C1334884,false;true;false;false,2780/10465
established atherosclerotic disease,C0443211;C0333482;C0012634;C1272684,false;false;true;false,2781/10465
ukraine,C0041580,true,2782/10465
negative for helicobacter pylori — no . / total no . ( % ),C4688581,false,2783/10465
other medical history — no . / total no . ( % ),C0262926;C1704706,false;false,2784/10465
left atrial anteroposterior diameter — mm,C0225860;C1301886;C4330985;C4554674;C0225861,true;false;false;false;false,2785/10465
any established peripheral arterial disease,C0443211;C0085096;C1704436;C1272684,false;true;true;false,2786/10465
serum k + level and drug treatment,C0302353;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,2787/10465
chronic inflammatory disease,C1290886,false,2788/10465
randomization to arrival in catheterization laboratory,C0034656;C1555577;C1706079,true;false;false,2789/10465
rituximab,C0393022,true,2790/10465
hemoglobin,C0019046,true,2791/10465
high risk ( receiving treatment for ) :,C0332167;C1514756;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3272283;C4050568;C4319571,false;false;true;true;false;false;false;false;false;false;false;false,2792/10465
c - reactive protein  median ( iqr )  mg / l,C0006560;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1413716;C4048285,true;false;false;false;false;false;false;false;false,2793/10465
anti - tnf - naive patients,C1448177;C0030705,true;true,2794/10465
lipids  mean ( sd )  mg / dlt,C0023779;C0444504;C2699239;C0024671;C1413248;C3273706;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,true;false;false;true;false;false;true;false;false;false;false;false;false;false,2795/10465
high - dose statin use at screening *,C0444956;C0360714;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,false;true;true;true;true;false;false;false;false;false;false;false,2796/10465
second primary ( estimated change in total updrs score from baseline to wk nmbr ),C0205436;C0205225;C0750572;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false,2797/10465
abciximab no . / total ( % ),C0288672,true,2798/10465
no . of non - tnfi,C1518422,false,2799/10465
current cvd / diabetes  n ( % ),C0521116;C0007222;C0011847;C0011849;C1705970,false;true;false;true;false,2800/10465
cv mortality,C3538987;C0026565;C0026566;C4048877;C4318503,false;true;true;true;false,2801/10465
duration of dementia symptoms  months,C0436359;C0011265;C0439231;C0497327,false;true;false;true,2802/10465
no pad baseline,C0182158;C0168634;C1442488;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,2803/10465
pre ' rtous eptscde ( s } d dvt / pe,C0332152;C0149871;C0070939;C1880476;C4284304;C2926618;C3899446;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,2804/10465
prior coronary artery bypass surgery,C0332152;C0010055;C2826257,false;true;false,2805/10465
interaction p - valuenmbr,C1704675,false,2806/10465
ipah  hpah  hiv  drug or toxin induced,C0152171;C0340543;C0019682;C0013227;C1254351;C0019699;C0637939;C1150929,false;true;true;true;false;true;true;false,2807/10465
< nmbr mg / dl simva ( n = nmbr],C0053917;C0439269;C1334884,true;false;false,2808/10465
location of disease  n ( % ),C0450429;C0012634;C1515974;C4284930;C4284931,false;true;false;false;false,2809/10465
mtx ( mean dose : nmbr . nmbr mg / wk ),C0366550;C0444504;C0053917;C1881833;C1334884;C2347634;C2348143,false;false;true;false;false;false;false,2810/10465
labs at the index acs event,C0587081;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,2811/10465
black race ( n = nmbr vs nmbr ),C0005680;C0053917;C1334884,true;true;false,2812/10465
treatment with any bp lowering drugs,C3469597;C0037623;C0441994;C2003888;C1415692;C1708288;C4318478,false;true;false;false;false;false;false,2813/10465
placebo nmbr / nmbr,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,2814/10465
diagnosed  y,C0011900,true,2815/10465
peri - op statins : no ( n = nmbr ),C0347985;C0360714,false;true,2816/10465
region  europe,C0017446;C0015176;C0205147,true;true;false,2817/10465
copd disease severity,C0024117;C0521117;C1412502;C3714496,true;false;false;false,2818/10465
baseline dyslipidemia,C0168634;C0242339;C1442488,true;true;false,2819/10465
difference in ls means ( nmbr % ci ) nmbr,C1705241;C0023668;C1704970;C0053917;C0008107;C3259781;C1334884;C1705242,false;true;false;true;true;false;false;false,2820/10465
male gender  n ( % ),C0086582;C1706180,true;false,2821/10465
( nmbr - nmbr - cm vas ),C0053917;C0042815;C3536884;C3827561;C1334884,true;true;true;false;false,2822/10465
screening absolute reversibility fevnmbr  ml,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,2823/10465
k - m %,C0597277;C0369637;C0441923;C1708601,false;false;false;false,2824/10465
type of surgery,C0332307;C0038894;C0038895;C0543467;C1274039;C1547052,false;false;true;true;true;false,2825/10465
hosp . worsening hf,C0332271;C0018488;C1313497;C1538440;C3273279;C1457868;C1546960,false;true;true;false;false;false;false,2826/10465
rest of the world,C0035253;C2700280;C1622890,true;false;false,2827/10465
placebo no . / total no .,C0032042;C1696465;C1706408,true;false;false,2828/10465
azathioprine / nmbr - mercaptopurine,C0004482;C0053917;C0000618;C1334884,true;true;true;false,2829/10465
duration of diabetes  mean ( sd )  y,C0449238;C0011847;C0444504;C2699239;C2347634;C2348143;C0011849;C2926735,false;false;false;false;false;false;true;false,2830/10465
cox - nmbr selective nsaid,C1565830;C0053917;C0036576;C0003211;C3536840;C1707391;C1334884,true;true;true;true;false;false;false,2831/10465
total ( n = nmbr  nmbr ) - -,C0439175;C0053917;C1334884;C0439810,false;true;false;false,2832/10465
laboratory variables,C0022877;C0439828;C3244292;C4283904,true;false;false;false,2833/10465
baseline anti - hyperglycemic medications,C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,2834/10465
ivabradine group ( n = nmbr ),C0257190;C0441848;C0053917;C1334884,true;false;true;false,2835/10465
undergoing major vascular surgery,,,2836/10465
< nmbr baseline killip class,C0053917;C0168634;C1881332;C1442488;C1334884,true;true;false;false;false,2837/10465
statin intensitynmbr * nmbr,C0360714;C0053917;C1334884,true;true;false,2838/10465
multivitamin use,C0301532;C0042153;C0457083;C1947944,false;true;false;false,2839/10465
baseline body weight quartile,C1303013;C2828255,false;false,2840/10465
baseline fpg  mean ( s . e . ),C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,2841/10465
primary pci n = nmbr,C0205225;C4049621;C0053917;C1334884;C0439612;C0439631,false;false;true;false;false;false,2842/10465
prior tnfi treatment,C1514463,false,2843/10465
multiple ( > nmbr ) chd risk factors that confer a nmbr - year risk of chd > nmbr %,C0439064;C0053917;C0280604;C0035648;C1553898;C3542407;C1334884,false;true;false;true;false;false;false,2844/10465
pctindopnl - indapamide ( n = nmbr ),C0021186;C0053917;C1334884,true;true;false,2845/10465
history of impaired renal function,C0019664;C1565489;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2846/10465
stroke of any etiology,C0038454;C0015127;C1314792;C1524003;C4554100,true;true;true;false;false,2847/10465
fasting insulin ( pmol / l ),C0015663;C0021641;C0439284;C1533581;C1579433;C3714501,true;true;false;false;false;false,2848/10465
total body ( without head ),C0229960;C0018670;C1706305,false;true;false,2849/10465
fatty acid composition,C0015684;C0486616;C1555710,true;false;false,2850/10465
cerebral hemorrhage,C2937358,true,2851/10465
pasinmbr response },C0871261;C1704632;C1706817;C2911692,false;false;false;false,2852/10465
nonglycemic cardiovascular risk factors systolic blood pressure — mmhg,C0850624;C0488055;C0439475;C0871470;C1306620,false;false;false;true;false,2853/10465
duration of diabetes ( months ),C0449238;C0011847;C0439231;C0011849;C2926735,false;false;false;true;false,2854/10465
alpha - glucosidase inhibitors,C1299007;C2756986;C3539108,true;false;false,2855/10465
anthropometry : mean ( sd ),C0003188;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,2856/10465
white ethnicity,C0007457;C0015031;C0243103;C0043157;C0220938,true;true;true;true;false,2857/10465
vascular history  %,C0005847;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1558950;C1801960,true;true;true;false;false;false;false;false;false,2858/10465
time from qualifying myocardial infarction,C0040223;C1514624;C0027051;C0428953;C2926063;C3810814;C4552959;C3541383,true;false;true;false;false;false;false;false,2859/10465
nmbr — nmbr nlmw,C0053917;C1334884,true;false,2860/10465
postoperative glucocorticoid use post - randomisation characteristic * *,C0032790;C0017710;C0042153;C0687676;C0034656;C1521970;C1704687;C3469826;C0457083;C1947944,true;true;true;false;true;false;false;false;false;false,2861/10465
sinus rhythm,C0232201,false,2862/10465
united states or canada,C0041703,true,2863/10465
heparin  ‘ ondaparinux or brvalirudin use between rxjex event,C0019134;C0770546,true;false,2864/10465
community hospital  n ( % ),C0020003,true,2865/10465
patient - reported outcome measures,C4277735,true,2866/10465
> nmbr . nmbr mg / liter antiplatelet agents,C0053917;C0024671;C0475211;C0085826;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;true;true;false;false;false;false;false;false,2867/10465
ara functional class — no . ( % ),C0325983;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C2316832;C3890184;C4282437;C4321455,false;false;false;false;false;false;false;false;false;false;false,2868/10465
left ventricular ejection fraction,C0428772;C0488728,false;false,2869/10465
restenotic vessel,C0333186;C0005847,false;true,2870/10465
mean nmbr - year cvd risk *,C0444504;C0053917;C0439234;C0007222;C0035647;C4552904;C0439508;C1334884;C2347634;C2348143,false;true;false;true;true;false;false;false;false;false,2871/10465
^median > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,2872/10465
ace inhibitors / sartans,C0003015;C1563745,true;true,2873/10465
duration of hypertension  y,C0449238;C0020538;C1963138;C2926735,false;true;false;false,2874/10465
history of pci — no . / total no . ( % ) : t,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,2875/10465
current cigarette smoker or within past year,C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,2876/10465
time to randomization from symptom onset,C0040223;C0034656;C3541383,true;true;false,2877/10465
motor weakness,C1513492;C3714552;C1705994,false;false;false,2878/10465
hospitalization for hf previous year  ( % ),C0019993;C0018488;C0205156;C0439234;C0439508;C1552607;C1313497;C1538440;C3273279,true;true;false;false;false;false;true;false;false,2879/10465
st - segment depression < nmbr . nmbr mv  %,C0520887;C0053917;C1454484;C1705503;C4281602;C1334884,false;true;true;false;false;false,2880/10465
ab / ff nmbr / nmbr pg ( n = nmbr ),C4554348;C0053917;C0030827;C0072225;C1266240;C1334884,false;true;true;true;false;false,2881/10465
severity of airflow obstruction,C0439793;C0231999;C0028778;C1882136;C0522510,false;false;false;false;false,2882/10465
tender - joint count ( of nmbr joints ),C0451530;C0053917;C1334884,false;true;false,2883/10465
tenecteplase,C0872913,true,2884/10465
median duration of symptoms ( range )  yr,C0549183;C0436359;C1514721;C0439234;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,2885/10465
history of pci / ptca,C0019664;C4049621;C2936173;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,2886/10465
only dvt,C0205171;C0149871;C2926618;C3899446;C1720467,false;true;false;false;false,2887/10465
glucose - lowering drug,C0017725;C0441994;C0013227;C1254351;C2003888,true;false;true;false;false,2888/10465
age group ( years ),C1510829;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0027362;C0439234;C2348001,false;false;false;true;false;false;false;true;false;false,2889/10465
renal events,C0022646;C0441471;C3541888,true;false;false,2890/10465
blood leucocyte concentration ( nmbr cells per l ),C0023516;C0086045;C0053917;C0347983;C1334884;C1446561;C3827302;C0427728;C0699870;C1313904,true;true;true;false;false;false;false;false;false;false,2891/10465
baricitinib nmbr mg,C4044947;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2892/10465
etd ( % ) [nmbr % ci],C1180255;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,2893/10465
ranolazine ( n = nmbr ),C0073633;C0053917;C1334884,true;true;false,2894/10465
below - knee popliteal,C0542339;C0022742;C0442037;C0022745;C1963703;C1552829,false;true;false;true;false;false,2895/10465
uacr ( mg / g ),C1300563,false,2896/10465
geographic location,C0017446,true,2897/10465
albuminuria,C0001925,true,2898/10465
angina  n ( % ),C0002962,true,2899/10465
acrnmbr response,C0871261;C1704632;C1706817;C2911692,false;false;false;false,2900/10465
dyslipidemianmbr,,,2901/10465
past or current,C1444637;C4284302,false;false,2902/10465
interval from randomization to angiography,C1272706;C0034656;C1552654;C1552713,false;true;false;false,2903/10465
enthesitis,C1282952,false,2904/10465
previous treatment,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,2905/10465
non - tnf inhibitors,C1518422;C1448177;C0243077,false;true;true,2906/10465
any blood - pressure - lowering drug 一 no . ( % ),C0003364,true,2907/10465
previous stroke — no . ( % ),C0205156;C1552607,false;false,2908/10465
proximal to the splenic flexure,C0205107;C0227387;C4489236,false;true;false,2909/10465
high eosinophil subgroup ( > nmbr / ml ) ( n = nmbr ),C0205250;C0014467;C1079230;C0053917;C0439526;C1705224;C3887665;C1334884;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;true;false;false;false;false;false;false;false;false;false;false;false,2910/10465
patients with egfr > nmbr ml / min / nmbr . nmbrmnmbr  n,C0030705;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;true;false;false;false;false,2911/10465
slo days,C1416602;C0439228;C3539661,false;false;false,2912/10465
cardiovascular mortality,C0007226;C0026565;C0026566;C3887460,true;true;true;false,2913/10465
mnmbr subgroup,C1079230;C1515021,false;false,2914/10465
valsartan ( n = nmbr ),C0216784;C0053917;C1334884,true;true;false,2915/10465
japan n = nmbr,C0022341;C0053917;C1334884,true;true;false,2916/10465
modified se - adl scale,C0392747;C0036919;C0001288;C0175659;C0349674;C1947916;C1420005;C3889737,false;true;true;true;false;false;false;false,2917/10465
corticosteroids only,C0001617;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false;false;false,2918/10465
p - value interaction,C1709380;C1704675,false;false,2919/10465
undetermined  other  or cardioembolism,C0205258;C3536725;C4082977,false;false;false,2920/10465
percentage patients reaching target,C0439165;C0030705;C1549488;C1561533,false;true;false;false,2921/10465
hispanic  n ( % ),C0086409,true,2922/10465
modified has - bled,C0392747;C3889737,false;false,2923/10465
insulin alone,C0021641;C1533581;C1579433;C3714501,true;false;false;false,2924/10465
statin only  n ( % ),C0360714;C0205171;C1720467,true;false;false,2925/10465
body - mass index categories — no . ( % ) : c,C0005893;C0683312;C0578022;C1305855,false;false;false;true,2926/10465
monocytes  nmbr / nl,C0026473;C0053917;C0027778;C0560008;C3892223;C1334884,true;true;true;false;false;false,2927/10465
criteria for subcortical vad ( by mri )  %,C0243161;C0815275;C0077973,true;false;true,2928/10465
crp mean ( mg / dl ± sd ),C3890735;C0444504;C0439269;C2699239;C2347634;C2348143;C4048285,false;false;false;false;false;false;false,2929/10465
angiographic features,C0002978;C1521970;C1706388;C2346469;C2348519,true;false;false;false;false,2930/10465
> nmbr years to < nmbr years ( n = nmbr ),C0053917;C0439234;C1334884,true;false;false,2931/10465
pathologic q waves  n ( % ),C0429090,false,2932/10465
duration of metformin therapy ( months ),C0444917;C0025598;C0439231,false;true;false,2933/10465
baseline bmi > nmbr kg / mnmbr  n = nmbr change from baseline to nmbr weeks,C0168634;C0578022;C0053917;C0022718;C0392747;C0439230;C0443172;C1705241;C4319952;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false;false;false;false;false;false,2934/10465
lesion location,C0221198;C0450429;C1515974;C4284930;C4284931;C1546698,false;false;false;false;false;false,2935/10465
patients treated with statins ( n = nmbr ),C0030705,true,2936/10465
copd exacerbations during the previous year,C0740304;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,2937/10465
biasp nmbr,C0053917;C1334884,true;false,2938/10465
insulin — iu,C0021641;C0049272;C0439453;C0694756;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,2939/10465
subject characteristics,C0681884;C1519021;C1706465,false;false;false,2940/10465
primary composite outcome,C0205225;C0205199;C1274040;C1547335;C0439612;C0439631,false;false;false;false;false;false,2941/10465
category nmbr and nmbr,C0683312;C0053917;C1334884;C3889287,false;true;false;false,2942/10465
race or ethnic background — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,2943/10465
renal function subgroups,C0232804;C1079230,false;false,2944/10465
percent of patients,C0439165;C0030705,false;true,2945/10465
placebo / simvastatin,C0032042;C0074554;C1696465;C1706408,true;true;false;false,2946/10465
% of predicted normal value *,C0681842;C0086715;C1882327,false;true;false,2947/10465
body - mass index ( kg / mnmbr )  mean ( sd ),C0005893;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;true,2948/10465
rolofylline dose,C0166128;C0178602;C0869039;C1114758,true;false;false;false,2949/10465
canagliflozin dose,C2974540;C0178602;C0869039;C1114758,true;false;false;false,2950/10465
pbo + statin nmbr,C0031962;C0360714;C0053917;C1334884,true;true;true;false,2951/10465
orthopaedic,C0029355,true,2952/10465
geographic region — number ( % ),C0017446;C0237753;C0449788,true;false;false,2953/10465
black race — no . / total no . ( % ) f,C0005680;C0027567;C0085756;C0439541,true;true;true;false,2954/10465
versus olodaterol nmbr pg,,,2955/10465
antihypertensive agents  n ( % ),C0003364,true,2956/10465
baseline cardiovascular medication,C0168634;C0007220;C1442488,true;true;false,2957/10465
alpha - blocker,C0001641,true,2958/10465
modified total sharp score * *,C0392747;C2964552;C1444775;C1539835;C3890003;C3889737,false;false;false;false;false;false,2959/10465
beta - blocker use at baseline,C0001645;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,2960/10465
all - cause,C0015127;C1524003,true;false,2961/10465
class nmbr or no symptoms,C0456387;C0053917;C1334884;C1518526;C1705943,false;true;false;false;false,2962/10465
laboratory variables at baseline,C0022877;C0439828;C0168634;C1442488;C3244292;C4283904,true;false;true;false;false;false,2963/10465
pneumonia in past year,C0032285;C4086728,true;false,2964/10465
apixaban  nmbr mg ( n = nmbr ),C1831808;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2965/10465
chd men,C0280604;C0025266;C3542407,false;true;false,2966/10465
calcium antagonist strategy ( cas ) ( events / n ),C0006684;C0679199;C0441471;C3541888,true;false;false;false,2967/10465
muscle twitching,C0015644;C0231530,true;false,2968/10465
other medication usage,C0013227;C0457083;C3244316;C4284232,true;false;false;false,2969/10465
qvanmbr nmbr / nmbr | ig od n = nmbr,C0053917;C0021027;C0229089;C0439164;C1512019;C3273373;C3665488;C0305052;C0360506;C1334884,true;true;false;false;false;true;true;false;false;false,2970/10465
female sex — number ( % ),C0086287;C0237753;C0449788,true;false;false,2971/10465
heart rate  beats / min  mean ± sd,C0018810,true,2972/10465
mitral insufficiency  n ( % ),C0026266,true,2973/10465
from baseline ( nmbr % ci ),C0168634;C0053917;C0008107;C3259781;C1334884;C1442488,true;true;true;false;false;false,2974/10465
compression stockings,C0038348,true,2975/10465
baseline triglycerides < nmbr mg / dl,C0168634;C0041004;C0053917;C0439269;C1334884;C1442488,true;true;true;false;false;false,2976/10465
apo b / apo a - l,C1447574;C0003592;C0523508;C4553344;C4521365,true;true;false;false;false,2977/10465
beta - carotene ( n = nmbr  nmbr ),C0053396;C0053917;C1334884;C0696105,true;true;false;false,2978/10465
> nmbr years baseline ldl - c,C0053917;C0439234;C0168634;C1442488;C1334884,true;false;true;false;false,2979/10465
prevalence of each metabolic syndrome criterion,C0033105;C0524620;C0243161;C0220900,true;true;true;true,2980/10465
sex  men / women  %,C0009253;C0025266;C0043210;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;true;false;false;true,2981/10465
high - dose statin use  n ( % ) e,C0444956;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,2982/10465
fasting glucose ( mmol / l ),C0015663;C0017725;C1532563,true;true;false,2983/10465
fistula at baseline  n ( % ),C0016169;C0168634;C1442488,true;true;false,2984/10465
dizziness,C0012833;C0042571;C1963093;C4084788;C4085547;C4085548;C4085549;C4553830,true;true;false;false;false;false;false;false,2985/10465
coronary angiography — no . ( % ),C0085532;C1548829,true;false,2986/10465
presenting signs and symptoms,C0449450;C0220912;C0220913;C0311392,false;true;false;false,2987/10465
moderate copdb [n z nmbr],C0205081;C0053917;C1334884;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,2988/10465
planned conservative therapy subgroup,C1301732;C0459914;C1079230;C1515021,false;true;false;false,2989/10465
sonti amenca,,,2990/10465
clopidogrel  nmbr mg *,C0070166;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,2991/10465
methotrexate,C0025677,true,2992/10465
hs - crp ( mg / l  median ),C3890735;C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,2993/10465
previously taken dmards other than methotrexate  %,,,2994/10465
non - ischaemic ( n = nmbronmbr ),C1518422;C0475224,false;false,2995/10465
progestins,C0033306,true,2996/10465
fasting serum glucose ( mg / dl )  median ( iqr ),C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430,true;false;false;false;false;false;false;false;false,2997/10465
normalized,C1882115,false,2998/10465
time from hospital admission to pci  h  median ( qnmbr  qnmbr ),C0040223;C0019994;C1959907;C1510665;C3541383,true;true;false;false;false,2999/10465
known t ' rc - iitoji cccndilon,C0205309;C1167159;C1419366,false;false;false,3000/10465
ii or iii,,,3001/10465
left ventricular ejection,C2733342,false,3002/10465
left ventricular ejection fraction — no . / total no . ( % ),C0428772;C0488728,false;false,3003/10465
previous loss of response to and intolerance of infliximab  n ( % ) *,C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,false;false;false;false;false;false;false,3004/10465
reported diabetes mellitus,C0684224;C0011849;C0700287;C4319718,true;true;false;false,3005/10465
other / missing,C1551393;C1705492;C3272743,false;false;false,3006/10465
severe or moderate,C0205082;C4050465;C4050466,false;false;false,3007/10465
coronary bypass  n ( % ),C0010055,true,3008/10465
new zealand,C0027978;C0324547,true;true,3009/10465
cox - nmbr selective nsaid use,C1565830;C0053917;C0036576;C0003211;C0042153;C0457083;C1947944;C3536840;C1707391;C1334884,true;true;true;true;true;false;false;false;false;false,3010/10465
heart failure cause,C0018801;C0015127;C1524003;C0018802;C4554158,true;true;false;true;false,3011/10465
sbp ( mmhg ) < nmbr,C0085805;C0439475;C0053917;C1334884,true;false;true;false,3012/10465
past smoker  n ( % ),C1444637;C0337664;C4284302,false;true;false,3013/10465
previous stroke — no . ( % ) concomitant treatment — no . ( % ),C0205156;C1552607,false;false,3014/10465
mean ( s . d . ) hdl cholesterol,C0444504;C0023822;C0392885;C2347634;C2348143,false;true;false;false;false,3015/10465
amiodarone ( n = nmbr ),C0002598;C0053917;C1334884,true;true;false,3016/10465
previous disease — no . ( % ) f,C0205156;C0012634;C1552607,false;true;false,3017/10465
esrd on placebo ( % ),C0022661;C0032042;C1696465;C1706408;C0035078;C2316810,true;true;false;false;true;false,3018/10465
acute respiratory insufficiency,C0865850,false,3019/10465
> nmbr % predicted arr ( n = nmbr ),C0053917;C0681842;C2170357;C4084934;C1882327;C1334884,true;false;false;false;false;false,3020/10465
associated with drug or toxin exposure,C0332281;C0013227;C1254351,false;true;false,3021/10465
ls mean change ± sea,C0023668;C0444504;C0392747;C0036493;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false,3022/10465
reversible ( % ),C0205343,false,3023/10465
left atrial dimension  cm,C2950135;C0018792;C0439534,false;true;false,3024/10465
aspirin alone ( n = nmbr ) nmbr . nmbr,C0004057;C0205171;C0053917;C1334884;C0439044;C0679994,true;false;true;false;false;false,3025/10465
diuretics ( % ),C0012798,true,3026/10465
ldl cholesterohhdl cholesterol ratio,C0023824;C0456603;C1547037;C0202117,true;false;false;false,3027/10465
renal insufficiencynmbr,C0022646,true,3028/10465
> nmbr : nmbr hrs : min ( n = nmbr ),C0053917;C1568891;C0702093;C1524029;C3813700;C1334884,true;true;false;false;false;false,3029/10465
sr ii b nmbr - cjl nmbr,C0753208;C1710602;C0053917;C1334884;C4082587;C1709991;C3813610;C3890900;C3891546,true;false;true;false;false;false;false;false;false,3030/10465
csdmards + mtx ( n = nmbr ),C0025677;C0053917;C1334884;C1417487,true;true;false;false,3031/10465
uc duration  y  mean ( range ),C0449238;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143;C2926735,false;false;false;false;false;false;false;false,3032/10465
ejection fraction category,C0489482;C0683312;C3889287;C2700378,false;false;false;false,3033/10465
high - probability ventilation / perfusion lung scanning,C4699572;C0560738;C0024109,false;true;true,3034/10465
mmse nmbr - nmbr,C0451306;C0053917;C1334884,true;true;false,3035/10465
use oforal glucose - lowering agent — no . ( % ),C0042153;C0457083;C1947944,true;false;false,3036/10465
baseline sgrq total score,C0168634;C2964552;C1442488,true;false;false,3037/10465
min - max age,C0702093;C0001779;C1524029;C3813700,false;false;false;false,3038/10465
baseline gfr < nmbr ml / min per nmbr . nmbr mnmbr  n ( % ),C0168634;C0017654;C0053917;C0439445;C1334884;C1424601;C1442488,true;true;true;false;false;false;false,3039/10465
ischemic stroke,C0948008,false,3040/10465
medications at discharge,C0806915,false,3041/10465
multiracial  n ( % ),C1881928,false,3042/10465
qnmbr : nmbr . nmbr to < nmbr . nmbr kg ( n = nmbr vs nmbr ),C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,3043/10465
heart rate,C0018810,true,3044/10465
self - reported disease severity  nmbr - nmbr scale *,C0681906;C0521117;C0053917;C0175659;C0349674;C1947916;C1334884;C2700446,false;false;true;true;false;false;false;true,3045/10465
concomitant aedsa,C0521115,false,3046/10465
immunosuppressant use  %,C0021081;C0042153;C0457083;C1947944,true;true;false;false,3047/10465
moderately high risk,C0205081;C0332167;C3272283;C4050568;C4319571;C1881878;C4085643;C4321491,false;false;false;false;false;false;false;false,3048/10465
triglycerides  median ( ql  qnmbr )  mmol / l,C0041004;C0549183;C1532563;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,3049/10465
nmbr = some restrictions  no help needed,C0053917;C1334884,true;false,3050/10465
nmbr or nmbr high - risk categories,C0053917;C1334884,true;false,3051/10465
calcium antagonist strategy ( n = nmbr nmbr ),C0006684;C0679199;C0053917;C1334884,true;false;true;false,3052/10465
time to balloon / needle  min *,C0040223;C0336867;C0027551;C0702093;C1524029;C3813700;C1882041;C0441144;C3541383,true;false;true;false;false;false;false;false;false,3053/10465
no - diuretics group ( n = nmbr ),C0012798;C0441848;C0053917;C1334884,true;false;true;false,3054/10465
egfr . nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr  nmbr ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,3055/10465
patients with any clinical,C0030705;C0205210,true;false,3056/10465
squamous cell carcinoma,C0007137;C1302853,true;false,3057/10465
( pg / mg ),C1627892,false,3058/10465
phosphodiesterase type nmbr inhibitors,C0031638;C0332307;C0053917;C1334884;C1547052;C1656262;C3539996,true;false;true;false;false;false;false,3059/10465
history of stroke ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3060/10465
age ^nmbr yrs  n ( % ),C0001779;C0053917;C1334884,false;true;false,3061/10465
cangrelor ( n = nmbr ),C1121991;C0053917;C1334884,true;true;false,3062/10465
previous cabg ( % total ),C0205156;C0010055;C0439175;C0439810;C1552607,false;true;false;false;false,3063/10465
baseline composite mayo clinic score,C0168634;C4055211;C0454788;C0002424;C0442592;C1077578;C1442488,true;false;false;true;false;false;false,3064/10465
ticlopidine after completion of study drug,C0040207;C2348557;C0013227;C1254351;C0205197;C0013175;C1554962,true;false;true;false;false;true;false,3065/10465
admission for hf in previous year  n ( % ),C0184666;C0018488;C1313497;C1538440;C3273279;C0809949,false;true;true;false;false;false,3066/10465
time since diagnosis — mo,C0040223;C3541383,true;false,3067/10465
left main coronary artery,C1261082,false,3068/10465
other llt at randomization,C2347090;C0034656,false;true,3069/10465
other anti - hypertensives,C0003364,true,3070/10465
a ngina > nmbr day s previously *,C0053917;C0332173;C0439228;C0439505;C1334884,true;false;false;false;false,3071/10465
% predicted,C0681842;C1882327,false;false,3072/10465
use of antihypertensive drugs,C1524063;C0003364,false;true,3073/10465
total cholesterol ( median  iqr )  mg / dl,C0201950;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193;C0543421,false;false;false;false;false;false;false;false,3074/10465
hr ( nmbr % ci ) p   value,C0053917;C0008107;C1709380;C3259781;C1334884,true;true;false;false;false,3075/10465
loop or thiazide diuretic : ! :,C0445022,false,3076/10465
monitoring group ( n = nmbr ),C0150369;C0441848;C0053917;C1334884;C1283169,false;false;true;false;false,3077/10465
ischemic coronary artery disease,C0852149,false,3078/10465
blood eosinophil count > nmbr / mmnmbr at screening — no . ( % ),C1511226;C0200638;C0053917;C1334884;C0750879,false;false;true;false;false,3079/10465
no known frtrontxtfufoc cond aon,C0205309,false,3080/10465
mssbp / msdbp,,,3081/10465
devices for heart failure at screening visit,C0025078;C0018787;C2024216;C0231174;C0680095;C0025080;C0018801;C0018802;C4554158;C0220819;C0699733,true;true;false;false;false;true;true;true;false;true;true,3082/10465
interleukin nmbr ( pg / ml ),C0021764;C0053917;C0439297;C1334884;C1527200,true;true;false;false;false,3083/10465
priorvascular disease  %,C0012634,true,3084/10465
planned thienopyridine at enrollment,C1709561;C1120149,false;true,3085/10465
background csdmard category,C1706907;C0683312;C3889287,false;false;false,3086/10465
relative risk ( nmbr % ci ) ofprimary end point,C0242492;C0053917;C0008107;C2349179;C2826544;C3259781;C1334884,true;true;true;false;false;false;false,3087/10465
history of gi bleeding or ulcer — no . / total no . ( % ),C0019664;C0017181;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,3088/10465
non - fibrin - specific,C0205370;C0015982,false;true,3089/10465
gly nmbr . nmbr mg b . i . d . n = nmbr,C1415124;C0053917;C0024671;C0152277;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;false;true;false;false;false;false;false;false,3090/10465
previous coronary angioplasty  n ( % ),C2114427,false,3091/10465
mean ± sd egfr  ml / min / nmbr . nmbr mnmbr,C0444504;C2699239;C1739039;C0439445;C0053917;C1334884;C3811844;C3812682;C2347634;C2348143,false;false;true;false;true;false;false;false;false;false,3092/10465
octave induction nmbr and nmbr,C0205263;C0053917;C1334884;C0857127,false;true;false;false,3093/10465
single vessel coronary artery diseasenmbr,C0265903;C0005847,false;true,3094/10465
greater than or equal to nmbr %,C0439093,false,3095/10465
baseline nih stroke scale — no . ( % ) ^,C0168634;C1697238;C3484372;C1442488,true;false;false;false,3096/10465
history of stroke or tia — no . ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3097/10465
chd + cerebrovascular disease men nmbr / nmbr ( nmbr . nmbr ),C0280604;C0007820;C0025266;C0053917;C1334884;C3542407,false;true;true;true;false;false,3098/10465
albumin ( mg / dl ),C0001924;C0439269,true;false,3099/10465
lp ( a ) ( pmol / l ),C0065058;C0439284;C1439335;C4553379,true;false;false;false,3100/10465
st - segment depression,C0520887,false,3101/10465
statin — no . / total no . ( % ),C0360714,true,3102/10465
> nmbr episodes of atrial fibrillation in previous nmbr mo,C0053917;C0332189;C0004238;C0344434;C1963067;C1334884,true;false;true;false;false;false,3103/10465
ascvd as per protocol,C3665365;C1698058,false;false,3104/10465
oral antidiabetes combination therapy without insulina  n ( % ),C0442027;C0009429;C0556895;C4521986,false;true;false;false,3105/10465
interquartile range — yr,C1711350;C0439234,false;false,3106/10465
beta - blockers through hospital discharge or day nmbr — %,C0001645;C0586003,true;false,3107/10465
korea  republic of,C0022773,true,3108/10465
corticosteroid ( without imm )  n,C0001617;C0205470;C3536709,true;false;false,3109/10465
index event subtype,C0600653;C0441471;C0449560;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,3110/10465
residual perfusion defect > nmbr % on lung scan  no . ( % ),C1609982;C1457869;C0053917;C1518040;C1334884,false;false;true;false;false,3111/10465
antiplatelet agent or anticoagulant,C0085826,true,3112/10465
atorvastatin monotherapy ( n = nmbr * ),C0286651;C0053917;C1334884,true;true;false,3113/10465
glycoprotein ilb / iiia inhibitor before pci],C0017968;C4697913;C1999216;C4049621,true;false;false;false,3114/10465
extensive disease other,C0849867,false,3115/10465
catheter access site,C0449652;C0444454;C1554204;C0085590;C0589360,false;false;false;true;false,3116/10465
number of individuals,C1549735,false,3117/10465
congenital heart disease,C0152021,false,3118/10465
ff nmbr gg ( n = nmbr  nmbr ),C4554348;C0053917;C0017454;C0018370;C1334884,false;true;true;true;false,3119/10465
time from event to randomization — days,C0040223;C0441471;C4019010;C3541383,true;false;false;false,3120/10465
clinical,C0205210,false,3121/10465
presence of mets ( % ) a,C0150312;C0812270;C1705694;C2939420;C0392148;C3854307,false;false;false;false;false;false,3122/10465
parental history of mii,C0030551;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,3123/10465
fasting serum glucose  mg / dl,C0015663;C0202041;C0439269;C3534430,true;false;false;false,3124/10465
treatment at randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,3125/10465
glomerular filtration rate ( ml / min / nmbr . nmbrma ,C0017654;C0439445;C0053917;C1334884;C1561549,true;false;true;false;false,3126/10465
qrs duration > nmbr ms  n ( % ),C0429025;C0053917;C2349943;C3539704;C3713294;C1334884;C0488377,false;true;false;false;true;false;false,3127/10465
median time to first exacerbation ( months [nmbr % ci] ),C0549183;C0205435;C4086268;C0556969;C0053917;C0008107;C3259781;C1334884;C1279901;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;true;false;false;false;false;false;false;false,3128/10465
fasting c - peptide ( nmol / l ) c,C0015663;C0006558;C0439282,true;true;false,3129/10465
tender joint count ( nmbr joints ),C0451530;C0053917;C1334884,false;true;false,3130/10465
all - cause hospitalization,C0015127;C0019993;C1524003,true;true;false,3131/10465
duration of full - dose warfarin therapy before enrollment ( mo ),C0444917;C0443225;C0366686,false;false;false,3132/10465
severe or very severe copd,C0205082;C4050465;C4050466,false;false;false,3133/10465
nmbrmg vs placebo,,,3134/10465
nmbrmwd  m,C0369637;C0441923,false;false,3135/10465
proportion ( nmbr % ci ) adjusted for baseline hbanmbrc  %,C1709707;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,3136/10465
waist ( cm ),C0230097,false,3137/10465
qualifying diagnosis,C1514624;C0011900;C1704338;C1704656,false;true;true;false,3138/10465
mean disease duration  y ( sd ),C0444504;C0872146;C2699239;C2347634;C2348143,false;false;false;false;false,3139/10465
daily activities / social functioning,C0871707;C0037395,false;true,3140/10465
saxa nmbr . nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,3141/10465
rosuva nmbr mg n = nmbr,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,3142/10465
bmi group — no . ( % ),C0578022;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;true;false;false;false,3143/10465
lv mass,C0455825,false,3144/10465
hours from clopidogrel loading  mean ( sd ),C0439227;C0070166;C1708715;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false;false,3145/10465
non - ischaemic,C1518422;C0475224,false;false,3146/10465
omega nmbr allocation,C1719844;C0053917;C1706778;C1334884,false;true;false;false,3147/10465
adjustednmbr risk reduction losartan vs placebo ( nmbr % cl ),C1137094;C0126174,true;true,3148/10465
n - nmbr pufa,C0369718;C0053917;C0032615;C1334884;C0441922,false;true;true;false;false,3149/10465
combined ( n = nmbr ),C0205195;C0053917;C1334884,false;true;false,3150/10465
lamotrigine,C0064636;C0524166,true;false,3151/10465
maximal diameter stenosis,C0205289;C1301886;C0678234;C1261287;C2632116;C0806909;C4049713,false;false;false;true;false;false;false,3152/10465
hispanic ethnic group  n ( % ),C0086409;C0015031;C0441848;C0680174,true;true;false;false,3153/10465
multivessel coronary artery disease — no . / total no . ( % ),C0010054;C0010068;C1956346,true;true;true,3154/10465
history,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,3155/10465
patient ' s global assessment of disease activity ( nmbr - nmbr mm vas )  mean ( sd ),C4054228;C0053917;C4330985;C0042815;C0444504;C2699239;C2347634;C2348143;C3536884;C3827561;C4554674;C1334884,false;true;false;true;false;false;false;false;true;false;false;false,3156/10465
prior cardiovascular event " ' ",C0332152;C1320716;C2826257,false;false;false,3157/10465
no . with event / total no . { % ),C0441471;C0439175;C0439810;C4019010,false;false;false;false,3158/10465
ras - aldosterone inhibitor^,C1514727;C0002006;C0034678;C0002007;C0525678,false;true;true;true;true,3159/10465
mean ( sd ) post - bronchodilator fevnmbr / fvc  %,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,3160/10465
non - hispanic white,C1518424;C0007457;C0043157;C0220938,false;true;true;false,3161/10465
ethacrynic acid,C0014963,true,3162/10465
aqlq ( s ) score,C4055434;C0449820;C4050231,false;false;false,3163/10465
patients who received negative results on test for antibodies to infliximabt,C0030705,true,3164/10465
non - hdl ( mg / dl ) < nmbr,C1518422;C3715113;C0439269;C0053917;C1334884,false;false;false;true;false,3165/10465
all completers,,,3166/10465
mean difference = seb,C0444504;C1705241;C0059386;C1309881;C1423585;C3815268;C1705242;C2347634;C2348143,false;false;true;true;false;false;false;false;false,3167/10465
> nmbr  n ( % ) gender  n ( % ),C0053917;C0079399;C1522384;C1334884,true;true;true;false,3168/10465
prior use of $ nmbr systemic therapies,C1514463;C1524063;C0053917;C0205373;C1334884;C0332152;C1515119;C2826257,false;false;true;false;false;false;false;false,3169/10465
health assessment questionnaire ( nmbr - nmbr range ),C0451208;C0053917;C1514721;C2348147;C3542016;C1334884,false;true;false;false;false;false,3170/10465
low - molecular - weight heparin,C0019139;C3536766,true;false,3171/10465
non - hdl cholesterol ( mmol / l ),C0729627;C1532563;C1535899,false;false;false,3172/10465
previous medication for respiratory disease — no . ( % ),C0205156;C0418986;C0012634;C0013227;C0035204;C0035242;C3244316;C4284232;C1552607,false;false;true;true;true;true;false;false;false,3173/10465
characteristics of the index ml,C1521970;C0600653;C0439526;C1705224;C3887665;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;true;false;false;false,3174/10465
history of heart failure,C0455531,false,3175/10465
prior cardiovascular history,C0332152;C1880008;C2826257,false;false;false,3176/10465
metabolic syndromenmbr *,C0311400;C1524026;C2707259,false;false;false,3177/10465
consistency of effect,C0332529;C1280500;C1518681;C2348382;C1547017,false;false;false;false;false,3178/10465
fondaparinux,C1098510,true,3179/10465
other lipid - modifying drug 一 no . ( % ),C0023779;C0392747;C0013227;C1254351,true;false;true;false,3180/10465
initial timi flow,C0205265;C3272266;C1279901;C1555582;C1705685,false;false;false;false;false,3181/10465
overall nmbr,C0282416;C0053917;C1334884;C1561607,true;true;false;false,3182/10465
absolute decrease > nmbr %,C0205344;C0392756;C0053917;C1334884;C0547047,false;false;true;false;false,3183/10465
recurrent hf hospitalization,C1455761;C0018488;C0019993;C1313497;C1538440;C3273279;C2945760,false;true;true;true;false;false;false,3184/10465
intrathoracic or intraperitoneal surgery,C0595836,false,3185/10465
former or never diabetes,C0205156;C0750523,false;false,3186/10465
geographic site  %,C0017446,true,3187/10465
history of high cholesterol ( a ) nmbr,C0019664;C0020443;C1522133;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3188/10465
history of heart failure  n ( % ),C0455531,false,3189/10465
sco . ’ ita ' rojs dvt . ' pe,C2986561;C0022277;C0149871;C0070939;C1880476;C4284304;C2926618;C3899446,false;true;true;true;false;false;false;false,3190/10465
general health vas  nmbr - nmbr mm,C0424575;C0042815;C0053917;C4330985;C4554674;C1334884;C3536884;C3827561;C4018875,false;true;true;false;false;false;true;false;false,3191/10465
placebo / open - label abatacept,C0032042;C1709323;C1619966;C1696465;C1706408,true;false;true;false;false,3192/10465
prior known stenosis > nmbr %,C0332152;C0205309;C0678234;C0053917;C1334884;C1261287;C2632116;C2826257,false;false;false;true;false;true;false;false,3193/10465
ras antagonist  %,C0034678;C0231491;C0525678,true;false;true,3194/10465
cancer medications,C0006826;C0013227;C0802604;C2598133;C4284232;C0998265;C1306459,true;true;false;false;false;false;false,3195/10465
current other ( predefined ) medical conditions,C0521116;C1705970,false;false,3196/10465
center location,C0205099,false,3197/10465
time from qualifying stroke to randomization,C0040223;C1514624;C0038454;C4554100;C3541383,true;false;true;false;false,3198/10465
geographical region  n ( % ),C0017446,true,3199/10465
priorbone disease,C0012634,true,3200/10465
laba - inhaled glucocorticoid use at screening,,,3201/10465
main concomitant treatments  no . ( % ),C0205225;C0521115;C0087111;C1542147,false;false;true;false,3202/10465
use of rescue medication,C0240320,false,3203/10465
p vs placebo,C0369773;C2603361,false;false,3204/10465
cardiac troponin t level > nmbr . nmbr pg / l,C3538889;C0441889;C0053917;C0439278;C1334884;C0456079;C1547707;C2946261,false;false;true;false;false;false;false;false,3205/10465
aspirin < nmbr day,C0004057;C0053917;C0332173;C0439228;C0439505;C1334884,true;true;false;false;false;false,3206/10465
native coronary,C0302891;C0018787,false;true,3207/10465
arthralgia,C0003862;C4551938,true;false,3208/10465
other bdmards ( no tnfi taken ) t  n ( % ),,,3209/10465
hmgcoa rl,C0047420;C1419337;C3539667,true;false;false,3210/10465
egfrmdrd  ml - min - nmbr - nmbr . nmbr m - nmbr,C0439445;C0053917;C0369637;C0441923;C1334884,false;true;false;false;false,3211/10465
prior angioplasty,C0332152;C0162577;C1548817;C2826257,false;true;false;false,3212/10465
anti - ccp antibody ( u /,C0003242;C1525410;C0439148;C1704514;C4318437;C0003241;C0021027;C1167408;C3665580,true;false;false;false;true;true;true;false;false,3213/10465
mean baseline ldl - c ( mmol / l ),C0444504;C0168634;C1532563;C1442488;C2347634;C2348143,false;true;false;false;false;false,3214/10465
composite events,C0205199;C0441471;C3541888;C1547335,false;false;false;false,3215/10465
foot fracture,C0272774,false,3216/10465
non - caucasian simva ( „ = nmbr },C1518422;C0007457;C0053917;C1334884;C0043157,false;true;true;false;true,3217/10465
tc  mean ( sd )  rrig / dl,C0039411;C0444504;C2699239;C3642216;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;true;true;true;false;false;false,3218/10465
high risk and fewer symptoms ( group c ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,3219/10465
type nmbr diabetes history  n ( % ),C1320657;C0053917;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1334884,false;true;true;true;false;false;false;false;false,3220/10465
total cholesterol / hdl - c,C0201950;C3715113;C0543421;C0439175;C0023822;C0439810,false;false;false;false;true;false,3221/10465
hypertension absent,C0020538;C1963138,true;false,3222/10465
warfarin,C0043031,true,3223/10465
moderate  n ( % ) a,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3224/10465
urine acr ( mg / g ),C0042036;C1412134;C1300563;C1515941;C0042037;C2963137,true;false;false;false;true;false,3225/10465
baseline systolic blood pressure,C4274438,false,3226/10465
hrnmbr and nmbr % cl,,,3227/10465
ventricular tachyarrhythmias,C3827656,false,3228/10465
sulfonylurea based,C0038766;C3536898,true;false,3229/10465
medication use — no . ( % ) ^ |,C0013227;C3244316;C4284232,true;false;false,3230/10465
bivalirudin ( n = nmbr ),C0168273;C0053917;C1334884,true;true;false,3231/10465
p - blockers  n ( % ),C0369773;C2603361,false;false,3232/10465
acarbose 一 no . ( % ),C0050393,true,3233/10465
unfractionated heparin,C0019134;C2825026,true;false,3234/10465
all patients n = nmbr,C0030705;C0053917;C1334884,true;true;false,3235/10465
sitagliptin no . / total no .,C1565750,true,3236/10465
% anti - ccp + ( > nmbr units ),C4318437;C0053917;C0439148;C1519795;C3853603;C1334884,true;true;false;false;false;false,3237/10465
septal anomaly — no . ( % ),C0442004;C0332447;C1704258,false;false;false,3238/10465
intensified ( n 二 nmbr ),C0053917;C1334884,true;false,3239/10465
long - acting bnmbr - agonists,C0205166;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;true;false;false;false,3240/10465
bodily pain,C3890602,false,3241/10465
mmrc grade,C3826977;C0441800;C0919553;C3244287,false;false;false;false,3242/10465
alcohol consumption > once weekly,C0001948,true,3243/10465
p - value for trend *,C1709380;C1521798;C4554533,false;false;false,3244/10465
blood eosinophil count > nmbr / mmnmbr in nmbr months before screening — no . ( % ),C0014467;C0750480;C0053917;C0439231;C1334884;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664,true;false;true;false;false;false;true;false;false;true;false,3245/10465
at entry,C1705654,false,3246/10465
tiotropium group ( n = nmbr ),C0213771;C0441848;C0053917;C1334884,true;false;true;false,3247/10465
nmbr - nmbr months ( n = nmbr ),C0053917;C0439231;C1334884,true;false;false,3248/10465
dapagliflozin nmbr mg group ( n = nmbr ),C2353951;C0053917;C0024671;C0441848;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,3249/10465
p value ( aged > nmbr vs . < nmbr years ),C1709380,false,3250/10465
valvular disease,C3258293,false,3251/10465
prior angina,C0332152;C0002962;C2826257,false;true;false,3252/10465
japan and south korea,C0022341,true,3253/10465
postoperative nsaid or glucocorticoid use post - randomisation characteristic * *,C0032790;C0003211;C3536840,true;true;false,3254/10465
all randomized patients,C0034656;C0030705;C3815594,true;true;false,3255/10465
pack - years  mean ( sd ),C1277691;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,3256/10465
epa hr events ( % ),C0441471;C3541888,false;false,3257/10465
type of myocardial infarction — no . ( % ),C0332307;C0027051;C0428953;C2926063;C3810814;C4552959;C1547052,false;true;false;false;false;false;false,3258/10465
pciperformed for qualifying event,C1514624;C0441471;C4019010,false;false;false,3259/10465
nonsustained ventricular tachycardia — no . ( % ) - j -,C0750194;C2919575,false;false,3260/10465
ventricular tachycardia or fibrillation,C0042514;C0344428;C1963247;C4554446,true;false;false;false,3261/10465
percutaneous intervention,C0522523;C0184661;C0886296;C1273869,false;true;false;false,3262/10465
hazard ratio for cardiovascular death  stroke  or myocardial infarction ( nmbr % ci ),C2985465;C0027051;C0011065;C1306577;C4082313;C4552775,false;true;true;false;false;false,3263/10465
hypercholesterolemia  n ( % ),C0020443;C1522133,true;false,3264/10465
diclofenac,C0012091,true,3265/10465
nmbr week to nmbr month,C0053917;C0332174;C0332177;C0439231;C0439230;C1334884,true;false;false;false;false;false,3266/10465
gp llb / llla inhibitors,C1705010;C0243077;C3811116,false;true;false,3267/10465
current  n ( % ),C0521116;C1705970,false;false,3268/10465
syndesmophyte present  n ( % ),C0221690;C0150312;C0449450,false;false;false,3269/10465
angiographic findings | |,C0002978;C2607943;C2926606;C3539655,true;true;false;false,3270/10465
apixaban  nmbr mg,C1831808;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3271/10465
bypass graft,C0185098,false,3272/10465
bmnmbr ( kg / mnmbr ),C0022718;C0439209;C4054209,true;false;false,3273/10465
nmbr = no symptoms,C0053917;C1334884,true;false,3274/10465
prior brachytherapy,C0332152;C0006098;C2826257,false;true;false,3275/10465
time since cessation of full - dose warfarin therapy,C0040223;C3541383,true;false,3276/10465
history of or current cardiac disorders  %,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,3277/10465
impaired glucose tolerance or impaired fasting glucose,C0271650,true,3278/10465
severe  n ( % ) b,C0205082;C4050465;C4050466,false;false;false,3279/10465
hospitalization for heart failure within previous nmbr mo — no . ( % ),C3898876,false,3280/10465
diuretics  n ( % ),C0012798,true,3281/10465
mmse ( points ),C0451306,true,3282/10465
apixaban ( n = nmbr ),C1831808;C0053917;C1334884,true;true;false,3283/10465
corticosteroid ( with or without immunosuppressants ),C0001617;C3536709,true;false,3284/10465
congestive heart failure,C0018802,true,3285/10465
chf on placebo ( % ),C0018802;C0032042;C1696465;C1706408,true;true;false;false,3286/10465
overall hr ( nmbr % cl ),C0282416;C0053917;C0596019;C1334884;C1561607,true;true;false;false;false,3287/10465
hyperlipidemia — no . ( % ),C0020473;C0428465;C4555212,true;false;false,3288/10465
p value for trend across tertiles,C1709380;C1521798;C4554533,false;false;false,3289/10465
nmbr - nmbr drinks / wk,C0053917;C1334884,true;false,3290/10465
> nmbr mg / dl — %,C0053917;C0439269;C1334884,true;false;false,3291/10465
diagnosis of allergic rhinitis,C0011900;C1334103;C2607914;C4552864;C1704338;C1704656,true;false;true;false;true;false,3292/10465
refractory to such therapy — no . ( % ),C0205269;C0039798;C0087111;C1363945,false;true;true;false,3293/10465
lymphocytes  nmbr / + il,C0024264;C0053917;C0020898;C0021764;C0022271;C1334884;C4018897,true;true;true;true;true;false;false,3294/10465
adjusted * or ( nmbr % ci ) p value,C0456081,false,3295/10465
fevnmbr % pred . ( post - albuterol )  %,C0032952;C0687676;C0001927;C1704687;C3469826;C0044955,true;false;true;false;false;true,3296/10465
known thrombophilia — no . ( % ),C0205309;C0398623,false;true,3297/10465
nmbr - nmbr ( mild ),C0053917;C1334884,true;false,3298/10465
simvastatin  n ( % ),C0074554,true,3299/10465
age  mean ( sd ) [range]  y,C0001779;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false;false,3300/10465
copd exacerbation history  n ( % ),C0740304;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,3301/10465
atio - pla,C0456170,false,3302/10465
cardiac troponin t level  median ( iqr )  pg / l,C3538889;C0441889;C0549183;C0439278;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261,false;false;false;false;false;false;false;false;false;false;false,3303/10465
estimated glomerular filtration rate  ml / min per nmbr . nmbr mnmbr,C3811844;C0439445;C0053917;C1334884,false;false;true;false,3304/10465
toast classification of qualifying stroke ( % ),C1710306;C1514624;C0038454;C4554100;C4521230,false;false;true;false;false,3305/10465
duration of diabetes by tertiles,C0449238;C0011847;C0011849;C2926735,false;false;true;false,3306/10465
on drug treatment ( % ),C0150270;C3469597,false;false,3307/10465
triglyceride ( median  mg / dl ) - nmbr [nmbr - nmbr percentile |,C0041004;C0549183;C0439269;C0053917;C1264641;C1334884;C0876920;C2347635;C2348144;C2939193,true;false;false;true;false;false;false;false;false;false,3308/10465
pre - specified hr ( nmbr % cl ),C2826245,false,3309/10465
cardiac medications during indexhospitalization and / or discharge,C0018787;C0013227;C0802604;C2598133;C4284232;C1522601,true;true;false;false;false;false,3310/10465
neither corticosteroid nor immunosuppressant,C0001617;C3536709,true;false,3311/10465
albumin / creatinine ratio  n ( % ),C0486293;C1318293,false;false,3312/10465
score on modified rankin scale — median ( iqr ),C0449820;C2984908;C0549183;C0876920;C2347635;C2348144;C2939193;C3854213;C4050231,false;false;false;false;false;false;false;false;false,3313/10465
placebo group,C0032042;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408,true;false;false;true;false;false;false;false;false,3314/10465
discontinuations due to ae,C0457454;C0678226;C3887670,false;false;false,3315/10465
creatinine clearance  n ( % ),C0812399,false,3316/10465
multi vessel ( or left main ),C0439064;C0005847;C3266262,false;true;true,3317/10465
infarct location,C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,3318/10465
elevated hscrp,C0205250;C3163633,false;false,3319/10465
laba + ics n = nmbr,C0815320;C0053917;C1334884;C4551720,false;true;false;true,3320/10465
renal function  severe,C0232804,false,3321/10465
high - density lipoprotein cholesterol  median  ( nmbrth — nmbrth percentiles )  mg / dl,C0023822;C0549183;C1264641;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false;false,3322/10465
mean ± sd fasting insulin  uu / ml,C0444504;C2699239;C0015663;C0021641;C0439342;C1533581;C1579433;C3714501;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false,3323/10465
at least nmbr / mo,C0053917;C0026544;C0332177;C1334884,true;true;false;false,3324/10465
atrial fibrillation — no . / total no . ( % ),C0004238;C0344434;C1963067,true;false;false,3325/10465
ls - mean between - group difference ( nmbr % ci ),C0023668;C2347634;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242,true;false;false;true;true;false;false;false,3326/10465
all others  n ( % ),C1955473;C3539125,false;false,3327/10465
joint swelling  effusion  or both on clinical examination — no . ( % ),C1253936;C0013604;C0038999;C1963136;C4554335;C0152031;C0013687;C2317432,true;true;false;false;false;false;false;false,3328/10465
median age ( nmbr %  nmbr % )  y,C0549183;C0001779;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false,3329/10465
history of cerebrovascular disease,C0585890,false,3330/10465
laba or lama ’,,,3331/10465
metformin ( n = nmbr ),C0025598;C0053917;C1334884,true;true;false,3332/10465
prior cabg ( before index acs ),C0332152;C0010055;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C2826257,false;true;true;true;false;true;false;false;false;false,3333/10465
anti - tnf - experienced patients,C1448177;C0030705,true;true,3334/10465
digoxin / digitalis glycoside,C0012265;C0012253,true;true,3335/10465
body mass index ( range ) ( kg / mnmbr ),C0005893;C1514721;C0022718;C0439209;C4054209;C2348147;C3542016;C0578022;C1305855,false;false;true;false;false;false;false;false;true,3336/10465
patients with previous loss of response to infliximab,C0030705;C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,true;false;false;false;false;false;false;false,3337/10465
treatment group,C0039798;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;true;false;false;false;false;false,3338/10465
haq - di  mean ( sd ),C3826998;C0444504;C2699239;C2347634;C2348143;C4321476,false;false;false;false;false;false,3339/10465
duration of copd ( years )  mean ( sd ),C0449238;C0024117;C0439234;C0444504;C2699239;C2347634;C2348143;C1412502;C3714496;C2926735,false;true;false;false;false;false;false;false;false;false,3340/10465
egfr < nmbr  ml / min / mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,3341/10465
carotid infarct,C0741968;C0021308,false;true,3342/10465
negative ( < nmbr . nmbr )  n ( % ),C0205160;C0053917;C1334884;C1513916;C2825415;C2825491;C3853545,false;true;false;false;false;false;false,3343/10465
endpoint week nmbr,C2349179;C0332174;C0053917;C1334884;C0439230;C2826544,false;false;true;false;false;false,3344/10465
homa - ir  mean ( sd ) ( mu / l $ mmol / l ) b,C0022065;C0444504;C2699239;C0439342;C0439190;C2347634;C2348143;C0022071;C1448132,true;false;false;false;false;false;false;true;true,3345/10465
lipid and lipoprotein values ( mg / dl ),C0023779,true,3346/10465
placebo no . of events / no .,C0032042;C1696465;C1706408,true;false;false,3347/10465
for treatment of index event,C0039798;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;true;false;false;false;true;false;false;false;false;false,3348/10465
mild ( > nmbr to < nmbr ),C2945599;C0053917;C1334884,false;true;false,3349/10465
heterogeneity p value,C0019409;C1709380;C0242960,false;false;true,3350/10465
number of stents ( per patient ),C0237753;C0038257;C0449788,false;true;false,3351/10465
preoperative serum creatinine > nmbr pmol / l,C0445204;C0201976;C0053917;C0439284;C1334884;C0600061,false;false;true;false;false;false,3352/10465
sacubitril / valsartan ( n = nmbr ),C4033631;C0053917;C1334884,true;true;false,3353/10465
mean ( s . d . ) apoc - ll nmbr  mg / dl,C0444504;C0003594;C2347634;C2348143,false;true;false;false,3354/10465
implanted cardioverter - defibrillator,C0021102;C0810516;C2828363,false;false;false,3355/10465
swollen joint count ( n / nmbr ),C0451521;C0053917;C1334884,false;true;false,3356/10465
postmenopausal ( % ),C0232970,false,3357/10465
coronary disease,C0010068;C1956346,true;true,3358/10465
prior lev treatment,C1514463;C0023556,false;true,3359/10465
rsg nmbr mg / day,C0053917;C0439422;C1334884,true;false;false,3360/10465
former or current smokers ( % ),C0205156;C0750523,false;false,3361/10465
topiramate,C0076829,true,3362/10465
hydrochlorothiazide,C0020261,true,3363/10465
toast classification of qualifying stroke  no . ( % ),C1710306;C1514624;C4521230,false;false;false,3364/10465
class nmbr antiarrhythmic agents,C0456387;C0053917;C0003195;C0301380;C1334884;C1518526;C1705943,false;true;true;false;false;false;false,3365/10465
age  mean nmbr sd years,C1510829;C0444504;C0053917;C2699239;C1334884;C2347634;C2348143,false;false;true;false;false;false;false,3366/10465
concomitant methotrexate  n ( % ),C0521115;C0025677,false;true,3367/10465
corticosteroids . immunosuppressants . and antimalarials,C0001617;C0021081;C3539185;C3540725;C3540726;C3540727,true;true;false;false;false;false,3368/10465
bl mean  mg / dl ( mmol / nmbr ),C0005918;C0444504;C0567349;C3642216;C0053917;C1334884;C2348885;C0439269;C0439190;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;true;false;false;false;false;false;false;true;false;false,3369/10465
history of diabetes mellitus  n ( % ),C0455488,false,3370/10465
median ( iqr ) admission data,C0549183;C0184666;C1511726;C3245479;C3714741;C0809949;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,3371/10465
not provided,C1518422,false,3372/10465
current bone disease,C0521116;C0005940;C1705970,false;true;false,3373/10465
triglyceride ( median : mg / dl ) a [nmbr - nmbr percentile],C0041004;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,3374/10465
stent plus abciximab,C0038257;C0332287;C0288672,true;false;true,3375/10465
systolic blood pressure < nmbr mm hg and diastolic blood pressure < nmbr mm hg,C0488055;C0053917;C0439475;C1334884;C0871470;C1306620,false;true;false;false;true;false,3376/10465
vasoprotectives,C0304533,false,3377/10465
associatedproximaldeep - veinthrombosisatdiagnosis  no . ( % ),,,3378/10465
discharge medication  n ( % ),C0012621;C0013227;C3244316;C4284232;C0030685;C2926602,false;true;false;false;true;false,3379/10465
other cardiac surgery  n ( % ),C0018821;C0524727,true;true,3380/10465
induction - trial group assignment — no . ( % ),C0205263;C1320290;C1516050;C0857127,false;false;false;false,3381/10465
bw  mean ( sd )  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0006041;C2986891,true;false;false;true;false;false;false;false;true;false,3382/10465
first procedure,C0205435;C0184661;C2700391;C3274430;C3539779;C1279901,false;true;false;false;false;false,3383/10465
prior af ablation  n ( % ),C0332152;C0344434;C0547070;C1261381;C4049859;C2826257,false;false;false;false;false;false,3384/10465
fevnmbr reversibilityz ( pre / post salbutamol )  %,C0332152;C0687676;C0001927;C1704687;C3469826;C0740175;C2257086;C3669034,false;false;true;false;false;false;false;false,3385/10465
second - generation stent,C0205436;C0079411;C0038257;C3146294;C0457385;C0565930;C1561503;C1705190,false;true;true;false;false;false;false;false,3386/10465
msasss  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,3387/10465
total cholesterohhdl cholesterol ratio,C0201950;C0456603;C1547037;C0543421,false;false;false;false,3388/10465
primary safety end point : severe / life - threatening,C2986535;C0036043;C0205082;C1546953;C2826244;C3537125;C4050465;C4050466;C1705187,false;true;false;false;false;false;false;false;false,3389/10465
nt - probnp ( pg / ml ) ( qnmbr - qnmbr ),C0669479;C0439297;C0754710,true;false;true,3390/10465
remodeling,,,3391/10465
smoking past,C0037369;C1444637;C4284302;C0453996;C1881674,true;false;false;true;false,3392/10465
cigarette smoking status,C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,3393/10465
use of concomitant lipid - lowering therapy - no . ( % ),C1524063;C0521115;C0585943,false;false;false,3394/10465
prior arrhythmias  n ( % ),C0332152;C0003811;C2826257,false;true;false,3395/10465
thienopyridine at enrollment,C1120149;C1516879;C1696073;C3888021,true;false;false;false,3396/10465
coronary risk factors — no . ( % ),C2024776,false,3397/10465
cardiovascular risk factors,C0850624,false,3398/10465
less than nmbr year,C0439092;C0053917;C0439234;C0439508;C1334884,false;true;false;false;false,3399/10465
anti - arthritic medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,3400/10465
some physical activity,C0015259;C0026606,true;true,3401/10465
first medical contact — no . ( % ) §,C0205435;C0199168;C0205476;C1279901,false;false;false;false,3402/10465
premature cad among family members,C0151526;C1504769;C0086282;C2239547;C3813548;C4284121;C0205252;C4018905,true;true;true;false;false;false;false;false,3403/10465
ppci in - nmbr,C0053917;C1334884,true;false,3404/10465
overall n = nmbr  nmbr,C0282416;C0053917;C1334884;C1561607,true;true;false;false,3405/10465
fevnmbr % predicted  post - albuterol  %,,,3406/10465
medical therapy only,C0418981;C0205171;C1720467,false;false;false,3407/10465
aspirin and thienopyridine therapy,C0004057,true,3408/10465
heart rate  mean ( sd )  beats / min,C0018810;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,3409/10465
tg  median ( interquartile range ),C0337445;C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,3410/10465
non - hispanic black,C1518424;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,3411/10465
normal renal function,C0232805,false,3412/10465
renal parameters,C0022646;C0449381,true;false,3413/10465
fasting blood glucose — mmol / liter,C0428568;C0439190;C0475211;C1261430,false;false;false;false,3414/10465
glycoprotein iib / iiiareceptorinhibitor,C0017968,true,3415/10465
plaque ( n  % ),C0011389;C0241148;C0332461;C0333463;C4316797,true;false;false;true;false,3416/10465
coronary angiography,C0085532;C1548829,true;false,3417/10465
age  mean ( min - max ) ( yrs ),C0001779;C0444504;C0702093;C1524029;C3813700;C2347634;C2348143,false;false;false;false;false;false;false,3418/10465
evolocumab nmbr mg every nmbrweeks ( n = nmbr ),C3529352;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3419/10465
patients not receiving immunosuppressive agents at baseline,C0030705,true,3420/10465
no . ( % ) with event [incidence rate per nmbr patient - y],C0441471;C1708485;C0053917;C0030705;C1334884;C4019010,false;false;true;true;false;false,3421/10465
screening hbanmbrc ( % ),C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,3422/10465
modified rankin scale — no . ( % ) |,C2984908;C3854213,false;false,3423/10465
previous cancer  n ( % ),C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,3424/10465
penetrating,C0205321,false,3425/10465
more than nmbr vessels stented,C0205172;C0053917;C0005847;C1334884,false;true;true;false,3426/10465
changes ( a ) in metabolic syndrome parameters hdl cholesterol,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3427/10465
baseline acq - nmbr score,C0168634;C2919686;C0053917;C0449820;C4050231;C1334884;C1442488,true;false;true;false;false;false;false,3428/10465
dm medication  n ( % ) c,C0011816;C0013227;C3244316;C4284232;C3250443,true;true;false;false;false,3429/10465
left main disease,C0205091;C0205225;C0012634;C1542147;C0443246;C1552822,false;false;true;false;false;false,3430/10465
> nmbr lesions per vessel,C0053917;C0221198;C0005847;C1334884,true;false;true;false,3431/10465
xanthinesnmbr,,,3432/10465
tg ( mmol / l  median ),C0337445;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,3433/10465
verapamil sr strategy ( n = nmbr  nmbr ),C1527129;C0679199;C0053917;C1334884,false;false;true;false,3434/10465
aspirin ( asa ) ( » = nmbr nmbr ),C0004057;C0053917;C1334884;C3853627,true;true;false;false,3435/10465
weight  mean nmbr sd kg,C0005910;C0444504;C0053917;C2699239;C0022718;C0439209;C4054209;C1334884;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;true;false;true;false;false;false;false;false;true;false;false,3436/10465
hispanic black,C0086409;C0005680;C0027567;C0085756;C0439541,true;true;true;true;false,3437/10465
atrial fibrillation or flutter — no . ( % ),C0004238;C0344434;C1963067,true;false;false,3438/10465
on - treatment,C4684449,false,3439/10465
killip class i — no . ( % ),C2697844,false,3440/10465
killip class ( interaction : p = nmbr . nmbr ),C1881332;C1704675;C0053917;C1334884,false;false;true;false,3441/10465
adjusted hr ( enl vs lcz ) ( nmbr % cl ),C0456081,false,3442/10465
total basdai  mean ( sd ),C0439175;C1998004;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,3443/10465
placebo + statin ( n = nmbr  nmbr ),C0032042;C0360714;C0053917;C1334884;C1696465;C1706408,true;true;true;false;false;false,3444/10465
thrombus aspiration,C0087086;C0220787;C0349707;C0700198;C2712334;C2827071;C0302148;C3146237,true;false;false;false;false;false;false;false,3445/10465
marital status  married,C0024819;C1716536;C3172566,true;false;false,3446/10465
no . of days to randomization — median ( iqr ),C0439228,false,3447/10465
exacerbations in previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,3448/10465
pain ( nmbr mm vas ),C0042815;C0053917;C4330985;C4554674;C1334884,true;true;false;false;false,3449/10465
angiogenesis,C0302600;C1519670,false;false,3450/10465
non - fatal mi,C1518422;C1302234;C3810814;C1705232,false;false;false;false,3451/10465
who functional class — no . ( % ) : c,C0205245;C0456387;C1518526;C1705943;C0542341;C2700217,false;false;false;false;false;false,3452/10465
diabetic patients,C0241863;C0030705,false;true,3453/10465
type nmbr  n ( % ),C0332307;C0053917;C1334884;C1547052,false;true;false;false,3454/10465
abatacept nmbr / — nmbr mg / kg ( n = nmbr ),C1619966;C0053917;C0439272;C1334884,true;true;false;false,3455/10465
black race and ss < nmbr ( n = nmbr vs nmbr ) ■ -,C0005680,true,3456/10465
baseline treatments  n ( % ) a,C0168634;C0087111;C1442488,true;true;false,3457/10465
imm ( without corticosteroid ),C0205470;C0001617;C3536709,false;true;false,3458/10465
mean ( sd ) number of exacerbations *,C0444504;C2699239;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false;false,3459/10465
s . e .,C0565930;C2603362,false;false,3460/10465
spiralcomputedtomographyangiography,,,3461/10465
p ( losartan versus placebo ),C0369773;C0126174;C2603361,false;true;false,3462/10465
apo b / apo a - l ratio ( mean ),C1447574;C0003592;C0456603;C0444504;C2347634;C2348143;C1547037;C0523508;C4553344;C4521365,true;true;false;false;false;false;false;false;false;false,3463/10465
mean ( s . d . ) non - hdl cholesterol,C0444504;C0729627;C1535899;C2347634;C2348143,false;false;false;false;false,3464/10465
secukinumab nmbr mg,C3179547;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3465/10465
early - start group ( n = nmbr ),C1279919,false,3466/10465
p interaction ( rx arm * sex ),C0369773;C1704675;C1425688;C0446516;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C3715044;C4553528;C1521941;C2709207;C2603361,false;false;false;true;true;true;true;false;false;true;false;false;false;false;false,3467/10465
left ventricular hypertrophy  n ( % ),C0149721;C3484363,true;false,3468/10465
af pattern,C0344434;C0449774;C4049859,false;false;false,3469/10465
severity of copd,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,3470/10465
post - bronchodilator fev   % predicted,C2599594;C3714541,false;true,3471/10465
copd or asthma  ( % ),C0024117;C1412502;C3714496,true;false;false,3472/10465
body - mass index — no . ( % ) $,C0005893;C0578022;C1305855,false;false;true,3473/10465
waist - to - hip ratio,C0205682,true,3474/10465
nmbr years or older,C0053917;C0439234;C1334884,true;false;false,3475/10465
years since myocardial infarction,C0439234,false,3476/10465
with alogliptin nmbr mg ( n nmbr nmbr ),C1958126;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3477/10465
hoehn and yahr stage,C0205390;C1300072;C1306673,false;false;false,3478/10465
elevated cardiac markers — no . ( % ) : t,C0205250;C1271630;C3163633,false;false;false,3479/10465
scores for global and pain assessments §,C0449820;C0205246;C2348867,false;false;false,3480/10465
documented coronary artery disease,C1301725;C0010054;C0010068;C1956346;C1609436,false;true;true;true;false,3481/10465
large vessel atherosclerosis,C0225990;C0003850;C0004153,false;true;true,3482/10465
hbalc < nmbr % ( < nmbr mmol / mol )  n ( % ),C0053917;C3829066;C1334884,true;false;false,3483/10465
copd severity,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,3484/10465
geometric mean,C2986759,false,3485/10465
assoc  with connective tissue disease,C0009782,true,3486/10465
chronic kidney disease stage : egfr ( ml / min per nmbr . nmbr mnmbr ),C1561643;C0205390;C1739039;C0439445;C0053917;C1334884;C3811844;C3812682;C1300072;C1306673;C4553188,true;false;true;false;true;false;false;false;false;false;false,3487/10465
haq - di ( nmbr - nmbr )  mean ( sd ),C3826998;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C4321476,false;true;false;false;false;false;false;false,3488/10465
egfr crcl < nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C1846718;C0053917;C0439445;C1334884;C3811844;C3812682,true;false;true;false;false;false;false,3489/10465
baseline weight  kg,C1303013;C0022718;C0439209;C4054209,false;true;false;false,3490/10465
bifurcation  n ( % ),C0184906;C3146289,false;false,3491/10465
pe ( with or without dvt ),C0070939;C1880476;C4284304,true;false;false,3492/10465
differencenmbr,,,3493/10465
dilatative  n ( % ),C0002940;C0012359;C0700124;C1322279,true;true;false;true,3494/10465
arterial access,C0003842;C0444454;C1554204;C0221464,true;false;false;false,3495/10465
serum cholesterol ( mg / l ) *,C0587184;C0439268,false;false,3496/10465
cerebral thrombosis,C0079102;C0151945;C0795687,true;false;false,3497/10465
rosuva nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,3498/10465
dose of atorvastatin,C0178602;C0286651;C0869039;C1114758,false;true;false;false,3499/10465
mean ( sd ) weight  kg,C0444504;C2699239;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;false;true;true;false;false;true;false;false;false;false,3500/10465
congestive heart failure — %,C0018802,true,3501/10465
no prior ms therapies,C1514463;C2349943;C3539704;C3713294,false;false;false;true,3502/10465
glucocorticoids only,C0017710;C0205171;C1720467;C3540777;C3540778,true;false;false;false;false,3503/10465
background aha therapy at screening  n ( % ),C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,3504/10465
established atherosclerotic cv disease §,C0443211;C0333482;C0007222;C1272684,false;false;true;false,3505/10465
angina symptoms^,C0858277,false,3506/10465
pain ( vas ),C0042815,true,3507/10465
stroke subtype  n ( % ),C0038454;C0449560;C4554100,true;false;false,3508/10465
with placebo,C0032042;C1696465;C1706408,true;false;false,3509/10465
relative risk ( nmbr % confidence interval ),C0242492;C0053917;C0009667;C1334884,true;true;true;false,3510/10465
r nmbr mg + fa ( « = nmbr ),C0205090;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0684010;C2603358,false;true;true;true;false;false;false;false;false;false;true;false,3511/10465
previous pci or cabg,C0205156;C4049621;C1552607,false;false;false,3512/10465
total pack - yrs,C0439175;C1968515;C2825051;C2828395;C0439810,false;false;false;false;false,3513/10465
baseline trl - c by quintiles,C0168634;C1508496;C1442488,true;false;false,3514/10465
mtx > nmbr and £ nmbr mg / week,C0025677;C0053917;C1334884;C1417487,true;true;false;false,3515/10465
ff / vi nmbr / nmbr | ig ( n = nmbr ),C4554348;C0205999;C0053917;C0021027;C0305052;C0360506;C1334884,false;true;true;true;false;false;false,3516/10465
( nmbr % ell ' ll,C0053917;C1427925;C3273466;C1334884,true;false;false;false,3517/10465
corticosteroids and immunosuppressants only,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,3518/10465
number of vessels treated  index pci,C0237753;C0005847;C0449788,false;true;false,3519/10465
mra ( spironolactone or eplerenone ),C0243032;C0037982;C1609165;C3891069,true;true;true;false,3520/10465
peripheral artery occlusive disease,C1306889,false,3521/10465
baseline value,C0168634;C1522609;C1442488,true;false;false,3522/10465
chronic cvd,C0205191;C0007222,false;true,3523/10465
established ( n = nmbr ),C0443211;C0053917;C1334884;C1272684,false;true;false;false,3524/10465
known thrombophilia,C0205309;C0398623,false;true,3525/10465
normal > nmbr - nmbr,C0205307;C0053917;C1334884;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false,3526/10465
estimated gfr renal function stage,C0750572;C0017654;C0232804;C0205390;C1300072;C1306673;C1424601,false;true;false;false;false;false;false,3527/10465
tg  mmol / l ( mg / dl ) [median],C0337445;C3898312;C3642216;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,3528/10465
clinical characteristics,C0683325,false,3529/10465
interval after index event,C1272706;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C1552654;C1552713,false;true;false;false;true;false;false;false;false;false,3530/10465
country  n ( % ),C0454664;C1511538,false;false,3531/10465
fractures ( site not specified ),C0016658,true,3532/10465
number of previous dmards,C0237753;C0205156;C0242708;C1552607;C0449788,false;false;true;false;false,3533/10465
non - hispanic,C1518424,false,3534/10465
proportion of patients in corticosteroid - free clinical remission at week nmbr,C1709707;C0030705,false;true,3535/10465
pramlintide,C0537551,true,3536/10465
height  inches,C0489786;C0439204,false;false,3537/10465
antithrombotic agents,C1704311,true,3538/10465
ambulance  n ( % ),C0002422;C3846685,true;false,3539/10465
chd risk - no . ( % ),C0280604;C3542407,false;false,3540/10465
infusion administered — no . / total no . ( % ),C0574032;C1827465,false;false,3541/10465
non - hdl cholesterol ( week nmbr ),C0729627;C0332174;C0053917;C1334884;C0439230;C1535899,false;false;true;false;false;false,3542/10465
inhaled glucocorticoid use at screening,C0004048;C0017710;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;true;true;false;false;false;false;false;false;false,3543/10465
type of vessel involved,C1282017,false,3544/10465
oral blood glucose - lowering drug nmbr ( nmbr . nmbr ),C0442027;C0018938;C0017725;C0441994;C0053917;C1334884;C2003888;C0005802;C0013227;C1254351;C4521986,false;true;true;false;true;false;false;true;true;false;false,3545/10465
baseline pos frequency per nmbr days  median ( min  max ),C0168634;C1262869;C0585290;C0053917;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C1334884;C3496112;C3496399;C1442488,true;true;false;true;false;false;false;false;false;false;false;false;false;false;false;false,3546/10465
mean ( sd ) mtx dose  mg / week,C0444504;C2699239;C0366550;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;false;true;false;false;true;false;false;false;false;false;false;false,3547/10465
laboratory ae  n ( % },C0022877;C3887670;C3244292;C4283904,true;false;false;false,3548/10465
use of concomitant lipid - lowering treatment,C1524063;C0521115;C0023779;C0441994;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2003888,false;false;true;false;true;true;false;false;false;false;false;false,3549/10465
age ( y )  median ( iqr ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3550/10465
heart failure  lvef < nmbr %  or both,C0018801;C0428772;C0053917;C1334884;C0488728;C0018802;C4554158,true;false;true;false;false;true;false,3551/10465
omalizumab ( lsm ),C0966225,true,3552/10465
baseline cv medications  n ( % ),C0168634;C3538987;C0013227;C0802604;C2598133;C4284232;C4048877;C4318503;C1442488,true;false;true;false;false;false;true;false;false,3553/10465
nmbr or nmbr high cardiovascular risk categories,C0053917;C1334884,true;false,3554/10465
pack - years smoked,C1277691,false,3555/10465
exenatide lar,C0167117,true,3556/10465
concomitant treatment,C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,3557/10465
score on the minnesota living with heart failure scaled,C0449820;C0026183;C0595998;C4520849;C4551704;C4050231,false;true;false;false;false;false,3558/10465
eosinophil count ( cells per pl ),C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;true;false;false;true;false,3559/10465
disease duration ( yr )  mean ± sd,C0872146;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,3560/10465
baseline total pcsknmbr level by median,C0168634;C0439175;C0441889;C0549183;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261;C0439810;C1442488,true;false;false;false;false;false;false;false;false;false;false;false;false,3561/10465
antiplatelet agents ( % ),C0085826,true,3562/10465
peripheral vascular disease  n ( % ),C0085096,true,3563/10465
duration of disease — yr : t,C0872146;C0439234,false;false,3564/10465
infarction nmbr - nmbr days,C0021308;C0053917;C0439228;C1334884,true;true;false;false,3565/10465
estimated difference ( nmbr % ci ),C0750572;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242,false;false;true;true;false;false;false,3566/10465
non - st - elevation myocardial infarction,C1536221;C1536222;C3537184;C4255010,false;false;false;true,3567/10465
aspirin i clopidogrel ( n = nmbr  nmbr ),C0004057;C0021966;C0070166;C0053917;C1334884;C0221138,true;true;true;true;false;false,3568/10465
pulmonary disease — no . ( % ),C0024115,true,3569/10465
etn nmbr mg + mtx n = nmbr,C0014758;C0053917;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0717758,true;true;true;true;false;true;false;false;false;false;false;false;true,3570/10465
all stroke,C0038454;C4554100,true;false,3571/10465
previous respiratory disease other than copd — no . ( % ),C0205156;C0035204;C0024117;C1412502;C3714496;C0035242;C1552607,false;true;true;false;false;true;false,3572/10465
history of stroke or transient ischemic attack,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3573/10465
pelvic fractures,C0149531,false,3574/10465
standard care allocation,C1442989;C1947933;C1706778;C2828392,false;false;false;false,3575/10465
ra duration ( months ) *,C3538806;C0449238;C0439231;C2926735;C4048756,false;false;false;false;false,3576/10465
other drugs — no . ( % ),C0013227;C3687832,true;false,3577/10465
atherosclerotic disease *,C0333482;C0012634,false;true,3578/10465
angiography and revascularization,C0002978,true,3579/10465
unfractionated heparin ( n = nmbr ),C0019134;C0053917;C1334884;C2825026,true;true;false;false,3580/10465
demographic and clinical characteristics,C0011298,true,3581/10465
mean lixi dose ± sd ( lg / day ),C0444504;C0178602;C2699239;C0023128;C0332173;C0439228;C0439505;C0694651;C0869039;C1114758;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,3582/10465
number ( % ),C0237753;C0449788,false;false,3583/10465
age subgroups,C0001779;C1079230,false;false,3584/10465
ind / gly nmbr / nmbr mg once daily ( n = nmbr ),C4049864;C0017890;C0053917;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0523677,false;true;true;true;false;true;false;false;false;false;false;false;false,3585/10465
glycated hemoglobin  mean ( sd )  %,C0017853;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,3586/10465
no . of events / no . of patients,C0441471;C3541888,false;false,3587/10465
carotid artery intervention *,C0007272;C0184661;C0886296;C1273869;C0162859;C0741968;C0397581,true;true;false;false;true;false;false,3588/10465
hope patients with coronary - artery disease ( n = nmbr ),C0392347;C0030705;C0010054;C0053917;C1334884;C0010068;C1956346,true;true;true;true;false;true;true,3589/10465
linagliptin / metformin,C3264599,false,3590/10465
ultrasound carotid arteries,C0948945,false,3591/10465
pci or cabg surgery for index event,C4049621,false,3592/10465
dasnmbr - nmbr ( esr ) nmbr,C0053917;C3811131;C1334884,true;false;false,3593/10465
cardiac therapy §,C3654025,false,3594/10465
low - dose statin,C0445550;C0360714;C1708745,false;true;false,3595/10465
oral anticoagulant  n ( % ),C0354604,false,3596/10465
p - value for interaction nmbr . nmbr,C1709380;C1704675;C0053917;C1334884,false;false;true;false,3597/10465
> nmbr des type,C0053917;C0011702;C0332307;C1547052;C4551552;C1334884,true;true;false;false;true;false,3598/10465
placebo patients with events / total,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,3599/10465
average age ( year ),C1510992;C0001779;C0439234;C0439508;C2825518,false;false;false;false;false,3600/10465
placebo + nmbr mg / d of simvastatin,C0032042;C0053917;C0439422;C0074554;C1334884;C1696465;C1706408,true;true;false;true;false;false;false,3601/10465
baseline hb nmbrg i nmbr n = nmbr,C0168634;C0062408;C0021966;C0053917;C1334884;C0221138;C1442488,true;true;true;true;false;false;false,3602/10465
type of end point,C0332307;C2349179;C2826544;C1547052,false;false;false;false,3603/10465
copd medication at study entry,C0024117;C0013175;C1705654;C1412502;C3714496,true;true;false;false;false,3604/10465
emphysema,C0013990;C0034067,true;true,3605/10465
mean ( sd ) esr  mm / h *,C0444504;C2699239;C3811131;C0456680;C2347634;C2348143,false;false;false;false;false;false,3606/10465
vilanterol  n = nmbr,C2935023;C0053917;C1334884,true;true;false,3607/10465
latin america ( n = nmbr ),C0023122;C0053917;C1334884,true;true;false,3608/10465
third heart sound,C0232237;C0232278,false;false,3609/10465
tnfi naive,,,3610/10465
continued thienopyridine ( n = nmbr ),C0549178;C1120149;C0053917;C1334884,false;true;true;false,3611/10465
total intravenous loop diuretic ( mg ) median,C0439175;C0348016;C0354100;C0024671;C0549183;C0876920;C2347635;C2348144;C2939193;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3536704;C0439810,false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false,3612/10465
mild to moderate,C1299392,false,3613/10465
median n - terminal probnp ( iqr ) — pg / ml,C0549183;C0669479;C0439297;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,3614/10465
degree of stenosis  % of diameter,C4034225;C1301886,false;false,3615/10465
diagnostic angiography,C0002978,true,3616/10465
left ventricular hypertrophy on echo,C0149721;C0058928;C1655045;C3484363,true;true;false;false,3617/10465
fasting serum glucose  median ( sd )  mg / dl,C0015663;C0202041;C0549183;C2699239;C0439269;C0876920;C2347635;C2348144;C2939193;C3534430,true;false;false;false;false;false;false;false;false;false,3618/10465
abatacept plus mtx ( n = nmbr ),C1619966;C0025677;C0053917;C1334884;C1417487,true;true;true;false;false,3619/10465
baseline measurements,C0168634;C0242485;C1442488,true;false;false,3620/10465
non - compliance,C0376405;C0457432,true;false,3621/10465
duration of pre - randomization anticoagulant therapy,C2711563;C0332152;C0034656;C0740175;C2257086;C3669034,false;false;true;false;false;false,3622/10465
bmi at baseline ( kg / mnmbr ),C0578022;C0168634;C0022718;C0439209;C4054209;C1442488,false;true;true;false;false;false,3623/10465
average maximum common and bifurcation cimt ( mm ),C1510992;C0806909;C1552615;C2826546;C2825518,false;false;false;false;false,3624/10465
location,C0450429;C1515974;C4284930;C4284931,false;false;false;false,3625/10465
kheeatne index dvt,C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,true;true;false;false;true;false;false;false,3626/10465
osteitis,C0029400,true,3627/10465
nmbr - nmbr months fn = nmbr . nmbr ),C0053917;C0439231;C1570610;C1334884,true;false;true;false,3628/10465
glinide 一 no . ( % ),C2266929,false,3629/10465
below - knee popliteal crural,C0542339;C0022742;C0442037;C0023216;C1140621;C0022745;C1963703;C1552829,false;true;false;true;true;true;false;false,3630/10465
pre - enrollment antihyperglycemic therapy,C1882440;C1516879;C0020616;C1696073;C3888021,false;false;true;false;false,3631/10465
symptom duration,C1457887;C0449238;C2926735;C3854129,false;false;false;false,3632/10465
% patients with no progression,C0030705;C0242656;C0449258,true;true;false,3633/10465
measured at clinic visit with automated device §,C0444706;C0008952;C3541902,false;true;false,3634/10465
previous episode of heart failure,C0205156;C0332189;C0018801;C0018802;C4554158;C1552607,false;false;true;true;false;false,3635/10465
liraglutide ( n = nmbr ),C1456408;C0053917;C1334884,true;true;false,3636/10465
hbanmbrc  % ( sd ),C2699239,false,3637/10465
post - bronchodilator fevnmbr — liters,C2599594;C0475211,false;false,3638/10465
renal insufficiency,C0035078;C1565489,true;true,3639/10465
lvef within nmbr mo  %,C0428772;C0053917;C0026544;C0332177;C1334884;C0488728,false;true;true;false;false;false,3640/10465
ldl cholesterol  mmol / l  mean ± sd,C0023824;C1532563;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,3641/10465
history of hypertension for nmbr mo or more,C0455527,false,3642/10465
fish oil ( n = nmbr ),C0016157;C0053917;C1334884,true;true;false,3643/10465
digitalis glycoside,C0012253,true,3644/10465
baseline mean,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,3645/10465
no previous dmard therapy,C0205156;C0242708;C0039798;C0087111;C1363945;C1552607,false;true;true;true;false;false,3646/10465
hbanmbrc at nmbr weeks *,C0053917;C0439230;C1334884,true;false;false,3647/10465
glycated hemoglobin,C0017853,true,3648/10465
elevated fasting glucose,C0205250;C3163633,false;false,3649/10465
no adk / e cancer,C1412243;C0006826;C0998265;C1306459,false;true;false;false,3650/10465
indacaterol + tiotropium ( n[nmbr ),C1722260;C0213771;C0053917;C1334884,true;true;true;false,3651/10465
ras % target dose,C0034678;C1521840;C0178602;C0869039;C1114758;C2986546;C0525678,true;false;false;false;false;false;true,3652/10465
history of upper gastrointestinal event,C0019664;C3203348;C0441471;C4019010;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,3653/10465
ibdq score |,,,3654/10465
first primary ( change in updrs score / wk  wk nmbr - nmbr ),C0205435;C0205225;C0392747;C3639721;C0443172;C1705241;C4319952;C0439612;C0439631;C1279901,false;false;false;true;false;false;false;false;false;false,3655/10465
overweight ( nmbr to < nmbr kg / mnmbr ),C0497406;C0053917;C0022718;C0439209;C4054209;C1334884,true;true;true;false;false;false,3656/10465
symptom onset - to -,C4086878,false,3657/10465
median ( iqr ) cholesterol ,C0549183;C0008377;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false,3658/10465
week nmbr mean ( se ),C0332174;C0053917;C0444504;C0036919;C2347634;C2348143;C1334884;C0439230,false;true;false;true;false;false;false;false,3659/10465
western europe  israel  australia  or south africa,C0043128;C0015176;C0022271;C0043129;C0004340,true;true;true;true;true,3660/10465
imm + corticosteroid  n,C0205470;C0001617;C3536709,false;true;false,3661/10465
tnmbrdm duration  y,C0449238;C2926735,false;false,3662/10465
previous myocardial infarction  n ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,3663/10465
no . ( % ) of participants,C0679646,false,3664/10465
previous tnf antagonist exposure  n ( % ),C0205156;C1448177;C0231491;C0274281;C0332157;C1552607,false;true;false;false;false;false,3665/10465
pharmacotherapy,C0013216;C0013217,true;true,3666/10465
ulcerative colitis,C0009324,true,3667/10465
received nmbr prior anti - tnf therapy  n,C1514756;C0053917;C0332152;C0432633;C0279936;C2826257;C1334884,false;true;false;false;false;false;false,3668/10465
placebo n ( rate ) *,C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,3669/10465
low - density lipoprotein,C0023823,true,3670/10465
family history^,C0241889,true,3671/10465
fvc ( % predicted ),C3714541,true,3672/10465
clinical ae  n ( % },C0205210;C3887670,false;false,3673/10465
dietary epa - dha intake ( mg / day ) *,C1286104;C0142831;C0439422;C2348308,false;true;false;false,3674/10465
other llt use,C2347090;C0042153;C0457083;C1947944,false;true;false;false,3675/10465
ada nmbr / nmbr n[nmbr,C1060325;C0053917;C1334884;C3811629,false;true;false;false,3676/10465
serious adverse events,C1519255,false,3677/10465
change from baseline at week nmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,3678/10465
medications at coronary angiography,C0013227;C0085532;C1548829;C0802604;C2598133;C4284232,true;true;false;false;false;false,3679/10465
nmbr nmbr years  n ( % ),C0053917;C0439234;C1334884,true;false;false,3680/10465
no . of subjects,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,3681/10465
fpg  mean ( sd )  mg / dl [mmol / l],C0444504;C2699239;C0439269;C1532563;C2347634;C2348143,false;false;false;false;false;false,3682/10465
acrnmbr response  n / n ( % ),C0871261;C1704632;C1706817;C2911692,false;false;false;false,3683/10465
sfc nmbr / nmbr mg twice daily ( n = nmbr  nmbr ),C4521536;C0053917;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;false;true;false;false;false;false;false;false,3684/10465
geometric mean blood eosinophil count ( sd on a loge scale ) — cells / mmnmbr,C2986759;C0200638;C2699239;C2697934;C0175659;C0349674;C1947916,false;false;false;false;true;false;false,3685/10465
copd - placebo ( n = nmbr ),C0024117;C0032042;C0053917;C1334884;C1696465;C1706408;C1412502;C3714496,true;true;true;false;false;false;false;false,3686/10465
pga subscore,C0016410;C3541266;C4050369,true;false;false,3687/10465
mafcaiancy at randorrtzaton,,,3688/10465
nmbr . nmbr mg / dl triglycerides^,C0053917;C0439269;C0041004;C1334884,true;false;true;false,3689/10465
antiplatelet within nmbr mo before randomization,C0053917;C0026544;C0332177;C1334884,true;true;false;false,3690/10465
lesion characteristics,C1286326,false,3691/10465
handihaler and diskus  n,,,3692/10465
baseline dyspnea index score,C1511069;C0449820;C4050231,false;false;false,3693/10465
creatinine clearance — no . ( % ),C0812399,false,3694/10465
any oral hypoglycemic drug 一 no . ( % ),C0359086,false,3695/10465
sfcnmbr / nmbr pg b . i . d . n = nmbr,C0053917;C2827928;C0021966;C0221138;C0030827;C0152277;C0072225;C1266240;C1334884,true;false;true;false;true;false;true;false;false,3696/10465
infarct related artery location,C0021308;C0439849;C0003842;C0450429;C1515974;C4284930;C4284931;C0226004;C0445223,true;false;true;false;false;false;false;false;false,3697/10465
pen - label empagliflozin nmbr mg ( baseline hbanmbrc > nmbr % ),C1424886;C0181496;C3490348;C0053917;C0024671;C0168634;C1442488;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C2827499;C4522130;C4551445;C3273588;C4319659,false;false;true;true;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,3698/10465
other vasculars,,,3699/10465
patients who received indeterminate results on test for antibodies to infliximabt,C0030705,true,3700/10465
history of diabetes requiring drugs,C0019664;C0020616;C0019665;C0262512;C0262926;C1705255;C2004062;C0011847;C1553893;C0011849,true;true;true;false;false;false;false;false;false;true,3701/10465
coronary intervention,C0018787;C0184661;C0886296;C1273869,true;true;false;false,3702/10465
elevated at wk nmbr — no . ( % ) !,C0205250;C0332174;C0053917;C1334884;C0439230;C3163633,false;false;true;false;false;false,3703/10465
body mass index category  no . ( % ) l,C0005893;C0683312;C3889287;C0578022;C1305855,false;false;false;false;true,3704/10465
liraglutide nmbr . nmbr mg mean ( n ),C1456408;C0053917;C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;true;false;false;false;false;false;false,3705/10465
habnmbrc ( mean ± sem )  %,C0444504;C2347634;C2348143,false;false;false,3706/10465
low risk ( nmbr - nmbr ),C3272281;C0053917;C1334884;C3538919,false;true;false;false,3707/10465
gfr as assessed by mdrd,C0017654;C1424601,true;false,3708/10465
history of ischemic stroke,C0019664;C0948008;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,3709/10465
nmbr - minute walk distance — m,C0053917;C0439232;C0429886;C0369637;C0441923;C0700321;C0702093;C1282918;C2347166;C1334884,true;false;false;false;false;false;false;false;false;false,3710/10465
male / female  %,C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429,true;true;true;false;false;false;false;false,3711/10465
current inhaler +,C0521116;C0021461;C1881212;C4319647;C1705970,false;true;false;false;false,3712/10465
phosphate ( mmol / l ),C0031603;C1532563;C0031701;C1601799,true;false;true;false,3713/10465
established cardiovascular disease,C0443211;C0007222;C1272684,false;true;false,3714/10465
smoker ( current / former ),C0337664;C0521116;C0205156;C0750523;C1705970,true;false;false;false;false,3715/10465
total cholesterol - to - hdl cholesterol ratio,C0428619,false,3716/10465
oral anticoagulant drugs  n ( % ),C0354604,false,3717/10465
definite,C0439544;C1704787,false;false,3718/10465
abciximab - facilitated pci ( n = nmbr ),C0288672;C4049621;C0053917;C1334884,true;false;true;false,3719/10465
computed tomographic angiography,C1536105,true,3720/10465
distribution — no . ( % ),C0520511;C1704711,false;true,3721/10465
intravenous heparin,C0354566,false,3722/10465
nmbr . nmbr to < nmbr . nmbr % ( nmbr to < nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,3723/10465
nmbr - month follow - up median ( iq range ),C0053917;C0332177;C0589120;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1522577;C1704685;C3274571;C0439231;C1334884,true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,3724/10465
biventricular pacemaker,C1719274,false,3725/10465
warfarin group,C0043031;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,3726/10465
nmbr aspirin ( n = nmbr nmbr ),C0053917;C0004057;C1334884,true;true;false,3727/10465
short form nmbr ( sf - nmbr ),C2964478;C0053917;C0037712;C1334884,false;true;true;false,3728/10465
individual intended study duration — no . ( % ),C0027361;C1283828;C0489652;C1551357;C0237401,true;false;false;false;false,3729/10465
male nyha class,C0086582;C1882083;C1706180;C1706428;C1706429,true;false;false;false;false,3730/10465
metoprolol group ( n = nmbr ),C0025859;C0441848;C0053917;C1334884,true;false;true;false,3731/10465
fenofibric acid,C0060179,true,3732/10465
warfarin at enrollment,C0043031;C1516879;C1696073;C3888021,true;false;false;false,3733/10465
global ischemia,C0205246;C0022116;C4321499;C2348867,false;true;false;false,3734/10465
p value § ( < nmbr vs . > = nmbr years ),C1709380;C0053917;C1334884,false;true;false,3735/10465
hf or lvef < nmbr % associated with index event,C0018488;C1313497;C1538440;C3273279,true;true;false;false,3736/10465
subject completion status  n ( % ),C3891295;C0205197;C1554962;C2348577;C0449438;C0681850;C0805732;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false;false;false;false;false,3737/10465
egfr — ml / min / nmbr . nmbr m * *,C1739039;C0439445;C0053917;C0369637;C0441923;C1334884;C3811844;C3812682,true;false;true;false;false;false;false;false,3738/10465
coronary angioplasty or stenting,C0002997;C0190211,true;false,3739/10465
death from cardiovascular causes,C0007465;C0007226;C3887460,true;true;false,3740/10465
nmbr mg / dl ldl cholesterol | |,C0053917;C0439269;C0023824;C0202117;C1334884,true;false;true;false;false,3741/10465
femur fracture,C0015802,true,3742/10465
erythrocyte sedimentation rate  mm / hour,C1176468;C4330985;C0439227;C0564385;C4554674;C1619634,false;false;false;false;false;true,3743/10465
insulin sensitivity — % §,C0920563;C4049919,true;false,3744/10465
anti - tnf agent ( s ),C0221141;C1448177;C0450442;C1254351;C1521826;C0313162,false;true;false;false;false;false,3745/10465
medication after enrolment,C0013227;C1516879;C1696073;C3888021;C3244316;C4284232,true;false;false;false;false;false,3746/10465
number insulin glargine,C0237753;C0907402;C0449788,false;true;false,3747/10465
asian ( nmbr . nmbr % ),C0078988;C0053917;C1334884,true;true;false,3748/10465
lifestyle modifications,C0870811;C2960841,false;false,3749/10465
change from,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3750/10465
% change  nmbr % ci ),C0392747;C0053917;C0008107;C3259781;C1334884;C0443172;C1705241;C4319952,false;true;true;false;false;false;false;false,3751/10465
< nmbrnwrrtn,,,3752/10465
moderate renal impairment,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3753/10465
major diabetic eye disease  n ( % ),C0205082;C0342245;C0205164;C4318856;C4521762,false;false;false;false;false,3754/10465
all participants,C0679646,false,3755/10465
history of atrial fibrillation / flutter  ( % ),C0729790;C0016385;C2242390;C1998417;C0232197,false;false;false;false;false,3756/10465
apixaban dose ( or matching placebo ),C1831808;C0178602;C0869039;C1114758,true;false;false;false,3757/10465
symptom onset,C4086878,false,3758/10465
prosthetic,,,3759/10465
disease hare . no . ( % ) i,C0012634,true,3760/10465
treatment by egfr stage,C0815181;C1739039;C3811844;C3812682,false;true;false;false,3761/10465
hormonal therapy — no . ( % ),C0279025,false,3762/10465
angina pectoris  ( % ),C0002962,true,3763/10465
type of stent at index procedure,C0332307;C0038257;C1547052,false;true;false,3764/10465
blood pressure lowering medication use,C0005823;C0441994;C0240320;C2003888;C1271104;C1272641,true;false;false;false;false;true,3765/10465
gpi used during pci,C1415351,false,3766/10465
lowzmedium intensity,C0522510,false,3767/10465
antihypertensive therapy  n ( % ),C0585941,false,3768/10465
any medication,C0013227;C3244316;C4284232,true;false;false,3769/10465
mean — mm hg level — no . ( % ),C0444504;C0439475;C0441889;C0456079;C1547707;C2946261;C2347634;C2348143,false;false;false;false;false;false;false;false,3770/10465
chd simva nmbr = nmbr],C0280604;C0053917;C1334884;C3542407,false;true;false;false,3771/10465
diabetic history ( years ) x,C0241863;C0019664;C0439234;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;true;false;false;false;false,3772/10465
urine albumin / creatinine ratio ( mg / g ),C0455271;C1300563;C1318330,false;false;false,3773/10465
extensive colitis or pancolitis,C0205231;C0009319;C1963084,false;true;false,3774/10465
moderate ckd at randomization,C0205081;C1561643;C0034656;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false,3775/10465
less than the median,C0439092;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3776/10465
qualifying cv event  n ( % ),C1514624;C3538987;C0441471;C4019010;C4048877;C4318503,false;false;false;false;true;false,3777/10465
peripheral artery occlusive disease ( stage nmbr / nmbr / nmbr / nmbr / nmbr ),C1306889;C0205390;C0053917;C1334884;C1300072;C1306673,false;false;true;false;false;false,3778/10465
or placebo treatment,,,3779/10465
diabetesnmbr ( % ),,,3780/10465
continued thienopyridine ( n nmbr nmbr ),C0549178;C1120149;C0053917;C1334884,false;true;true;false,3781/10465
saxagliptin nmbr . nmbr mg,C1611934;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3782/10465
patients with ra  as  or psa ( n = nmbr ),C0030705;C3538806;C4048756,true;false;false,3783/10465
chronic bronchitis ( % ),C0008677,true,3784/10465
reduction 
 in risk 
 ( nmbr % ci ) %,C1137094;C0053917;C0008107;C3259781;C1334884;C0035647;C0520870;C4552904,true;true;true;false;false;true;false;false,3785/10465
moderate disease activity : > nmbr . nmbr to < nmbr . nmbr  n ( % ),C1513375;C0012634;C0053917;C1334884;C3833417;C0205081;C1292728;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false;false;false;false,3786/10465
age nmbr years or more,C1510829;C0053917;C1334884,false;true;false,3787/10465
valsartan / hctz ( n = nmbr ),C0216784;C0020261;C0053917;C1334884,true;true;true;false,3788/10465
ics users  n ( % ),C0815320;C1706077;C4551720,false;false;true,3789/10465
since onset,,,3790/10465
diabetes at randomization,C0011847;C0034656;C0011849,false;true;true,3791/10465
treated with pci — no . / total no . ( % ),C0332293;C4049621,false;false,3792/10465
device group ( n = nmbr ),C0025080;C0441848;C0053917;C1334884;C0699733,true;false;true;false;true,3793/10465
left main coronary artery  n ( % ),C1261082,false,3794/10465
statin use at study entry  n ( % ),C0360714;C0869040;C1705654,true;false;false,3795/10465
lipid disorder,C0154251,true,3796/10465
history of atrial fibrillation  type 一 no . ( % ),C0729790;C0332307;C1547052,false;false;false,3797/10465
total diuretic dose ( iv + oral ) on day nmbr  mg,C2986497;C0012798;C0022326;C4265176,false;true;true;false,3798/10465
enthesitis  n ( % ),C1282952,false,3799/10465
immobazaton,,,3800/10465
digit symbol substitution,C0582802;C0679214;C1555721;C1706204;C1698987;C3241971,false;false;false;false;false;false,3801/10465
prior coronary revascularization ( pci or cabg ),C0332152;C0877341;C4049621;C2826257,false;false;false;false,3802/10465
hbalc  median ( ql  qnmbr )  %,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,3803/10465
fasting cholesterol — mg / dl,C0015663;C0008377;C0439269,true;true;false,3804/10465
idiopathic,C0332240,false,3805/10465
mean ( sd ) [range],C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,3806/10465
inhaled corticosteroids,C0004048;C0001617;C3539185;C3540725;C3540726;C3540727,true;true;false;false;false;false,3807/10465
fasting insulin — pmol / liter,C0015663;C0021641;C0439192;C0475211;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,3808/10465
watchman ( n = nmbr ),C0335390;C0053917;C1334884,false;true;false,3809/10465
apixaban  nmbr . nmbr mg ( n = nmbr ),C1831808;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3810/10465
primary renal endpoint,C2986535;C0022646,false;true,3811/10465
hgb  g / dl,C0019029;C0439267;C0019046;C0518015;C1424337,false;false;true;false;false,3812/10465
normal ( > nmbr ),C0205307;C0053917;C1334884;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false,3813/10465
type of des at index procedure,C0332307;C0011702;C4551552;C1547052,false;true;true;false,3814/10465
nmbr vitamin e ( n = nmbr nmbr ),C0053917;C0042874;C3714803;C1334884,true;true;false;false,3815/10465
persistent wrf ( n = nmbr ),C0205322;C0053917;C1334884;C0332996,false;true;false;false,3816/10465
estonia,C0014908,true,3817/10465
score on modified rankin scale ( ' % / ',C0449820;C2984908;C3854213;C4050231,false;false;false;false,3818/10465
atrial fibrillation or flutter ( ecg ) §,C0004238;C0344434;C1963067,true;false;false,3819/10465
adcs - adl score *,C3641947;C0449820;C4050231,false;false;false,3820/10465
mean sfnmbr score ( nmbr % ci ),C3533236;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,3821/10465
qrs > nmbr ms  n ( % )  available for nmbr patients,C0053917;C2349943;C3539704;C3713294;C1334884,true;false;false;true;false,3822/10465
baseline high - sensitivity crp,C0168634;C1441604;C3890735;C4048285;C1442488,true;false;false;false;false,3823/10465
heart rates ( beats / minutes ),C0018810,true,3824/10465
insulin glargine allocation,C0907402;C1706778,true;false,3825/10465
left side of colon,C0227388,false,3826/10465
left ventricular hypertrophy,C0149721;C3484363,true;false,3827/10465
non - cortical,C1518422;C0001613;C0007776;C0022655,false;true;true;true,3828/10465
low - density lipoprotein cholesterol  median  ( nmbrth — nmbrth percentiles )  mg / dl,C0023824;C0549183;C1264641;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false;false,3829/10465
unsuccessful procedure,C1272705;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,3830/10465
previous angina  n ( % ),C0205156;C0002962;C1552607,false;true;false,3831/10465
nmbr . nmbr to nmbr . nmbr ( % ),C0053917;C1334884,true;false,3832/10465
nt - pro - bnp — pmol / liter - j -,C0669479;C0439192;C0475211;C0754710,true;false;false;true,3833/10465
sirukumab nmbr mg qnmbrw,C3254570;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3834/10465
baseline post - bronchodilator % predicted fev  > nmbr % and concurrent tiotropium use,C0168634;C1442488,true;false,3835/10465
euroscore additive  median ( nmbrth  nmbrth % ) §,C3164744;C0442796;C0549183;C0876920;C2347635;C2348144;C2939193;C1550602,false;false;false;false;false;false;false;false,3836/10465
lev - naive,C0023556,true,3837/10465
clinical disease activity index score ( nmbr - nmbr ),C3869583;C0449820;C0053917;C1334884;C4050231,false;false;true;false;false,3838/10465
black / african - american ( nmbr . nmbr % ),C0085756;C0053917;C1334884,true;true;false,3839/10465
chronic coxnmbr inhibitors,C0205191;C0243077,false;true,3840/10465
no . of coronary vessels with > nmbr % diameter stenosis,C0010075,true,3841/10465
history of claudication,C2315493,false,3842/10465
seated sbp at nmbr weeks  mmhg +,C0277814;C0085805;C0053917;C0439230;C0439475;C1334884;C1283233,true;true;true;false;false;false;false,3843/10465
ended > nmbr days before trial entry,C1272693;C0053917;C0439228;C0008976;C1705654;C1334884;C2746065,false;true;false;true;false;false;false,3844/10465
rope score * *,C1563164;C0449820;C4050231,false;false;false,3845/10465
inter p - value,C0205103;C1548610,false;false,3846/10465
risk factor profile index event,C0035648;C1979963;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C2003903,true;false;true;false;false;true;false;false;false;false,3847/10465
use of ace inhibitor  arb  or both — no . ( % ),C1524063;C0003015;C3888198;C4541021,false;true;false;false,3848/10465
clopidogrel  nmbr mg loading dose !,C0070166;C0053917;C4086581;C1708715;C0024671;C3714444;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;false;true;false;true;false;false;false;false;false;false,3849/10465
adverse eventy,,,3850/10465
discontinued,C1444662,false,3851/10465
duration of osteoarthritis symptoms — yr,C0436359;C0029408;C0439234,false;true;false,3852/10465
total cholesterol - mg / dl * *,C0201950;C0439269;C0543421,false;false;false,3853/10465
peripheral revascularization ( n = nmbr ),C0205100;C0581603;C0053917;C1334884,false;false;true;false,3854/10465
smoking in past yr,C0037369;C1444637;C0439234;C4284302;C0453996;C1881674,true;false;false;false;true;false,3855/10465
percentage of patients using ics or ics / laba on entry,C0439165;C0030705;C1549488;C1561533,false;true;false;false,3856/10465
mean change ,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,3857/10465
neither ics nor laba,C0815320;C4551720,false;true,3858/10465
combination - facilitated pci ( n = nmbr ),C0205195;C1947911;C3811910,false;false;false,3859/10465
bifurcation,C0184906;C3146289,false;false,3860/10465
coronary heart disease death,C0010054;C0011065;C1306577;C4082313;C4552775;C0010068;C1956346,true;true;false;false;false;true;true,3861/10465
< nmbr mg / dl eze / simva ( n = nmbr },C0053917;C0439269;C1334884,true;false;false,3862/10465
a / v ( n = nmbr ) v ( n = nmbr ),C0560268;C0053917;C1334884;C3887614;C1272460,false;true;false;false;false,3863/10465
hypertrophic cardiomyopathy,C0007194;C4551472,true;true,3864/10465
median body mass index  kg / mnmbr ( iqr ),C0549183;C0005893;C0022718;C0439209;C4054209;C0578022;C1305855;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;true;false;false;false;false,3865/10465
nmbr - year framingham chd risk ( % ) nmbr mean / sd ),C0053917;C0439234;C3166866;C1282512;C0444504;C2699239;C2347634;C2348143;C0439508;C1334884,true;false;false;false;false;false;false;false;false;false,3866/10465
ecrcl  ml / min,C0439445,false,3867/10465
time from longest event to randomisation,C0040223;C1522425;C0441471;C4019010;C3541383,true;false;false;false;false,3868/10465
no prior hf hospitalization,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,3869/10465
conservative,,,3870/10465
serum creatinine ( pmol / l )  mean ( sd ),C0201976;C0439284;C0444504;C2699239;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,3871/10465
any cv history / risk factors  n ( % ),C3538987;C0019664;C0035648;C1553898;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503,false;true;true;false;true;false;false;false;false;true;false,3872/10465
vte at day nmbr +,C0630906;C0332173;C0053917;C1334884;C0439228;C0439505,true;false;true;false;false;false,3873/10465
age of completion of highest education  years ( sd ),C1510829;C0205197;C1522410;C0013621;C2699239;C0013622;C0013658;C0039401;C1554962,false;false;false;true;false;true;true;true;false,3874/10465
pfo + asa,C0004057;C3853627,true;false,3875/10465
nmbr mg / day - placebo,C0053917;C0439422;C0032042;C1696465;C1706408;C1334884,true;false;true;false;false;false,3876/10465
mtss cfb,C0009002;C1824728,true;false,3877/10465
mental component summary,C0229992;C0449432;C1552616;C1706244;C1705248,false;false;false;false;false,3878/10465
low - density lipoprotein cholesterol tx difference vs pbo  ls mean % change from baseline ( se ),C0023824;C0041403;C1705241;C1705242,true;true;false;false,3879/10465
dihydropyridine calcium - channel blocker,C2945601,false,3880/10465
germany,C0017480,true,3881/10465
high sensitivity c - reactive protein ( mg / l ),C1441604;C0006560;C0439268;C1413716;C4048285,false;true;false;false;false,3882/10465
azathioprine,C0004482,true,3883/10465
high risk ( ri ≥ nmbr ),C0332167;C0035487;C0053917;C1334884;C1826843;C3272283;C4050568;C4319571,false;true;true;false;false;false;false;false,3884/10465
egfr ( ml / min per nmbr - nmbr m ' ),C1739039;C0439445;C0053917;C0369637;C0441923;C1334884;C3811844;C3812682,true;false;true;false;false;false;false;false,3885/10465
ez / simva nmbr mg,C0206578;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,3886/10465
patients receiving immunosuppressive agents at baseline,C0030705,true,3887/10465
demographics age  years  mean ( sd ),C0011298;C1510829;C0444504;C2699239;C2347634;C2348143;C1704791,true;false;false;false;false;false;false,3888/10465
previous aorta - femoral or lower extremity bypass surgery  pta of iliac  or infrainguinal artery,C0205156;C0003483;C1552607,false;true;false,3889/10465
fracture,C0016658,true,3890/10465
clopidogrel loading dose nmbr mg,C0070166;C3714444;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;false;true;true;true;false;false;false;false;false;false,3891/10465
renal insufficiency — no . ( % ),C0035078;C1565489,true;true,3892/10465
caucasian eze / simva ( „ = nmbr },C0007457;C0053917;C1334884;C0043157,true;true;false;true,3893/10465
tg mg / dl  median ( sd ),C0337445;C0439269;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,3894/10465
locafon of index dvt,C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,true;true;false;false;true;false;false;false,3895/10465
baseline nihss,C0168634;C1697238;C1442488,true;false;false,3896/10465
clinical details,C0205210;C1522508,false;false,3897/10465
limited i -,C0439801;C0021966;C0221138;C2674459;C3542948;C4050251,false;true;false;false;false;false,3898/10465
intracranial disease of major artery 寸,C0524466;C0852949;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false;false,3899/10465
mean bp ( mmhg ),C0444504;C0037623;C0439475;C1415692;C1708288;C4318478;C2347634;C2348143,false;true;false;false;false;false;false;false,3900/10465
no chd eze / simva nmbr = nmbr },C0280604;C0053917;C1334884;C3542407,false;true;false;false,3901/10465
heart rate  b . p . m . mean ± sd,C0018810;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923,true;false;false;false;false;false;false,3902/10465
estimated glomerular filtration rate - no . ( % ) : :,C3811844,false,3903/10465
moderate n z nmbr,C0205081;C0053917;C1334884;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,3904/10465
central nervous system,C3540014;C3714787,false;true,3905/10465
drug - eluting stent implanted — no . ( % ),C1322815,true,3906/10465
elevated bnp ( nmbr pg / ml )  %,C0205250;C0054015;C0053917;C0439297;C1334884;C1095989;C1417808;C2982014;C3163633,false;true;true;false;false;false;false;false;false,3907/10465
verapamil - sr strategy,C1527129;C0679199,false;false,3908/10465
baseline steroids,C0168634;C0038317;C1442488,true;true;false,3909/10465
c - reactive protein  median ( qnmbr  qnmbr ),C0006560;C0549183;C0876920;C2347635;C2348144;C2939193;C1413716;C4048285,true;false;false;false;false;false;false;false,3910/10465
albumin measurements^^,C0201838,false,3911/10465
dactylitis,C0239161,false,3912/10465
no hypertension ( n = nmbr ),C0020538;C0053917;C1334884;C1963138,true;true;false;false,3913/10465
history of other medical conditions  n ( % ),C0262926;C0012634;C0348080;C1705253;C3864998,false;true;false;false;false,3914/10465
placebo allocation,C0032042;C1706778;C1696465;C1706408,true;false;false;false,3915/10465
cyclosporin,C0010592;C0010594,true;true,3916/10465
symptom onset to hospital arrival  hours,C4086878;C0019994;C1555577;C0439227;C1706079;C1510665,false;true;false;false;false;false,3917/10465
before amendment,C0680532;C2346732,false;false,3918/10465
baseline erosion,C0168634;C0333307;C1880549;C1959609;C3887524;C1442488,true;false;false;false;false;false,3919/10465
minimal important change threshold ( improvement ) a,C3845594;C3898777;C0449864;C2986411;C4084912,false;false;false;false;false,3920/10465
digoxin,C0012265,true,3921/10465
left ventricular ejection fraction  mean ( sd )  %,C0428772;C0444504;C2699239;C2347634;C2348143;C0488728,false;false;false;false;false;false,3922/10465
new york heart association congestive heart failure class,C1882083;C0018802,false;true,3923/10465
haemoglobin ( g / dl )  mean + sd  available for nmbr patients,C1319312;C3642216;C0444504;C2699239;C2347634;C2348143;C0019046;C0439267,false;false;false;false;false;false;true;false,3924/10465
peripheral arterial revascularization,C0205100;C0003842;C0581603;C0221464,false;true;false;false,3925/10465
median daily dose - iu ™,C0549183;C2348070;C0049272;C0439453;C0694756;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false,3926/10465
hla - bnmbr positive  n ( % ),C1426226;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,3927/10465
renal function ( egfr  ml / min / nmbr . nmbr mnmbr ),C0232804;C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,false;true;false;true;false;false;false,3928/10465
ldl particle numbers ( week nmbr ),C2612459;C0237753;C0332174;C0053917;C1334884;C0439230;C0449788,false;false;false;true;false;false;false,3929/10465
serum ldl cholesterol,C0428474,false,3930/10465
all grafts,,,3931/10465
stroke thought due to atherothrombotic disease,C0038454;C4554100,true;false,3932/10465
first hhf,C0205435;C1279901,false;false,3933/10465
primary angioplasty ( n = nmbr ),C0205225;C0162577;C0053917;C1334884;C1548817;C0439612;C0439631,false;true;true;false;false;false;false,3934/10465
atenolol strategy ( n = nmbr ),C0004147;C0679199;C0053917;C1334884,true;false;true;false,3935/10465
prothrombin mutation ( % ),C1610621,false,3936/10465
cardiovascular risk factors and medical history,C0850624,false,3937/10465
valsartan  n ( % ),C0216784,true,3938/10465
qrs > nmbr msec nmbr - min walk test,C0053917;C0439223;C0702093;C4277740;C1524029;C3813700;C1334884,true;false;false;true;false;false;false,3939/10465
immobilization at randomization  n ( % ),C0020944;C0034656;C4048292,true;true;false,3940/10465
difference,C1705241;C1705242,false;false,3941/10465
participants n,C0679646,false,3942/10465
left ventricular ejection fraction  median ( iqr )  %,C0428772;C0549183;C0876920;C2347635;C2348144;C2939193;C0488728,false;false;false;false;false;false;false,3943/10465
associated with corrected,C0332281;C0205202,false;false,3944/10465
ckd ( egfr < nmbrb ),C1561643;C1739039;C3811844;C3812682,true;true;false;false,3945/10465
lowering drugs,C0441994;C0013227;C3687832;C2003888,false;true;false;false,3946/10465
concomitant cardiovascular therapy ( taken > nmbr days ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,3947/10465
post - bronchodilator fevnmbr / fvc ( % ) a,C2599594;C3714541,false;true,3948/10465
no . evenls,,,3949/10465
medical treatment,C0679624,false,3950/10465
previous angina pectoris,C0205156;C0002962;C1552607,false;true;false,3951/10465
indeterminate ! !,C0205258,false,3952/10465
select lipids and lipoproteins,C1707391,false,3953/10465
nmbr - year framingham chd risk,C0053917;C0439234;C3166866;C1282512;C0439508;C1334884,true;false;false;false;false;false,3954/10465
> qnmbr ( nmbr . nmbr ) - qnmbr ( nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,3955/10465
egfr ( ckd - epi  cystatin c )  ml / min / nmbr . nmbr mnmbr,C1739039;C1561643;C0162734;C0071744;C0439445;C0053917;C1334884;C1413772;C4281721;C3811844;C3812682,true;true;true;true;false;true;false;false;false;false;false,3956/10465
previous receipt of therapy against tnf - a — no . ( % ),C0205156;C0039798;C0087111;C1363945;C1552607,false;true;true;false;false,3957/10465
prior to index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,3958/10465
race  % of patients,C0034510;C0030705;C1706779;C3853635,true;true;false;false,3959/10465
apo a - i  mg / dl,C0085201;C0439269;C1677784,true;false;true,3960/10465
vessel treated  n,C0005847,true,3961/10465
non - smokers receiving lipid - lowering drugs  p blockers ,C0337672;C4554605,false;true,3962/10465
estrogen therapy,C0279494,false,3963/10465
haq - di total score  mean ( sd ),C3826998;C2964552;C0444504;C2699239;C2347634;C2348143;C4321476,false;false;false;false;false;false;false,3964/10465
high density lipoprotein cholesterol - mg / dl * *,C0023822;C0439269,true;false,3965/10465
systolic pulmonary arterial pressure  mean ( sd )  mm hg,C0871470;C0024109;C0444504;C2699239;C0439475;C2347634;C2348143;C2707265;C2709248;C4522268;C0039155;C1168098,true;true;false;false;false;false;false;false;false;false;true;false,3966/10465
> qnmbr ( nmbr ) - qnmbr ( nmbr . nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,3967/10465
das - nmbr ( crp )  mean ( sd ),C0051767;C0053917;C3890735;C0444504;C2699239;C2347634;C2348143;C4048285;C1334884;C0057671,true;true;false;false;false;false;false;false;false;true,3968/10465
blood transfusion,C0005841;C0281867,true;false,3969/10465
partial evolving to secondarily generalized ( ic ),C0728938;C0332253;C0205246;C0020750;C4554818;C1550516,false;false;false;true;false;false,3970/10465
hscrp > nmbr to < nmbr mg / l,C0053917;C0439268;C1334884,true;false;false,3971/10465
ra symptom duration < nmbr months — number ( % ),C3538806;C1457887;C0449238;C0053917;C0439231;C0237753;C0449788;C1334884;C2926735;C3854129;C4048756,false;false;false;true;false;false;false;false;false;false;false,3972/10465
ldl - c < nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,3973/10465
ace / arb medication ( % ),C1452534;C3888198;C0013227;C3244316;C4284232;C4284014,true;false;true;false;false;false,3974/10465
positive family history of type nmbr diabetes ( % ),C0439178;C1313937;C0332307;C0053917;C1334884;C1547052;C1446409;C1514241;C2825490;C3812269,false;false;false;true;false;false;false;false;false;false,3975/10465
urinary albumimcreatinine ratio,C1273442,false,3976/10465
diabetes treatment,C0011847;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0011849,false;true;true;false;false;false;false;false;true,3977/10465
mucolytics,C0026698,true,3978/10465
pooled analysis,C1709595;C0002778;C0936012;C1524024;C2349200;C4522255,false;false;false;true;false;false,3979/10465
infliximab,C0666743,true,3980/10465
iduration of symptoms > nmbr min,C0683368;C0053917;C0702093;C1524029;C3813700;C1334884;C1457887,true;true;false;false;false;false;false,3981/10465
estrogens,C0014939;C3537250;C3541386;C3714615,true;false;false;false,3982/10465
nmbr mg twice daily n = nmbr,C0053917;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;true;false;false;false;false;false;false,3983/10465
major gastro - intestinal bleeding,C0205082;C0017181;C0205164;C4318856;C4521762,false;true;false;false;false,3984/10465
anti - ccp antibody positive  n ( % ),C0432633;C1525410;C0741132;C1704514,false;false;false;false,3985/10465
egfrmdrd  ml / min / nmbr . nmbr mnmbr bsa,C0439445;C0053917;C1334884,false;true;false,3986/10465
weight > nmbr kg  n ( % ),C0005910;C0053917;C0022718;C0439209;C4054209;C1334884;C0043100;C1305866;C1705104,true;true;true;false;false;false;true;false;false,3987/10465
multiple diagnoses,C0439064;C0011900,false;true,3988/10465
cholecystitis chronic,C0008325;C1963083;C4553186,true;false;false,3989/10465
baseline % bsa involvement,C0168634;C1314939;C1442488,true;false;false,3990/10465
> nmbr corticosteroids or immunosuppressants,C0053917;C0001617;C3539185;C3540725;C3540726;C3540727;C1334884,true;true;false;false;false;false;false,3991/10465
history of atrial arrhythmia  n ( % ),C0019664;C0085611;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,3992/10465
chronic pulmonary disease,C0746102,false,3993/10465
> nmbr  obesity class nmbr,C0053917;C0028754;C0456387;C1518526;C1705943;C1963185;C1334884,true;true;false;false;false;false;false,3994/10465
congestive heart failure ( definite ),C0018802,true,3995/10465
average dose ( mg / week ),C1510992;C0178602;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C2825518,false;false;true;false;false;true;false;false;false;false;false;false;false;false,3996/10465
urinary albumin : creatinine ratio *,C0455271;C1318330,false;false,3997/10465
previous pci ( % total ),C0205156;C4049621;C0439175;C0439810;C1552607,false;false;false;false;false,3998/10465
highest killip classiciation pre - pci,C1522410,false,3999/10465
edss stratification  no . ( % ),C0451246;C1514983;C3887783,false;false;false,4000/10465
exenatide no . of events / total no . ( % ),C0167117,true,4001/10465
method used to diagnose the incident pulmonary embolism  no . ( % ),C0025663;C0449851;C0871511,true;false;false,4002/10465
blood glucose,C0005802,true,4003/10465
rf or acpa positive,C0035448;C0201660;C0748398;C1547111,true;false;false;false,4004/10465
congestive heart failure — no . ( % ),C0018802,true,4005/10465
mean ucsd - sobq score * ( sd ),C3533236;C2699239,false;false,4006/10465
morphine use for index event / pci,C0242000;C0600653;C0441471;C4049621;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;true;false;false;false,4007/10465
albumin - to - creatinine ratio ,C0486293;C1318293,false;false,4008/10465
region  north america,C0017446;C0028405;C0205147,true;true;false,4009/10465
medical therapy alone,C0418981,false,4010/10465
continuation,,,4011/10465
nmbr ( fevi nmbr - < nmbr % pred ),C0053917;C0429706;C0849974;C1561566;C4528367;C1334884,true;false;false;false;false;false,4012/10465
anmbrs - hydroxy -,,,4013/10465
qrs interval > nmbr msec — no . ( % ),C0520880;C0053917;C0439223;C1334884,false;true;false;false,4014/10465
streptokinase,C0038418,true,4015/10465
haq - di improvement > nmbr . nmbr,C3826998;C2986411;C0053917;C1334884;C4321476,false;false;true;false;false,4016/10465
baseline cv treatment  n ( % ) y,C0168634;C3538987;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4048877;C4318503;C1442488,true;false;true;true;false;false;false;false;false;true;false;false,4017/10465
adalimumab croup  n / n ( % ),C1122087;C0010380,true;true,4018/10465
apob ( week nmbr ),C0003593;C0332174;C0053917;C1334884;C0439230;C3252643,true;false;true;false;false;true,4019/10465
systemic arterial hypertension  n ( % ),C0020538,true,4020/10465
reversibility to salbutamol  %,C1271924,false,4021/10465
overall  male : female,C0282416;C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1561607,true;true;true;true;false;false;false;false;false;false,4022/10465
nmbr p value,C0053917;C1709380;C1334884,true;false;false,4023/10465
evolocumab ( nmbr mg ),C3529352;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,4024/10465
bifurcation lesion,C0184906;C0221198;C1546698;C3146289,false;false;false;false,4025/10465
time from onset of symptoms to randomization — days,C1320528,false,4026/10465
thiazide at last follow - up,C0541746;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,4027/10465
% change median baseline crp > nmbrmg / l,C0392747;C0443172;C1705241;C4319952,false;false;false;false,4028/10465
blood pressure systolic  mm hg,C0005823;C0039155;C0439475;C1271104;C1272641,true;true;false;false;true,4029/10465
hf hospitalizations  median ( iqr ),C0018488;C0019993;C0549183;C0876920;C2347635;C2348144;C2939193;C1313497;C1538440;C3273279,true;true;false;false;false;false;false;true;false;false,4030/10465
history of carotid artery disease,C0019664;C0007273;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,4031/10465
history of diabetes mellitus,C0455488,false,4032/10465
prior treatment historynmbr,C1514463,false,4033/10465
patients with bw decrease of $ nmbr % in patients with baseline bmi of $ nmbr kg / mnmbr +,C0030705;C0005910;C0392756;C0053917;C1334884;C0547047;C0006041;C2986891,true;true;false;true;false;false;true;false,4034/10465
interactionnmbr,,,4035/10465
no history of migraine,C0455512,false,4036/10465
mild ( gold nmbr ),C2945599;C0018026;C0053917;C1334884;C1304897,false;true;true;false;false,4037/10465
iii : fevnmbr > nmbr % - < nmbr % predicted,C0439070;C0053917;C1334884;C1705160,false;true;false;false,4038/10465
cat score category,C0007450;C0449820;C0683312;C3889287;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;false;false;true;false;false;false;false,4039/10465
baseline bmi nmbr to < nmbr kg / mnmbr  n = nmbr  nmbr,C0168634;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false,4040/10465
statin only,C0360714;C0205171;C1720467,true;false;false,4041/10465
drug therapy at admission 一 no . ( % ) aspirin,C0013216;C0184666;C0809949;C0013217,true;false;false;true,4042/10465
fatty acid profile,C0015684;C1979963;C2003903,true;false;false,4043/10465
residual deep - vein thrombosis  no . ( % ),C1609982;C0149871,false;true,4044/10465
unstable angina  n ( % ),C0002965,true,4045/10465
completed trial,C0205197;C0008976;C3854010,false;true;false,4046/10465
duration of symptoms  h,C0436359;C0033727;C0369286;C0441932;C0564385;C4528284,false;true;false;false;false;false,4047/10465
% predicted ” fev  at baseline  % *,C0681842;C3714541;C0168634;C1442488;C1882327,false;true;true;false;false,4048/10465
aspirin dose at randomization,C4696290;C0034656,false;true,4049/10465
normoglycemia^,C0580545,false,4050/10465
race / ethnicity,C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,4051/10465
oral antidiabetic drugs,C0029167;C0935929;C0175795;C0304289;C0442027;C4521986,true;true;false;false;false;false,4052/10465
ef nmbr - nmbr % hfmref ( n = nmbr  nmbr % ),C0053917;C1334884,true;false,4053/10465
cerebral embolism,C0007780,true,4054/10465
fevnmbr / fvc prebronchodilatort,C3714541,true,4055/10465
previous use of antiplatelet drugs,C0205156;C1524063;C0085826;C2963157;C1552607,false;false;true;false;false,4056/10465
laba non - users,C1518422;C1706077,false;false,4057/10465
thiazolidinedione based,C0289779;C1257987;C3537039,true;true;false,4058/10465
chronic respiratory failure,C0264492,false,4059/10465
coronary artery disease history,C0010054;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0010068;C1956346,true;true;true;false;false;false;false;true;true,4060/10465
current prescribed medications,C0521116;C3166216;C3202967;C1705970,false;false;false;false,4061/10465
current weekly alcohol use ( % ),C0521116;C0332174;C0001948;C1705970,false;false;true;false,4062/10465
calcium ( mmol / l ),C0006675;C1532563;C0006726;C2936886;C3540037;C3714611,true;false;true;false;false;false,4063/10465
region ( pooled ),C0017446;C0205147,true;false,4064/10465
bdmard - naive,,,4065/10465
general andthoracic epidural,C0205246;C0228134;C0812144;C3812897;C3891294;C4521767,false;true;false;false;false;false,4066/10465
first co - primary outcome,C0205435;C3245499;C0205225;C1274040;C0439612;C0439631;C1279901,false;true;false;false;false;false;false,4067/10465
cvd  mi  stroke  or recurrent ischemia - urgent revascularization  or hospitalization for unstable angina,C0007222;C3810814;C0038454;C4554100,true;false;true;false,4068/10465
age at enrolment  years,C1510829;C1516879;C1696073;C3888021,false;false;false;false,4069/10465
not available,C0686905,false,4070/10465
use of antiplatelet agents^,C1524063;C0085826,false;true,4071/10465
aspirin or thienopyridines ( % ),C0004057,true,4072/10465
baseline trig > nmbr millycerides g / dl,C0168634;C0202236;C0053917;C0439267;C1334884;C1519533;C1442488,true;false;true;false;false;false;false,4073/10465
baseline anti - hypertensive usea,C0168634;C0003364;C1442488,true;true;false,4074/10465
intent - to - treat population  n ( % ),C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C1550453,true;true;true;true;false;false;false;false,4075/10465
dyslipidaemia and hypertension  n ( % ),C0242339,true,4076/10465
saxa nmbr . nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,4077/10465
estimated response rate and odds ratio,C0750572;C0237629,false;false,4078/10465
first loading dose,C0205435;C3714444;C1279901,false;false;false,4079/10465
ex - smokers nmbr,C0337671;C0053917;C1334884;C4555205,false;true;false;true,4080/10465
atrial fibrillation ldl cholesterol level,C0004238;C0023824;C0441889;C0456079;C1547707;C2946261;C0202117;C0344434;C1963067,true;true;false;false;false;false;false;false;false,4081/10465
duration of,C0449238;C2926735,false;false,4082/10465
weight ab  %,C0005910;C0043100;C1305866;C1705104,true;true;false;false,4083/10465
race or ethnic group — no . / total no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,4084/10465
loop at enrollment,C0445022;C1516879;C1696073;C3888021,false;false;false;false,4085/10465
current cigarette use  n ( % ),C0521116;C0694535;C1705970,false;false;false,4086/10465
central europe,C0682369,false,4087/10465
atopic ( based on phadiatop test ),C0392707,false,4088/10465
baseline bmi nmbr to < nmbr kg / mnmbr  n = nmbr change from baseline to nmbr weeks,C0168634;C0578022;C0053917;C0022718;C0392747;C0439230;C0443172;C1705241;C4319952;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false;false;false;false;false;false,4089/10465
kccq ( nmbr months ),C3476798;C0053917;C0439231;C1334884,false;true;false;false,4090/10465
mean eq - nmbrd response ( nmbr % ci ),C0444504;C0205163;C0871261;C0053917;C0008107;C3259781;C1334884;C1704632;C1706817;C2911692;C0439185;C2347634;C2348143,false;false;false;true;true;false;false;false;false;false;false;false;false,4091/10465
tp vs no tp,C0036183;C3541334,true;false,4092/10465
mitral insufficiency,C0026266,true,4093/10465
r nmbr mg + fa,C0205090;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0684010;C2603358,false;true;true;true;false;false;false;false;false;false;true;false,4094/10465
total study population,C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,4095/10465
subacute ( nmbr - nmbr days ),C0205365;C0053917;C0439228;C1334884,false;true;false;false,4096/10465
assoc  with corrected congenital shunts,C0205202;C0009678;C0232180;C0542331;C1442858;C1744681,false;true;false;false;false;false,4097/10465
spinal fractures,C0080179;C0518450,true;false,4098/10465
multivessel disease  n ( % ),C0012634,true,4099/10465
normoalbuminuria or microalbuminuria,,,4100/10465
low ( no risk factor ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,4101/10465
hospitalisation for chf within nmbr years of randomisation,C0019993;C0018802,true;true,4102/10465
rec . ischemia due to ecg changes,C1424025;C0022116;C0678226;C1623258;C4321499;C2606415,false;true;false;true;false;true,4103/10465
event / patients ( nmbr / pt - y ),C0441471;C0030705;C0053917;C0032743;C0699718;C1334884;C4019010,false;true;true;true;false;false;false,4104/10465
calcium - channel antagonists,C0006684;C2757014,true;false,4105/10465
angiotensin receptor,C0034787;C1622222,true;true,4106/10465
dbp  mean ( sd )  mm hg glycaemic parameters,C0536221;C0444504;C2699239;C0439475;C0005802;C0449381;C2347634;C2348143;C3813197;C4281799,true;false;false;false;true;false;false;false;false;false,4107/10465
priorother ( predefined ) medical conditions,,,4108/10465
tnmbr lesion volume  mmnmbr,C0221198;C0449468;C1690016;C1705102;C2700258;C1546698,false;false;false;false;false;false,4109/10465
african - american / african heritage ( n = nmbr ),C0085756;C2986513;C0053917;C1334884,true;false;true;false,4110/10465
new anti - anginal therapy,C3242274;C1874267;C3537168,false;false;false,4111/10465
smoking : current smoker,C0037369;C0453996;C1881674,true;true;false,4112/10465
total cataract,C3665439,false,4113/10465
no . of patients ( % ),C0030705,true,4114/10465
ami nmbr mg n = nmbr,C4319936;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,4115/10465
baseline lvef,C0168634;C0428772;C0488728;C1442488,true;false;false;false,4116/10465
change from baseline stage nmbr ckd,C0168634;C0597205;C0053917;C1561643;C1334884;C0679846;C1442488,true;false;true;true;false;false;false,4117/10465
indacaterol group ( n = nmbr ),C1722260;C0441848;C0053917;C1334884,true;false;true;false,4118/10465
iv : fevnmbr < nmbr % predicted,C0022326;C0053917;C1334884;C4265176,true;true;false;false,4119/10465
education nmbr - nmbr years,C0013621;C0053917;C0439234;C1334884;C0013622;C0013658;C0039401,true;true;false;false;true;true;true,4120/10465
waist circumference,C0455829,true,4121/10465
hispanic — no . ( % ),C0086409,true,4122/10465
> nmbr . nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,4123/10465
rituximab  n = nmbr,C0393022;C0053917;C1334884,true;true;false,4124/10465
stroke  n ( % ),C0038454;C4554100,true;false,4125/10465
family history of premature,C0241889;C0151526;C0205252;C4018905,true;true;false;false,4126/10465
change in bp  mm hg,C1268766;C0439475,false;false,4127/10465
nonfatal ischemic stroke,C0948008,false,4128/10465
pci delay due to low risk,C4049621,false,4129/10465
prior percutaneous coronary intervention,C0332152;C1532338;C2826257,false;true;false,4130/10465
oral anticoagulant agent,C0354604,false,4131/10465
alcohol intake ( a ),C0001948,true,4132/10465
hbanmbrc subgroups,C1079230,false,4133/10465
history of atherosclerotic vascular disease — no . ( % ) §,C0683519;C0333482;C0005847;C1558950;C1801960;C0730226;C0850708;C0944983,false;false;true;false;false;false;false;false,4134/10465
renal function : creatinine clearance,C0232804;C0812399,false;false,4135/10465
mercaptopurine,C0000618,true,4136/10465
transient monocular blindness,C0149793,true,4137/10465
nyha functional class  n ( % ),C1882083;C0205245;C0542341;C2700217,false;false;false;false,4138/10465
entire cohort gender,C0439751;C0009247;C0079399;C1522384;C0599755;C0444667,false;true;true;true;false;false,4139/10465
inhaled §,C0004048,true,4140/10465
patient global assessment of pain ( vas nmbr - nmbr mm ),C4054229;C0042815;C0053917;C4330985;C4554674;C1334884,false;true;true;false;false;false,4141/10465
rituximab ( nmbrxnmbr mg ) + mtx ( n = nmbr ),C0393022;C0024671;C0025677;C0053917;C1334884;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;true;false;false;false;false;false,4142/10465
peripheral artery revascularization without amputation,C0489868;C0581603;C0002688;C0332840;C1546539,false;false;true;false;false,4143/10465
other cause  n ( % ),C0015127;C1524003,true;false,4144/10465
immunosuppressants and antimalarials only,C0021081,true,4145/10465
* * positive stress test,C0439178;C0015260;C3494508;C1446409;C1514241;C2825490;C3812269,false;true;true;false;false;false;false,4146/10465
aspirin use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,4147/10465
randomisation scheme,C0034656;C1519193,true;false,4148/10465
ala carriers,C0523459;C0007294;C3888236,false;true;false,4149/10465
arterial hypertension — no . ( % ),C0020538,true,4150/10465
bmi ( median  iqr )  kg / mnmbr,C0578022;C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false,4151/10465
alternative disability,C1523987;C0231170,false;false,4152/10465
non - hdl cholesterol / apob ( ratio ),C0729627;C0003593;C0456603;C1547037;C3252643;C1535899;C1518422;C2938854,false;true;false;false;true;false;false;false,4153/10465
other risk factors,C0035648;C1553898,true;false,4154/10465
hf hospitalization or cardiovascular death,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,4155/10465
no revascularization for index acs event,C0581603;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,4156/10465
p - value for variance,C1709380;C1711260;C2348152,false;false;false,4157/10465
apo b  mean ( sd )  mg / dl,C0003593;C0444504;C2699239;C0439269;C2347634;C2348143;C3252643,true;false;false;false;false;false;true,4158/10465
at ldl - c ( bq ) goal * at baseline - no . ( % ),C0560038;C0018017;C0168634;C1442488;C1571704;C3541236,false;true;true;false;false;false,4159/10465
missing data initial diagnosis — no .,C4684714;C0205265;C0011900;C1704338;C1704656;C1279901;C1555582;C1705685,false;false;true;true;false;false;false;false,4160/10465
aspirin at enrollment,C0004057;C1516879;C1696073;C3888021,true;false;false;false,4161/10465
prespecified analysis,C0002778;C0936012;C1524024,false;false;true,4162/10465
k ( rate ),C0597277;C0871208;C1521828;C1708601,false;false;false;false,4163/10465
r | r ' ' ' ( nmbr % ci ),C0205090;C0053917;C0008107;C3259781;C1334884;C0684010;C2603358,false;true;true;false;false;true;false,4164/10465
glyburide dose duringthe study ( mg ),C0017628;C0178602;C0557651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2603343;C0869039;C1114758,true;false;false;true;true;false;false;false;false;false;false;false;false,4165/10465
ptca / cabg,C2936173;C0010055,true;true,4166/10465
score  %,C0449820;C4050231,false;false,4167/10465
seizure types reported during baseline  b n ( % ),C0036572;C0332307;C1959629;C4553401,true;false;false;false,4168/10465
biologic therapeutic failure,C0005515;C0087111;C0231174;C0680095;C0302350;C0205460,true;true;false;false;false;false,4169/10465
simva ( „ = nmbr },C0053917;C1334884,true;false,4170/10465
partial mayo score  mean ( sd ),C0728938;C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578;C1550516,false;false;false;false;false;false;false;false;false;false,4171/10465
selected clinical characteristics — no . / total no . ( % ),C1707391;C0683325,false;false,4172/10465
. nmbr . nmbr ml / s / mnmbr ( nmbr ml / min / nmbr . nmbr mnmbr )  n ( % ),C0053917;C0439445;C1334884,true;false;false,4173/10465
prior use of conventional dmards only ( biologic - nai ' ve )  n ( % ),C0332152;C1524063;C0439858;C0205171;C4055380;C3537218;C0042469;C3714652;C4321495;C1720467;C2826257,false;false;false;false;false;false;true;false;false;false;false,4174/10465
family history  n ( % ),C0241889,true,4175/10465
patients with diabetes mellitus,C0030705;C0011849,true;true,4176/10465
thiazolidinedione ( includes pioglitazone ),C0289779;C1257987;C3537039,true;true;false,4177/10465
corticosteroids and antimalarials only,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,4178/10465
total pack - years mean ( sd ),C0439175;C1277691;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,4179/10465
medications at study entry — no . / total no . ( % ),C0013175;C1705654,true;false,4180/10465
gold iii - iv,C0018026;C0439070;C0022326;C4265176;C1705160;C1304897,true;false;true;false;false;false,4181/10465
reason for enrollment in active a,C0392360;C1516879;C1696073;C3888021,false;false;false;false,4182/10465
asia / australia / new zealand,C0003980;C4289954,true;false,4183/10465
octave induction nmbr,C0205263;C0053917;C1334884;C0857127,false;true;false;false,4184/10465
tachyarrhythmias  n ( % ),C0080203,true,4185/10465
europe n z nmbr,C0015176;C0053917;C1334884,true;true;false,4186/10465
atrial fibrillation alone ) ,C0004238;C0344434;C1963067,true;false;false,4187/10465
supraventricular tachyarrhythmias ( incl . atrial,C1698480;C3853833,false;false,4188/10465
previous cerebrovascular event,C0205156;C1880018;C0441471;C4019010;C1552607,false;false;false;false;false,4189/10465
stroke — no . ( % ),C0038454;C4554100,true;false,4190/10465
bronchodilator response  ml,C0006280;C0871261;C0439526;C1705224;C3887665;C1704632;C1706817;C2911692,true;false;false;false;false;false;false;false,4191/10465
nmbr ( fevi ^nmbr % pred ),C0053917;C0429706;C0849974;C1561566;C4528367;C1334884,true;false;false;false;false;false,4192/10465
mental component,C0229992;C0449432;C1705248,false;false;false,4193/10465
apo a - l ( g / l ),C0628062,true,4194/10465
veflonzumao,,,4195/10465
pfo with large shunt and atrial septal aneurysm,C0549177;C0232180;C0542331;C1442858,false;false;false;false,4196/10465
classification of index venous thromboembolism — no . ( % ),C0008902;C0600653;C1997614;C0918012;C1552854;C1637833;C2986546;C0008903;C0678229,true;true;false;true;false;false;false;true;false,4197/10465
fevnmbr at baseline,C0168634;C1442488,true;false,4198/10465
incidence rate per nmbr person - years,C1708485;C0053917;C0027361;C0439234;C2347489;C1334884,false;true;true;false;false;false,4199/10465
time of randomization ( interaction : p = nmbr . nmbr ),C0040223;C0034656;C1704675;C0053917;C1334884;C3541383,true;true;false;true;false;false,4200/10465
chronic renal failure  n ( % ),C0022661;C1561643;C2316810,true;true;false,4201/10465
both deep - vein thrombosis and pulmonary embolism,C0149871,true,4202/10465
myocardial infarction without st - segment elevation — no . ( % ),C1536220,true,4203/10465
pooled eze / simva,C1709595;C2349200;C4522255,false;false;false,4204/10465
other sglt - nmbr inhibitor,C0053917;C1999216;C1334884,true;false;false,4205/10465
clavicle fracture,C0159658,false,4206/10465
ecg abnormality ( resting )  %,C1623258;C1704258,true;false,4207/10465
musculoskeletal stiffness,C0497254;C0427008;C2707260,false;false;false,4208/10465
psoriatic arthritis  %,C0003872,true,4209/10465
medication prior to admission  ( % ),C0013227;C0332152;C0184666;C0809949;C3244316;C4284232,true;false;false;false;false;false,4210/10465
death / st,C0011065;C0036056;C3272372;C1306577;C4082313;C4552775,true;true;false;false;false;false,4211/10465
bdi focal score,C0006448;C0205234;C0449820;C4050231;C0451022;C3714938;C3889415,true;false;false;false;false;false;false,4212/10465
time to randomisation [hours] ( interaction : p = nmbr . nmbr ),C0040223;C0034656;C0439227;C1704675;C0053917;C1334884;C3541383,true;true;false;false;true;false;false,4213/10465
laboratory examination,C0260877,false,4214/10465
placebo patients with events,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,4215/10465
organ system involvement  no . ( % ),C0460002;C1314939,false;false,4216/10465
enalapril lcznmbr ( n = nmbr ) ( n = nmbr ),C0014025;C0053917;C1334884,true;true;false,4217/10465
high - dose statin,C0444956;C0360714,false;true,4218/10465
peripheral,C0205100,false,4219/10465
ldl cholesicrol ( minol / l ),,,4220/10465
hispanic / latino ethnicity  n ( % ),C0086409;C0086528;C0015031;C0243103,true;true;true;true,4221/10465
nmbr - nmbr drinks,C0053917;C0452428;C1334884,true;false;false,4222/10465
aborted cardiac arrest,C1550015;C1609614;C4085625;C4318470,false;false;false;false,4223/10465
baseline crp < nmbrmg / l,C0168634;C3890735;C4048285;C1442488,true;false;false;false,4224/10465
relative risk reduction ( nmbr % cl ) percent,C0242492;C0301630;C0053917;C0596019;C0439165;C1334884;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039,true;false;true;false;false;false;false;false;false;true;true;false;false,4225/10465
unprotected left main stented,C0205091;C0205225;C0038257;C1542147;C0443246;C1552822,false;false;true;false;false;false,4226/10465
catheterization performed for qualifying event,C0007430,true,4227/10465
fraction ( % ),C1264633;C1554103,false;false,4228/10465
nmbr % ci for difference,C0053917;C0008107;C1705241;C1705242;C3259781;C1334884,true;true;false;false;false;false,4229/10465
index event to randomization  median ( iqr )  h,C0600653;C0441471;C0034656;C0549183;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;true;false;true;false;false;false;false;false;false;false;false;false;true;false;false;false,4230/10465
inclusion criteria — no . ( % ),C1512693,false,4231/10465
normal hscrp,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,4232/10465
^nmbr - cell function — % §,C0053917;C0007613;C1334884,true;true;false,4233/10465
previous tnf - antagonist use  n ( % ),C0205156;C1448177;C0231491;C0042153;C0457083;C1947944;C1552607,false;true;false;true;false;false;false,4234/10465
depressed only,C0344315;C0549249,false;true,4235/10465
acute infection without septic shock,C0275518;C0036983,false;true,4236/10465
mtss units,C0439148;C1519795;C3853603,false;false;false,4237/10465
previous statin use,C0205156;C0360714;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,4238/10465
mean ( s . d . ) calculated ldl cholesterol,C0444504;C2347634;C2348143,false;false;false,4239/10465
nmbr % confidence interval,C0053917;C0009667;C1334884,true;true;false,4240/10465
type of concomitant statin by daily dose,C0332307;C0521115;C0360714;C1547052,false;false;true;false,4241/10465
statin with ezetimibe,C0360714;C1142985,true;true,4242/10465
history of ml or ischemic stroke,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,4243/10465
within nmbr h,C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,4244/10465
placebo n = nmbr n ( % ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,4245/10465
nyha class not reported,C1882083,false,4246/10465
neither uh or lmw heparin,,,4247/10465
fpg tx difference vs pbo  median change from baseline ( se ) nmbr,C0041403;C1705241;C1705242,true;false;false,4248/10465
iglarlixi ( fixed - ratio combination ),C0443218;C0456603;C0205195;C1947911;C3811910;C1547037;C2827483;C3714578,false;false;false;false;false;false;false;false,4249/10465
previous congestive heart failure,C0205156;C0018802;C1552607,false;true;false,4250/10465
periostin ( ng / ml ),C0219433;C0439275;C1424662;C3812270,true;false;false;false,4251/10465
belimumab nmbr mg sc ( n nmbr ),C1723401;C0053917;C0024671;C0282380;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;true;false;false;false;false;false;false,4252/10465
glycatedhemoglobin category  %,C0683312;C3889287,false;false,4253/10465
canvas - r,C3281223;C0205090;C0684010;C2603358,false;false;true;false,4254/10465
waist circumference  cm mean ( sd ),C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,4255/10465
tg > nmbr . hdl < nmbr ( mg / dl ) ( / ? = nmbr ),C0337445;C0053917;C3715113;C0439269;C1334884,false;true;false;false;false,4256/10465
africa  asia  or the middle east,C0001737;C0003980,true;true,4257/10465
history of gestational diabetes mellitus — no . ( % of women ),C2183115,false,4258/10465
non - black race ( n = nmbr vs nmbr ),C1518422;C0005680;C0053917;C1334884,false;true;true;false,4259/10465
community hospital,C0020003,true,4260/10465
not - japan n = nmbr  nmbr,C1518422;C0022341;C0053917;C1334884,false;true;true;false,4261/10465
stage > nmbr chronic kidney disease ( % ),C0205390;C0053917;C1561643;C4553188;C1334884;C1300072;C1306673,false;true;true;false;false;false;false,4262/10465
nmbr - hr plasma glucose — mg / dl,C0053917;C0202042;C0439269;C0455280;C1334884,true;false;false;false;false,4263/10465
not at goal,C1518422;C0018017;C1571704,false;true;false,4264/10465
concomitant aminosalicylates  n [ % ] concomitant corticosteroids  n [ % ] mayo score  mean [sd],C0521115;C0368663;C0001617;C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578;C3539185;C3540725;C3540726;C3540727,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,4265/10465
baseline fecal caicrctectin,C0168634;C0015733;C1442488,true;true;false,4266/10465
hospitalization for unstable angina,C0019993;C0002965,true;true,4267/10465
patients having exacerbation,C0030705,true,4268/10465
regular alcohol consumption per week  no . ( % ),C0205272;C0001948;C0332174;C0439230,false;true;false;false,4269/10465
improving anemia bsl hb < nmbrg i - nmbr  yr nmbr > nmbrg i - nmbr,C1272745;C0002871;C1549954;C0019046;C0021966;C0053917;C0439234;C1334884;C0221138;C1000483;C4554633,false;true;false;true;true;true;false;false;false;false;false,4270/10465
qualifying peripheral arterial disease,C1514624,false,4271/10465
previous bypass surgery  n ( % ),C0205156;C1536078;C1552607,false;false;false,4272/10465
anthropometric characteristics,C0003188;C1521970,true;false,4273/10465
baseline fevnmbr  l *,C0168634;C1442488,true;false,4274/10465
nmbr - lead ecg heart rate  beats / min,C0053917;C0179504;C0018810;C1334884,true;false;true;false,4275/10465
aspirin + dipyridamole ( n = nmbr ),C0732279;C0053917;C1334884,true;true;false,4276/10465
patients entering pt period n = nmbr,C0030705,true,4277/10465
surgical technique,C0683469,false,4278/10465
psoriatic arthropathy,C0003872,true,4279/10465
with alogliptin nmbr mg,C1958126;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,4280/10465
revascularisation but no antiplatelets  lipid - lowering agents  or p blockers,C0581603,false,4281/10465
pfo with large shunt without atrial septal aneurysm,C0549177;C0232180;C0542331;C1442858,false;false;false;false,4282/10465
clinical and patient - reported characteristics at baseline and randomization,C0205210,false,4283/10465
or ( unadjusted ),,,4284/10465
unknown or missing,C0439673;C3541433;C4050014,false;false;false,4285/10465
reported high cholesterol ' !,C0684224;C0020443;C1522133;C0700287;C4319718,true;true;false;false;false,4286/10465
syndecan - nmbr ( ng / ml ),C0075691;C0053917;C0439275;C1334884;C1419891,true;true;false;false;false,4287/10465
long - acting,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,4288/10465
use of antiarrhythmic agent,C1524063;C0003195;C0301380,false;true;false,4289/10465
egfr using cg / mdrd formulae  % of patients,C1739039;C3811844;C3812682,true;false;false,4290/10465
baseline body mass index,C0168634;C0005893;C0578022;C1305855;C1442488,true;false;false;true;false,4291/10465
swollen - joint count ( of nmbr joints ),C0451521;C0053917;C1334884,false;true;false,4292/10465
region  n ( % ),C0017446;C0205147,true;false,4293/10465
> nmbr - nmbr mg / week,C0053917;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;false;true;false;false;false;false;false;false,4294/10465
hypertensionnmbr ( % ),,,4295/10465
psa - modified total shs,C3810537;C3813209,false;false,4296/10465
minor ischaemic stroke,C0026193;C0948008;C0205165,true;false;false,4297/10465
annualized rate ind / gly sfc,C0871208;C4049864;C0017890;C4521536;C0523677;C1521828,false;false;true;false;false;false,4298/10465
sulfasalazine,C0036078,true,4299/10465
mean change at week nmbr,C0444504;C0392747;C0332174;C0053917;C1334884;C0439230;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,4300/10465
acpa positive ( > nmbr iu / ml )  n ( % ),C1525410;C0439178;C0053917;C0439458;C1334884;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;true;false;false;false;false;false;false;false,4301/10465
history of strokenmbr,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,4302/10465
long - term warfarin ( n - nmbr ),C0443252;C0043031;C0053917;C1334884,false;true;true;false,4303/10465
crp ( mg / l )  median ± sd,C3890735;C0439268;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false,4304/10465
obese ( > nmbr kg / mnmbr ),C0028754;C0053917;C0022718;C0439209;C4054209;C1334884,true;true;true;false;false;false,4305/10465
facit - fatigue . mean nmbrsd ( range nmbr - nmbr ),C3476791;C0015672;C0444504;C1514721;C0053917;C1334884;C2348147;C3542016;C2347634;C2348143;C3463815;C4050243;C4554645,false;true;false;false;true;false;false;false;false;false;false;false;false,4306/10465
infarct location ( interactsn $ : p = nmbr . nmbr ),C0021308;C0450429;C0053917;C1334884;C1515974;C4284930;C4284931,true;false;true;false;false;false;false,4307/10465
not hospitalized for heart failure in the year prior to study enrollment,C1518422,false,4308/10465
calcification  n ( % ),C0006660;C0006663;C0175895;C1533591;C1879982;C2242558,true;true;false;false;false;false,4309/10465
all ischemic stroke,C0948008,false,4310/10465
rosuvastatin  n ( % ),C0965129,true,4311/10465
hormone replacement therapy use,C0282402;C0042153;C0457083;C1947944,true;true;false;false,4312/10465
older than nmbr years,C0580836;C0053917;C0439234;C1334884,false;true;false;false,4313/10465
rolofylline,C0166128,true,4314/10465
apo a - nmbr  mean ( sd )  mg / dl,C0003592;C0053917;C0444504;C2699239;C0439269;C2347634;C2348143;C1334884;C0523508;C4553344;C4553379,true;true;false;false;false;false;false;false;false;false;false,4315/10465
long - term antiplatelet therapy,C0443252;C1096021,false;false,4316/10465
prior bypass graft surgery,C0455610;C0185098,false;false,4317/10465
bone erosion ( judged by physician )  n ( % ),C0587240,false,4318/10465
triglyceride ( mm,C0041004;C4330985;C4554674,true;false;false,4319/10465
cigarettesmoking  %,,,4320/10465
pentraxin - nmbr ( ng / ml ),C0053917;C0439275;C1334884,true;false;false,4321/10465
tnfi exposed,,,4322/10465
history of atrial fibrillation  n ( % ),C0729790,false,4323/10465
asa or antiplatelet agent,C0004057;C3853627,true;false,4324/10465
ischemic stroke ( vs . tia ),C0948008,false,4325/10465
men : women ( % ),C0025266;C0043210,true;true,4326/10465
patients not treated with statins ( n = nmbr ),C0030705,true,4327/10465
severe renal impairment,C0205082;C1565489;C4050465;C4050466,false;true;false;false,4328/10465
om nmbr mg / aml nmbr mg / hctz nmbr mg,C0028971;C0053917;C1319635;C0023465;C0020261;C0023467;C1334884;C1705272,true;true;false;true;true;true;false;false,4329/10465
history of atrial fibrillation,C0729790,false,4330/10465
corticosteroid use at baseline,C0239126;C0168634;C1442488,false;true;false,4331/10465
sedentary,C0205254,false,4332/10465
no . of patients ( indacaterol / placebo ),C0030705;C1722260;C0032042;C1696465;C1706408,true;true;true;false;false,4333/10465
insulin plus oral,C0021641;C0442027;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false,4334/10465
> nmbr . nmbr  n ( % ),C0053917;C1334884,true;false,4335/10465
ics use  %,C0815320;C4551720,false;true,4336/10465
age category ( years )  n ( % ),C1510829;C0683312;C3889287,false;false;false,4337/10465
atherosclerotic disease ( % ),C0333482;C0012634,false;true,4338/10465
copd duration  y,C0024117;C0449238;C2926735;C1412502;C3714496,true;false;false;false;false,4339/10465
thrombolytic therapy,C0040044,true,4340/10465
acpa positive  n ( % ),C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,4341/10465
baseline bmi nmbr to < nmbr kg / mnmbr  n = nmbr  nmbr change from baseline to nmbr weeks,C0168634;C0578022;C0053917;C0022718;C0392747;C0439230;C0443172;C1705241;C4319952;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false;false;false;false;false;false,4342/10465
acei vs . non - acei,,,4343/10465
risk factors for atherosclerosis,C0035648;C0003850;C0004153;C1553898,true;true;true;false,4344/10465
bifurcation lesion with side branch $ nmbr . nmbr mm stented,C0184906;C0221198;C0441987;C0205384;C0053917;C4330985;C4554674;C1334884;C1253959;C1881507;C2700383;C2826234;C1546698;C3146289,false;false;false;false;true;false;false;false;false;false;false;false;false;false,4345/10465
fevi  % predicted *,C0849974;C1561566;C4528367,false;false;false,4346/10465
heart rate at rest in the supine position ( beats / min ),C0018810;C0035253;C1622890,true;true;false,4347/10465
feno nmbr mg / eze nmbr mg ( n = nmbr ),C0053917;C1319635;C1334884,true;false;false,4348/10465
mean ( s . d . ) total pcsknmbr  ng / ml,C0444504;C0439175;C0439275;C0439810;C2347634;C2348143,false;false;false;false;false;false,4349/10465
baseline cdai score  mean ( sd ),C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,4350/10465
severity of copd  combined assessment  n ( % ),C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4351/10465
ambulance ( % ),C0002422;C3846685,true;false,4352/10465
estimated means and difference,C0750572;C1704970,false;false,4353/10465
concomitant medication ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,4354/10465
qualifying atherosclerosis,C1514624;C0003850;C0004153,false;true;true,4355/10465
ada impaired fasting glucose,C1060325;C1272092;C3811629,false;false;false,4356/10465
death  q wave mi or ischemia - driven revasc,C0011065;C0861151;C1306577;C4082313;C4552775,true;false;false;false;false,4357/10465
stented vessels,C0183521,false,4358/10465
diabetes duration  n ( % ),C0011847;C0449238;C2926735;C0011849,false;false;false;true,4359/10465
tender - joint count  of nmbr joints examined,C0451530;C0053917;C1334884,false;true;false,4360/10465
verapamil sr,C1527129,false,4361/10465
thiazolidinedione 一 no . ( % ),C0289779;C1257987;C3537039,true;true;false,4362/10465
difference  % median,C1705241;C0549183;C0876920;C2347635;C2348144;C2939193;C1705242,false;false;false;false;false;false;false,4363/10465
edema  ( % ),C0013604;C1717255,true;false,4364/10465
medications on admission  %,C0013227;C0802604;C2598133;C4284232,true;false;false;false,4365/10465
rf positive ( > nmbr iu / ml )  n ( % ),C0035448;C0439178;C0053917;C0439458;C1334884;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;true;false;false;false;false;false;false;false;false;false,4366/10465
worsening heart failure,C0332271;C0018801;C0018802;C4554158;C1457868;C1546960,false;true;true;false;false;false,4367/10465
previous limb or foot amputation,C0205156;C0015385;C1552607,false;true;false,4368/10465
alcohol consumption ( % ),C0001948,true,4369/10465
uacr  mgg nmbr ( gm ),C0053917;C0017480;C3854019;C1334884,true;true;true;false,4370/10465
om nmbr / aml nmbr /,C0028971;C0053917;C0023465;C0023467;C1334884;C1705272,true;true;true;true;false;false,4371/10465
hypertension history,C0020538;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1963138,true;true;true;false;false;false;false;false,4372/10465
swollen - joint count  of nmbr joints examined,C0451521;C0053917;C1334884,false;true;false,4373/10465
racial group  n ( % ),C0034510;C0441848;C1706779;C3669213;C3853635,true;false;false;false;false,4374/10465
nmbr to < nmbr ml per nmbr - nmbr mnmbr,C0053917;C0439526;C1705224;C3887665;C1334884,true;false;false;false;false,4375/10465
risk factors,C0035648;C1553898,true;false,4376/10465
deep vein thrombosis only,C0149871;C0205171;C1720467,true;false;false,4377/10465
within last nmbr d,C1517741;C0053917;C1334884,false;true;false,4378/10465
egfr at baseline  nmbr ml / min ( % ) b,C1739039;C0168634;C0053917;C0439445;C1334884;C1442488;C3811844;C3812682,true;true;true;false;false;false;false;false,4379/10465
low - density lipoprotein cholesterol  mean ( sd )  mmol / l,C0023824;C0444504;C2699239;C1532563;C2347634;C2348143,true;false;false;false;false;false,4380/10465
intermediate,C0205103;C1550465;C2827755;C3889971,false;false;false;false,4381/10465
duration of hypertension ( months ),C0449238;C0020538;C0439231;C1963138;C2926735,false;true;false;false;false,4382/10465
wapnmbrc ( ng / ml ),C0439275,false,4383/10465
left circumflex artery  n ( % ),C0226037,false,4384/10465
fpg  median ( ql  qnmbr )  mmol / l,C0549183;C1532563;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4385/10465
ischaemic cause,C0475224;C0015127;C1524003,false;true;false,4386/10465
total cholesterol > nmbr mg / dl,C0201950;C0053917;C0439269;C1334884;C0543421,false;true;false;false;false,4387/10465
intention - to - treat,C0162425;C1283828,true;false,4388/10465
enoxaparin / vka n / n ( % ) nmbr / nmbr ( nmbr . nmbr ),C0206460;C0053917;C1334884,true;true;false,4389/10465
in - stent restenosis,C3272317,false,4390/10465
high risk without atherosclerotic vascular disease +,C0332167;C0004153;C3272283;C4050568;C4319571,false;true;false;false;false,4391/10465
priorother ( not predefined ) medical conditions,,,4392/10465
reteplase / abciximab - facilitated pci ( n = nmbr ),C0256103;C0288672;C4049621;C0053917;C1334884,true;true;false;true;false,4393/10465
established atherosclerotic disease  n ( % ),C0443211;C0333482;C0012634;C1272684,false;false;true;false,4394/10465
concomitant drugs  %,C0521115;C0013227;C3687832,false;true;false,4395/10465
after amendment ( % ),C0680532;C2346732,false;false,4396/10465
antianginal medications,C1874267;C0013227;C0802604;C2598133;C4284232;C3537168,false;true;false;false;false;false,4397/10465
eular good response,C0205170;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,4398/10465
ls means difference ( nmbr % ci ) nmbr,C0023668;C1704970;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242,true;false;false;true;true;false;false;false,4399/10465
prior stroke ( before index event ),C0332152;C0456712;C0441471;C4019010;C2826257,false;false;false;false;false,4400/10465
interval from onset of symptoms,C1272706;C4086878;C1552654;C1552713,false;false;false;false,4401/10465
low risk ( ri = nmbr - nmbr ),C3272281;C0035487;C0053917;C1334884;C1826843;C3538919,false;true;true;false;false;false,4402/10465
patients with prior copd - related,C0030705;C0332152;C0024117;C0439849;C0445223;C1412502;C3714496;C2826257,true;false;true;false;false;false;false;false,4403/10465
duration of ra  mean ( min - max ) ( yrs ),C0449238;C3538806;C0444504;C0702093;C1524029;C3813700;C2347634;C2348143;C4048756;C2926735,false;false;false;false;false;false;false;false;false;false,4404/10465
myocardial infarction / cabg / pci < nmbr years,C0027051;C0010055;C4049621;C0053917;C0439234;C1334884;C0428953;C2926063;C3810814;C4552959,true;true;false;true;false;false;false;false;false;false,4405/10465
dilatative,C0002940;C0012359;C0700124;C1322279,true;true;false;true,4406/10465
ncep atp iii risk factors,C2744579;C0439070;C0035648;C1553898;C1705160;C4552600,true;false;true;false;false;false,4407/10465
change from baseline  adjusted mean ( nmbr % ci ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,4408/10465
antiarrhythmic therapy,C0003195;C0039798;C0087111;C1363945;C3537142,true;true;true;false;false,4409/10465
mean ( sd ) tender joint count *,C0444504;C2699239;C0451530;C2347634;C2348143,false;false;false;false;false,4410/10465
• ? sd ml / min,C2699239;C0439445,false;false,4411/10465
renal function ( egfr  ml / min / nmbr . nmbr mnmbr  according to mdrd )  n ( % ),C0232804;C1739039;C0439445;C0053917;C0680240;C3839656;C1334884;C3811844;C3812682,false;true;false;true;false;false;false;false;false,4412/10465
serum creatinine,C0201976;C0600061,false;false,4413/10465
first - recorded event  no . ( and % ) of patients,C0205435;C1279901,false;false,4414/10465
fevi  l  mean ( sd ) nmbr,C0429706;C0444504;C2699239;C0053917;C1334884;C2347634;C2348143;C0849974;C1561566;C4528367,false;false;false;true;false;false;false;false;false;false,4415/10465
male / female,C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429,true;true;true;false;false;false;false;false,4416/10465
unknown ( none of the above ),C0439673;C3541433;C4050014,false;false;false,4417/10465
baseline creatinine clearance,C0168634;C0812399;C1442488,true;false;false,4418/10465
drug - eluting stent — no . ( % ),C1322815,true,4419/10465
mean disease duration  years,C0444504;C0872146;C0439234;C2347634;C2348143,false;false;false;false;false,4420/10465
spacer use during the study,C0221874;C0869040,false;false,4421/10465
non - end - stage renal dysfunction,C1518422;C0205088;C1565489;C3279454,false;false;true;false,4422/10465
duration of epilepsy  years  mean ( sd ),C0449238;C0014544;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735,false;true;false;false;false;false;false;false,4423/10465
blood pressure control,C0005823;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1271104;C1272641,true;true;false;false;false;false;false;false;true,4424/10465
medications through day nmbr,C0013227;C0332173;C0053917;C1334884;C0439228;C0439505;C0802604;C2598133;C4284232,true;false;true;false;false;false;false;false;false,4425/10465
nyha class ii ( n = nmbrlnmbr ),C1882085,false,4426/10465
nadroparin,C0206232,true,4427/10465
past smoking,C1444637;C0037369;C0453996;C1881674;C4284302,false;true;true;false;false,4428/10465
nmbr - min walk distance ( m ),C0053917;C0702093;C0429886;C0369637;C0441923;C1524029;C3813700;C1334884,true;false;false;false;false;false;false;false,4429/10465
biologics user,C0005515;C1548600;C1706077;C0005522;C4553887,true;false;false;true;true,4430/10465
other medical history — no . ( % ),C0262926;C1704706,false;false,4431/10465
blood pressure ( % ),C0005823;C1271104;C1272641,true;false;true,4432/10465
sfc nmbr mg / nmbr mg,C4521536;C0053917;C1319635;C1334884,false;true;false;false,4433/10465
cardioversion in previous nmbr wk,C0013778;C0205156;C0053917;C0332174;C0439230;C1334884;C1552607,true;false;true;false;false;false;false,4434/10465
nmbr - nmbr ( low risk ),C0053917;C3272281;C3538919;C1334884,true;false;false;false,4435/10465
hypercholesterolemia ( > nmbr mg / dl ),C0020443;C0053917;C0439269;C1334884;C1522133,true;true;false;false;false,4436/10465
use of medication at baseline — no . ( % ),C1524063;C0013227;C3244316;C4284232,false;true;false;false,4437/10465
revascularization during index hospitalization  %,C0581603;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,4438/10465
gender  %,C0079399;C1522384,true;true,4439/10465
brv dosage  mg / d,C0155502;C0178602;C0439422;C2986497,true;false;false;false,4440/10465
not rando . in na *,C1518422;C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false;false,4441/10465
age  median ( iqr )  years,C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4442/10465
oral antidiabetic drugs / insulin ( % / % ),C0029167;C0935929;C0021641;C1533581;C1579433;C3714501;C0175795;C0304289;C0442027;C4521986,true;true;true;false;false;false;false;false;false;false,4443/10465
risk factors specified as inclusion criteria — no . ( % ) f,C0035648;C1553898,true;false,4444/10465
asian or pacific islander,C0078988,true,4445/10465
reversibility : > nmbr - < nmbr %,C0449261;C0053917;C1334884,false;true;false,4446/10465
average daily dose ( % of target ) *,C1510992;C2348070;C1521840;C2986546;C2825518,false;false;false;false;false,4447/10465
target - vessel revascularization,C0449618;C0581603,false;false,4448/10465
severity of copd — no . ( % ) f,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4449/10465
lvef  %  median ( iqr ),C0428772;C0549183;C0876920;C2347635;C2348144;C2939193;C0488728,false;false;false;false;false;false;false,4450/10465
fevnmbr / fvc  post - albuterol  %,C3714541,true,4451/10465
esrd saxa nmbr . nmbr mg ( n = nmbr ),C0022661;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0035078;C2316810,true;true;true;true;false;false;false;false;false;false;true;false,4452/10465
time since diagnosis of pah — yrf,C0040223;C3541383,true;false,4453/10465
right coronary artery  n ( % ),C1261316,false,4454/10465
younger patients ( agednmbr years ),C0332239;C0030705;C0439234,false;true;false,4455/10465
fvc ( l ) proportion taking pulmonary medications ( % ) b,C3714541;C1709707,true;false,4456/10465
vein graft stented,C0042449;C0181074;C0332835;C1961139,true;false;true;false,4457/10465
qualifying stroke,C1514624;C0038454;C4554100,false;true;false,4458/10465
difference vs . pbof mean ( s . e . ) t,C1705241;C1705242,false;false,4459/10465
oral hypoglycaemics only,C0359086;C0205171;C1720467,false;false;false,4460/10465
baseline history of vascular disease ( % ),C0168634;C0683519;C0005847;C1558950;C1801960;C0730226;C0850708;C0944983;C1442488,true;false;true;false;false;false;false;false;false,4461/10465
prednisone - equivalent dose — mg,C0032952;C0205163;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C0439185,true;false;false;true;true;false;false;false;false;false;false;false;false,4462/10465
aspirin alone group no of events / total n ( % ),C0004057;C2826346,true;false,4463/10465
known thrombophilic condition — no . ( % ),C0205309;C0398623;C0012634;C0348080;C1705253;C3864998,false;true;true;false;false;false,4464/10465
blood eosinophil proportion ( % ),C0014467;C1709707,true;false,4465/10465
( a ) demographics,C0011298;C1704791,true;false,4466/10465
cox bsl + yr nmbr hbd,C1565830;C1549954;C0439234;C0053917;C1334884,true;false;false;true;false,4467/10465
direct thrombin inhibitors,C0003440;C3541936,true;false,4468/10465
body - mass index - kg / mnmbr  median ( iqr ),C0005893;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;false;true,4469/10465
acute coronary syndrome,C0948089,true,4470/10465
waist circumference  cm ( sd ),C0455829;C2699239,true;false,4471/10465
moderate impairment ( egfr nmbr - nmbr ),C0205081;C0221099;C1739039;C0053917;C1334884;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;true;false;false;false;false;false;false;false;false;false,4472/10465
use of supplemental oxygen  n ( % ),C4067893;C4554557,false;false,4473/10465
unadjusted or ( nmbr % ci ) p value,C1439367,false,4474/10465
rarely / never,C4035880,false,4475/10465
st - elevation myocardial infarction,C1536220;C3538872,true;false,4476/10465
woscops,,,4477/10465
age ( yrs )  mean *,C0001779;C0444504;C2347634;C2348143,false;false;false;false,4478/10465
non - ischaemic cardiomyopathy,C1518422;C0349782,false;false,4479/10465
history of myocardial infarction  n ( % ),C1275835,false,4480/10465
cardiac catheterization,C0018795,true,4481/10465
estimated glomerular filtration rate  n ( % ),C3811844,false,4482/10465
no aspirin or ppi,C0004057,true,4483/10465
inadequate response,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,4484/10465
drinking  n ( % ),C0001948;C0684271,true;true,4485/10465
non - ics +,C1518422;C0815320;C4551720,false;false;true,4486/10465
endovascular,C0524425,false,4487/10465
sbp ( mmhg )  mean ± sd,C0085805;C0439475;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,4488/10465
hormone - refractory prostate carcinoma,C1328504,false,4489/10465
drug - eluting stent implanted ( at least one ),C1322815,true,4490/10465
pah origin / cause,C1418251;C0015127;C1524003,false;true;false,4491/10465
experience,C0237607;C0596545,false;false,4492/10465
chinese subgroup,C0008120;C1079230;C1515021;C0152035,false;false;false;true,4493/10465
history of cardiovascular events,C1880008;C0441471;C3541888;C0019664;C1320716;C0019665;C0262512;C0262926;C1705255;C2004062,false;false;false;true;false;true;false;false;false;false,4494/10465
disease duration : < baseline mean,C0872146;C0168634;C0444504;C2347634;C2348143;C1442488,false;true;false;false;false;false,4495/10465
physician ' s global assessment . mean nmbr sd,C4050369;C0444504;C0053917;C2699239;C1334884;C2347634;C2348143,false;false;true;false;false;false;false,4496/10465
glycated hemoglobin < median,C0017853;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,4497/10465
% stenosis  as assessed by core laboratory,C0678234;C1261287;C2632116,false;true;false,4498/10465
upper respiratory tract infection,C0041912,true,4499/10465
antibiotics * *,C0003232;C0003237;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710,true;true;false;false;false;false;false;false;false,4500/10465
normoalbuminuria — no . / total no . ( % ),,,4501/10465
aggressive ( nmbr ),C0001807;C0053917;C1334884;C0580822,true;true;false;false,4502/10465
patients with specific disease characteristics,C0030705;C0205369;C0599878;C1552740,true;false;false;false,4503/10465
work and school,C0043227,true,4504/10465
activity ( nmbr - nmbr vas ),C0205177;C0053917;C0042815;C3536884;C3827561;C1334884;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;true;true;true;false;false;false;false;false;false;false;false,4505/10465
age ( yrs ) nmbr - nmbr,C0001779;C0053917;C1334884,false;true;false,4506/10465
afcaps /,,,4507/10465
clinical presentation of vte at initial diagnosis — no . ( % ),C2708283;C0630906,false;true,4508/10465
aspirin < nmbr hours,C0004057;C0053917;C0439227;C1334884,true;true;false;false,4509/10465
glucosamine ( n = nmbr ),C0017718;C0053917;C1334884,true;true;false,4510/10465
neither ace inhibitor nor arb,C0003015;C4541021,true;false,4511/10465
previous coronary intervention,C0205156;C0018787;C0184661;C0886296;C1273869;C1552607,false;true;true;false;false;false,4512/10465
time since diagnosis of diabetes — no . ( % ),C0040223;C3541383,true;false,4513/10465
egfr ( ckd - epi  cystatinc )  ml / min / nmbr . nmbr mnmbr  n ( % ),C1739039;C1561643;C0162734;C0439445;C0053917;C1334884;C4281721;C3811844;C3812682,true;true;true;false;true;false;false;false;false,4514/10465
dyslipidaemia and hypertensiont,C0242339,true,4515/10465
presence of erosions  n ( % ),C0150312;C0333307;C1959609;C0392148;C3854307,false;false;false;false;false,4516/10465
sitting pulse  bpma,C0277814;C0232117;C0391850;C1947910;C2584297;C4050224,true;true;false;false;true;false,4517/10465
post - cabg,C0687676;C0010055;C1704687;C3469826,false;true;false;false,4518/10465
cigarette smoking  mean pack - years ( sd ),C1303175;C0037369;C0444504;C2699239;C2347634;C2348143;C0453996;C1881674,false;true;false;false;false;false;true;false,4519/10465
> nmbr - nmbr ( moderate risk ),C0053917;C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335;C1334884,true;false;true;false;false;false;false;false;false;false,4520/10465
triglycerides tx difference vs pbo  ls mean % change from baseline ( se ),C0041004;C0041403;C1705241;C1705242,true;true;false;false,4521/10465
nmbr - nmbr / nmbr - nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,4522/10465
body mass indexa < median,C0518010;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4523/10465
dmard user,C0242708;C1548600;C1706077,true;false;false,4524/10465
admission for hf in previous year,C0184666;C0018488;C1313497;C1538440;C3273279;C0809949,false;true;true;false;false;false,4525/10465
duplex ultrasonography,C3825392,false,4526/10465
all of the colon,C0009368;C3888384,true;false,4527/10465
nmbr - nmbr - nmbr  obesity class nmbr,C0053917;C0028754;C0456387;C1518526;C1705943;C1963185;C1334884,true;true;false;false;false;false;false,4528/10465
coronary artery disease — no . / total no . ( % ),C0010054;C0010068;C1956346,true;true;true,4529/10465
body mass index  mean + sd ( kg / m ),C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,4530/10465
> nmbr previous venous thromboembolisms ( % ),C0053917;C0205156;C1997614;C1552607;C1334884,true;false;false;false;false,4531/10465
remission at maintenance - trial entry — no . ( % ),C0544452;C0024501;C0008976;C1705654;C0687702,false;true;true;false;false,4532/10465
improved,C0184511;C0332272;C1561611;C4084203,false;false;false;false,4533/10465
treatment stratum^ :,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,4534/10465
red blood cell counting  nmbr / l,C0332575;C0005767;C0022827;C0750480;C0053917;C1334884;C1705566;C0005768;C0229664;C1260956;C4049926,false;true;true;false;true;false;false;true;false;false;false,4535/10465
nmbr - wk kaplan - meier rate  %,C0053917;C0332174;C0871208;C1521828;C0439230;C1334884,true;false;false;false;false;false,4536/10465
continuous variables  mean ( sd ),C0549178;C0439828;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,4537/10465
intensified nmbr months ( n - nmbr ),C0053917;C0439231;C1334884,true;false;false,4538/10465
elevated troponin,C0205250;C0041199;C3163633,false;true;false,4539/10465
smoking history : current smoker,C1519384;C3173209;C3241966,false;false;false,4540/10465
jbs - nmbr primary prevention onlynmbr,C0175692;C0053917;C0033144;C1334884;C0795841;C1416527,true;true;true;false;true;false,4541/10465
( se]tf hdl - c,C0036919;C4048299;C3715113;C4048587,true;false;false;false,4542/10465
baseline hs - crp tertiles ( mg / i],C0168634;C3890735;C0024671;C0021966;C0221138;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285;C1442488,true;false;true;true;false;true;false;false;false;false;false;false;false,4543/10465
not reported,C1518422,false,4544/10465
diabetes and currently on an oral hypoglycaemic agent orinsulin,C0011847;C0011849,false;true,4545/10465
standard care n ( % ) / nmbrpy,C1442989;C1947933;C2828392,false;false;false,4546/10465
apremilast,C1678805,true,4547/10465
anterior myocardial infarction — no . ( % ),C0340293,true,4548/10465
oxcarbazepine,C0069751,true,4549/10465
mildly impaired,C0750532;C2945599,false;false,4550/10465
incidence [n / n ( rate per nmbr person - years ) ],C1708485;C0053917;C0027361;C0439234;C2347489;C1334884,false;true;true;false;false;false,4551/10465
blood pressure at target level ( % ) §,C0005823;C1521840;C0441889;C0456079;C1547707;C2946261;C2986546;C1271104;C1272641,true;false;false;false;false;false;false;false;true,4552/10465
egfrmdrd ， ml - min - nmbr - nmbr . nmbr m_nmbr,C0439445;C0053917;C0369637;C0441923;C1334884,false;true;false;false;false,4553/10465
benign prostatic hyperplasia,C1704272,true,4554/10465
> nmbr erosion  n ( % ),C0053917;C0333307;C1880549;C1959609;C3887524;C1334884,true;false;false;false;false;false,4555/10465
body - mass index > nmbr,C0005893;C0053917;C1334884;C0578022;C1305855,false;true;false;false;true,4556/10465
alcohol consumption  n ( % ),C0001948,true,4557/10465
rhabdomyolysis or myopathy,C0035410;C4552660,true;false,4558/10465
treatment arm,C1522541,false,4559/10465
concomitant therapies at hospital discharge,C1707479;C0586003,false;false,4560/10465
hbanmbrc in patients with baseline hbanmbrc > nmbr % ( > nmbr mmol / mol )  % [mmol / mol]  la  n baseline ( sd ) adjusted mean change ( nmbr % ci ) placebo - subtracted change ( se ),C0030705,true,4561/10465
specific risk of bleeding^,C0205369;C3251812;C1552740,false;false;false,4562/10465
number resulting in emergency department visit,C0237753;C0449788,false;false,4563/10465
elevated troponin ( > nmbr . nmbr pg / l ),C0205250;C0041199;C0053917;C0439278;C1334884;C3163633,false;true;true;false;false;false,4564/10465
hi ) ah ( % ),C0018619;C1836672;C0239849;C1412082;C1412316;C1431594;C4552857,true;true;true;false;false;true;false,4565/10465
number of exacerbations,C0237753;C4086268;C0449788,false;false;false,4566/10465
cpk > nmbr times uln,C0053917;C0040223;C1519815;C1632851;C1334884,true;true;false;false;false,4567/10465
glucosamine + chondroitin sulfate ( n = nmbr ),C0017720;C0008454;C0053917;C1334884;C0876712;C0038720;C0474702;C0475337;C3536965;C0017718;C0008466,true;true;true;false;false;true;false;false;false;true;true,4568/10465
serum trap - nmbrb ( u / liter ),C0229671;C0184047;C0439148;C0475211;C1336677;C1566918;C1706005;C1710330;C3887583;C1546774;C1550100,true;false;false;false;false;true;false;false;false;false;false,4569/10465
sex ( male ) ethnic origin,C0086582;C0015031,true;true,4570/10465
no corticosteroids or immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,4571/10465
lvef within nmbr months  %,C0428772;C0053917;C0439231;C1334884;C0488728,false;true;false;false;false,4572/10465
ls mean change from baselinenmbr,C0023668;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false,4573/10465
uric acid ( mg / dl ) creatinine clearance ( ml / min per nmbr . nmbr mnmbr ),C0041980;C0439269;C0151280;C0053917;C1334884,true;false;false;true;false,4574/10465
weight — kg ( median ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,4575/10465
non - black,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,4576/10465
myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,4577/10465
duration of assigned regimen before surgery,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,4578/10465
asian / black / white / hispanic / other ( % ) clinical parameters,C0078988;C1533017;C0007457;C0043157;C0220938;C1533018;C0005680;C1533020;C1533021;C0027567;C0085756;C0439541,true;false;true;true;false;false;true;false;false;true;true;false,4579/10465
> nmbr mg / dl eze / simva nmbr = nmbr },C0053917;C0439269;C1334884,true;false;false,4580/10465
risk factors for pad,C0035648;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C1553898,true;false;false;false;false;false;false;false,4581/10465
baseline hemoglobin  median ( iqr  g / dl ),C0168634;C1319312;C0549183;C3642216;C0876920;C2347635;C2348144;C2939193;C0019046;C0439267;C1442488,true;false;false;false;false;false;false;false;true;false;false,4582/10465
insulin  iu / ml  median ( qnmbr  qnmbr ),C0021641;C0439458;C0549183;C0876920;C2347635;C2348144;C2939193;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,4583/10465
prior percutaneous coronary intervention — no . ( % ),C0332152;C1532338;C2826257,false;true;false,4584/10465
other bdmard §,,,4585/10465
icd therapy ( n =,C0021122;C0039798;C0087111;C1363945,true;true;true;false,4586/10465
apo a - l ( mg / dl ) - mean ± sd,C1447574;C0439269;C0444504;C2699239;C2347634;C2348143;C4521365,true;false;false;false;false;false;false,4587/10465
with alogliptin nmbr . nmbr mg ( n nmbr nmbr ),C1958126;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,4588/10465
symptomatic pad of lower extremities *,C0231220;C0182158;C0023216;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;true;false;false;false;false;false,4589/10465
pfor heterogeneity,C1151635;C0019409;C0242960,false;false;true,4590/10465
severe impairment ( egfr < nmbr ),C0205082;C0221099;C1739039;C0053917;C1334884;C3811844;C3812682;C0684336;C4050465;C4050466,false;false;true;true;false;false;false;false;false;false,4591/10465
previous use of amiodarone,C0205156;C1524063;C0002598;C1552607,false;false;true;false,4592/10465
levetiracetam,C0377265;C3693636,true;false,4593/10465
peri - op beta - blockers : no ( n = nmbr ),C0347985;C0001645,false;true,4594/10465
patient global assessment ( nmbr - nmbr mm vas ),C4054229;C0053917;C4330985;C0042815;C3536884;C3827561;C4554674;C1334884,false;true;false;true;true;false;false;false,4595/10465
background treatment  n ( % ),C1706907;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,4596/10465
high titre ( > nmbr times of uln )  n ( % ),C0205250;C0475208;C0053917;C0040223;C1519815;C1632851;C1334884;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;true;false;false;false;false;false;false;false;false;false,4597/10465
no corticosteroid  no imm,C0001617;C3536709,true;false,4598/10465
greater than or equal to nmbr mm hg,C0439093,false,4599/10465
antiarrhythmic agent,C0003195;C0301380,true;false,4600/10465
white not of hispanic origin,C0007457;C0043157;C0220938,true;true;false,4601/10465
cause of dvt or pe — no . ( % ),C0015127;C0149871;C2926618;C3899446;C1524003,true;true;false;false;false,4602/10465
sulfonylurea — no . ( % ),C0038766;C3536898,true;false,4603/10465
mean preoperative abpi of the index,C0444504;C0445204;C0600653;C0918012;C1552854;C1637833;C2986546;C2347634;C2348143,false;false;true;true;false;false;false;false;false,4604/10465
met criterion at finalt,C0428210;C0243161;C1550543;C4317104,false;true;false;false,4605/10465
orthopnea  ( % ),C0085619,false,4606/10465
total mortality,C0439175;C0026565;C0026566;C0439810,false;true;true;false,4607/10465
pace  no . ( nmbr ),C0287990;C1552930;C4048252,true;false;false,4608/10465
non - caucasian simva,C1518422;C0007457;C0043157,false;true;true,4609/10465
high periostin subgroup ( > nmbr ng / ml ) ( n = nmbr ),C0205250;C0219433;C1079230;C0053917;C0439275;C1334884;C1515021;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;true;false;false;false;false;false;false;false;false;false;false;false,4610/10465
overall population,C0282416;C0032659;C1257890;C1561607,true;true;true;false,4611/10465
all randomized women,C0034656;C0043210;C3815594,true;true;false,4612/10465
respiratory - related^,C0521346;C0439849;C0445223;C1546767,false;false;false;false,4613/10465
treated vessel - native coronary,C1522326;C0005847;C0302891;C0018787,false;true;false;true,4614/10465
< nmbr . nmbr mmol / liter estimated gfr,C0053917;C0439190;C0475211;C1334884,true;false;false;false,4615/10465
prior ms treatment with ifn - beta or,C1514463;C2349943;C0015980;C3539704;C3713294,false;false;true;false;true,4616/10465
no hemoconcentration hemoconcentration,C0549409;C0854379,false;false,4617/10465
clopidogrel  nmbr - mg loading dose,C0070166;C0053917;C4086581;C1708715;C0024671;C3714444;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;false;true;false;true;false;false;false;false;false;false,4618/10465
body weight ( kg )  mean ( s . d . ),C0005910;C1275571;C0444504;C2347634;C2348143;C1305866,true;false;false;false;false;false,4619/10465
dasnmbr ( c - reactive protein ),C0006560;C1413716;C4048285,true;false;false,4620/10465
blood pressure  pbo y patients with diabe teristics ( ncep atp i,C0005823;C0031962;C0030705;C2744579;C0021966;C0221138;C4552600;C1271104;C1272641,true;true;true;true;true;false;false;false;true,4621/10465
patients with normoalbuminuria at baseline,C0030705,true,4622/10465
stenting plus medical therapy ( n = nmbr ),C0038257;C0418981;C0053917;C1334884;C2348535,true;false;true;false;false,4623/10465
mean - sd change in pre - bronchodilator fevnmbr  l,C0444504;C2699239;C0392747;C2599602;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,4624/10465
change from baseline in % predicted fevnmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,4625/10465
patients with uncomplicated events ( p = o - nmbr 十 ),C0030705;C0443334;C0441471;C0053917;C1334884;C3541888,true;false;false;true;false;false,4626/10465
post - bronchodilator percent of predicted fevnmbr  % ( sd ),C2599594;C1882327;C2699239,false;false;false,4627/10465
comparison with baseline,C1707455;C0168634;C1442488,false;true;false,4628/10465
previous ml ( interaction : p = nmbr . nmbr ),C0205156;C0439526;C1704675;C0053917;C1334884;C1705224;C3887665;C1552607,false;false;false;true;false;false;false;false,4629/10465
cardiac glycosides,C0007158,true,4630/10465
previously taken any other dmards  n ( % ),,,4631/10465
crp ( normal range : nmbr - nmbr . nmbr )  mg / dl  mean ( sd ),C3890735;C0086715;C0053917;C0439269;C0444504;C2699239;C2347634;C2348143;C1334884;C4048285,false;true;true;false;false;false;false;false;false;false,4632/10465
modified rankin score,C0392747;C0449820;C4050231;C3889737,false;false;false;false,4633/10465
a a ( nmbr ( % ),,,4634/10465
mean involved bsa  % ( nmbr % ci ),C0444504;C2347634;C2348143,false;false;false,4635/10465
other defined,C1704788;C3539106,false;false,4636/10465
without ( n = nmbr nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,4637/10465
treatment with drugeluting stent,C0039798;C1322815;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,4638/10465
nmbr - nmbr ( moderate ),C0053917;C1334884,true;false,4639/10465
angiography,C0002978,true,4640/10465
sbp / dbp $ nmbr / $ nmbr mmhg,C0085805;C0536221;C0053917;C0439475;C1334884;C3813197;C4281799,true;true;true;false;false;false;false,4641/10465
non - extensive,C1518422;C0205231,false;false,4642/10465
electrocardiographic findings — no . ( % ),C0438154,false,4643/10465
beta receptor antagonist,C0330390;C4543207;C0439096;C2004068,false;false;false;false,4644/10465
baseline triglycerides by quintiles,C0168634;C0041004;C1508496;C1442488,true;true;false;false,4645/10465
median albumin - to - creatinine ratio ( interquartile range ),C0549183;C0486293;C1711350;C1318293;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4646/10465
< nmbr regardless of historical count,C0053917;C3641650;C1552658;C0750480;C1705566;C1552723;C2004062;C1334884,true;false;false;false;false;false;false;false,4647/10465
stent type,C0038257;C0332307;C1547052,true;false;false,4648/10465
nmbr vessel pci,C0053917;C0005847;C4049621;C1334884,true;true;false;false,4649/10465
body mass index subgroups,C0005893;C1079230;C0578022;C1305855,false;false;false;true,4650/10465
pioglitazone,C0071097,true,4651/10465
b - agonists ( long - acting ) a,C0243192;C2987634,true;false,4652/10465
tg ( mg / dl )  median ± sd,C0337445;C0439269;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4653/10465
risk factors for recurrent vte — no . ( % ) f,C0035648;C1455761;C0630906;C2945760;C1553898,true;false;true;false;false,4654/10465
caucasian eze / simva,C0007457;C0043157,true;true,4655/10465
nmbr - < nmbr mvmin,C0053917;C1334884,true;false,4656/10465
pioglitazone ( n = nmbr  nmbr ),C0071097;C0053917;C1334884,true;true;false,4657/10465
time from onset to medication  h  mean ± sd,C0449244,false,4658/10465
baseline insulin daily dose / kg,C0168634;C0366513;C0332173;C0022718;C0439209;C4054209;C0021641;C2348070;C1533581;C1579433;C3714501;C1442488,true;false;false;true;false;false;true;false;false;false;false;false,4659/10465
mean — ml / min / nmbr . nmbr mnmbr of body - surface area,C0444504;C1641597;C0053917;C0242821;C0460148;C1268086;C4082212;C1334884;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false,4660/10465
telmisartan group ( n = nmbr ),C0248719;C0441848;C0053917;C1334884,true;false;true;false,4661/10465
total cholesterol ( mmo nmbr / nmbr ),C0201950;C0053917;C1334884;C0543421,false;true;false;false,4662/10465
african - latin american,C0085756,true,4663/10465
more than nmbr lesions per vessel,C0205172;C0053917;C0221198;C1334884,false;true;false;false,4664/10465
fpg  mg / dl ( mmol / l ),C0439269;C1532563,false;false,4665/10465
> = nmbr % and < nmbr % ( > = nmbrand < nmbr mmol / mol ),C0053917;C1334884,true;false,4666/10465
no . of events / total no . ( % ),C0441471;C3541888,false;false,4667/10465
ind nmbr mg q . d . n = nmbr,C4049864;C0053917;C0439422;C1334884,false;true;false;false,4668/10465
smoking history : ex - smoker,C1519384;C0337664,false;true,4669/10465
troponin level,C0041199;C0441889;C0456079;C1547707;C2946261,true;false;false;false;false,4670/10465
duration of copd — days^,C0449238;C0024117;C0439228;C1412502;C3714496;C2926735,false;true;false;false;false;false,4671/10465
other antiplatelet agents  n ( % ),C0085826,true,4672/10465
thienopyridine at randomization,C1120149;C0034656,true;true,4673/10465
bmi ( kg / mnmbr ) cardiovascular history,C0578022;C0022718;C1880008;C0439209;C4054209,false;true;false;false;false,4674/10465
controllednmbr — no . ( % ),,,4675/10465
sulfonylurea derivatives,C0038766,true,4676/10465
score nmbr - nmbr,C0449820;C0053917;C1334884;C4050231,false;true;false;false,4677/10465
radial access site,C0442038;C0589360;C0920847,false;false;false,4678/10465
use of parenteral antithrombotic agents — no . ( % ),C1524063;C0030547;C1704311;C4522267,false;true;true;false,4679/10465
immunosuppressant ( with or without corticosteroid ),C0021081,true,4680/10465
ml with st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,4681/10465
remission in overall population,C0544452;C0282416;C0032659;C1257890;C1561607;C0687702,false;true;true;true;false;false,4682/10465
v / hctz,C0020261,true,4683/10465
pulse ( beats / min ) cholesterol ( mmol / l ),C0232117;C0391850;C1947910,true;false;false,4684/10465
number of participants,C0237753;C0679646;C0449788,false;false;false,4685/10465
beta - carotene,C0053396;C0696105,true;false,4686/10465
hemispheric stroke n = nmbr,C0205139;C0038454;C0053917;C1334884;C4554100,false;true;true;false;false,4687/10465
pci for index mi ( % ),C4049621;C0600653;C3810814;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false,4688/10465
absolute fvc decrease > nmbr %,C0205344;C3714541;C0392756;C0053917;C1334884;C0547047,false;true;false;true;false;false,4689/10465
hemoglobin ( gl ' ),C0019046;C0018229;C1423073;C1427674,true;true;false;false,4690/10465
low ( nmbr - nmbr ) ( n = nmbr  nmbr  nmbr % ),C0205251;C0053917;C1334884;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false,4691/10465
> nmbr % and < nmbr % predicted arr ( n = nmbr  nmbr ),C0053917;C1334884,true;false,4692/10465
duration from hospital admission to pci  h ( median  iqr ),C0449238;C0019994;C1959907;C1510665;C2926735,false;true;false;false;false,4693/10465
prednisone,C0032952,true,4694/10465
enalapril dm = nmbr non - dm = nmbr,C0014025;C0011816;C0053917;C1518422;C1334884;C3250443,true;true;true;false;false;false,4695/10465
entire cohort,C0439751;C0009247;C0599755;C0444667,false;true;false;false,4696/10465
intravenous loop diuretics !,C0348016;C0354100,false;true,4697/10465
peripheral revascularization,C0205100;C0581603,false;false,4698/10465
no ischemia ( n = nmbr  nmbr ),C0022116;C0053917;C1334884;C4321499,true;true;false;false,4699/10465
fp / sal nmbr / nmbr pg ( n = nmbr ),C0016704;C0036140;C0053917;C0030827;C0072225;C1266240;C1334884;C0037494;C0206136;C1419068;C1419906;C3541238;C3541412,true;true;true;true;true;false;false;true;true;false;false;false;false,4700/10465
antithrombotic use,C0042153;C0457083;C1947944,true;false;false,4701/10465
p lace of randomization ( interaction : p = nmbr . nmbr ),C0369773;C0280109;C0034656;C1704675;C0053917;C1334884;C0453991;C2603361,false;false;true;false;true;false;false;false,4702/10465
km event rate ( % ),C3887676;C0441471;C0871208;C1521828;C4019010,false;false;false;false;false,4703/10465
revascularisation + antiplatelets + lipid - lowering agents + p blockers,C0581603;C0086440,false;true,4704/10465
betanmbr selective,,,4705/10465
iii and iv ejection fraction,C0439070;C1705160,false;false,4706/10465
antiarrhythmic drug,C0003195;C0301380,true;false,4707/10465
median time since diagnosis * ( range )  yr,C0549183;C0040223;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,4708/10465
bmi  kg / mnmbr uac  no . ( % ),C0578022;C0022718;C0439209;C4054209,false;true;false;false,4709/10465
high - density lipoprotein cholesterol  mean ( sd )  mmol / l,C0023822;C0444504;C2699239;C1532563;C2347634;C2348143,true;false;false;false;false;false,4710/10465
serum potassium ( mmol / l ),C0302353;C1532563;C0543465,false;false;false,4711/10465
gissi prevention nmbr / nmbr - nmbr / nmbr,C0199176;C0053917;C1334884;C1706420;C2700409,false;true;false;false;true,4712/10465
nyha class nmbr or higher,C1882083;C0053917;C1334884,false;true;false,4713/10465
concomitant medication — no . ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,4714/10465
history of major cardiovascular disease  n ( % ),C0455539;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false,4715/10465
versus tiotropium nmbr pg,,,4716/10465
nyha functional class at screening,C1882083;C0205245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0542341;C2700217,false;false;true;true;false;false;false;false;false;false;false,4717/10465
time from most recent qualifying,C0040223;C0332185;C1514624;C3541383,true;false;false;false,4718/10465
use of loop diuretics  n ( % ),C1524063;C0354100,false;true,4719/10465
glycemia  mg / dl,C0005802;C0439269,true;false,4720/10465
duration of asthma  years,C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,4721/10465
bisphosphonates,C0012544;C3541401,true;false,4722/10465
cardiovascular disease history,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,4723/10465
no pci or cabg — no . ( % ),C4049621,false,4724/10465
any statin ( with / without llt ),C0360714,true,4725/10465
associated with drug / toxin,C0332281;C0013221,false;true,4726/10465
non - diabetic patients,C1829939;C0241863,false;false,4727/10465
baseline hbanmbrc in nmbr classes,C0168634;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1442488,true;true;false;false;false;false;false;false,4728/10465
coronary artery disease — no . ( % ) : ! :,C0010054;C0010068;C1956346,true;true;true,4729/10465
patients with egfr nmbr > nmbr to < nmbr ml / min / nmbr . nmbrmnmbr  n,C0030705;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;true;false;false;false;false,4730/10465
baseline corticosteroidst ( mean dose : nmbr . nmbr mg / day )  n ( % ),C0168634;C0444504;C0178602;C0053917;C0439422;C1334884;C0869039;C1114758;C2347634;C2348143;C1442488,true;false;false;true;false;false;false;false;false;false;false,4731/10465
vka  only reason,,,4732/10465
reported in ecrf,C0684224;C4551412;C0700287;C4319718,true;false;false;false,4733/10465
evidence or thombus  n ( % ),C3887511,false,4734/10465
prior aortocoronary bypass surgery 一 no . ( % ),C0455610;C0010055,false;true,4735/10465
regional anaesthesia,C0002911,true,4736/10465
events / n,C0441471;C3541888,false;false,4737/10465
anti - coagulants - no . ( % ),C0848112,false,4738/10465
other antihypertensive,C0003364,true,4739/10465
thrombus - containing lesion,C0087086;C0332256;C0221198;C1546698;C2700400;C0302148;C3146237,true;false;false;false;false;false;false,4740/10465
sgrq total score ( week,C2964552;C0332174;C0439230,false;false;false,4741/10465
americas ( n = nmbr ),C0002454;C0053917;C1334884;C0596070,true;true;false;false,4742/10465
placebo - adjusted mean difference in % hbanmbrc ( nmbr % ci  [ p value] ),C0032042;C1696465;C1706408,true;false;false,4743/10465
serum total cholesterol ( mmol / l )  mean ( sd ),C0587184;C1532563;C0444504;C2699239;C2347634;C2348143;C1287371,false;false;false;false;false;false;false,4744/10465
creatinine level,C0428279,false,4745/10465
heart rate  mean ( sd ) [range]  beats / min,C0018810;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,true;false;false;false;false;false;false;false,4746/10465
cv death / mi / stroke / ucr,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,4747/10465
irbesartan,C0288171,true,4748/10465
time from acs to randomization,C0040223;C0742343;C4318612;C3541383,true;true;false;false,4749/10465
time intervals  h,C0872291;C0033727;C0369286;C0441932;C0564385;C4528284,false;true;false;false;false;false,4750/10465
history of stroke or tia,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4751/10465
medications at timing of randomization  n ( % ),C2359859;C0034656,false;true,4752/10465
cv death or hf hospitalization n,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,4753/10465
cvd events,C0007222;C0441471;C3541888,true;false;false,4754/10465
nmbr - point mace,C0053917;C1552961;C0349381;C0949745;C1445339;C2347617;C3714763;C1334884,true;false;false;true;false;false;false;false,4755/10465
low - dose aspirin use,C2608320;C0042153;C0457083;C1947944,false;true;false;false,4756/10465
moderate / severe exacerbations  itt population  n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4757/10465
lp ( a ) §,C0065058;C1439335;C4553379,true;false;false,4758/10465
hbanmbrc levels,C0441889,false,4759/10465
weekly,C0332174,false,4760/10465
> nmbr ( high risk ),C0053917;C1334884,true;false,4761/10465
percentage of time in therapeutic inr range  mean ( sd ),C0439165;C0040223;C3541383;C1549488;C1561533,false;true;false;false;false,4762/10465
> nmbr prior myocardial infarction — no . ( % ),C0053917;C0155668;C1334884,true;false;false,4763/10465
threatened abrupt vessel closure,C1276802;C0005847;C0185003;C1521802,false;true;false;false,4764/10465
prior therapy  %,C1514463,false,4765/10465
duration of pci ( min )  median n ( iqr ),C0449238;C4049621;C0702093;C0549183;C0876920;C2347635;C2348144;C2939193;C1524029;C3813700;C2926735,false;false;false;false;false;false;false;false;false;false;false,4766/10465
age > nmbr y  n ( % ),C0001779;C0053917;C1334884,false;true;false,4767/10465
van der heijde mtss  mean ( sd ),C0557775;C1511780;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,4768/10465
form / bud,C0348078;C2700462;C2945744;C0376315;C1522492;C4255237,false;false;false;true;false;false,4769/10465
no . of patients ind / gly sfc,C0030705;C4049864;C0017890;C4521536;C0523677,true;false;true;false;false,4770/10465
missing hb at yr nmbr,C1551393;C0019046;C0439234;C0053917;C1334884;C1705492;C3272743,false;true;false;true;false;false;false,4771/10465
within nmbr h after,C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,4772/10465
left ventricular ejection fraction < nmbr %,C0428772;C0053917;C1334884;C0488728,false;true;false;false,4773/10465
mestizos,C0682082,false,4774/10465
ankle - brachial index < nmbr . nmbr,C1328319;C0053917;C1334884;C3888326,true;true;false;false,4775/10465
p - value ( anova ),C1709380;C0753802,false;true,4776/10465
patients with > nmbr exacerbations resulting in emergency department visit,C0030705;C0053917;C4086268;C1334884,true;true;false;false,4777/10465
difference in change,C1705241;C0392747;C0443172;C4319952;C1705242,false;false;false;false;false,4778/10465
established atherosclerotic cardiovascular disease,C0443211;C0004153;C1272684,false;true;false,4779/10465
other vascular disease,C0042373,true,4780/10465
black race and ss > nmbr ( n = nmbr vs nmbr ),C0005680,true,4781/10465
qualifying mi : stemi,C1514624;C3810814;C1536220;C3538872,false;false;true;false,4782/10465
coenzyme qnmbr,C0009235,true,4783/10465
history of a transient ischaemic attack,C0455536,false,4784/10465
known tiromtcch * c ccndifeon,C0205309,false,4785/10465
total patients,C0439175;C0030705;C0439810,false;true;false,4786/10465
periprocedural medications  n ( % ) clopidogrel  nmbr mg *,C0013227;C0070166;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0802604;C2598133;C4284232,true;true;true;true;true;false;false;false;false;false;false;false;false;false,4787/10465
swollen joint count ( nmbr - nmbr possible joints ),C0451521;C0053917;C0332149;C1705910;C2362652;C1334884,false;true;false;false;false;false,4788/10465
prior amputation,C0332152;C0002688;C0332840;C1546539;C2826257,false;true;false;false;false,4789/10465
weight  kg  median ( range ),C0005910;C0022718;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;false;false;false;true;false;false,4790/10465
arterial area ( mmnmbr ),C0003842;C0017446;C0205146;C0221464,true;true;false;false,4791/10465
statin + fibrate or,C0360714,true,4792/10465
presence of enthesitis  n ( % ),C0150312;C1282952;C0392148;C3854307,false;false;false;false,4793/10465
nyha class ( when patient was last in stable condition before admission )  %,C1882083,false,4794/10465
history of second prior mi  n ( % ),C0019664;C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;false;false;true;false;false;false;false,4795/10465
ischaemic ( n = nmbrlnmbr ),C0475224,false,4796/10465
sbp > nmbr mmhg and / or dbp > nmbr mmhg,C0085805;C0053917;C0439475;C1334884,true;true;false;false,4797/10465
caucasian  n ( % ),C0007457;C0043157,true;true,4798/10465
use of cardiac medication *,C1524063;C0018787;C0013227;C3244316;C4284232;C1522601,false;true;true;false;false;false,4799/10465
pioglitazone ( n = nmbr ),C0071097;C0053917;C1334884,true;true;false,4800/10465
hdl cholesterol < nmbr ( men ) or < nmbr mg / dl ( women ),C0023822;C0053917;C0025266;C1334884;C0392885,true;true;true;false;false,4801/10465
cardiac valvular disease,C0018824,true,4802/10465
randomized to receive vitamin e,C0034656;C3815594,true;false,4803/10465
indication for index procedure,C2315323;C0600653;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false,4804/10465
total c ( mmol / l  mean ),C0439175;C1532563;C0444504;C2347634;C2348143;C0439810,false;false;false;false;false;false,4805/10465
left ventricular ejection fraction — %,C0428772;C0488728,false;false,4806/10465
non - reversible ( % ),C1518422;C0205343,false;false,4807/10465
peripheral neuropathy,C0031117,true,4808/10465
acuity major,C0750509,false,4809/10465
standard therapyy ( n = nmbr ),C1442989;C0053917;C1334884;C2828392,false;true;false;false,4810/10465
acqnmbr score,C0449820;C4050231,false;false,4811/10465
baseline cardiovascular disease,C0168634;C0007222;C1442488,true;true;false,4812/10465
myalgia,C0231528;C4552646,true;false,4813/10465
time since as diagnosis  mean ( sd ) years,C0040223;C3541383,true;false,4814/10465
albumin / creatinine ratio - mg / mmol  median ( iqr ),C0486293;C0567349;C0549183;C0876920;C2347635;C2348144;C2939193;C2348885;C1318293,false;false;false;false;false;false;false;false;false,4815/10465
change in dasnmbr - esr ( mean ) i physical function outcomes week nmbr,C0392747;C3811131;C0444504;C0021966;C0516981;C1274040;C0332174;C0053917;C1334884;C0439230;C4049916;C0221138;C2347634;C2348143;C0443172;C1705241;C4319952,false;false;false;true;false;false;false;true;false;false;false;false;false;false;false;false;false,4816/10465
venous insufficiency,C0042485,true,4817/10465
pdqol scale,C0175659;C0349674;C1947916,true;false;false,4818/10465
baseline nmbr - asa,C0168634;C0053917;C0004057;C3853627;C1334884;C1442488,true;true;true;false;false;false,4819/10465
current medication  n ( % ),C0746467,false,4820/10465
baseline pulmonary medication,C0168634;C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false,4821/10465
median ( range ),C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4822/10465
mean ( sd ) aqlq,C0444504;C2699239;C4055434;C2347634;C2348143,false;false;false;false;false,4823/10465
humerus fracture,C0020162,true,4824/10465
high - density lipoprotein cholesterol tx difference vs pbo  ls mean % change from baseline ( se ),C0023822;C0041403;C1705241;C1705242,true;true;false;false,4825/10465
clopidogrel pretreatment duration,C0070166;C1550147;C0449238;C2926735;C2709094;C3539075;C3539076,true;false;false;false;false;false;false,4826/10465
lower than normal range — % ^,C0441994;C0086715;C1548802;C2003888,false;true;false;false,4827/10465
months ( log - transformed ),C0439231,false,4828/10465
saba reversibility,C0449261,false,4829/10465
previous stroke or tia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,4830/10465
high disease activity : > nmbr . nmbr  n ( % ),C4699623;C0012634;C0053917;C1334884;C0205250;C1292728;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;false;false;false;false;false;false;false;false;false,4831/10465
alcohol use ( % ),C0001948,true,4832/10465
americas  excluding us,C0002454;C0596070,true;false,4833/10465
acitretin,C0050559,true,4834/10465
stratification variables,C1514983;C0439828,false;false,4835/10465
factor v leiden or prothrombin mutation,C0380964;C0584960;C1414509;C3542419,true;false;false;false,4836/10465
simplified disease activity index score,C3869582;C0449820;C4050231,false;false;false,4837/10465
diabetic kidney disease,C0011881,true,4838/10465
prior coronary artery disease yes,C0332152;C0010054;C1549445;C1705108;C1710701;C0010068;C1956346;C2826257,false;true;false;false;false;true;true;false,4839/10465
intravenous nitrates,C0348016;C0028125,false;true,4840/10465
toast classification,C1710306;C4521230,false;false,4841/10465
£ nmbr . nmbr % * *,C0053917;C1334884,true;false,4842/10465
yes previous revascularization,C1549445;C0205156;C0581603;C1552607;C1705108;C1710701,false;false;false;false;false;false,4843/10465
no . / nmbr person - yr,C0053917;C0027361;C0439234;C2347489;C1334884,true;true;false;false;false,4844/10465
p - blocker intake at randomisation ( n = nmbro ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,4845/10465
> l : nmbrhrs : min ( n = nmbr ),C0439393;C0053917;C1334884,false;true;false,4846/10465
oral glucocorticoid use at baseline — no . ( % ) : t,C1527415;C0017710;C0168634;C1442488,false;true;true;false,4847/10465
adjusted mean change,C0456081;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false,4848/10465
age at completion of highest level of,C0001779;C0205197;C4321237;C1554962,false;false;false;false,4849/10465
age group 一 ％,C0027362;C2348001,true;false,4850/10465
combined macro + micro,C0205195;C2984010;C0085672;C1553035;C3811161;C4049106,false;false;false;false;false;false,4851/10465
race / ethnicity chinese,C0034510;C0015031;C0008120;C0152035;C0243103;C1706779;C3853635,true;true;false;true;true;false;false,4852/10465
history of more than nmbr prior mi ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,4853/10465
physical activity §,C0015259;C0026606,true;true,4854/10465
systolic blood pressure  mm hg < nmbr,C0488055;C0439475;C0053917;C1334884;C0871470;C1306620,false;false;true;false;true;false,4855/10465
diagnoses / risk factors  n ( % ),C0011900;C0035648;C1553898,true;true;false,4856/10465
medication effects,C1319171,false,4857/10465
insulin glargine,C0907402,true,4858/10465
mean age  years ( sd ),C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,4859/10465
diuretic thiazide,C0012802,true,4860/10465
paclitaxel,C0144576,true,4861/10465
total back pain  mean ( sd ),C0439175;C0004604;C0444504;C2699239;C2347634;C2348143;C1963071;C4553945;C0439810,false;true;false;false;false;false;false;false;false,4862/10465
previous intolerance of infliximab  n ( % ) *,C0205156;C0231199;C0666743;C1744706;C2355652;C1552607,false;false;true;false;false;false,4863/10465
uae ( p  g / min ),C1519789;C0560021,false;false,4864/10465
any statin versus no statin at randomization,C0360714,true,4865/10465
adalimumab group ( n = nmbr ) t,C1122087;C0036669;C0053917;C1334884,true;true;true;false,4866/10465
hgb  g / dl < nmbr men  < nmbr women,C0019029;C0439267;C0053917;C0025266;C0043210;C1334884;C0019046;C0518015;C1424337,false;false;true;true;true;false;true;false;false,4867/10465
fracture during follow - up,C0016658;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,4868/10465
biguanides,C0005382;C0360396;C3540012,true;false;false,4869/10465
> nmbr . nmbr kg / mnmbr hypertension :,C0053917;C0022718;C0020538;C1963138;C0439209;C4054209;C1334884,true;true;true;false;false;false;false,4870/10465
values are expressed as percentages unless otherwise indicated . bmi  body mass index  cabg  coronary artery bypass ischemic attack  nsaids  nonsteroidal anti - inflammatory drugs  sbp  systolic bp  dbp  diastolic bp . * history of or currently taking antidiabetic or lipid - lowering medications .,C0042295,false,4871/10465
aminosalicylates,C0368663,false,4872/10465
prediabetes — no . ( % ) nmbr,C0362046,true,4873/10465
history of pci with stenting,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,4874/10465
brain volume  cmnmbr,C1113695,false,4875/10465
swollen joint count ( nmbr - nmbr ),C0451521;C0053917;C1334884,false;true;false,4876/10465
no . of strokes ( % ),C0038454,true,4877/10465
demographic and medical variables,C0011298,true,4878/10465
australia / nz,C0004340;C0027978,true;true,4879/10465
no . of events / patients,C0441471;C0030705;C3541888,false;true;false,4880/10465
chd history  n ( % ),C0280604;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3542407,false;true;true;false;false;false;false;false,4881/10465
jsn score ( nmbr - nmbr ),C0449820;C0053917;C1334884;C4050231,false;true;false;false,4882/10465
ascvdor > nmbr cv risk factors,C0053917;C3538987;C0035648;C1553898;C4048877;C4318503;C1334884,true;false;true;false;true;false;false,4883/10465
previous transient ischemic attack,C0205156;C0007787;C0917805;C1552607,false;true;true;false,4884/10465
number of stent = l or nmbr or nmbr,C0237753;C0038257;C0449788,false;true;false,4885/10465
ischemic stroke with hemnrrhnaic cnnversinn,C0948008,false,4886/10465
chronic stable angina,C0340288,true,4887/10465
fenofibric acid + low - dose statin,C0060179;C0445550;C0360714;C1708745,true;false;true;false,4888/10465
daily iglar dose at week nmbr ( u ),C2348070;C0053917;C0560588;C1334884,false;true;false;false,4889/10465
anticholinergic,C0242896;C3537004,true;false,4890/10465
contrast volume,C0009924;C0449468;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false,4891/10465
rituximab ( nmbrxnmbr mg ) + mtx,C0393022;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,4892/10465
> nmbr mg / dl simva nmbr = nmbr],C0053917;C0439269;C1334884,true;false;false,4893/10465
glucagon - like peptide - nmbr agonist,C0014361;C0053917;C2987634;C1334884,true;true;false;false,4894/10465
acrnmbr response at week nmbr  n ( % ),C0871261;C0332174;C0053917;C1334884;C0439230;C1704632;C1706817;C2911692,false;false;true;false;false;false;false;false,4895/10465
alcohol intake ( + ) ( % ),C0001948,true,4896/10465
# of prior tnfi among non - tnfi naive,C0332152;C1518422;C2826257,false;false;false,4897/10465
remission,C0544452;C0687702,false;false,4898/10465
triglycerides ( median  iqr )  mg / dl,C0041004;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,4899/10465
total antihypertensive use,C0439175;C0003364;C0042153;C0457083;C1947944;C0439810,false;true;true;false;false;false,4900/10465
anmbrc distribution ( % ),C0520511;C1704711,false;true,4901/10465
middle third,C0442050,false,4902/10465
symptom score ( sd ),C3476546;C2699239,false;false,4903/10465
atorvastatin factorial study,C0286651;C2826344,true;false,4904/10465
former / non - drinker,C0205156;C0457801;C0750523,false;false;false,4905/10465
electrocardiographic findings at randomization,C0438154;C0034656,false;true,4906/10465
lumbar spine bmd t - score,C0024091;C0449820;C4050231;C3887615,true;false;false;false,4907/10465
multiple ( nmbr + ) chd risk,C0439064;C0053917;C1282512;C1334884,false;true;false;false,4908/10465
hyperlipidemia  n ( % ),C0020473;C0428465;C4555212,true;false;false,4909/10465
place of randomization,C0442504;C0034656;C1533810;C1704765;C1882509,false;true;false;false;false,4910/10465
beta - blocker % target dose,C0001645;C1521840;C0178602;C0869039;C1114758;C2986546,true;false;false;false;false;false,4911/10465
left circumflex  n ( % ),C0205091;C1880089;C0443246;C1552822,false;false;false;false,4912/10465
ranolazine vs . placebo km failure rate,C0073633,true,4913/10465
biomarker high ( periostin > nmbrng / ml or blood eosinophils > nmbrcells per pl )  na,C0005516;C0205250;C0219433;C0439526;C1705224;C3887665;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,true;false;true;false;false;false;false;false;false;false;false;false;false;false,4914/10465
at or above the median,,,4915/10465
indacaterol - glycopyrronium group ( n = nmbr ),C1722260;C3814772;C0441848;C0053917;C1334884,true;false;false;true;false,4916/10465
infarct on brain imaging 丰,C0751955,true,4917/10465
baseline laboratory values  median ( iqr ) d,C0168634;C0022877;C0042295;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904;C1442488,true;true;false;false;false;false;false;false;false;false;false,4918/10465
timi major or minor bleeding,,,4919/10465
olodaterol nmbr mg ( n = nmbr ),C2934193;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,4920/10465
race / ethnicity white,C0034510;C0015031;C0007457;C0043157;C0220938;C0243103;C1706779;C3853635,true;true;true;true;false;true;false;false,4921/10465
tnfi ( no other bdmard taken ) t  n ( % ),,,4922/10465
patients treated,C0030705,true,4923/10465
distribution time,C0520511;C0040223;C3541383;C1704711,false;true;false;true,4924/10465
previous treatment failure — no . ( % ) § * *,C0205156;C0162643;C0235828;C0521983;C1547544;C1552607,false;true;false;false;false;false,4925/10465
median body weight — kg,C3821165;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0549183;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false;false,4926/10465
raas inhibitor use,C1999216;C0042153;C0457083;C1947944,false;true;false;false,4927/10465
previous cardiovascular event at randomization,C0205156;C1320716;C0034656;C1552607,false;false;true;false,4928/10465
aspirin alone ( n = nmbr ),C0004057;C0205171;C0053917;C1334884;C0439044;C0679994,true;false;true;false;false;false,4929/10465
wml load at baseline mri,C1550025;C0168634;C0024485;C1824234;C3890166;C1442488;C1704782;C1708715,false;true;true;false;false;false;false;false,4930/10465
clopidogrel plus aspirin,C0070166;C0332287;C0004057,true;false;true,4931/10465
alanine aminotransferase or aspartate aminotransferase > nmbrx upper limit of normal ( n = nmbr ),C0001899;C0057041;C1415274;C3887708,true;true;false;false,4932/10465
non - endstage renal dysfunction *,C1518422;C0205088;C1565489;C3279454,false;false;true;false,4933/10465
active inflammatory bowel disease,C0205177;C0021390;C3853793;C3888249,false;true;false;false,4934/10465
current alcohol use — no . / total no . ( % ),C0521116;C0001962;C0001975;C1705970,false;true;true;false,4935/10465
complex partial ( ib ),C0439855;C0728938;C2744579;C3890035;C4283819;C1550516;C1704241,false;false;true;false;false;false;false,4936/10465
saxagliptin ( n = nmbr  nmbr ),C1611934;C0053917;C1334884,true;true;false,4937/10465
low subgroup,C0205251;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,4938/10465
high - dose statin pretreatment ( n = nmbr ),C0444956;C0360714;C1550147;C0053917;C1334884;C2709094;C3539075;C3539076,false;true;false;true;false;false;false;false,4939/10465
common study baseline,C0205214;C0557651;C0168634;C1442488;C2603343;C1522138;C3245511,false;false;true;false;false;false;false,4940/10465
lm bifurcation treated,C1261082;C0184906;C3146289;C1551056,false;false;false;false,4941/10465
renal impairment  n ( % ),C1565489,true,4942/10465
> nmbr failure,C0053917;C0231174;C0680095;C1334884,true;false;false;false,4943/10465
coronary revascularization procedure,C0877341,false,4944/10465
intensified baseline ( n - nmbr ),C0168634;C0053917;C1334884;C1442488,true;true;false;false,4945/10465
time from onset of qualifying stroke to randomization,C0449244;C1514624;C0038454;C4554100,false;false;true;false,4946/10465
statin non - users ( n = nmbr ),C0360714;C1518422;C1706077;C0053917;C1334884,true;false;false;true;false,4947/10465
barc nmbr - nmbr,C0053917;C1334884,true;false,4948/10465
laba use  % patients,C0042153;C0030705;C0457083;C1947944,true;true;false;false,4949/10465
enoxaparin ( n = nmbr ),C0206460;C0053917;C1334884,true;true;false,4950/10465
who / idf impaired fasting glucose,C1272092,false,4951/10465
dip involvement  ! n ( % ),C3539618;C1314939,false;false,4952/10465
copd severity ( gold nmbr ),C0024117;C0439793;C0018026;C0053917;C1334884;C1304897;C0522510;C1412502;C3714496,true;false;true;true;false;false;false;false;false,4953/10465
erosion score ( nmbr - nmbr ),C0333307;C0449820;C0053917;C1334884;C4050231;C1880549;C1959609;C3887524,false;false;true;false;false;false;false;false,4954/10465
st - segment depression > nmbr . nmbr mv,C0520887;C0053917;C1454484;C1705503;C4281602;C1334884,false;true;true;false;false;false,4955/10465
fasting tgs §,C0015663;C1156212;C1537574,true;false;false,4956/10465
total cataract extraction,C3665439;C0185115;C0684295;C0439175;C0007389;C0439810,false;false;false;false;true;false,4957/10465
nmbr mg / day early - start,C0053917;C0439422;C1334884,true;false;false,4958/10465
nmbr - nmbr with cv risk but not disease ( n = nmbr ),C0053917;C3538987;C0035647;C4552904;C4048877;C4318503;C1334884,true;false;true;false;true;false;false,4959/10465
oral treprostinil ( n = nmbr ),C0442027;C1145760;C0053917;C1334884;C4521986,false;true;true;false;false,4960/10465
acute ( < nmbr hr ),C0205178;C0053917;C1334884,false;true;false,4961/10465
total ldl - c *,C0439175;C0439810,false;false,4962/10465
obese patients  ! n ( % ),C0028754;C0030705,true;true,4963/10465
baseline aspirin dose < nmbr mg,C0168634;C4696290;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1442488,true;false;true;true;true;false;false;false;false;false;false;false,4964/10465
immunologic,C0152036;C0205470,true;false,4965/10465
high - dose aspirin,C0444956;C0004057,false;true,4966/10465
a - glucosidase inhibitor,C1512211,false,4967/10465
history of stroke  n ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4968/10465
crusade bleeding score,C0019080;C0449820;C4050231,true;false;false,4969/10465
% with haq - di decrease > nmbr . nmbr,C3826998;C0392756;C0053917;C1334884;C0547047;C4321476,false;false;true;false;false;false,4970/10465
= nmbr ’ ),C0053917;C1334884,true;false,4971/10465
simple partial ( ia ),C0205352;C0728938;C0020980;C0694634;C1947960;C1550516,false;false;true;false;false;false,4972/10465
monitoring ( n = nmbr ),C0150369;C0053917;C1334884;C1283169,false;true;false;false,4973/10465
crp median ( se )  rng / l,C3890735;C0549183;C0036919;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;true;false;false;false;false;false,4974/10465
no . of previous venous thromboembolic events,C0205156;C1861172;C1997614;C3160733;C1552607,false;true;false;false;false,4975/10465
d / mi / idr / st,C0073187;C3810814;C0036056;C3272372;C0332173;C4484261,true;false;true;false;false;false,4976/10465
smoking ( % ) laboratory parameters,C0037369;C0022877;C0449381;C3244292;C4283904;C0453996;C1881674,true;true;false;false;false;true;false,4977/10465
female sex  n ( % ) race  n ( % ),C0086287;C0034510;C1706779;C3853635,true;true;false;false,4978/10465
hypertension  treated,C0020538;C1963138,true;false,4979/10465
no . in the nmbr mo before screening,C0053917;C0026544;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0332177;C1334884,true;true;true;true;false;false;false;false;false;false;false,4980/10465
severity of copd  n ( % ) *,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4981/10465
reduced ef,C0392756,false,4982/10465
disease duration  years : median ( range ),C0872146;C0439234;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,4983/10465
absent ( < nmbr mg / dl ),C0332197;C0053917;C0439269;C1334884;C4285062,false;true;false;false;false,4984/10465
sgrq total score * *,C2964552,false,4985/10465
black race  n ( % ),C0005680,true,4986/10465
indication for index pci,C0392360;C0600653;C4049621;C0918012;C1552854;C1637833;C2986546;C3146298,false;true;false;true;false;false;false;false,4987/10465
forearm fracture,C1305215,false,4988/10465
clinical copd phenotype^,C0205210;C0024117;C0031437;C1285572;C1412502;C3714496,false;true;true;false;false;false,4989/10465
symptoms and feelings,C0683368;C1457887,true;false,4990/10465
extent of index event,C0439792;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,4991/10465
gold stage — no . ( % ) * *,C0018026;C1304897,true;false,4992/10465
drugs used in diabetes,C0013227;C3687832,true;false,4993/10465
baseline short - acting anticholinergics  n ( % ),C0168634;C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002;C1442488,true;false;true;true;false;false;false;true;false;false;false;false;false,4994/10465
stent plus medical therapy,C0038257;C0418981,true;false,4995/10465
significant worsening in kccq clinical score ( > nmbr ) at nmbr monthsnmbr,C0332271;C3476798;C2826293;C0449820;C0053917;C1334884;C4050231;C1457868;C1546960;C0237881;C0205210;C0750502;C1546944,false;false;false;false;true;false;false;false;false;false;false;false;false,4996/10465
diet + pravastatin,C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,4997/10465
doubling of serum creatinine,C0205173;C0201976;C0600061;C1705764,false;false;false;false,4998/10465
before index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,4999/10465
global ischemia ( % ) * *,C0205246;C0022116;C4321499;C2348867,false;true;false;false,5000/10465
il - nmbr  ng / l,C0020898;C0053917;C0439297;C1334884;C0021764;C0022271,true;true;false;false;true;true,5001/10465
> nmbr . nmbr to < nmbr . nmbr mu / l $ mmol / l,C0053917;C0439342;C0439190;C1334884,true;false;false;false,5002/10465
glycoprotein llb / llla inhibitors,C0017968;C0243077,true;true,5003/10465
statin intolerancenmbr  n ( % ),C0360714,true,5004/10465
ccsc at nmbr month before enrollment,C1516705;C0053917;C0332177;C0439231;C1334884,false;true;false;false;false,5005/10465
fevi aucnmbr - nmbrl,C0429706;C0849974;C1561566;C4528367,false;false;false;false,5006/10465
total  adjusted weight of nmbr . nmbr for gastrointestinal bleeding,C0439175;C0456081;C0005910;C0053917;C1334884;C0043100;C1305866;C1705104;C0439810,false;false;true;true;false;true;false;false;false,5007/10465
indacaterol n = nmbr,C1722260;C0053917;C1334884,true;true;false,5008/10465
cv risk factors  % of patients,C3538987;C0035648;C0030705;C1553898;C4048877;C4318503,false;true;true;false;true;false,5009/10465
egfr  median ( sd )  ml / min,C1739039;C0549183;C2699239;C0439445;C0876920;C2347635;C2348144;C2939193;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,5010/10465
% rf +,C0035448;C0201660;C0748398;C1547111,true;false;false;false,5011/10465
moderate or severe copd exacerbations,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,5012/10465
beta - blocker use at randomization,C0001645;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,5013/10465
hscrp > nmbr mg / l,C0053917;C0439268;C1334884,true;false;false,5014/10465
exacerbation rate in the previous year ( range ),C4086268;C0871208;C0205156;C0439234;C1514721;C2348147;C3542016;C0439508;C1552607;C1521828,false;false;false;false;false;false;false;false;false;false,5015/10465
bdp / ff / g ( n = nmbr ),C0004906;C4554348;C0439267;C0053917;C1334884;C1422585;C1538710,true;false;false;true;false;false;false,5016/10465
high density lipoprotein ( mg / dl ),C0023821;C0439269,true;false,5017/10465
dose ( n ),C0178602;C0869039;C1114758,false;false;false,5018/10465
hormone replacement therapy,C0282402,true,5019/10465
europe ( eu ),C0015176;C0015179;C3665627,true;true;false,5020/10465
events / statin group,C0441471;C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888,false;true;false;false;true;false;false;false;false,5021/10465
site of disease — no . ( % ),C2945843;C0012634,false;true,5022/10465
proximal - mainleft,C0205107;C4489236,false;false,5023/10465
pharmaco - invasive n = nmbr,C0205281;C0053917;C1334884;C1334278,false;true;false;false,5024/10465
nmbr % c . i .,C0053917;C0021966;C0221138;C1334884,true;true;false;false,5025/10465
metformin : no / yes  %,C0025598,true,5026/10465
laba or lamab n = nmbr,,,5027/10465
physical role,C0031809;C0035820;C1705810;C3871154;C0205485;C1509143,true;true;false;false;false;false,5028/10465
colorectal cancer,C0009402;C0346629;C1527249;C2984278;C3542412,true;false;true;false;false,5029/10465
estimated odds ratio,C0750572;C0028873,false;true,5030/10465
secukinumab intravenous nmbr mg ( n = nmbr ),C3179547;C0348016;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;false;true;true;true;false;false;false;false;false;false,5031/10465
clopidogrel dose,C0070166;C0178602;C0869039;C1114758,true;false;false;false,5032/10465
ex - smoker / smoker  %,C0337671;C4555205,false;true,5033/10465
moderate ( > nmbr to < nmbr ),C0205081;C0053917;C1334884;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,5034/10465
stroke of undetermined cause,C0038454;C0015127;C1524003,true;true;false,5035/10465
screening visit,C0220908;C0545082;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;false;true;false;false;false;false;false,5036/10465
medications before admission,C0013227;C0184666;C0809949;C0802604;C2598133;C4284232,true;false;false;false;false;false,5037/10465
antiplatelet therapy dual,C1096021,false,5038/10465
fenofibric acid nmbr = nmbr,C0060179;C0053917;C1334884,true;true;false,5039/10465
asia / pacific ( % ),C0003980,true,5040/10465
number of patients with fractures,C2360800,false,5041/10465
before amendment ( % ),C0680532;C2346732,false;false,5042/10465
( haq - di  nmbr - nmbr ),C3826998;C0053917;C1334884;C4321476,false;true;false;false,5043/10465
race or ethnic group — no . f,C0034510;C1706779;C3853635,true;false;false,5044/10465
loss of response : ! : : ! :,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,5045/10465
post - bronchodilator fevnmbr — % of predicted value,C2599594;C0681842;C1522609;C1882327,false;false;false;false,5046/10465
medical history duration of heart failure ( years ) primary cause of heart failure,C0199168;C0455531;C0449238;C0439234;C0205225;C0015127;C1524003;C0439612;C0439631;C2926735;C0205476,false;false;false;false;false;true;false;false;false;false;false,5047/10465
major cardiovascular,C0205082;C0007226;C3887460;C0205164;C4318856;C4521762,false;true;false;false;false;false,5048/10465
bmi > nmbr ( % ),C0578022;C0053917;C1334884,false;true;false,5049/10465
high risk ( nmbr - nmbr ),C0332167;C0053917;C1334884;C3272283;C4050568;C4319571,false;true;false;false;false;false,5050/10465
seronegative ( rf - ve and acpa - ve ) subgroup,C0521144;C0035448;C0042469;C3714652;C4321495;C0201660;C0748398;C1547111,false;true;true;false;false;false;false;false,5051/10465
functional outcome ( mrs nmbr - nmbr ),C0205245;C1274040;C1522706;C0053917;C1334884;C2349188;C3714939;C3854213;C0542341;C2700217,false;false;false;true;false;false;false;false;false;false,5052/10465
previous balloon angioplasty,C0205156;C0002996;C0002997;C1552607,false;true;true;false,5053/10465
mean number of exacerbations in previous nmbr months ( sd ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,5054/10465
duration from clopidogrel / placebo to pci  min ( median  iqr ),C0449238;C0070166;C0032042;C1696465;C1706408;C2926735,false;true;true;false;false;false,5055/10465
( ci ) b,C0008107;C3259781,true;false,5056/10465
hispanic ethnic group — no . / total no . ( % ) ‘ j ‘,C0086409;C0015031;C1879937,true;true;false,5057/10465
age  y . o .,C0001779,false,5058/10465
serum triglycerides  mg / dle,C0542495;C0024671;C0024138;C3542918;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;true;false;false;false;false;false,5059/10465
post - acute ischemic stroke,C0687676;C0751956;C0475224;C0205178;C0948008;C1704687;C3469826,false;true;false;false;false;false;false,5060/10465
death / mi / idr / st / gusto - defined moderate or severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,5061/10465
use of rescue albuterol  puffs / day *,C1524063;C0001927;C1533107;C0332173;C0439228;C0439505,false;true;false;false;false;false,5062/10465
intent of conservative strategy  %,C0162425;C0679199;C1283828;C1550453,true;false;false;false,5063/10465
> < nmbr . nmbr  < nmbr . nmbr  r < mmse = mini - mental ,C0053917;C0205090;C0451306;C0684010;C2603358;C1334884,true;false;true;true;false;false,5064/10465
estimated gfr,C0750572;C0017654;C1424601,false;true;false,5065/10465
stenosis > nmbr %,C0678234;C0053917;C1334884;C1261287;C2632116,false;true;false;true;false,5066/10465
nmbr - year rates in placebo groups,C0053917;C0439234;C0871208;C0032042;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1696465;C1706408;C1521828;C0439508;C1334884,true;false;false;true;false;false;true;false;false;false;false;false;false;false;false;false,5067/10465
previously on acei + arb,C3888198,false,5068/10465
peripheral artery disease details,C1704436;C4025272,true;false,5069/10465
egfr ( median  iqr )  ml / min / nmbr  nmbrmnmbr,C1739039;C0549183;C0439445;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C3811844;C3812682,true;false;false;true;false;false;false;false;false;false;false,5070/10465
dipeptidyl peptidase - nmbr inhibitor,C0003015;C0053917;C1334884;C2757044;C3536837,true;true;false;false;false,5071/10465
body mass indexnmbr,C0518010,false,5072/10465
traditional nsaid,C0443324;C0003211;C3536840;C1548559,false;true;false;false,5073/10465
menopausal status and use of ht,C1513126,false,5074/10465
standard care,C1442989;C1947933;C2828392,false;false;false,5075/10465
non - european trial,C1518422;C0239307;C0008976;C1535514,false;false;true;false,5076/10465
patient ' s assessment of pain ( nmbr - nmbr vas ),C0679830;C0042815;C0053917;C1334884,false;true;true;false,5077/10465
tdi total score ( week nmbr,C0205976;C2964552;C0332174;C0053917;C1334884;C0439230;C2674784;C3714807,true;false;false;true;false;false;false;false,5078/10465
p  treatment - by - region interaction,C0369773;C0039798;C0017446;C1704675;C0205147;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2603361,false;true;true;false;false;true;false;false;false;false;false;false,5079/10465
insulin only,C0021641;C0205171;C1720467;C1533581;C1579433;C3714501,true;false;false;false;false;false,5080/10465
catscorecategory  n ( % ),,,5081/10465
anacetrapib ( n = nmbr  nmbr ),C2604745;C0053917;C1334884,true;true;false,5082/10465
control nmbr months ( n - nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,5083/10465
no immomtedion,,,5084/10465
delayed reaction,C0205421;C0443286;C1545665;C3272602,false;false;false;false,5085/10465
disease site — no . of patients ( % ) |,C0012634;C0205145;C1515974;C2825164,true;false;false;false,5086/10465
nmbr . nmbr - < nmbr,C0053917;C1334884,true;false,5087/10465
sgrq total score ( units ) : ! :,C2964552;C0439148;C1519795;C3853603,false;false;false;false,5088/10465
qualifying myocardial infarction,C1514624,false,5089/10465
psoriasis,C0033860,true,5090/10465
no glucocorticoids or immunosuppressants,C0017710;C3540777;C3540778,true;false;false,5091/10465
mean ± s . d . hbanmbrc,C0444504;C2347634;C2348143,false;false;false,5092/10465
time from last dose of pnmbrynmbr inhibitor  days,C0946444;C1999216;C0439228,false;false;false,5093/10465
snmbr gallop  n ( % ),,,5094/10465
any condition,C0012634;C0348080;C1705253;C3864998,true;false;false;false,5095/10465
sitagliptin n = nmbr,C1565750;C0053917;C1334884,true;true;false,5096/10465
mean weight  kg  mean = sd,C0444504;C0005910;C0022718;C2699239;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false;false,5097/10465
abciximab ( n = nmbr ),C0288672;C0053917;C1334884,true;true;false,5098/10465
antiplatelet — no . ( % ),,,5099/10465
ischemic heart disease indicator no ( n = nmbrl ),C0010054;C0021212;C1235732;C1522602;C0151744,true;true;false;false;true,5100/10465
ifg / prediabetes^,C1334085;C0362046;C1708411,false;true;false,5101/10465
no . of target vessels,C0449618,false,5102/10465
adjusted mean ± se ( nmbr % ci ),C0456081;C0444504;C0036919;C0053917;C0008107;C3259781;C1334884;C2347634;C2348143,false;false;true;true;true;false;false;false;false,5103/10465
albuminuria < nmbr gram / gram cr,C0001925;C0053917;C1319635;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337;C1334884,true;true;false;false;false;true;false;false;false;false,5104/10465
nyha lll - iv,C1275491;C1261077;C0022326;C4265176,false;false;true;false,5105/10465
chronic kidney disease  n ( % ),C1561643;C4553188,true;false,5106/10465
patients with fistulas at baseline,C0030705;C0016169,true;true,5107/10465
standard control,C1442989;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2828392,false;true;false;false;false;false;false;false,5108/10465
cvd  mi  stroke  or recurrent ischemia - urgent revascularization,C0007222;C3810814;C0038454;C4554100,true;false;true;false,5109/10465
white race  %,C0007457;C0043157,true;true,5110/10465
> nmbr / tmol / liter — no . ( % ),C0053917;C0475211;C1334884,true;false;false,5111/10465
renin inhibitors,C2917241;C3653375,false;false,5112/10465
not localized,C1518422,false,5113/10465
ischemic stroke without hemorrhagic conversior,C0948008;C0333275;C0475224;C0553692,false;false;false;true,5114/10465
constitutional,C1511487,false,5115/10465
smoking status  n ( % ) former,C1519386,false,5116/10465
crp ( mg / dl ) * *,C3890735;C0439269;C4048285,false;false;false,5117/10465
ularitide ( n = nmbr ),C0077910;C0053917;C1334884,true;true;false,5118/10465
vorapaxar placebo nmbr - yr . km %,C2974521;C0032042;C0053917;C0439234;C3887676;C1334884;C1696465;C1706408,true;true;true;false;false;false;false;false,5119/10465
cv death  ml  ischemic stroke  hosp . for hf  cor . revasc .  ua,C3538987;C0011065;C0439526;C0948008;C0018488;C0018787;C0378365;C0041580;C0042014;C0056331;C1313497;C1538440;C3273279;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;true;true;true;true;true;true;true;false;false;false;false;false;false;false;true;false,5120/10465
prior anti - tnf therapy,C0332152;C0281481;C2826257,false;false;false,5121/10465
reinfarction,,,5122/10465
sgrq total score,C2964552,false,5123/10465
first primary composite outcome,C0205435;C0205225;C0205199;C1274040;C1547335;C0439612;C0439631;C1279901,false;false;false;false;false;false;false;false,5124/10465
score on modified mini - mental state examination — median ( iqr ),C4304091;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5125/10465
hormone replacement,C0282402,true,5126/10465
composite endpoint of doubling of serum creatinine  esrd ,C0205199;C2349179;C0205173;C0201976;C0022661;C0035078;C2316810;C0600061;C1705764;C2826544;C1547335,false;false;false;false;true;true;false;false;false;false;false,5127/10465
exercise ( % ),C0015259;C1522704,true;false,5128/10465
history of ischemic heart disease — no . ( % ),C0683519;C0475224;C0018787;C0730226;C0850708;C0944983,false;false;true;false;false;false,5129/10465
statin therapy,C1278454,false,5130/10465
stratified analyses,C0205363;C0002778;C0936012;C1524024,false;false;false;true,5131/10465
seated sbp at nmbr weeks  mmhg + * *,C0277814;C0085805;C0053917;C0439230;C0439475;C1334884;C1283233,true;true;true;false;false;false;false,5132/10465
former / current smoker  n ( % ),C0337671;C0521116;C1705970;C0205156;C3173209;C3241966;C0750523,false;false;false;false;false;false;false,5133/10465
( sd )  mg / dl,C2699239;C0439269,false;false,5134/10465
primary trial end point,C2986535;C0008976,false;true,5135/10465
fasting blood glucose,C0428568;C1261430,false;false,5136/10465
number ( % ) reporting migraine on nmbr - month questionnaire,C0237753;C0700287;C0149931;C0053917;C0332177;C0034394;C0439231;C1334884;C0449788,false;false;true;true;false;true;false;false;false,5137/10465
concomitant corticosteroid use,C0521115;C0239126,false;false,5138/10465
elevated bun ( > nmbr . nmbr meq / l ),C0151539;C0053917;C0439375;C1334884,false;true;false;false,5139/10465
slowest third,C0439834;C0205437,false;false,5140/10465
clinical features of hf,C0683325;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,5141/10465
tertile nmbr index pci performed,C0053917;C0600653;C4049621;C0918012;C1552854;C1637833;C2986546;C1334884,true;true;false;true;false;false;false;false,5142/10465
risk factor ( predefined ) for falling at screening  n ( % ),C0035648,true,5143/10465
left ventricular dysfunction,C0242698,true,5144/10465
serum cholesterol  mg / dld,C0587184;C0024671;C1414063;C2826331;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;true;false;false;false;false;false,5145/10465
acs treatment,C0742343;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4318612,true;true;true;false;false;false;false;false;false,5146/10465
< nmbr ml / min / nmbr . nmbr mnmbr nt - pro - bnp,C0053917;C0439445;C0669479;C0754710;C1334884,true;false;true;true;false,5147/10465
prednisone use  %,C0032952;C0042153;C0457083;C1947944,true;true;false;false,5148/10465
actual treatment strategy,C0237400;C0039798;C0679199;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;true;false;false;false;false;false,5149/10465
other antiplatelet agent 一 no . ( % ),C0085826,true,5150/10465
% change from baseline ls means ( se ),C0392747;C0168634;C0023668;C1704970;C0036919;C1442488;C0443172;C1705241;C4319952,false;true;true;false;true;false;false;false;false,5151/10465
use of blood pressure lowering medication *,C1524063;C0020649;C0013227;C3244316;C4284232,false;true;true;false;false,5152/10465
multivessel disease 一 no . ( % ),C0012634,true,5153/10465
patients using concurrent tiotropium,C0030705,true,5154/10465
time since copd diagnosis ( yrs ),C0040223;C3541383,true;false,5155/10465
use of medications for pah — no . ( % ),C1524063;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,5156/10465
ace - i or arb use at baseline,C1452534;C0021966;C0221138;C4284014,true;true;false;false,5157/10465
medical history of diabetic retinopathy §,C0262926;C0011884,false;true,5158/10465
anmbr + ez n = nmbr anmbr n = nmbr,C0206578;C0053917;C1334884,true;true;false,5159/10465
anti - tnf - naive patientsnmbr,C1448177,true,5160/10465
total patients  n,C0439175;C0030705;C0439810,false;true;false,5161/10465
heterogeneity test,C0019409;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0242960,false;false;false;false;false;false;false;false;true,5162/10465
infarction  date not reported,C0021308;C0011008;C2348077,true;true;true,5163/10465
rates per nmbr patient - years,C0871208;C0053917;C0030705;C0439234;C1334884;C1521828,false;true;true;false;false;false,5164/10465
% difference  nmbr % ci ),C1705241;C0053917;C0008107;C3259781;C1334884;C1705242,false;true;true;false;false;false,5165/10465
tofacitinib nmbr mg bid,C2930696;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5166/10465
smoking index — pack - yr §,C0037369;C0600653;C1968515;C0439234;C2825051;C2828395;C0918012;C1552854;C1637833;C2986546;C0453996;C1881674,true;true;false;false;false;false;true;false;false;false;true;false,5167/10465
body weight ( kg )  n ( % ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,5168/10465
spironolactone,C0037982,true,5169/10465
non - frail,C1518422;C0871754,false;false,5170/10465
nmbr vitamin e,C0053917;C0042874;C3714803;C1334884,true;true;false;false,5171/10465
low potencyc,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,5172/10465
osteopontin ( ng / ml ),C0069676;C0439275;C1420369;C1505427;C4084879,true;false;false;true;false,5173/10465
pvaluefor any mi versus no mi,,,5174/10465
prerandomization statin therapy,C1278454,false,5175/10465
multivessel cad  n ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5176/10465
glomerular filtration rate §,C0017654;C1561549,true;false,5177/10465
nmbr mg sirukumab every nmbr weeks ( n = nmbr ),C0053917;C0024671;C3254570;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5178/10465
baseline lvef  %,C0168634;C0428772;C0488728;C1442488,true;false;false;false,5179/10465
hypertension ( % ) : t,C0020538;C1963138,true;false,5180/10465
previous loss of response to infliximab  n ( % ) *,C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,false;false;false;false;false;false;false,5181/10465
number of treated vessels,C0237753;C1522326;C0005847;C0449788,false;false;true;false,5182/10465
extracranial carotid stenosis  n ( % ),C0580586;C0007282,false;true,5183/10465
coronary artery disease  n ( % ),C0010054;C0010068;C1956346,true;true;true,5184/10465
telmisartan,C0248719,true,5185/10465
physician,C0031831;C0804815,true;false,5186/10465
black and other,C0005680;C0027567;C0085756;C0439541,true;true;true;false,5187/10465
diclofenac nmbr mg ( n nmbr nmbr )  . . n . . . ( . % . . ) . . . . . . . . . . . . . . . . .,C0012091;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5188/10465
smokers ( at baseline ),C0337664;C0168634;C1442488,true;true;false,5189/10465
baseline use of hormone therapy ( % ),C0168634;C1524063;C0279025;C1442488,true;false;false;false,5190/10465
high hdl - c ( for men ≥ nmbr   mg / dl / for women ≥ nmbr   mg / dl ),C0205250;C3715113;C0025266;C0053917;C0439269;C1334884;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;true;false;false;false;false;false;false;false;false,5191/10465
myocardial infarction or angina,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,5192/10465
exposed ( n = nmbr ),C0332157;C0053917;C1334884,false;true;false,5193/10465
primary composite end point,C2986535;C0205199;C1547335,false;false;false,5194/10465
fasting insulin ( giu / ml ),C0015663;C0021641;C0439526;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false,5195/10465
met criterion at final ( n [ % ] ),C0428210;C0243161;C0205088;C1546485;C3853528;C1550543;C4317104,false;true;false;false;false;false;false,5196/10465
mean ( sd ) bmi ( kg / mnmbr ),C0444504;C2699239;C0578022;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;false;true;false;false;false;false,5197/10465
mean body weight ( sd )  kg,C0444504;C0005910;C2699239;C0022718;C0439209;C4054209;C1305866;C2347634;C2348143,false;true;false;true;false;false;false;false;false,5198/10465
lean ( < nmbr kg / mnmbr ),C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,5199/10465
previous treatment with a laba and / or lama  n ( % ) c,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,5200/10465
new des ( n = nmbr ),C0205314;C0011702;C0053917;C1334884;C4551552,false;true;true;false;true,5201/10465
homa - ir index — median ( iqr ),C0022065;C0600653;C0549183;C0876920;C2347635;C2348144;C2939193;C0918012;C1552854;C1637833;C2986546;C0022071;C1448132,true;true;false;false;false;false;false;true;false;false;false;true;true,5202/10465
timi risk score ( interaction : p = nmbr . nmbr ),C0035647;C0449820;C1704675;C0053917;C1334884;C4050231;C4552904,true;false;false;true;false;false;false,5203/10465
prior use of systemic,C0332152;C1524063;C0205373;C2826257,false;false;false;false,5204/10465
all randomized,,,5205/10465
obesity ( % ) §,C0028754;C1963185,true;false,5206/10465
diabetes therapy,C3274787;C3539002,false;false,5207/10465
balloon angioplasty,C0002996;C0002997,true;true,5208/10465
ibdq domain scores  mean [sd],C1880389;C1883221;C3541951,false;false;false,5209/10465
rosiglitazone ( n = nmbr ),C0289313;C0053917;C1334884,true;true;false,5210/10465
smoking ( ever ),C0037369;C0453996;C1881674,true;true;false,5211/10465
patella fracture,C0159849,false,5212/10465
screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,5213/10465
medical history and risk factors,C0262926;C1704706,false;false,5214/10465
ineffective therapy,C3242229;C0039798;C0087111;C1363945,false;true;true;false,5215/10465
risk group,C0242444,true,5216/10465
hdl - c ( mg / dl ) - mean ± sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,5217/10465
very severe ( gold nmbr ),C3641272;C0018026;C0053917;C1334884;C1304897;C4050419,false;true;true;false;false;false,5218/10465
glycated hemoglobin  n ( % ),C3666909;C0062408,false;true,5219/10465
antihypertensive therapy — no . ( % ),C0585941,false,5220/10465
non - ischaemic cause,C1518422;C0475224;C0015127;C1524003,false;false;true;false,5221/10465
low periostin subgroup (  nmbr ng / ml ) ( n = nmbr ),C0205251;C0219433;C1079230;C0053917;C0439275;C1334884;C1515021;C1424662;C3812270;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;true;false;false;false;false;false;false;false;false;false;false,5222/10465
infarct location — no . / total no . ( % ),C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,5223/10465
enrollment by region  no . ( % ),C1516879;C0017446;C0205147;C1696073;C3888021,false;true;false;false;false,5224/10465
fixed triple ( n = nmbr ),C0443218;C0205174;C0053917;C1334884;C2827483;C3714578,false;false;true;false;false;false,5225/10465
multivessel stenting,C0038257;C2348535,true;false,5226/10465
estimated creatinine clearance < nmbr rmb ' mint,C0750572;C0812399;C0053917;C0452249;C0522467;C1337213;C1576800;C3890003;C1334884,false;false;true;false;true;false;false;false;false,5227/10465
event rate,C0441471;C0871208;C1521828;C4019010,false;false;false;false,5228/10465
fevnmbr  litres ( pre salbutamol )  mean ( sd ),C0475211;C0332152;C0001927;C0444504;C2699239;C2347634;C2348143;C0740175;C2257086;C3669034,false;false;true;false;false;false;false;false;false;false,5229/10465
gpifeellla inhibitor use before angography,C1999216;C0042153;C0457083;C1947944,false;true;false;false,5230/10465
gender  female  n ( % ),C0079399;C0043210;C0086287;C1705497;C1705498;C1522384,true;true;true;false;false;true,5231/10465
latin america or south africa,C0023122,true,5232/10465
patients with complicated events ( p = nmbr - nmbr 十 ),C0030705;C0231242;C0441471;C0053917;C1334884;C3541888,true;false;false;true;false;false,5233/10465
triglycerides $ nmbr mg / dl ( nmbr . nmbr mmol / l ),C0041004;C0053917;C0439269;C1532563;C1334884,true;true;false;false;false,5234/10465
patients with > nmbr exacerbations resulting in ed visit,C0030705;C0053917;C4086268;C1334884,true;true;false;false,5235/10465
use of statins,C1524063;C0360714,false;true,5236/10465
time between cessation of full - dose warfarin therapy and enrollment ( mo ),C1880019;C0682295;C0366686;C0039798;C0087111;C1363945;C0178602;C4303340;C0869039;C1114758,false;false;false;true;true;false;false;false;false;false,5237/10465
egfr nmbr - nmbr,C1739039;C0053917;C1334884;C3811844;C3812682,true;true;false;false;false,5238/10465
egfr > = nmbrml / min / nmbr . nmbrmnmbr n = nmbr  nmbr ( nmbr . nmbr % ),C1739039;C0702093;C0053917;C1334884;C1524029;C3813700;C3811844;C3812682,true;false;true;false;false;false;false;false,5239/10465
peri - op ace - inhibitors / arbs : no ( n = nmbr ),C0347985;C0003015;C3888198,false;true;false,5240/10465
cangrelor ( n = nmbr ) n / n ( % ),C1121991;C0053917;C1334884,true;true;false,5241/10465
baseline fevnmbr % predicted,C0168634;C1442488,true;false,5242/10465
age ( range ) ( years ),C1510829;C1514721;C2348147;C3542016,false;false;false;false,5243/10465
mean — yr age group — no . ( % ),C0444504;C0439234;C0027362;C2348001;C2347634;C2348143,false;false;true;false;false;false,5244/10465
history of atrial fibrillation or flutter treatment at randomisation,C0729790,false,5245/10465
previous stenting ( % previous pci ),C0205156;C0038257;C4049621;C2348535;C1552607,false;true;false;false;false,5246/10465
bivalirudin only,C0168273;C0205171;C1720467,true;false;false,5247/10465
medical history ( % ),C0262926;C1704706,false;false,5248/10465
clopidogrel given before procedure,C0070166,true,5249/10465
ezetimibe + simvastatin ( n = nmbr  nmbr * ),C1532737;C0053917;C1334884,true;true;false,5250/10465
aliskiren / valsartan ( n = nmbr ),C2733073;C0053917;C1334884,false;true;false,5251/10465
urinary protein - to - creatinine ratio | |,C1096054,false,5252/10465
cerebrovascular accident,C0038454,true,5253/10465
male sex — no . ( % ) weight — no . ( % ),C0086582,true,5254/10465
weight — no . ( % ),C0005910;C0043100;C1305866;C1705104,true;true;false;false,5255/10465
nmbr non - mtx,C0053917;C1518422;C0025677;C1417487;C1334884,true;false;true;false;false,5256/10465
fasting triglycerides — mg / dl,C0015663;C0041004;C0439269,true;true;false,5257/10465
concomitant csdmards other than methotrexate  n ( % ),C0521115;C0025677,false;true,5258/10465
( b ) concomitant respiratory medications [n ( % ) ],C0521115;C0418986,false;false,5259/10465
copd population ( n = nmbr ),C0024117;C0032659;C0053917;C1334884;C1257890;C1412502;C3714496,true;true;true;false;true;false;false,5260/10465
ibdq score  mean ( sd ),C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false,5261/10465
lifestyle,C0023676,true,5262/10465
disease location  %,C0012634;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,5263/10465
haq - di  number ( % ),C3826998;C0237753;C0449788;C4321476,false;false;false;false,5264/10465
cardiac pacemaker — no . ( % ),C0030163;C0037189,true;true,5265/10465
patient ' s preference not to take,C0376409,true,5266/10465
tofacitinib  nmbr mg twice daily,C2930696;C0053917;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,5267/10465
diet + pravastatin group,C0012155;C0085542;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0012159;C1519433;C2983588;C3668949,true;true;false;false;true;false;false;false;true;false;false;false,5268/10465
glycated hemoglobin level,C0202054,false,5269/10465
asthma population ( n = nmbr ),C0004096;C0032659;C0053917;C1334884;C1257890;C2984299,true;true;true;false;true;false,5270/10465
albumin creatinine ratio,C0486293;C1318293,false;false,5271/10465
apolipoproiein b ( mij / nmbr ),C0053917;C1334884,true;false,5272/10465
aliskiren ( dm - vs . dm + ),C1120110;C0011816;C3250443,true;true;false,5273/10465
regadenoson,C1698215,true,5274/10465
change in erosion score ( mean ),C0392747;C0333307;C3533236;C1880549;C1959609;C3887524;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false;false,5275/10465
fecal calprotectin — pg / g * *,C0015733;C0950624;C1638318;C1335798;C1366582,true;true;false;false;false,5276/10465
infarction before age nmbr ( a ),C0021308;C0001779;C0053917;C1334884,true;false;true;false,5277/10465
patients  no . / total no . ( % ),C0030705,true,5278/10465
prior biologic use,C0332152;C0005515;C0042153;C0457083;C1947944;C0205460;C2826257,false;true;true;false;false;false;false,5279/10465
time since diagnosis of type nmbr diabetes - no . ( % ),C0040223;C3541383,true;false,5280/10465
metabolic syndrome visit nmbr low - density lipoprotein cholesterol strata,C0524620;C0545082;C0053917;C0023824;C1334884;C1512346;C2826704,true;false;true;true;false;false;false,5281/10465
nonbiologic disease - modifying drug other than methotrexate : :,C0392747;C4036059;C0025677,false;false;true,5282/10465
moderate risk ( nmbr - nmbr ),C0205081;C0035647;C0053917;C1334884;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false;false,5283/10465
csf a ( nmbr ( pm ),C3540512;C3889436,false;false,5284/10465
combination - facilitated pci ( % ),C0205195;C4049621;C1947911;C3811910,false;false;false;false,5285/10465
time since psa diagnosis ( years )  mean ( sd ),C0040223;C3541383,true;false,5286/10465
deep - vein thrombosis,C0149871,true,5287/10465
> nmbr to < nmbr - nmbr mg / week,C0053917;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;false;true;false;false;false;false;false;false,5288/10465
aspirin alone ( n / n ),C0004057;C0205171;C0439044;C0679994,true;false;false;false,5289/10465
prior treatment — %,C1514463,false,5290/10465
homa - ir ( % ) b,C0022065;C0022071;C1448132,true;true;true,5291/10465
duration of diabetes  median ( iqr ),C0449238;C0011847;C0549183;C0876920;C2347635;C2348144;C2939193;C0011849;C2926735,false;false;false;false;false;false;false;true;false,5292/10465
interquartile range height — cm,C1711350;C0489786,false;false,5293/10465
mild thrombocytopenia ( < nmbrx nmbr / l ),C1856453;C0053917;C1334884,false;true;false,5294/10465
reversibility ( anticholinergic )  %  mean ( sd ) $,C0449261;C0242896;C0444504;C2699239;C2347634;C2348143;C3537004,false;true;false;false;false;false;false,5295/10465
number of exacerbation in the previous nmbr months  n ( % ),C0237753;C4086268;C0449788,false;false;false,5296/10465
established cvd ( age > nmbr ),C0443211;C0007222;C0001779;C0053917;C1334884;C1272684,false;true;false;true;false;false,5297/10465
crci > nmbr - < nmbr,C0053917;C1334884,true;false,5298/10465
who functional class ii / iii,C0205245;C0441887;C1710602;C4082587;C2698969;C0441886;C0439070;C1705160;C2698968;C0542341;C2700217,false;false;false;false;false;false;false;false;false;false;false,5299/10465
( n nmbr nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,5300/10465
cigarette smoking in the past year,C0239059;C4086728;C0700219,false;false;true,5301/10465
candesartan,C0717550,true,5302/10465
previous pci / cabg  n ( % ),C0205156;C4049621;C0010055;C1552607,false;false;true;false,5303/10465
coronary angiography during the index hospitalization,C0085532;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546;C1548829;C0428776;C0002978,true;true;true;true;false;false;false;false;false;true,5304/10465
baseline free pcsknmbr level by median,C0168634;C0332296;C0441889;C0549183;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261;C1880497;C1996904;C1442488,true;false;false;false;false;false;false;false;false;false;false;false;false;false,5305/10465
( se]tf total - c,C0036919;C4048299;C0439175;C0439810;C4048587,true;false;false;false;false,5306/10465
continued thienopyridine %,C0549178;C1120149,false;true,5307/10465
before pci,C4049621,false,5308/10465
glomerular filtration rate  nmbr ml / min / nmbr . nmbr mnmbr,C0017654;C0053917;C0439445;C1334884;C1561549,true;true;false;false;false,5309/10465
elevated troponin t ( > nmbr . nmbr / xg / l ),C0205250;C0077404;C0053917;C0017209;C1292284;C1421532;C1334884;C1420827;C3163633,false;true;true;true;false;false;false;false;false,5310/10465
rivaroxaban,C1739768,true,5311/10465
prior history ml or stroke,C0332152;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;false;false;true;false;false;false;false;false,5312/10465
atorvastatin nmbr mg ( n = nmbr  nmbr ),C0286651;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5313/10465
alcohol  % with > nmbr drink / d,C0053917;C0001948;C0556297;C1334884,true;true;false;false,5314/10465
western europe and lebanon,C0043129,true,5315/10465
body mass index  kg / mnmbr ( sd ),C0005893;C0022718;C2699239;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;true,5316/10465
current smoker ( > nmbr cigarettes / day ) — no . ( % ),C3173209;C0053917;C0677453;C0332173;C0439228;C0439505;C1334884;C3241966,false;true;true;false;false;false;false;false,5317/10465
atorvastatin nmbr mg ( n = nmbr ),C0286651;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5318/10465
unstable angina > nmbr mo ago,C0002965;C0053917;C0026544;C0332177;C1334884,true;true;true;false;false,5319/10465
amlodipine / valsartan nmbr / nmbr vs nmbr / nmbr mg,C1962523;C0053917;C1334884,true;true;false,5320/10465
mean ( s . d . ) apob  mg / dl,C0444504;C0003593;C0439269;C3252643;C2347634;C2348143,false;true;false;true;false;false,5321/10465
tobacco use — no . ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,5322/10465
previousdistaldeep - veinthrombosisorsuperficial - vein thrombosis,C0042487,true,5323/10465
dapagliflozin nmbr mg / day ( n = nmbr ),C2353951;C0053917;C0439422;C1334884,true;true;false;false,5324/10465
edema  peripheral,C0013604;C1717255,true;false,5325/10465
peripheral vascular disease,C0085096,true,5326/10465
angina ( past nmbr weeks ),C0002962;C2987125;C0053917;C1334884,true;false;true;false,5327/10465
drug - eluting stent implanted,C1322815,true,5328/10465
rhabdomyolysis ( n = nmbr ),C0035410;C0053917;C1334884;C4552660,true;true;false;false,5329/10465
hospitalizations  n,C0019993,true,5330/10465
baseline heart failure severity amongthose with priorheartfailure  %,C0168634;C0018801;C0439793;C0522510;C0018802;C4554158;C1442488,true;true;false;false;true;false;false,5331/10465
patients with end point,C0030705;C2349179;C2826544,true;false;false,5332/10465
us resident,C1320928;C1549439;C2347958;C3835651,false;false;false;false,5333/10465
less than nmbr mm hg,C0439092;C0053917;C0439475;C1334884,false;true;false;false,5334/10465
p value for mra vs no mra,C1709380;C0243032;C1609165;C3891069,false;true;true;false,5335/10465
insulin - treated diabetes,C0021641;C1533581;C1579433;C3714501,true;false;false;false,5336/10465
nmbrrrmnl ),,,5337/10465
metastatic disease,C0027627;C2939419;C2939420,true;false;false,5338/10465
no stroke n = nmbr nmbr,C0038454;C0053917;C1334884;C4554100,true;true;false;false,5339/10465
physical component score ( pcs ),C4483112;C0449432;C1864389;C1882368;C1705248,false;false;false;true;false,5340/10465
bmi > nmbr — no . ( % ) f,C0578022;C0053917;C1334884,false;true;false,5341/10465
oral contraceptive pills — no . / total no . ( % ),C0009905;C0009906;C0029151,true;true;false,5342/10465
renal function  moderate,C0232804,false,5343/10465
nmbr - yr risk of coronary heart disease ( % ) ^ |,C0053917;C0439234;C1277690;C1334884,true;false;false;false,5344/10465
llt other than statin at randomization,C2347090;C0360714,false;true,5345/10465
other antihypertensive agents,C0003364,true,5346/10465
ace inhibitor at enrollment,C0003015;C1516879;C1696073;C3888021;C4541021,true;false;false;false;false,5347/10465
b - agonists ( short - acting ) a,C0243192;C2987634,true;false,5348/10465
egfr nmbr - nmbr ml / min / nmbr . nmbrmnmbr n = nmbr  nmbr ( nmbr . nmbr % ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,5349/10465
hemoglobin anmbrc  mean ( sd )  % b,C0062248;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,5350/10465
duration of ulcerative colitis,C0449238;C0009324;C2926735,false;true;false,5351/10465
positive for rheumatoid factor — no . ( % ) : t,C0439178;C0035448;C0201660;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false,5352/10465
euroscore logistic  median ( nmbrth  nmbrth % ) £,C3164744;C0242415;C0549183;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,5353/10465
simvastatin nmbr mg plus fenofibrate nmbr mg ( n = nmbr /,C0074554;C0053917;C1319635;C0332287;C0033228;C1334884,true;true;false;false;true;false,5354/10465
age — mean ( sd ) ( years ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5355/10465
cerebrovascular or peripheral arterial disease  n ( % ),C1880018,false,5356/10465
low feno subgroup (  nmbr . nmbr ppb ) ( n = nmbr ),C0205251;C1079230;C0053917;C1415800;C1334884;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;true;false;false;false;false;false;false;false;false,5357/10465
blood - pressure medications at randomization — no . / total no . ( % ),C0849164;C0033095;C0034656;C0460139;C1306345;C4284008;C0005823;C0013227;C0802604;C2598133;C4284232;C1271104;C1272641,false;true;true;false;false;false;true;true;false;false;false;false;true,5358/10465
index event  n ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,5359/10465
other or missing data,,,5360/10465
number of copd exacerbations in the previous year  n ( % ),C0237753;C0740304;C0449788,false;false;false,5361/10465
rivaroxaban plus aspirin ( n = nmbr ),C1739768;C0332287;C0004057;C0053917;C1334884,true;false;true;true;false,5362/10465
diuretics * *,C0012798,true,5363/10465
one vessel,C0205447;C0005847,false;true,5364/10465
intended duration of anticoagulation,C1283828;C0449238;C0003281;C2917212;C2919015;C3537050;C2926735;C1551357,false;false;false;false;false;false;false;false,5365/10465
non - stenotic vessels  n ( % ),C1518422;C0679403,false;false,5366/10465
gusto severe,,,5367/10465
> nmbr . nmbr bpm current smoker,C0053917;C3173209;C3241966;C1334884,true;false;false;false,5368/10465
patients with any clinical event,C0030705;C0205210;C0441471;C4019010,true;false;false;false,5369/10465
previous diabetes,C0205156;C0011847;C0011849;C1552607,false;false;true;false,5370/10465
mmrc dyspnea scale  n ( % ),C3826977;C0013404;C0175659;C0349674;C1947916;C1963100,false;true;true;false;false;false,5371/10465
brv nmbr mg / day ( n = nmbr ),C0155502;C0053917;C0439422;C1334884,true;true;false;false,5372/10465
urinary tract infection,C0042029;C0262655;C4554638,true;false;false,5373/10465
baseline bmi > nmbr kg / mnmbr  n = nmbr  nmbr,C0168634;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false,5374/10465
hospitalization for heart failure,C3898876,false,5375/10465
any history of congestive heart failure,C0455531;C0742742,false;false,5376/10465
time from study drug administration to coronary revascularization  median ( iqr )  h,C0040227;C0150270;C3469597;C0206209;C0013175;C2349982,true;false;false;true;true;false,5377/10465
heart failure ( class i — iii ),C0018801;C0441887;C0021966;C0221138;C2698969;C0441885;C0439070;C1705160;C1319793;C2698967;C0018802;C4554158,true;false;true;false;false;false;false;false;false;false;true;false,5378/10465
c - reactive protein — mg / liter * *,C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,true;true;false;true;false;false;false;false;false;false;false,5379/10465
liraglutide nmbr . nmbr mg  n = nmbr  nmbr,C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5380/10465
placebo nmbr yr km %,C0032042;C0053917;C0439234;C3887676;C1334884;C1696465;C1706408,true;true;false;false;false;false;false,5381/10465
prebronchodilator fevnmbr ( % predicted normal ) t,C2599602,false,5382/10465
rest of world,C0035253;C2700280;C1622890,true;false;false,5383/10465
mean age ( sd )  y,C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,5384/10465
low - molecular weight heparin or intravenous unfractionated heparin,C0019139;C3536766,true;false,5385/10465
nmbr early intervention ( n = nmbr ),C0053917;C0242687;C1964029;C1334884,true;true;false;false,5386/10465
no statin ( + / - llt ),C0360714;C2347090,true;false,5387/10465
treatment satisfaction,C3476649,false,5388/10465
pathologic q waves — no . ( % ),C0429090,false,5389/10465
total periventricular wml score  mean ( sd ),C2964552;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5390/10465
laboratory values at admission ( median and iqr ),C0022877;C0042295;C0184666;C0549183;C0876920;C2347635;C2348144;C2939193;C0809949;C3244292;C4283904,true;false;false;false;false;false;false;false;false;false;false,5391/10465
corticosteroid use  nmbr n ( % ),C0239126;C0053917;C1334884,false;true;false,5392/10465
use of inhaled glucocorticoids at screening — no . ( % ),C1524063;C0004048;C0017710;C3540777;C3540778,false;true;true;false;false,5393/10465
comorbidity score  mean ( sd ) t,C0009488;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,true;false;false;false;false;false;false,5394/10465
non - smokers ( at baseline ),C0337672;C0168634;C1442488;C4554605,false;true;false;true,5395/10465
tender joint count ( n / nmbr ),C0451530;C0053917;C1334884,false;true;false,5396/10465
total intravenous loop diuretics  mg,C0439175;C0348016;C0354100;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439810,false;false;true;true;true;false;false;false;false;false;false,5397/10465
atorvastatin nmbr mg + ezetimibe nmbr mg ( n = nmbr ),C0286651;C0053917;C1319635;C1142985;C1334884,true;true;false;true;false,5398/10465
angiotensin ll - receptor antagonist — no . ( % ),C0003018;C4521302,true;false,5399/10465
mean serum glucose  mg / dl  mean = sd,C0444504;C0202041;C0439269;C2699239;C3534430;C2347634;C2348143,false;false;false;false;false;false;false,5400/10465
gold stage ( % ) f,C0018026;C0205390;C0016327;C1300072;C1306673;C1304897,true;false;true;false;false;false,5401/10465
non - hdl - c / hdl - c,C1518422;C3715113,false;false,5402/10465
multivessel ( two vessel  three vessel  or left main ),C4012475;C0205449;C4037954,false;false;false,5403/10465
body weight index ( kg / mnmbr ),C0005910;C0600653;C0022718;C0439209;C4054209;C0918012;C1552854;C1637833;C2986546;C1305866,true;true;true;false;false;true;false;false;false;false,5404/10465
triglycerides  mmoltnmbr ( gm * ),C0041004;C0017480;C3854019,true;true;true,5405/10465
procalcitonin ( ng / ml ),C0072027;C0439275,true;false,5406/10465
fasting blood glucose > nmbr mg / dl,C0428568;C0053917;C0439269;C1334884;C1261430,false;true;false;false;false,5407/10465
category nmbr,C0683312;C0053917;C1334884;C3889287,false;true;false;false,5408/10465
type of event,C1561488,false,5409/10465
quality of life,C0034380;C0518214,true;false,5410/10465
diagnosis ( y )  mean ( sd ),C0011900;C0444504;C2699239;C2347634;C2348143;C1704338;C1704656,true;false;false;false;false;true;false,5411/10465
persistent or permanent immobilization,C0205322;C0332996,false;false,5412/10465
modified rankin scale at screening  nmbr - nmbr,C2984908;C0220908;C0053917;C1334884;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3854213,false;true;true;false;true;false;false;false;false;false;false,5413/10465
placebo nmbr . nmbr pt yrs,C0032042;C0053917;C0032743;C0699718;C1334884;C1696465;C1706408,true;true;true;false;false;false;false,5414/10465
diet controlled or no,C0743195,false,5415/10465
body weight,C0005910;C1305866,true;false,5416/10465
cvd  mi  or stroke,C0007222;C3810814,true;false,5417/10465
no . of patients / no . of events,C0030705,true,5418/10465
intravenous study drug administered — no . ( % ),C0683092;C0557651;C2603343;C0348016;C0013175,false;false;false;false;true,5419/10465
number of females n ( % ),C0237753;C0086287;C0449788,false;true;false,5420/10465
> nmbr . nmbr % and ≤ nmbr . nmbr %,C0053917;C1334884,true;false,5421/10465
treatment with statins,C0039798;C0360714;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,5422/10465
prior heart failure  n ( % ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,5423/10465
systemic symptoms,C0205373;C0683368;C1457887,false;true;false,5424/10465
persistent or paroxysmal,C0205322;C0332996,false;false,5425/10465
metabolic syndrome w / o tnmbrdm,C0524620,true,5426/10465
stroke — no . / total no . ( % ),C0038454;C4554100,true;false,5427/10465
nice primary prevention onlyb,C4087029;C0033144,false;true,5428/10465
cv death  mi  ischemic stroke  hospitalization for hf  coronary revascularization  ua,C3538987;C0011065;C3810814;C0948008;C0019993;C0018488;C0877341;C0041580;C0042014;C1313497;C1538440;C3273279;C1306577;C0376297;C0581603;C4082313;C4552775;C4048877;C4318503,false;true;false;false;true;true;false;true;true;true;false;false;false;true;false;false;false;true;false,5429/10465
change from pre - to,C0392747;C0332152;C0740175;C2257086;C3669034;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false,5430/10465
any lipid - lowering agent,C0086440,true,5431/10465
abatacept,C1619966,true,5432/10465
indacaterol - glycopyrronium group,C1722260;C3814772;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;false;true;false;false;false,5433/10465
warfarin naive,C0043031,true,5434/10465
prior or new diabetes,C0332152;C2826257,false;false,5435/10465
tender and swollen joints — mean no . : :,C0234234,false,5436/10465
systolic blood pressure > nmbr mm hg or diastolic blood pressure > nmbr mm hg,C0488055;C0053917;C0439475;C1334884;C0871470;C1306620,false;true;false;false;true;false,5437/10465
rolofylline ( n = nmbr  nmbr ),C0166128;C0053917;C1334884,true;true;false,5438/10465
total stent length ( mm )  mean ± sd,C0439175;C0038257;C1444754;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674;C1706316;C0439810,false;true;false;false;false;false;false;false;false;false;false,5439/10465
swollen joint count ( nmbr joints ),C0451521;C0053917;C1334884,false;true;false,5440/10465
mean nmbr sd,C0444504;C0053917;C2699239;C1334884;C2347634;C2348143,false;true;false;false;false;false,5441/10465
previously taken methotrexate  %,,,5442/10465
gusto moderate,,,5443/10465
procedure * *,C0184661;C2700391;C3274430;C3539779,true;false;false;false,5444/10465
hormone replacement ! !,C0282402,true,5445/10465
other cardiovascular risk factors,C0850624,false,5446/10465
severe copdc [n z nmbr],C0205082;C0053917;C1334884;C4050465;C4050466,false;true;false;false;false,5447/10465
cardiac biomarker status !,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,5448/10465
nmbr - mercaptopurine,C0053917;C0000618;C1334884,true;true;false,5449/10465
patient presentation,C0030705;C0449450,true;false,5450/10465
baseline serum k +  meq / l,C0168634;C0302353;C0439375;C1442488,true;false;false;false,5451/10465
other sulfonylurea 一 no . ( % ),C0038766;C3536898,true;false,5452/10465
hctz * ( n = nmbr ),C0020261;C0053917;C1334884,true;true;false,5453/10465
cardiometabolic syndrome  ^n ( % ),C0039082,true,5454/10465
carotid artery — no . ( % ),C0007272;C0162859,true;true,5455/10465
cardiac valve surgery : no ( n = nmbr ),C0018821;C0184252;C1186983;C1704414;C3888056;C0524727;C0018826;C0038894;C0038895;C0543467;C1274039,true;false;false;false;false;true;true;false;true;true;true,5456/10465
other cause,C0015127;C1524003,true;false,5457/10465
beyond popliteal pedal,C0442037;C0016504;C0687080,false;true;false,5458/10465
> nmbr cv risk factors 咐 or established atherosclerotic cv disease,C0053917;C3538987;C0035648;C1553898;C4048877;C4318503;C1334884,true;false;true;false;true;false;false,5459/10465
oral anticoagulant drugs,C0354604,false,5460/10465
fracture history ( predefined )  n ( % ),C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,5461/10465
any coronary revascularization,C0877341,false,5462/10465
ex - / current smoker,C0337671;C0521116;C1705970;C4555205;C1704625;C3173209;C3241966,false;false;false;true;false;false;false,5463/10465
vorapaxar nmbr - y,C2974521;C0053917;C1334884,true;true;false,5464/10465
fluindione  no . ( % ),C0117899,true,5465/10465
current n z nmbr,C0521116;C0053917;C1334884;C1705970,false;true;false;false,5466/10465
concomitant oral corticosteroids  n ( % ) * *,C0521115;C0442027;C0001617;C3539185;C3540725;C3540726;C3540727;C4521986,false;false;true;false;false;false;false;false,5467/10465
anaesthesia / analgesia,C0002905,true,5468/10465
local eosinophil count ( cells per pl ) t,C0205276;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;false;true;false;false;true;false,5469/10465
age ( years )  mean ( s . d . ),C1510829;C0444504;C2347634;C2348143,false;false;false;false,5470/10465
ethnic group ( % ),C0015031;C1879937,true;false,5471/10465
physician ' s global assessment ( vas ),C4050369;C0042815;C3536884;C3827561,false;true;true;false,5472/10465
antihypertensive drugs,C0003364,true,5473/10465
median age — yr §,C0549183;C0001779;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,5474/10465
cad and / or crvd ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5475/10465
chronic obstructive lung disease,C0024117,true,5476/10465
exercise category ( % ),C3669314,false,5477/10465
prior congestive heart failure yes,C0332152;C0018802;C1549445;C1705108;C1710701;C2826257,false;true;false;false;false;false,5478/10465
secondary prevention subgroup,C0679699;C1079230;C1515021,true;false;false,5479/10465
aspirin nmbr mg ( n = nmbr ),C0004057;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5480/10465
night - time awakenings / week,C0860510;C0332174;C0439230,false;false;false,5481/10465
non - hdl - c  mean ( sd )  rng / dl,C1518422;C3715113;C0444504;C2699239;C3642216;C2347634;C2348143,false;false;false;false;false;false;false,5482/10465
laa closure ( n - nmbr ),C0185003;C0053917;C1334884;C1521802,false;true;false;false,5483/10465
p - value * ' ',C1709380,false,5484/10465
known prothrombotic genotype,C0205309;C0017431,false;true,5485/10465
> nmbr concomitant medication,C0053917;C0521115;C0013227;C3244316;C4284232;C1334884,true;false;true;false;false;false,5486/10465
function subscale,C0031843;C0542341;C0700205;C1705273,true;false;false;false,5487/10465
high risk and more symptoms ( group d ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,5488/10465
white ( nmbr . nmbr % ),C0007457;C0053917;C1334884;C0043157;C0220938,true;true;false;true;false,5489/10465
osteoarthritis,C0029408,true,5490/10465
age ( y )  median ( nmbrth to nmbrth percentiles ),C0001779;C0549183;C1264641;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,5491/10465
history of microalbuminuria — no . ( % ),C3532606,false,5492/10465
tender joint count ( nmbr joints )  mean ( sd ),C0451530;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884,false;true;false;false;false;false;false,5493/10465
nmbr mg / day delayed - start,C0053917;C0439422;C1334884,true;false;false,5494/10465
documented symptomatic chdb,C1301725;C0231220;C1609436,false;false;false,5495/10465
c - reactive protein,C0006560;C1413716;C4048285,true;false;false,5496/10465
ejection fraction  percent ( sd ),C0489482;C0439165;C2699239;C2700378,false;false;false;false,5497/10465
previous pneumonia,C0205156;C0032285;C1552607,false;true;false,5498/10465
dasnmbr - esr remission  %,C3811131;C0544452;C0687702,false;false;false,5499/10465
budesonide — no . ( % ),C0054201,true,5500/10465
linagliptin  patients with events / total patients,C2746078;C0030705;C0441471;C0439175;C0439810;C3541888,true;true;false;false;false;false,5501/10465
middle tg tertile,C0444598;C0337445;C0549183;C1552826,false;false;false;false,5502/10465
density lipoprotein  csf =,C0178587;C0023820;C3540512;C3889436,false;true;false;false,5503/10465
hscrp  median ( min  max )  mg / l,C0549183;C2827895;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5504/10465
concomitant medication after randomisation,C0521115;C0013227;C0034656;C3244316;C4284232,false;true;true;false;false,5505/10465
non - black ( n = nmbr ),C1518422;C0005680;C0053917;C1334884;C0027567;C0085756;C0439541,false;true;true;false;true;true;false,5506/10465
dmard or corticosteroid,C0242708,true,5507/10465
non - epa number of <,C1518422;C0237753;C0449788,false;false;false,5508/10465
hbalc tx difference vs pbo  median change from baseline ( se ) nmbr,C0041403;C1705241;C1705242,true;false;false,5509/10465
trough fevi l,C0444506;C0429706;C0849974;C1561566;C4528367,false;false;false;false;false,5510/10465
eq - nmbrd ( visual analog score ),C0205163;C0234621;C0243071;C0449820;C4050231;C0439185,false;false;false;false;false;false,5511/10465
antihypertensive medication  open - label  no . ( % ),C0003364,true,5512/10465
mer ’ s disease assessment,C0673013;C0012634;C1261322;C1516048;C3810521;C4281714,true;true;false;false;false;false,5513/10465
baseline ldl - c strata  n ( ° / o ),C0168634;C1442488,true;false,5514/10465
with alogliptin nmbr . nmbr mg,C1958126;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5515/10465
anacetrapib ( n = nmbr ),C2604745;C0053917;C1334884,true;true;false,5516/10465
secondary dvt . ' fe,C0027627;C0149871;C3848561;C2926618;C3899446;C0175668;C0205436,true;true;false;false;false;false;false,5517/10465
with laba  n ( % ) pretreatment,C1550147;C2709094;C3539075;C3539076,false;false;false;false,5518/10465
basal insulin analogue dose * ( coefficient,C0650607;C0243071;C0178602;C1707429;C0869039;C1114758;C0205112;C0366513;C2825028,false;false;false;false;false;false;false;false;false,5519/10465
theophyllines,C0039771,true,5520/10465
angina class iii or iv — no . ( % ),C0264677,false,5521/10465
n ( nmbryr km event rate  % ),C0369718;C3887676;C0441471;C0871208;C1521828;C4019010;C0441922,false;false;false;false;false;false;false,5522/10465
age — year ( median ),C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C0439508,false;false;false;false;false;false;false;false,5523/10465
tnt and ideal ( pooled ),,,5524/10465
cabg or ptca / pci,C0010055,true,5525/10465
ex - smoker ( n z nmbr ),C0337671;C0053917;C1334884;C4555205,false;true;false;true,5526/10465
event rate ( % ) of primary endpoints,C0441471;C0871208;C2986535;C1521828;C4019010,false;false;false;false;false,5527/10465
insulin - dependent diabetes,C0011854,true,5528/10465
malignancy at randomization,C0006826;C0034656;C1306459;C4282132,true;true;false;false,5529/10465
short - acting,C1282927;C0079613;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;false;true;false;false;false;false,5530/10465
serum potassium  meq / l,C0302353;C0439375;C0543465,false;false;false,5531/10465
rest of world n z nmbr,C0035253;C2700280;C0053917;C1334884;C1622890,true;false;true;false;false,5532/10465
never smoked  n ( % ),C2003901;C0037366;C0439994;C1881674,false;true;false;false,5533/10465
seizure worry,C0036572;C0233481;C1959629;C4553401,true;false;false;false,5534/10465
placebo group ( n = nmbr nmbr ) ( nmbr nmbr person years ),C0032042;C0441848;C0053917;C0027361;C0439234;C2347489;C1334884;C1696465;C1706408,true;false;true;true;false;false;false;false;false,5535/10465
rest - of - world ( n = nmbr ),C0035253;C2700280;C0053917;C1334884;C1622890,true;false;true;false;false,5536/10465
no use ofdiabetes drugs — no . ( % ),C0240320,false,5537/10465
no estimate,C0750572,false,5538/10465
baseline ( n ),C0168634;C1442488,true;false,5539/10465
pci > nmbr month ago,C4049621;C0053917;C0332177;C0439231;C1334884,false;true;false;false;false,5540/10465
swollen joint count ( nmbr joints )  mean ( sd ),C0451521;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884,false;true;false;false;false;false;false,5541/10465
> nmbr years nmbr / nmbr ( nmbr . nmbr ),C0053917;C0439234;C1334884,true;false;false,5542/10465
time in therapeutic range before inclusion,C1554109;C0087111;C0302350;C0040223;C0460097;C3541383,false;true;false;true;false;false,5543/10465
initial diagnosis — no . ( % ),C0205265;C0011900;C1704338;C1704656;C1279901;C1555582;C1705685,false;true;true;false;false;false;false,5544/10465
angiotension converting enzyme - inhibitor,C0014432;C0919438;C4521603,true;false;false,5545/10465
xanthines,C0043318;C3541955,true;false,5546/10465
management distribution medical treatment,C0030677;C0520511;C0199168;C0205476;C1704711;C0001554;C0679624;C0376636;C1273870;C3273539,true;false;false;false;true;true;false;true;false;false,5547/10465
pharmaco - invasive ( n = nmbr ),C0205281;C0053917;C1334884;C1334278,false;true;false;false,5548/10465
estrogen - containing hormones,C0014939;C0332256;C0019932;C2700400;C2936882;C4542544,true;false;true;false;false;false,5549/10465
uac nmbr - nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,5550/10465
nmbr % < hbanmbrc < = nmbr % ( n nmbr nmbr ),C0053917;C1334884,true;false,5551/10465
mean ( s . d . ) measured ldl cholesterol,C0444504;C2347634;C2348143,false;false;false,5552/10465
history of hypertension — no . ( % ),C0455527,false,5553/10465
prior cv history  n ( % ),C0332152;C3538987;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503;C2826257,false;false;true;true;false;false;false;false;true;false;false,5554/10465
time to end - of - study ivus  median ( iqr )  days,C0439548;C0444930;C0557651;C1456025;C0549183;C0876920;C2347635;C2348144;C2939193;C2603343;C2746065,false;false;false;false;false;false;false;false;false;false;false,5555/10465
steroids ( inhaled ) a,C0038317,true,5556/10465
> qnmbr ( nmbr . nmbr ) - qnmbr ( nmbr . nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,5557/10465
previous angioplasty  n ( % ),C0205156;C0162577;C1548817;C1552607,false;true;false;false,5558/10465
time since diagnosis of diabetes,C0040223;C3541383,true;false,5559/10465
uric acid tertile nmbr ( nmbr . nmbr to < nmbr . nmbr mg / dl ),C0041980;C0053917;C0439269;C1334884,true;true;false;false,5560/10465
major hypoglycemia,C0205082;C0020615;C4553659;C0205164;C4318856;C4521762,false;true;false;false;false;false,5561/10465
prosper,,,5562/10465
dyspnea at rest ( nyha iv )  ( % ),C0743330;C1275491;C0022326;C4265176,false;false;true;false,5563/10465
czech republic,C0206578,true,5564/10465
gusto moderate or severe bleeding,,,5565/10465
baseline cdai ,C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,5566/10465
% change from baseline  mean ( s . e . ),C0392747;C0168634;C0444504;C2347634;C2348143;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false;false;false;false,5567/10465
enalapril + aliskiren ( n = nmbr ),C0014025;C1120110;C0053917;C1334884,true;true;true;false,5568/10465
non - calcium antagonist strategy ( n = nmbr nmbr ),C1518422;C0006684;C0679199;C0053917;C1334884,false;true;false;true;false,5569/10465
ankle fracture,C0159877;C4552974,true;false,5570/10465
number standard care,C0237753;C1442989;C1947933;C2828392;C0449788,false;false;false;false;false,5571/10465
digitalis  n ( % ),C0012252;C0304520,true;false,5572/10465
warfarin at last follow - up,C0043031;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,5573/10465
pci data,C4049621;C1511726;C3245479;C3714741,false;false;false;false,5574/10465
end of follow - up,C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,5575/10465
handihaler only  n,C0205171;C1720467,false;false,5576/10465
certolizumab pegol ( n = nmbr ),C1872109;C0053917;C1334884,true;true;false,5577/10465
mean — ml / min / nmbr . nmbr mnmbr level — no . ( % ),C0444504;C0439445;C0053917;C0441889;C0456079;C1547707;C2946261;C1334884;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,5578/10465
egfr via mdrd ( ml / min / nmbr . nmbrmnmbr ),C1739039;C3839656;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;false;true;false;false;false,5579/10465
core laboratory percent stenosis,C0444669;C0022877;C0439165;C0678234;C1261287;C2632116;C3244292;C4283904;C1167518;C1706352;C1882467;C3274653,false;true;false;false;true;false;false;false;false;false;false;false,5580/10465
native american / alaskan,C0682125;C0596070;C0282204;C0238611;C1515945,true;false;true;false;false,5581/10465
mean cdai score ( sd ),C0444504;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false,5582/10465
insulin glargine vs standard care least - squares mean ( nmbr % cl ),C0907402,true,5583/10465
difference in ls meannmbr ( nmbr % cl ),C1705241;C0023668;C0053917;C0596019;C1334884;C1705242,false;true;true;false;false;false,5584/10465
prior diagnosis - no . ( % ),C0332132,false,5585/10465
moderate - dose statin,C1709056;C0360714,false;true,5586/10465
tnf - alpha ( pg / ml ),C1448177;C0439297;C1456820;C1522669,true;false;true;false,5587/10465
antithrombotic drug use at time of event,C0013227;C1524063;C0040223;C0441471;C4019010;C3541383;C1254351,true;false;true;false;false;false;false,5588/10465
jbs - nmbr secondary prevention onlynmbr,C0175692;C0053917;C0679699;C1334884;C0795841;C1416527,true;true;true;false;true;false,5589/10465
full cohort,C0443225;C0009247;C0599755,false;true;false,5590/10465
c - peptide,C0006558,true,5591/10465
immobilization,C0020944;C4048292,true;false,5592/10465
death  mi  idr  st  or gusto moderate / severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,5593/10465
thienopyridine ( n = nmbr ),C1120149;C0053917;C1334884,true;true;false,5594/10465
nmbr - year framingham chd risk  %,C0053917;C0439234;C3166866;C1282512;C0439508;C1334884,true;false;false;false;false;false,5595/10465
etoricoxib,C0972314,true,5596/10465
previous coronary artery disease  n ( % ),C0205156;C0010054;C0010068;C1956346;C1552607,false;true;true;true;false,5597/10465
elevated cardiac markers,C0205250;C1271630;C3163633,false;false;false,5598/10465
ifx + aza ( n = nmbr ),C0020823;C0004482;C0053917;C1334884,true;true;true;false,5599/10465
open - label clopidogrel after completion of study drug,C1709323;C0070166;C0205197;C0013227;C1254351;C1554962,false;true;false;true;false;false,5600/10465
baseline low - density lipoprotein cholesterol ( mg / dl ),C0168634;C0023824;C0439269;C1442488,true;true;false;false,5601/10465
symptom onset to randomization,C4086878;C0034656,false;true,5602/10465
stricturing,C1261287,true,5603/10465
insulin tx difference vs pbo  median change from baseline ( se ) nmbr,C0021641;C0041403;C1705241;C1705242;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,5604/10465
duration of rheumatoid arthritis ( years ),C0449238;C0003873;C0439234;C2926735,false;true;false;false,5605/10465
beta - blocker — no . / total no . ( % ),C0001645,true,5606/10465
second loading dose,C0205436;C3714444;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,5607/10465
trochanter,C0162370,true,5608/10465
low perceived social support only,C0205251;C0030971;C0037438;C0205171;C1720467;C0748877;C1540833;C3669642;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;true;false;false;false;false;false;false;false,5609/10465
white / other,C0007457;C0043157;C0220938,true;true;false,5610/10465
treatment groups [n / nb ( % ) ],C0039798;C0441848;C0028101;C0919442;C1705347;C4553907;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;true;false;false;false;false;false,5611/10465
cardiovascular medication usage,C0007220;C0457083,true;false,5612/10465
non - calcium antagonist strategy ( ncas ) ( events / n ),C1518422;C0006684;C0679199;C1413309;C0441471;C3541888;C3813543,false;true;false;false;false;false;false,5613/10465
simvastatin ( nmbr / nmbr mg / d ) ( n = nmbr ),C0074554;C0053917;C0439422;C1334884,true;true;false;false,5614/10465
baseline bmi > nmbr kg / mnmbr  n = nmbr,C0168634;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false,5615/10465
n / n nmbr / nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,5616/10465
not - japan,C1518422;C0022341,false;true,5617/10465
previous cardiovascular events,C0205156;C1320716;C1552607,false;false;false,5618/10465
trigl yeerides * ( m mol / l ),C0456616;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C0369637;C0347982;C0441923,false;true;true;false;false;false;false;false;false;false,5619/10465
total cholesterol : hdl - c ratio,C0439175;C0523558;C0439810,false;false;false,5620/10465
proadm ( ng / ml ),C0439275,false,5621/10465
interact !,,,5622/10465
older des ( n = nmbr ),C0580836;C0011702;C0053917;C1334884;C4551552,false;true;true;false;true,5623/10465
second co - primary outcome,C0205436;C3245499;C0205225;C1274040;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;true;false;false;false;false;false;false;false;false,5624/10465
pe ± dvt,C0070939;C0149871;C2926618;C3899446;C1880476;C4284304,true;true;false;false;false;false,5625/10465
previous warfarin use  no . ( % ),C0205156;C0043031;C1552607,false;true;false,5626/10465
nice secondary prevention onlyb,C4087029;C0679699,false;true,5627/10465
ankle / brachial index,C1328319;C3888326,true;false,5628/10465
non - caucasian eze / simva,C1518422;C0007457;C0043157,false;true;true,5629/10465
use of compression stockings  no . ( % ),C1524063;C0038348,false;true,5630/10465
prior angiography showing stenosis > nmbr %  n = nmbr °,C0332152;C0002978;C2826257,false;true;false,5631/10465
previous use of antiarrhythmic drugs,C0205156;C1524063;C0003195;C1552607,false;false;true;false,5632/10465
location  n ( % ),C0450429;C1515974;C4284930;C4284931,false;false;false;false,5633/10465
associated with ctd,C0332281;C1335071;C1442905,false;false;false,5634/10465
clopidogrel ( n = nmbr ) n / n ( % ),C0070166;C0053917;C1334884,true;true;false,5635/10465
physical exam oedema,C0031809;C0013604;C1717255,true;true;false,5636/10465
triglyceride ( mmol / l ) * blood pressure,C0041004;C1532563;C0005823;C1271104;C1272641,true;false;true;false;true,5637/10465
valproate,C0080356,true,5638/10465
ls - mean change from baseline ( nmbr % ci ),C0023668;C0444504;C0392747;C0168634;C0053917;C0008107;C3259781;C1334884;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;true;false;false;false;false;false;false;false;false,5639/10465
median age ( iqr  years ),C0549183;C1510829;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5640/10465
cardiac medications during index hospital stay and / or discharge,C0428776;C0013227;C3489408;C0802604;C2598133;C4284232,false;true;true;false;false;false,5641/10465
cardiac medications during index hospitalization  %,C0428776;C0013227;C0019993;C0802604;C2598133;C4284232,false;true;true;false;false;false,5642/10465
no ipst ( n = nmbr  nmbr ),C0053917;C1334884,true;false,5643/10465
non high dose statin ( n = nmbr  nmbr ),C1518422;C0444956;C0360714;C0053917;C1334884,false;false;true;true;false,5644/10465
gall bladder adverse event ( n = nmbr ),C0016976;C0877248;C0053917;C1334884,true;false;true;false,5645/10465
elevated crp ( > ulnt )  n ( % ),C0742906,false,5646/10465
liraglutide,C1456408,true,5647/10465
type of drug - eluting stent  n ( % ),C0457591;C0038257;C0332307;C1322815;C1547052,false;true;false;true;false,5648/10465
ratio of fevnmbr to fvc,C0456603;C1547037,false;false,5649/10465
infarct localization  n ( % ),C0021308;C0475264;C1744691,true;false;false,5650/10465
racial category *,C0034510;C0683312;C3889287;C1706779;C3669213;C3853635,true;false;false;false;false;false,5651/10465
inhaled jnmbr - agonist §,C0004048;C2987634,true;false,5652/10465
nonwhite race — no . ( % ) ejection fraction,,,5653/10465
theophylline use at screening,C0241361;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,5654/10465
history of omalizumab treatment,C0019664;C0966225;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;true;false;false;false;false;false;true;false;false;false;false,5655/10465
symptom onset to arrival in catheterization laboratory,C4086878;C1555577;C1706079,false;false;false,5656/10465
omega - nmbr fatty acid vs placebo least - squares mean ( nmbr % cl ),C1719844;C0053917;C0015684;C1334884,false;true;true;false,5657/10465
tnfi and other bdmardst  n ( % ),,,5658/10465
atenolol strategy ( n = nmbr  nmbr ),C0004147;C0679199;C0053917;C1334884,true;false;true;false,5659/10465
left atrial diameter : < nmbr mm ( n = nmbr ),C0225860;C1301886;C0053917;C4330985;C4554674;C1334884;C0225861,true;false;true;false;false;false;false,5660/10465
ethnic group,C0015031;C1879937,true;false,5661/10465
baseline bmi > nmbr kg / mnmbr  n = nmbr  nmbr change from baseline to nmbr weeks,C0168634;C0578022;C0053917;C0022718;C0392747;C0439230;C0443172;C1705241;C4319952;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false;false;false;false;false;false,5662/10465
rf ( iu / ml ),C0035448;C0439458;C0201660;C0748398;C1547111,true;false;false;false;false,5663/10465
coronary heart disease risk equivalents  n ( % ) c,C1277690;C0439185;C4049980,false;false;false,5664/10465
medical history of hypertension,C0262926;C0020538;C1963138;C0199168;C0455527;C0205476,false;true;false;false;false;false,5665/10465
mepolizumab group,C0969324;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,5666/10465
microalbuminuria or macroalbuminuria,C0730345,false,5667/10465
baseline ldl - c > nmbr mg / dl,C0168634;C0053917;C0439269;C1334884;C1442488,true;true;false;false;false,5668/10465
combination therapy * *,C0009429;C0556895,true;false,5669/10465
uac > nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,5670/10465
health assessment questionnaire score,C2960025,false,5671/10465
age at onset  y,C0206132;C3870509,true;false,5672/10465
antidiabetes drug usage [ % ( n ) ],C0242510,false,5673/10465
ibdq total score  mean [sd],C2964552;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5674/10465
fenofibric,,,5675/10465
era and pdenmbr inhibitors,C1521863;C3495919,true;false,5676/10465
allogliptin,,,5677/10465
current smoker ( n = nmbr  nmbr ),C3173209;C0053917;C1334884;C3241966,false;true;false;false,5678/10465
weight ( kg )  mean ( s . d . ),C0005910;C1275571;C0444504;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,5679/10465
previous stroke or tia ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,5680/10465
average of maximum common carotid cimt ( mm ),C1510992;C0806909;C0205214;C0741968;C4330985;C4554674;C1522138;C3245511;C1552615;C2826546;C2825518,false;false;false;false;false;false;false;false;false;false;false,5681/10465
new or suspected thrombus,C0205314,false,5682/10465
lacosamide,C0893761,true,5683/10465
natalizumab ( n = nmbr ) f,C1172734;C0053917;C0016327;C1334884,true;true;true;false,5684/10465
family history of coronary disease,C0850707;C0018787,false;true,5685/10465
multivessel cad ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5686/10465
long - acting bronchodilator use at screening,C0205166;C0079613;C0006280;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;true;true;true;false;false;false;false;false;false;false;false;true;false;false;false,5687/10465
fevnmbr / fvc ratio  % ( sd ),C3714541;C0456603;C2699239;C1547037,true;false;false;false,5688/10465
mild impairment ( egfr nmbr - nmbr ),C2945599;C0221099;C1739039;C0053917;C1334884;C3811844;C3812682;C0684336,false;false;true;true;false;false;false;false,5689/10465
all randomly assigned,,,5690/10465
diet and exercise,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5691/10465
diabetesduration  mean ( sd )  y,C0444504;C2699239;C2347634;C2348143,false;false;false;false,5692/10465
median feno  ppba,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5693/10465
non - detectable / unknown,C1518422;C3830527;C0439673;C3541433;C4050014,false;false;false;false;false,5694/10465
primary enrollment diagnoses  n ( % ),C0332137;C1516879;C1696073;C3888021;C0801658,false;false;false;false;false,5695/10465
low hdl - c ( for men < nmbr   mg / dl / for women < nmbr   mg / dl ),C0151691;C0025266;C0053917;C0439269;C1334884,false;true;true;false;false,5696/10465
mean body mass index ( sd )  kg / mnmbr,C0444504;C0005893;C2699239;C0022718;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;false;true;false;false;false;true;false;false,5697/10465
ace inhibitor or angiotensin ii receptor,C0003015;C4541021,true;false,5698/10465
diet diet + pravastatin,C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,5699/10465
unspecified,C0205370;C1549663;C2983689;C4048188,false;false;false;false,5700/10465
atherosclerotic cardiovascular disease,C0004153,true,5701/10465
dilated cardiomyopathy,C0007193;C2984282,true;false,5702/10465
participation in phase a,C0679823;C0205390;C1710475,false;false;false,5703/10465
region of enrollment,C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,5704/10465
white race  n ( % ),C0007457;C0043157,true;true,5705/10465
after amendment,C0680532;C2346732,false;false,5706/10465
laba + ics versus indzgly lsm difference ( nmbr % cl ),C0815320;C4551720,false;true,5707/10465
number of patients > nmbr years ( % ),C2360800;C0053917;C0439234;C1334884,false;true;false;false,5708/10465
hypoglycemia,C0020615;C4553659,true;false,5709/10465
gold stage [n ( % ) ],C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,5710/10465
not treated,C1518422,false,5711/10465
motor subscale ( range  nmbr - nmbr ),C1513492;C1514721;C0053917;C1334884;C2348147;C3542016;C1705994,false;false;true;false;false;false;false,5712/10465
feno + eze,,,5713/10465
total group,C0439175;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0439810,false;false;false;true;false;false;false;false,5714/10465
asthma control test score at baseline,C2733224;C0168634;C1442488,false;true;false,5715/10465
lipid values  mmol / l,C0023779;C0042295;C1532563,true;false;false,5716/10465
esr  nmbr - nmbr mm / hour,C3811131;C0053917;C4330985;C0439227;C0564385;C4554674;C1334884,false;true;false;false;false;false;false,5717/10465
europe and canada,C0015176,true,5718/10465
total mayo score $ | |,C2964552;C0454788;C1077578,false;false;false,5719/10465
egfr  nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,5720/10465
as - needed inhalations / day,C1879745;C0004048;C0332173;C0439228;C0439505;C0354922;C1883728,false;true;false;false;false;false;false,5721/10465
warfarin  no . ( % ),C0043031,true,5722/10465
habitual fish intake : < nmbr servings / wk ( n = nmbr ),C0205353;C0556216;C0053917;C1519269;C0332174;C0439230;C1334884,false;false;true;false;false;false;false,5723/10465
number resulting in hospital admission,C0237753;C0449788,false;false,5724/10465
infarction > nmbr days previously,C0021308;C0053917;C0439228;C1334884,true;true;false;false,5725/10465
pasi score ( nmbr - nmbr ) t  mean ( sd ),C4528685;C0449820;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C4050231,false;false;true;false;false;false;false;false;false,5726/10465
index mi ( n - nmbr  nmbr ),C0600653;C3810814;C0053917;C1334884;C0918012;C1552854;C1637833;C2986546,true;false;true;false;true;false;false;false,5727/10465
> nmbr % coronary stenosis,C0053917;C0242231;C1334884,true;true;false,5728/10465
mean ( s . d . ) egfr  ml / min / nmbr . nmbr mnmbr,C0444504;C1739039;C0439445;C0053917;C1334884;C3811844;C3812682;C2347634;C2348143,false;true;false;true;false;false;false;false;false,5729/10465
triglycerides  mmol / l  mean ± sd,C0041004;C1532563;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,5730/10465
losartan + lisinopril,C0126174;C0065374,true;true,5731/10465
male  n / n ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,5732/10465
isolated deep - vein thrombosis,C0205409;C0149871;C1548221,false;true;false,5733/10465
esrd or death,C0022661;C0035078;C2316810,true;true;false,5734/10465
tiotropium nmbr . nmbr mg,C0213771;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5735/10465
other major risk factors,C0205082;C0035648;C1553898;C0205164;C4318856;C4521762,false;true;false;false;false;false,5736/10465
csf lathosterol ( | jlg / cll ),C3540512;C0064673;C0023434;C3889436,false;true;true;false,5737/10465
diagnosis at presentation — no . ( % ),C0011900;C0449450;C1704338;C1704656,true;false;true;false,5738/10465
number of concomitant csdmards  n ( % ),C0237753;C0521115;C0449788,false;false;false,5739/10465
radiographic characteristics at baseline and randomization,C0444708;C4684572,false;false,5740/10465
probability " of event %,C0033204;C0441471;C4019010,true;false;false,5741/10465
d - dimer ( ng / ml ),C0060323;C0439275,true;false,5742/10465
insulin  median ( ql  qnmbr )  pmol / l,C0021641;C0549183;C0439284;C0876920;C2347635;C2348144;C2939193;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,5743/10465
cerebrovascular,C1880018,false,5744/10465
methotrexate use at randomisation,C0025677;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,5745/10465
method of identification ofstenosis ( % ),C1301921,false,5746/10465
treatment of the index ml,C0039798;C0600653;C0439526;C1705224;C3887665;C0918012;C1552854;C1637833;C2986546;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;true;false;false;false;true;false;false;false;false;false,5747/10465
saba puffs per day at baseline,C1533107;C0332173;C0439228;C0439505,false;false;false;false,5748/10465
joint space narrowing score,C1859695;C0449820;C4050231,false;false;false,5749/10465
evolocumab nmbr mg monthly ( n = nmbr ),C3529352;C0053917;C0024671;C0332177;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,5750/10465
intent - to - treatb,C0162425;C1283828;C1550453,true;false;false,5751/10465
ace - i or angiotensin receptor blocker,C1452534;C0021966;C0221138;C4284014,true;true;false;false,5752/10465
body mass index > nmbr — no . ( % ) f,C0005893;C0053917;C1334884;C0578022;C1305855,false;true;false;false;true,5753/10465
mean change  % ( se ),C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,5754/10465
prebronchodilator fevnmbr / fvc,C2599602;C3714541,false;true,5755/10465
less than nmbr ml / min / nmbr . nmbrmnmbr,C0439092;C0053917;C0439445;C1334884,false;true;false;false,5756/10465
previous tia or stroke,C0205156;C0007787;C0917805;C1054154;C1552607,false;true;true;false;false,5757/10465
non - ischaemic aetiology,C1518422;C0475224;C0015127;C1314792;C1524003,false;false;true;true;false,5758/10465
stroke n = nmbr,C0038454;C0053917;C1334884;C4554100,true;true;false;false,5759/10465
crp concentration > nmbr mg / l  n ( % ) \,C3890735;C0086045;C0053917;C0439268;C1334884;C1446561;C3827302;C4048285,false;true;true;false;false;false;false;false,5760/10465
european quality of life - nmbr dimensions - nmbr level ( eq - nmbrd ),C0239307;C0034380;C0053917;C0439534;C0441889;C0205163;C0439185;C0456079;C1547707;C2946261;C1334884;C0518214;C1535514,false;true;true;false;false;false;false;false;false;false;false;false;false,5761/10465
major clinical response,C0205082;C4055223;C0205164;C4318856;C4521762,false;false;false;false;false,5762/10465
mean ham - d score ( nmbr % ci ),C3533236;C1570167;C0053917;C0008107;C3259781;C1334884;C3853311,false;true;true;true;false;false;false,5763/10465
bowel function,C0011135,true,5764/10465
laa ostium,C0444567,false,5765/10465
bnp o nmbr pg / ml or nt pro - bnp o nmbr pg / ml  n ( % ),C0054015;C0053917;C0439297;C1334884;C1095989;C1417808;C2982014,true;true;false;false;false;false;false,5766/10465
laa length,C1444754;C1706316,false;false,5767/10465
patient ' s preference not to take vka  only reason * *,C0376409,true,5768/10465
risk factors and immobility level  n ( % ),C0035648;C1553898,true;false,5769/10465
pasi score > nmbr *,C4528685;C0449820;C0053917;C1334884;C4050231,false;false;true;false;false,5770/10465
cardiac history,C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1522601,true;true;true;false;false;false;false;false,5771/10465
drug - eluting stent  n ( % ),C1322815,true,5772/10465
copd — no . ( % ) medication use,C0024117;C1412502;C3714496,true;false;false,5773/10465
interquartile range,C1711350,false,5774/10465
acute stroke of other determined cause,C0751956;C0521095;C0015127;C1524003,true;false;true;false,5775/10465
severe exacerbations  itt population  n ( % ),C0205082;C4086268;C0032659;C1257890;C4050465;C4050466,false;false;true;true;false;false,5776/10465
europe nmbr,C0015176;C0053917;C1334884,true;true;false,5777/10465
male gender ( % ),C0086582;C1706180,true;false,5778/10465
no . of vessels,C0005847,true,5779/10465
n - nmbr fatty acids - placebo lsm ( nmbr % cl ),C0369718;C0053917;C0015684;C0032042;C0596019;C1696465;C1706408;C1334884;C0441922,false;true;true;true;false;false;false;false;false,5780/10465
rheumatoid arthritis,C0003873,true,5781/10465
> nmbr % focal seizure frequency responders,C0053917;C0751495;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1334884,true;true;true;false;false;false;false;false;false;false;false;false,5782/10465
medication within nmbr days before enrolment,C0013227;C0053917;C0439228;C1334884;C3244316;C4284232,true;true;false;false;false;false,5783/10465
sex ( male ) - no . ( % ),C0086582,true,5784/10465
worsened,C1457868;C4084902,false;false,5785/10465
digoxin at enrollment,C0012265;C1516879;C1696073;C3888021,true;false;false;false,5786/10465
prostate cancer,C0376358;C0600139;C2984325;C3541264,true;false;false;false,5787/10465
pre - bronchodilator fvc ( l ),C2599602;C3714541,false;true,5788/10465
creatinine clearance,C0812399,false,5789/10465
no . of treated lesions,C1522326;C0221198,false;false,5790/10465
cholecystectomy ( n = nmbr ),C0008320;C0053917;C1334884,true;true;false,5791/10465
# of prior non - tnfi bdmards *,C0332152;C1518422;C2826257,false;false;false,5792/10465
immunosuppressive agents only,C0021081;C0205171;C1720467,true;false;false,5793/10465
enalapril ( n = nmbr ),C0014025;C0053917;C1334884,true;true;false,5794/10465
deep - vein thrombosis or pulmonary embolism — no . ( % ),C0149871,true,5795/10465
age - years  median ( iqr ),C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5796/10465
total no . of patients,C0439175;C0439810,false;false,5797/10465
n - nmbr fatty acids ( n = nmbr ),C0369718;C0053917;C0015684;C1334884;C0441922,false;true;true;false;false,5798/10465
baseline cv treatment,C0168634;C3538987;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4048877;C4318503;C1442488,true;false;true;true;false;false;false;false;false;true;false;false,5799/10465
selena - sledai ( range u - nmbrunmbr ) t,C0451528;C1514721;C0439148;C2348147;C3542016,false;false;false;false;false,5800/10465
bnp > nmbr pg / ml  n = nmbr,C0054015;C0053917;C0439297;C1334884;C1095989;C1417808;C2982014,true;true;false;false;false;false;false,5801/10465
ms & ng,C2349943;C0017887;C0028074;C3539704;C3713294,false;true;true;false;true,5802/10465
global assessment of disease status score,C0281858;C3176928;C0449820;C4050231,false;false;false;false,5803/10465
all patients ( n = nmbr ),C0030705;C0053917;C1334884,true;true;false,5804/10465
isolated impaired glucose tolerance — no .,C0205409;C1548221,false;false,5805/10465
angiographic extent of disease,C0002978;C0449279;C4553144,true;false;false,5806/10465
type of concomitant statin by daily dose - no . ( % ),C0332307;C0521115;C0360714;C1547052,false;false;true;false,5807/10465
postoperative nsaid or glucocorticoid use,C0032790;C0003211;C3536840,true;true;false,5808/10465
airflow reversibility — no . ( % ) |,C0231999;C0449261,false;false,5809/10465
devices,C0025080;C0220819;C0699733,true;true;true,5810/10465
age at enrollment ( years ),C1510829;C1516879;C1696073;C3888021,false;false;false;false,5811/10465
mean ( sd ) disease duration  years,C0444504;C2699239;C0872146;C0439234;C2347634;C2348143,false;false;false;false;false;false,5812/10465
race - white ( n = nmbr  nmbr ),C0034510;C1706779;C3853635,true;false;false,5813/10465
fluticasone furoate  n = nmbr,C1948374;C0053917;C1334884,true;true;false,5814/10465
baseline hbanmbrc  n ( % ),C0168634;C1442488,true;false,5815/10465
aldosterone antagonists ( e . g . spironolactone ),C0002007;C2757004,true;false,5816/10465
pci duration in min ( median  iqr ),C4049621;C0449238;C0702093;C0549183;C0876920;C2347635;C2348144;C2939193;C1524029;C3813700;C2926735,false;false;false;false;false;false;false;false;false;false;false,5817/10465
age > nmbr years  n ( % ),C1510829;C0053917;C1334884,false;true;false,5818/10465
active cancer — no . ( % ),C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,5819/10465
insulina  n ( % ),,,5820/10465
skull  and facial bone fractures,C0037303;C2951888,true;false,5821/10465
nmbr - aminosalicylates {,C0053917;C0368663;C1334884,true;false;false,5822/10465
hemorrhagic stroke,C0553692,true,5823/10465
immy ( without corticosteroid )  n,C0001617;C3536709,true;false,5824/10465
renal function  normal - mild,C0232804;C0205307;C2945599;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false,5825/10465
log rank p - value,C1708728;C0667477;C1709380;C0699794;C2986775,false;true;false;false;false,5826/10465
prior myocardial infarction  n ( % ),C0155668,false,5827/10465
high - density lipoprotein,C0023821,true,5828/10465
antibodies to infliximab  n ( % ) * *,C3533054,false,5829/10465
safety : non - cabg - related bleeding,C0036043;C1518422;C0010055;C1705187,true;false;true;false,5830/10465
diabetes mellitus — no . ( % ),C0011849,true,5831/10465
mmrc grade  n ( % ),C3826977;C0441800;C0919553;C3244287,false;false;false;false,5832/10465
inspiratory capacity ( l ),C0021610;C0802663,true;false,5833/10465
hf  lvd  or both,C0018488;C1313497;C1538440;C3273279,true;true;false;false,5834/10465
percent of predicted fevnmbr,C1882327,false,5835/10465
ace inhibitor or angiotensin - receptor blocker — no . / total no . ( % ),C0003015;C4541021,true;false,5836/10465
diuretics group ( n = nmbr ),C0012798;C0441848;C0053917;C1334884,true;false;true;false,5837/10465
prior aortocoronary bypass surgery,C0455610;C0010055,false;true,5838/10465
neutrophils  nmbr / nl,C0027950;C0053917;C0027778;C0560008;C3892223;C1334884,true;true;true;false;false;false,5839/10465
antiplatelet or anti - inflammatory drugs,,,5840/10465
presentation of index event,C0449450;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,5841/10465
statin at enrollment,C0360714;C1516879;C1696073;C3888021,true;false;false;false,5842/10465
ethnicitya hispanic or latino,C0086409,true,5843/10465
waist circumference snmbr ( men ) or > nmbr cm ( women ),C0455829;C0025266,true;true,5844/10465
baseline mssbp / msdbp  mm hg,C0168634;C0439475;C1442488,true;false;false,5845/10465
hispanic american,C0019576,true,5846/10465
hba]c ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,5847/10465
men / women,C0025266;C0043210,true;true,5848/10465
pbo ( nnmbr nmbr ),C0031962;C0053917;C1334884,true;true;false,5849/10465
creatinine clearance < nmbr ml / min ( % ),C0812399;C0053917;C0439445;C1334884,false;true;false;false,5850/10465
total comparators ( n = nmbr ),C0439175;C1707454;C0053917;C1334884;C4553389;C4553390;C0439810,false;false;true;false;false;false;false,5851/10465
heart rate ( b . p . m . ),C0018810;C0369637;C0441923,true;false;false,5852/10465
smoking history  n ( % ),C1519384,false,5853/10465
disease duration  mean yr ( sd ),C0872146;C0444504;C0439234;C2699239;C2347634;C2348143,false;false;false;false;false;false,5854/10465
high feno subgroup ( > nmbr . nmbr ppb ) ( n = nmbr ),C0205250;C1079230;C0053917;C1415800;C1334884;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false;false,5855/10465
hbanmbrc in patients with baseline hbanmbrc < nmbr % ( < nmbr mmol / l )  % [mmol / mol]  la  n baseline ( sd ) adjusted mean change ( nmbr % ci ) placebo - subtracted change ( se ),C0030705,true,5856/10465
overall event rate,C0282416;C0441471;C0871208;C1521828;C4019010;C1561607,true;false;false;false;false;false,5857/10465
prior biologic therapeutic failures  n ( % ),C0332152;C0005515;C0087111;C0231174;C0680095;C0302350;C0205460;C2826257,false;true;true;false;false;false;false;false,5858/10465
losartan plus lisinopril ( n = nmbr ),C0126174;C0332287;C0065374;C0053917;C1334884,true;false;true;true;false,5859/10465
us site of enrollment,C2945843;C1516879;C1696073;C3888021,false;false;false;false,5860/10465
killip class lll - iv,C2697847;C1261077,false;false,5861/10465
coronary artery osteochondrosis,C0205042;C0029376;C0029429;C0729346,true;true;true;false,5862/10465
time from onset of pain to randomization  median ( nmbrth — nmbrth percentiles )  n,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,5863/10465
subset of patients not on metformin,C1515021;C0030705,false;true,5864/10465
no persistent wrf ( n = nmbr  nmbr ),C0205322;C0053917;C1334884;C0332996,false;true;false;false,5865/10465
clopidogrel plus aspirin % / yr,C0070166;C0332287;C0004057;C0439234,true;false;true;false,5866/10465
percutaneous coronary revascularization,C1532338,true,5867/10465
plus metformin,C0332287;C0025598,false;true,5868/10465
calcium - channel inhibitor,C0006685;C1999216,true;false,5869/10465
uacra  mg / g  gmean = gcv,C1300563;C0017066,false;true,5870/10465
cure trial,C1880198;C0008976,false;true,5871/10465
ratio ( nmbr % ci ) *,C0456603;C0053917;C0008107;C3259781;C1334884;C1547037,false;true;true;false;false;false,5872/10465
baseline pre - bronchodilator fevnmbr  l,C0168634;C2599602;C1442488,true;false;false,5873/10465
physical component summary,C0031809;C0449432;C1552616;C1706244;C1705248;C0205485;C1509143,true;false;false;false;false;false;false,5874/10465
placebo croup  n / n ( % ),C0032042;C0010380;C1696465;C1706408,true;true;false;false,5875/10465
smoking status at screening,C1519386;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0037369;C0421330;C0453996;C1881674,false;true;true;false;false;false;false;false;true;false;true;false,5876/10465
copd medication taken for at least nmbr months before st,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,5877/10465
st - segment - elevation myocardial infarction — no . ( % ),C1536220,true,5878/10465
ada nmbr / nmbr ( n[nmbr ),C1060325;C0053917;C1334884;C3811629,false;true;false;false,5879/10465
previous segmental resection — no . ( % ),C0205156;C2987624;C1552607,false;false;false,5880/10465
older patients ( aged > nmbr years ),C0580836;C0030705,false;true,5881/10465
pre - operative cardiac medications *,C2347660;C1882154;C0018787;C1522601,false;false;true;false,5882/10465
other forms of,C0348078;C0376315,false;true,5883/10465
mean ( s . d . ) hbalc  mmol / mol,C0444504;C3829066;C2347634;C2348143,false;false;false;false,5884/10465
number of ( % ) patients > nmbr years,C2360800;C0053917;C0439234;C1334884,false;true;false;false,5885/10465
ck - mb  ng / ml,C0010290;C0439275,true;false,5886/10465
prior cardiovascular disease,C0332152;C0007222;C2826257,false;true;false,5887/10465
current / past smoker,C3173209;C1444637;C4284302;C3241966,false;false;false;false,5888/10465
on - pump time : < l : nmbrhrs : min ( n = nmbr ),C3842462;C0040223;C0702093;C0053917;C1334884;C1524029;C3813700;C3541383,false;true;false;true;false;false;false;false,5889/10465
diuretic — no . ( % ) surgery,C0012798,true,5890/10465
< nmbr ml / min / nmbr . nmbr mnmbr  n ( % ),C0053917;C0439445;C1334884,true;false;false,5891/10465
types of fibrinolytic agent,C0332307;C0016018,false;true,5892/10465
u » c » ( mg / g ),C1532633;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2608091;C1638407;C0439267;C0439148;C1300563,false;true;true;false;false;false;false;false;false;false;false;false;false,5893/10465
anticoagulant group ( n = nmbr ),C0003280;C0441848;C0053917;C1334884;C0848112;C3536711,true;false;true;false;false;false,5894/10465
< nmbr yr of education — no . ( % ),C0053917;C0439234;C0013621;C0013622;C0013658;C0039401;C1334884,true;false;true;true;true;true;false,5895/10465
non - colorectal cancer,C1518422;C0009402;C0346629;C1527249;C2984278;C3542412,false;true;false;true;false;false,5896/10465
all bleeding,,,5897/10465
hbalc ( % )  mean ( sd ) ^,C0444504;C2699239;C2347634;C2348143,false;false;false;false,5898/10465
simvastatin nmbr mg ( n = nmbr  nmbr ),C0074554;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,5899/10465
losmapimod ( n = nmbr ),C3272847;C0053917;C1334884,true;true;false,5900/10465
number of e,C0237753;C0449788,false;false,5901/10465
region  europe union,C0017446;C0015179;C0205147,true;true;false,5902/10465
hydochlorothiazide ( n = nmbr ),C0053917;C1334884,true;false,5903/10465
continued treatment study,C0549178;C3161471,false;false,5904/10465
death / q - wave mi / idr,C0011065;C0861151;C1306577;C4082313;C4552775,true;false;false;false;false,5905/10465
p value for trend,C1709380;C1521798;C4554533,false;false;false,5906/10465
time since diagnosis of heart failure,C0040223;C3541383,true;false,5907/10465
mean ( s . d . ) ldl particle size  nm,C0444504;C3641256;C0203634;C0312860;C3890923;C2347634;C2348143,false;false;false;false;false;false;false,5908/10465
single vessel pci,C0037179;C0005847;C4049621;C0087136;C0205171,true;true;false;true;false,5909/10465
pfo with mild - to - moderate shunt and atrial septal aneurysm,C1299392;C0232180;C0542331;C1442858,false;false;false;false,5910/10465
obesity ( bmi > nmbr kg / mnmbr )  %,C0028754;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1963185,true;false;true;true;false;false;false;false,5911/10465
colon only,C0009368;C0205171;C1720467;C3888384,true;false;false;false,5912/10465
lp ( a ) ( week nmbr ),C0065058;C0332174;C0053917;C1334884;C0439230;C1439335;C4553379,true;false;true;false;false;false;false,5913/10465
n - nmbr pufa events / patients ( % ),C0369718;C0053917;C0032615;C0441471;C0030705;C3541888;C1334884;C0441922,false;true;true;false;true;false;false;false,5914/10465
arthritis type *,C0003864;C0332307;C1547052;C4552845,true;false;false;false,5915/10465
aml / val  nmbr / nmbr mg rr = nmbr *,C0023465;C0042285;C0053917;C0024671;C4554402;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0523975;C0023467,true;true;true;true;false;true;false;false;false;false;false;false;false;true,5916/10465
in emergency department before ambulance transfer,C0562508;C0002422;C0040671;C1705822;C4319192;C3846685,true;true;true;false;false;false,5917/10465
gold d,C0018026;C1304897,true;false,5918/10465
saaca,,,5919/10465
ecg,C1623258,true,5920/10465
之 nmbr,C0053917;C1334884,true;false,5921/10465
total ( n = nmbr ),C0439175;C0053917;C1334884;C0439810,false;true;false;false,5922/10465
race  %,C0034510;C1706779;C3853635,true;false;false,5923/10465
race — no . ( % ) |,C0034510;C1706779;C3853635,true;false;false,5924/10465
% nmbr - nmbr,C0053917;C1334884,true;false,5925/10465
severe,C0205082;C4050465;C4050466,false;false;false,5926/10465
pbo  n = nmbr,C0031962;C0053917;C1334884,true;true;false,5927/10465
bnp,C0054015;C1095989;C1417808;C2982014,true;false;false;false,5928/10465
male sex  ( % ),C0086582,true,5929/10465
females  %,C0086287,true,5930/10465
< nmbr mm,C0053917;C4330985;C4554674;C1334884,true;false;false;false,5931/10465
snmbr %,,,5932/10465
age ' ^nmbr yrs,C0001779;C0053917;C1334884,false;true;false,5933/10465
atvnmbr mg ( n = nmbr ),C0024671;C0053917;C1334884;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,5934/10465
female  no . ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,5935/10465
> nmbr mo,C0053917;C0026544;C0332177;C1334884,true;true;false;false,5936/10465
male sex — %,C0086582,true,5937/10465
lvh,C0149721,true,5938/10465
stent,C0038257,true,5939/10465
acrnmbr,,,5940/10465
diet,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5941/10465
cg / ld,C0043444;C0694649;C1567075;C3540479,true;false;true;false,5942/10465
age ( years ) *,C1510829,false,5943/10465
nonsmoker,C0337672;C0425293;C4554605,false;false;true,5944/10465
ics use,C0815320;C4551720,false;true,5945/10465
no ( % ),,,5946/10465
lips,C0023759,true,5947/10465
≤ nmbr,C0053917;C1334884,true;false,5948/10465
ocs,,,5949/10465
tg < = nmbr . nmbr,C0337445;C0053917;C1334884,false;true;false,5950/10465
vka,,,5951/10465
rate * ( n ),C0871208;C1521828,false;false,5952/10465
statin ( n - nmbr ),C0360714;C0053917;C1334884,true;true;false,5953/10465
« snmbr - nmbr,C0053917;C1334884,true;false,5954/10465
nmbr to < nmbrmmhg,C0053917;C1334884,true;false,5955/10465
males ( % ),C0086582,true,5956/10465
三 nmbr to < nmbr,C0053917;C1334884,true;false,5957/10465
cough,C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,5958/10465
> median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5959/10465
smoking *,C0037369;C0453996;C1881674,true;true;false,5960/10465
etd ( nmbr % ci ),C1180255;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,5961/10465
% ( se ),C0036919,true,5962/10465
pm  n ( % ),C0030266;C4049155,true;false,5963/10465
placebo  n ( % ),C0032042;C1696465;C1706408,true;false;false,5964/10465
n ( % ),C0369718;C0441922,false;false,5965/10465
> nmbr beds,C0053917;C0004916;C1334884,true;true;false,5966/10465
number,C0237753;C0449788,false;false,5967/10465
male  no ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,5968/10465
> nmbr years ( n = nmbr ),C0053917;C0439234;C1334884,true;false;false,5969/10465
femaleb,,,5970/10465
< nmbr hr,C0053917;C1334884,true;false,5971/10465
> nmbr to < nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,5972/10465
deaths,C0011065;C1306577,true;false,5973/10465
uvb,C0454530;C0564461,false;false,5974/10465
asian ( n — nmbr ),C0078988;C0053917;C1334884,true;true;false,5975/10465
bms,,,5976/10465
p - int,C0369773;C3272375;C2603361,false;false;false,5977/10465
l ’ - value ’,C0439394;C1522609;C1706495;C3642217,false;false;false;false,5978/10465
abnormal,C0205161;C2347472;C2699333,false;false;false,5979/10465
placebo,C0032042;C1696465;C1706408,true;false;false,5980/10465
crt,,,5981/10465
sex :,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,5982/10465
icd,C0021122,true,5983/10465
cabg,C0010055,true,5984/10465
≤ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5985/10465
nmbr - nmbr ft,C0053917;C1881534;C3890579;C1334884,true;false;false;false,5986/10465
lad,,,5987/10465
nmbr yrs,C0053917;C1334884,true;false,5988/10465
hs - crp,C3890735;C4048285,false;false,5989/10465
no prior llt,C0332152;C2347090;C2826257,false;false;false,5990/10465
range,C1514721;C2348147;C3542016,false;false;false,5991/10465
phi ( n = nmbr ),C1333690;C0053917;C1334884;C1704947;C1706536;C2975867;C4084801,false;true;false;false;false;true;false,5992/10465
> nmbr h,C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,5993/10465
women ( n = nmbr ),C0043210;C0053917;C1334884,true;true;false,5994/10465
> nmbr - < nmbr years,C0053917;C0439234;C1334884,true;false;false,5995/10465
men ( % ),C0025266,true,5996/10465
> nmbr ug / g,C0053917;C0439272;C1334884,true;false;false,5997/10465
cdai,C0683448;C1413248;C3273706,false;false;false,5998/10465
age nmbr,C0001779;C0053917;C1334884,false;true;false,5999/10465
age > = nmbr years,C1510829;C0053917;C1334884,false;true;false,6000/10465
hbalc < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6001/10465
arr ( nmbr % ci ),C2170357;C0053917;C0008107;C3259781;C1334884;C4084934,false;true;true;false;false;false,6002/10465
msdbp,,,6003/10465
ato nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6004/10465
redon,,,6005/10465
daily,C0332173,false,6006/10465
placebo n / n ( % ),C0032042;C1696465;C1706408,true;false;false,6007/10465
statin ( n = nmbr ),C0360714;C0053917;C1334884,true;true;false,6008/10465
white,C0007457;C0043157;C0220938,true;true;false,6009/10465
blockers,,,6010/10465
idr,,,6011/10465
p - valuec,C0369773;C2603361,false;false,6012/10465
nmbr ( > nmbr % ),C0053917;C1334884,true;false,6013/10465
≥ nmbr . nmbr years,C0053917;C0439234;C1334884,true;false;false,6014/10465
men  %,C0025266,true,6015/10465
anmbr n = nmbr,C0053917;C1334884,true;false,6016/10465
p valued,C0369773;C2603361,false;false,6017/10465
study,C0557651;C2603343,false;false,6018/10465
> nmbr % nmbr,C0053917;C1334884,true;false,6019/10465
no pci,C4049621,false,6020/10465
igm,,,6021/10465
ex - smoker,C0337671;C4555205,false;true,6022/10465
etn  no,C0014758;C0717758,true;true,6023/10465
rales  n ( % ),C0034642;C0240859,true;false,6024/10465
pooled,C1709595;C2349200;C4522255,false;false;false,6025/10465
total,C0439175;C0439810,false;false,6026/10465
female sex ( % ),C0086287,true,6027/10465
acs,C0742343;C4318612,true;false,6028/10465
nmbr . nmbr min,C0053917;C0702093;C1524029;C3813700;C1334884,true;false;false;false;false,6029/10465
motor,C1513492;C1705994,false;false,6030/10465
apo bt,,,6031/10465
age  years,C1510829,false,6032/10465
asian  n ( % ),C0078988,true,6033/10465
age < nmbr yr,C0001779;C0053917;C0439234;C1334884,false;true;false;false,6034/10465
hr nmbr % cl,C0053917;C0596019;C1334884,true;false;false,6035/10465
sal nmbr mg,C0036140;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0037494;C0206136,true;true;true;true;false;false;false;false;false;false;true;true,6036/10465
frail,C0871754,false,6037/10465
> lnmbr years,C0439234,false,6038/10465
iv ( n z nmbr ),C0022326;C0053917;C1334884;C4265176,true;true;false;false,6039/10465
( nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,6040/10465
* p value,C1709380,false,6041/10465
arb,C3888198,false,6042/10465
oad,,,6043/10465
fema le,C0023190;C0439090;C1423767;C2697858,true;false;false;false,6044/10465
nmbr enmbr years,C0053917;C0439234;C1334884,true;false;false,6045/10465
black ( n = nmbr ),C0005680;C0053917;C1334884;C0027567;C0085756;C0439541,true;true;false;true;true;false,6046/10465
missing,C1551393;C1705492;C3272743,false;false;false,6047/10465
single,C0037179;C0087136;C0205171,true;true;false,6048/10465
events ( % ),C0441471;C3541888,false;false,6049/10465
> nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,6050/10465
s,C0565930;C2603362,false;false,6051/10465
< nmbr ng / ml,C0053917;C0439275;C1334884,true;false;false,6052/10465
rr ( nmbr % ci ),C4554402;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,6053/10465
result,C1274040;C1546471;C2825142,false;false;false,6054/10465
age > nmbr years  %,C1510829;C0053917;C1334884,false;true;false,6055/10465
patients n,C0030705,true,6056/10465
placebo [n = nmbr |,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6057/10465
nmbr % cl,C0053917;C0596019;C1334884,true;false;false,6058/10465
nmbr nmbr,C0053917;C1334884,true;false,6059/10465
> nmbr %,C0053917;C1334884,true;false,6060/10465
hbak < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6061/10465
yes,C1549445;C1705108;C1710701,false;false;false,6062/10465
> nmbr yr sex,C0053917;C0439234;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C1334884,true;false;true;true;true;false;false;true;false,6063/10465
< nmbr,C0053917;C1334884,true;false,6064/10465
> = nmbr years,C0053917;C0439234;C1334884,true;false;false,6065/10465
nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,6066/10465
ascvd  n ( % ),C3665365,false,6067/10465
lgm ( n = nmbr ),C0053917;C1334884,true;false,6068/10465
mace,C0349381;C0949745;C1445339,false;true;false,6069/10465
neither,,,6070/10465
> = nmbrkg,,,6071/10465
( se ) t *,C0036919,true,6072/10465
esrd,C0022661;C0035078;C2316810,true;true;false,6073/10465
placebo n[nmbr,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6074/10465
death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,6075/10465
mtx,C0025677;C1417487,true;false,6076/10465
loop,C0445022,false,6077/10465
japanese,C0376247;C1556094,false;true,6078/10465
chda,,,6079/10465
> nmbr lb,C0053917;C1334884,true;false,6080/10465
age ( years ) +,C1510829,false,6081/10465
l ( % ),C0439394;C1706495;C3642217,false;false;false,6082/10465
chadsnmbr,,,6083/10465
( n = nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,6084/10465
new om,C0205314;C0028971;C1705272,false;true;false,6085/10465
nmbr % nmbr,C0053917;C1334884,true;false,6086/10465
former  n ( % ),C0205156;C0750523,false;false,6087/10465
b lack,C0332268,false,6088/10465
median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6089/10465
nmbr — < nmbr years,C0053917;C0439234;C1334884,true;false;false,6090/10465
hdl - cd,C3715113;C0007928;C0034283;C4552032,false;true;true;false,6091/10465
low,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,6092/10465
> nmbr ( n — nmbr ),C0053917;C1334884,true;false,6093/10465
rr *,,,6094/10465
iii / iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6095/10465
pla,C0456170,false,6096/10465
hr,,,6097/10465
placebo ,C0032042;C1696465;C1706408,true;false;false,6098/10465
bmi < nmbr,C0578022;C0053917;C1334884,false;true;false,6099/10465
nmbr . nmbr yrs,C0053917;C1334884,true;false,6100/10465
plac,C0048838,true,6101/10465
women  n ( % ),C0043210,true,6102/10465
other  n ( % ),C0369718;C0441922,false;false,6103/10465
lmwh,C0019139;C3536766,true;false,6104/10465
mexico,C0025885,true,6105/10465
lcznmbr ( n = nmbr ),C0053917;C1334884,true;false,6106/10465
nmbr % cit,C0053917;C0008864;C0523573;C1427027;C4553421;C1334884,true;true;false;false;false;false,6107/10465
black ( n — nmbr ),C0005680;C0053917;C1334884;C0027567;C0085756;C0439541,true;true;false;true;true;false,6108/10465
< nmbr yr,C0053917;C0439234;C1334884,true;false;false,6109/10465
< nmbr » < nmbry,C0053917;C1334884,true;false,6110/10465
hba „ ( % ),C0019016;C1825777;C3538758,true;false;false,6111/10465
htn,C0020538,true,6112/10465
p for i,C0369773;C0021966;C0221138;C2603361,false;true;false;false,6113/10465
af,C0344434;C4049859,false;false,6114/10465
# nmbr year,C0053917;C0439234;C0439508;C1334884,true;false;false;false,6115/10465
beta - blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6116/10465
naive ( n = nmbr ),C0053917;C1334884,true;false,6117/10465
changenmbr,,,6118/10465
< lnmbr years,C0439234,false,6119/10465
treated,C1522326,false,6120/10465
tnmbrd,,,6121/10465
mtx n = nmbr,C0025677;C0053917;C1334884;C1417487,true;true;false;false,6122/10465
white ( n — nmbr ),C0007457;C0053917;C1334884;C0043157;C0220938,true;true;false;true;false,6123/10465
pasi *,C4528685,false,6124/10465
aged ^nmbr years,C0001779;C0053917;C0439234;C1334884;C0001792;C1999167,false;true;false;false;true;false,6125/10465
> nmbr - < nmbr mmhg,C0053917;C0439475;C1334884,true;false;false,6126/10465
copd ( n = nmbr ),C0024117;C0053917;C1334884;C1412502;C3714496,true;true;false;false;false,6127/10465
nmbrto < nmbrmmhg,,,6128/10465
nmbr +,C0053917;C1334884,true;false,6129/10465
< nmbrkg,,,6130/10465
< nmbr ( n — nmbr ),C0053917;C1334884,true;false,6131/10465
bmi > nmbr,C0578022;C0053917;C1334884,false;true;false,6132/10465
lsm ( nmbr % ci ),C0053917;C0008107;C3259781;C1334884,true;true;false;false,6133/10465
dd,C3538867;C3814791,false;false,6134/10465
x / n,,,6135/10465
age yrs,C0001779,false,6136/10465
diet alone,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,6137/10465
sfc ( n [nmbr ),C4521536;C0053917;C1334884,false;true;false,6138/10465
> nmbr / > nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,6139/10465
former,C0205156;C0750523,false;false,6140/10465
< nmbr ft,C0053917;C1881534;C3890579;C1334884,true;false;false;false,6141/10465
■ nmbr years,C0053917;C0439234;C1334884,true;false;false,6142/10465
nmbr - nmbr years,C0053917;C0439234;C1334884,true;false;false,6143/10465
p value *,C1709380,false,6144/10465
beta blocker,C0001645,true,6145/10465
< nmbr years ( n = nmbr ),C0053917;C0439234;C1334884,true;false;false,6146/10465
beta - blocker  %,C0001645,true,6147/10465
race ( % ) $,C0034510;C1706779;C3853635,true;false;false,6148/10465
fibrate,,,6149/10465
primary pci,C0205225;C4049621;C0439612;C0439631,false;false;false;false,6150/10465
egfr,C1739039;C3811844;C3812682,true;false;false,6151/10465
colon,C0009368;C3888384,true;false,6152/10465
n,C0369718;C0441922,false;false,6153/10465
arb  n ( % ),C3888198,false,6154/10465
aphasia,C0003537,true,6155/10465
heparin,C0019134;C0770546,true;false,6156/10465
white  %,C0007457;C0043157;C0220938,true;true;false,6157/10465
low ’,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,6158/10465
f emale,C0016327,true,6159/10465
igm ( n = nmbr ),C1706005;C0053917;C1334884,false;true;false,6160/10465
> nmbr nmbr,C0053917;C1334884,true;false,6161/10465
< nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6162/10465
ics : yes,C0815320;C1549445;C1705108;C1710701;C4551720,false;false;false;false;true,6163/10465
< nmbr ml,C0053917;C0439526;C1705224;C3887665;C1334884,true;false;false;false;false,6164/10465
placebo ( n = nmbr,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6165/10465
unprovoked,,,6166/10465
strategy,C0679199,false,6167/10465
asia ( n = nmbr ),C0003980;C0053917;C1334884,true;true;false,6168/10465
region  %,C0017446;C0205147,true;false,6169/10465
cse] +,,,6170/10465
age > nmbr y * *,C0001779;C0053917;C1334884,false;true;false,6171/10465
i % nmbr,C0021966;C0053917;C1334884;C0221138,true;true;false;false,6172/10465
mca,C0149566,true,6173/10465
taci ( n = nmbr ),C0666480;C0053917;C1334884;C1425349;C4284230,true;true;false;false;false,6174/10465
hdl - c,C3715113,false,6175/10465
medium,C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false,6176/10465
placebo ( n = nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6177/10465
women men,C0043210;C0025266,true;true,6178/10465
both,,,6179/10465
rca  n ( % ),,,6180/10465
events,C0441471;C3541888,false;false,6181/10465
patients  n,C0030705,true,6182/10465
italy,C0022277,true,6183/10465
 nmbr,C0053917;C1334884,true;false,6184/10465
> nmbr - nmbr years,C0053917;C0439234;C1334884,true;false;false,6185/10465
snmbr,,,6186/10465
chf,C0018802,true,6187/10465
^ - blockers,,,6188/10465
nmbr ( n = nmbr ),C0053917;C1334884,true;false,6189/10465
ale,C0678386;C2632076,false;false,6190/10465
p valuea,C0369773;C2603361,false;false,6191/10465
age ( yrs ),C0001779,false,6192/10465
≤ nmbr %,C0053917;C1334884,true;false,6193/10465
nmbrmg,,,6194/10465
placebo n = nmbr,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6195/10465
anemia,C0002871;C1000483;C4554633,true;false;false,6196/10465
eze,,,6197/10465
mean *,C0444504;C2347634;C2348143,false;false;false,6198/10465
atv nmbr mg,C0210243;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0674679;C1145759;C1334862,true;true;true;true;false;false;false;false;false;false;true;true;false,6199/10465
ef nmbr - nmbr %,C0053917;C1334884,true;false,6200/10465
open — no . ( % ),C0175566,false,6201/10465
oriental,C0078988;C0699027,true;false,6202/10465
\nmbr %,C0053917;C1334884,true;false,6203/10465
anakinra,C0245109,true,6204/10465
of patients,C0030705,true,6205/10465
arb  %,C3888198,false,6206/10465
sex  men ( % ),C0009253;C0025266;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;false;false;true,6207/10465
sedbp,,,6208/10465
£ nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,6209/10465
japan,C0022341,true,6210/10465
> nmbr hrs,C0053917;C1568891;C1334884,true;true;false,6211/10465
female ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6212/10465
hbak > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6213/10465
aspirin  n ( % ),C0004057,true,6214/10465
other — no . ( % ),,,6215/10465
male ( n z nmbr ),C0086582;C0053917;C1334884;C1706180;C1706428;C1706429,true;true;false;false;false;false,6216/10465
dm absent,C0011816;C3250443,true;false,6217/10465
vora,,,6218/10465
* nmbr to < nmbry,C0053917;C1334884,true;false,6219/10465
male,C0086582;C1706180;C1706428;C1706429,true;false;false;false,6220/10465
never smoking,C2003901,false,6221/10465
female sex — no . ( % ),C0086287,true,6222/10465
( gm ),C0017480;C3854019,true;true,6223/10465
st +,C0036056;C3272372,true;false,6224/10465
≥ nmbr to < nmbr %,C0053917;C1334884,true;false,6225/10465
aqe inmbr,,,6226/10465
n / pyr,C0369718;C0441922,false;false,6227/10465
< nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,6228/10465
apobe,,,6229/10465
age : > nmbr years,C1510829;C0053917;C1334884,false;true;false,6230/10465
crci > nmbr,C0053917;C1334884,true;false,6231/10465
nmbr mg bid,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6232/10465
psa ( n = nmbr ),C3810537;C0053917;C1334884;C3813209,false;true;false;false,6233/10465
ldl *,,,6234/10465
pin /,C0175718;C1168556;C1704584,true;false;false,6235/10465
overall,C0282416;C1561607,true;false,6236/10465
( se]tf,C0036919;C4048299;C4048587,true;false;false,6237/10465
oa,C0029408;C3887876,true;false,6238/10465
grade nmbr,C0441800;C0053917;C1334884;C0919553;C3244287,false;true;false;false;false,6239/10465
off omt,,,6240/10465
gold a,C0018026;C1304897,true;false,6241/10465
no ascvd,C3665365,false,6242/10465
mean bmi,C0444504;C0578022;C2347634;C2348143,false;false;false;false,6243/10465
female sex,C0086287,true,6244/10465
serum,C0229671;C1546774;C1550100,true;false;false,6245/10465
othersc,,,6246/10465
eze nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6247/10465
crt - p,,,6248/10465
itherchdt,,,6249/10465
dm present,C0011816;C0150312;C0449450;C3250443,true;false;false;false,6250/10465
non - smoker,C0337672;C0425293;C4554605,false;false;true,6251/10465
> = nmbr - < nmbr mmhg,C0053917;C0439475;C1334884,true;false;false,6252/10465
nmbr or nmbr days,C0053917;C1334884,true;false,6253/10465
group d,C0441838,false,6254/10465
age  nmbr years,C1510829;C0053917;C1334884,false;true;false,6255/10465
placebo pts / n ( % ),C0032042;C1419129;C2698747;C1696465;C1706408,true;false;false;false;false,6256/10465
= snmbr,,,6257/10465
nmbr - nmbr min,C0053917;C0702093;C1524029;C3813700;C1334884,true;false;false;false;false,6258/10465
ii ( n = nmbr ),C1710602;C0053917;C1334884;C4082587,false;true;false;false,6259/10465
rectum,C0034896,true,6260/10465
age  yrs *,C0001779,false,6261/10465
total *,C0439175;C0439810,false;false,6262/10465
 nmbr ( n = nmbr ),C0053917;C1334884,true;false,6263/10465
< nmbr . nmbr %,C0053917;C1334884,true;false,6264/10465
cana nmbrmg ( n = nmbr ),C1418845;C0053917;C1334884,false;true;false,6265/10465
mae,C0286540;C4085238,true;false,6266/10465
nmbr % - nmbr %,C0053917;C1334884,true;false,6267/10465
^nmbr - nmbr,C0053917;C1334884,true;false,6268/10465
on omt,,,6269/10465
race — no . ( % ),C0034510;C1706779;C3853635,true;false;false,6270/10465
age : < nmbr years,C1510829;C0053917;C1334884,false;true;false,6271/10465
hdl - cy,C3715113;C0010622;C0332298;C2239193,false;true;false;false,6272/10465
≥ nmbr %,C0053917;C1334884,true;false,6273/10465
africa,C0001737,true,6274/10465
cardiac,C0018787;C1522601,true;false,6275/10465
feno nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6276/10465
lvef < nmbr %,C0428772;C0053917;C1334884;C0488728,false;true;false;false,6277/10465
pa,C0030428;C3541314,true;false,6278/10465
hr ( nmbr % ci ),C0053917;C0008107;C3259781;C1334884,true;true;false;false,6279/10465
nsaid,C0003211;C3536840,true;false,6280/10465
pe,C0070939;C1880476;C4284304,true;false;false,6281/10465
white ( n = nmbr ),C0007457;C0053917;C1334884;C0043157;C0220938,true;true;false;true;false,6282/10465
placebo n ( % ),C0032042;C1696465;C1706408,true;false;false,6283/10465
egfr > nmbr,C1739039;C0053917;C1334884;C3811844;C3812682,true;true;false;false;false,6284/10465
other *,,,6285/10465
> nmbr . nmbr yrs,C0053917;C1334884,true;false,6286/10465
past,C1444637;C4284302,false;false,6287/10465
< nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,6288/10465
> nmbr % to < nmbr %,C0053917;C1334884,true;false,6289/10465
known chd,C0205309;C0280604;C3542407,false;false;false,6290/10465
sex  n ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6291/10465
nnt,C1417750,false,6292/10465
all ( n = nmbrf ),C0369718;C0441922,false;false,6293/10465
tia,C0007787;C0917805;C1054154,true;true;false,6294/10465
nmbr / nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6295/10465
mmse < nmbr,C0451306;C0053917;C1334884,true;true;false,6296/10465
> nmbr - nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,6297/10465
< nmbr . nmbr bpm,C0053917;C1334884,true;false,6298/10465
placebo ( n z nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6299/10465
locf ),C2825507,false,6300/10465
< nmbr days,C0053917;C0439228;C1334884,true;false;false,6301/10465
erosion,C0333307;C1880549;C1959609;C3887524,false;false;false;false,6302/10465
smokers  %,C0337664,true,6303/10465
weight,C0005910;C0043100;C1305866;C1705104,true;true;false;false,6304/10465
iiiv,,,6305/10465
( i - blocker,C0021966;C0221138,true;false,6306/10465
dasnmbr,,,6307/10465
all ( n = nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,6308/10465
placebo  n = nmbr,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6309/10465
no htn,C0020538,true,6310/10465
sex  no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6311/10465
race ( % ),C0034510;C1706779;C3853635,true;false;false,6312/10465
vitality,C0424589,false,6313/10465
us,,,6314/10465
pain,C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false,6315/10465
age — y £,C0001779,false,6316/10465
< nmbr week,C0053917;C0332174;C0439230;C1334884,true;false;false;false,6317/10465
hbalc  %,,,6318/10465
open,C0175566,false,6319/10465
> nmbr y,C0053917;C1334884,true;false,6320/10465
avm ( n = nmbr ),C0003857;C0053917;C1334884;C0279476,true;true;false;false,6321/10465
mild,C2945599,false,6322/10465
ami nmbr mg,C4319936;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,6323/10465
nmbr mg / day,C0053917;C0439422;C1334884,true;false;false,6324/10465
ever - smoker,C3887636;C0337664,false;true,6325/10465
no . ( % ),,,6326/10465
lateral,C0205093,false,6327/10465
placebo  n / n ( % ),C0032042;C1696465;C1706408,true;false;false,6328/10465
region — no . ( % ),C0017446;C0205147,true;false,6329/10465
age ^nmbr,C0001779;C0053917;C1334884,false;true;false,6330/10465
pvd,C0085096;C4521226,true;false,6331/10465
> nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,6332/10465
romania,C0035826,true,6333/10465
nmbr < - nmbr,C0053917;C1334884,true;false,6334/10465
< nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,6335/10465
patients,C0030705,true,6336/10465
n / n ( % ),C0369718;C0441922,false;false,6337/10465
> = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6338/10465
> nmbr ( n = nmbr ),C0053917;C1334884,true;false,6339/10465
nmbr — nmbr years,C0053917;C0439234;C1334884,true;false;false,6340/10465
> nmbr % and < nmbr %,C0053917;C1334884,true;false,6341/10465
cancer,C0006826;C0998265;C1306459,true;false;false,6342/10465
macce,,,6343/10465
£ nmbr to < nmbr years,C0053917;C0439234;C1334884,true;false;false,6344/10465
or nmbr % ci,,,6345/10465
> i,C0021966;C0221138,true;false,6346/10465
any use,C0042153;C0457083;C1947944,true;false;false,6347/10465
never,C2003901,false,6348/10465
p - blocker,C0369773;C2603361,false;false,6349/10465
age > nmbr,C0001779;C0053917;C1334884,false;true;false,6350/10465
period i,C0439531;C0021966;C0221138;C1948053,false;true;false;false,6351/10465
nmbr to < nmbr hr,C0053917;C1334884,true;false,6352/10465
swollen,C0038999,false,6353/10465
rrr ( nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,6354/10465
≤ nmbr . nmbr %,C0053917;C1334884,true;false,6355/10465
hscrp,,,6356/10465
nmbr % ci,C0053917;C0008107;C3259781;C1334884,true;true;false;false,6357/10465
second ( n = nmbr ),C0205436;C0053917;C1334884;C0457385;C0565930;C1561503;C1705190,false;true;false;false;false;false;false,6358/10465
chd death,C0280604;C0011065;C1306577;C4082313;C4552775;C3542407,false;true;false;false;false;false,6359/10465
pbo ( n = nmbr ),C0031962;C0053917;C1334884,true;true;false,6360/10465
mean — kg,C0444504;C0022718;C0439209;C4054209;C2347634;C2348143,false;true;false;false;false;false,6361/10465
ab nmbr pg ( n = nmbr ),C0053917;C0030827;C0072225;C1266240;C1334884,true;true;true;false;false,6362/10465
p +,C0369773;C2603361,false;false,6363/10465
yes *,C1549445;C1705108;C1710701,false;false;false,6364/10465
age,C0001779,false,6365/10465
ageadj,,,6366/10465
aqc < nmbr,C0053917;C1334884,true;false,6367/10465
rr^ ( nmbr % ci ),C4554402;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,6368/10465
nmbr mmhg,C0053917;C0439475;C1334884,true;false;false,6369/10465
nmbr - nmbr mo,C0053917;C0026544;C0332177;C1334884,true;true;false;false,6370/10465
> nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,6371/10465
age - years,C1510829,false,6372/10465
statin usage,C0360714;C0457083,true;false,6373/10465
age nmbr y,C0001779;C0053917;C1334884,false;true;false,6374/10465
race — no . ( % ) 卞,C0034510;C1706779;C3853635,true;false;false,6375/10465
> nmbr / day,C0053917;C0332173;C0439228;C0439505;C1334884,true;false;false;false;false,6376/10465
des,C0011702;C4551552,true;true,6377/10465
< median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6378/10465
nmbr - < nmbr yrs,C0053917;C1334884,true;false,6379/10465
taiwan,C0039260,true,6380/10465
nmbr - nmbr yrs,C0053917;C1334884,true;false,6381/10465
some,,,6382/10465
≥ nmbr years,C0053917;C0439234;C1334884,true;false;false,6383/10465
> nmbr to < nmbr years,C0053917;C0439234;C1334884,true;false;false,6384/10465
female  no ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6385/10465
cabg — no . ( % ),C0010055,true,6386/10465
women - no . ( % ),C0043210,true,6387/10465
paci,C1165245,false,6388/10465
anmbrc,,,6389/10465
age :,C0001779,false,6390/10465
vldl,C0523560,false,6391/10465
lvef ( % ),C0428772;C0488728,false;false,6392/10465
nmbr - nmbr hr,C0053917;C1334884,true;false,6393/10465
mi,C3810814,false,6394/10465
ls mean,C0023668;C0444504;C2347634;C2348143,true;false;false;false,6395/10465
n *,C0369718;C0441922,false;false,6396/10465
ldl,,,6397/10465
risk *,C0035647;C4552904,true;false,6398/10465
present,C0150312;C0449450,false;false,6399/10465
age > nmbr y  %,C0001779;C0053917;C1334884,false;true;false,6400/10465
sex,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6401/10465
bid,,,6402/10465
pci,C4049621,false,6403/10465
statin use,C0360714;C0042153;C0457083;C1947944,true;true;false;false,6404/10465
monthnmbr,,,6405/10465
primary,C0205225;C0439612;C0439631,false;false;false,6406/10465
placebo ( n = nmbro ),C0032042;C1696465;C1706408,true;false;false,6407/10465
< nmbr years,C0053917;C0439234;C1334884,true;false;false,6408/10465
niacini,,,6409/10465
dm,C0011816;C3250443,true;false,6410/10465
nmbr to < nmbr yr,C0053917;C0439234;C1334884,true;false;false,6411/10465
edge,C0205154;C2697523,false;false,6412/10465
spoke,,,6413/10465
bmi < = nmbr,C0578022;C0053917;C1334884,false;true;false,6414/10465
epa ( n = nmbr ),C0053917;C1334884,true;false,6415/10465
mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,6416/10465
cdmard,,,6417/10465
sd,C2699239,false,6418/10465
nmbr mo to nmbr yr,C0053917;C0026544;C0439234;C0332177;C1334884,true;true;false;false;false,6419/10465
pfor,C1151635,false,6420/10465
nmbr - < nmbr %,C0053917;C1334884,true;false,6421/10465
alert,C0239110;C2004580;C3665546;C3669039;C4084853;C4553014,false;false;false;false;false;false,6422/10465
lvef,C0428772;C0488728,false;false,6423/10465
$ nmbr,C0053917;C1334884,true;false,6424/10465
apo - b,C0003593;C3252643,true;true,6425/10465
cohort,C0009247;C0599755,true;false,6426/10465
ali,,,6427/10465
ace,C1452534;C4284014,true;false,6428/10465
woman,C0043210;C4281745,true;false,6429/10465
apob,C0003593;C3252643,true;true,6430/10465
nmbr to < nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,6431/10465
£ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6432/10465
ckd,C1561643,true,6433/10465
or ( nmbr % cl ),,,6434/10465
af alone,C0344434;C4049859,false;false,6435/10465
region ,C0017446;C0205147,true;false,6436/10465
nsclc,C0007131,true,6437/10465
other ( n  % ),C0369718;C0441922,false;false,6438/10465
monthly,C0332177,false,6439/10465
beta - blockers,C0001645,true,6440/10465
race  n ( % ),C0034510;C1706779;C3853635,true;false;false,6441/10465
australasia,C0282279;C1257882,true;true,6442/10465
fp nmbr mg,C0016704;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1419068;C1419906;C3541238;C3541412,true;true;true;true;false;false;false;false;false;false;false;false;false;false,6443/10465
mean ( se ),C0444504;C0036919;C2347634;C2348143,false;true;false;false,6444/10465
iii - iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6445/10465
nmbr or nmbr,C0053917;C1334884,true;false,6446/10465
or [nmbr % ci],,,6447/10465
asian,C0078988,true,6448/10465
itt,,,6449/10465
id ( n = nmbr ),C0009450;C0053917;C1334884;C0600091;C1441613,true;true;false;false;false,6450/10465
state,C1301808;C1442792;C3148680,false;false;false,6451/10465
anmbr,,,6452/10465
hub,C0063034;C1414372;C1708389,true;false;false,6453/10465
> nmbr hr,C0053917;C1334884,true;false,6454/10465
lsm ( nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,6455/10465
pci  n ( % ),C4049621,false,6456/10465
no . ( % ) *,,,6457/10465
≥ nmbr to < nmbr years,C0053917;C0439234;C1334884,true;false;false,6458/10465
wssng,,,6459/10465
f,C0016327,true,6460/10465
fp ( n [nmbr ),C0016704;C0053917;C1334884;C1419068;C1419906;C3541238;C3541412,true;true;false;false;false;false;false,6461/10465
» nmbr yr,C0053917;C0439234;C1334884,true;false;false,6462/10465
mean — yr,C0444504;C0439234;C2347634;C2348143,false;false;false;false,6463/10465
prior dm,C0332152;C0011816;C3250443;C2826257,false;true;false;false,6464/10465
pre - h,C0332152;C0033727;C0369286;C0441932;C0564385;C4528284;C0740175;C2257086;C3669034,false;true;false;false;false;false;false;false;false,6465/10465
acid,C0001128;C0202406,true;false,6466/10465
hctz,C0020261,true,6467/10465
rnmbr,,,6468/10465
korean,C1556095,true,6469/10465
placebo %,C0032042;C1696465;C1706408,true;false;false,6470/10465
. nmbr,C0053917;C1334884,true;false,6471/10465
age < median,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,6472/10465
nste - acs,C0742343;C4318612,true;false,6473/10465
age £ nmbr,C0001779;C0053917;C1334884,false;true;false,6474/10465
w,,,6475/10465
p - value *,C1709380,false,6476/10465
stent ( n = nmbr ),C0038257;C0053917;C1334884,true;true;false,6477/10465
> nmbrh,,,6478/10465
value *,C1522609,false,6479/10465
sso - nmbr,C0053917;C1334884,true;false,6480/10465
id,C0009450;C0600091;C1441613,true;false;false,6481/10465
iorii ( n z nmbr ),C0053917;C1334884,true;false,6482/10465
belgium,C0004950,true,6483/10465
hbalca median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6484/10465
use,C0042153;C0457083;C1947944,true;false;false,6485/10465
male sex ( % ),C0086582,true,6486/10465
> nmbr yrs sex :,C0053917;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C1334884,true;true;true;true;false;false;true;false,6487/10465
female ( n z nmbr ),C0043210;C0053917;C1334884;C0086287;C1705497;C1705498,true;true;false;true;false;false,6488/10465
pci ( % ),C4049621,false,6489/10465
or ( nmbr % ci ),,,6490/10465
( e - blocker,,,6491/10465
nsteacs,,,6492/10465
other ',,,6493/10465
bmi^,C0578022,false,6494/10465
smoking,C0037369;C0453996;C1881674,true;true;false,6495/10465
race n ( % ),C0034510;C1706779;C3853635,true;false;false,6496/10465
risk,C0035647;C4552904,true;false,6497/10465
homa,,,6498/10465
africa *,C0001737,true,6499/10465
sex ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6500/10465
jvp  ( % ),,,6501/10465
rnmbr ( n = nmbr ),C0053917;C1334884,true;false,6502/10465
py = nmbr ),C0030428;C0053917;C1334884;C3538810,true;true;false;false,6503/10465
a - blocker,,,6504/10465
p blocker,C0369773;C2603361,false;false,6505/10465
hba  c ( % ),C0019016;C1825777;C3538758,true;false;false,6506/10465
r nmbr mg,C0205090;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0684010;C2603358,false;true;true;true;false;false;false;false;false;false;true;false,6507/10465
female sex  n ( % ),C0086287,true,6508/10465
> nmbr,C0053917;C1334884,true;false,6509/10465
> nmbr to < nmbr,C0053917;C1334884,true;false,6510/10465
rales  ( % ),C0034642;C0240859,true;false,6511/10465
tion — no . ( % ),,,6512/10465
p trend,C0369773;C1521798;C4554533;C2603361,false;false;false;false,6513/10465
ada  no,C1060325;C3811629,false;false,6514/10465
macce ( % ),,,6515/10465
nonwhite,,,6516/10465
pt,C0032743;C0699718,true;false,6517/10465
apo b *,C0003593;C3252643,true;true,6518/10465
% ( nmbr % ci ),C0053917;C0008107;C3259781;C1334884,true;true;false;false,6519/10465
^ - blocker,,,6520/10465
no betablocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6521/10465
age  ( years ),C1510829,false,6522/10465
> nmbr type,C0053917;C0332307;C1547052;C1334884,true;false;false;false,6523/10465
female,C0043210;C0086287;C1705497;C1705498,true;true;false;false,6524/10465
us ( n = nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,6525/10465
tzd,,,6526/10465
nmbr - < nmbr,C0053917;C1334884,true;false,6527/10465
peace ( n = nmbr ),C0680443;C0053917;C1334884,false;true;false,6528/10465
< nmbr lb,C0053917;C1334884,true;false,6529/10465
< nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,6530/10465
non - mtx,C1518422;C0025677;C1417487,false;true;false,6531/10465
age  year,C0001779;C0439234;C0439508,false;false;false,6532/10465
py *,C0030428;C3538810,true;false,6533/10465
feno,,,6534/10465
mental,C0229992,false,6535/10465
smokers,C0337664,true,6536/10465
> nmbr ft,C0053917;C1881534;C3890579;C1334884,true;false;false;false,6537/10465
women  %,C0043210,true,6538/10465
mssbp,,,6539/10465
uac =,,,6540/10465
acei,,,6541/10465
usa,C0041703,true,6542/10465
class > nmbr,C0456387;C0053917;C1334884;C1518526;C1705943,false;true;false;false;false,6543/10465
europe ii,C0015176;C1710602;C4082587,true;false;false,6544/10465
/ ’ - value ",C1522609,false,6545/10465
sabaa,,,6546/10465
prior mi,C0332152;C3810814;C2826257,false;false;false,6547/10465
no statin,C0360714,true,6548/10465
cv death,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,6549/10465
age > = nmbr,C0001779;C0053917;C1334884,false;true;false,6550/10465
nmbr §,C0053917;C1334884,true;false,6551/10465
alone,C0205171;C0439044;C0679994,false;false;false,6552/10465
r,C0205090;C0684010;C2603358,false;true;false,6553/10465
ultra,C0728475,false,6554/10465
paci ( n = nmbr ),C1165245;C0053917;C1334884,false;true;false,6555/10465
age < nmbr,C0001779;C0053917;C1334884,false;true;false,6556/10465
stage nmbr,C0205390;C0053917;C1334884;C1300072;C1306673,false;true;false;false;false,6557/10465
laba alone,,,6558/10465
eze nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6559/10465
no prior ml,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,6560/10465
nmbr ( < nmbr % ),C0053917;C1334884,true;false,6561/10465
statin,C0360714,true,6562/10465
nnmbr yrs,,,6563/10465
male ( n = nmbr ),C0086582;C0053917;C1334884;C1706180;C1706428;C1706429,true;true;false;false;false;false,6564/10465
psa,C3810537;C3813209,false;false,6565/10465
nmbr / nmbr,C0053917;C1334884,true;false,6566/10465
region - no . ( % ),C0017446;C0205147,true;false,6567/10465
placebo ( n = nmbrl ),C0032042;C1696465;C1706408,true;false;false,6568/10465
otherz,,,6569/10465
nmbr years,C0053917;C0439234;C1334884,true;false;false,6570/10465
nmbr yr,C0053917;C0439234;C1334884,true;false;false,6571/10465
asp,C0206293;C0206298;C1332656;C1528298;C3541260;C3890396;C4048238;C4321307;C4553371,false;true;false;true;false;false;false;false;false,6572/10465
aqe < nmbr,C0053917;C1334884,true;false,6573/10465
n = nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,6574/10465
fh ii,C1854107,true,6575/10465
overallb,,,6576/10465
nitrate,C0028125;C0699857;C3848573,true;false;false,6577/10465
age > nmbr y,C0001779;C0053917;C1334884,false;true;false,6578/10465
black,C0005680;C0027567;C0085756;C0439541,true;true;true;false,6579/10465
new dm,C0205314;C0011816;C3250443,false;true;false,6580/10465
< nmbr mon ( n = nmbr ),C0053917;C1334884,true;false,6581/10465
lower,C0441994;C1548802;C2003888,false;false;false,6582/10465
age  mean,C0001779;C0444504;C2347634;C2348143,false;false;false;false,6583/10465
dvt,C0149871;C2926618;C3899446,true;false;false,6584/10465
m,C0369637;C0441923,false;false,6585/10465
black  n ( % ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,6586/10465
obesity,C0028754;C1963185,true;false,6587/10465
women,C0043210,true,6588/10465
nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6589/10465
il - nmbr,C0020898;C0053917;C1334884;C0021764;C0022271,true;true;false;true;true,6590/10465
< nmbr y ( n = nmbr ),C0053917;C1334884,true;false,6591/10465
placebo r %,C0032042;C0205090;C0684010;C2603358;C1696465;C1706408,true;false;true;false;false;false,6592/10465
mg / dl,C0439269,false,6593/10465
ml c,C0439526;C1705224;C3887665,false;false;false,6594/10465
tg +,C0337445,false,6595/10465
sotalol,C0037707,true,6596/10465
cdai < nmbrt,C0683448;C1413248;C3273706,false;false;false,6597/10465
nmbr ( nmbr % ),C0053917;C1334884,true;false,6598/10465
mmse > nmbr,C0451306;C0053917;C1334884,true;true;false,6599/10465
tg §,C0337445,false,6600/10465
v ( n = nmbr ),C0053917;C1334884,true;false,6601/10465
= nmbr,C0053917;C1334884,true;false,6602/10465
p,C0369773;C2603361,false;false,6603/10465
race  no . ( % ),C0034510;C1706779;C3853635,true;false;false,6604/10465
fa nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6605/10465
none,,,6606/10465
no smoking,C0037369;C0453996;C1881674,true;true;false,6607/10465
usa ( n = nmbr ),C0041703;C0053917;C1334884,true;true;false,6608/10465
rate *,C0871208;C1521828,false;false,6609/10465
gender,C0079399;C1522384,true;true,6610/10465
male ( n - nmbr ),C0086582;C0053917;C1334884;C1706180;C1706428;C1706429,true;true;false;false;false;false,6611/10465
austria,C0004348,true,6612/10465
$ nmbr years,C0053917;C0439234;C1334884,true;false;false,6613/10465
fh nmbr,C0053917;C1334884,true;false,6614/10465
no ?,,,6615/10465
dd ( n = nmbr ),C3538867;C0053917;C1334884;C3814791,false;true;false;false,6616/10465
lu / kg,C0024171;C0022718;C0439209;C4054209;C0024176;C2697939,true;true;false;false;true;false,6617/10465
no ststm,,,6618/10465
st -,C0036056;C3272372,true;false,6619/10465
p - valuea,C0369773;C2603361,false;false,6620/10465
yes ( n = nmbr ),C1549445;C0053917;C1334884;C1705108;C1710701,false;true;false;false;false,6621/10465
abi < nmbr . nmbr,C1328319;C0053917;C1334884;C3888326,true;true;false;false,6622/10465
iv,C0022326;C4265176,true;false,6623/10465
sama,C1075468,false,6624/10465
latvia,C0023128,true,6625/10465
mra,C0243032;C1609165;C3891069,true;true;false,6626/10465
asian *,C0078988,true,6627/10465
bm i < nmbr,C0006416;C0021966;C0053917;C1334884;C0221138,true;true;true;false;false,6628/10465
age > nmbr yrs,C0001779;C0053917;C1334884,false;true;false,6629/10465
chf ( % ),C0018802,true,6630/10465
ef  %,,,6631/10465
vi nmbr mg ( n = nmbr ),C0205999;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,6632/10465
< nmbr % ( n = nmbr ),C0053917;C1334884,true;false,6633/10465
hbaic ( % ),,,6634/10465
tjc,,,6635/10465
cvd,C0007222,true,6636/10465
> nmbr ml,C0053917;C0439526;C1705224;C3887665;C1334884,true;false;false;false;false,6637/10465
nmbr to < nmbr,C0053917;C1334884,true;false,6638/10465
obese,C0028754,true,6639/10465
gold  n ( % ),C0018026;C1304897,true;false,6640/10465
age $ nmbr yrs,C0001779;C0053917;C1334884,false;true;false,6641/10465
placebo ( % ),C0032042;C1696465;C1706408,true;false;false,6642/10465
rr ( nmbr % cl ),C4554402;C0053917;C0596019;C1334884,false;true;false;false,6643/10465
« nmbr - nmbr,C0053917;C1334884,true;false,6644/10465
whitea,C1021495,false,6645/10465
age > : nmbr,C0001779;C0053917;C1334884,false;true;false,6646/10465
stroke,C0038454;C4554100,true;false,6647/10465
median ( iqr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6648/10465
sjc,,,6649/10465
< nmbr h,C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,6650/10465
pbo,C0031962,true,6651/10465
nmbr - nmbr yr,C0053917;C0439234;C1334884,true;false;false,6652/10465
< nmbr %,C0053917;C1334884,true;false,6653/10465
chadsnmbr^,,,6654/10465
p blockers,C0369773;C2603361,false;false,6655/10465
£ nmbr years,C0053917;C0439234;C1334884,true;false;false,6656/10465
> nmbr / week,C0053917;C0332174;C0439230;C1334884,true;false;false;false,6657/10465
nmbr - < nmbr y,C0053917;C1334884,true;false,6658/10465
non - c,C1518422,false,6659/10465
group a,C0441835;C4522145,false;false,6660/10465
< nmbr - nmbr,C0053917;C1334884,true;false,6661/10465
ldu - c,,,6662/10465
$ nmbr ( n = nmbr ),C0053917;C1334884,true;false,6663/10465
≥ nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,6664/10465
> nmbr % ( n = nmbr ),C0053917;C1334884,true;false,6665/10465
rca,,,6666/10465
age  n ( % ),C0001779,false,6667/10465
nyha ii,C1275491;C1710602;C4082587,false;false;false,6668/10465
nmbr . nmbr,C0053917;C1334884,true;false,6669/10465
£ nmbr yo ( n = nmbr ),C0053917;C1413296;C1334884,true;false;false,6670/10465
ni,C0028075;C2348274;C3869926;C3869927,true;false;false;false,6671/10465
noneh,,,6672/10465
» nmbry,,,6673/10465
saba §,,,6674/10465
cabg  n ( % ),C0010055,true,6675/10465
nitrates,C0028125;C0699857;C3848573,true;false;false,6676/10465
sita nmbr,C0053917;C1334884,true;false,6677/10465
anmbr + eznmbr,,,6678/10465
male sex  %,C0086582,true,6679/10465
laaca,,,6680/10465
> nmbr mmhg,C0053917;C0439475;C1334884,true;false;false,6681/10465
age > nmbr yr,C0001779;C0053917;C0439234;C1334884,false;true;false;false,6682/10465
bmi,C0578022,false,6683/10465
stemi ( % ),C1536220;C3538872,true;false,6684/10465
cabg ( % ),C0010055,true,6685/10465
european,C0239307;C1535514,false;false,6686/10465
pvalue,,,6687/10465
lll - iv,C1261077;C0022326;C4265176,false;true;false,6688/10465
bmi > = nmbr,C0578022;C0053917;C1334884,false;true;false,6689/10465
onmbr,,,6690/10465
fp ( n = nmbr ),C0016704;C0053917;C1334884;C1419068;C1419906;C3541238;C3541412,true;true;false;false;false;false;false,6691/10465
crt - d,,,6692/10465
severity,C0439793;C0522510,false;false,6693/10465
normal,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,6694/10465
age > nmbr yrs  %,C0001779;C0053917;C1334884,false;true;false,6695/10465
patients ( n ),C0030705,true,6696/10465
hr  nmbr % cl,C0053917;C0596019;C1334884,true;false;false,6697/10465
sdai < nmbr t,C3871128;C0053917;C1334884,false;true;false,6698/10465
no *,,,6699/10465
age years,C1510829,false,6700/10465
row,C1552840;C1552846,false;false,6701/10465
beta blockers,C0001645,true,6702/10465
lvmi ( nmbr,C0053917;C1334884,true;false,6703/10465
care,C1947933,false,6704/10465
egfr -,C1739039;C3811844;C3812682,true;false;false,6705/10465
prior om,C0332152;C0028971;C1705272;C2826257,false;true;false;false,6706/10465
n %,C0369718;C0441922,false;false,6707/10465
early ( n = nmbr ),C1279919;C0053917;C1334884,false;true;false,6708/10465
nmbr to < nmbr cells,C0053917;C0007584;C0007634;C1334884,true;true;true;false,6709/10465
mm hg,C0439475,false,6710/10465
any death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,6711/10465
> nmbr < nmbr,C0053917;C1334884,true;false,6712/10465
cl nmbr %,C0596019;C0053917;C1334884,false;true;false,6713/10465
poci ( n = nmbr ),C0053917;C1334884,true;false,6714/10465
pbo n ( % ),C0031962,true,6715/10465
$ nmbr years ( n = nmbr ),C0053917;C0439234;C1334884,true;false;false,6716/10465
all patients,C0030705,true,6717/10465
laba ',,,6718/10465
< nmbr ( n = nmbr ),C0053917;C1334884,true;false,6719/10465
smoking  %,C0037369;C0453996;C1881674,true;true;false,6720/10465
male  %,C0086582;C1706180;C1706428;C1706429,true;false;false;false,6721/10465
level nmbr,C0441889;C0053917;C1334884;C0456079;C1547707;C2946261,false;true;false;false;false;false,6722/10465
placebo  n = inmbr,C0032042;C1696465;C1706408,true;false;false,6723/10465
< nmbr mmhg,C0053917;C0439475;C1334884,true;false;false,6724/10465
no psa,C3810537;C3813209,false;false,6725/10465
nmbrenmbr,,,6726/10465
placebo [n z nmbr],C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6727/10465
ls mean ( se ),C0023668;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,6728/10465
prior stemi,C0332152;C1536220;C3538872;C2826257,false;true;false;false,6729/10465
betablocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6730/10465
aml nmbr /,C0023465;C0053917;C1334884;C0023467,true;true;false;true,6731/10465
acr,C1412134;C1515941,false;false,6732/10465
\nmbr,C0053917;C1334884,true;false,6733/10465
homa > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6734/10465
p - blocker yes,C0369773;C1549445;C1705108;C1710701;C2603361,false;false;false;false;false,6735/10465
> = nmbr mmhg,C0053917;C0439475;C1334884,true;false;false,6736/10465
no dm ( n = nmbr ),C0011816;C0053917;C1334884;C3250443,true;true;false;false,6737/10465
otherx,,,6738/10465
age — yrf,C0001779,false,6739/10465
fragile,C0302113,false,6740/10465
no beta - blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6741/10465
n o,C0369718;C0441922,false;false,6742/10465
asa > nmbr mg,C0004057;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C3853627,true;true;true;true;false;false;false;false;false;false;false,6743/10465
mra  ( % ),C0243032;C1609165;C3891069,true;true;false,6744/10465
india,C0021201;C2700456,true;false,6745/10465
gold nmbr,C0018026;C0053917;C1334884;C1304897,true;true;false;false,6746/10465
csf,C3540512;C3889436,false;false,6747/10465
nmbr mo,C0053917;C0026544;C0332177;C1334884,true;true;false;false,6748/10465
sites,C0205145,false,6749/10465
aspirin ( n = nmbr ),C0004057;C0053917;C1334884,true;true;false,6750/10465
< nmbr days ( n = nmbr ),C0053917;C0439228;C1334884,true;false;false,6751/10465
first ( n = nmbr ),C0205435;C0053917;C1334884;C1279901,false;true;false;false,6752/10465
age > nmbr  y,C0001779;C0053917;C1334884,false;true;false,6753/10465
sesbp,,,6754/10465
( se]t *,C0036919,true,6755/10465
value,C1522609,false,6756/10465
ics usage,C0815320;C0457083;C4551720,false;false;true,6757/10465
> nmbr to < nmbr yr,C0053917;C0439234;C1334884,true;false;false,6758/10465
< nmbr beds,C0053917;C0004916;C1334884,true;true;false,6759/10465
ptca,C2936173,true,6760/10465
≥ nmbr bpm ( n = nmbr ),C0053917;C1334884,true;false,6761/10465
no beta - blocker,C0001645,true,6762/10465
age < nmbr y,C0001779;C0053917;C1334884,false;true;false,6763/10465
fa nmbr mg ( « = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6764/10465
p value 十,C1709380,false,6765/10465
spinal,C0521329,false,6766/10465
arr,C2170357;C4084934,false;false,6767/10465
acm,C0001143;C1549040,true;false,6768/10465
age > nmbr yrs *,C0001779;C0053917;C1334884,false;true;false,6769/10465
orc ( nmbr % cl ),C1167125;C0053917;C0596019;C1334884,false;true;false;false,6770/10465
saba,,,6771/10465
in - h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6772/10465
males,C0086582,true,6773/10465
female  n ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6774/10465
brachial,C0445456,false,6775/10465
month nmbr,C0332177;C0053917;C1334884;C0439231,false;true;false;false,6776/10465
nmbryr,,,6777/10465
age ( yr ),C0001779;C0439234,false;false,6778/10465
italy ( n = nmbr ),C0022277;C0053917;C1334884,true;true;false,6779/10465
nmbr - nmbr,C0053917;C1334884,true;false,6780/10465
hiv,C0019682;C0019699,true;true,6781/10465
ale < nmbr,C0678386;C0053917;C1334884;C2632076,false;true;false;false,6782/10465
chd *  n ( % ),C0280604;C3542407,false;false,6783/10465
region,C0017446;C0205147,true;false,6784/10465
iglar,,,6785/10465
arbs,C3888198,false,6786/10465
age in years,C1510829,false,6787/10465
l / ll,C0439394;C1706495;C3642217,false;false;false,6788/10465
> nmbr yrs,C0053917;C1334884,true;false,6789/10465
tg ’,C0337445,false,6790/10465
age < nmbryrs,C0001779,false,6791/10465
ff nmbr pg ( n = nmbr ),C4554348;C0053917;C0030827;C0072225;C1266240;C1334884,false;true;true;true;false;false,6792/10465
pad,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,6793/10465
arr ( nmbr % cl ),C2170357;C0053917;C0596019;C1334884;C4084934,false;true;false;false;false,6794/10465
americas,C0002454;C0596070,true;false,6795/10465
st,C0036056;C3272372,true;false,6796/10465
hctz *,C0020261,true,6797/10465
> nmbr . nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,6798/10465
placebo ( n - nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6799/10465
gold ii,C0018026;C1710602;C4082587;C1304897,true;false;false;false,6800/10465
lama,C0999593;C1416775,false;false,6801/10465
chd,C0280604;C3542407,false;false,6802/10465
median  iqr,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6803/10465
cv death n,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,6804/10465
ldl  - c,,,6805/10465
p - value,C1709380,false,6806/10465
edge ii,C0205154;C1710602;C4082587;C2697523,false;false;false;false,6807/10465
nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,6808/10465
both ( % ),,,6809/10465
ml,C0439526;C1705224;C3887665,false;false;false,6810/10465
cana nmbr mg ( n = nmbr ),C1418845;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,6811/10465
cad,C1504769;C2239547;C3813548;C4284121,true;false;false;false,6812/10465
all,,,6813/10465
age > nmbr years,C1510829;C0053917;C1334884,false;true;false,6814/10465
sa,C0036243;C0038702;C1539696;C1825840;C3539736;C4521691,true;true;false;false;false;false,6815/10465
racea,,,6816/10465
male sex  n ( % ),C0086582,true,6817/10465
others,C1955473;C3539125,false;false,6818/10465
reqion,,,6819/10465
m / f,C1306057,false,6820/10465
cat > nmbr,C0007450;C0053917;C1334884;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;true;false;false;true;false;false;false;false,6821/10465
atv n ( % ),C0210243;C0674679;C1145759;C1334862,true;true;true;false,6822/10465
< nmbry,,,6823/10465
> nmbr days,C0053917;C0439228;C1334884,true;false;false,6824/10465
ebria,C1917247,false,6825/10465
other,,,6826/10465
no pa,C0030428;C3541314,true;false,6827/10465
poland,C0032356,true,6828/10465
prior pci,C0332152;C4049621;C2826257,false;false;false,6829/10465
b - blocker,,,6830/10465
( n = nmbr ,C0369718;C0053917;C1334884;C0441922,false;true;false;false,6831/10465
abi # nmbr . nmbr,C1328319;C0053917;C1334884;C3888326,true;true;false;false,6832/10465
oradj ( nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,6833/10465
labaa,,,6834/10465
hr nmbr % ci,C0053917;C0008107;C3259781;C1334884,true;true;false;false,6835/10465
minor,C0026193;C0205165,true;false,6836/10465
ufh,,,6837/10465
dm ( n = nmbr ),C0011816;C0053917;C1334884;C3250443,true;true;false;false,6838/10465
never smoked,C2003901,false,6839/10465
copd,C0024117;C1412502;C3714496,true;false;false,6840/10465
v total ( n = nmbr ),C0439175;C0053917;C1334884;C0439810,false;true;false;false,6841/10465
egfr < nmbr,C1739039;C0053917;C1334884;C3811844;C3812682,true;true;false;false;false,6842/10465
other !,,,6843/10465
hba < median,C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,6844/10465
event ( % ),C0441471;C4019010,false;false,6845/10465
general,C0205246;C3812897;C3891294;C4521767,false;false;false;false,6846/10465
≤ nmbr ug / g,C0053917;C0439272;C1334884,true;false;false,6847/10465
rr ( nmbr % ci ) *,C4554402;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,6848/10465
yes ( % ),C1549445;C1705108;C1710701,false;false;false,6849/10465
post - mi,C0856742,false,6850/10465
laba,,,6851/10465
 nmbr years ( n = nmbr ),C0053917;C0439234;C1334884,true;false;false,6852/10465
sdai,C3871128,false,6853/10465
> nmbr mg,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6854/10465
p value,C1709380,false,6855/10465
stemi,C1536220;C3538872,true;false,6856/10465
< nmbr ( n z nmbr ),C0053917;C1334884,true;false,6857/10465
age > nmbr  %,C0001779;C0053917;C1334884,false;true;false,6858/10465
area,C0017446;C0205146,true;false,6859/10465
male sex — no . ( % ),C0086582,true,6860/10465
teaes,,,6861/10465
sex — no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6862/10465
age  y,C0001779,false,6863/10465
male ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6864/10465
cvd death,C0007222;C0011065;C1306577;C4082313;C4552775,true;true;false;false;false,6865/10465
chinese,C0008120;C0152035,false;true,6866/10465
nstemi,C3537184;C4255010,false;true,6867/10465
qmi,,,6868/10465
nmbr - nmbrh,C0053917;C1334884,true;false,6869/10465
apo b,C0003593;C3252643,true;true,6870/10465
> nmbr mm ( n = nmbr ),C0053917;C4330985;C4554674;C1334884,true;false;false;false,6871/10465
female sex  %,C0086287,true,6872/10465
all n = nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,6873/10465
abi,C1328319;C3888326,true;false,6874/10465
any statin,C0360714,true,6875/10465
tg > nmbr . nmbr,C0337445;C0053917;C1334884,false;true;false,6876/10465
nmbry,,,6877/10465
race — no . ( % ) : c,C0034510;C1706779;C3853635,true;false;false,6878/10465
e,,,6879/10465
angina,C0002962,true,6880/10465
ns,C0038944;C1112705;C1705982,true;false;false,6881/10465
age  yr,C0001779;C0439234,false;false,6882/10465
oretal,,,6883/10465
no smo king,C1311076;C1364142;C1423784,true;false;false,6884/10465
women  n ( % ) *,C0043210,true,6885/10465
p value c,C1709380,false,6886/10465
mets,C0812270;C1705694;C2939420,false;false;false,6887/10465
pbo ( n = nmbr ) vs,C0031962;C0053917;C1334884,true;true;false,6888/10465
race — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,6889/10465
lipid,C0023779,true,6890/10465
females,C0086287,true,6891/10465
nmbrmg ( n = nmbr ),C0053917;C1334884,true;false,6892/10465
ada  yes,C1060325;C1549445;C1705108;C1710701;C3811629,false;false;false;false;false,6893/10465
placebo [n = nmbr],C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6894/10465
< nmbr mo,C0053917;C0026544;C0332177;C1334884,true;true;false;false,6895/10465
$ nmbr %,C0053917;C1334884,true;false,6896/10465
> = nmbr . nmbr,C0053917;C1334884,true;false,6897/10465
< nmbr min,C0053917;C0702093;C1524029;C3813700;C1334884,true;false;false;false;false,6898/10465
no .,,,6899/10465
hbaic — %,,,6900/10465
n .,C0369718;C0441922,false;false,6901/10465
russia,C0035970,true,6902/10465
race *,C0034510;C1706779;C3853635,true;false;false,6903/10465
< nmbr hrs,C0053917;C1568891;C1334884,true;true;false,6904/10465
hps,C0242994,true,6905/10465
patients ( ft ),C0030705,true,6906/10465
prior stent,C0332152;C0038257;C2826257,false;true;false,6907/10465
nmbr — < nmbr,C0053917;C1334884,true;false,6908/10465
all ( n = nmbr * ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,6909/10465
asa < nmbr mg,C0004057;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C3853627,true;true;true;true;false;false;false;false;false;false;false,6910/10465
< nmbr year,C0053917;C0439234;C0439508;C1334884,true;false;false;false,6911/10465
stage nmbrb,C0205390;C1300072;C1306673,false;false;false,6912/10465
iv nitrates,C0022326;C4265176,true;false,6913/10465
pio nmbr,C0030800;C0053917;C1334884;C2347712,true;true;false;false,6914/10465
beta - blocker !,C0001645,true,6915/10465
femoral,C0015811,true,6916/10465
australia,C0004340,true,6917/10465
placeboa,,,6918/10465
pint,C0560012;C3811619;C3890014;C3890556,false;false;false;false,6919/10465
hdl,C3715113,false,6920/10465
 nmbr / week,C0053917;C0332174;C0439230;C1334884,true;false;false;false,6921/10465
> nmbr y ( n = nmbr ),C0053917;C1334884,true;false,6922/10465
phi ( n - nmbr ),C1333690;C0053917;C1334884;C1704947;C1706536;C2975867;C4084801,false;true;false;false;false;true;false,6923/10465
iii & iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6924/10465
aqe ^nmbr,C0053917;C1334884,true;false,6925/10465
region ( % ),C0017446;C0205147,true;false,6926/10465
nmbr to < nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,6927/10465
< nmbr y,C0053917;C1334884,true;false,6928/10465
age # nmbr yrs,C0001779;C0053917;C1334884,false;true;false,6929/10465
placebo ( n nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,6930/10465
anemia ( % ),C0002871;C1000483;C4554633,true;false;false,6931/10465
pbo ( nnmbr ),C0031962,true,6932/10465
ckdc  n ( % ),,,6933/10465
provoked,C1444748,false,6934/10465
race,C0034510;C1706779;C3853635,true;false;false,6935/10465
mtx ( n = nmbr ),C0025677;C0053917;C1334884;C1417487,true;true;false;false,6936/10465
> nmbr years,C0053917;C0439234;C1334884,true;false;false,6937/10465
upper,C1282910,false,6938/10465
mean a ± sdt,C0444504;C2347634;C2348143,false;false;false,6939/10465
no prior mi,C0332152;C3810814;C2826257,false;false;false,6940/10465
mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,6941/10465
female ( n — nmbr ),C0043210;C0053917;C1334884;C0086287;C1705497;C1705498,true;true;false;true;false;false,6942/10465
tics — no . ( % ),C0040188;C0278076;C2169806;C3889970,true;true;false;false,6943/10465
apo a - i,C0085201;C1677784,true;true,6944/10465
ascvd,C3665365,false,6945/10465
glipizide,C0017642,true,6946/10465
years,C0439234,false,6947/10465
stage nmbra,C0205390;C1300072;C1306673,false;false;false,6948/10465
asian ( n = nmbr ),C0078988;C0053917;C1334884,true;true;false,6949/10465
ics alone,C0815320;C4551720,false;true,6950/10465
i / ii,C0021966;C1710602;C4082587;C0221138,true;false;false;false,6951/10465
%,,,6952/10465
lesions,C0221198,false,6953/10465
total c,C0439175;C0439810,false;false,6954/10465
> nmbr mon ( n = nmbr ),C0053917;C1334884,true;false,6955/10465
nstemi ( % ),C3537184;C4255010,false;true,6956/10465
ppci ( n = nmbr ),C0053917;C1334884,true;false,6957/10465
women  no . ( % ),C0043210,true,6958/10465
no ipst,,,6959/10465
( n = ms ),C0369718;C2349943;C3539704;C3713294;C0441922,false;false;false;true;false,6960/10465
uti,C0042029;C0077906;C1412376,true;true;false,6961/10465
obesityj,,,6962/10465
asia,C0003980,true,6963/10465
p [int],C0369773;C3272375;C2603361,false;false;false,6964/10465
rarely,C0522498,false,6965/10465
tc,C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;false;false;false,6966/10465
qd,C0332173,false,6967/10465
age  yrs,C0001779,false,6968/10465
age ( year ),C0001779;C0439234;C0439508,false;false;false,6969/10465
age  years *,C1510829,false,6970/10465
> nmbr mm,C0053917;C4330985;C4554674;C1334884,true;false;false;false,6971/10465
europe,C0015176,true,6972/10465
≥ nmbr,C0053917;C1334884,true;false,6973/10465
nmbr min,C0053917;C0702093;C1524029;C3813700;C1334884,true;false;false;false;false,6974/10465
statins,C0360714,true,6975/10465
canvas,C3281223,false,6976/10465
niacin,C0027996;C1142562,true;false,6977/10465
study nmbr,C0557651;C0053917;C1334884;C2603343,false;true;false;false,6978/10465
graft  n ( % ),C0181074;C0332835;C1961139,false;true;false,6979/10465
c,,,6980/10465
ipst ( n = nmbr ),C0053917;C1334884,true;false,6981/10465
f * >,C0016327,true,6982/10465
high  %,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,6983/10465
ml ),C0439526;C1705224;C3887665,false;false;false,6984/10465
male sex 一 no . ( % ),C0086582,true,6985/10465
£ nmbr %,C0053917;C1334884,true;false,6986/10465
no po,C0032729;C0442027,true;false,6987/10465
y es,C0013754;C0205944,true;true,6988/10465
ff - blocker,C4554348,false,6989/10465
no prior stemi,C0332152;C1536220;C3538872;C2826257,false;true;false;false,6990/10465
< nmbr . nmbr years,C0053917;C0439234;C1334884,true;false;false,6991/10465
african,C0027567,true,6992/10465
fibrates,C1449704;C3540783,true;false,6993/10465
canada,C0006823,true,6994/10465
nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,6995/10465
venous,C0042449;C0348013,true;false,6996/10465
nmbr - < nmbr ( % ),C0053917;C1334884,true;false,6997/10465
total n = nmbr,C0439175;C0053917;C1334884;C0439810,false;true;false;false,6998/10465
mate,C0682323;C1260875,false;false,6999/10465
i,C0021966;C0221138,true;false,7000/10465
met ( n = nmbr ),C0428210;C0053917;C1334884;C1550543;C4317104,false;true;false;false;false,7001/10465
nausea,C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767,true;false;false;false;false;false;false;false;false;false;false;false,7002/10465
other chd,C0280604;C3542407,false;false,7003/10465
lda  %,C4553195,false,7004/10465
ics : no,C0815320;C4551720,false;true,7005/10465
aspirin,C0004057,true,7006/10465
age ( years ),C1510829,false,7007/10465
rrr,,,7008/10465
nmbr - nmbr days,C0053917;C0439228;C1334884,true;false;false,7009/10465
hr ( nmbr % cl ),C0053917;C0596019;C1334884,true;false;false,7010/10465
etn  yes,C0014758;C1549445;C1705108;C1710701;C0717758,true;false;false;false;true,7011/10465
> nmbr and < nmbr %,C0053917;C1334884,true;false,7012/10465
male sex — no . ( % ) f,C0086582,true,7013/10465
n nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,7014/10465
ipst,,,7015/10465
age > = nmbr yrs,C0001779;C0053917;C1334884,false;true;false,7016/10465
m being,C0369637;C0441923,false;false,7017/10465
oral,C0442027;C4521986,false;false,7018/10465
race  zz ( % ),C0034510;C1706779;C3853635,true;false;false,7019/10465
> nmbr - < nmbr,C0053917;C1334884,true;false,7020/10465
tgt,C1421391;C1428265;C4321338,false;false;false,7021/10465
sfc ( n = nmbr ),C4521536;C0053917;C1334884,false;true;false,7022/10465
prior llt,C0332152;C2347090;C2826257,false;false;false,7023/10465
> = nmbr y,C0053917;C1334884,true;false,7024/10465
p - value ",C1709380,false,7025/10465
non - white,C1518422;C0007457;C0043157;C0220938,false;true;true;false,7026/10465
ldl - c,,,7027/10465
( nmbr % ci]h,C0053917;C0008107;C0033727;C0369286;C0441932;C0564385;C4528284;C3259781;C1334884,true;true;true;false;false;false;false;false;false,7028/10465
gold b,C0018026;C1304897,true;false,7029/10465
men  n ( % ),C0025266,true,7030/10465
hbalc ( % ),,,7031/10465
never smoker,C0425293,false,7032/10465
men,C0025266,true,7033/10465
≥ nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,7034/10465
≥ nmbr ng / ml,C0053917;C0439275;C1334884,true;false;false,7035/10465
no psa ( n = nmbr ),C3810537;C0053917;C1334884;C3813209,false;true;false;false,7036/10465
nmbr - i,C0053917;C0021966;C0221138;C1334884,true;true;false;false,7037/10465
low  %,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,7038/10465
haq,C0102923;C0451208,true;false,7039/10465
beta - blocker,C0001645,true,7040/10465
urti,,,7041/10465
renal,C0022646,true,7042/10465
lama +,C0999593;C1416775,false;false,7043/10465
( sem ),,,7044/10465
primary *,C0205225;C0439612;C0439631,false;false;false,7045/10465
no mi,C3810814,false,7046/10465
age < nmbr yrs,C0001779;C0053917;C1334884,false;true;false,7047/10465
statini,,,7048/10465
n_,C0369718;C0441922,false;false,7049/10465
metsyn,,,7050/10465
< nmbr / < nmbr mm hg,C0053917;C0439475;C1334884,true;false;false,7051/10465
no use,C0042153;C0457083;C1947944,true;false;false,7052/10465
> nmbr . nmbr %,C0053917;C1334884,true;false,7053/10465
tvr,,,7054/10465
laa,,,7055/10465
om nmbr /,C0028971;C0053917;C1334884;C1705272,true;true;false;false,7056/10465
arm,C0446516;C3715044;C4553528,true;false;false,7057/10465
r nmbr mg ( « = nmbr ),C0205090;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0684010;C2603358,false;true;true;true;false;false;false;false;false;false;true;false,7058/10465
female  %,C0043210;C0086287;C1705497;C1705498,true;true;false;false,7059/10465
cancer §,C0006826;C0998265;C1306459,true;false;false,7060/10465
hbalc > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7061/10465
men ( n = nmbr ),C0025266;C0053917;C1334884,true;true;false,7062/10465
crcl < nmbr,C1846718;C0053917;C1334884,false;true;false,7063/10465
chd  n ( % ),C0280604;C3542407,false;false,7064/10465
age — yr,C0001779;C0439234,false;false,7065/10465
gold c,C0018026;C1304897,true;false,7066/10465
mean = sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,7067/10465
avr,C0449217,false,7068/10465
epa,,,7069/10465
lnmbr,,,7070/10465
treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,7071/10465
< nmbr yo ( n = nmbr ),C0053917;C1413296;C1334884,true;false;false,7072/10465
wegu,,,7073/10465
hbanmbrc,,,7074/10465
( se] +,C0036919,true,7075/10465
cards,C2930619;C3275277,true;false,7076/10465
nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,7077/10465
hdl *,C3715113,false,7078/10465
year nmbr,C0439234;C0053917;C1334884;C0439508,false;true;false;false,7079/10465
p - blockers,C0369773;C2603361,false;false,7080/10465
< nmbr yrs,C0053917;C1334884,true;false,7081/10465
( se]t,C0036919,true,7082/10465
no prior pci,C0332152;C4049621;C2826257,false;false;false,7083/10465
nmbr . nmbr %,C0053917;C1334884,true;false,7084/10465
diet ( n 二 nmbr ),C0012155;C0053917;C1334884;C0012159;C1519433;C2983588;C3668949,true;true;false;true;false;false;false,7085/10465
pnorpci,,,7086/10465
hr ( nmbr % cl ) *,C0053917;C0596019;C1334884,true;false;false,7087/10465
iu,C0049272;C0439453;C0694756,true;false;false,7088/10465
^median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7089/10465
> nmbr min,C0053917;C0702093;C1524029;C3813700;C1334884,true;false;false;false;false,7090/10465
nmbr to < nmbr mo,C0053917;C0026544;C0332177;C1334884,true;true;false;false,7091/10465
> = nmbr yea ' s,C0053917;C1334884,true;false,7092/10465
median — yr,C0549183;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,7093/10465
nnmbr,,,7094/10465
nmbr to < nmbr years,C0053917;C0439234;C1334884,true;false;false,7095/10465
no des,C0011702;C4551552,true;true,7096/10465
> nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,7097/10465
> nmbr . nmbr,C0053917;C1334884,true;false,7098/10465
hrqol,C4279947;C4300252,true;false,7099/10465
p values,C1709380,false,7100/10465
no acs,C0742343;C4318612,true;false,7101/10465
othernmbr,,,7102/10465
> nmbr to nmbr years,C0053917;C0439234;C1334884,true;false;false,7103/10465
cat < nmbr,C0007450;C0053917;C1334884;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;true;false;false;true;false;false;false;false,7104/10465
age > nmbr yr 十,C0001779;C0053917;C0439234;C1334884,false;true;false;false,7105/10465
smoker,C0337664,true,7106/10465
oads  n ( % ),,,7107/10465
paod,,,7108/10465
nmbr or more,C0053917;C1334884,true;false,7109/10465
site,C0205145;C1515974;C2825164,false;false;false,7110/10465
> = nmbr years ( n = nmbr ),C0053917;C0439234;C1334884,true;false;false,7111/10465
ifg,C1334085;C1708411,false;false,7112/10465
cancer * *,C0006826;C0998265;C1306459,true;false;false,7113/10465
race — no . ( % ) ' (,C0034510;C1706779;C3853635,true;false;false,7114/10465
aged < nmbr years,C0001779;C0053917;C0439234;C1334884;C0001792;C1999167,false;true;false;false;true;false,7115/10465
( ri = nmbr ),C0035487;C0053917;C1334884;C1826843,true;true;false;false,7116/10465
x / n *,,,7117/10465
s £ nmbr,C0565930;C0053917;C1334884;C2603362,false;true;false;false,7118/10465
aml,C0023465;C0023467,true;true,7119/10465
age ( years ) :,C1510829,false,7120/10465
htn hx,C0020538;C0262926;C3814444,true;false;false,7121/10465
lvef > nmbr %,C0428772;C0053917;C1334884;C0488728,false;true;false;false,7122/10465
non - dm,C1518422;C0011816;C3250443,false;true;false,7123/10465
group b,C4522078,false,7124/10465
total hip,C0439175;C0019552;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;true;true;false;false;false,7125/10465
obesity t,C0028754;C1963185,true;false,7126/10465
b,,,7127/10465
no,,,7128/10465
total  n = nmbr,C0439175;C0053917;C1334884;C0439810,false;true;false;false,7129/10465
race - no . ( % ),C0034510;C1706779;C3853635,true;false;false,7130/10465
< nmbrh,,,7131/10465
< nmbr . nmbr,C0053917;C1334884,true;false,7132/10465
r nmbr mg ( n = nmbr ),C0687673;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,7133/10465
ics # #,C0815320;C4551720,false;true,7134/10465
off pump,C1518543;C0182537,false;false,7135/10465
china,C0008115,true,7136/10465
abi > nmbr . nmbr,C1328319;C0053917;C1334884;C3888326,true;true;false;false,7137/10465
male  n ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,7138/10465
female ( n = nmbr ),C0043210;C0053917;C1334884;C0086287;C1705497;C1705498,true;true;false;true;false;false,7139/10465
age  ya,C0001779,false,7140/10465
adl,C0001288;C1420005,true;false,7141/10465
ii - iv,C1710602;C0022326;C4265176;C4082587,false;true;false;false,7142/10465
any,,,7143/10465
ff nmbr | ig ( n = nmbr ),C4554348;C0053917;C0021027;C0305052;C0360506;C1334884,false;true;true;false;false;false,7144/10465
crp,C3890735;C4048285,false;false,7145/10465
nste - mi,C3537184;C4255010,false;true,7146/10465
n =,C0369718;C0441922,false;false,7147/10465
korea,C0022771,true,7148/10465
ckd  n ( % ) t,C1561643,true,7149/10465
icd  n ( % ),C0021122,true,7150/10465
poba  n ( % ),,,7151/10465
no aspirin,C0004057,true,7152/10465
yes  n ( % ),C1549445;C1705108;C1710701,false;false;false,7153/10465
placebo nmbr,C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,7154/10465
no chd,C0280604;C3542407,false;false,7155/10465
sfc,C4521536,false,7156/10465
asthma,C0004096;C2984299,true;false,7157/10465
[nmbr % cl],C0053917;C0596019;C1334884,true;false;false,7158/10465
nmbr to < nmbr ( % ),C0053917;C1334884,true;false,7159/10465
lvef  %,C0428772;C0488728,false;false,7160/10465
> = nmbr,C0053917;C1334884,true;false,7161/10465
ynmbr,,,7162/10465
age < nmbr years,C1510829;C0053917;C1334884,false;true;false,7163/10465
n / n,C0369718;C0441922,false;false,7164/10465
racenmbr,,,7165/10465
placebo ( n[nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,7166/10465
vdhmtss,,,7167/10465
poci,,,7168/10465
> nmbr . nmbr min,C0053917;C0702093;C1524029;C3813700;C1334884,true;false;false;false;false,7169/10465
placebo ( n = nmbr * ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,7170/10465
aicd  ( % ),C0972395;C2611803;C3537205;C3546309,false;false;false;false,7171/10465
hscrp §,,,7172/10465
nmbr,C0053917;C1334884,true;false,7173/10465
major,C0205082;C0205164;C4318856;C4521762,false;false;false;false,7174/10465
prior,C0332152;C2826257,false;false,7175/10465
ccb,C0006684,true,7176/10465
male - no . ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,7177/10465
b - blockers,,,7178/10465
placebo ( lsm ),C0032042;C1696465;C1706408,true;false;false,7179/10465
median — vr,C0549183;C3476815;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,7180/10465
ileum,C0020885,true,7181/10465
no ( n = nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,7182/10465
> nmbr - nmbr,C0053917;C1334884,true;false,7183/10465
no statin use,C0360714;C0042153;C0457083;C1947944,true;true;false;false,7184/10465
absent,C0332197;C4285062,false;false,7185/10465
age $ nmbr years § *,C1510829;C0053917;C1334884,false;true;false,7186/10465
ics,C0815320;C4551720,false;true,7187/10465
laci,C1420705;C3273314;C4281721,false;false;false,7188/10465
< nmbr bpm ( n = nmbr ),C0053917;C1334884,true;false,7189/10465
% pred,C0032952;C0044955,true;true,7190/10465
prior ml,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,7191/10465
> nmbr yr,C0053917;C0439234;C1334884,true;false;false,7192/10465
on nmbr,C0053917;C1334884,true;false,7193/10465
tg,C0337445,false,7194/10465
> = nmbr kg,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,7195/10465
on pump,C3842462,false,7196/10465
tnmbrdm,,,7197/10465
others  n ( % ),C1955473;C3539125,false;false,7198/10465
mean,C0444504;C2347634;C2348143,false;false;false,7199/10465
high,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,7200/10465
hazard,C0598697,false,7201/10465
p valuey,C0369773;C2603361,false;false,7202/10465
cana nmbr mg,C1418845;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,7203/10465
age ( y ),C0001779,false,7204/10465
( nmbr % ci ),C0053917;C0008107;C3259781;C1334884,true;true;false;false,7205/10465
age ( yij,C0001779,false,7206/10465
ssi - nmbr,C0053917;C1334884,true;false,7207/10465
« = nmbr,C0053917;C1334884,true;false,7208/10465
ucr,,,7209/10465
tender,C0234234,false,7210/10465
p *,C0369773;C2603361,false;false,7211/10465
iii ( n z nmbr ),C0439070;C0053917;C1334884;C1705160,false;true;false;false,7212/10465
cyclo,C1172566,true,7213/10465
hbalc < medan,,,7214/10465
non - hdl,C1518422;C3715113,false;false,7215/10465
sodium,C0037473;C0597484;C3541959;C3714642,true;false;false;false,7216/10465
£ nmbr,C0053917;C1334884,true;false,7217/10465
simva,,,7218/10465
laci ( n = nmbr ),C1420705;C0053917;C1334884;C3273314;C4281721,false;true;false;false;false,7219/10465
puva,C0853073;C1704892,false;false,7220/10465
icsa,,,7221/10465
ua,C0041580;C0042014,true;true,7222/10465
hr ( nmbr % ci ) “,C0053917;C0008107;C3259781;C1334884,true;true;false;false,7223/10465
asa,C0004057;C3853627,true;false,7224/10465
ng,C0017887;C0028074,true;true,7225/10465
patient,C0030705,true,7226/10465
rr,,,7227/10465
race ( % ) ) ',C0034510;C1706779;C3853635,true;false;false,7228/10465
> nmbr to nmbr,C0053917;C1334884,true;false,7229/10465
ii,,,7230/10465
otherb,,,7231/10465
ldl - cz,C0206578,true,7232/10465
( a blocker,,,7233/10465
event,C0441471;C4019010,false;false,7234/10465
iii,C0439070;C1705160,false;false,7235/10465
^nmbr,C0053917;C1334884,true;false,7236/10465
ef < nmbr %,C0053917;C1334884,true;false,7237/10465
israel,C0022271,true,7238/10465
glinide,C2266929,false,7239/10465
brazil,C0006137,true,7240/10465
nmbr to < nmbrkg,C0053917;C1334884,true;false,7241/10465
pasi^i,C4528685;C0021966;C0221138,false;true;false,7242/10465
indian,C1524069,false,7243/10465
europe i,C0015176;C0021966;C0221138,true;true;false,7244/10465
male sex,C0086582,true,7245/10465
 nmbr years,C0053917;C0439234;C1334884,true;false;false,7246/10465
ifx ( n = nmbr ),C0020823;C0053917;C1334884,true;true;false,7247/10465
week nmbr,C0332174;C0053917;C1334884;C0439230,false;true;false;false,7248/10465
right,C0205090;C0444532,false;false,7249/10465
tg *,C0337445,false,7250/10465
samanmbr,,,7251/10465
high *,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,7252/10465
hope ( n = nmbr ),C0392347;C0053917;C1334884,true;true;false,7253/10465
active ( n = nmbr ),C0205177;C0053917;C1334884;C3853793;C3888249,false;true;false;false;false,7254/10465
> nmbr  < nmbr,C0053917;C1334884,true;false,7255/10465
group c,C0441837,false,7256/10465
ex - smokers,C0337671;C4555205,false;true,7257/10465
male sex  no . ( % ),C0086582,true,7258/10465
with ( n = nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,7259/10465
poor,C0032854;C0542537;C2700379,true;false;false,7260/10465
radial,C0442038;C0920847,false;false,7261/10465
nnmbr / nnmbr,,,7262/10465
ef > nmbr %,C0053917;C1334884,true;false,7263/10465
stalin,,,7264/10465
> = nmbr yr,C0053917;C0439234;C1334884,true;false;false,7265/10465
sfc ( n[nmbr ),C4521536;C0053917;C1334884,false;true;false,7266/10465
race  n ( % ) b,C0034510;C1706779;C3853635,true;false;false,7267/10465
ra,C3538806;C4048756,false;false,7268/10465
sal nmbr pg ( n = nmbr ),C0036140;C0053917;C0030827;C0072225;C1266240;C1334884;C0037494;C0206136,true;true;true;true;false;false;true;true,7269/10465
pci — no . ( % ),C4049621,false,7270/10465
hrt,C0282402,true,7271/10465
fp ( n[nmbr ),C0016704;C0053917;C1334884;C1419068;C1419906;C3541238;C3541412,true;true;false;false;false;false;false,7272/10465
mtss,,,7273/10465
nmbre < nmbr %,C0053917;C1334884,true;false,7274/10465
yes ',C1549445;C1705108;C1710701,false;false;false,7275/10465
ratio,C0456603;C1547037,false;false,7276/10465
sal ( n = nmbr ),C0036140;C0053917;C1334884;C0037494;C0206136,true;true;false;true;true,7277/10465
nyhaii,,,7278/10465
women — no . ( % ),C0043210,true,7279/10465
smoking status  no . ( % ),C1519386,false,7280/10465
smoking status  n ( % ),C1519386,false,7281/10465
smoking status — no . ( % ),C1519386,false,7282/10465
systolic bp  mm hg,C0871470;C0439475,true;false,7283/10465
systolic bp ( mm hg ),C0871470;C0439475,true;false,7284/10465
diastolic ( mmhg ),C0012000;C0439475,true;false,7285/10465
systolic — mm hg,C0039155;C0439475,true;false,7286/10465
diastolic ( mm hg ),C0012000;C0439475,true;false,7287/10465
systolic bp ( mmhg ),C0871470;C0439475,true;false,7288/10465
systolic ( mm hg ),C0039155;C0439475,true;false,7289/10465
diastolic bp  mm hg,C0428883;C0439475,true;false,7290/10465
systolic ( mmhg ),C0039155;C0439475,true;false,7291/10465
diastolic bp ( mmhg ),C0428883;C0439475,true;false,7292/10465
diastolic — mm hg,C0012000;C0439475,true;false,7293/10465
diastolic bp ( mm hg ),C0428883;C0439475,true;false,7294/10465
dasnmbr ( esr ),C3811131,false,7295/10465
dasnmbr - crp §,C3890735;C4048285,false;false,7296/10465
dasnmbr - hscrp,,,7297/10465
dasnmbr ( crp ),C3890735;C4048285,false;false,7298/10465
dasnmbr - crp,C3890735;C4048285,false;false,7299/10465
dasnmbr - esr,C3811131,false,7300/10465
unadjusted,C1439367,false,7301/10465
unadjusted hr,C1439367,false,7302/10465
unadjusted irr,C1439367;C4082285,false;true,7303/10465
adjusted,C0456081,false,7304/10465
unadjusted hr .,C1439367,false,7305/10465
ejection fraction,C0489482;C2700378,false;false,7306/10465
lv ejection fraction,C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,7307/10465
apolipoprotein anmbr ( g / l ),C1447574;C0439267;C4319541;C0003591;C0439294;C0456615,true;false;true;true;false;false,7308/10465
apolipoprotein anmbr ( mg / dl ),C0003591;C0439269,true;false,7309/10465
fpg  mmol / l,C1532563,false,7310/10465
fpg ( mmol / l ),C1532563,false,7311/10465
tg ( mmol / l ) c,C0337445;C1532563,false;false,7312/10465
na ( mmol / l ),C0597484;C1532563;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false;false,7313/10465
k ( mmol / l ),C0597277;C1532563;C1708601,false;false;false,7314/10465
ldl ( mmol / l ),C1532563,false,7315/10465
bun  mmol / l,C1532563,false,7316/10465
tc ( mmol / l ),C0039411;C1532563;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,7317/10465
tg ( mmol / l ),C0337445;C1532563,false;false,7318/10465
ffa ( mmol / l ),C0015688;C1532563,true;false,7319/10465
fpg  mmol / lt,C0439190;C0023376;C0230426;C3887647;C4521399,false;true;false;false;false,7320/10465
mdg ( mmol / l ),C0024443;C1532563;C1417239;C2986643,true;false;false;false,7321/10465
ppg  mmol / l,C1418888;C1532563,false;false,7322/10465
hdl ( mmol / l ),C3715113;C1532563,false;false,7323/10465
mssbp  mm hg,C0439475,false,7324/10465
dbp ( mmhg ),C0536221;C0439475;C3813197;C4281799,true;false;false;false,7325/10465
sbp ( mm hg ),C0085805;C0439475,true;false,7326/10465
sbp  mmhg,C0085805;C0439475,true;false,7327/10465
dbp  mm hg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,7328/10465
sbp ( mmhg ),C0085805;C0439475,true;false,7329/10465
dbp  mmhg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,7330/10465
msdbp  mm hg,C0439475,false,7331/10465
msdbp  mm hga,C4330985;C4554674,false;false,7332/10465
mssbp  mm hga,C4330985;C4554674,false;false,7333/10465
sbp  mm hg,C0085805;C0439475,true;false,7334/10465
dbp ( mm hg ),C0536221;C0439475;C3813197;C4281799,true;false;false;false,7335/10465
map ( mmhg ),C0024779;C0439475;C1706473;C4050322,true;false;false;false,7336/10465
cvd subjects,C0007222,true,7337/10465
all subjects,,,7338/10465
mrf subjects,C0312443;C1412879,false;false,7339/10465
c - reactive protein ( mg / l ),C0006560;C0439268;C1413716;C4048285,true;false;false;false,7340/10465
c - reactive protein ( mg / dl ),C0006560;C0439269;C1413716;C4048285,true;false;false;false,7341/10465
c - reactive protein  mg / l,C0006560;C0439268;C1413716;C4048285,true;false;false;false,7342/10465
c - reactive protein  * mg / l,C0006560;C0439268;C1413716;C4048285,true;false;false;false,7343/10465
c - reactive protein ( mg / dl_ ),C0006560;C0439269;C1413716;C4048285,true;false;false;false,7344/10465
body - mass index ( kg / mnmbr ) t,C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7345/10465
body mass index - kg / mnmbrt,C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7346/10465
body mass index ( kg / mnmbr ) ,C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7347/10465
body mass index  kg / mnmbr,C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7348/10465
body mass index ( kg / nr ),C0005893;C0022718;C0027496;C3844738;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;false;true,7349/10465
body mass index ( kg / mnmbr ),C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7350/10465
body - mass index ( kg / mnmbr ),C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7351/10465
bodymass index ( kg / mnmbr ),C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7352/10465
body mass index ( kg / mnmbr ) * ',C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7353/10465
body mass index  * kg / mnmbr,C0005893;C0022718;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;true,7354/10465
comorbidities  n ( % ) a,C0009488,true,7355/10465
comorbidites  n ( % ),,,7356/10465
controls ( n = nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7357/10465
control ( n z nmbr ),C0243148;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false;false,7358/10465
control ( nznmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7359/10465
control ( n = nmbr ),C0243148;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false;false,7360/10465
control ( n - nmbr ),C0243148;C0053917;C1334884;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false;false,7361/10465
african - american,C0085756,true,7362/10465
african american,C0085756,true,7363/10465
african americans,C0085756,true,7364/10465
african america,C0085756,true,7365/10465
history of hypertension ( n = nmbr ),C0455527;C0053917;C1334884,false;true;false,7366/10465
no history of hypertension ( n = nmbr ),C0455527;C0053917;C1334884,false;true;false,7367/10465
egfr ( ml / min ),C1739039;C0439445;C3811844;C3812682,true;false;false;false,7368/10465
egfr  ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,7369/10465
- ics / + laba n z nmbr,C0815320;C0053917;C1334884;C4551720,false;true;false;true,7370/10465
+ ics / + laba nz nmbr,C0815320;C0027978;C0053917;C1334884;C4551720,false;true;true;false;true,7371/10465
baseline mean ( se ),C0168634;C0444504;C0036919;C2347634;C2348143;C1442488,true;false;true;false;false;false,7372/10465
baseline ( mean  sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7373/10465
baseline  mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7374/10465
no current smoking,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7375/10465
current smoker  %,C3173209;C3241966,false;false,7376/10465
current smokers,C3173209;C3241966,false;false,7377/10465
current smokers ( % ),C3173209;C3241966,false;false,7378/10465
current smoker ( % ),C3173209;C3241966,false;false,7379/10465
current smoker,C3173209;C3241966,false;false,7380/10465
current non - smoker,C0425311,false,7381/10465
current smoking,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7382/10465
current smokers  %,C3173209;C3241966,false;false,7383/10465
current smokers *,C3173209;C3241966,false;false,7384/10465
current smoking *,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7385/10465
current nonsmoker,C0521116;C0337672;C0425293;C4554605;C1705970,false;false;false;true;false,7386/10465
current smoker ,C3173209;C3241966,false;false,7387/10465
current smoker yes,C3173209;C1549445;C1705108;C1710701;C3241966,false;false;false;false;false,7388/10465
current nonsmokers,C0521116;C0337672;C4554605;C1705970,false;false;true;false,7389/10465
prior ptca or pci,C0332152;C2936173;C2826257,false;true;false,7390/10465
prior ptca / pci,C0332152;C2936173;C4049621;C2826257,false;true;false;false,7391/10465
interactior p - value,C1709380,false,7392/10465
interaction p - value,C1704675;C1709380,false;false,7393/10465
interaction p value 中,C1704675;C1709380,false;false,7394/10465
interaction p value §,C1704675;C1709380,false;false,7395/10465
interaction p value,C1704675;C1709380,false;false,7396/10465
duration of copd ( yr ),C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7397/10465
duration of copd  y,C0449238;C0024117;C1412502;C3714496;C2926735,false;true;false;false;false,7398/10465
duration of copd — yr,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7399/10465
duration of copd  yr,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7400/10465
duration of copd  years,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7401/10465
duration of pd  y,C0449238;C4553228;C4553229;C2926735,false;false;false;false,7402/10465
duration of copd ,C0449238;C0024117;C1412502;C3714496;C2926735,false;true;false;false;false,7403/10465
duration of copd ( years ),C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7404/10465
multivariate p - value,C1709380,false,7405/10465
univariate p - value,C1709380,false,7406/10465
group b ( n = nmbr ),C0441848;C0053917;C1334884;C4522078,false;true;false;false,7407/10465
group c ( n = nmbr ),C0441848;C0053917;C1334884;C0441837,false;true;false;false,7408/10465
group a ( n = nmbr ),C0441848;C0053917;C1334884;C0441835;C4522145,false;true;false;false;false,7409/10465
rage ( ng / ml ),C0034634;C0439275;C3539760;C3815186,true;false;false;false,7410/10465
ltbr ( ng / ml ),C1416931;C0439275,false;false,7411/10465
pigr ( ng / ml ),C1418569;C0439275,false;false,7412/10465
vegfr ( ng / ml ),C1568520;C0439275,true;false,7413/10465
imt ( nmbr ),C0334121;C0053917;C1334884;C1704614;C4318736,true;true;false;false;false,7414/10465
imt ( mm ),C0334121;C4330985;C4554674;C1704614;C4318736,true;false;false;false;false,7415/10465
haq - di *,C3826998;C4321476,false;false,7416/10465
haq - di,C3826998;C4321476,false;false,7417/10465
haq - di * *,C3826998;C4321476,false;false,7418/10465
non - fatal stroke,C1518422;C1302234;C0038454;C4554100;C1705232,false;false;true;false;false,7419/10465
nonfatal stroke,C0038454;C4554100,true;false,7420/10465
antiplatelet or anticoagulant,,,7421/10465
antiplatelets or anticoagulants,,,7422/10465
hypercholesterolemia — no . ( % ) *,C0020443;C1522133,true;false,7423/10465
hypercholesterolemia — no . ( % ),C0020443;C1522133,true;false,7424/10465
hypercholesterolemia 一 no . ( % ),C0020443;C1522133,true;false,7425/10465
pre - menopausal without hormone replacement,C0206158;C0282402,true;true,7426/10465
post - menopausal with hormone replacement,C0019930,true,7427/10465
pre - menopausal with hormone replacement,C0206158;C0282402,true;true,7428/10465
post - menopausal without hormone replacement,C0019930,true,7429/10465
bumetanide,C0006376,true,7430/10465
budesonide,C0054201,true,7431/10465
nmbr - hour madbp  mm hg,C0053917;C0439227;C0439475;C0564385;C1334884,true;false;false;false;false,7432/10465
nmbr - hour masbp  mm hg,C0053917;C0439227;C0439475;C0564385;C1334884,true;false;false;false;false,7433/10465
no prior heart failure,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7434/10465
prior heart failure,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7435/10465
prior cancer,C0332152;C0006826;C0998265;C1306459;C2826257,false;true;false;false;false,7436/10465
no prior cancer,C0332152;C0006826;C0998265;C1306459;C2826257,false;true;false;false;false,7437/10465
nmbr to < nmbr ( n = nmbr ),C0053917;C1334884,true;false,7438/10465
$ nmbr to  nmbr ( n = nmbr ),C0053917;C1334884,true;false,7439/10465
nmbr to < nmbr ( n z nmbr ),C0053917;C1334884,true;false,7440/10465
ace - i or arb,C1452534;C0021966;C0221138;C4284014,true;true;false;false,7441/10465
no ace - i / arb,C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,7442/10465
ace - lorarb,C1452534;C4284014,true;false,7443/10465
ace - i / arb,C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,7444/10465
acei or arb,,,7445/10465
ace - l / arbs,C1452534;C3888198;C4284014,true;false;false,7446/10465
aceis / arbs,C3888198,false,7447/10465
acei / arb,C3888198,false,7448/10465
triglycerides,C0041004,true,7449/10465
triglyceride a,C0041004,true,7450/10465
triglycerides *,C0041004,true,7451/10465
triglycerides * *,C0041004,true,7452/10465
triglyceride,C0041004,true,7453/10465
fluvastatin ( n = nmbr ),C0082608;C0053917;C1334884,true;true;false,7454/10465
simvastatin ( n = nmbr ),C0074554;C0053917;C1334884,true;true;false,7455/10465
rosuvastatin ( n = nmbr ),C0965129;C0053917;C1334884,true;true;false,7456/10465
diabetic yes,C0241863;C1549445;C1705108;C1710701,false;false;false;false,7457/10465
diabetes,C0011847;C0011849,false;true,7458/10465
antidiabetic,C0935929,true,7459/10465
diabetesnmbr,,,7460/10465
nondiabetic,,,7461/10465
prediabetes  %,C0362046,true,7462/10465
diabetic no,C0241863,false,7463/10465
non - diabetic,C1518422;C0241863,false;false,7464/10465
diabetes ( % ),C0011847;C0011849,false;true,7465/10465
diuretics,C0012798,true,7466/10465
diuretic use,C0012798;C0042153;C0457083;C1947944,true;true;false;false,7467/10465
diabeticnmbr,,,7468/10465
diabetesf,,,7469/10465
diabetes  %,C0011847;C0011849,false;true,7470/10465
prediabeticb,,,7471/10465
diureticff,,,7472/10465
n o diabetes,C0369718;C0011847;C0011849;C0441922,false;false;true;false,7473/10465
diabetes *,C0011847;C0011849,false;true,7474/10465
dabetes,,,7475/10465
non - diabetes,C1518422;C0011847;C0011849,false;false;true,7476/10465
non - diabetics,C1518422;C0241863,false;false,7477/10465
diabetics,C0241863,false,7478/10465
diuretic,C0012798,true,7479/10465
no diabetes,C0011847;C0011849,false;true,7480/10465
diurciic,,,7481/10465
diabetic,C0241863,false,7482/10465
diabeticb,,,7483/10465
stage nmbra : egfr > = nmbr and < nmbr ml / min per nmbr . nmbr mnmbr,C0205390;C1739039;C0053917;C1334884;C3811844;C3812682;C1300072;C1306673,false;true;true;false;false;false;false;false,7484/10465
stage nmbrb : egfr > = nmbr and < nmbr ml / min per nmbr . nmbr mnmbr,C0205390;C1300072;C1306673,false;false;false,7485/10465
pm pef ( sd )  l / min,C0030266;C0030771;C2699239;C0702093;C1524029;C3813700;C1518922;C1542834;C4049155,true;true;false;false;false;false;false;false;false,7486/10465
am pef ( sd )  l / min,,,7487/10465
fevnmbr : fvc ratio,C3714541;C0456603;C1547037,true;false;false,7488/10465
fevnmbr : fvc ratio ,C3714541;C0456603;C1547037,true;false;false,7489/10465
fevnmbr / fvc ratio *,C3714541;C0456603;C1547037,true;false;false,7490/10465
egfr  * ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,7491/10465
egfr  ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,7492/10465
egfr ( ml / min / nmbr . nmbrmnmbr ),C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,7493/10465
egfr ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,7494/10465
egfr ( ml / min / nmbr . nmbr mnmbr ) §,C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,7495/10465
dyslipidaemiat,,,7496/10465
dyslipidaemia,C0242339,true,7497/10465
dyslipidaemia 本,C0242339,true,7498/10465
dyslipidemia,C0242339,true,7499/10465
nmbr st < nmbr . nmbr,C0053917;C0036056;C3272372;C1334884,true;true;false;false,7500/10465
nmbr / nmbr ( nmbr ),C0053917;C1334884,true;false,7501/10465
nmbr ( nmbr  nmbr ),C0053917;C1334884,true;false,7502/10465
nmbr ( nmbr . nmbr % ),C0053917;C1334884,true;false,7503/10465
nmbr ( nmbre < nmbr % ),C0053917;C1334884,true;false,7504/10465
> nmbr - nmbr - nmbr,C0053917;C1334884,true;false,7505/10465
nmbrrd > nmbr . nmbr,C0053917;C1334884,true;false,7506/10465
nmbr - nmbr . nmbr,C0053917;C1334884,true;false,7507/10465
nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,7508/10465
nmbr . nmbr % ( nmbr ),C0053917;C1334884,true;false,7509/10465
nmbr - < nmbr . nmbr,C0053917;C1334884,true;false,7510/10465
oral hypoglycemic,C0359086,false,7511/10465
oral hypoglycemics,C0359086,false,7512/10465
north america ( % ),C0028405,true,7513/10465
south america ( % ),C0037713,true,7514/10465
sitagliptin nmbr mg n = nmbr,C1565750;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,7515/10465
sitagliptin nmbrmg n = nmbr,C1565750;C0053917;C1334884,true;true;false,7516/10465
disease activity],C1292728,false,7517/10465
disease activity,C1292728,false,7518/10465
ease activity],C1331418;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false,7519/10465
class i,C0441885;C1319793;C2698967,false;false;false,7520/10465
class ia,C0456387;C0020980;C0694634;C1947960;C1518526;C1705943,false;true;false;false;false;false,7521/10465
class iii,C0441887;C2698969,false;false,7522/10465
class ii,C0441886;C2698968,false;false,7523/10465
class ib,C0456387;C2744579;C3890035;C4283819;C1518526;C1705943,false;true;false;false;false;false,7524/10465
class ic,C0456387;C0020750;C4554818;C1518526;C1705943,false;true;false;false;false,7525/10465
class iv,C0441888;C2698970,false;false,7526/10465
nt - probnp  pg / mlt,C0669479;C0030827;C4553833;C0072225;C1266240;C0754710,true;true;false;true;false;true,7527/10465
nt - probnp ( pg / ml ) h,C0669479;C2827929;C0439526;C1705224;C3887665;C0439297;C0033727;C0369286;C0441932;C0564385;C4528284;C0030827;C0439391;C0072225;C1266240;C0754710,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;true,7528/10465
nt - probnp ( pg / ml ),C0669479;C0439297;C0754710,true;false;true,7529/10465
nt - probnp — pg / ml * *,C0669479;C0439297;C0754710,true;false;true,7530/10465
nt - probnp  pg / ml,C0669479;C0439297;C0754710,true;false;true,7531/10465
drug - eluting stent,C1322815,true,7532/10465
drug eluting stent,C1322815,true,7533/10465
race : non - white,C0034510;C1706779;C3853635,true;false;false,7534/10465
race  nonwhite,C0034510;C1706779;C3853635,true;false;false,7535/10465
race - non - white,C0034510;C1706779;C3853635,true;false;false,7536/10465
race nonwhitet,C0034510;C1706779;C3853635,true;false;false,7537/10465
race  % nonwhite,C0034510;C1706779;C3853635,true;false;false,7538/10465
race  non - white,C0034510;C1706779;C3853635,true;false;false,7539/10465
smoking status *,C1519386,false,7540/10465
smokinq status,C0449438,false,7541/10465
smoking status,C1519386,false,7542/10465
nyha iii or iv,C1275491;C0439070;C1705160,false;false;false,7543/10465
nyhaiiioriv,,,7544/10465
csf cholesterol,C3540512;C0008377;C3889436,false;true;false,7545/10465
hdl - cholesterol,C0023822;C0392885,true;false,7546/10465
vldl cholesterol,C0023826;C0523560,true;false,7547/10465
ldl cholesterolt,,,7548/10465
ldl - cholesterol (,C0023824;C0202117,true;false,7549/10465
hdl cholesterol §,C0023822;C0392885,true;false,7550/10465
ldl cholesterol,C0023824;C0202117,true;false,7551/10465
tolal choleslerol,,,7552/10465
total cholesterol *,C0201950;C0543421,false;false,7553/10465
hdl cholesterol *,C0023822;C0392885,true;false,7554/10465
total cholesterol  %,C0201950;C0543421,false;false,7555/10465
total cholesterol,C0201950;C0543421,false;false,7556/10465
hdl choleslerol,C3715113,false,7557/10465
ldl choleslerol,,,7558/10465
aldl cholesterol,C0008377,true,7559/10465
hdl cholesterol,C0023822;C0392885,true;false,7560/10465
ldl - cholesterol,C0023824;C0202117,true;false,7561/10465
medical therapy,C0418981,false,7562/10465
medical therapies,C0418981,false,7563/10465
topical therapy,C0332237;C0039798;C0087111;C1363945,false;true;true;false,7564/10465
hbanmbrc ( n ),,,7565/10465
> nmbr  no . ( % ),C0053917;C1334884,true;false,7566/10465
> nmbr h  n ( % ),C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,7567/10465
> nmbr days ( % ),C0053917;C0439228;C1334884,true;false;false,7568/10465
< nmbr h  n ( % ),C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,7569/10465
< nmbr %  n ( % ),C0053917;C1334884,true;false,7570/10465
> nmbr ( % ),C0053917;C1334884,true;false,7571/10465
anmbrc ( % ),,,7572/10465
> nmbry  no . ( % ),,,7573/10465
hbanmbrc  %,,,7574/10465
hbanmbrc  % §,,,7575/10465
> nmbr %  n ( % ),C0053917;C1334884,true;false,7576/10465
hbanmbrc ( % ),,,7577/10465
> nmbr yr — no . ( % ),C0053917;C0439234;C1334884,true;false;false,7578/10465
< nmbr vr — no . ( % ),C0053917;C3476815;C1334884,true;false;false,7579/10465
$ nmbr %  n ( % ),C0053917;C1334884,true;false,7580/10465
> nmbr  n ( % ),C0053917;C1334884,true;false,7581/10465
< nmbr { % ),C0053917;C1334884,true;false,7582/10465
< nmbr y  n ( % ),C0053917;C1334884,true;false,7583/10465
^nmbr y  n ( % ),C0053917;C1334884,true;false,7584/10465
aabnmbr ( % ),,,7585/10465
< nmbr yr — no . ( % ),C0053917;C0439234;C1334884,true;false;false,7586/10465
< nmbr ( % ),C0053917;C1334884,true;false,7587/10465
> = nmbr * ( % ),C0053917;C1334884,true;false,7588/10465
> nmbr yr ( % ),C0053917;C0439234;C1334884,true;false;false,7589/10465
> = nmbr ( % ),C0053917;C1334884,true;false,7590/10465
> nmbr y  n ( % ),C0053917;C1334884,true;false,7591/10465
> nmbr y  no . ( % ),C0053917;C1334884,true;false,7592/10465
< nmbr days ( % ),C0053917;C0439228;C1334884,true;false;false,7593/10465
> nmbr y . n ( % ),C0053917;C1334884,true;false,7594/10465
< nmbr  n ( % ),C0053917;C1334884,true;false,7595/10465
£ median ( nmbr ),C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,7596/10465
> median ( nmbr % ),C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,7597/10465
> median ( nmbr kg ),C0549183;C0053917;C0022718;C0439209;C4054209;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false,7598/10465
> median ( nmbr mm ),C0549183;C0053917;C4330985;C4554674;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,7599/10465
> median ( nmbr ),C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,7600/10465
< median ( nmbr kg ),C0549183;C0053917;C0022718;C0439209;C4054209;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false,7601/10465
women < nmbr years,C0043210;C0053917;C0439234;C1334884,true;true;false;false,7602/10465
women > nmbr years,C0043210;C0053917;C0439234;C1334884,true;true;false;false,7603/10465
diclofenac ( n = nmbr  nmbr ),C0012091;C0053917;C1334884,true;true;false,7604/10465
diclofenac ( n = nmbr nmbr ),C0012091;C0053917;C1334884,true;true;false,7605/10465
previous mi — no . ( % ),C0205156;C3810814;C1552607,false;false;false,7606/10465
previous vte — no . ( % ),C0205156;C0630906;C1552607,false;true;false,7607/10465
previous chf — no . ( % ),C0205156;C0018802;C1552607,false;true;false,7608/10465
bl h / y : bilateral,C0005918;C0033727;C0369286;C0441932;C0564385;C4528284;C0006413;C1552663;C2827109,true;true;false;false;false;false;true;false;false,7609/10465
bl h / y : unilateral,C0005918;C0033727;C0369286;C0441932;C0564385;C4528284;C0006413;C1552663;C2827109,true;true;false;false;false;false;true;false;false,7610/10465
diabetes status,C1317301,false,7611/10465
diabetic status,C0241863;C0449438,false;false,7612/10465
mean ( sd ) age in years,C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7613/10465
mean ( sd ) age  yr,C0444504;C2699239;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false;false,7614/10465
mean ( sd ) age  years,C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7615/10465
mean ( sd ) age ( years ),C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7616/10465
no symptoms,C0683368;C1457887,true;false,7617/10465
symptoms,C0683368;C1457887,true;false,7618/10465
age at randomization,C0001779;C0034656,false;true,7619/10465
age at randomisation,C0001779;C0034656,false;true,7620/10465
vadas score *,,,7621/10465
mmse score *,C0451306;C0449820;C4050231,true;false;false,7622/10465
mean acrn,C0444504;C2347634;C2348143,false;false;false,7623/10465
rope score,C1563164;C0449820;C4050231,false;false;false,7624/10465
cat score,C0007450;C0449820;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;true;false;false;false;false,7625/10465
sss score,C0037052;C0723181,true;false,7626/10465
gds score *,C0451184;C1149049;C1418244,false;false;false,7627/10465
mmse score,C0451306;C0449820;C4050231,true;false;false,7628/10465
edss score,C0451246;C3887783,false;false,7629/10465
chads score,C0007928;C1413373,true;false,7630/10465
mean score,C3533236,false,7631/10465
mhis score,C0449820;C4050231,false;false,7632/10465
cat scoreff,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,7633/10465
kccq score,C3476798,false,7634/10465
aqlq score,C4055434,false,7635/10465
accp score,C0449820;C4050231,false;false,7636/10465
baseline sbp ( mm hg ),C0168634;C0085805;C0439475;C1442488,true;true;false;false,7637/10465
baseline dbp ( mm hg ),C0168634;C0536221;C0439475;C3813197;C4281799;C1442488,true;true;false;false;false;false,7638/10465
itt population,C0032659;C1257890,true;true,7639/10465
mitt population,C0032659;C1257890,true;true,7640/10465
tiotropium + placebo ( n[nmbr ),C0213771;C0032042;C0053917;C1334884;C1696465;C1706408,true;true;true;false;false;false,7641/10465
tiotropium + placeb ( n[nmbr ),C0213771;C0053917;C1334884,true;true;false,7642/10465
myocardial infarction  n ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,7643/10465
myocardial infarction  ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,7644/10465
sinusitis,C0037199;C4553555,true;false,7645/10465
synovitis,C0039103,true,7646/10465
no history of tia / stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7647/10465
history of tia or stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7648/10465
history of tia / stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7649/10465
heart rate ( beats per min ),C0018810,true,7650/10465
heart rate  beats / min,C0018810,true,7651/10465
heart rate  beats per min,C0018810,true,7652/10465
heart rate — beats / min,C0018810,true,7653/10465
heart rate ( beats / min ),C0018810,true,7654/10465
heart rate ( beats per minute ),C0018810,true,7655/10465
pga  nmbr - nmbr,C0016410;C0053917;C1334884;C3541266;C4050369,true;true;false;false;false,7656/10465
tjc  nmbr - nmbr,C0053917;C1334884,true;false,7657/10465
sjc  nmbr - nmbr,C0053917;C1334884,true;false,7658/10465
ptga  nmbr - nmbr,C0053917;C1334884,true;false,7659/10465
region latin american,C0017446;C0205147,true;false,7660/10465
region  latin america,C0017446;C0023122;C0205147,true;true;false,7661/10465
calcium - channel blockers,C0006684;C2757014,true;false,7662/10465
calcium channel blockers,C0006684;C2757014,true;false,7663/10465
calcium - channel blocker,C0006684;C3536851;C4521885,true;false;false,7664/10465
calcium channel blocker,C0006684;C3536851;C4521885,true;false;false,7665/10465
calcium - channel blockerf,C0006685,true,7666/10465
baseline median [mg / l],C0168634;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7667/10465
baseline median  mg / dl,C0168634;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7668/10465
baseline mean  mg / dl,C0168634;C0444504;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false,7669/10465
baseline mean ( mg / dl],C0168634;C0444504;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false,7670/10465
baseline median  mg / l,C0168634;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7671/10465
baseline mean mtss,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,7672/10465
baseline mean 士 sd,C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7673/10465
glucocorticoids,C0017710;C3540777;C3540778,true;false;false,7674/10465
glucocorticoid,C0017710,true,7675/10465
glucocorticoids *,C0017710;C3540777;C3540778,true;false;false,7676/10465
esr ( mm / h ),C3811131;C0456680,false;false,7677/10465
esr  mm / hour,C3811131;C4330985;C0439227;C0564385;C4554674,false;false;false;false;false,7678/10465
esr — mm / hr,C3811131;C4330985;C4554674,false;false;false,7679/10465
esr ( mm / hour )git config --global user.name "Your Name",C3811131;C4330985;C0439227;C1418224;C2827597;C0205246;C1548600;C1706077;C2348867;C0564385;C4554674,false;false;false;false;false;false;false;false;false;false;false,7680/10465
ns cardiac cisease,C0038944;C0018787;C1522601;C1112705;C1705982,true;true;false;false;false,7681/10465
cardiac disease,C0018799,true,7682/10465
no cardiac disease,C0018799,true,7683/10465
education < nmbr years,C0013621;C0053917;C0439234;C1334884;C0013622;C0013658;C0039401,true;true;false;false;true;true;true,7684/10465
education > nmbr years,C0013621;C0053917;C0439234;C1334884;C0013622;C0013658;C0039401,true;true;false;false;true;true;true,7685/10465
triglyceride ( mmol / l ),C0041004;C1532563,true;false,7686/10465
triglyceride ( mmol / l ) t,C0041004;C1532563,true;false,7687/10465
triglyceride  mmol / l,C0041004;C1532563,true;false,7688/10465
triglycerides ( mmol / l ) :,C0041004;C1532563,true;false,7689/10465
triglycerides ( mmol / l ),C0041004;C1532563,true;false,7690/10465
triglycerides  mg / l,C0041004;C0439268,true;false,7691/10465
triglycerides  mmol / l §,C0041004;C1532563,true;false,7692/10465
triglycerides * ( mg / dl ),C0041004;C0439269,true;false,7693/10465
triglycerides  mg / dl,C0041004;C0439269,true;false,7694/10465
triglyceride ( mg / dl ) d,C0041004;C0439422;C3642216,true;false;false,7695/10465
triglycerides — mg / dl,C0041004;C0439269,true;false,7696/10465
triglycerides ( mg / dl ),C0041004;C0439269,true;false,7697/10465
triglycerides  mg / dl^,C0041004;C0439269,true;false,7698/10465
triglycerides  mmol / l,C0041004;C1532563,true;false,7699/10465
triglyceride ( mg / dl ),C0041004;C0439269,true;false,7700/10465
triglycerides  mmol / lf,C0041004;C0439190;C1416933;C2986618;C4554443,true;false;false;false;false,7701/10465
patients without diabetesb,C0030705,true,7702/10465
patients with diabetesb,C0030705,true,7703/10465
no prior heart failure ( n = nmbr  nmbr ),C0332152;C0018801;C0053917;C1334884;C0018802;C4554158;C2826257,false;true;true;false;true;false;false,7704/10465
prior heart failure ( n = nmbr  nmbr ),C0332152;C0018801;C0053917;C1334884;C0018802;C4554158;C2826257,false;true;true;false;true;false;false,7705/10465
prior lev use,C0332152;C0023556;C2826257,false;true;false,7706/10465
prior asa use,C0332152;C0004057;C0042153;C0457083;C1947944;C3853627;C2826257,false;true;true;false;false;false;false,7707/10465
postmenopausal ,C0232970,false,7708/10465
postmenopausal,C0232970,false,7709/10465
premenopausal,C0279752,false,7710/10465
hs - crp ( mg / l ),C3890735;C0439268;C4048285,false;false;false,7711/10465
apob  mg / dl,C0003593;C0439269;C3252643,true;false;true,7712/10465
fpg  mg / dl,C0439269,false,7713/10465
bnp ( pg / ml ),C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,7714/10465
fpg ( mg / dl ),C0439269,false,7715/10465
hs - crp  mg / l,C3890735;C0439268;C4048285,false;false;false,7716/10465
bun  mg / dl,C0439269,false,7717/10465
crp — mg / l,C3890735;C0439268;C4048285,false;false;false,7718/10465
crp ( ng / ml ),C3890735;C0439275;C4048285,false;false;false,7719/10465
hscrp  mg / l,C0439268,false,7720/10465
apob  g / l,C0003593;C0439294;C0456615;C3252643,true;false;false;true,7721/10465
bun ( mg / dl ),C0439269,false,7722/10465
tgs ( mg / dl ),C1156212;C0439269;C1537574,false;false;false,7723/10465
hdl ( mg / dl ),C3715113;C0439269,false;false,7724/10465
ppg  mg / dl,C1418888;C0439269,false;false,7725/10465
bnp  pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,7726/10465
apo b ( g / l ),C0003593;C0439294;C0456615;C3252643,true;false;false;true,7727/10465
crp ( mg / dl ),C3890735;C0439269;C4048285,false;false;false,7728/10465
apoal  mg / dl,C0439269,false,7729/10465
mpo ( ng / ml ),C0439275,false,7730/10465
hscrp ( mg / l ),C0439268,false,7731/10465
hscrp  mg / dl,C0439269,false,7732/10465
hscrp ( mg / l ) c,C0439268,false,7733/10465
apo b  mg / dl,C0003593;C0439269;C3252643,true;false;true,7734/10465
hscrp ( nmol / l ),C0439282,false,7735/10465
troy ( ng / ml ),C1420811;C0439275;C1883402,false;false;false,7736/10465
apob ( mg / dl ),C0003593;C0439269;C3252643,true;false;true,7737/10465
bnp ( pg / ml ) h,C0054015;C2827929;C0439526;C1705224;C3887665;C0439297;C0033727;C0369286;C0441932;C0564385;C4528284;C0030827;C0439391;C0072225;C1266240;C1095989;C1417808;C2982014,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;false;false;false,7738/10465
crp  mg / l,C3890735;C0439268;C4048285,false;false;false,7739/10465
bnp  pg / mlt,C0054015;C0030827;C4553833;C0072225;C1266240;C1095989;C1417808;C2982014,true;true;false;true;false;false;false;false,7740/10465
triglycerides nmbr  d third,C0041004;C0053917;C0205437;C1334884,true;true;false;false,7741/10465
triglycerides nmbrst third,C0041004;C0205437,true;false,7742/10465
triglycerides nmbrnd third,C0041004;C0205437,true;false,7743/10465
no multivessel disease,C0012634,true,7744/10465
multivessel disease,C0012634,true,7745/10465
fastng plasma glucose < median,C0202042;C0549183;C0876920;C2347635;C2348144;C2939193;C0455280,false;false;false;false;false;false;false,7746/10465
fascng plasma glucose a medan,C0202042;C0455280,false;false,7747/10465
fasting plasma glucose < median,C0015663;C0202042;C0549183;C0876920;C2347635;C2348144;C2939193;C0455280,true;false;false;false;false;false;false;false,7748/10465
caucasian  %,C0007457;C0043157,true;true,7749/10465
caucasian ( % ),C0007457;C0043157,true;true,7750/10465
caucasiana ( % ),,,7751/10465
concomitant cardiovascular therapies — no . ( % ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,7752/10465
concomitant cardiovascular therapy — no . ( % ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,7753/10465
dissatisfied with / stopped $ nmbr prior systemic therapies because of side effects,C0870433;C1272691;C0053917;C1514463;C0205373;C0332152;C1515119;C2826257;C1334884;C4085546,false;false;true;false;false;false;false;false;false;false,7754/10465
dissatisfied with / stopped $ nmbr prior systemic therapy because of side effects,C0870433;C1272691;C0053917;C1514463;C0205373;C0332152;C1515119;C2826257;C1334884;C4085546,false;false;true;false;false;false;false;false;false;false,7755/10465
linagliptin ( n z nmbr ),C2746078;C0053917;C1334884,true;true;false,7756/10465
vildagliptin ( n = nmbr ),C1570906;C0053917;C1334884,true;true;false,7757/10465
linagliptin ( n = nmbr ),C2746078;C0053917;C1334884,true;true;false,7758/10465
sitagliptin ( n = nmbr ),C1565750;C0053917;C1334884,true;true;false,7759/10465
smoking — current,C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,7760/10465
smoking  % current,C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,7761/10465
current smoking — no . ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7762/10465
current smoking  n ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7763/10465
current smoker 一 no . ( % ),C3173209;C3241966,false;false,7764/10465
current smokers  n ( % ),C3173209;C3241966,false;false,7765/10465
current smoker — no . ( % ),C3173209;C3241966,false;false,7766/10465
current smoker  n ( % ),C3173209;C3241966,false;false,7767/10465
current smoker  no ( % ),C3173209;C3241966,false;false,7768/10465
without tnmbrdm n = nmbr,C0053917;C1334884,true;false,7769/10465
with tnmbrdm n = nmbr,C0053917;C1334884,true;false,7770/10465
val / hctz ( n = nmbr ),C0042285;C0020261;C0053917;C1334884;C0523975,true;true;true;false;false,7771/10465
v / hctz ( n = nmbr ),C0020261;C0053917;C1334884,true;true;false,7772/10465
aml / hctz ( n = nmbr ),C0023465;C0020261;C0053917;C1334884;C0023467,true;true;true;false;true,7773/10465
ind / gly,C4049864;C0017890;C0523677,false;true;false,7774/10465
indzgly,,,7775/10465
gdf - nmbr ( ng / ml ),C1418244;C0053917;C0439275;C1334884,false;true;false;false,7776/10465
mmp - nmbr ( ng / ml ),C0623362;C0053917;C0439275;C1334884;C0919336,true;true;false;false;false,7777/10465
st - nmbr ( ng / ml ),C0036056;C0053917;C0439275;C1334884;C3272372,true;true;false;false;false,7778/10465
mmp - nmbr ( ng / ml ) *,C0623362;C0053917;C0439275;C1334884;C0919336,true;true;false;false;false,7779/10465
il - nmbr ( pg / ml ),C0020898;C0053917;C0439297;C1334884;C0021764;C0022271,true;true;false;false;true;true,7780/10465
diabetes  n ( % ),C0011847;C0011849,false;true,7781/10465
diabetes — no . ( % ),C0011847;C0011849,false;true,7782/10465
diabetes  no . ( % ),C0011847;C0011849,false;true,7783/10465
diabetes  * n ( % ),C0011847;C0011849,false;true,7784/10465
prediabetes  n ( % ),C0362046,true,7785/10465
unstable angina — no . ( % ),C0002965,true,7786/10465
stable angina — no . ( % ),C0340288,true,7787/10465
anmbrc < nmbr . nmbr % ( median ),C0053917;C0549183;C0876920;C2347635;C2348144;C2939193;C1334884,true;false;false;false;false;false;false,7788/10465
anmbr = nmbr . nmbr % ( median ),C0053917;C0549183;C0876920;C2347635;C2348144;C2939193;C1334884,true;false;false;false;false;false;false,7789/10465
hazard ratio ( nmbr % cl ),C2985465;C0053917;C0596019;C1334884,false;true;false;false,7790/10465
hazard ratio ( nmbr % ci ) *,C2985465;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,7791/10465
hazard ratio ( nmbr % ci ),C2985465;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,7792/10465
hazard ratio * ( nmbr % ci ),C2985465;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,7793/10465
hazard ratiof ( nmbr % ci ),C0598697;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,7794/10465
lipid - lowering agent §,C0086440,true,7795/10465
lipid - lowering agents,C0086440,true,7796/10465
lipid - lowering agent,C0086440,true,7797/10465
zotarolimus,C1700035,true,7798/10465
zotarolimust,,,7799/10465
pci orcabg,C4049621,false,7800/10465
prior cabg,C0332152;C0010055;C2826257,false;true;false,7801/10465
no prior cabg,C0332152;C0010055;C2826257,false;true;false,7802/10465
pnorcabg,,,7803/10465
diastolic blood pressure  mm hg  median ( range ),C0428883;C0439475;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1305849,true;false;false;false;false;false;false;false;false;false;false,7804/10465
systolic blood pressure  mm hg  median ( range ),C0488055;C0439475;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0871470;C1306620,false;false;false;false;false;false;false;false;false;false;true;false,7805/10465
very severe,C3641272;C4050419,false;false,7806/10465
more severe^,C0205172;C0205082;C4050465;C4050466,false;false;false;false,7807/10465
less severe,C0439092;C0205082;C4050465;C4050466;C0547044,false;false;false;false;false,7808/10465
more severe,C0205172;C0205082;C4050465;C4050466,false;false;false;false,7809/10465
cholesterol ( mg / dl ),C0008377;C0439269,true;false,7810/10465
cholesterol — mg / dl,C0008377;C0439269,true;false,7811/10465
treatment difference ( nmbr % cl ),C0039798;C1705241;C0053917;C0596019;C1334884;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;true;false;false;false;false;false,7812/10465
treatment difference ( nmbr % ci ),C0039798;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;true;false;false;false;true;false;false;false;false;false,7813/10465
insulin,C0021641;C1533581;C1579433;C3714501,true;false;false;false,7814/10465
insulina,,,7815/10465
> median ( nmbr ) — number / n ( % ),C0549183;C0053917;C0237753;C0449788;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,7816/10465
< median ( nmbr ) — number / n ( % ),C0549183;C0053917;C0237753;C0449788;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,7817/10465
baseline mssbp ( mmhg )  mean ± sd,C0168634;C0439475;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,7818/10465
baseline msdbp ( mmhg )  mean ± sd,C0168634;C0439475;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,7819/10465
age range ( years ),C1510829;C1514721;C2348147;C3542016,false;false;false;false,7820/10465
age range  years,C1510829;C1514721;C2348147;C3542016,false;false;false;false,7821/10465
inflammation,C0021368,true,7822/10465
inflammatory,C0333348,false,7823/10465
hispanic or latino,C0086409,true,7824/10465
hispanic / latino,C0086409;C0086528,true;true,7825/10465
< nmbr cells / pl,C0053917;C0007584;C3897966;C4049765;C0007634;C1334884,true;true;false;false;true;false,7826/10465
> nmbr cells / pl,C0053917;C0007584;C3897966;C4049765;C0007634;C1334884,true;true;false;false;true;false,7827/10465
american indian,C0002460,true,7828/10465
american indian /,C0002460,true,7829/10465
with an sfua,,,7830/10465
without an sfua,,,7831/10465
men  > nmbr cm,C0025266;C0053917;C1334884,true;true;false,7832/10465
men  < nmbr cm,C0025266;C0053917;C1334884,true;true;false,7833/10465
women  < nmbr cm,C0043210;C0053917;C1334884,true;true;false,7834/10465
women  > nmbr cm,C0043210;C0053917;C1334884,true;true;false,7835/10465
sulphonylureas,C0038766,true,7836/10465
sulphonylurea,C0038766;C3536898,true;false,7837/10465
on sulfonylurea,C0038766;C3536898,true;false,7838/10465
sulfonylureaa,,,7839/10465
sulfonylurea,C0038766;C3536898,true;false,7840/10465
pbo + mtx,C0031962;C0025677;C1417487,true;true;false,7841/10465
czp + mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,7842/10465
caucasians,C0007457;C0043157,true;true,7843/10465
caucasian,C0007457;C0043157,true;true,7844/10465
noncaucasian,,,7845/10465
non - caucasian,C1518422;C0007457;C0043157,false;true;true,7846/10465
ldl cholesterol ( mg / dl )  mean + sd  available for nmbr patients,C0023824;C0439269;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,7847/10465
hdl cholesterol ( mg / dl )  mean + sd  available for nmbr patients,C0023822;C0439269;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;false;false;false;false;false,7848/10465
previous or current use of im or cs : no,C0205156;C1552607,false;false,7849/10465
previous or current use of im and cs : no,C0205156;C1552607,false;false,7850/10465
nmbr to < nmbr ml / min / nmbr . nmbrmnmbr,C0053917;C0439445;C1334884,true;false;false,7851/10465
nmbr to o nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,7852/10465
nmbr to onmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,7853/10465
≥ nmbr to < nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,7854/10465
nmbr to < nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,7855/10465
without psoriasis ( zi = nmbr ),C0033860;C0043476;C0053917;C1334884,true;true;true;false,7856/10465
with psoriasis ( n = nmbr ),C0033860;C0053917;C1334884,true;true;false,7857/10465
with psoriasis ( zi = nmbr ),C0033860;C0043476;C0053917;C1334884,true;true;true;false,7858/10465
placebo events / patients ( % ),C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,7859/10465
placebo  events / patients ( % ),C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,7860/10465
ldl - cholesterol ( mg / dl ),C0023824;C0439269;C0202117,true;false;false,7861/10465
ldl cholesterol  mg / dl,C0023824;C0439269;C0202117,true;false;false,7862/10465
hdl cholesterol ( mg / dl ),C0023822;C0439269;C0392885,true;false;false,7863/10465
ldl cholesterol — mg / dl,C0023824;C0439269;C0202117,true;false;false,7864/10465
i idl cholesterol ( mg / dl ),C0619865;C0523559;C0439269;C0021966;C0123167;C0221138,true;false;false;true;true;false,7865/10465
hdl cholesterol — mg / dl,C0023822;C0439269;C0392885,true;false;false,7866/10465
hdl cholesterol  mg / dl,C0023822;C0439269;C0392885,true;false;false,7867/10465
ldl cholesterol ( mg / dl ),C0023824;C0439269;C0202117,true;false;false,7868/10465
hdl - cholesterol ( mg / dl ),C0023822;C0439269;C0392885,true;false;false,7869/10465
baseline ldl - c,C0168634;C1442488,true;false,7870/10465
baseline ldl - c :,C0168634;C1442488,true;false,7871/10465
who fc ii symptoms at baseline,C2983605;C1710602;C0683368;C0168634;C1442488;C1457887;C4082587,false;false;true;true;false;false;false,7872/10465
who fc iii symptoms at baseline,C2983605;C0439070;C0683368;C0168634;C1442488;C1457887;C1705160,false;false;true;true;false;false;false,7873/10465
nmbr . nmbr - < nmbr . nmbr,C0053917;C1334884,true;false,7874/10465
> nmbr - nmbr - nmbr - nmbr,C0053917;C1334884,true;false,7875/10465
nmbr - nmbr - nmbr - nmbr,C0053917;C1334884,true;false,7876/10465
nmbr . nmbr to nmbr . nmbr %,C0053917;C1334884,true;false,7877/10465
> nmbr . nmbr - < nmbr . nmbr,C0053917;C1334884,true;false,7878/10465
nmbr . nmbr - nmbr . nmbr,C0053917;C1334884,true;false,7879/10465
nmbr . nmbr + nmbr . nmbr,C0053917;C1334884,true;false,7880/10465
nmbr nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,7881/10465
nmbr . nmbr - < nmbr . nmbr %,C0053917;C1334884,true;false,7882/10465
nmbr  nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,7883/10465
nmbr  nmbr - < nmbr . nmbr,C0053917;C1334884,true;false,7884/10465
nmbr / nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,7885/10465
nmbr . nmbr to nmbr . nmbr,C0053917;C1334884,true;false,7886/10465
> nmbr . nmbr to < nmbr . nmbr,C0053917;C1334884,true;false,7887/10465
nmbr . nmbr ( nmbr . nmbr ),C0053917;C1334884,true;false,7888/10465
> nmbr . nmbrto < nmbr . nmbr %,C0053917;C1334884,true;false,7889/10465
nmbr . nmbr % - nmbr . nmbr %,C0053917;C1334884,true;false,7890/10465
no mra at baseline,C0243032;C0168634;C1442488;C1609165;C3891069,true;true;false;true;false,7891/10465
mra at baseline,C0243032;C0168634;C1442488;C1609165;C3891069,true;true;false;true;false,7892/10465
ss at baseline,C2699257;C0168634;C1442488;C3891295;C4551874,false;true;false;false;false,7893/10465
mmrc at baseline,C3826977;C0168634;C1442488,false;true;false,7894/10465
pad at baseline,C0182158;C0168634;C1442488;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,7895/10465
nihss at baseline,C1697238;C0168634;C1442488,false;true;false,7896/10465
aspirin dose,C4696290,false,7897/10465
aspirin alone,C0004057,true,7898/10465
aspirin use,C0004057;C0042153;C0457083;C1947944,true;true;false;false,7899/10465
arrhythmia,C0003811,true,7900/10465
arrhythmia !,C0003811,true,7901/10465
arrhythmias,C0003811,true,7902/10465
hypertensive,C0857121,false,7903/10465
hypertensiont,,,7904/10465
hypertension  n ( % ),C0020538;C1963138,true;false,7905/10465
hypertension 本,C0020538;C1963138,true;false,7906/10465
hypotension,C0020649;C3163620,true;false,7907/10465
hypertension  * n ( % ),C0020538;C1963138,true;false,7908/10465
hyper - tension,C0020538;C1963138,true;false,7909/10465
hypertension,C0020538;C1963138,true;false,7910/10465
hypertension  %,C0020538;C1963138,true;false,7911/10465
hypertension ( % ),C0020538;C1963138,true;false,7912/10465
hypertension  ( % ),C0020538;C1963138,true;false,7913/10465
no hypertension,C0020538;C1963138,true;false,7914/10465
hyperlension,,,7915/10465
hypertension *,C0020538;C1963138,true;false,7916/10465
hypertensive  n ( % ),C0857121,false,7917/10465
hypertension §,C0020538;C1963138,true;false,7918/10465
hypertension !,C0020538;C1963138,true;false,7919/10465
unstable angina *,C0002965,true,7920/10465
unstable angina age,C0002965;C0001779,true;false,7921/10465
unstable angina §,C0002965,true,7922/10465
unstable anginad,C0443343;C1883468,false;false,7923/10465
unstableangina,,,7924/10465
stable angina,C0340288,true,7925/10465
unstable anginat,C0443343;C1883468,false;false,7926/10465
unstable angina,C0002965,true,7927/10465
arb monotherapy,C3888198,false,7928/10465
era monotherapy,C1521863;C3495919,true;false,7929/10465
cardioembolism,,,7930/10465
cardioembolic,,,7931/10465
age category >,C0001779;C0683312;C3889287,false;false;false,7932/10465
bmi category,C0578022;C0683312;C3889287,false;false;false,7933/10465
age category,C0001779;C0683312;C3889287,false;false;false,7934/10465
aspirin or other antiplatelet agents,C0004057,true,7935/10465
aspirin or other antiplatelet agent,C0004057,true,7936/10465
mean ( sd ) pga vas *,C0444504;C2699239;C0016410;C0042815;C3536884;C3827561;C3541266;C4050369;C2347634;C2348143,false;false;true;true;true;false;false;false;false;false,7937/10465
mean ( sd ) ptga vas *,C0444504;C2699239;C0042815;C3536884;C3827561;C2347634;C2348143,false;false;true;true;false;false;false,7938/10465
mean ( sd ) pain vas *,C0444504;C2699239;C0042815;C2347634;C2348143,false;false;true;false;false,7939/10465
previous ml ( before index acs ),C0205156;C0439526;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1705224;C3887665;C1552607,false;false;true;true;false;true;false;false;false;false;false;false,7940/10465
previous pci ( before index acs ),C0205156;C4049621;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1552607,false;false;true;true;false;true;false;false;false;false,7941/10465
fibula fracture,C0149699,false,7942/10465
tibia fracture,C0040185,true,7943/10465
weight in kg  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7944/10465
weight  kg  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7945/10465
weight  kg : mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7946/10465
weight ( kg )  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7947/10465
weight ( kg )  mean ± sd,C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7948/10465
serum creatinine  umol / lf,C0201976;C0439194;C1416933;C2986618;C4554443;C0600061,false;false;false;false;false;false,7949/10465
serum creatinine  gmol / l |,C0201976;C0600061,false;false,7950/10465
serum creatinine ( gmol / ),C0201976;C0600061,false;false,7951/10465
serum creatinine ( mmol / l ),C0201976;C1532563;C0600061,false;false;false,7952/10465
serum creatinine  ^mol / l,C0201976;C0347982;C0600061,false;false;false,7953/10465
> nmbr years eze / simva ( „ = nmbr },C0053917;C0439234;C1334884,true;false;false,7954/10465
< nmbr years eze / simva ( n = nmbr },C0053917;C0439234;C1334884,true;false;false,7955/10465
im use : no,,,7956/10465
cs use : no,C0010182;C0271160;C3540510;C4085345,true;false;false;false,7957/10465
stent diameter < nmbr mm,C0038257;C1301886;C0053917;C4330985;C4554674;C1334884,true;false;true;false;false;false,7958/10465
stent diameter $ nmbr mm,C0038257;C1301886;C0053917;C4330985;C4554674;C1334884,true;false;true;false;false;false,7959/10465
overall ( n = nmbr  nmbr ),C0282416;C0053917;C1334884;C1561607,true;true;false;false,7960/10465
overall ( n = nmbr vs nmbr ),C0282416;C0053917;C1334884;C1561607,true;true;false;false,7961/10465
leukotriene receptor antagonists,C0595726;C2757015;C3542962,true;false;false,7962/10465
leukotriene - receptor antagonist,C0595726;C3537183;C4521995,true;false;false,7963/10465
high - sensitivity c - reactive protein  mg / ltt,C1441604;C0006560;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,false;true;true;true;false;false;false;false;false;false;false,7964/10465
high - sensitivityc - reactive protein  mg / l,C0205250;C0205332;C0033684;C0439268;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false,7965/10465
etn + mtx ( n = nmbr ),C0014758;C0025677;C0053917;C1334884;C1417487;C0717758,true;true;true;false;false;true,7966/10465
hcq + mtx ( n = nmbr ),C0020336;C0025677;C0053917;C1334884;C1417487,true;true;true;false;false,7967/10465
ssz + mtx ( n = nmbr ),C0025677;C0053917;C1334884;C1417487,true;true;false;false,7968/10465
lef + mtx ( n = nmbr ),C0025677;C0053917;C1334884;C1417487,true;true;false;false,7969/10465
> nmbr drinks,C0053917;C0452428;C1334884,true;false;false,7970/10465
nmbr drinks,C0053917;C0452428;C1334884,true;false;false,7971/10465
glucose ( mg / dl ),C0017725;C0439269,true;false,7972/10465
glucose — mg / dl,C0017725;C0439269,true;false,7973/10465
thienopyridine,C1120149,true,7974/10465
+ thienopyridine,C1120149,true,7975/10465
no thienopyridine,C1120149,true,7976/10465
- thienopyridine,C1120149,true,7977/10465
acholesterol ( % ),,,7978/10465
cholesterol ( % ),C0008377,true,7979/10465
< nmbr . nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,7980/10465
> nmbr . nmbr mg / mmol,C0053917;C0567349;C2348885;C1334884,true;false;false;false,7981/10465
> nmbr . nmbr - g / l,C0053917;C0439294;C0456615;C1334884,true;false;false;false,7982/10465
nmbr - nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,7983/10465
nmbr nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,7984/10465
≥ nmbr to < nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,7985/10465
> nmbr . nmbr mg / l,C0053917;C0439268;C1334884,true;false;false,7986/10465
> nmbr . nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,7987/10465
≥ nmbr to < nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,7988/10465
< nmbr . nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,7989/10465
< nmbr . nmbr mg / mmol,C0053917;C0567349;C2348885;C1334884,true;false;false;false,7990/10465
> nmbr & < nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,7991/10465
> nmbr and < nmbr mg / dl,C0053917;C1334884,true;false,7992/10465
> nmbr to nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,7993/10465
> nmbr but < nmbr mg / dl,C0053917;C1334884,true;false,7994/10465
< nmbr . nmbr ng / ml,C0053917;C0439275;C1334884,true;false;false,7995/10465
> nmbr + nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,7996/10465
nmbr - nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,7997/10465
. nmbr . nmbr mg / mmol,C0053917;C0567349;C2348885;C1334884,true;false;false;false,7998/10465
< nmbr - nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,7999/10465
 nmbr . nmbr mg / mmol,C0053917;C0567349;C2348885;C1334884,true;false;false;false,8000/10465
nmbr to nmbr mg / g,C0053917;C1300563;C1334884,true;false;false,8001/10465
nmbr to < nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,8002/10465
> nmbr . nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,8003/10465
> nmbr  < nmbr mg / dl,C0053917;C0439269;C1334884,true;false;false,8004/10465
< nmbr . nmbr l - g / l,C0053917;C0439267;C1334884,true;false;false,8005/10465
> nmbr . nmbr ng / ml,C0053917;C0439275;C1334884,true;false;false,8006/10465
> nmbr ' nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,8007/10465
> nmbr - nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,8008/10465
< nmbr . nmbrmg / l,C0053917;C1334884,true;false,8009/10465
cerebral vascular disease,C0007820,true,8010/10465
cerebrovascular disease,C0007820,true,8011/10465
linagliptin,C2746078,true,8012/10465
vildagliptin,C1570906,true,8013/10465
sitagliptin,C1565750,true,8014/10465
saxagliptin,C1611934,true,8015/10465
mean ( s . e . ),C0444504;C2347634;C2348143,false;false;false,8016/10465
mean ( s . e . ) t,C0444504;C2347634;C2348143,false;false;false,8017/10465
mean ( s . d . ),C0444504;C2347634;C2348143,false;false;false,8018/10465
mean bmi  kg / mnmbr ( sd ),C0444504;C0578022;C0022718;C2699239;C0439209;C4054209;C2347634;C2348143,false;false;true;false;false;false;false;false,8019/10465
mean bmi ( kg / mnmbr ) ( sd ),C0444504;C0578022;C0022718;C2699239;C0439209;C4054209;C2347634;C2348143,false;false;true;false;false;false;false;false,8020/10465
tiotropium ( nznmbr ),C0213771,true,8021/10465
tiotropium ( n z nmbr ),C0213771;C0053917;C1334884,true;true;false,8022/10465
tiotropium ( n = nmbr ),C0213771;C0053917;C1334884,true;true;false,8023/10465
gastroduodenum,C0391900,false,8024/10465
gastroduodenal,C0450199,false,8025/10465
primary endpoint,C2986535,false,8026/10465
primary end point ",C2986535,false,8027/10465
primary end point,C2986535,false,8028/10465
dyslipidemia — no . ( % ),C0242339,true,8029/10465
dyslipidemia — no . ( % ) |,C0242339,true,8030/10465
tjc ( nmbr - nmbr )  mean ( sd ),C0053917;C0444504;C2699239;C2347634;C2348143;C1334884,true;false;false;false;false;false,8031/10465
sjc ( nmbr - nmbr )  mean ( sd ),C0053917;C0444504;C2699239;C2347634;C2348143;C1334884,true;false;false;false;false;false,8032/10465
non cv mortality,C1518422;C3538987;C0026565;C0026566;C4048877;C4318503,false;false;true;true;true;false,8033/10465
non - cv mortality,C1518422;C3538987;C0026565;C0026566;C4048877;C4318503,false;false;true;true;true;false,8034/10465
patients with prevalent kidney disease at baseline,C0030705;C0022646;C0683921;C0227665,true;true;false;false,8035/10465
patients without prevalent kidney disease at baseline,C0030705;C0022646;C0683921;C0227665,true;true;false;false,8036/10465
mean ( s . d . ) age  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,8037/10465
mean ± s . d . age  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,8038/10465
nmbr mg / day early - start - delayed - start,C0053917;C0439422;C1334884,true;false;false,8039/10465
nmbr mg / day early - start - delayed start,C0053917;C0439422;C1334884,true;false;false,8040/10465
£ nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8041/10465
anmbr kg / mnmbr,C0022718;C0439209;C4054209,true;false;false,8042/10465
< nmbr kg / m nmbr,C0053917;C1532718;C1334884,true;false;false,8043/10465
> nmbrkg / mnmbr,,,8044/10465
< nmbrkg / mnmbr,,,8045/10465
snmbr kg / mnmbr,C0022718;C0439209;C4054209,true;false;false,8046/10465
< nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8047/10465
≥ nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8048/10465
> nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8049/10465
hypokalemia ‡   ( potassium < nmbr . nmbr mmol / l ),C0020621;C0032821;C0053917;C1532563;C1334884;C0202194;C0304475;C0597277;C3714637;C4553966,true;true;true;false;false;false;false;false;false;false,8050/10465
hyperkalemia ‡   ( potassium ≥ nmbr . nmbr mmol / l ),C0020461;C0032821;C0053917;C1532563;C1334884;C0202194;C0304475;C0597277;C3714637;C4552983,true;true;true;false;false;false;false;false;false;false,8051/10465
heparin only,C0019134;C0205171;C1720467;C0770546,true;false;false;false,8052/10465
aspirin only,C0004057;C0205171;C1720467,true;false;false,8053/10465
mitral regurgitation  n ( % ),C0026266,true,8054/10465
mitral regurgitation  ( % ),C0026266,true,8055/10465
< nmbr years n z nmbr,C0053917;C0439234;C1334884,true;false;false,8056/10465
> nmbr years n z nmbr,C0053917;C0439234;C1334884,true;false;false,8057/10465
age < nmbr y ( n = nmbr ),C0001779;C0053917;C1334884,false;true;false,8058/10465
age ' nmbr y ( n nmbr ),C0001779;C0053917;C1334884,false;true;false,8059/10465
age > nmbr y ( n = nmbr ),C0001779;C0053917;C1334884,false;true;false,8060/10465
ace inhibitor  %,C0003015;C4541021,true;false,8061/10465
ace inhibitor,C0003015;C4541021,true;false,8062/10465
ace inhibitors,C0003015,true,8063/10465
tnf inhibitors,C1448177;C0243077,true;true,8064/10465
tnf inhibitor,C1448177;C1999216,true;false,8065/10465
ace inhibitor yes,C0003015;C1549445;C1705108;C1710701;C4541021,true;false;false;false;false,8066/10465
body - mass index : ! :,C0005893;C0578022;C1305855,false;false;true,8067/10465
body - mass index  ! ,C0005893;C0578022;C1305855,false;false;true,8068/10465
change from baseline to eos  uu / ml,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8069/10465
change from baseline to eos  mg / dl,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8070/10465
right coronary artery,C1261316,false,8071/10465
r ight coronar y artery,C0205090;C0003842;C0226004;C0684010;C2603358,false;true;false;true;false,8072/10465
duration of tnmbrdm > nmbr years,C0449238;C0053917;C0439234;C1334884;C2926735,false;true;false;false;false,8073/10465
duration of tnmbrdm < nmbr years,C0449238;C0053917;C0439234;C1334884;C2926735,false;true;false;false;false,8074/10465
time to randomization,C0040223;C0034656;C3541383,true;true;false,8075/10465
time of randomization,C0040223;C0034656;C3541383,true;true;false,8076/10465
p value ( cangrelor versus clopidogrel in men ),C1709380;C1121991,false;true,8077/10465
p value ( cangrelor versus clopidogrel in women ),C1709380;C1121991,false;true,8078/10465
weight ( kg ),C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8079/10465
weight  kg *,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8080/10465
height — cm,C0489786,false,8081/10465
w eight ( k g ),C0205454;C0597277;C0439267;C1708601,false;false;false;false,8082/10465
weight  lbs,C0005910;C0439219;C3161851;C0043100;C1305866;C1705104,true;false;false;true;false;false,8083/10465
weight  kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8084/10465
height  cm,C0489786,false,8085/10465
weight 一 kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8086/10465
height ( cm ),C0489786,false,8087/10465
weight — kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8088/10465
weight - kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8089/10465
height  cm *,C0489786,false,8090/10465
ldl - c  mmol / l ( mg / dl ),C3898312;C3642216,false;false,8091/10465
hdl - c  mmol / l ( mg / dl ),C3715113;C3898312;C3642216,false;false;false,8092/10465
body - mass index ) -,C0005893;C0578022;C1305855,false;false;true,8093/10465
body mass index  %,C0005893;C0578022;C1305855,false;false;true,8094/10465
body - mass indexj,C0518010,false,8095/10465
body - mass indexf,C0518010,false,8096/10465
body - mass index ) ",C0005893;C0578022;C1305855,false;false;true,8097/10465
body - mass index ),C0005893;C0578022;C1305855,false;false;true,8098/10465
body - mass index *,C0005893;C0578022;C1305855,false;false;true,8099/10465
body - mass index §,C0005893;C0578022;C1305855,false;false;true,8100/10465
body mass index *,C0005893;C0578022;C1305855,false;false;true,8101/10465
body - mass index $,C0005893;C0578022;C1305855,false;false;true,8102/10465
body mass indexc,C0518010,false,8103/10465
body mass index +,C0005893;C0578022;C1305855,false;false;true,8104/10465
body mass index,C0005893;C0578022;C1305855,false;false;true,8105/10465
body mass index :,C0005893;C0578022;C1305855,false;false;true,8106/10465
body - mass index,C0005893;C0578022;C1305855,false;false;true,8107/10465
family history of premature chd,C0241889;C0151526;C0280604;C3542407;C0205252;C4018905,true;true;false;false;false;false,8108/10465
family history of premature chdj,C0241889;C0151526;C0205252;C4018905,true;true;false;false,8109/10465
abatacept nmbr mg / kg ( n = nmbr ),C1619966;C0053917;C0439272;C1334884,true;true;false;false,8110/10465
abatacept ~ nmbr mg / kg ( n = nmbr ),C1619966;C0053917;C0439272;C1334884,true;true;false;false,8111/10465
prior tnf antagonist failure - no,C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,8112/10465
prior tnf antagonist failure - yes,C0332152;C1448177;C0231491;C0231174;C1549445;C1705108;C1710701;C0680095;C2826257,false;true;false;false;false;false;false;false;false,8113/10465
previous cabg,C0205156;C0010055;C1552607,false;true;false,8114/10465
previous mi,C0205156;C3810814;C1552607,false;false;false,8115/10465
previous ptca,C0205156;C2936173;C1552607,false;true;false,8116/10465
previous pci,C0205156;C4049621;C1552607,false;false;false,8117/10465
previous hf,C0205156;C0018488;C1313497;C1538440;C3273279;C1552607,false;true;true;false;false;false,8118/10465
previous tia,C0205156;C0007787;C0917805;C1054154;C1552607,false;true;true;false;false,8119/10465
previous ml,C0205156;C0439526;C1705224;C3887665;C1552607,false;false;false;false;false,8120/10465
previous chf,C0205156;C0018802;C1552607,false;true;false,8121/10465
previous cad,C0205156;C1504769;C2239547;C3813548;C4284121;C1552607,false;true;false;false;false;false,8122/10465
previous ami,C0205156;C4319936;C1552607,false;false;false,8123/10465
previously,,,8124/10465
previous,C0205156;C1552607,false;false,8125/10465
w event ( rate ),C0441471;C0871208;C1521828;C4019010,false;false;false;false,8126/10465
n event ( rate ),C0369718;C0441471;C0871208;C1521828;C4019010;C0441922,false;false;false;false;false;false,8127/10465
type nmbr diabetes ( n = nmbr  nmbr ),C1320657;C0053917;C1334884,false;true;false,8128/10465
no type nmbr diabetes ( n = nmbr  nmbr ),C1320657;C0053917;C1334884,false;true;false,8129/10465
family history of vte,C0241889;C0630906,true;true,8130/10465
family history of cad,C0241889;C1504769;C2239547;C3813548;C4284121,true;true;false;false;false,8131/10465
with p blockers,C0369773;C2603361,false;false,8132/10465
without p blockers,C0369773;C2603361,false;false,8133/10465
triglycerides < nmbr - nmbr mmol / l,C0041004;C0053917;C1532563;C1334884,true;true;false;false,8134/10465
triglycerides > nmbr - nmbr mmol / l,C0041004;C0053917;C1532563;C1334884,true;true;false;false,8135/10465
non - hdl - c  mg / dl,C1518422;C3715113;C0439269,false;false;false,8136/10465
non - hdl - c ( mg / dl ),C1518422;C3715113;C0439269,false;false;false,8137/10465
lipid - lowering medications^,C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,8138/10465
lipid - lowering medications,C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,8139/10465
lipid - lowering medication,C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,8140/10465
history of cad,C0019664;C1504769;C2239547;C3813548;C4284121;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;true;false;false;false;false,8141/10465
no history of af,C0019664;C0344434;C4049859;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8142/10465
history of pci,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8143/10465
history of copd,C0019664;C0024117;C1412502;C3714496;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,8144/10465
history pci,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8145/10465
history of mi,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8146/10465
history of vte,C0019664;C0630906;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8147/10465
history of chf,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8148/10465
history of chd,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8149/10465
history of cabg,C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8150/10465
no history of chf,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8151/10465
history of pad,C0019664;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;true;false;false;false;false,8152/10465
history of ml,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,8153/10465
history of hf,C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,8154/10465
history of af,C0019664;C0344434;C4049859;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8155/10465
lesion length $ nmbr mm,C0221198;C1444754;C0053917;C4330985;C4554674;C1334884;C1706316;C1546698,false;false;true;false;false;false;false;false,8156/10465
lesion length > nmbr mm,C0221198;C1444754;C0053917;C4330985;C4554674;C1334884;C1706316;C1546698,false;false;true;false;false;false;false;false,8157/10465
male gender,C0086582;C1706180,true;false,8158/10465
female gender,C0086287,true,8159/10465
ratio of hrs ( nmbr % cl )  p for sex interaction,C0456603;C1568891;C0053917;C0596019;C1334884;C1547037,false;true;true;false;false;false,8160/10465
ratio of hrs ( nmbr % ci )  p for sex interaction,C0456603;C1568891;C0053917;C0008107;C3259781;C1334884;C1547037,false;true;true;true;false;false;false,8161/10465
statins / ezetimibe,C0360714;C1142985,true;true,8162/10465
statin or ezetimibe,C0360714,true,8163/10465
> median ( nmbr . nmbr ) — number / n ( % ),C0549183;C0053917;C0237753;C0449788;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,8164/10465
< median ( nmbr . nmbr ) — number / n ( % ),C0549183;C0053917;C0237753;C0449788;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,8165/10465
renal impairment,C1565489,true,8166/10465
renal impairmentt,C0022646,true,8167/10465
antiplatelet drugs,C0085826;C2963157,true;false,8168/10465
antiplatelet drug,C0085826,true,8169/10465
chanmbrdsnmbr - vasc $ nmbr,C0053917;C1334884,true;false,8170/10465
chanmbrdsnmbr - vasc # nmbr,C0053917;C1334884,true;false,8171/10465
chanmbrdsnmbr - vasc > nmbr,C0053917;C1334884,true;false,8172/10465
reversibility to,C0449261,false,8173/10465
reversibility ( % ) t,C0449261,false,8174/10465
reversibility *,C0449261,false,8175/10465
reversibility,C0449261,false,8176/10465
reversibility  %,C0449261,false,8177/10465
reversibility ( % ),C0449261,false,8178/10465
reversibility %,C0449261,false,8179/10465
present ( £ nmbr mg / dl ),C0150312;C0053917;C0439269;C1334884;C0449450,false;true;false;false;false,8180/10465
present ( > nmbr mg / dl ),C0150312;C0053917;C0439269;C1334884;C0449450,false;true;false;false;false,8181/10465
hbanmbrc < = nmbr %,C0053917;C1334884,true;false,8182/10465
hbanmbrc < nmbr %,C0053917;C1334884,true;false,8183/10465
hbanmbrc > nmbr %,C0053917;C1334884,true;false,8184/10465
hbanmbrc > = nmbr %,C0053917;C1334884,true;false,8185/10465
metformin 一 no . ( % ),C0025598,true,8186/10465
metformin — no . ( % ),C0025598,true,8187/10465
women / men [ % ],C0043210;C0025266,true;true,8188/10465
women / men  %,C0043210;C0025266,true;true,8189/10465
nmbr . nmbr to # nmbr . nmbr mg / mmol,C0053917;C0567349;C2348885;C1334884,true;false;false;false,8190/10465
nmbr . nmbr - < nmbr . nmbr mg / mmol,C0053917;C0567349;C2348885;C1334884,true;false;false;false,8191/10465
baseline tav - > = median ( n = nmbr  nmbr ),C0168634;C0279686;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;true;false;false;false;false;false;false,8192/10465
baseline pav - > = median ( n = nmbr  nmbr ),C0168634;C0058890;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;true;false;false;false;false;false;false,8193/10465
baseline tav - < median ( n = nmbr  nmbr ),C0168634;C0279686;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;true;false;false;false;false;false;false,8194/10465
baseline pav - < median ( n = nmbr  nmbr ),C0168634;C0058890;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;true;false;false;false;false;false;false,8195/10465
ifg / igt,C1334085;C1708411,false;false,8196/10465
ifg and igt,C1334085;C1708411,false;false,8197/10465
< nmbr % ( < nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,8198/10465
> nmbr % ( > nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,8199/10465
> = nmbr % ( nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,8200/10465
< nmbr % ( nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,8201/10465
no mi ( n - nmbr  nmbr ),C3810814;C0053917;C1334884,false;true;false,8202/10465
pad ( n - nmbr  nmbr ),C0182158;C0053917;C1334884;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,8203/10465
no mvd ( n - nmbr  nmbr ),C1417507;C0053917;C1334884;C3272839,false;true;false;false,8204/10465
acs ( n - nmbr  nmbr ),C0742343;C0053917;C1334884;C4318612,true;true;false;false,8205/10465
mvd ( n - nmbr  nmbr ),C1417507;C0053917;C1334884;C3272839,false;true;false;false,8206/10465
any mi ( n - nmbr  nmbr ),C3810814;C0053917;C1334884,false;true;false,8207/10465
no pad ( n - nmbr  nmbr ),C0182158;C0053917;C1334884;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,8208/10465
total cholesterol > nmbr - nmbr mmol / lt,C0201950;C0053917;C0439190;C0023376;C0230426;C3887647;C4521399;C1334884;C0543421,false;true;false;true;false;false;false;false;false,8209/10465
total cholesterol < nmbr nmbr mmol / lt,C0201950;C0053917;C0439190;C0023376;C0230426;C3887647;C4521399;C1334884;C0543421,false;true;false;true;false;false;false;false;false,8210/10465
total cholesterol < nmbr - nmbr mmol / lt,C0201950;C0053917;C0439190;C0023376;C0230426;C3887647;C4521399;C1334884;C0543421,false;true;false;true;false;false;false;false;false,8211/10465
total cholesterol > nmbr ' nmbr mmol / lt,C0201950;C0053917;C0439190;C0023376;C0230426;C3887647;C4521399;C1334884;C0543421,false;true;false;true;false;false;false;false;false,8212/10465
body mass index  mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8213/10465
body mass index  mean ( sd ) t,C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8214/10465
body massindex  mean ( sd ) a,C0242821;C0444504;C2699239;C2347634;C2348143;C0460148;C1268086;C4082212,true;false;false;false;false;false;false;false,8215/10465
body - mass index  mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8216/10465
body mass index  mean ( sd ) d,C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8217/10465
change from baseline *,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8218/10465
change from baseline,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8219/10465
% change from baseline,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8220/10465
rectal bleeding subscore {,C0018932;C0267596,true;false,8221/10465
rectal bleeding subscore,C0018932;C0267596,true;false,8222/10465
ldl - c ( mmol / l ),C1532563,false,8223/10465
ldl - c  mmol / l,C1532563,false,8224/10465
hdl - c  mmol / l,C3715113;C1532563,false;false,8225/10465
hdl - c ( mmol / l ),C3715113;C1532563,false;false,8226/10465
ldl - c * ( mmol / l ),C1532563,false,8227/10465
insulin - dependent,C0021641;C0429964;C0429986;C0851827;C1701901;C3244310;C4321395;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,8228/10465
insulin dependentc,C0021641;C1533581;C1579433;C3714501,true;false;false;false,8229/10465
antihypertensive therapy,C0585941,false,8230/10465
anti - hypertensive therapy,C0585941,false,8231/10465
ace inhibitors or angiotensin - receptor blockers^,C0003015,true,8232/10465
ace inhibitor or angiotensin receptor blocker,C0003015;C4541021,true;false,8233/10465
ace inhibitor or angiotensin ii receptor blocker,C0003015;C4541021,true;false,8234/10465
ace inhibitors or angiotensin receptor blockers,C0003015,true,8235/10465
diabetes duration  years,C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,8236/10465
diabetes duration ( years ),C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,8237/10465
age ( years ) mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8238/10465
age  y  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8239/10465
cdai  mean ( sd ),C0683448;C0444504;C2699239;C2347634;C2348143;C1413248;C3273706,false;false;false;false;false;false;false,8240/10465
age  years ( sd ),C1510829;C2699239,false;false,8241/10465
age  years  mean + sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8242/10465
age  yr mean ( sd ),C0001779;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8243/10465
age  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8244/10465
bmi  mean ( sd ),C0578022;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8245/10465
age ( years ) mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8246/10465
age ( years ) ( mean  sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8247/10465
tc  mean ( sd ),C0039411;C0444504;C2699239;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;true;true;true;false;false;false,8248/10465
bmi  mean ( sd ) b,C0578022;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8249/10465
ibdq  mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,8250/10465
age ( years )  mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8251/10465
age  y  mean ± sd,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8252/10465
age  years  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8253/10465
bmi  mean ± sd,C0578022;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8254/10465
age  yr  mean ( sd ),C0001779;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8255/10465
sdai  mean ( sd ),C3871128;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8256/10465
age  mean ± sd,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8257/10465
age ( yrs )  mean ± sd,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8258/10465
age ( years )  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8259/10465
age  years  mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8260/10465
age  mean yr ( sd ),C0001779;C0444504;C0439234;C2699239;C2347634;C2348143,false;false;false;false;false;false,8261/10465
basfi  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,8262/10465
age in years  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8263/10465
age ( years ) - mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8264/10465
age  yrs  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8265/10465
one of the above,C0205447,false,8266/10465
two of the above,C0205448,false,8267/10465
all of the above,C1282910;C1552828,false;false,8268/10465
none of the above,C1282910;C1552828,false;false,8269/10465
any of the above,C1282910;C1552828,false;false,8270/10465
asian or oriental,C0078988,true,8271/10465
asian / oriental,C0078988;C0699027,true;false,8272/10465
no . of stents,C0038257,true,8273/10465
no . of events,C0441471;C3541888,false;false,8274/10465
no . of patients,C0030705,true,8275/10465
serum creatinine — mg / dl §,C0201976;C0439269;C0600061,false;false;false,8276/10465
serum creatinine ( mg / dl ),C0201976;C0439269;C0600061,false;false;false,8277/10465
serum creatinine — mg / dl,C0201976;C0439269;C0600061,false;false;false,8278/10465
serum creatinine  mg / dlb,C0201976;C0024671;C0752347;C3890365;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0600061,false;true;true;false;true;false;false;false;false;false;false,8279/10465
serum creatinine  mg / dl,C0201976;C0439269;C0600061,false;false;false,8280/10465
no diabetes ( n - nmbr  nmbr ),C0011847;C0053917;C1334884;C0011849,false;true;false;true,8281/10465
diabetes ( n - nmbr  nmbr ),C0011847;C0053917;C1334884;C0011849,false;true;false;true,8282/10465
final median  mg / l,C0205088;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1546485;C3853528,false;false;false;false;false;false;false;false;false,8283/10465
final mean  mg / dl,C0205088;C0444504;C0439269;C2347634;C2348143;C1546485;C3853528,false;false;false;false;false;false;false,8284/10465
nonwhite race !,C0034510;C1706779;C3853635,true;false;false,8285/10465
nonwhite race,C0034510;C1706779;C3853635,true;false;false,8286/10465
white race,C0007457;C0043157,true;true,8287/10465
non - white race,C1518422;C0007457;C0043157,false;true;true,8288/10465
non - white raceb,C1518422;C0007457;C0043157;C0220938,false;true;true;false,8289/10465
> nmbr egfr  ml / min / nmbr . nmbr mnmbr,C0053917;C1739039;C0439445;C3811844;C3812682;C1334884,true;true;false;false;false;false,8290/10465
> nmbr egfr  ml / min / nmbr . nmbr mnmbr a,C0053917;C1739039;C0439445;C3811844;C3812682;C1334884,true;true;false;false;false;false,8291/10465
current cigarette smoker,C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,8292/10465
current cigarette smoking,C0521116;C0239059;C0700219;C1705970,false;false;true;false,8293/10465
at home systolic pressure > nmbr mm hg,C4534363;C0871470;C0053917;C0439475;C1334884,false;true;true;false;false,8294/10465
at home diastolic pressure < nmbr mm hg,C4534363;C0428883;C0053917;C0439475;C1334884,false;true;true;false;false,8295/10465
at home diastolic pressure > nmbr mm hg,C4534363;C0428883;C0053917;C0439475;C1334884,false;true;true;false;false,8296/10465
at home systolic pressure < nmbr mm hg,C4534363;C0871470;C0053917;C0439475;C1334884,false;true;true;false;false,8297/10465
hx stroke / tia,C0262926;C0038454;C0007787;C0917805;C1054154;C4554100;C3814444,false;true;true;true;false;false;false,8298/10465
stroke or tia,C0038454;C4554100,true;false,8299/10465
stroke ortiab,C0038454;C4554100,true;false,8300/10465
stroke / tia,C0038454;C0007787;C0917805;C1054154;C4554100,true;true;true;false;false,8301/10465
no stroke / tia,C0038454;C0007787;C0917805;C1054154;C4554100,true;true;true;false;false,8302/10465
clinical history — no . ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,8303/10465
clinical history  no . ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,8304/10465
clinical history  n ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,8305/10465
combination therapy ( n = nmbr ),C0009429;C0053917;C1334884;C0556895,true;true;false;false,8306/10465
combination therapy  n = nmbr,C0009429;C0053917;C1334884;C0556895,true;true;false;false,8307/10465
anmbrc at baseline < nmbr . nmbr %,C0168634;C0053917;C1334884;C1442488,true;true;false;false,8308/10465
anmbrc at baseline ≥ nmbr . nmbr %,C0168634;C0053917;C1334884;C1442488,true;true;false;false,8309/10465
native american,C0282204;C1515945,true;false,8310/10465
latin american,C1553378,false,8311/10465
latin america,C0023122,true,8312/10465
liraglutide nmbr . nmbr mg ,C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8313/10465
liraglutide nmbr . nmbr mg,C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8314/10465
medical history  no . ( % ),C0262926;C1704706,false;false,8315/10465
medical history — no . ( % ),C0262926;C1704706,false;false,8316/10465
medical history  n ( % ),C0262926;C1704706,false;false,8317/10465
diabetes mellitus :,C0011849,true,8318/10465
diabetes mellitus,C0011849,true,8319/10465
no diabetes mellitus,C0011849,true,8320/10465
diabetes mellitus  n ( % ),C0011849,true,8321/10465
diabetes mellitus !,C0011849,true,8322/10465
diabetes mellitus  § n ( % ),C0011849,true,8323/10465
diabetes mellitus  %,C0011849,true,8324/10465
diabetes mellitus ( % ),C0011849,true,8325/10465
diabetes mellitus  ( % ),C0011849,true,8326/10465
since diagnosis,,,8327/10465
index diagnosis,C0600653;C0011900;C1704338;C1704656;C0918012;C1552854;C1637833;C2986546,true;true;true;false;true;false;false;false,8328/10465
> nmbr months  mean ( sd ),C0053917;C0439231;C0444504;C2699239;C2347634;C2348143;C1334884,true;false;false;false;false;false;false,8329/10465
< nmbr months  mean ( sd ),C0053917;C0439231;C0444504;C2699239;C2347634;C2348143;C1334884,true;false;false;false;false;false;false,8330/10465
placebo ( n = nmbr nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,8331/10465
placebo ( n = nmbr  nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,8332/10465
placebo ( n - nmbr . nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,8333/10465
placebo ( n nmbr nmbr ),C0032042;C0053917;C1334884;C1696465;C1706408,true;true;false;false;false,8334/10465
second mi,C0205436;C3810814;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,8335/10465
no second mi,C0205436;C3810814;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,8336/10465
controlled,C2587213;C2911690,false;false,8337/10465
coronary,C0018787,true,8338/10465
country,C0454664;C1511538,false;false,8339/10465
controlld,,,8340/10465
uncontrolled,C0205318,false,8341/10465
control,C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,8342/10465
diabetes status  n ( % ),C1317301,false,8343/10465
diabetes status  no . ( % ),C1317301,false,8344/10465
ezetimibe nmbr mg ( n = nmbr * ),C1142985;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8345/10465
ezetimibe nmbr mg ( n = nmbr ),C1142985;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8346/10465
chadsnmbr score,C0449820;C4050231,false;false,8347/10465
chadsnmbr score *,C0449820;C4050231,false;false,8348/10465
chadsnmbr scoreb,,,8349/10465
age  mean = sd  years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8350/10465
age  mean ± sd ( year ),C0001779;C0444504;C2699239;C0439234;C0439508;C2347634;C2348143,false;false;false;false;false;false;false,8351/10465
age  mean ± sd years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8352/10465
age  mean ( sd ) years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8353/10465
age  mean ( sd )  years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8354/10465
age  mean ( sd )  y,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8355/10465
age  mean ( sd )  yrs,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8356/10465
age  mean ± sd  years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8357/10465
aiirocumab ( n = nmbr ),C0053917;C1334884,true;false,8358/10465
alirocumab ( n = nmbr ),C3491162;C0053917;C1334884,true;true;false,8359/10465
< nmbr enroll,C0053917;C1334884,true;false,8360/10465
> nmbr enroll,C0053917;C1334884,true;false,8361/10465
dasnmbr - crp  ls mean change from baseline ( se ) ¥,C3890735;C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C4048285,false;true;false;false;true;true;false;false;false;false;false;false;false,8362/10465
dasnmbr - crp  ls mean change from baseline ( se ) §,C3890735;C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C4048285,false;true;false;false;true;true;false;false;false;false;false;false;false,8363/10465
anacetrapib nmbr mg ( n = nmbr ),C2604745;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8364/10465
anacetrapib nmbrmg ( n = nmbr ),C2604745;C0053917;C1334884,true;true;false,8365/10465
anacetrapib nmbr mg ( n - nmbr ),C2604745;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8366/10465
current,C0521116;C1705970,false;false,8367/10465
currently,C0521116,false,8368/10465
total stent length - mm,C0439175;C0038257;C1444754;C4330985;C4554674;C1706316;C0439810,false;true;false;false;false;false;false,8369/10465
total stent length  mm,C0439175;C0038257;C1444754;C4330985;C4554674;C1706316;C0439810,false;true;false;false;false;false;false,8370/10465
body mass index > nmbr kg / mnmbr *,C0005893;C0053917;C0022718;C0439209;C4054209;C1334884;C0578022;C1305855,false;true;true;false;false;false;false;true,8371/10465
body mass index < nmbr kg / mnmbr,C0005893;C0053917;C0022718;C0439209;C4054209;C1334884;C0578022;C1305855,false;true;true;false;false;false;false;true,8372/10465
p inleraclion,C0369773;C2603361,false;false,8373/10465
p nmbr interaction,C0369773;C0053917;C1704675;C1334884;C2603361,false;true;false;false;false,8374/10465
p for interaction,C0369773;C1704675;C2603361,false;false;false,8375/10465
pfor interaction,C1151635;C1704675,false;false,8376/10465
p interaction,C0369773;C1704675;C2603361,false;false;false,8377/10465
pinteraction,,,8378/10465
p  interaction !,C0369773;C1704675;C2603361,false;false;false,8379/10465
p for interaction *,C0369773;C1704675;C2603361,false;false;false,8380/10465
interaction p,C1704675,false,8381/10465
age - interaction,C0001779;C1704675,false;false,8382/10465
interaction - p,C1704675,false,8383/10465
p - interaction,C0369773;C1704675;C2603361,false;false;false,8384/10465
p . interaction,C0369773;C1704675;C2603361,false;false;false,8385/10465
p : interaction,C0369773;C1704675;C2603361,false;false;false,8386/10465
p - interactio n,C0369773;C2603361,false;false,8387/10465
angiotensin receptor blockers,C0521942;C0815017,true;true,8388/10465
angiotensin receptor blocker yes,C0034787;C1549445;C1705108;C1710701;C1622222,true;false;false;false;true,8389/10465
angiotensin ii receptor blocker,C0521942;C3536793,true;false,8390/10465
angiotensin - receptor blocker,C0034787;C1622222,true;true,8391/10465
angiotensin receptor blocker,C0034787;C1622222,true;true,8392/10465
angiotensin ll - receptor blocker,C0003018;C4521302,true;false,8393/10465
creatinine — mg / dl,C0010294;C0439269;C1561535,true;false;false,8394/10465
creatinine  mg / dl_,C0010294;C0439269;C1561535,true;false;false,8395/10465
creatinine ( mg / dl ),C0010294;C0439269;C1561535,true;false;false,8396/10465
creatinine  mg / dl,C0010294;C0439269;C1561535,true;false;false,8397/10465
baseline post - bronchodilator % predicted fev  > nmbr % and no prior ics use,C0168634;C1442488,true;false,8398/10465
baseline post - bronchodilator % predicted fev  > nmbr % and prior ics use,C0168634;C1442488,true;false,8399/10465
fevnmbr ( % predicted ),,,8400/10465
fevnmbr  % predicted,,,8401/10465
fevnmbr  % predicteda,,,8402/10465
fevnmbr % predicted,,,8403/10465
fevnmbr  l *,,,8404/10465
fevnmbr  l,,,8405/10465
fevnmbr  la,C0023031;C0023749;C0230347;C2346906;C4553351,true;true;false;false;false,8406/10465
fevnmbr ( l ),,,8407/10465
mean sitting sbp ( mmhg ),C0444504;C0277814;C0085805;C0439475;C2584297;C4050224;C2347634;C2348143,false;true;true;false;true;false;false;false,8408/10465
mean sitting dbp ( mmhg ),C0444504;C0277814;C0536221;C0439475;C3813197;C4281799;C2584297;C4050224;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false,8409/10465
potassium ( mmol / l ),C0032821;C1532563;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,8410/10465
potassium ( meq / l ),C0032821;C0439375;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,8411/10465
potassium  mmol / l,C0032821;C1532563;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,8412/10465
£ nmbr ( men ) / £ nmbr ( women ),C0053917;C0025266;C0043210;C1334884,true;true;true;false,8413/10465
< nmbr ( men ) / < nmbr ( women ),C0053917;C0025266;C0043210;C1334884,true;true;true;false,8414/10465
creat clearance < nmbr ml / min,C0201975;C0449297;C0053917;C0439445;C1334884;C1382187;C2825073;C4554548,false;false;true;false;false;false;false;false,8415/10465
creat clearance > nmbr ml / min,C0201975;C0449297;C0053917;C0439445;C1334884;C1382187;C2825073;C4554548,false;false;true;false;false;false;false;false,8416/10465
pre - bronchodilator,C2599602,false,8417/10465
prebronchodilator,C2599602,false,8418/10465
post - bronchodilator,C2599594,false,8419/10465
postbronchodilator,C2599594,false,8420/10465
heritable,C0439660,false,8421/10465
variable,C0439828;C4553760,false;false,8422/10465
apolipoprotein b ( mg / dl ),C0003593;C0439269,true;false,8423/10465
apolipoprotein b ( g / l ),C0003593;C0439294;C0456615,true;false;false,8424/10465
tiotropiumc,,,8425/10465
tiotropium,C0213771,true,8426/10465
no prior statin use,C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,8427/10465
prior statin use,C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,8428/10465
nyha iv  n ( % ),C1275491;C0022326;C4265176,false;true;false,8429/10465
nyha ii  n ( % ),C1275491;C1710602;C4082587,false;false;false,8430/10465
nyha iii  n ( % ),C1275491;C0439070;C1705160,false;false;false,8431/10465
metabolic syndrome,C0524620,true,8432/10465
metabolic syndrome ,C0524620,true,8433/10465
metabolic syndrome *,C0524620,true,8434/10465
tiotropium nmbr mg,C0213771;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8435/10465
tiotropium nmbrmg,C0213771,true,8436/10465
tiotropium nmbr m g,C0213771;C0053917;C0456715;C1334884,true;true;false;false,8437/10465
pitavastatin nmbr mg,C1101838;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8438/10465
pravastatin nmbr mg,C0085542;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8439/10465
rosuvastatin nmbr mg,C0965129;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8440/10465
simvastatin nmbr mg,C0074554;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8441/10465
atorvastatin nmbr mg,C0286651;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8442/10465
fluvastatin nmbr mg,C0082608;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8443/10465
lovastatin nmbr mg,C0024027;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8444/10465
stage nmbrb : nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0205390;C1300072;C1306673,false;false;false,8445/10465
stage nmbra : nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0205390;C0053917;C0439445;C1334884;C1300072;C1306673,false;true;false;false;false;false,8446/10465
stage nmbr : nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0205390;C0053917;C0439445;C1334884;C1300072;C1306673,false;true;false;false;false;false,8447/10465
readmission ( n = nmbr ),C1548168;C0053917;C1334884;C4489276,false;true;false;false,8448/10465
no readmission ( n = nmbr ),C1548168;C0053917;C1334884;C4489276,false;true;false;false,8449/10465
nyha class iii,C1882086,false,8450/10465
nyha class iv,C1882087,false,8451/10465
nyha class,C1882083,false,8452/10465
nyha class ii,C1882085,false,8453/10465
nyha class > ii,C1882085,false,8454/10465
nyha class i,C1882084,false,8455/10465
no prior cv event,C0332152;C3538987;C0441471;C4019010;C4048877;C4318503;C2826257,false;false;false;false;true;false;false,8456/10465
prior lgi event,C0332152;C0441471;C4019010;C2826257,false;false;false;false,8457/10465
prior ugi event,C0332152;C0560042;C0441471;C4019010;C2826257,false;false;false;false;false,8458/10465
no prior ugi event,C0332152;C0560042;C0441471;C4019010;C2826257,false;false;false;false;false,8459/10465
prior cv event,C0332152;C3538987;C0441471;C4019010;C4048877;C4318503;C2826257,false;false;false;false;true;false;false,8460/10465
major cv event,C0205082;C3538987;C0441471;C4019010;C4048877;C4318503;C0205164;C4318856;C4521762,false;false;false;false;true;false;false;false;false,8461/10465
no prior lgi event,C0332152;C0441471;C4019010;C2826257,false;false;false;false,8462/10465
prior peripheralarterialdisease,C0332152;C2826257,false;false,8463/10465
prior peripheral arterial disease,C0332152;C0085096;C1704436;C2826257,false;true;true;false,8464/10465
pre - bronchodilator fevnmbr ( l ),C2599602,false,8465/10465
post - bronchodilator fevnmbr  l,C2599594,false,8466/10465
post - bronchodilator fevnmbr  l *,C2599594,false,8467/10465
postbronchodilator fevnmbr  l,C2599594,false,8468/10465
prebronchodilator fevnmbr ( l ) t,C2599602,false,8469/10465
post - bronchodilator fevnmbr ( l ) a,C2599594,false,8470/10465
post - bronchodilator fevnmbr ( l ) *,C2599594,false,8471/10465
prebronchodilator fevnmbr ( l ),C2599602,false,8472/10465
prebronchodilator fevnmbr  l,C2599602,false,8473/10465
post - bronchodilator fevnmbr ( l ),C2599594,false,8474/10465
pre - bronchodilator fevnmbr  l *,C2599602,false,8475/10465
amlodipine / valsartan nmbr / nmbr mg ( n = nmbr ),C1962523;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8476/10465
amlodipine / valsartan nmbr / nmbr mg ( n = nmbri ),C1962523;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8477/10465
noncardiovascular,,,8478/10465
cardiovascular,C0007226;C3887460,true;false,8479/10465
etoricoxib ( n = nmbr  nmbr ),C0972314;C0053917;C1334884,true;true;false,8480/10465
etoricoxib ( n = nmbr nmbr ),C0972314;C0053917;C1334884,true;true;false,8481/10465
no previous cv event,C0205156;C3538987;C0441471;C4019010;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,8482/10465
previous cv event,C0205156;C3538987;C0441471;C4019010;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,8483/10465
asa use at baseline  n ( % ),C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8484/10465
ics use at baseline  n ( % ),C0815320;C4551720,false;true,8485/10465
ics users at baseline  n ( % ),C0815320;C1706077;C0168634;C1442488;C4551720,false;false;true;false;true,8486/10465
icsusers atbaseline  n ( % ),,,8487/10465
mean fvc ± sd,C0444504;C3714541;C2699239;C2347634;C2348143,false;true;false;false;false,8488/10465
mean dlco ± sd,C0444504;C1516251;C2699239;C2347634;C2348143,false;false;false;false;false,8489/10465
saphenous vein graft,C0729538,false,8490/10465
saphenous - vein graft,C0729538,false,8491/10465
hypercholesterolemia,C0020443;C1522133,true;false,8492/10465
hypercholesterolemia *,C0020443;C1522133,true;false,8493/10465
hypercholesterolemiat,,,8494/10465
hypercholesterolaemia,C0020443;C1522133,true;false,8495/10465
one tnfi and,C0205447,false,8496/10465
one tnfi *,C0205447,false,8497/10465
with stent^l,C0038257,true,8498/10465
with stent,C0038257,true,8499/10465
without stent,C0038257,true,8500/10465
postmenopausal and current hrt,C0232970,false,8501/10465
postmenopausal and current ht,C0232970,false,8502/10465
postmenopausal  current hrt,C0232970;C0521116;C0282402;C1705970,false;false;true;false,8503/10465
end point,C2349179;C2826544,false;false,8504/10465
endpoint,C2349179;C2826544,false;false,8505/10465
end points,C2349179,false,8506/10465
endpointc,,,8507/10465
telmisartan ( n = nmbr ),C0248719;C0053917;C1334884,true;true;false,8508/10465
irbesartan ( n = nmbr ),C0288171;C0053917;C1334884,true;true;false,8509/10465
olmesartan ( n = nmbr ),C1098320;C0053917;C1334884,true;true;false,8510/10465
duration of rheumatoid arthritis  year,C0449238;C0003873;C0439234;C0439508;C2926735,false;true;false;false;false,8511/10465
duration of rheumatoid arthritis — yr,C0449238;C0003873;C0439234;C2926735,false;true;false;false,8512/10465
dyslipidaemia  n ( % ),C0242339,true,8513/10465
dyslipidemia  n ( % ),C0242339,true,8514/10465
heart failure nmbr mo before admission,C0018801;C0053917;C0026544;C0184666;C0809949;C0332177;C1334884;C0018802;C4554158,true;true;true;false;false;false;false;true;false,8515/10465
heart failure nmbr month before admission,C0018801;C0053917;C0332177;C0184666;C0809949;C0439231;C1334884;C0018802;C4554158,true;true;false;false;false;false;false;true;false,8516/10465
no anemia bsl hb > nmbrg i - nmbr  yr nmbr > nmbrg i - nmbr,C0002871;C1549954;C0019046;C0021966;C0053917;C0439234;C1334884;C0221138;C1000483;C4554633,true;false;true;true;true;false;false;false;false;false,8517/10465
new anemia bsl hb > nmbrg i - nmbr  yr nmbr < nmbrg i - nmbr,C0205314;C0002871;C1549954;C0019046;C0021966;C0053917;C0439234;C1334884;C0221138;C1000483;C4554633,false;true;false;true;true;true;false;false;false;false;false,8518/10465
no previous myocardial infarction,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,8519/10465
previous myocardial infarction,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,8520/10465
peripheral artery disease,C1704436;C4025272,true;false,8521/10465
peripheral arterial disease,C0085096;C1704436,true;true,8522/10465
peripheral - artery disease,C1704436;C4025272,true;false,8523/10465
peripheral artery disease *,C1704436;C4025272,true;false,8524/10465
peripheral artery diseasef,C0489868,false,8525/10465
history of pvd  n ( % ),C4534349,false,8526/10465
history of chd  n ( % ),C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8527/10465
history of mi  n ( % ),C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8528/10465
history of chf  n ( % ),C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8529/10465
history of tia  n ( % ),C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,8530/10465
history of pci  n ( % ),C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8531/10465
history of cabg  n ( % ),C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8532/10465
white race — no . / total no . ( % ) $,C0007457;C0043157;C0220938,true;true;false,8533/10465
white race — no . / total no . ( % ) f,C0007457;C0043157;C0220938,true;true;false,8534/10465
aspirin nmbr,C0004057;C0053917;C1334884,true;true;false,8535/10465
aspirin nmbr mg,C0004057;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8536/10465
total cholesterol  mmol / l,C0201950;C1532563;C0543421,false;false;false,8537/10465
total cholesterol ( mmol / l ),C0201950;C1532563;C0543421,false;false;false,8538/10465
total cholesterol  mmol / l 本,C0201950;C1532563;C0543421,false;false;false,8539/10465
total cholesterol ( mmol / l ) :,C0201950;C1532563;C0543421,false;false;false,8540/10465
no myocardial infarction at presentation ( n = nmbr ),C0027051;C0449450;C0053917;C1334884;C0428953;C2926063;C3810814;C4552959,true;false;true;false;false;false;false;false,8541/10465
myocardial infarction at presentation ( n = nmbr ),C0027051;C0449450;C0053917;C1334884;C0428953;C2926063;C3810814;C4552959,true;false;true;false;false;false;false;false,8542/10465
< nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,8543/10465
> nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,8544/10465
black / african american,C0085756,true,8545/10465
black or african - american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,8546/10465
black / african - american,C0085756,true,8547/10465
black or african american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,8548/10465
black or african america,C0005680;C0027567;C0085756;C0439541,true;true;true;false,8549/10465
black / african american *,C0085756,true,8550/10465
saxagliptin nmbr . nmbr mg ( n = nmbr ),C1611934;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8551/10465
saxagliptin nmbr . nmbr mg ( n z nmbr ),C1611934;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8552/10465
bmi ( kg / mnmbr )  mean ± sd,C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8553/10465
bmi ( kg / mnmbr ) mean ± sd,C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8554/10465
bmi ( kg / mnmbr )  mean ( sd ),C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8555/10465
bmi  kg / mnmbr  mean + sd,C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8556/10465
bmi  kg / mnmbr  mean ( sd ),C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8557/10465
bmi  kg / mnmbr  mean ± sd,C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8558/10465
bmi in kg / mnmbr  mean ( sd ),C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8559/10465
bmi ( kg / mnmbr ) mean ( sd ),C0578022;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209,false;true;false;false;false;false;false;false,8560/10465
> nmbr years  n ( % ),C0053917;C0439234;C1334884,true;false;false,8561/10465
< nmbr years  n ( % ),C0053917;C0439234;C1334884,true;false;false,8562/10465
hazard ratio or differencenmbr * ( nmbr % cl ) p - value,C2985465,false,8563/10465
hazard ratio or differencenmbr ( nmbr % cl ) p - value,C2985465,false,8564/10465
history of hypertension ( a ) c,C0455527,false,8565/10465
history of hypertension ( % ),C0455527,false,8566/10465
women ( n = nmbr )  n / n ( % ),C0043210;C0053917;C1334884,true;true;false,8567/10465
men ( n = nmbr )  n / n ( % ),C0025266;C0053917;C1334884,true;true;false,8568/10465
aldosterone antagonists,C0002007;C2757004,true;false,8569/10465
aldosterone antagonist,C0002007;C2757004;C3536833,true;false;false,8570/10465
diastolic blood pressure  mm hg  mean ± sd,C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,8571/10465
diastolic blood pressure ( mm hg )  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,8572/10465
systolic blood pressure  mm hg  mean ± sd,C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,8573/10465
systolic blood pressure ( mm hg )  mean ( sd ),C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,8574/10465
systolic blood pressure  mm hg  mean ( sd ),C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,8575/10465
diastolic blood pressure  mm hg  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,8576/10465
length of stent > median,C0449462;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8577/10465
length of stent < median,C0449462;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8578/10465
£ median ( nmbr . nmbr ),C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,8579/10465
< median ( nmbr . nmbr ),C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,8580/10465
> median ( nmbr . nmbr ),C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,8581/10465
with previous surgery,C0205156;C0038894;C0038895;C0543467;C1274039;C1552607,false;false;true;true;true;false,8582/10465
without previous surgery,C0205156;C0038894;C0038895;C0543467;C1274039;C1552607,false;false;true;true;true;false,8583/10465
corticosteroids,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,8584/10465
corticosteroid use,C0239126,false,8585/10465
no corticosteroid,C0001617;C3536709,true;false,8586/10465
corticosteroidsa,,,8587/10465
corticosteroid,C0001617;C3536709,true;false,8588/10465
full population,C0443225;C0032659;C1257890,false;true;true,8589/10465
full po pulatio n,C0443225;C0946289,false;false,8590/10465
no epa group n = nmbr,C0441848;C0053917;C1334884,false;true;false,8591/10465
epa group n = nmbr,C0441848;C0053917;C1334884,false;true;false,8592/10465
coronary artery disease — %,C0010054;C0010068;C1956346,true;true;true,8593/10465
coronary artery disease ( % ),C0010054;C0010068;C1956346,true;true;true,8594/10465
olodaterol nmbr m g,C2934193;C0053917;C0456715;C1334884,true;true;false;false,8595/10465
olodaterol nmbr mg,C2934193;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8596/10465
baseline : > nmbr . nmbr meq / l eos : < nmbr . nmbr meq / l,C0168634;C0053917;C0439375;C1623465;C1861303;C1334884;C1442488,true;true;false;false;true;false;false,8597/10465
baseline : > nmbr . nmbr meq / l eos : > nmbr . nmbr meq / l,C0168634;C0053917;C0439375;C1623465;C1861303;C1334884;C1442488,true;true;false;false;true;false;false,8598/10465
digoxin  ( % ),C0012265,true,8599/10465
digoxin  n ( % ),C0012265,true,8600/10465
vitamin k antagonists,C3653316,false,8601/10465
vitamin k antagonist,C1096489;C2267235,false;false,8602/10465
off omt ( n = nmbr ),C0053917;C1334884,true;false,8603/10465
on omt ( n = nmbr ),C0053917;C1334884,true;false,8604/10465
ticlopidine,C0040207,true,8605/10465
ticlopidin,,,8606/10465
type nmbr diabetes  n ( % ),C1320657;C0053917;C1334884,false;true;false,8607/10465
type nmbr diabetes  n ( % ) d,C1320657;C0053917;C1334884,false;true;false,8608/10465
laba use at screening  n ( % ),C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;false;false;false;false;false;false;false,8609/10465
lama use at screening  n ( % ),C0999593;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1416775,false;true;true;true;false;false;false;false;false;false;false;false,8610/10465
dasnmbr - nmbr ( esr ) < nmbr . nmbr *,C0053917;C3811131;C1334884,true;false;false,8611/10465
dasnmbr - nmbr ( esr ) < nmbr . nmbrt,C0053917;C3811131;C1334884,true;false;false,8612/10465
modified acc / aha lesion class bnmbr / c,C0392747;C0101856;C0050451;C0221198;C0456387;C1518526;C1705943;C1546698;C0772110;C3889737,false;true;true;false;false;false;false;false;false;false,8613/10465
modified acc - aha lesion class bnmbr or c,C0392747;C4072694;C0221198;C0456387;C1518526;C1705943;C1546698;C3889737,false;false;false;false;false;false;false;false,8614/10465
modified acc / aha lesion class bnmbr or cj,C0392747;C4072694;C0221198;C0456387;C1518526;C1705943;C1546698;C3889737,false;false;false;false;false;false;false;false,8615/10465
modified acc or aha lesion class bnmbr or c,C0392747;C0175754;C0282160;C3541413;C3889737,false;true;true;false;false,8616/10465
mtss ( nmbr - nmbr ),C0053917;C1334884,true;false,8617/10465
vas ( nmbr - nmbr ),C0042815;C0053917;C1334884;C3536884;C3827561,true;true;false;true;false,8618/10465
oad only,C0205171;C1720467,false;false,8619/10465
diet only,C0012155;C0205171;C1720467;C0012159;C1519433;C2983588;C3668949,true;false;false;true;false;false;false,8620/10465
past only,C1444637;C0205171;C1720467;C4284302,false;false;false;false,8621/10465
cabg only,C0010055;C0205171;C1720467,true;false;false,8622/10465
dvt only,C0149871;C0205171;C1720467;C2926618;C3899446,true;false;false;false;false,8623/10465
ptca only,C2936173;C0205171;C1720467,true;false;false,8624/10465
ics only,C0815320;C0205171;C1720467;C4551720,false;false;false;true,8625/10465
< nmbr ml / min per nmbr - nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,8626/10465
> nmbr ml / min per nmbr - nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,8627/10465
gold stage,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,8628/10465
gold stage  %,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,8629/10465
gold stage ii,C0018026;C0441767;C1304897,true;false;false,8630/10465
gold stage iv,C0018026;C0205390;C0022326;C4265176;C1300072;C1306673;C1304897,true;false;true;false;false;false;false,8631/10465
gold stage iii,C0018026;C0441771;C1304897,true;false;false,8632/10465
gold stage #,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,8633/10465
austrafca and new zealand,,,8634/10465
australia / new zealand,C4289954,false,8635/10465
australia and new zealand,C0004340,true,8636/10465
simvastatin,C0074554,true,8637/10465
pravastatin,C0085542,true,8638/10465
subjects $ nmbr years of age  n ( % ),C2348575;C0053917;C0439234;C1334884;C0681850;C1510829;C1550501;C1706203;C2349001;C2697811,false;true;false;false;false;false;false;false;false;false,8639/10465
subjects  nmbr years of age  n ( % ),C2348575;C0053917;C0439234;C1334884;C0681850;C1510829;C1550501;C1706203;C2349001;C2697811,false;true;false;false;false;false;false;false;false;false,8640/10465
previous mi  n ( % ),C0205156;C3810814;C1552607,false;false;false,8641/10465
previous ami  n ( % ),C0205156;C4319936;C1552607,false;false;false,8642/10465
previous cabg  n ( % ),C0205156;C0010055;C1552607,false;true;false,8643/10465
previous pci  n ( % ),C0205156;C4049621;C1552607,false;false;false,8644/10465
nmbr - nmbr vr — no . ( % ),C0053917;C3476815;C1334884,true;false;false,8645/10465
nmbr - nmbr yr — no . ( % ),C0053917;C0439234;C1334884,true;false;false,8646/10465
nmbr = nmbr yr — no . ( % ),C0053917;C0439234;C1334884,true;false;false,8647/10465
ldl cholesterol  mmol / l 丰,C0023824;C1532563;C0202117,true;false;false,8648/10465
hdl cholesterol  mmol / 冲,C0023822;C0439190;C0392885,true;false;false,8649/10465
hdl cholesterol ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,8650/10465
ldl - cholesterol ( mmol / ),C0023824;C0439190;C0202117,true;false;false,8651/10465
hdl cholesterol ( mmol / l ) :,C0023822;C1532563;C0392885,true;false;false,8652/10465
hdl cholesterol  mmol / l,C0023822;C1532563;C0392885,true;false;false,8653/10465
kdl cholesterol ( mmol / ),C0008377;C0439190,true;false,8654/10465
ldl - cholesterol ( mmol / l ),C0023824;C1532563;C0202117,true;false;false,8655/10465
hdl cholesterol  ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,8656/10465
ldl cholesterol ( mmol / l ) :,C0023824;C1532563;C0202117,true;false;false,8657/10465
hdl cholesterol  mmol / l *,C0023822;C1532563;C0392885,true;false;false,8658/10465
ldl cholesterol ( mmol / l ),C0023824;C1532563;C0202117,true;false;false,8659/10465
ldl cholesterol  mmol / l,C0023824;C1532563;C0202117,true;false;false,8660/10465
ldl cholesterol  mmol / l *,C0023824;C1532563;C0202117,true;false;false,8661/10465
hdl - cholesterol ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,8662/10465
no renal dysfunction,C1565489;C3279454,true;false,8663/10465
renal dysfunction,C1565489;C3279454,true;false,8664/10465
renal function,C0232804,false,8665/10465
prebronchodilator fevnmbr  % predicted,C2599602,false,8666/10465
postbronchodilator fevnmbr  % predicted,C2599594,false,8667/10465
post - bronchodilator fevnmbr  % predicted,C2599594,false,8668/10465
< qnmbr ( nmbr . nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,8669/10465
> qnmbr ( nmbr . nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,8670/10465
p valuenmbr,C0369773;C2603361,false;false,8671/10465
p value * nmbr,C1709380;C0053917;C1334884,false;true;false,8672/10465
eze / simva - nmbryr km rale ( % ),C3887676;C0034642,false;true,8673/10465
pbo / simva - nmbryr km rale ( % ),C0031962;C3887676;C0034642,true;false;true,8674/10465
age  median ( iqr ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8675/10465
bmi  median ( iqr ),C0578022;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8676/10465
inter .,C0205103;C1548610,false;false,8677/10465
intense,C0522510,false,8678/10465
< nmbr . nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8679/10465
nmbr - nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8680/10465
> nmbr . nmbr kg / mnmbr,C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8681/10465
thiazide,C0541746,true,8682/10465
thiazides,C0541746,true,8683/10465
antiplatelet agents,C0085826,true,8684/10465
antiplatelet agent,C0085826,true,8685/10465
hemoglobin  g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,8686/10465
haemoglobin ( g / dl ),C1319312;C3642216;C0019046;C0439267,false;false;true;false,8687/10465
haemoglobin ( g / l ),C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,8688/10465
hemoglobin ( g / dl ),C1319312;C3642216;C0019046;C0439267,false;false;true;false,8689/10465
hemoglobin ( gm / dl ),C0019046;C0017480;C3642216;C3854019,true;true;false;true,8690/10465
hemoglobin  mg / dl,C0019046;C0439269,true;false,8691/10465
hemoglobin  g / l,C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,8692/10465
haemoglobin  mg / dl,C0019046;C0439269,true;false,8693/10465
hemoglobin — g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,8694/10465
hemoglobin  g / dlf,C1319312,false,8695/10465
usual care ( n = nmbrla ),C3538928;C1947933,false;false,8696/10465
usual care ( n = nmbra ),C3538928;C1947933,false;false,8697/10465
usual care ( n = nmbr ),C3538928;C1947933;C0053917;C1334884,false;false;true;false,8698/10465
ace - inhibitors  n ( % ),C0003015,true,8699/10465
ace inhibitor  n ( % ),C0003015;C4541021,true;false,8700/10465
total ho population ( n = nmbr ),C3258257;C0019905;C0053917;C1334884;C1832110;C3889614,false;true;true;false;false;false,8701/10465
total population ( n = nmbr ),C3258257;C0053917;C1334884,false;true;false,8702/10465
mean age  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,8703/10465
mean age ( years ),C0444504;C1510829;C2347634;C2348143,false;false;false;false,8704/10465
mean age  yrs,C0444504;C0001779;C2347634;C2348143,false;false;false;false,8705/10465
mean age ( yrs ),C0444504;C0001779;C2347634;C2348143,false;false;false;false,8706/10465
mean age — yr,C0444504;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false,8707/10465
waist - to - hip  female,C0230097;C0019552;C0043210;C0086287;C1705497;C1705498;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false;true;true;false;false,8708/10465
waist - to - hip  male,C0230097;C0019552;C0086582;C1706180;C1706428;C1706429;C0022122;C1505163;C3538851;C4284725,false;true;true;false;false;false;true;true;false;false,8709/10465
at index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,8710/10465
index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,8711/10465
chronic bronchitis !,C0008677,true,8712/10465
chronic bronchitis,C0008677,true,8713/10465
post - bronchodilation fevnmbr,C0439576,false,8714/10465
pre - bronchodilation fevnmbr,C0439566,false,8715/10465
pre - bronchodilator fevnmbr,C2599602,false,8716/10465
lama use at screening,C0999593;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1416775,false;true;true;true;false;false;false;false;false;false;false;false,8717/10465
laba use at screening,C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;false;false;false;false;false;false;false,8718/10465
exetimibe / simvastatin,C0074554,true,8719/10465
ezetimibe / simvastatin,C1532737,true,8720/10465
cv death  ml  ischemic stroke,C3538987;C0011065;C0439526;C0948008;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;false;false;true;false,8721/10465
cv death  mi  ischemic stroke,C3538987;C0011065;C3810814;C0948008;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;true;false,8722/10465
cv death  mi  or ischemic stroke,C3538987;C0011065;C3810814;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;true;false,8723/10465
proton pump inhibitors,C0358591;C1384478;C3540020,true;false;false,8724/10465
proton - pump inhibitors,C0358591;C1384478;C3540020,true;false;false,8725/10465
proton - pump inhibitor,C0358591;C3536754;C4521480,true;false;false,8726/10465
proton pump inhibitor use,C0358591;C0042153;C0457083;C1947944;C3536754;C4521480,true;true;false;false;false;false,8727/10465
duration of tnmbrdm ( years ),C0449238;C0439234;C2926735,false;false;false,8728/10465
duration of tnmbrdm  years,C0449238;C0439234;C2926735,false;false;false,8729/10465
duration of tnmbrd ( years ),C0449238;C0439234;C2926735,false;false;false,8730/10465
anti platelet therapy,C0005821;C0039798;C0087111;C1363945,true;true;true;false,8731/10465
anti - platelet therapy,C0005821;C0039798;C0087111;C1363945,true;true;true;false,8732/10465
no antiplatelet therapy,C1096021,false,8733/10465
antiplatelet therapy,C1096021,false,8734/10465
antiplatelet therapy §,C1096021,false,8735/10465
diastolic blood pressurea  mmhg,C0012000;C0005767;C0439475;C0005768;C0229664,true;true;false;true;false,8736/10465
systolic blood pressure — mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8737/10465
diastolic blood pressure ( mm hg ),C0428883;C0439475;C1305849,true;false;false,8738/10465
systolic blood pressure  mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8739/10465
systolic blood pressure ( mmhg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,8740/10465
diastolic blood pressure ( mm hg ) :,C0428883;C0439475;C1305849,true;false;false,8741/10465
systolic blood pressurea  mm hg,C0039155;C0005767;C0439475;C0005768;C0229664,true;true;false;true;false,8742/10465
diastolic blood pressure  mm hg,C0428883;C0439475;C1305849,true;false;false,8743/10465
systolic blood pressure ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,8744/10465
diastolic blood pressure  mmhg,C0428883;C0439475;C1305849,true;false;false,8745/10465
diastolic blood pressure - mmhg,C0428883;C0439475;C1305849,true;false;false,8746/10465
diastolic blood pressure ( mmhg ),C0428883;C0439475;C1305849,true;false;false,8747/10465
systolic blood pressure - mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8748/10465
systolic blood pressure  mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8749/10465
diastolic blood pressure — mm hg,C0428883;C0439475;C1305849,true;false;false,8750/10465
mineralocorticoid receptor antagonist,C1579268,true,8751/10465
mineralocorticoid receptor antagonists,C1373021;C1579268,false;true,8752/10465
diet group ( n = nmbr ),C0012155;C0441848;C0053917;C1334884;C0012159;C1519433;C2983588;C3668949,true;false;true;false;true;false;false;false,8753/10465
stent group ( n = nmbr ),C0038257;C0441848;C0053917;C1334884,true;false;true;false,8754/10465
haq - di scoreff,C3826998;C4321476,false;false,8755/10465
haq - di scored,C3826998;C4321476,false;false,8756/10465
haq - di score,C3826998;C0449820;C4050231;C4321476,false;false;false;false,8757/10465
sirolimus,C0072980,true,8758/10465
everolimus,C0541315,true,8759/10465
ambulance,C0002422;C3846685,true;false,8760/10465
in ambulance,C0002422;C3846685,true;false,8761/10465
p value for heterogeneity,C1709380;C0019409;C0242960,false;false;true,8762/10465
pvalue for heterogeneity,C0019409;C0242960,false;true,8763/10465
race  while,C0034510;C1706779;C3853635,true;false;false,8764/10465
racea white,C0007457;C0043157;C0220938,true;true;false,8765/10465
nmbr . nmbr - nmbr . nmbr mg / l,C0053917;C0439268;C1334884,true;false;false,8766/10465
nmbr . nmbr - nmbr . nmbr mmol / l,C0053917;C1532563;C1334884,true;false;false,8767/10465
macroalbuminuria  n ( % ),,,8768/10465
microalbuminuria  n ( % ),C0730345,false,8769/10465
womac score,C0449820;C4050231,false;false,8770/10465
total score,C2964552,false,8771/10465
lacunar,C0241970;C1459585,false;false,8772/10465
vascular,C0005847;C1558950;C1801960,true;false;false,8773/10465
dbp  mm hg  mean ± sdc,C0536221;C0439475;C0444504;C1419891;C3273112;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false;false,8774/10465
sbp  mm hg  mean ± sdc,C0085805;C0439475;C0444504;C1419891;C3273112;C2347634;C2348143,true;false;false;false;false;false;false,8775/10465
sbp  mm hg  mean + sdc,C0085805;C0439475;C0444504;C1419891;C3273112;C2347634;C2348143,true;false;false;false;false;false;false,8776/10465
mean dlqi score ( nmbr % ci ),C0444504;C3899393;C2347634;C2348143,false;false;false;false,8777/10465
mean pasi score ( nmbr % ci ),C3533236;C4528685;C0053917;C0008107;C3259781;C1334884,false;false;true;true;false;false,8778/10465
tc  mmol / l ( mg / dl ),C0039411;C3898312;C3642216;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;true;true;true;false;false;false,8779/10465
fpg  mmol / l ( mg / dl ),C3898312;C3642216,false;false,8780/10465
body weight  mean ± sd  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C1305866,true;false;false;true;false;false;false;false;false,8781/10465
body weight  mean = sd  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C1305866,true;false;false;true;false;false;false;false;false,8782/10465
race / ethnicity n ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8783/10465
race / ethnicity  n ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8784/10465
race / ethnicity  no . ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8785/10465
race or ethnicity  n ( % ),C0034510;C1706779;C3853635,true;false;false,8786/10465
arial flutter or fibrillation,C0016385;C2242390,false;false,8787/10465
atrial flutter / fibrillation,C0155709,false,8788/10465
current smoker ( n z nmbr ),C3173209;C0053917;C1334884;C3241966,false;true;false;false,8789/10465
current smoker ( n = nmbr ),C3173209;C0053917;C1334884;C3241966,false;true;false;false,8790/10465
waist circumference  mean ( sd )  cm,C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,8791/10465
waist circumference  mean ( sd )  in,C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,8792/10465
empagliflozin,C3490348,true,8793/10465
dapagliflozint,,,8794/10465
canagliflozin,C2974540,true,8795/10465
coronary - artery bypass grafting,C0010055,true,8796/10465
coronary artery bypass grafting,C0010055,true,8797/10465
coronary artery bypass graft,C0010055;C1260596,true;false,8798/10465
sex : male,C0086582,true,8799/10465
sex  male,C0086582,true,8800/10465
sex  % female,C0086287,true,8801/10465
sexa male,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8802/10465
sex : female,C0086287,true,8803/10465
sex  female,C0086287,true,8804/10465
sex ( female ),C0086287,true,8805/10465
dbp  mean ( sd )  mm hg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,8806/10465
sbp  mean ( sd )  mmhg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8807/10465
dbp  mean ( sd )  mmhg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,8808/10465
sbp  mean ( sd )  mm hg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8809/10465
sbp  mean = sd  mmhg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8810/10465
contrast volume ( ml ),C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,8811/10465
contrast volume  ml,C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,8812/10465
crp — mg / liter^,C3890735;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;true;false;true;false;false;false;false;false;false,8813/10465
hscrp — mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,8814/10465
omega - nmbr fa intake nmbrnd third,C1719844;C0053917;C1512806;C0205437;C1334884,false;true;false;false;false,8815/10465
omega - nmbr fa intake nmbrst third,C1719844;C0053917;C1512806;C0205437;C1334884,false;true;false;false;false,8816/10465
omega - nmbr fa intake nmbr  d third,C1719844;C0053917;C1512806;C0205437;C1334884,false;true;false;false;false,8817/10465
mean ( sd ) pre - bronchodilator,C0444504;C2699239;C2599602;C2347634;C2348143,false;false;false;false;false,8818/10465
mean ( sd ) post - bronchodilator,C0444504;C2699239;C2347634;C2348143,false;false;false;false,8819/10465
former smoking,C0205156;C0037369;C0453996;C1881674;C0750523,false;true;true;false;false,8820/10465
former smoker,C0337671,false,8821/10465
egfr > nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8822/10465
egfr > nmbr ml / min / nmbr - nmbr mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8823/10465
egfr < nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8824/10465
egfr > nmbr ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8825/10465
egfr < nmbr ml / min / nmbr - nmbr mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8826/10465
egfr > nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8827/10465
egfr < nmbr ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8828/10465
egfr < nmbr ml / min / nmbr . nmbr mnmbr *,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8829/10465
egfr £ nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8830/10465
egfr < nmbr ml / min / nmbr . nmbr mnmbr §,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8831/10465
egfr < nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,8832/10465
primary outcomes,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8833/10465
primary outcome !,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8834/10465
primary outcome,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8835/10465
nmbr vessel,C0053917;C0005847;C1334884,true;true;false,8836/10465
nmbr vessels,C0053917;C0005847;C1334884,true;true;false,8837/10465
non - st - segment elevation mi,C1518422;C0520886;C3810814,false;false;false,8838/10465
non - st - segment elevation acs,C1518422;C0520886;C0742343;C4318612,false;false;true;false,8839/10465
rate ratio ( nmbr % ci ),C0871208;C0456603;C0053917;C0008107;C3259781;C1334884;C1547037;C1521828,false;false;true;true;false;false;false;false,8840/10465
rate ratio ( nmbr % cl ),C0871208;C0456603;C0053917;C0596019;C1334884;C1547037;C1521828,false;false;true;false;false;false;false,8841/10465
extensive colitisy,C0205231,false,8842/10465
extensive colitis,C0205231;C0009319;C1963084,false;true;false,8843/10465
lipid - lowering therapy — no . ( % ),C0585943,false,8844/10465
lipid - lowering therapy - no . ( % ),C0585943,false,8845/10465
patients with at least one concomitant disease *,C0030705;C0205447;C0243087,true;false;true,8846/10465
patients with at least one concomitant disease | |,C0030705;C0205447;C0243087,true;false;true,8847/10465
hyperlipidemia ( % ) §,C0020473;C0428465;C4555212,true;false;false,8848/10465
hyperlipidemia  %,C0020473;C0428465;C4555212,true;false;false,8849/10465
hyperlipidaemia ( % ),C0020473;C0428465;C4555212,true;false;false,8850/10465
hyperlipidemia ( % ),C0020473;C0428465;C4555212,true;false;false,8851/10465
diagnosed diabetes ( n = nmbr ),C0011900;C0011847;C0053917;C1334884;C0011849,true;false;true;false;true,8852/10465
undiagnosed diabetes ( n = nmbr ),C1408353;C0011847;C0053917;C1334884;C0011849,false;false;true;false;true,8853/10465
salmeterol ( n[nmbr ),C0073992;C0053917;C1334884,true;true;false,8854/10465
salmeterol ( n [nmbr ),C0073992;C0053917;C1334884,true;true;false,8855/10465
physician ' s judgment that vka inappropriate],C0031831;C0022423;C0804815,true;true;false,8856/10465
physician ' s judgment that vka inappropriate,C0031831;C0022423;C0804815,true;true;false,8857/10465
female simva,C0043210;C0086287;C1705497;C1705498,true;true;false;false,8858/10465
male simva,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8859/10465
western europe ( n = nmbr ),C0043129;C0053917;C1334884,true;true;false,8860/10465
eastern europe ( n = nmbr ),C0015177;C0053917;C1334884,true;true;false,8861/10465
elevated creatine kinase - mb ( > nmbr u / l ),C0151576;C0024853;C0053917;C0439339;C1334884;C0205250;C0010290;C0523584;C3163633,false;true;true;false;false;false;true;false;false,8862/10465
elevated creatine kinase mb ( > nmbr u / l ),C0151576;C0024853;C0053917;C0439339;C1334884;C0205250;C0010290;C0523584;C3163633,false;true;true;false;false;false;true;false;false,8863/10465
current tobacco use,C0521116;C0040335;C0543414;C0841002;C3853727;C1705970,false;false;true;false;false;false,8864/10465
no current tobacco use,C0521116;C0040335;C0543414;C0841002;C3853727;C1705970,false;false;true;false;false;false,8865/10465
bare metal,C0025552,true,8866/10465
bare - metal,C0025552,true,8867/10465
corticosteroid or azathioprine / nmbr - mercaptopurine,C0001617;C3536709,true;false,8868/10465
corticosteroid - azathioprine / nmbr - mercaptopurine,C0001617;C0004482;C0053917;C0000618;C1334884;C3536709,true;true;true;true;false;false,8869/10465
dapagliflozin nmbr mg,C2353951;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8870/10465
dapagliflozin nmbrmg,C2353951,true,8871/10465
empagliflozin nmbr mg,C3490348;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8872/10465
ertugliflozin nmbr mg,C4079805;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8873/10465
ics / lama,C0815320;C0999593;C1416775;C4551720,false;false;false;true,8874/10465
ics / laba,C0815320;C4551720,false;true,8875/10465
ics + laba,C0815320;C4551720,false;true,8876/10465
duration of disease — yr,C0872146;C0439234,false;false,8877/10465
duration of disease — mo,C0872146;C0026544;C0332177,false;true;false,8878/10465
eze + statin,C0360714,true,8879/10465
pbo + statin,C0031962;C0360714,true;true,8880/10465
ze + statin,C0360714,true,8881/10465
coronary endpoint,C0018787;C2349179;C2826544,true;false;false,8882/10465
coronary end point,C0018787;C2349179;C2826544,true;false;false,8883/10465
patients with baseline crp concentration £ nmbr mg / l,C0030705;C0168634;C3890735;C0086045;C0053917;C0439268;C1334884;C1446561;C3827302;C4048285;C1442488,true;true;false;true;true;false;false;false;false;false;false,8884/10465
patients with baseline crp concentration < nmbr mg / l,C0030705;C0168634;C3890735;C0086045;C0053917;C0439268;C1334884;C1446561;C3827302;C4048285;C1442488,true;true;false;true;true;false;false;false;false;false;false,8885/10465
none 一 no . ( % ),,,8886/10465
score  no . ( % ),C0449820;C4050231,false;false,8887/10465
score 一 no . ( % ),C0449820;C4050231,false;false,8888/10465
female simva ( „ = nmbr },C0043210;C0053917;C1334884;C0086287;C1705497;C1705498,true;true;false;true;false;false,8889/10465
male simva ( „ = nmbr },C0086582;C0053917;C1334884;C1706180;C1706428;C1706429,true;true;false;false;false;false,8890/10465
aspirin — no . ( % ),C0004057,true,8891/10465
aspirin 一 no . ( % ),C0004057,true,8892/10465
adas — cog score,C3539026;C0449820;C4050231,false;false;false,8893/10465
adas - cog score *,C3539026;C0449820;C4050231,false;false;false,8894/10465
troponin nmbr at baseline *,C0041199;C0053917;C0168634;C1442488;C1334884,true;true;true;false;false,8895/10465
troponin nmbr at baseline,C0041199;C0053917;C0168634;C1442488;C1334884,true;true;true;false;false,8896/10465
lower limb fracture,C0023216;C0016658;C0441994;C0596838;C1548802;C2003888,true;true;false;false;false;false,8897/10465
upper limb fractures,C1140618,true,8898/10465
upper limb fracture,C0178316,false,8899/10465
lower limb fractures,C0023216,true,8900/10465
inflix  yes,C0666743;C1549445;C1705108;C1710701,true;false;false;false,8901/10465
inflix  no,C0666743,true,8902/10465
east europe,C1707877;C0015176,false;true,8903/10465
e . europe,C0015176,true,8904/10465
western europe,C0043129,true,8905/10465
w . europe,C0015176,true,8906/10465
eastern europe,C0015177,true,8907/10465
w est europe,C3811127;C0015176;C3890902,false;true;false,8908/10465
eastern european,C0239309,false,8909/10465
general health,C0424575;C4018875,false;false,8910/10465
mental health,C0025353,true,8911/10465
canakinumab dose ( per mo ),C2718773;C0178602;C0026544;C0332177;C0869039;C1114758,true;false;true;false;false;false,8912/10465
canakinumab dose ( per month ),C2718773;C0178602;C0332177;C0439231;C0869039;C1114758,true;false;false;false;false;false,8913/10465
age ( years ) : < nmbr,C1510829;C0053917;C1334884,false;true;false,8914/10465
age ( years ) : > nmbr,C1510829;C0053917;C1334884,false;true;false,8915/10465
chd status §,C0280604;C0449438;C3542407,false;false;false,8916/10465
chd status,C0280604;C0449438;C3542407,false;false;false,8917/10465
rheumatoid factor positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,8918/10465
rheumatoid factor - positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,8919/10465
priorheartfailure  %,,,8920/10465
prior heart failure yes,C0332152;C0018801;C1549445;C1705108;C1710701;C0018802;C4554158;C2826257,false;true;false;false;false;true;false;false,8921/10465
prior heart failure  %,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,8922/10465
gender  male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,8923/10465
gender male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,8924/10465
metabolic syndrome * n = nmbr,C0524620;C0053917;C1334884,true;true;false,8925/10465
metabolic syndrome ( n = nmbr ),C0524620;C0053917;C1334884,true;true;false,8926/10465
nonmetabolic syndrome ( n = nmbr ),C0039082;C0053917;C1334884,true;true;false,8927/10465
bmi ( kg / mnmbr ),C0578022;C0022718;C0439209;C4054209,false;true;false;false,8928/10465
bmi  kg / mnmbr,C0578022;C0022718;C0439209;C4054209,false;true;false;false,8929/10465
bmi  kg / mnmbr  n,C0578022;C0022718;C0439209;C4054209,false;true;false;false,8930/10465
bmi ( kg / mnmbr ) *,C0578022;C0022718;C0439209;C4054209,false;true;false;false,8931/10465
baseline bmi < nmbr kg / mnmbr,C0168634;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false,8932/10465
baseline bmi > nmbr kg / mnmbr,C0168634;C0578022;C0053917;C0022718;C0439209;C4054209;C1334884;C1442488,true;false;true;true;false;false;false;false,8933/10465
duration of assigned regimen before surgery post - randomisation characteristic *,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,8934/10465
duration of assigned regimen before surgery post - randomisation characteristic * *,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,8935/10465
asa use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8936/10465
no asa use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8937/10465
ics use at baseline,C0815320;C4551720,false;true,8938/10465
female eze / simva ( „ = nmbr },C0043210;C0053917;C1334884;C0086287;C1705497;C1705498,true;true;false;true;false;false,8939/10465
male eze / simva ( „ = nmbr },C0086582;C0053917;C1334884;C1706180;C1706428;C1706429,true;true;false;false;false;false,8940/10465
body mass index  kg / mnmbr  mean + sd,C0005893;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;true,8941/10465
body mass index  kg / mnmbr  mean ( sd ),C0005893;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;true,8942/10465
body mass index  kg / mnmbr  mean ± sd,C0005893;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;true,8943/10465
abdominal obesity *,C0311277,true,8944/10465
abdominal obesity,C0311277,true,8945/10465
cohort nmbr ( n = nmbr ),C0009247;C0053917;C1334884;C0599755,true;true;false;false,8946/10465
cohort nmbr ( n = nmbr ) f,C0009247;C0053917;C0016327;C1334884;C0599755,true;true;true;false;false,8947/10465
age  median ( nmbrth - nmbrth percentiles )  y,C0001779;C0549183;C1264641;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,8948/10465
age  median ( nmbrth — nmbrth percentiles )  y,C0001779;C0549183;C1264641;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,8949/10465
baseline hbanmbrc  %,C0168634;C1442488,true;false,8950/10465
baseline hbanmbrc ( % ),C0168634;C1442488,true;false,8951/10465
no aminosalicylates  n,C0368663,false,8952/10465
aminosalicylates * *,C0368663,false,8953/10465
aminosalicylates  n,C0368663,false,8954/10465
vildagliptin nmbr mg qd,C1570906;C0053917;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,8955/10465
vildagliptin nmbr mg bid,C1570906;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,8956/10465
< nmbr kg / mnmbr ( n — nmbr ),C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8957/10465
> nmbr kg / mnmbr ( n — nmbr ),C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,8958/10465
baseline ldl - c > nmbr . nmbr to < nmbr . nmbr mmol / lc,C0168634;C0053917;C0439190;C1334884;C1442488,true;true;false;false;false,8959/10465
baseline ldl - c nmbr . nmbr to < nmbr . nmbr mmol / lc,C0168634;C0053917;C0439190;C1334884;C1442488,true;true;false;false;false,8960/10465
methotrexate use,C0025677;C0042153;C0457083;C1947944,true;true;false;false,8961/10465
methotrexate user,C0025677;C1548600;C1706077,true;false;false,8962/10465
bare metal stent,C2825200,false,8963/10465
bare - metal stent,C2825200,false,8964/10465
other ( n = nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,8965/10465
other ( n — nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,8966/10465
amputationsa,,,8967/10465
amputation,C0002688;C0332840;C1546539,true;false;false,8968/10465
p — value for interaction,C1709380;C1704675,false;false,8969/10465
p - value for interaction *,C1709380;C1704675,false;false,8970/10465
p value for interactiont,C1709380,false,8971/10465
p value for interaction,C1709380;C1704675,false;false,8972/10465
p - value for interaction,C1709380;C1704675,false;false,8973/10465
p value for interaction^,C1709380;C1704675,false;false,8974/10465
p value fo interactio,C1709380,false,8975/10465
waisthip ratio,C0205682;C0456603;C1547037,true;false;false,8976/10465
waist - hip ratio,C0205682,true,8977/10465
tnglycendes < median,,,8978/10465
tngtycerides a median,,,8979/10465
tngtycendes a median,,,8980/10465
tngtycerides < median,,,8981/10465
furosemide,C0016860,true,8982/10465
torsemide,C0076840,true,8983/10465
drinker ( % ) a,C0556338,false,8984/10465
drinker ( % ),C0556338,false,8985/10465
uncertain,C0087130;C4085655,true;false,8986/10465
uncerlain,,,8987/10465
mean diastolic blood pressure  mm hg,C0428886;C0012000;C0439475;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;false;true;false;false;false,8988/10465
mean systolic blood pressure  mm hg,C0428886;C0039155;C0439475;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;true;false;false;false,8989/10465
maximum cimt < median,C0806909;C0549183;C0876920;C2347635;C2348144;C2939193;C1552615;C2826546,false;false;false;false;false;false;false;false,8990/10465
maximum cimt a med an,C0806909;C1552615;C2826546,false;false;false,8991/10465
at clinic diastolic pressure > nmbr mm hg,C0002424;C0428883;C0053917;C0439475;C1334884;C0442592,true;true;true;false;false;false,8992/10465
at clinic systolic pressure > nmbr mm hg,C0002424;C0871470;C0053917;C0439475;C1334884;C0442592,true;true;true;false;false;false,8993/10465
at clinic systolic pressure < nmbr mm hg,C0002424;C0871470;C0053917;C0439475;C1334884;C0442592,true;true;true;false;false;false,8994/10465
at clinic diastolic pressure < nmbr mm hg,C0002424;C0428883;C0053917;C0439475;C1334884;C0442592,true;true;true;false;false;false,8995/10465
thiazolidinediones,C1257987;C3541957,true;false,8996/10465
thiazolidinedioneb,,,8997/10465
thiazolidinedione no,C0289779;C1257987;C3537039,true;true;false,8998/10465
thiazolidinedione,C0289779;C1257987;C3537039,true;true;false,8999/10465
thiazolidinedione yes,C0289779;C1549445;C1705108;C1710701;C1257987;C3537039,true;false;false;false;true;false,9000/10465
crcl < nmbr ml / min,C1846718;C0053917;C0439445;C1334884,false;true;false;false,9001/10465
crcl > nmbr ml / min,C1846718;C0053917;C0439445;C1334884,false;true;false;false,9002/10465
ecrcl < nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9003/10465
stroke or transient ischemic attack,C0038454;C4554100,true;false,9004/10465
stroke / transient ischemic attack,C0038454;C4554100,true;false,9005/10465
hdl cholesterol  mmol / l  women  mean ± sd,C0023822;C1532563;C0043210;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;true;false;false;false;false;false,9006/10465
hdl cholesterol  mmol / l  men  mean ± sd,C0023822;C1532563;C0025266;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;true;false;false;false;false;false,9007/10465
disease duration > nmbr years ( n = nmbr ),C0872146;C0053917;C0439234;C1334884,false;true;false;false,9008/10465
disease duration b nmbr years ( n = nmbr ),C0872146;C0053917;C0439234;C1334884,false;true;false;false,9009/10465
bmi ( kg / rrr ),C0578022;C0022718;C0439209;C4054209,false;true;false;false,9010/10465
bmi ( kg / m ),C0578022;C1532718,false;false,9011/10465
anterior ( n  % ),C0205094,false,9012/10465
inferior ( n  % ),C0542339;C0678975,false;false,9013/10465
blood pressure — mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,9014/10465
blood pressure  mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,9015/10465
blood pressure — mmhg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,9016/10465
blood pressure  mm,C0005823;C4330985;C4554674;C1271104;C1272641,true;false;false;false;true,9017/10465
blood pressure ( mm hg ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,9018/10465
blood pressure ( mmhg ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,9019/10465
blood pressure  mmhg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,9020/10465
non - st - elevation mi,C1518422;C0520886;C3810814,false;false;false,9021/10465
non - st — elevation mi,C1518422;C0520886;C3810814,false;false;false,9022/10465
non - st - elevation ml,C1518422;C0520886;C0439526;C1705224;C3887665,false;false;false;false;false,9023/10465
nmbr - nmbr . nmbr : overweight,C0053917;C0497406;C1334884,true;true;false,9024/10465
nmbr - nmbr - nmbr  overweight,C0053917;C0497406;C1334884,true;true;false,9025/10465
intention - to - treat with st - segment - elevation myocardial infarction,C0162425;C1283828,true;false,9026/10465
intention - to - treat without st - segment - elevation myocardial infarction,C0162425;C1283828,true;false,9027/10465
no history of cancer,C0455471,false,9028/10465
history of cancer,C0455471,false,9029/10465
antidiabetic agent,C0935929,true,9030/10465
antidiabetic agents,C0935929,true,9031/10465
age > = nmbr years old,C1510829;C0053917;C1334884,false;true;false,9032/10465
age < nmbr years old,C1510829;C0053917;C1334884,false;true;false,9033/10465
ics use at baseline : no,C0815320;C4551720,false;true,9034/10465
ics use at baseline : yes,C0815320;C4551720,false;true,9035/10465
crp $ nmbr mg / l  n,C3890735;C0053917;C0439268;C1334884;C4048285,false;true;false;false;false,9036/10465
crp < nmbr mg / l  n,C3890735;C0053917;C0439268;C1334884;C4048285,false;true;false;false;false,9037/10465
stent thrombosis *,C3897493,false,9038/10465
stent thrombosis,C3897493,false,9039/10465
high - dosage ics plus laba with baseline blood eosinophils > nmbr cells per pl ( n = nmbr ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,9040/10465
high - dosage ics plus laba with baseline blood eosinophils anmbr cells per pl ( n = nmbr ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,9041/10465
high - dosage ics plus laba with baseline blood eosinophils < nmbr cells per pl ( n = nmbr ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,9042/10465
not hispanic or latino ( n = nmbr ),C1518424,false,9043/10465
not hispanic or latino ( n — nmbr ),C1518424,false,9044/10465
< nmbr mg / dl simva,C0053917;C0439269;C1334884,true;false;false,9045/10465
> nmbr mg / dl simva,C0053917;C0439269;C1334884,true;false;false,9046/10465
cardiovasculardeath,,,9047/10465
cardiovascular death !,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,9048/10465
cardiovascular death,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,9049/10465
mean body - mass index  kg / mnmbr,C0444504;C0005893;C0022718;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;true;false;false;false;true;false;false,9050/10465
mean body mass index  kg / mnmbr,C0444504;C0005893;C0022718;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;true;false;false;false;true;false;false,9051/10465
mean body mass index ( kg / mnmbr ) *,C0444504;C0005893;C0022718;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;true;false;false;false;true;false;false,9052/10465
mean body mass index ( kg / mnmbr ),C0444504;C0005893;C0022718;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;true;false;false;false;true;false;false,9053/10465
anmbr + enmbr ( n = nmbr ),C0053917;C1334884,true;false,9054/10465
anmbr / nmbr ( n = nmbr ),C0053917;C1334884,true;false,9055/10465
nmbr - nmbr ( n = nmbr ),C0053917;C1334884,true;false,9056/10465
mean sd nmbr - h asbp  mm hg,C0444504;C2699239;C0053917;C0033727;C0439475;C0369286;C0441932;C0564385;C4528284;C1334884;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false;false,9057/10465
mean ± sd nmbr - h adbp  mm hg,C0444504;C2699239;C0053917;C0033727;C0168370;C0439475;C0369286;C0441932;C0564385;C4528284;C1334884;C2347634;C2348143,false;false;true;true;true;false;false;false;false;false;false;false;false,9058/10465
egfr nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,9059/10465
egfr nmbr – nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,9060/10465
egfr nmbr - nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,9061/10465
nmbr - nmbr / month,C0053917;C0332177;C0439231;C1334884,true;false;false;false,9062/10465
nmbr - nmbr months,C0053917;C0439231;C1334884,true;false;false,9063/10465
with corticosteroid treatment < nmbr,C0001617;C0039798;C0053917;C1334884;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3536709,true;true;true;false;true;false;false;false;false;false;false,9064/10465
with corticosteroid treatment > nmbr,C0001617;C0039798;C0053917;C1334884;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3536709,true;true;true;false;true;false;false;false;false;false;false,9065/10465
postmenopausal  no hrt,C0232970,false,9066/10465
postmenopausal and no ht,C0232970,false,9067/10465
poslmenopausal  no ht,,,9068/10465
postmenopausal and no hrt,C0232970,false,9069/10465
poslmenopausal  ht,C0018510;C0677607,true;true,9070/10465
depression,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,9071/10465
depression^,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,9072/10465
no depression,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,9073/10465
concomitant medications,C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9074/10465
concomitant medication,C0521115;C0013227;C3244316;C4284232,false;true;false;false,9075/10465
nmbr blocker,C0053917;C1334884,true;false,9076/10465
( nmbr - blockers,C0053917;C1334884,true;false,9077/10465
nmbr blockers,C0053917;C1334884,true;false,9078/10465
( nmbr blocker,C0053917;C1334884,true;false,9079/10465
/ nmbr - blockers,C0053917;C1334884,true;false,9080/10465
 nmbr - blockers,C0053917;C1334884,true;false,9081/10465
no prior stroke / tia,C0332152;C0038454;C0007787;C0917805;C1054154;C4554100;C2826257,false;true;true;true;false;false;false,9082/10465
prior stroke / tia,C0332152;C0038454;C0007787;C0917805;C1054154;C4554100;C2826257,false;true;true;true;false;false;false,9083/10465
prior stroke or tia,C0332152;C0038454;C4554100;C2826257,false;true;false;false,9084/10465
cv entry criteria,C3538987;C1705654;C0243161;C4048877;C4318503,false;false;true;true;false,9085/10465
entry criteria,C1705654;C0243161,false;true,9086/10465
fevnmbr / fvc  % a,C3714541,true,9087/10465
fevnmbr / fvc  % *,C3714541,true,9088/10465
placebo  % > ( n / n ),C0032042;C1696465;C1706408,true;false;false,9089/10465
placebo  % ( n / n ),C0032042;C1696465;C1706408,true;false;false,9090/10465
mayo < nmbr  n,C0454788;C0053917;C1334884;C1077578,false;true;false;false,9091/10465
mayo $ nmbr  n,C0454788;C0053917;C1334884;C1077578,false;true;false;false,9092/10465
weight in kg  median ( iqr ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,9093/10465
weight - kg  median ( iqr ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,9094/10465
weight ( kg )  median ( iqr ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,9095/10465
prior myocardial infarction — no . ( % ),C0155668,false,9096/10465
prior myocardial infarction 一 no . ( % ),C0155668,false,9097/10465
baseline ics use : no,C0168634;C0815320;C4551720;C1442488,true;false;true;false,9098/10465
baseline ics use : yes,C0168634;C0815320;C4551720;C1442488,true;false;true;false,9099/10465
tg  median ( min  max ),C0337445;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,9100/10465
mtss  median ( min  max ),C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9101/10465
jsn  median ( min  max ),C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9102/10465
all - cause mortality or hf hospitalization,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9103/10465
all - cause mortality or hf hospitalization^,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9104/10465
fbs < nmbr mg / dl,C3812213;C0053917;C0439269;C1334884,false;true;false;false,9105/10465
fbs > = nmbr mg / dl,C3812213;C0053917;C0439269;C1334884,false;true;false;false,9106/10465
amlodipine / valsartan nmbr / nmbr mg,C1962523;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9107/10465
amlodipine / wlsartan inmbr / nmbr mg,C0051696;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9108/10465
all - cause mortality,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9109/10465
all cause mortality,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9110/10465
renal insufficiency / failure,C0035078;C0231179;C1963154;C0231174;C0680095;C1565489,true;false;false;false;false;true,9111/10465
renal insufficiency or failure,C0035078;C1565489,true;true,9112/10465
anticoagulants,C0003280,true,9113/10465
anti - coagulants,C0848112,false,9114/10465
anticoagulant,C0003280;C0848112;C3536711,true;false;false,9115/10465
oral corticosteroids,C0442027;C0001617;C3539185;C3540725;C3540726;C3540727;C4521986,false;true;false;false;false;false;false,9116/10465
oral corticosteroid,C0442027;C0001617;C3536709;C4521986,false;true;false;false,9117/10465
prior lower gi clinical event,C0332152;C0441994;C1708130;C0205210;C0441471;C4019010;C3539617;C4050121;C1548802;C2003888;C2826257,false;false;false;false;false;false;false;false;false;false;false,9118/10465
prior upper gi clinical event,C0332152;C0203057;C0205210;C0441471;C4019010;C2826257,false;false;false;false;false;false,9119/10465
complex anatomy ( n - nmbr  nmbr ),C0439855;C0002808;C0053917;C1334884;C0700276;C1384516;C1704241,false;true;true;false;false;true;false,9120/10465
noncomplex anatomy ( n - nmbr  nmbr ),C0002808;C0053917;C1334884;C0700276;C1384516,true;true;false;false;true,9121/10465
all cana,C1418845,false,9122/10465
all cancer,C0006826;C0998265;C1306459,true;false;false,9123/10465
ace inhibitors / arb,C0003015,true,9124/10465
ace inhibitor or arb,C0003015;C4541021,true;false,9125/10465
ace inhibitors and arb,C0003015,true,9126/10465
ace inhibitors or arb,C0003015,true,9127/10465
ace inhibitors or arbs,C0003015,true,9128/10465
ace inhibitors / arbs,C0003015;C3888198,true;false,9129/10465
physician ' s global assessment,C4050369,false,9130/10465
physician ' s global assessment !,C4050369,false,9131/10465
previous or current im use : no,C0205156;C1552607,false;false,9132/10465
previous or current cs use : no,C0205156;C1552607,false;false,9133/10465
nyha class  n ( % ) i,C1882083,false,9134/10465
nyha class  n ( % ),C1882083,false,9135/10465
nyha class  n ( % ) ii,C1882085,false,9136/10465
nyha class  ( % ),C1882083,false,9137/10465
baseline heart rate ( beat / min ),C0168634;C0425583;C0871208;C0702093;C1524029;C3813700;C1521828;C1442488,true;false;false;false;false;false;false;false,9138/10465
baseline heart rate ( beats / min ),C0168634;C0018810;C1442488,true;true;false,9139/10465
concomitant medications  %,C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9140/10465
concomitant medication | |,C0521115;C0013227;C3244316;C4284232,false;true;false;false,9141/10465
metabolic syndrome  ! n ( % ),C0524620,true,9142/10465
metabolic syndrome  n ( % ),C0524620,true,9143/10465
body weight ( kg ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9144/10465
body weight  %,C0005910;C1305866,true;false,9145/10465
body weight  kg,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9146/10465
body weight — kg,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9147/10465
bodyweight ( kg ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9148/10465
body weighta  kg,C0242821;C0022718;C0439209;C4054209;C0460148;C1268086;C4082212,true;true;false;false;false;false;false,9149/10465
fev_ ( l ) :,C3714541,true,9150/10465
fvc  l,C3714541,true,9151/10465
fvc ( l ) ,C3714541,true,9152/10465
fvc ( l ) *,C3714541,true,9153/10465
fvc ( l ),C3714541,true,9154/10465
no fracture history,C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,9155/10465
fracture history,C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,9156/10465
nmbr to < nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9157/10465
> nmbr to < nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9158/10465
nmbr - < nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9159/10465
nmbr - nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9160/10465
met criterion at blt ( n [ % ] ),C0428210;C0243161;C1563149;C1708627;C1550543;C4317104,false;true;false;false;false;false,9161/10465
met criterion at bl ( n [ % ] ),C0428210;C0243161;C0005918;C0006413;C1552663;C2827109;C1550543;C4317104,false;true;true;true;false;false;false;false,9162/10465
( % ) ( nmbr . nmbr ),C0053917;C1334884,true;false,9163/10465
( % ) ( nmbr - nmbr ),C0053917;C1334884,true;false,9164/10465
post - bronchodilator fevnmbr reversibility  % a,C2599594;C0449261,false;false,9165/10465
postbronchodilator fevnmbr reversibility  %,C2599594;C0449261,false;false,9166/10465
post - bronchodilator fevnmbr reversibility  %,C2599594;C0449261,false;false,9167/10465
cigarette smoking,C0239059;C0700219,false;true,9168/10465
cigarette smoker,C0337667,false,9169/10465
daily dose nmbr mg n = nmbr,C2348070;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,9170/10465
daily dose > nmbr mg n = nmbr,C2348070;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,false;true;true;true;false;false;false;false;false;false,9171/10465
female ( n = nmbr  nmbr ),C0043210;C0053917;C1334884;C0086287;C1705497;C1705498,true;true;false;true;false;false,9172/10465
male ( n = nmbr  nmbr ),C0086582;C0053917;C1334884;C1706180;C1706428;C1706429,true;true;false;false;false;false,9173/10465
hemoglobin ( g rnmbr ),C1319312,false,9174/10465
hemoglobin ( g nmbr ! ),C1319312;C0053917;C1334884,false;true;false,9175/10465
with lipid - lowering agents,C0086440,true,9176/10465
without lipid - lowering agents,C0086440,true,9177/10465
macroalbuminuria,,,9178/10465
macroalbuminuriaf,,,9179/10465
microalbuminuria,C0730345,false,9180/10465
macro - albuminuria,C2984010;C0001925,false;true,9181/10465
micro - albuminuria,C0085672;C0001925;C1553035;C3811161;C4049106,false;true;false;false;false,9182/10465
egfr ( ml / min per nmbr - nmbr mnmbr ),C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,9183/10465
egfr ( ml / min per nmbr - nmbr mnmbr ) t,C1739039;C0439445;C0053917;C1334884;C3811844;C3812682,true;false;true;false;false;false,9184/10465
macroalbuminuria — no . / total no . ( % ),,,9185/10465
microalbuminuria — no . / total no . ( % ),C0730345,false,9186/10465
chd simva,C0280604;C3542407,false;false,9187/10465
no chd simva,C0280604;C3542407,false;false,9188/10465
> nmbr . nmbr mu / l $ mmol / l,C0053917;C0439342;C0439190;C1334884,true;false;false;false,9189/10465
< nmbr . nmbr mu / l $ mmol / l,C0053917;C0439342;C0439190;C1334884,true;false;false;false,9190/10465
stage nmbra : > = nmbr and < nmbr,C0205390;C1300072;C1306673,false;false;false,9191/10465
stage nmbrb : > = nmbr and < nmbr,C0205390;C1300072;C1306673,false;false;false,9192/10465
canakinumab  hscrp > nmbr - nmbr mg / l at nmbr months ( n = nmbr ),C2718773;C0053917;C0439268;C0439231;C1334884,true;true;false;false;false,9193/10465
canakinumab  hscrp < nmbr - nmbr mg / l at nmbr months ( n = nmbr ),C2718773;C0053917;C0439268;C0439231;C1334884,true;true;false;false;false,9194/10465
post - bronchodilator screening fevnmbr ml,C2599594;C0220908;C0439526;C1705224;C3887665;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;false;false;false;true;false;false;false;false;false,9195/10465
pre - bronchodilator screening fevnmbr ml,C2599602;C0220908;C0439526;C1705224;C3887665;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;false;false;false;true;false;false;false;false;false,9196/10465
duration of hypercholesterolaemia  mean ± sd ( year ),C0449238;C0020443;C0444504;C2699239;C0439234;C0439508;C2347634;C2348143;C1522133;C2926735,false;true;false;false;false;false;false;false;false;false,9197/10465
duration of hypercholesterolemia  mean ± sd ( years ),C0449238;C0020443;C0444504;C2699239;C0439234;C2347634;C2348143;C1522133;C2926735,false;true;false;false;false;false;false;false;false,9198/10465
< nmbr with no historical count > nmbr,C0053917;C1552658;C0750480;C1705566;C1552723;C2004062;C1334884,true;false;false;false;false;false;false,9199/10465
< nmbr with historical count > nmbr,C0053917;C1552658;C0750480;C1705566;C1552723;C2004062;C1334884,true;false;false;false;false;false;false,9200/10465
baseline hbalc > nmbr . nmbr % ( nmbr mmol / mol ) nmbr,C0168634;C0053917;C3829066;C1334884;C1442488,true;true;false;false;false,9201/10465
baseline hbalc < nmbr . nmbr % ( nmbr mmol / mol ) nmbr,C0168634;C0053917;C3829066;C1334884;C1442488,true;true;false;false;false,9202/10465
difference from placebo ( nmbr % ci ),C1705241;C0032042;C0053917;C0008107;C3259781;C1334884;C1696465;C1706408;C1705242,false;true;true;true;false;false;false;false;false,9203/10465
difference from placebo * ( nmbr % ci ),C1705241;C0032042;C0053917;C0008107;C3259781;C1334884;C1696465;C1706408;C1705242,false;true;true;true;false;false;false;false;false,9204/10465
central eosinophil count ( cells per pl ),C0205099;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879;C1879652,false;false;true;false;false;true;false;false,9205/10465
central eosinophil count ( cells per pl ) t,C0205099;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879;C1879652,false;false;true;false;false;true;false;false,9206/10465
other anti - platelet agents,C0040616;C0005821,true;true,9207/10465
other antiplatelet agents,C0085826,true,9208/10465
other forms of atherosclerosis^,C0348078;C0003850;C0004153;C0376315,false;true;true;true,9209/10465
other forms of atherosclerosis ’,C0348078;C0003850;C0004153;C0376315,false;true;true;true,9210/10465
race or ethnic group  no . ( % ),C0034510;C1706779;C3853635,true;false;false,9211/10465
race or ethnic group — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,9212/10465
prior smoker,C0337671,false,9213/10465
prior stroke,C0332152;C0038454;C4554100;C2826257,false;true;false;false,9214/10465
no prior stroke,C0332152;C0038454;C4554100;C2826257,false;true;false;false,9215/10465
gender  n ( % ),C0079399;C1522384,true;true,9216/10465
gender  no . ( % ),C0079399;C1522384,true;true,9217/10465
coronary heart disease  n ( % ) b,C0010054;C0010068;C1956346,true;true;true,9218/10465
coronary heart disease  n ( % ) t,C0010054;C0010068;C1956346,true;true;true,9219/10465
mean ± s . d . fpg,C0444504;C2347634;C2348143,false;false;false,9220/10465
mean ( s . d . ) fpg,C0444504;C2347634;C2348143,false;false;false,9221/10465
troponin i ( pg / ml ),C0077401;C0439297,true;false,9222/10465
troponin t ( pg / ml ),C0077404;C0439297;C1420827,true;false;false,9223/10465
> nmbr ml / min / nmbr . nmbrmnmbr,C0053917;C0439445;C1334884,true;false;false,9224/10465
≥ nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,9225/10465
< nmbr ml / min / nmbr . nmbrmnmbr,C0053917;C0439445;C1334884,true;false;false,9226/10465
< nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,9227/10465
> nmbr ml / min / nmbr . nmbr mnmbr,C0053917;C0439445;C1334884,true;false;false,9228/10465
ischemia - driven revascularization,C0022116;C4321499,true;false,9229/10465
ischemia driven revascularization,C0022116;C4321499,true;false,9230/10465
timi minor,,,9231/10465
timi major,,,9232/10465
history of major microvascular disease  n ( % ),C0683519;C0205082;C0443258;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false;false,9233/10465
history of major macrovascular disease  n ( % ),C0683519;C0205082;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false,9234/10465
pre - bronchodilation fvc,C0439566;C3714541,false;true,9235/10465
post - bronchodilation fvc,C0439576;C3714541,false;true,9236/10465
nmbr . nmbr ( nmbr . nmbr – nmbr . nmbr ),C0053917;C1334884,true;false,9237/10465
nmbr . nmbr ( nmbr . nmbr - nmbr . nmbr ),C0053917;C1334884,true;false,9238/10465
nmbr . nmbr ( nmbr . nmbr . nmbr . nmbr ),C0053917;C1334884,true;false,9239/10465
history of macrovascular disease ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,9240/10465
history of microvascular disease ( % ),C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,9241/10465
patient characteristics,C0815172,false,9242/10465
patients ' characteristics,C0815172,false,9243/10465
treatment with anti - platelet drugs,C0039798;C2963157;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,9244/10465
treatment with antiplatelet drugs,C3469597,false,9245/10465
concomitant medications  * n ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9246/10465
concomitant medication  n ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,9247/10465
concomitant medications  n ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9248/10465
fpg  mean ( sd )  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,9249/10465
fpg  mean ( sd )  mg / dlt,C0444504;C2699239;C0024671;C1413248;C3273706;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;true;false;false;true;false;false;false;false;false;false;false,9250/10465
one - vessel disease,C3275121,false,9251/10465
two - vessel disease,C0581375,false,9252/10465
ethnicity,C0015031;C0243103,true;true,9253/10465
ethnicity ,C0015031;C0243103,true;true,9254/10465
ind / glyb n = nmbr,C4049864;C1415124;C0053917;C1334884,false;false;true;false,9255/10465
ind / gly n = nmbr,C4049864;C0017890;C0053917;C1334884;C0523677,false;true;true;false;false,9256/10465
non - hispanic / latino,C1518424;C0086528,false;true,9257/10465
not hispanic or latino,C1518424,false,9258/10465
not hispanic / latino,C1518424;C0086528,false;true,9259/10465
north american,C0425358;C2700615,false;false,9260/10465
north america,C0028405,true,9261/10465
south africa,C0037712,true,9262/10465
south american,C0425359,false,9263/10465
sou ti africa,C0039247;C0001737;C0040302;C1553045;C1704756,true;true;true;false;false,9264/10465
south america,C0037713,true,9265/10465
northamerica,,,9266/10465
bloodpressure  mean ( sd )  m m hg,C0428886;C2699239;C1709500;C0025424;C0428257;C2347108;C2347109;C2348272,true;false;false;true;false;false;false;false,9267/10465
blood pressure  mean ( sd )  mm hg,C0428886;C2699239;C0439475,true;false;false,9268/10465
tiotropium / olodaterol nmbr . nmbr / nmbr mg,C4032878;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9269/10465
tiotropium + olodaterol nmbr . nmbr / nmbr mg,C4032878;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9270/10465
tiotropium + olodaterol nmbr . nmbr / nmbr pg,C4032878;C0053917;C0030827;C0072225;C1266240;C1334884,true;true;true;true;false;false,9271/10465
diastolic bp  mmhg ( sd ),C0428883;C0439475;C2699239,true;false;false,9272/10465
systolic bp  mmhg ( sd ),C0871470;C0439475;C2699239,true;false;false,9273/10465
postamendment,,,9274/10465
preamendment,C1548596,false,9275/10465
fasting glucose — mg / dl,C0015663;C0017725;C0439269,true;true;false,9276/10465
fasting glucose ( mg / dl ),C0015663;C0017725;C0439269,true;true;false,9277/10465
fasting glucose ( mg / dl ) ,C0015663;C0017725;C0439269,true;true;false,9278/10465
mean systolic bp  mmhg  mean = sd,C0444504;C0871470;C0439475;C2699239;C2347634;C2348143,false;true;false;false;false;false,9279/10465
mean diastolic bp  mmhg  mean = sd,C0444504;C0428883;C0439475;C2699239;C2347634;C2348143,false;true;false;false;false;false,9280/10465
number of prior aeds  n ( % ) b,C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,9281/10465
number of prior aeds  n ( % ),C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,9282/10465
mean ( sd ) sdai *,C0444504;C2699239;C3871128;C2347634;C2348143,false;false;false;false;false,9283/10465
mean ( sd ) cdai *,C0444504;C2699239;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false;false,9284/10465
age > nmbr yearsnmbr,C0001779;C0053917;C1334884,false;true;false,9285/10465
age < nmbr yearsnmbr,C0001779;C0053917;C1334884,false;true;false,9286/10465
baseline systolic blood pressure ( mm hg ),C4274438;C0439475,false;false,9287/10465
baseline diastolic blood pressure ( mm hg ),C4274392;C0439475,false;false,9288/10465
adp antagonist,C0523452;C0231491,false;false,9289/10465
tnf antagonist,C1448177;C0231491,true;false,9290/10465
comorbidities,C0009488,true,9291/10465
co - morbidities,C0009488,true,9292/10465
vildagliptin nmbr mg bid n = nmbr,C1570906;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9293/10465
vildagliptin nmbr mg qd n = nmbr,C1570906;C0053917;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,9294/10465
migraine with aura,C0154723,true,9295/10465
migraine without aura,C0338480,true,9296/10465
previous cancer,C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,9297/10465
previous cancerc,C0205156;C1552607,false;false,9298/10465
lipid - lowering drugs,C0086440,true,9299/10465
lipid - lowerinq druq,C0023779,true,9300/10465
lipid - lowering drug,C0086440,true,9301/10465
des type,C0011702;C0332307;C1547052;C4551552,true;false;false;true,9302/10465
acs type,C0742343;C0332307;C1547052;C4318612,true;false;false;false,9303/10465
fevnmbr ( post - albuterol )  l,C0687676;C0001927;C1704687;C3469826,false;true;false;false,9304/10465
fevnmbr  pre - albuterol  l,C0332152;C0001927;C0740175;C2257086;C3669034,false;true;false;false;false,9305/10465
fevnmbr ( pre - albuterol )  l,C0332152;C0001927;C0740175;C2257086;C3669034,false;true;false;false;false,9306/10465
fevnmbr  post - albuterol  l,C0687676;C0001927;C1704687;C3469826,false;true;false;false,9307/10465
p blockers ( % ),C0369773;C2603361,false;false,9308/10465
p - blocker ( % ),C0369773;C2603361,false;false,9309/10465
severe or very severe,C0205082;C4050465;C4050466,false;false;false,9310/10465
severe / very severea,C0205082;C0442824;C2984081;C4050465;C4050466,false;false;false;false;false,9311/10465
difference ( nmbr % cl ),C1705241;C0053917;C0596019;C1334884;C1705242,false;true;false;false;false,9312/10465
difference ( nmbr % ci ) *,C1705241;C0053917;C0008107;C3259781;C1334884;C1705242,false;true;true;false;false;false,9313/10465
nmbr months,C0053917;C0439231;C1334884,true;false;false,9314/10465
nmbr mentis,C0053917;C1334884,true;false,9315/10465
nmbr mortis,C0053917;C1334884,true;false,9316/10465
> nmbr months,C0053917;C0439231;C1334884,true;false;false,9317/10465
< nmbr months,C0053917;C0439231;C1334884,true;false;false,9318/10465
nmbr montlts,C0053917;C1334884,true;false,9319/10465
seated sbp  mean ( sd )  mmhg,C0277814;C0085805;C0444504;C2699239;C0439475;C2347634;C2348143;C1283233,true;true;false;false;false;false;false;false,9320/10465
seated dbp  mean ( sd )  mmhg,C0277814;C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799;C1283233,true;true;false;false;false;false;false;false;false;false,9321/10465
alcohol abuse,C0085762;C4050601,true;false,9322/10465
alcohol use,C0001948,true,9323/10465
> nmbr microg / l,C0053917;C1334884,true;false,9324/10465
< nmbr microg / l,C0053917;C1334884,true;false,9325/10465
tobacco abuse,C0040336,true,9326/10465
tobacco use,C0040335;C0543414;C0841002;C3853727,false;true;false;false,9327/10465
hospital stay ( days ),C3489408;C0439228,true;false,9328/10465
hospital stay  days,C3489408;C0439228,true;false,9329/10465
fevnmbr — % of predicted value,C0681842;C1522609;C1882327,false;false;false,9330/10465
fevnmbr ( % of predicted value ),C0681842;C1522609;C1882327,false;false;false,9331/10465
maternal history  n ( % ),C0559473,false,9332/10465
paternal history  n ( % ),C0424909,false,9333/10465
plp - c  mean ( sd )  mg / dl,C0034266;C0444504;C2699239;C0439269;C2347634;C2348143;C1175541;C1257874;C1705623,true;false;false;false;false;false;true;true;false,9334/10465
ldl - c  mean ( sd )  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,9335/10465
hdl - c  mean ( sd )  mg / dl,C3715113;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,9336/10465
nmbr drinks / wk,C0053917;C1334884,true;false,9337/10465
> nmbr drinks / week,C0053917;C1334884,true;false,9338/10465
nmbr + drinks / wk,C0053917;C1334884,true;false,9339/10465
> nmbr drinks / wk,C0053917;C1334884,true;false,9340/10465
prior hypertension yes,C0332152;C0020538;C1549445;C1705108;C1710701;C1963138;C2826257,false;true;false;false;false;false;false,9341/10465
prior hypertensiona yes,C0332152;C1549445;C1705108;C1710701;C2826257,false;false;false;false;false,9342/10465
drug - related ae *,C0013227;C0439849;C3887670;C0445223;C1254351,true;false;false;false;false,9343/10465
drug - related teaes *,C0013227;C0439849;C0445223;C1254351,true;false;false;false,9344/10465
subgroup p valuef,C1079230;C1515021,false;false,9345/10465
subgroup p value 本,C1079230;C1709380;C1515021,false;false;false,9346/10465
white ethnic origin,C0007457;C0015031;C0043157;C0220938,true;true;true;false,9347/10465
while ethnic origin,,,9348/10465
> nmbr yr since menopause,C0053917;C0439234;C1334884,true;false;false,9349/10465
< nmbr yr since menopause,C0053917;C0439234;C1334884,true;false;false,9350/10465
ls mean difference ( nmbr % ci ),C0023668;C0444504;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false,9351/10465
( mean difference  nmbr % ci ),C0444504;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242;C2347634;C2348143,false;false;true;true;false;false;false;false;false,9352/10465
( mean % difference  nmbr % ci ),C0444504;C1705241;C0053917;C0008107;C3259781;C1334884;C1705242;C2347634;C2348143,false;false;true;true;false;false;false;false;false,9353/10465
reversibility : < nmbr %,C0449261;C0053917;C1334884,false;true;false,9354/10465
reversibility : > nmbr %,C0449261;C0053917;C1334884,false;true;false,9355/10465
male eze / simva,C0086582;C1706180;C1706428;C1706429,true;false;false;false,9356/10465
all ez / simva,C0206578,true,9357/10465
female eze / simva,C0043210;C0086287;C1705497;C1705498,true;true;false;false,9358/10465
glycated hemoglobin - % ’,C0017853,true,9359/10465
glycated hemoglobin  %,C0017853,true,9360/10465
glycated hemoglobin ( % ),C0017853,true,9361/10465
glycated hemoglobin — %,C0017853,true,9362/10465
glycated haemoglobin ( % ),C0017853,true,9363/10465
anmbrc ( mmol / mol ),C3829066,false,9364/10465
hbanmbrc  mmol / mol,C3829066,false,9365/10465
hbanmbrc ( mmol / mol ),C3829066,false,9366/10465
arterial hypertension *,C0020538,true,9367/10465
arterial hypertension,C0020538,true,9368/10465
intervention,C0184661;C0886296;C1273869,true;false;false,9369/10465
interruption,C0332453;C1512900,false;false,9370/10465
waist circumference ( cm ),C0455829,true,9371/10465
waist circumference — cm,C0455829,true,9372/10465
waist circumference  ( cm ),C0455829,true,9373/10465
waist circumference  cm,C0455829,true,9374/10465
dbp ( mm hg )  median ( iqr ),C0536221;C0439475;C0549183;C0876920;C2347635;C2348144;C2939193;C3813197;C4281799,true;false;false;false;false;false;false;false;false,9375/10465
sbp ( mm hg )  median ( iqr ),C0085805;C0439475;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,9376/10465
total cholesterol  mg / dl,C0201950;C0439269;C0543421,false;false;false,9377/10465
total cholesterol — mg / dl,C0201950;C0439269;C0543421,false;false;false,9378/10465
total cholesterol ( mg / dl ),C0201950;C0439269;C0543421,false;false;false,9379/10465
toial cholcsierol ( mg / dl ),C0439269,false,9380/10465
total cholesterol  mg / dl^,C0201950;C0439269;C0543421,false;false;false,9381/10465
no change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,9382/10465
% change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,9383/10465
> nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9384/10465
£ nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9385/10465
< nmbr ml / min,C0053917;C0439445;C1334884,true;false;false,9386/10465
smoking history ( pack - years ),C1519384;C1277691,false;false,9387/10465
smoking history  pack - years,C1519384;C1277691,false;false,9388/10465
smoking history ( pack - yr ),C1519384;C1968515;C0439234;C2825051;C2828395,false;false;false;false;false,9389/10465
dm + ( aliskiren vs . placebo ),C0011816;C1120110;C3250443,true;true;false,9390/10465
dm - ( aliskiren vs . placebo ),C0011816;C1120110;C3250443,true;true;false,9391/10465
without beta blocker,C0001645,true,9392/10465
with beta blocker,C0001645,true,9393/10465
timi risk score !,C0035647;C0449820;C4050231;C4552904,true;false;false;false,9394/10465
timi risk score,C0035647;C0449820;C4050231;C4552904,true;false;false;false,9395/10465
timi risk score  %,C0035647;C0449820;C4050231;C4552904,true;false;false;false,9396/10465
angiotensin - converting enzyme inhibitor,C0003015;C2757044;C3536837;C4541021,true;false;false;false,9397/10465
angiotensin - converting - enzyme inhibitor,C0003015;C2757044;C3536837;C4541021,true;false;false;false,9398/10465
total asthma symptom score,C3533163;C0004096;C2984299,false;true;false,9399/10465
total asthma symptom score :,C3533163;C0004096;C2984299,false;true;false,9400/10465
diastolic bp  mmhg  mean ± sd,C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C0012000;C0488053,true;false;false;false;false;false;true;false,9401/10465
systolic bp  mmhg  mean ± sd,C0871470;C0439475;C0444504;C2699239;C2347634;C2348143;C0039155;C0488053,true;false;false;false;false;false;true;false,9402/10465
uric acid fertile nmbr ( > nmbr . nmbr mg / dl ),C0041980;C0015895;C0053917;C0439269;C1334884,true;true;true;false;false,9403/10465
uric acid tertile nmbr ( < nmbr . nmbr mg / dl ),C0041980;C0053917;C0439269;C1334884,true;true;false;false,9404/10465
uric acid tertile nmbr ( > nmbr . nmbr mg / dl ),C0041980;C0053917;C0439269;C1334884,true;true;false;false,9405/10465
> nmbr . nmbr mmol / liter,C0053917;C0439190;C0475211;C1334884,true;false;false;false,9406/10465
> nmbr . nmbr mg / liter,C0053917;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;true;false;false;false;false;false;false,9407/10465
< nmbr . nmbr mg / liter,C0053917;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;false;true;false;false;false;false;false;false,9408/10465
< nmbr . nmbr mmol / liter,C0053917;C0439190;C0475211;C1334884,true;false;false;false,9409/10465
< nmbr . nmbr pmol / liter,C0053917;C0439192;C0475211;C1334884,true;false;false;false,9410/10465
age ( years ) - < median ( n = nmbr  nmbr ),C1510829;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false,9411/10465
age ( years ) - > = median ( n = nmbr  nmbr ),C1510829;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false,9412/10465
macrovascular disease  n ( % ),C0012634,true,9413/10465
microvascular disease  n ( % ),C0443258;C0012634,false;true,9414/10465
vorapaxar ( n = nmbr . nmbr ),C2974521;C0053917;C1334884,true;true;false,9415/10465
vorapaxar ( n = nmbr nmbr ),C2974521;C0053917;C1334884,true;true;false,9416/10465
vorapaxar ( n = nmbr  nmbr ),C2974521;C0053917;C1334884,true;true;false,9417/10465
risk difference,C0035647;C1705241;C1705242;C4552904,true;false;false;false,9418/10465
lsm difference,C1705241;C1705242,false;false,9419/10465
aspirin ( n = nmbr  nmbr ),C0004057;C0053917;C1334884,true;true;false,9420/10465
aspirin ( n = nmbr nmbr ),C0004057;C0053917;C1334884,true;true;false,9421/10465
rosuvastatin,C0965129,true,9422/10465
rosuvastatin +,C0965129,true,9423/10465
metformin use,C0025598;C0042153;C0457083;C1947944,true;true;false;false,9424/10465
no metformin use,C0025598;C0042153;C0457083;C1947944,true;true;false;false,9425/10465
copd severity  n ( % ) a,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,9426/10465
copd severity  n ( % ),C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,9427/10465
copd severity  n ( % ) *,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,9428/10465
prior revascularization,C0332152;C0581603;C2826257,false;false;false,9429/10465
pci revascularization,C4049621;C0581603,false;false,9430/10465
ldl - c : hdl - c,C3715113,false,9431/10465
ldl - c / hdl - c,C3715113,false,9432/10465
ldl - c / hdl - cx,C3715113,false,9433/10465
oral agents,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,9434/10465
two agents,C0205448;C0450442;C1254351;C1521826,false;false;false;false,9435/10465
ras agents,C0034678;C0450442;C1254351;C1521826;C0525678,true;false;false;false;true,9436/10465
mean ( sd ) fevnmbr ( l ) pre - bronchodilator,C0444504;C2699239;C2599602;C2347634;C2348143,false;false;false;false;false,9437/10465
mean ( sd ) fevnmbr ( l ) post - bronchodilator,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9438/10465
< nmbr years simva ( n = nmbr },C0053917;C0439234;C1334884,true;false;false,9439/10465
> nmbr years simva ( „ = nmbr },C0053917;C0439234;C1334884,true;false;false,9440/10465
bmi > nmbr kg / mnmbr,C0578022;C0053917;C0022718;C0439209;C4054209;C1334884,false;true;true;false;false;false,9441/10465
bmi < nmbr kg / mnmbr,C0578022;C0053917;C0022718;C0439209;C4054209;C1334884,false;true;true;false;false;false,9442/10465
bmi  xnmbr kg / mnmbr,C0578022;C0022718;C0439209;C4054209,false;true;false;false,9443/10465
bmi < nmbrkg / mnmbr,C0578022,false,9444/10465
bmi > = nmbrkg / mnmbr,C0578022,false,9445/10465
bmi  median ( sd )  kg / mnmbr,C0578022;C0549183;C2699239;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false,9446/10465
bmi  mean ( sd )  kg / mnmbr,C0578022;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;false;true;false;false;false;false,9447/10465
physical function,C0516981;C4049916,false;false,9448/10465
physical functioning,C0516981;C4049916,false;false,9449/10465
ldl - c ( mg / dl ),C0439269,false,9450/10465
hdl - c ( mg / dl ),C3715113;C0439269,false;false,9451/10465
hdl - c  mg / dl,C3715113;C0439269,false;false,9452/10465
ldl - c  mg / dl,C0439269,false,9453/10465
regular aspirin use,C0205272;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,9454/10465
no regular aspirin use,C0205272;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,9455/10465
> nmbr beats / min,C0053917;C1334884,true;false,9456/10465
< nmbr beats / min,C0053917;C1334884,true;false,9457/10465
antiplatelets,,,9458/10465
antiplatelet,,,9459/10465
characteristics,C1521970,false,9460/10465
characteristic,C1521970,false,9461/10465
hypokalemia,C0020621;C4553966,true;false,9462/10465
hvookalemia,,,9463/10465
hyperkalemiab,,,9464/10465
hungary,C0020174,true,9465/10465
surgery,C0038894;C0038895;C0543467;C1274039,false;true;true;true,9466/10465
baseline uacr < nmbr mg / g,C0168634;C0053917;C1300563;C1334884;C1442488,true;true;false;false;false,9467/10465
baseline uacr > nmbr mg / g,C0168634;C0053917;C1300563;C1334884;C1442488,true;true;false;false;false,9468/10465
insulin plus nmbr oral agent,C0021641;C0332287;C0053917;C0442027;C0450442;C1254351;C1521826;C4521986;C1334884;C1533581;C1579433;C3714501,true;false;true;false;false;false;false;false;false;false;false;false,9469/10465
insulin plus > nmbr oral agent,C0021641;C0332287;C0053917;C0442027;C0450442;C1254351;C1521826;C4521986;C1334884;C1533581;C1579433;C3714501,true;false;true;false;false;false;false;false;false;false;false;false,9470/10465
long - acting nitrates,C0205166;C0079613;C0028125;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;true;false;false;false,9471/10465
long acting nitratef,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,9472/10465
long - acting nitrate,C0205166;C0079613;C0028125;C0699857;C3848573;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;false;true;false;false;false,9473/10465
ischaemic aetiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,9474/10465
ischemic aetiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,9475/10465
systolic blood pressure  mean ( sd )  mm hga,C0488055;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;false;true;false;true;true,9476/10465
systolic blood pressure  mean ( sd )  mm hg,C0488055;C0444504;C2699239;C0439475;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,9477/10465
hscrp < nmbr . nmbr mg / l,C0053917;C0439268;C1334884,true;false;false,9478/10465
hscrp > nmbr . nmbr mg / l,C0053917;C0439268;C1334884,true;false;false,9479/10465
hscrp > nmbr . nmbr mga .,C0053917;C0065879;C1334884,true;true;false,9480/10465
hs - crp > nmbr . nmbr mg / l,C3890735;C0053917;C0439268;C1334884;C4048285,false;true;false;false;false,9481/10465
hs - crp < nmbr . nmbr mg / l,C3890735;C0053917;C0439268;C1334884;C4048285,false;true;false;false;false,9482/10465
hs - crp < nmbr . nmbr g / l,C3890735;C0053917;C0439294;C0456615;C1334884;C4048285,false;true;false;false;false;false,9483/10465
creatinine clearance  ml / min,C0812399;C0439445,false;false,9484/10465
creatine clearance  ml / min,C0373595;C0439445,false;false,9485/10465
creatinine clearance ( ml / min ),C0812399;C0439445,false;false,9486/10465
total cholesterolnmbr < nmbr mg / dl,C0439175;C0053917;C0439269;C1334884;C0439810,false;true;false;false;false,9487/10465
total cholesterolnmbr > nmbr mg / dl,C0439175;C0053917;C0439269;C1334884;C0439810,false;true;false;false;false,9488/10465
rosuvastatin  n ( rate ),C0965129;C0871208;C1521828,true;false;false,9489/10465
rosuvastatin n ( rate ) *,C0965129;C0871208;C1521828,true;false;false,9490/10465
rosuvastatin n ( rate ),C0965129;C0871208;C1521828,true;false;false,9491/10465
tiotropium / olodaterol nmbr / nmbr mg,C4032878;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9492/10465
tiotropium + olodaterol nmbr / nmbr mg,C4032878;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9493/10465
tiotropium + olodaterol nmbr / nmbr pg,C4032878;C0053917;C0030827;C0072225;C1266240;C1334884,true;true;true;true;false;false,9494/10465
diastolic blood pressure,C0428883;C1305849,true;false,9495/10465
diastolic blood pressure ,C0428883;C1305849,true;false,9496/10465
systolic blood pressure,C0488055;C0871470;C1306620,false;true;false,9497/10465
systolic blood pressure ,C0488055;C0871470;C1306620,false;true;false,9498/10465
cardiac failure *,C0018801;C0018802,true;true,9499/10465
cardiac failure §,C0018801;C0018802,true;true,9500/10465
cardiac failure,C0018801;C0018802,true;true,9501/10465
major cardiovascular event,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,9502/10465
major cardiovascular event *,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,9503/10465
major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,9504/10465
no concomitant immunosuppressive and / or prior anti - tnf use,C0521115;C0021081,false;true,9505/10465
concomitant immunosuppressive and / or prior anti - tnf use,C0521115;C0021081,false;true,9506/10465
triglycerides - mg / dl * *,C0041004;C0439269,true;false,9507/10465
triglycerides ( mg / dl ) * *,C0041004;C0439269,true;false,9508/10465
nmbr - nmbr months  n ( % ),C0053917;C0439231;C1334884,true;false;false,9509/10465
nmbr - < nmbr months  n ( % ),C0053917;C0439231;C1334884,true;false;false,9510/10465
received nmbr prior biologic therapies  n,C1514756;C0053917;C0278947;C1334884,false;true;false;false,9511/10465
received nmbr prior biologic therapy  n,C1514756;C0053917;C0278947;C1334884,false;true;false;false,9512/10465
immunosuppressants onlyff,C0021081,true,9513/10465
immunosuppressants only,C0021081;C0205171;C1720467,true;false;false,9514/10465
mtx > nmbr mg / week,C0025677;C0053917;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1417487,true;true;true;false;false;true;false;false;false;false;false;false;false,9515/10465
mtx £ nmbr mg / week,C0025677;C0053917;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1417487,true;true;true;false;false;true;false;false;false;false;false;false;false,9516/10465
active smoking,C0205177;C0037369;C0453996;C1881674;C3853793;C3888249,false;true;true;false;false;false,9517/10465
active smoker,C0205177;C0337664;C3853793;C3888249,false;true;false;false,9518/10465
cardiovascular risk factors  no . ( % ),C0850624,false,9519/10465
cardiovascular risk factors  n ( % ),C0850624,false,9520/10465
demographic,C0011298,true,9521/10465
demographics,C0011298;C1704791,true;false,9522/10465
demography,C0011298,true,9523/10465
no stroke ( n = nmbr ),C0038454;C0053917;C1334884;C4554100,true;true;false;false,9524/10465
any stroke ( n = nmbr ),C0038454;C0053917;C1334884;C4554100,true;true;false;false,9525/10465
left main,C0205091;C0205225;C1542147;C0443246;C1552822,false;false;false;false;false,9526/10465
back pain,C0004604;C1963071;C4553945,true;false;false,9527/10465
neck pain,C0007859;C1963180;C4553909,true;false;false,9528/10465
rest pain,C0234253,false,9529/10465
< nmbr mg / dl eze / simva,C0053917;C0439269;C1334884,true;false;false,9530/10465
> nmbr mg / dl eze / simva,C0053917;C0439269;C1334884,true;false;false,9531/10465
no st depression or elevation,C0520887,false,9532/10465
st depression or elevation,C0520887,false,9533/10465
medication use at baseline  n ( % ),C0240320;C0168634;C1442488,false;true;false,9534/10465
medications at baseline  n ( % ),C0013227;C0168634;C1442488;C0802604;C2598133;C4284232,true;true;false;false;false;false,9535/10465
history of atrial fibrillation or fl utter,C0729790,false,9536/10465
history of atrial fibrillation / flutter,C0729790;C0016385;C2242390;C1998417;C0232197,false;false;false;false;false,9537/10465
statin without other llt,C0360714;C2347090,true;false,9538/10465
statin with other llt,C0360714;C2347090,true;false,9539/10465
< qnmbr ( nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,9540/10465
> qnmbr ( nmbr ) — number / n ( % ),C0053917;C0237753;C0449788;C1334884,true;false;false;false,9541/10465
time from qualifying mi  %,C0040223;C1514624;C3810814;C3541383,true;false;false;false,9542/10465
time from qualifying mi  yrs,C0040223;C1514624;C3810814;C3541383,true;false;false;false,9543/10465
prior history of ml or ischemic stroke,C0332152;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;false;false;true;false;false;false;false;false,9544/10465
prior history of mi or ischaemic stroke,C0332152;C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;true;false;false;false;false;false,9545/10465
hazard ratio ( nmbr % confi dence interval ),C2985465;C0053917;C1272706;C1552654;C1552713;C1334884,false;true;false;false;false;false,9546/10465
hazard ratio ( nmbr % confidence interval ),C2985465;C0053917;C0009667;C1334884,false;true;true;false,9547/10465
hazard ratio ( nmbr % confidence interval ) *,C2985465;C0053917;C0009667;C1334884,false;true;true;false,9548/10465
with antiplatelets,,,9549/10465
without antiplatelets,,,9550/10465
range  ( min  max ),C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,9551/10465
range : min  max,C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,9552/10465
range ( min  max ),C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,9553/10465
aml nmbr mg / hctz nmbr mg,C0023465;C0053917;C1319635;C0020261;C1334884;C0023467,true;true;false;true;false;true,9554/10465
om nmbr mg / hctz nmbr mg,C0028971;C0053917;C1319635;C0020261;C1334884;C1705272,true;true;false;true;false;false,9555/10465
insulin therapy,C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,true;true;true;false;false;false;false,9556/10465
noninsulin therapy,C0039798;C0087111;C1363945,true;true;false,9557/10465
mean ± sd  n,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9558/10465
mean ± sd ( yr ),C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false,9559/10465
mean ± sd ( n ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9560/10465
stage nmbr : > nmbr ml / min / nmbr . nmbr mnmbr,C0205390;C0053917;C0439445;C1334884;C1300072;C1306673,false;true;false;false;false;false,9561/10465
stage nmbr : < nmbr ml / min / nmbr . nmbr mnmbr,C0205390;C0053917;C0439445;C1334884;C1300072;C1306673,false;true;false;false;false;false,9562/10465
median ( qnmbr  qnmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9563/10465
median ( qnmbr : qnmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9564/10465
bmi category ( % ),C0578022;C0683312;C3889287,false;false;false,9565/10465
age category ( % ),C0001779;C0683312;C3889287,false;false;false,9566/10465
supplementary oxygen,C0030054,true,9567/10465
supplemental oxygen,C4534306,false,9568/10465
fvc ( liters ),C3714541;C0475211,true;false,9569/10465
fvc — liters,C3714541;C0475211,true;false,9570/10465
> nmbr years of age,C0053917;C1510829;C1334884,true;false;false,9571/10465
< nmbr years of age,C0053917;C1510829;C1334884,true;false;false,9572/10465
$ nmbr exacerbations,C0053917;C4086268;C1334884,true;false;false,9573/10465
nmbr exacerbation,C0053917;C4086268;C1334884,true;false;false,9574/10465
> nmbr exacerbations,C0053917;C4086268;C1334884,true;false;false,9575/10465
nmbr exacerbations,C0053917;C4086268;C1334884,true;false;false,9576/10465
history of mi ( n = nmbr  nmbr ),C0019664;C3810814;C0053917;C1334884;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,9577/10465
no history of mi ( n = nmbr  nmbr ),C0019664;C3810814;C0053917;C1334884;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,9578/10465
vka therapy,C0039798;C0087111;C1363945,true;true;false,9579/10465
dual therapy,C0205173;C0039798;C0087111;C1363945;C1554184,false;true;true;false;false,9580/10465
egfr  mean ( sd )  ml / min / nmbr . nmbr mnmbr,C1739039;C0444504;C2699239;C0439445;C0053917;C1334884;C2347634;C2348143;C3811844;C3812682,true;false;false;false;true;false;false;false;false;false,9581/10465
egfr  mean = sd  ml / min / nmbr . nmbr mnmbr,C1739039;C0444504;C2699239;C0439445;C0053917;C1334884;C2347634;C2348143;C3811844;C3812682,true;false;false;false;true;false;false;false;false;false,9582/10465
nt - probnp ， pmol / h,C0669479;C0439192;C0033727;C0369286;C0441932;C0564385;C4528284;C0754710,true;false;true;false;false;false;false;true,9583/10465
nt - probnp  pmol / l^,C0669479;C0439284;C0754710,true;false;true,9584/10465
nt - probnp  pmol / l,C0669479;C0439284;C0754710,true;false;true,9585/10465
antihypertensive,C0003364,true,9586/10465
antihypertensives,C0003364,true,9587/10465
gender  n ( % ) male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,9588/10465
gender  n [ % ] male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,9589/10465
ldl - c ( mmol / l  mean ),C1532563;C0444504;C2347634;C2348143,false;false;false;false,9590/10465
hdl - c ( mmol / l  mean ),C3715113;C1532563;C0444504;C2347634;C2348143,false;false;false;false;false,9591/10465
all patients ( « = nmbr nmbr ),C0030705;C0053917;C1334884,true;true;false,9592/10465
all patients ( n = nmbr  nmbr ),C0030705;C0053917;C1334884,true;true;false,9593/10465
eastern europe ( % ),C0015177,true,9594/10465
western europe ( % ),C0043129,true,9595/10465
om nmbrmg / aml nmbr mg,C0028971;C0023465;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;false;true;false,9596/10465
om nmbr mg / aml nmbr mg,C0028971;C0053917;C1319635;C0023465;C0023467;C1334884;C1705272,true;true;false;true;true;false;false,9597/10465
ischaemic heart disease,C0010054;C0151744,true;true,9598/10465
ischemic heart disease,C0010054;C0151744,true;true,9599/10465
hbanmbrc  mean ( sd )  %,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9600/10465
hbanmbrc  mean = sd  %,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9601/10465
hbanmbrc  median ( sd )  %,C0549183;C2699239;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9602/10465
asia pacific,C0003980,true,9603/10465
asia - pacific,C0003980,true,9604/10465
asia / pacific,C0003980,true,9605/10465
previous coronary revascularization,C0205156;C0877341;C1552607,false;false;false,9606/10465
previous coronary revascularisation,C0205156;C0877341;C1552607,false;false;false,9607/10465
corticosteroid use at baseline - no,C0239126;C0168634;C1442488,false;true;false,9608/10465
corticosteroid use at baseline - yes,C0239126;C0168634;C1549445;C1705108;C1710701;C1442488,false;true;false;false;false;false,9609/10465
fevnmbr reversibility  % *,C0449261,false,9610/10465
fevnmbr reversibility  % b,C0449261,false,9611/10465
serum triglycerides — mmol / liter,C0542495;C0439190;C0475211,false;false;false,9612/10465
serum triglycerides — pmol / liter,C0542495;C0439192;C0475211,false;false;false,9613/10465
angina pectoris,C0002962,true,9614/10465
angina pectoris 本,C0002962,true,9615/10465
angina pectoris *,C0002962,true,9616/10465
angina pectorisf,C0002962,true,9617/10465
alc > = nmbr . nmbr %,C1424945;C0053917;C1334884;C3811058,false;true;false;false,9618/10465
alc < nmbr . nmbr %,C1424945;C0053917;C1334884;C3811058,false;true;false;false,9619/10465
major bleeding,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,9620/10465
minor bleeding,C0026193;C0019080;C0205165,true;true;false,9621/10465
a from baselineb,,,9622/10465
a from baseline,C0168634;C1442488,true;false,9623/10465
bmi : < nmbr . nmbr kg / mnmbr,C0578022;C0053917;C0022718;C0439209;C4054209;C1334884,false;true;true;false;false;false,9624/10465
bmi : > nmbr . nmbr kg / mnmbr,C0578022;C0053917;C0022718;C0439209;C4054209;C1334884,false;true;true;false;false;false,9625/10465
mayo score  mean ( sd ),C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578,false;false;false;false;false;false;false;false,9626/10465
mayo score ( mean ± sd ),C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578,false;false;false;false;false;false;false;false,9627/10465
total ( n = nmbr nmbr ),C0439175;C0053917;C1334884;C0439810,false;true;false;false,9628/10465
total  n = nmbr nmbr,C0439175;C0053917;C1334884;C0439810,false;true;false;false,9629/10465
total ( n = nmbr  nmbr ),C0439175;C0053917;C1334884;C0439810,false;true;false;false,9630/10465
> median ( nmbr . nmbr years ) — number / n ( % ),C0549183;C0053917;C0439234;C0237753;C0449788;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,9631/10465
< median ( nmbr . nmbr years ) — number / n ( % ),C0549183;C0053917;C0439234;C0237753;C0449788;C1334884;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,9632/10465
difference vs placebo * *,C1705241;C1705242,false;false,9633/10465
difference vs placebo ',C1705241;C1705242,false;false,9634/10465
difference vs . placebo,C1705241;C1705242,false;false,9635/10465
difference vs placebo,C1705241;C1705242,false;false,9636/10465
avm % △ ( se ),C0003857;C0036919;C0279476,true;true;false,9637/10465
met % △ ( se ),C0428210;C0036919;C1550543;C4317104,false;true;false;false,9638/10465
chronic kidney diseased,C2364010,false,9639/10465
chronic kidney disease,C1561643;C4553188,true;false,9640/10465
estimated difference %,C0750572;C1705241;C1705242,false;false;false,9641/10465
estimated difference,C0750572;C1705241;C1705242,false;false;false,9642/10465
u . s . site,C0041703;C0205145;C1515974;C2825164,true;false;false;false,9643/10465
u . s . sites,C0041703;C0205145,true;false,9644/10465
history of diabetes ( n = nmbr ),C0019664;C0011847;C0053917;C1334884;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;true;false;false;false;false,9645/10465
no history of diabetes ( n = nmbr ),C0019664;C0011847;C0053917;C1334884;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;true;false;false;false;false,9646/10465
< nmbr months  median ( min  max ),C0053917;C0439231;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C1334884,true;false;false;false;false;false;false;false;false;false;false,9647/10465
> nmbr months  median ( min  max ),C0053917;C0439231;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C1334884,true;false;false;false;false;false;false;false;false;false;false,9648/10465
posterior circulation,C0205095;C0005775;C1516559,false;true;false,9649/10465
anterior circulation,C0205094;C0005775;C1516559,false;true;false,9650/10465
insulin yes,C0021641;C1549445;C1705108;C1710701;C1533581;C1579433;C3714501,true;false;false;false;false;false;false,9651/10465
insulin use,C0240016,false,9652/10465
insulin based,C0021641;C1533581;C1579433;C3714501,true;false;false;false,9653/10465
non - black race and ss > nmbr ( n = nmbr vs nmbr ),C1518422;C0005680,false;true,9654/10465
non - black race and ss < nmbr ( n = nmbr vs nmbr ),C1518422;C0005680,false;true,9655/10465
family history of diabetes ( % ) *,C1313937,false,9656/10465
family history of diabetes ( - ),C1313937,false,9657/10465
family history of diabetes ( + ),C1313937,false,9658/10465
duration of diabetes  years,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9659/10465
duration ofdiabetes — yr,C0449238;C0439234;C2926735,false;false;false,9660/10465
duration of diabetes ( years ),C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9661/10465
duration of diabetes — yr,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9662/10465
duration of diabetes  yrs,C0449238;C0011847;C0011849;C2926735,false;false;true;false,9663/10465
duration of diabetes ( y ),C0449238;C0011847;C0011849;C2926735,false;false;true;false,9664/10465
duration of diabetes ( years ) t,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9665/10465
duration diabetes ( years ),C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9666/10465
at index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,9667/10465
index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,9668/10465
moderate ckd,C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,9669/10465
moderate ’,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,9670/10465
moderatey,,,9671/10465
no moderate ckd,C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,9672/10465
moderate,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,9673/10465
weight < nmbr . nmbr kg  n,C0005910;C0053917;C0022718;C0439209;C4054209;C1334884;C0043100;C1305866;C1705104,true;true;true;false;false;false;true;false;false,9674/10465
weight $ nmbr . nmbr kg  n,C0005910;C0053917;C0022718;C0439209;C4054209;C1334884;C0043100;C1305866;C1705104,true;true;true;false;false;false;true;false;false,9675/10465
history of microvascular disease,C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,9676/10465
history of macrovascular disease,C0683519;C0730226;C0850708;C0944983,false;false;false;false,9677/10465
disease duration  years,C0872146;C0439234,false;false,9678/10465
disease duration ( years ),C0872146;C0439234,false;false,9679/10465
disease duration ( yr ),C0872146;C0439234,false;false,9680/10465
glycated hemoglobin  nonstandardized level — %,C0202054,false,9681/10465
glycated hemoglobin  standardized level — %,C0017853,true,9682/10465
baseline characteristics,C4684572,false,9683/10465
baseline characteristic,C0168634;C1442488,true;false,9684/10465
patients without chronic,C0030705;C0205191,true;false,9685/10465
patients with chronic,C0030705;C0205191,true;false,9686/10465
baseline egfr < nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false,9687/10465
baseline egfr < nmbr ml / min / nmbr . nmbr mnmbrc,C0168634;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false,9688/10465
baseline egfr > nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false,9689/10465
ldl - c  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9690/10465
tchdl - c  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9691/10465
hdl - c  mean ( sd ),C3715113;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,9692/10465
symptomatic pad,C0231220;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false;false,9693/10465
symptomatic padt,C0231220,false,9694/10465
statin during admission,C0360714;C0184666;C0809949,true;false;false,9695/10465
no statin during admission,C0360714;C0184666;C0809949,true;false;false,9696/10465
rosuvastatin events / patients ( % ),C0965129;C0441471;C0030705;C3541888,true;false;true;false,9697/10465
rosuvastatin  events / patients ( % ),C0965129;C0441471;C0030705;C3541888,true;false;true;false,9698/10465
average weekly mtx dose ( mg / week ),C1510992;C0332174;C0366550;C0024671;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;true;false;false;false;false;false;false,9699/10465
average weekly mtx dose ( mg / week ) t,C1510992;C0332174;C0366550;C0024671;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;true;false;false;false;false;false;false,9700/10465
all teaes *,,,9701/10465
all teaes,,,9702/10465
mild teaes,C2945599,false,9703/10465
sbp  mean ± sd ( mmhg ),C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,9704/10465
dbp  mean ± sd ( mmhg ),C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,9705/10465
death ( all - cause ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,9706/10465
death ( all cause ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,9707/10465
qnmbr : > nmbr . nmbr kg ( n = nmbrvsnmbr ),C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,9708/10465
qnmbr : < nmbr . nmbr kg ( n = nmbrvsnmbr ),C0053917;C0022718;C0439209;C4054209;C1334884,true;true;false;false;false,9709/10465
> = nmbr years ( placebo n = nmbr  nmbr  saxagliptin n = nmbr  nmbr ),C0053917;C0439234;C0032042;C1611934;C1696465;C1706408;C1334884,true;false;true;true;false;false;false,9710/10465
< nmbr years ( placebo n = nmbr  nmbr  saxagliptin n = nmbr  nmbr ),C0053917;C0439234;C0032042;C1611934;C1696465;C1706408;C1334884,true;false;true;true;false;false;false,9711/10465
without psoriasis ( zi = nmbr  nmbr ),C0033860;C0043476;C0053917;C1334884,true;true;true;false,9712/10465
without psoriasis ( n = nmbr  nmbr ),C0033860;C0053917;C1334884,true;true;false,9713/10465
heart rate > nmbr bpm,C0018810;C0053917;C1334884,true;true;false,9714/10465
heart rate < nmbr bpm,C0018810;C0053917;C1334884,true;true;false,9715/10465
inferior,C0542339;C0678975,false;false,9716/10465
non - anterior,C1518422;C0205094,false;false,9717/10465
nonanterior,,,9718/10465
not anterior,C1518422;C0205094,false;false,9719/10465
anterior,C0205094,false,9720/10465
hyperlipidaemia,C0020473;C0428465;C4555212,true;false;false,9721/10465
hyperlipidemia,C0020473;C0428465;C4555212,true;false;false,9722/10465
hyperlipidemia^,C0020473;C0428465;C4555212,true;false;false,9723/10465
left - sided colitisz,C0205091;C0443246,false;false,9724/10465
left sided colitis,C2887821,false,9725/10465
left - sided colitis,C2887821,false,9726/10465
nadroparin ( n = nmbr ),C0206232;C0053917;C1334884,true;true;false,9727/10465
no nadroparin ( n = nmbr ),C0206232;C0053917;C1334884,true;true;false,9728/10465
social functioning,C0037395,true,9729/10465
social function,C0037395,true,9730/10465
eze / simva,,,9731/10465
ez / simva,C0206578,true,9732/10465
aniagonisi,,,9733/10465
antagonist,C0231491,false,9734/10465
all - cause death n,C0015127;C0011065;C1306577;C4082313;C4552775;C1524003,true;true;false;false;false;false,9735/10465
all - cause death,C0015127;C0011065;C1306577;C4082313;C4552775;C1524003,true;true;false;false;false;false,9736/10465
family history of cancera,C0241889,true,9737/10465
family history of cancerf,C0241889,true,9738/10465
indacaterol nmbr mg,C1722260;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9739/10465
indacaterol nmbr pg,C1722260;C0053917;C0030827;C0072225;C1266240;C1334884,true;true;true;true;false;false,9740/10465
p  regional difference,C0369773;C0682132;C2603361,false;false;false,9741/10465
p  regional difference *,C0369773;C0682132;C2603361,false;false;false,9742/10465
liraglutide nmbr . nmbr mg  n = nmbr,C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9743/10465
liraglutide nmbr . nmbr mg n = nmbr,C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9744/10465
liraglutide nmbr - nmbr mg ( n = nmbr ),C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9745/10465
liraglutide nmbr . nmbr mg ( n = nmbr ),C1456408;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9746/10465
fevnmbr pre - bronchodilator,C2599602,false,9747/10465
fevnmbr post - bronchodilator,,,9748/10465
ace inhibitors / arbs  n ( % ),C0003015;C3888198,true;false,9749/10465
ace - inhibitors / arbs  n ( % ),C0003015;C3888198,true;false,9750/10465
increase creatinine  < nmbr . nmbr mg / dl,C0442805;C0010294;C0053917;C0439269;C1334884;C1561535,false;true;true;false;false;false,9751/10465
increase creatinine  > nmbr . nmbr mg / dl,C0442805;C0010294;C0053917;C0439269;C1334884;C1561535,false;true;true;false;false;false,9752/10465
> nmbr . nmbr ( % ),C0053917;C1334884,true;false,9753/10465
< nmbr . nmbr ( % ),C0053917;C1334884,true;false,9754/10465
baseline lipid and lipoprotein values,C0168634;C0023779;C1442488,true;true;false,9755/10465
baseline lipid / lipoprotem values,C0168634;C0023779;C0042295;C1442488,true;true;false;false,9756/10465
baseline lipid / lipoprotein values,C0168634;C0443602;C0042295;C1442488,true;false;false;false,9757/10465
previous stroke *,C0205156;C0038454;C4554100;C1552607,false;true;false;false,9758/10465
previous stroke,C0205156;C0038454;C4554100;C1552607,false;true;false;false,9759/10465
hypertension — no . ( % ),C0020538;C1963138,true;false,9760/10465
hypertension — no . ( % ) |,C0020538;C1963138,true;false,9761/10465
overall ( n = unmbr ),C0282416;C1561607,true;false,9762/10465
overall ( n = nmbr ),C0282416;C0053917;C1334884;C1561607,true;true;false;false,9763/10465
history of diabetes :,C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9764/10465
history of diabetes,C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9765/10465
beta - blockers  n ( % ),C0001645,true,9766/10465
beta - blockers  ( % ),C0001645,true,9767/10465
history of hypertension *,C0455527,false,9768/10465
history of hypertension,C0455527,false,9769/10465
ischemic heart disease  ( % ),C0010054;C0151744,true;true,9770/10465
ischemic heart disease  n ( % ),C0010054;C0151744,true;true,9771/10465
ischaemic heart disease  n ( % ),C0010054;C0151744,true;true,9772/10465
patients receiving enl  no . ( % ),C0030705,true,9773/10465
patients receiving lcz  no . ( % ),C0030705,true,9774/10465
urinary albumin : creatinine ratioa ( mg / g ),C0455271;C1300563;C1318330,false;false;false,9775/10465
urinary albumin : creatinine ratio ( mg / g ),C0455271;C1300563;C1318330,false;false;false,9776/10465
indian ( american ) or alaska native,C1524069;C0596070,false;false,9777/10465
indian ( american ) or alaskan native,C1524069;C0596070,false;false,9778/10465
saxagliptin nmbr mg,C1611934;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9779/10465
saxagliptin nmbrmg,C1611934,true,9780/10465
mssbp < nmbrmmhg,,,9781/10465
mssbp > nmbrmmhg,,,9782/10465
infarct localisation,C0021308;C0475264;C1744691,true;false;false,9783/10465
infarct localization,C0021308;C0475264;C1744691,true;false;false,9784/10465
placebo group ( n = nmbr ),C0032042;C0441848;C0053917;C1334884;C1696465;C1706408,true;false;true;false;false;false,9785/10465
placebo group ( n = nmbr ) f,C0032042;C0441848;C0053917;C0016327;C1334884;C1696465;C1706408,true;false;true;true;false;false;false,9786/10465
sjc ( nmbr joints ),C0053917;C0022417;C0392905;C1334884,true;true;false;false,9787/10465
sjc ( / nmbr joints ),C0053917;C0022417;C0392905;C1334884,true;true;false;false,9788/10465
tjc ( / nmbr joints ),C0053917;C0022417;C0392905;C1334884,true;true;false;false,9789/10465
tjc ( nmbr joints ),C0053917;C0022417;C0392905;C1334884,true;true;false;false,9790/10465
oral anticoagulants,C0354604,false,9791/10465
oral anticoagulant,C0354604,false,9792/10465
ischemia,C0022116;C4321499,true;false,9793/10465
ischaemic,C0475224,false,9794/10465
disease characteristics,C0599878,false,9795/10465
disease characteristics *,C0599878,false,9796/10465
nyha functional class,C1882083;C0205245;C0542341;C2700217,false;false;false;false,9797/10465
ara functional class,C0325983;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C2316832;C3890184;C4282437;C4321455,false;false;false;false;false;false;false;false;false;false;false,9798/10465
teaes ( > nmbr % in any treatment group ) *,C0053917;C0374505;C1334884,true;false;false,9799/10465
teaes ( > nmbr % in any treatment group ),C0053917;C0374505;C1334884,true;false;false,9800/10465
history myocardial infarction,C0155668;C1275835,false;false,9801/10465
history of myocardial infarction,C1275835,false,9802/10465
acq - nmbr score *,C2919686;C0053917;C0449820;C4050231;C1334884,false;true;false;false;false,9803/10465
npi - nmbr score *,C1412208;C0053917;C0449820;C4050231;C1334884;C1549728;C3539727,false;true;false;false;false;false;false,9804/10465
acq - nmbr scoret,C2919686;C0053917;C1334884,false;true;false,9805/10465
nmbr - h ppg ( mmol / l ),C0053917;C2827804;C1418888;C1334884,true;false;false;false,9806/10465
nmbr - h ppg ( mmol / l ) *,C0053917;C2827804;C1418888;C1334884,true;false;false;false,9807/10465
nmbr - h pg ( mmol / l ),C0053917;C2827798;C0439190;C2827804;C0030827;C0072225;C1266240;C1334884,true;false;false;false;true;true;false;false,9808/10465
fvc post - bronchodilator,C3714541,true,9809/10465
fvc pre - bronchodilator,C3714541;C2599602,true;false,9810/10465
baseline su dose < nmbr / nmbr maximal,C0168634;C0038642;C0178602;C0053917;C1334884;C0869039;C1114758;C1705534;C1442488,true;true;false;true;false;false;false;false;false,9811/10465
baseline su dose > nmbr / nmbr maximal,C0168634;C0038642;C0178602;C0053917;C1334884;C0869039;C1114758;C1705534;C1442488,true;true;false;true;false;false;false;false;false,9812/10465
mean sd ldl - c  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,9813/10465
mean sd hdl - c  mg / dl,C0444504;C2699239;C3715113;C0439269;C2347634;C2348143,false;false;false;false;false;false,9814/10465
laa closure,C0185003;C1521802,false;false,9815/10465
pfo closure,C0185003;C1521802,false;false,9816/10465
cdai < nmbr . nmbr *,C0683448;C0053917;C1334884;C1413248;C3273706,false;true;false;false;false,9817/10465
sdai < nmbr . nmbr *,C3871128;C0053917;C1334884,false;true;false,9818/10465
nyha class — no . ( % ) $,C1882083,false,9819/10465
nyha class — no . ( % ),C1882083,false,9820/10465
drug - eluting,C0013227;C1254351,true;false,9821/10465
drug eluting,C0013227;C1254351,true;false,9822/10465
homa - p,,,9823/10465
homa - ir,C0022065;C0022071;C1448132,true;true;true,9824/10465
no . of patients with psa,C0030705,true,9825/10465
no . of patients with ra,C0030705,true,9826/10465
no . of patients with as,C0030705,true,9827/10465
ng ( n = nmbr  nmbr ),C0017887;C0053917;C1334884;C0028074,true;true;false;true,9828/10465
no ( n = nmbr  nmbr ),C0369718;C0053917;C1334884;C0441922,false;true;false;false,9829/10465
nmbr ( n = nmbr  nmbr ),C0053917;C1334884,true;false,9830/10465
sf - nmbrvnmbr mcs  mean [sd],C0037712;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,9831/10465
sf - nmbrvnmbr pcs  mean [sd],C0037712;C1864389;C0444504;C2699239;C2347634;C2348143;C1882368,true;false;false;false;false;false;true,9832/10465
regular ppi use,C0205272;C0358591;C0871125;C3811894,false;true;true;false,9833/10465
no regular ppi use,C0205272;C0358591;C0871125;C3811894,false;true;true;false,9834/10465
hospitalization for acs,C0019993;C0742343;C4318612,true;true;false,9835/10465
hospitalization for,C0019993,true,9836/10465
hospitalization for hf,C0019993;C0018488;C1313497;C1538440;C3273279,true;true;true;false;false,9837/10465
pbo + mtx to mtx,C0031962;C0025677;C1417487,true;true;false,9838/10465
czp + mtx to mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,9839/10465
tg  mg / dl  mean ± sd,C0337445;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,9840/10465
tc  mg / dl  mean ± sd,C0039411;C0439269;C0444504;C2699239;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;true;true;true;false;false;false,9841/10465
tc  mg / dl  mean + sd,C0039411;C0439269;C0444504;C2699239;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;true;true;true;false;false;false,9842/10465
aiirocumab,,,9843/10465
alirocumab,C3491162,true,9844/10465
hispanic or latino ethnic groupf,C0086409,true,9845/10465
hispanic or latino ethnic group !,C0086409,true,9846/10465
hispanic or latino ethnic groupb,C0086409,true,9847/10465
hispanic or latino ethnic group *,C0086409,true,9848/10465
prior aspirin,C0332152;C0004057;C2826257,false;true;false,9849/10465
no prior aspirin,C0332152;C0004057;C2826257,false;true;false,9850/10465
medication  n ( % ),C0013227;C3244316;C4284232,true;false;false,9851/10465
medications  n ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,9852/10465
medication — no . ( % ),C0013227;C3244316;C4284232,true;false;false,9853/10465
medications . no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,9854/10465
medications  no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,9855/10465
eze + statin n = nmbr,C0360714;C0053917;C1334884,true;true;false,9856/10465
pbo + statin n = nmbr,C0031962;C0360714;C0053917;C1334884,true;true;true;false,9857/10465
incidence *,C0021149;C0220856,true;true,9858/10465
incidence  %,C0021149;C0220856,true;true,9859/10465
incidencea,,,9860/10465
asia  pacific and other,C0003980,true,9861/10465
asia pacific or other,C0003980,true,9862/10465
asia pacific and other,C0003980,true,9863/10465
apo b : apo a - i ratio,C0003593;C0085201;C0456603;C1547037;C1677784;C3252643,true;true;false;false;true;true,9864/10465
apob : apoal ratio,C0003593;C0456603;C1547037;C3252643,true;false;false;true,9865/10465
apob : apoa - l ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,9866/10465
saxa + met n = nmbr,,,9867/10465
dapa + met n = nmbr,,,9868/10465
patients with uncomplicated events,C0030705;C0443334;C0441471;C3541888,true;false;false;false,9869/10465
patients with complicated events,C0030705;C0231242;C0441471;C3541888,true;false;false;false,9870/10465
sf - nmbr mcs  mean ± sd,C0037712;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884,true;true;false;false;false;false;false,9871/10465
sf - nmbr pcs  mean ± sd,C0037712;C0053917;C1864389;C0444504;C2699239;C2347634;C2348143;C1882368;C1334884,true;true;false;false;false;false;false;true;false,9872/10465
systolic blood pressure subgroups,C0488055;C1079230;C0871470;C1306620,false;false;true;false,9873/10465
diastolic blood pressure subgroups,C0428883;C1079230;C1305849,true;false;false,9874/10465
losartan  n / n ( % ),C0126174,true,9875/10465
valsartan  n / n ( % ),C0216784,true,9876/10465
persistent,C0205322;C0332996,false;false,9877/10465
persistent af,C0205322;C0344434;C4049859;C0332996,false;false;false;false,9878/10465
ukpds nmbr - year risk score < nmbr %,C0053917;C0439234;C0035647;C0449820;C4050231;C4552904;C0439508;C1334884,true;false;true;false;false;false;false;false,9879/10465
ukpds nmbr - year risk score > nmbr %,C0053917;C0439234;C0035647;C0449820;C4050231;C4552904;C0439508;C1334884,true;false;true;false;false;false;false;false,9880/10465
sirolimus - eluting,C0072980,true,9881/10465
everolimus - eluting,C0541315,true,9882/10465
immunosuppressants,C0021081,true,9883/10465
immunosuppressant^^,C0021081,true,9884/10465
hdl - c  mg / dl  mean ± sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,9885/10465
ldl - c  mg / dl  mean + sd,C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,9886/10465
ldl - c  mg / dl  mean ± sd,C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,9887/10465
hdl - c  mg / dl  mean + sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,9888/10465
medication use,C0240320,false,9889/10465
medication,C0013227;C3244316;C4284232,true;false;false,9890/10465
education *,C0013621;C0013622;C0013658;C0039401,true;true;true;true,9891/10465
medications *,C0013227;C0802604;C2598133;C4284232,true;false;false;false,9892/10465
medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,9893/10465
sgrq total score * ( units ),C2964552;C0439148;C1519795;C3853603,false;false;false;false,9894/10465
sgrq total score  units,C2964552;C0439148;C1519795;C3853603,false;false;false;false,9895/10465
sgrq total score ( units ),C2964552;C0439148;C1519795;C3853603,false;false;false;false,9896/10465
weight  median ( sd )  kg,C0005910;C0549183;C2699239;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;false;false;true;false;false,9897/10465
weight  mean ( sd ) kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,9898/10465
weight  median ( iqr )  kg,C0005910;C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;true;false;false;false;false;false;false;true;false;false,9899/10465
weight  mean ( sd )  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,9900/10465
diclofenac nmbr mg ( n nmbr nmbr )  . . . n . . ( . % . . ) . . . . . . . . . . . .,C0012091;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9901/10465
diclofenac nmbr mg ( n nmbr nmbr )  . . . n . . ( . % . . ) . . . . . . . . . . .,C0012091;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,9902/10465
total no .,C0439175;C0439810,false;false,9903/10465
total body,C0229960,false,9904/10465
ind / gly ( n = nmbr ),C4049864;C0017890;C0053917;C1334884;C0523677,false;true;true;false;false,9905/10465
ind + pbo ( n = nmbr ),C4049864;C0031962;C0053917;C1334884,false;true;true;false,9906/10465
ind + gly ( n = nmbr ),C4049864;C0017890;C0053917;C1334884;C0523677,false;true;true;false;false,9907/10465
score of $ nmbr  no . ( % ),C0449820;C0053917;C1334884;C4050231,false;true;false;false,9908/10465
score of # nmbr  no . ( % ),C0449820;C0053917;C1334884;C4050231,false;true;false;false,9909/10465
body - mass index ( kg / m ' ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,9910/10465
body - mass index ( kg / m - ) !,C0005893;C1532718;C0578022;C1305855,false;false;false;true,9911/10465
body - mass index ( kg / m - ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,9912/10465
time to treatment initiation ( min ,C3494202;C0589507;C0702093;C1524029;C3813700;C1158830;C1704686,true;false;false;false;false;false;false,9913/10465
time to treatment initiation ( min ),C3494202;C0589507;C0702093;C1524029;C3813700;C1158830;C1704686,true;false;false;false;false;false;false,9914/10465
patients with microalbuminuria at baseline,C0030705;C0730345,true;false,9915/10465
patients with macroalbuminuria at baseline,C0030705,true,9916/10465
atrial fibrillation !,C0004238;C0344434;C1963067,true;false;false,9917/10465
atrial fibrillation  %,C0004238;C0344434;C1963067,true;false;false,9918/10465
atrial fibrillation,C0004238;C0344434;C1963067,true;false;false,9919/10465
atrial fibrillation ( % ),C0004238;C0344434;C1963067,true;false;false,9920/10465
prior tnf antagonist treatment - no,C1514463;C1448177;C0231491,false;true;false,9921/10465
prior tnf antagonist treatment - yes,C1514463;C1448177;C0231491;C1549445;C1705108;C1710701,false;true;false;false;false;false,9922/10465
pt baseline ( week nmbr ),C0032743;C0168634;C0332174;C0053917;C1334884;C0439230;C1442488;C0699718,true;true;false;true;false;false;false;false,9923/10465
db baseline ( week nmbr ),C1418892;C0168634;C0332174;C0053917;C1334884;C0439230;C1442488,false;true;false;true;false;false;false,9924/10465
odds ratio ( nmbr % ci ),C0028873;C0053917;C0008107;C3259781;C1334884,true;true;true;false;false,9925/10465
odds ratio ( nmbr % cl ),C0028873;C0053917;C0596019;C1334884,true;true;false;false,9926/10465
ethnicity  n ( % ),C0015031;C0243103,true;true,9927/10465
ethnicity  no . ( % ),C0015031;C0243103,true;true,9928/10465
ethnicity - no . ( % ),C0015031;C0243103,true;true,9929/10465
pacemaker  n ( % ),C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,9930/10465
pacemaker  ( % ),C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,9931/10465
physical examination,C0031809;C1744699,true;false,9932/10465
physical examinations,C0031809,true,9933/10465
ileum and colon,C0020885,true,9934/10465
ileum or colon,C0020885,true,9935/10465
killip class > ii ( % ),C2697845,false,9936/10465
killip class  n ( % ),C1881332,false,9937/10465
qrs < nmbr msec,C0053917;C0439223;C1334884,true;false;false,9938/10465
qrs > nmbr ms *,C0053917;C2349943;C3539704;C3713294;C1334884,true;false;false;true;false,9939/10465
hbanmbrc  %  mean ( sd ) b,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9940/10465
hbanmbrc  %  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9941/10465
hbanmbrc  %  mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9942/10465
< nmbr % blood eosinophils at baseline,C0053917;C0014467;C0168634;C1442488;C1334884,true;true;true;false;false,9943/10465
> nmbr % blood eosinophils at baseline,C0053917;C0014467;C0168634;C1442488;C1334884,true;true;true;false;false,9944/10465
czp nmbr mg ( n nmbr ),C0054841;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1861828;C1872109,true;true;true;true;false;false;false;false;false;false;true;true,9945/10465
czp nmbr mg ( nnmbr ),C0054841;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884;C1861828;C1872109,true;true;true;true;false;false;false;false;false;false;true;true,9946/10465
age ( median  iqr )  y,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9947/10465
age  median ( iqr )  y,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9948/10465
atrial fibrillation / flutter,C0155709,false,9949/10465
atrial fibrillation or flutter,C0004238;C0344434;C1963067,true;false;false,9950/10465
metformin,C0025598,true,9951/10465
no metformin,C0025598,true,9952/10465
q wave,C0429089;C1305738,false;false,9953/10465
q wave mi,C0861151,false,9954/10465
q - wave mi,C0861151,false,9955/10465
hand fracture,C0435632,false,9956/10465
hip fracture,C0019557;C0149531;C4552776,true;false;false,9957/10465
canagliflozin ( n = nmbr ),C2974540;C0053917;C1334884,true;true;false,9958/10465
empagliflozin ( n = nmbr ),C3490348;C0053917;C1334884,true;true;false,9959/10465
smoking history,C1519384,false,9960/10465
smoking history ,C1519384,false,9961/10465
post - bronchodilator fevnmbr / fvc  %,C2599594;C3714541,false;true,9962/10465
postbronchodilator fevnmbr / fvc  %,C2599594;C3714541,false;true,9963/10465
smoker ( % ),C0337664,true,9964/10465
smoker ( % ) a,C0337664,true,9965/10465
ast  u / l,C1415181;C0439339;C3891303,false;false;false,9966/10465
alt  u / l,C1266129;C0439339;C4553172,false;false;false,9967/10465
non - hdl - c  mmol / l,C1518422;C3715113;C1532563,false;false;false,9968/10465
non - hdl - c ( mmol / l ),C1518422;C3715113;C1532563,false;false;false,9969/10465
menopause and ht,C0025320;C0567312,true;false,9970/10465
menopause and hrt,C0025320;C0567312,true;false,9971/10465
minimum - maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,9972/10465
minimum : maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,9973/10465
patients < nmbr %,C0030705;C0053917;C1334884,true;true;false,9974/10465
patients > nmbr %,C0030705;C0053917;C1334884,true;true;false,9975/10465
women ( n = nmbr vs nmbr ),C0043210;C0053917;C1334884,true;true;false,9976/10465
men ( n = nmbr vs nmbr ),C0025266;C0053917;C1334884,true;true;false,9977/10465
men ( n = nmbr nmbr ),C0025266;C0053917;C1334884,true;true;false,9978/10465
diastolic — mean ( sd ) ( mm hg ),C0012000;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,9979/10465
systolic — mean ( sd ) ( mm hg ),C0039155;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,9980/10465
active cancer,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,9981/10465
no active cancer,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,9982/10465
ac tve cancer,C0001246;C0006826;C0998265;C1306459;C0003354;C1412573;C2000891;C3539770,true;true;false;false;true;false;true;false,9983/10465
physical activity  kcal / wk,C0015259;C0439259;C0332174;C0439230;C0026606,true;false;false;false;true,9984/10465
physical activity  kcal / wk *,C0015259;C0439259;C0332174;C0439230;C0026606,true;false;false;false;true,9985/10465
loop or thiazide diuretic,C0445022,false,9986/10465
loop or thiazide diuretic #,C0445022,false,9987/10465
alcohol use  drinks / wk,C0001948,true,9988/10465
alcohol use  drinks / wk *,C0001948,true,9989/10465
total population,C3258257,false,9990/10465
total population n,C3258257,false,9991/10465
interruption ( n = nmbr ),C0332453;C0053917;C1334884;C1512900,false;true;false;false,9992/10465
intervention ( n = nmbr ),C0184661;C0053917;C1334884;C0886296;C1273869,true;true;false;false;false,9993/10465
non - st - segment elevation myocardial infarction,C1536221;C0441635;C1536222;C3537184;C4255010;C1518422;C1536220,false;false;false;false;true;false;true,9994/10465
non — st - segment — elevation myocardial infarction,C1536221;C0441635;C1536222;C3537184;C4255010;C1518422;C1536220,false;false;false;false;true;false;true,9995/10465
% risk reduction ( nmbr % ci ),C1137094;C0053917;C0008107;C3259781;C1334884,true;true;true;false;false,9996/10465
risk reduction ( nmbr % cl ),C1137094;C0053917;C0596019;C1334884,true;true;false;false,9997/10465
use of beta - blocker,C1524063;C0001645,false;true,9998/10465
use of beta - blockers,C1524063;C0001645,false;true,9999/10465
hf hospitalization,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,10000/10465
hf hospitalization n,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,10001/10465
hospitalization,C0019993,true,10002/10465
r elative risk ( nmbr % ci ),C0205090;C0233492;C0035647;C0053917;C0008107;C3259781;C1334884;C4552904;C0684010;C2603358,false;false;true;true;true;false;false;false;true;false,10003/10465
relative risk ( nmbr % ci ),C0242492;C0053917;C0008107;C3259781;C1334884,true;true;true;false;false,10004/10465
relative risk ( nmbr % cl ),C0242492;C0053917;C0596019;C1334884,true;true;false;false,10005/10465
> nmbr . nmbr ( n — nmbr ),C0053917;C1334884,true;false,10006/10465
< nmbr . nmbr ( n — nmbr ),C0053917;C1334884,true;false,10007/10465
mi > nmbr months *,C3810814;C0053917;C0439231;C1334884,false;true;false;false,10008/10465
mi < nmbr months *,C3810814;C0053917;C0439231;C1334884,false;true;false;false,10009/10465
> nmbr months — number / n ( % ),C0053917;C0439231;C0237753;C0449788;C1334884,true;false;false;false;false,10010/10465
< nmbr months — number / n ( % ),C0053917;C0439231;C0237753;C0449788;C1334884,true;false;false;false;false,10011/10465
all n = nmbr  nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,10012/10465
all n = nmbr nmbr,C0369718;C0053917;C1334884;C0441922,false;true;false;false,10013/10465
any clinical or lesion rf for st,C0205210,false,10014/10465
no clinical or lesion rfs for st,C0205210,false,10015/10465
neuropathy,C0442874,false,10016/10465
nephropathy,C0022658,true,10017/10465
hbanmbrc > nmbr % ( n nmbr nmbr ),C0053917;C1334884,true;false,10018/10465
hbanmbrc < = nmbr % ( n nmbr nmbr ),C0053917;C1334884,true;false,10019/10465
am △ 士 s . e .,C3813124;C3890196;C4520798,false;false;false,10020/10465
ama 士 s . e .,C0002461;C0279755;C2825862,true;false;false,10021/10465
im or cs use : no,,,10022/10465
im and cs use : no,,,10023/10465
hdlnmbr - c,,,10024/10465
ldlnmbr - c,,,10025/10465
at randomization,C0034656,true,10026/10465
randomization,C0034656,true,10027/10465
to randomization,C0034656,true,10028/10465
> nmbr years simva,C0053917;C0439234;C1334884,true;false;false,10029/10465
< nmbr years simva,C0053917;C0439234;C1334884,true;false;false,10030/10465
simvastatin nmbr mg ( n = nmbr ) *,C0074554;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10031/10465
simvastatin nmbr mg ( n = nmbr ),C0074554;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10032/10465
hispanic or latino ( n — nmbr ),C0086409,true,10033/10465
hispanic or latino ( n = nmbr ),C0086409,true,10034/10465
copd exacerbation : yes,C0740304;C1549445;C1705108;C1710701,false;false;false;false,10035/10465
copd exacerbation : no,C0740304,false,10036/10465
hdl cholesterol > nmbr - nmbr mmol / l,C0023822;C0053917;C1532563;C1334884;C0392885,true;true;false;false;false,10037/10465
ldl cholesterol < nmbr - nmbr mmol / l,C0023824;C0053917;C1532563;C1334884;C0202117,true;true;false;false;false,10038/10465
ldl cholesterol > nmbr - nmbr mmol / l,C0023824;C0053917;C1532563;C1334884;C0202117,true;true;false;false;false,10039/10465
hdl cholesterol < nmbr - nmbr mmol / l,C0023822;C0053917;C1532563;C1334884;C0392885,true;true;false;false;false,10040/10465
sex  female  n ( % ),C0086287,true,10041/10465
sex ( male )  n ( % ),C0086582,true,10042/10465
sex  male  n ( % ),C0086582,true,10043/10465
sex  male  no . ( % ),C0086582,true,10044/10465
adjusted p - value for interaction,C0456081;C1709380;C1704675,false;false;false,10045/10465
unadjusted p - value for interaction,C1439367;C1709380;C1704675,false;false;false,10046/10465
no chd eze / simva,C0280604;C3542407,false;false,10047/10465
chd eze / simva,C0280604;C3542407,false;false,10048/10465
aspirin use ( p = nmbr - nmbrt ),C0004057;C0042153;C0053917;C1334884;C0457083;C1947944,true;true;true;false;false;false,10049/10465
aspirin use ( p = nmbr - nmbr 十 ),C0004057;C0042153;C0053917;C1334884;C0457083;C1947944,true;true;true;false;false;false,10050/10465
dapagliflozin nmbr mg ( n = nmbr ),C2353951;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10051/10465
ertugliflozin nmbr mg ( n = nmbr ),C4079805;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10052/10465
empagliflozin nmbr mg ( n = nmbr ),C3490348;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10053/10465
prior coronary artery bypass grafting,C0332152;C0010055;C2826257,false;true;false,10054/10465
prior coronary artery bypass graft,C0332152;C0010055;C1260596;C2826257,false;true;false;false,10055/10465
cholesterol ( mmol / l ),C0008377;C1532563,true;false,10056/10465
cholesterol  mmol / l,C0008377;C1532563,true;false,10057/10465
fevnmbr  litres ( pre ipratropium )  mean ( sd ),C0475211;C0332152;C0027235;C0444504;C2699239;C2347634;C2348143;C0740175;C2257086;C3669034,false;false;true;false;false;false;false;false;false;false,10058/10465
fevnmbr  litres ( post ipratropium )  mean ( sd ),C0475211;C0687676;C0027235;C0444504;C2699239;C2347634;C2348143;C1704687;C3469826,false;false;true;false;false;false;false;false;false,10059/10465
insulin ( pmol / l ),C0021641;C0439284;C1533581;C1579433;C3714501,true;false;false;false;false,10060/10465
insulin  pmol / l,C0021641;C0439284;C1533581;C1579433;C3714501,true;false;false;false;false,10061/10465
proprotein convertase subtil / kexin typnmbr ( ng / ml ) - baseline - < median ( n = nmbr  nmbr ),C1100660;C0165249;C0439275;C0168634;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;true;false;true;false;false;false;false;false;false,10062/10465
proprotein convertase subtil / kexin typnmbr ( ng / ml ) - baseline - > = median ( n = nmbr  nmbr ),C1100660;C0165249;C0439275;C0168634;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;true;false;true;false;false;false;false;false;false,10063/10465
( mmol / l],C1532563,false,10064/10465
mmol / mol,C3829066,false,10065/10465
mmol / l,C1532563,false,10066/10465
wc ( cm ),C0013123;C2825512,true;false,10067/10465
rr ( cl ),C4554402;C0596019,false;false,10068/10465
patient ' s global assessment,C4054229,false,10069/10465
patient ' s global assessment !,C4054229,false,10070/10465
patient ' s global assessment of,C4054229,false,10071/10465
no epa group no . of events ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,10072/10465
epa group no . of events ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,10073/10465
nitrates  ( % ),C0028125;C0699857;C3848573,true;false;false,10074/10465
nitrates  n ( % ),C0028125;C0699857;C3848573,true;false;false,10075/10465
cox hr ( nmbr % ci ),C1565830;C0053917;C0008107;C3259781;C1334884,true;true;true;false;false,10076/10465
cmh rr ( nmbr % ci ),C4554402;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,10077/10465
coronary revascularization,C0877341,false,10078/10465
coronary revascularisation,C0877341,false,10079/10465
n - nmbr pufa ( n = nmbr ),C0369718;C0053917;C0032615;C1334884;C0441922,false;true;true;false;false,10080/10465
n - nmbr - pufa ( n = nmbr ),C0369718;C0053917;C0032615;C1334884;C0441922,false;true;true;false;false,10081/10465
antihypertensive agents,C0003364,true,10082/10465
antihypertensive agents *,C0003364,true,10083/10465
mean ( sd )  y,C0444504;C2699239;C2347634;C2348143,false;false;false;false,10084/10465
mean ( sd ) bmi,C0444504;C2699239;C0578022;C2347634;C2348143,false;false;false;false;false,10085/10465
non - high density lipoprotein ( mg / dl ) - baseline - > = median ( n = nmbr  nmbr ),C1535899;C0439269;C0168634;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,false;false;true;false;true;false;false;false;false;false;false,10086/10465
non - high density lipoprotein ( mg / dl ) - baseline - < median ( n = nmbr  nmbr ),C1535899;C0439269;C0168634;C0549183;C0053917;C1334884;C0876920;C2347635;C2348144;C2939193;C1442488,false;false;true;false;true;false;false;false;false;false;false,10087/10465
aldosterone blocker,C0002006,true,10088/10465
aldosterone blockers,C0002006,true,10089/10465
adjusted hr ( nmbr % ci ),C0456081;C0053917;C0008107;C3259781;C1334884,false;true;true;false;false,10090/10465
adjusted hr ( nmbr % cl ),C0456081;C0053917;C0596019;C1334884,false;true;false;false,10091/10465
cohort nmbr ( uacr < nmbr . nmbr mg / g ),C0009247;C0053917;C1300563;C1334884;C0599755,true;true;false;false;false,10092/10465
cohort nmbr ( uacr > nmbr . nmbr mg / g ),C0009247;C0053917;C1300563;C1334884;C0599755,true;true;false;false;false,10093/10465
no extensive colitis  n,C0205231;C0009319;C1963084,false;true;false,10094/10465
extensive colitis  n,C0205231;C0009319;C1963084,false;true;false,10095/10465
prior migraine,C0332152;C0149931;C2826257,false;true;false,10096/10465
prior migraine *,C0332152;C0149931;C2826257,false;true;false,10097/10465
primary endpoint death / mi / idr / st,C2986535;C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,false;true;false;true;false;false;false;false,10098/10465
primary end point : death / mi / idr / st,C2986535;C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,false;true;false;true;false;false;false;false,10099/10465
difference from placebo,C1705241;C0032042;C1696465;C1706408;C1705242,false;true;false;false;false,10100/10465
difference from placeboa,C1705241;C1705242,false;false,10101/10465
difference from placebo ¥,C1705241;C0032042;C1696465;C1706408;C1705242,false;true;false;false;false,10102/10465
standing after nmbr minute change from baseline,C0231472;C0053917;C0439232;C0392747;C0443172;C1705241;C4319952;C0700321;C0702093;C1282918;C2347166;C1334884,true;true;false;false;false;false;false;false;false;false;false;false,10103/10465
standing after nmbr minutes change from baseline,C0231472;C0053917;C0439232;C0700321;C0702093;C1282918;C2347166;C1334884,true;true;false;false;false;false;false;false,10104/10465
american indian or alaskan native,C0002460,true,10105/10465
american indian / alaska native,C0002460,true,10106/10465
american indian or alaska native,C0002460,true,10107/10465
multiracial,C1881928,false,10108/10465
multi - racial,C0439064;C0034510;C1706779;C3669213;C3853635;C3266262,false;true;false;false;false;true,10109/10465
aqlq ( s ) + nmbr scored,C4055434;C0053917;C1334884,false;true;false,10110/10465
aqlq ( s ) + nmbr scorets,C4055434;C0053917;C1334884,false;true;false,10111/10465
antiarrhythmic,C0003195;C3537142,true;false,10112/10465
anti arrhythmic,C0003195;C3537142,true;false,10113/10465
ct findings,C0007673;C2607943;C2926606;C3539655;C3540513;C3813556;C3888140,true;true;false;false;false;false;false,10114/10465
ecg findings,C0438154,false,10115/10465
lipoprotein ( a ) ( nmol / l ),C0065058;C0439282;C0125953;C1096202;C1439335,true;false;true;false;false,10116/10465
lipoprotein ( a ) ( mmol / l ),C0065058;C1532563;C0125953;C1096202;C1439335,true;false;true;false;false,10117/10465
baseline . mean _ sd  mg / dl,C0168634;C0444504;C2699239;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,10118/10465
baseline . mean _ sd . mg / mg,C0168634;C0444504;C2699239;C1319635;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,10119/10465
baseline . mean _ sd . mg / dl,C0168634;C0444504;C2699239;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,10120/10465
≤ nmbr u / kg / day,C0053917;C1532634;C1334884,true;false;false,10121/10465
> nmbr u / kg / day,C0053917;C1532634;C1334884,true;false;false,10122/10465
valsartan,C0216784,true,10123/10465
bosentan,C0252643,true,10124/10465
losartan,C0126174,true,10125/10465
history of stroke,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,10126/10465
history of stroke *,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,10127/10465
patients without syndesmophytes at baseline,C0030705;C0221690,true;false,10128/10465
patients with syndesmophytes at baseline,C0030705;C0221690,true;false,10129/10465
lipid - lowering,C0023779;C0441994;C2003888,true;false;false,10130/10465
lipid lowering,C0023779;C0441994;C2003888,true;false;false,10131/10465
stratum ii,C1710602;C4082587,false;false,10132/10465
stratum i,C0021966;C0221138,true;false,10133/10465
aaponmbr at rest  mm hg,C0035253;C0439475;C1622890,true;false;false,10134/10465
paonmbr at rest  mm hg,C0035253;C0439475;C1622890,true;false;false,10135/10465
mean ( s . d . ) systolic blood pressure  mm hg,C0428886;C0039155;C0439475;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;true;false;false;false,10136/10465
mean ( s . d . ) diastolic blood pressure  mm hg,C0428886;C0012000;C0439475;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;false;true;false;false;false,10137/10465
> nmbr to < nmbr h  n ( % ),C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,10138/10465
nmbr to < nmbr h  n ( % ),C0053917;C0033727;C0369286;C0441932;C0564385;C4528284;C1334884,true;true;false;false;false;false;false,10139/10465
coronary artery disease^,C0010054;C0010068;C1956346,true;true;true,10140/10465
coronaiy artery disease,C0852949,false,10141/10465
coronary artery disease,C0010054;C0010068;C1956346,true;true;true,10142/10465
> o - nmbr - i - i,C0483204;C0053917;C0021966;C0221138;C1334884,false;true;true;false;false,10143/10465
> o - nmbr - ii,C0483204;C0053917;C1710602;C4082587;C1334884,false;true;false;false;false,10144/10465
egfr  ml / min / nmbr . nmbr mnmbr  mean ( sd ),C1739039;C0439445;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C3811844;C3812682,true;false;true;false;false;false;false;false;false;false,10145/10465
egfr  ml / min / nmbr . nmbr mnmbr  mean ± sd,C1739039;C0439445;C0053917;C0444504;C2699239;C2347634;C2348143;C1334884;C3811844;C3812682,true;false;true;false;false;false;false;false;false;false,10146/10465
baseline fevnmbr,C0168634;C1442488,true;false,10147/10465
baseline fevnmbr #,C0168634;C1442488,true;false,10148/10465
nmbr ( n nmbr nmbr ),C0053917;C1334884,true;false,10149/10465
nmbr mg ( n nmbr nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,10150/10465
respiratory rate  breaths / min,C0231832;C0439386;C0489258,true;false;false,10151/10465
respiratory rate ( breaths / min ),C0231832;C0439386;C0489258,true;false;false,10152/10465
karnofsky score < nmbr,C0206065,true,10153/10465
karnofsky score 竺 nmbr,C0206065,true,10154/10465
ldl - csmedian,,,10155/10465
ldl - c > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10156/10465
non - hdl - c *,C1518422;C3715113,false;false,10157/10465
non - hdl - c,C1518422;C3715113,false;false,10158/10465
duration of pci — min,C0449238;C4049621;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,10159/10465
duration of pci  min,C0449238;C4049621;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,10160/10465
mean ( s . d . ) bmi  kg / mnmbr,C0444504;C0578022;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;true;false;false;false;false,10161/10465
mean ± s . d . bmi  kg / mnmbr,C0444504;C0578022;C0022718;C0439209;C4054209;C2347634;C2348143,false;false;true;false;false;false;false,10162/10465
baselinec,,,10163/10465
( baseline ),C0168634;C1442488,true;false,10164/10465
baselineb,,,10165/10465
baseline ,C0168634;C1442488,true;false,10166/10465
baseline,C0168634;C1442488,true;false,10167/10465
< nmbr . nmbr % ( nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,10168/10465
≥ nmbr . nmbr % ( ≥ nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,10169/10465
inferior ( % ),C0542339;C0678975,false;false,10170/10465
anterior { % ),C0205094,false,10171/10465
age group  no . ( % ),C0027362;C2348001,true;false,10172/10465
age group  n ( % ),C0001779;C0441848,false;false,10173/10465
qualifying mi < nmbr yrs prior,C1514624;C3810814;C0053917;C1334884,false;false;true;false,10174/10465
qualifying mi $ nmbr yrs prior,C1514624;C3810814;C0053917;C1334884,false;false;true;false,10175/10465
hawaiian / pacific islander,C0337920;C0242191,true;true,10176/10465
hawaiian pacific islander,C0337920;C0242191,true;true,10177/10465
bl mean ( mmhg ),C0005918;C0444504;C0439475;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;false;true;false;false,10178/10465
bl mean ( cm ),C0005918;C0444504;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;true;false;false,10179/10465
no or unknown,,,10180/10465
no / unknown,C0439673;C3541433;C4050014,false;false;false,10181/10465
loop diuretic,C0354100;C3536704,true;false,10182/10465
loop diuretics,C0354100,true,10183/10465
non diuretics,C1518422;C0012798,false;true,10184/10465
esam ( ng / ml ),C1424976;C0439275,false;false,10185/10465
ngal ( ng / ml ),C0215955;C0439275;C1416806;C2346625,true;false;false;false,10186/10465
fevnmbr / fvc,C3714541,true,10187/10465
fevnmbr / fvc %,C3714541,true,10188/10465
history of diabetes ( a ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,10189/10465
history of diabetes ( % ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,10190/10465
age : < nmbr years ( n = nmbr ),C1510829;C0053917;C1334884,false;true;false,10191/10465
age < nmbr years ( n = nmbr ),C1510829;C0053917;C1334884,false;true;false,10192/10465
age  years  mean ( range ),C1510829;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,10193/10465
age  years : median ( range ),C1510829;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,10194/10465
metabolic syndrome ( % ) b,C0524620,true,10195/10465
metabolic syndrome ( % ),C0524620,true,10196/10465
peripheral artery disease — no . ( % ),C1704436;C4025272,true;false,10197/10465
peripheral - artery disease — no . ( % ),C1704436;C4025272,true;false,10198/10465
aiorvasiaiin,,,10199/10465
atorvastatin,C0286651,true,10200/10465
epa ( mol % ),C0027960;C0324740;C0439189;C1456781;C1824986;C3665593,true;true;false;false;false;false,10201/10465
aa  mol %,C0282379;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C1235746;C1882141;C4554792,true;true;true;false;false;false;false;false;false;false,10202/10465
epa  mol %,C0027960;C0324740;C0439189;C1456781;C1824986;C3665593,true;true;false;false;false;false,10203/10465
cardiovasculardeath / myocardial infarction / stroke,C0027051;C0038454;C4554100;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false,10204/10465
cardiovascular death / myocardial infarction / stroke,C0027051;C0011065;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775,true;true;false;false;false;false;false;false;false,10205/10465
m o nito ring treatment,C0369637;C0521164;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1260969;C1882954;C0441923,false;false;true;true;false;false;false;false;false;false;false;false,10206/10465
monitoring treatment,C0150369;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1283169,false;true;true;false;false;false;false;false;false,10207/10465
baseline focal seizure frequency / nmbr days  median ( qnmbr  qnmbr ),C0168634;C0751495;C0376249;C0053917;C0439228;C0549183;C0876920;C2347635;C2348144;C2939193;C1334884;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1442488,true;true;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,10208/10465
baseline focal seizure frequency / nmbr days  median ( qnmbr - qnmbr ),C0168634;C0751495;C0376249;C0053917;C0439228;C0549183;C0876920;C2347635;C2348144;C2939193;C1334884;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1442488,true;true;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,10209/10465
thiazide diuretics,C0012802,true,10210/10465
thiazide diuretic,C0012802;C3536861,true;false,10211/10465
diabetes present nmbr ( nmbr . nmbr ),C0011847;C0150312;C0053917;C1334884;C0449450;C0011849,false;false;true;false;false;true,10212/10465
diabetes absent nmbr ( nmbr . nmbr ),C0011847;C0332197;C0053917;C1334884;C4285062;C0011849,false;false;true;false;false;true,10213/10465
baseline medication,C0168634;C0013227;C3244316;C4284232;C1442488,true;true;false;false;false,10214/10465
baseline cv medications,C0168634;C3538987;C0013227;C0802604;C2598133;C4284232;C4048877;C4318503;C1442488,true;false;true;false;false;false;true;false;false,10215/10465
baseline medications,C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,10216/10465
calcium aniagonisi,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,10217/10465
calcium antagonist,C0006684,true,10218/10465
calcium antagonists,C0006684,true,10219/10465
at qualifying event,C1514624;C0441471;C4019010,false;false;false,10220/10465
qualifying event,C1514624;C0441471;C4019010,false;false;false,10221/10465
nmbr - nmbr . nmbr : obese class ii,C0053917;C3853263;C1334884,true;false;false,10222/10465
nmbr - nmbr . nmbr : obese class i,C0053917;C3853264;C1334884,true;false;false,10223/10465
white race — no . ( % ) f,C0007457;C0043157;C0220938,true;true;false,10224/10465
white race — no . ( % ) : t,C0007457;C0043157;C0220938,true;true;false,10225/10465
white race — no . ( % ) :,C0007457;C0043157;C0220938,true;true;false,10226/10465
ileocolon,,,10227/10465
lleocolon,,,10228/10465
tiotropium nmbrmg ( n = nmbr,C0213771;C0053917;C1334884,true;true;false,10229/10465
tiotropium nmbr mg ( n = nmbr ),C0213771;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10230/10465
multi - vessel coronary artery disease,C1299432,false,10231/10465
multivessel coronary artery disease,C0010054;C0010068;C1956346,true;true;true,10232/10465
mean ± sd msdbp  mm hg,C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false,10233/10465
mean sd mssbp  mm hg,C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false,10234/10465
mean age  y ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,10235/10465
mean age ( y ) ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,10236/10465
age in nmbr classes,C0001779;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884,false;true;false;false;false;false;false,10237/10465
egfr in nmbr classes,C1739039;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C3811844;C3812682,true;true;false;false;false;false;false;false;false,10238/10465
heart rate  bpm,C0018810,true,10239/10465
heart rate — bpm,C0018810,true,10240/10465
heart rate ( bpm ),C0018810,true,10241/10465
biguanide ( metformin ),C0005382;C0025598;C3537187;C4317165,true;true;false;false,10242/10465
biguanides ( metformin ),C0005382;C0025598;C0360396;C3540012,true;true;false;false,10243/10465
naive : no,,,10244/10465
naive : yes,C1549445;C1705108;C1710701,false;false;false,10245/10465
no steroids ( n = nmbr vs nmbr ),C0038317;C0053917;C1334884,true;true;false,10246/10465
steroids ( n = nmbr vs nmbr ),C0038317;C0053917;C1334884,true;true;false,10247/10465
secondary ' outcomes,C0027627;C1274040;C0175668;C0205436,true;false;false;false,10248/10465
secondary outcomes,C0027627;C1274040;C0175668;C0205436,true;false;false;false,10249/10465
clopidogrel,C0070166,true,10250/10465
clopiodogrel,,,10251/10465
antiplatelet - onl group ( n = nmbr ),C0441848;C0053917;C1334884,false;true;false,10252/10465
antiplatelet - only group ( n = nmbr ),C0205171;C0441848;C0053917;C1334884;C1720467,false;false;true;false;false,10253/10465
myopathyt,,,10254/10465
myopathy,C0026848,true,10255/10465
baseline hdl - c in nmbr classes,C0168634;C3715113;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1442488,true;false;true;false;false;false;false;false;false,10256/10465
baseline trl - c in nmbr classes,C0168634;C0053917;C0456387;C1518526;C1705943;C4019422;C1334884;C1442488,true;true;false;false;false;false;false;false,10257/10465
with diabetes,C0011847;C0011849,false;true,10258/10465
without diabetes,C0011847;C0011849,false;true,10259/10465
treated vessel,C1522326;C0005847,false;true,10260/10465
treated vessel !,C1522326;C0005847,false;true,10261/10465
estimated glomerular filtration rate - ml / min / nmbr . nmbrmnmbrtt,C3811844;C0439445;C0053917;C1334884,false;false;true;false,10262/10465
estimated glomerular filtration rate ( ml / min / nmbr . nmbrmnmbr ),C3811844;C0439445;C0053917;C1334884,false;false;true;false,10263/10465
inferior or posterior,C0542339;C0678975,false;false,10264/10465
inferior / posterior,C0542339;C0205095;C0678975,false;false;false,10265/10465
weight > nmbr kg,C0005910;C0053917;C0022718;C0439209;C4054209;C1334884;C0043100;C1305866;C1705104,true;true;true;false;false;false;true;false;false,10266/10465
weight < nmbr kg,C0005910;C0053917;C0022718;C0439209;C4054209;C1334884;C0043100;C1305866;C1705104,true;true;true;false;false;false;true;false;false,10267/10465
systolic ( mean  sd ),C0039155;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,10268/10465
diastolic ( mean  sd ),C0012000;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,10269/10465
tertile nmbr ( > nmbr . nmbr pg / ml ) n - nmbr,C0053917;C0439297;C1334884,true;false;false,10270/10465
tertile nmbr ( < nmbr . nmbr ng / ml ) n - nmbr,C0053917;C0439275;C1334884,true;false;false,10271/10465
patients with egfr > nmbr ml / min / nmbr . nmbrmnmbr at baseline,C0030705;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;true;false;false;false;false,10272/10465
patients with egfr < nmbr ml / min / nmbr . nmbrmnmbr at baseline,C0030705;C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;true;false;false;false;false,10273/10465
baseline hbanmbrc > nmbr . nmbr %,C0168634;C0053917;C1334884;C1442488,true;true;false;false,10274/10465
baseline hbanmbrc < nmbr . nmbr %,C0168634;C0053917;C1334884;C1442488,true;true;false;false,10275/10465
nmbr . nmbr - nmbr . nmbr % f,C0053917;C0016327;C1334884,true;true;false,10276/10465
nmbr . nmbr - nmbr . nmbr % t,C0053917;C1334884,true;false,10277/10465
number of stents,C0237753;C0038257;C0449788,false;true;false,10278/10465
number of patients,C2360800,false,10279/10465
tjc ( nmbr joints )  mean ( sd ),C0053917;C0022417;C0444504;C2699239;C2347634;C2348143;C0392905;C1334884,true;true;false;false;false;false;false;false,10280/10465
sjc ( nmbr joints )  mean ( sd ),C0053917;C0022417;C0444504;C2699239;C2347634;C2348143;C0392905;C1334884,true;true;false;false;false;false;false;false,10281/10465
body mass index  median ( iqr ) b,C0005893;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;true,10282/10465
body mass index  median ( iqr ),C0005893;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;true,10283/10465
all other,,,10284/10465
all others,C1955473;C3539125,false;false,10285/10465
secondary *,C0027627;C0175668;C0205436,true;false;false,10286/10465
secondary pci,C0027627;C4049621;C0175668;C0205436,true;false;false;false,10287/10465
no . of prior aeds  n ( % ),C0332152;C0180309;C2826257,false;true;false,10288/10465
no . of prior aeds  c n ( % ),C0332152;C0180309;C2826257,false;true;false,10289/10465
( mean change  nmbr % ci ),C0444504;C0392747;C0053917;C0008107;C3259781;C1334884;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false,10290/10465
( mean % change  nmbr % ci ),C0444504;C0392747;C0053917;C0008107;C3259781;C1334884;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false,10291/10465
hazard ratiof,C0598697,false,10292/10465
hazard ratio,C2985465,false,10293/10465
prior myocardial infarction yes,C0155668;C1549445;C1705108;C1710701,false;false;false;false,10294/10465
prior myocardial infarction  %,C0155668,false,10295/10465
dpp - nmbr inhibitor,C1414174;C0053917;C1999216;C1334884,false;true;false;false,10296/10465
dpp - nmbr inhibitors,C1414174;C0053917;C0243077;C1334884,false;true;true;false,10297/10465
ldl - c / hdl - c ratio,C0428621,false,10298/10465
ldl - c : hdl - c ratio,C0428621,false,10299/10465
modified has - bled $ nmbr,C0392747;C3889737,false;false,10300/10465
modified has - bled < nmbr,C0392747;C3889737,false;false,10301/10465
subgroup,C1079230;C1515021,false;false,10302/10465
subgroups,C1079230,false,10303/10465
old stroke *,C1536121,false,10304/10465
new stroke *,C0205314;C0038454;C4554100,false;true;false,10305/10465
low risk,C3272281;C3538919,false;false,10306/10465
lower risk,C3272281;C3538919,false;false,10307/10465
high - intensity statin,C4081854;C0360714,false;true,10308/10465
high - intensity statin *,C4081854;C0360714,false;true,10309/10465
no high - intensity statin,C4081854;C0360714,false;true,10310/10465
smoker  ! n ( % ),C0337664,true,10311/10465
smokers  n ( % ),C0337664,true,10312/10465
ics use yes / no  %,C0815320;C4551720,false;true,10313/10465
ics use  yes / no %,C0815320;C4551720,false;true,10314/10465
ics use  yes / no  %,C0815320;C4551720,false;true,10315/10465
present smokerc,C0150312;C0449450,false;false,10316/10465
present smoker,C0150312;C0337664;C0449450,false;true;false,10317/10465
p - value ( int ),C1709380;C3272375,false;false,10318/10465
p value ( int ),C1709380;C3272375,false;false,10319/10465
alteplase,C0032143,true,10320/10465
reteplase,C0256103,true,10321/10465
western europe / australia,C0043128;C0015176;C0043129;C0004340,true;true;true;true,10322/10465
western europe and australia,C0043129,true,10323/10465
geographical region,C0017446,true,10324/10465
geographic region,C0017446,true,10325/10465
tiotropium nmbr mg respimat ® ( n z nmbr ),C0213771;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10326/10465
tiotropium nmbr mg respimat ® ( n = nmbr ),C0213771;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10327/10465
body - mass index > nmbr  n ( % ),C0005893;C0053917;C1334884;C0578022;C1305855,false;true;false;false;true,10328/10465
body mass index > nmbr  n ( % ),C0005893;C0053917;C1334884;C0578022;C1305855,false;true;false;false;true,10329/10465
pbo + mtx n = nmbr,C0031962;C0025677;C0053917;C1334884;C1417487,true;true;true;false;false,10330/10465
czp + mtx n = nmbr,C0054841;C0025677;C0053917;C1334884;C1417487;C1861828;C1872109,true;true;true;false;false;true;true,10331/10465
ef < nmbr % hfref ( n = nmbr  nmbr % ),C0053917;C1334884,true;false,10332/10465
ef > nmbr % hfpef ( n = nmbr  nmbr % ),C0053917;C1334884,true;false,10333/10465
macroalbuminuria at baseline ( nmbr % of patients treated ),C0168634;C0053917;C0030705;C1334884;C1442488,true;true;true;false;false,10334/10465
microalbuminuria at baseline ( nmbr % of patients treated ),C0730345;C0168634;C0053917;C0030705;C1334884;C1442488,false;true;true;true;false;false,10335/10465
any coronary artery disease,C0010054;C0010068;C1956346,true;true;true,10336/10465
only coronary artery disease,C0205171;C0010054;C0010068;C1956346;C1720467,false;true;true;true;false,10337/10465
estimated gfr < nmbr ml / min / nmbr . nmbr mnmbr,C0750572;C0017654;C0053917;C0439445;C1334884;C1424601,false;true;true;false;false;false,10338/10465
estimated gfr > nmbr ml / min / nmbr . nmbr mnmbr,C0750572;C0017654;C0053917;C0439445;C1334884;C1424601,false;true;true;false;false;false,10339/10465
female patients  n ( % ),C0150905,false,10340/10465
male patients  n ( % ),C0150904,false,10341/10465
history  pack - years,C0019664;C1277691;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,10342/10465
history ( pack - years ),C0019664;C1277691;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,10343/10465
duration of diabetes > nmbr years,C0449238;C0011847;C0053917;C0439234;C1334884;C0011849;C2926735,false;false;true;false;false;true;false,10344/10465
duration of diabetes < nmbr years,C0449238;C0011847;C0053917;C0439234;C1334884;C0011849;C2926735,false;false;true;false;false;true;false,10345/10465
structural heart disease §,C1290384,false,10346/10465
structural heart disease,C1290384,false,10347/10465
no family history of chd ( n = nmbr  nmbr ),C0241889;C0280604;C0053917;C1334884;C3542407,true;false;true;false;false,10348/10465
family history of chd ( n = nmbr  nmbr ),C0241889;C0280604;C0053917;C1334884;C3542407,true;false;true;false;false,10349/10465
subcortical wml load diameter  mm  mean ( sd ),C0815275;C1550025;C0552409;C4330985;C2699239;C4554674;C1704782;C1708715,false;false;false;false;false;false;false;false,10350/10465
subcortical wml load diameter  mm   mean ( sd ),C0815275;C1550025;C0552409;C4330985;C2699239;C4554674;C1704782;C1708715,false;false;false;false;false;false;false;false,10351/10465
etoricoxib nmbr mg ( n nmbr nmbr )  . . . n . . . ( . % . . ) . . . . . . . . . . .,C0972314;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10352/10465
etoricoxib nmbr mg ( n nmbr nmbr )  . . . n . . ( . % . . ) . . . . . . . . . . .,C0972314;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10353/10465
glycoprotein iib / iiia inhibitor,C0016011;C1999216,true;false,10354/10465
glycoprotein iib / iiia inhibitors,C0016011;C0243077,true;true,10355/10465
with acei / arb,C3888198,false,10356/10465
without acei / arb,C3888198,false,10357/10465
corticosteroid or immunosuppressant,C0001617;C3536709,true;false,10358/10465
corticosteroids and immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,10359/10465
corticosteroid and immunosuppressant,C0001617;C3536709,true;false,10360/10465
egfr < nmbr ml / min,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,10361/10465
egfr > nmbr ml / min,C1739039;C0053917;C0439445;C1334884;C3811844;C3812682,true;true;false;false;false;false,10362/10465
st - segment — elevation myocardial infarction,C1536220,true,10363/10465
st - segment elevation myocardial infarction,C1536220,true,10364/10465
patients with psoriasis ( n = nmbr ),C0030705;C0033860;C0053917;C1334884,true;true;true;false,10365/10465
patients without psoriasis ( n = nmbr ),C0030705;C0033860;C0053917;C1334884,true;true;true;false,10366/10465
egfr < nmbr ml / min / nmbr . nmbr mz,C1739039;C0053917;C0439445;C0026655;C1705291;C1334884;C3811844;C3812682,true;true;false;true;false;false;false;false,10367/10465
egfr > nmbr ml / min / nmbr . nmbr mz,C1739039;C0053917;C0439445;C0026655;C1705291;C1334884;C3811844;C3812682,true;true;false;true;false;false;false;false,10368/10465
age > nmbr years ( median ),C1510829;C0053917;C1334884,false;true;false,10369/10465
age < nmbr years ( median ),C1510829;C0053917;C1334884,false;true;false,10370/10465
no . pts,C1419129;C2698747,false;false,10371/10465
no . men,C0025266,true,10372/10465
nmbr mg qw nmbr . nmbr pt yrs,C0053917;C0024671;C0043011;C0032743;C0699718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;true;false;false;false;false;false;false,10373/10465
nmbr mg biw nmbr . nmbr pt yrs,C0053917;C0024671;C0032743;C0699718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,10374/10465
fasting plasma glucose ( mg / dl ),C0015663;C0202042;C0439269;C0455280,true;false;false;false,10375/10465
fasting plasma glucose — mg / dl,C0015663;C0202042;C0439269;C0455280,true;false;false;false,10376/10465
antidiabetic medications,C0935929,true,10377/10465
antidiabetic medication,C0935929,true,10378/10465
ldl - c ( median  iqr )  mg / dl,C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10379/10465
hdl - c ( median  iqr )  mg / dl,C3715113;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,10380/10465
nonischemic cardiomyopathy,C0878544,true,10381/10465
ischaemic cardiomyopathy,C0349782,false,10382/10465
ischemic cardiomyopathy,C0349782,false,10383/10465
no ilb / iiia inhibitors,C4697913;C0243077,false;true,10384/10465
ilb / iiia inhibitors,C4697913;C0243077,false;true,10385/10465
nontatal ml,C0439526;C1705224;C3887665,false;false;false,10386/10465
nonfatal ml,C0439526;C1705224;C3887665,false;false;false,10387/10465
no of events women men *,C0441471;C0043210;C0025266;C3541888,false;true;true;false,10388/10465
no of events womenmen *,C0441471;C3541888,false;false,10389/10465
demographic features,C0683970,false,10390/10465
demographic feature,C0683970,false,10391/10465
non - epa ( n = nmbr ),C1518422;C0053917;C1334884,false;true;false,10392/10465
non - us ( n = nmbr ),C1518422,false,10393/10465
heart failure *,C0018801;C0018802;C4554158,true;true;false,10394/10465
heart failure,C0018801;C0018802;C4554158,true;true;false,10395/10465
heart failurea,C0018787,true,10396/10465
acetylsalicylic acid,C0004057,true,10397/10465
acetyl - salicylic acid,C0004057,true,10398/10465
difference ( % ),C1705241;C1705242,false;false,10399/10465
difference ( se ),C1705241;C0036919;C1705242,false;true;false,10400/10465
exercise > once weekly,C0015259;C1522704,true;false,10401/10465
exercise > once weekly ?,C0015259;C1522704,true;false,10402/10465
nmbr - nmbr days ( % ),C0053917;C0439228;C1334884,true;false;false,10403/10465
nmbr - nmbr yr ( % ),C0053917;C0439234;C1334884,true;false;false,10404/10465
number stent > nmbr,C0237753;C0038257;C0053917;C1334884;C0449788,false;true;true;false;false,10405/10465
number ste " t > nmbr,C0237753;C1420459;C0053917;C1334884;C3811127;C0449788,false;false;true;false;false;false,10406/10465
most common concomitant aeds  d n ( % ),C0205393;C0205214;C0521115;C0180309;C1522138;C3245511,false;false;false;true;false;false,10407/10465
most common concomitant aeds  n ( % ),C0205393;C0205214;C0521115;C0180309;C1522138;C3245511,false;false;false;true;false;false,10408/10465
> nmbr % to < nmbr % ( > nmbr to nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,10409/10465
> nmbr % to < nmbr % ( > nmbr to < nmbr mmol / mol ),C0053917;C3829066;C1334884,true;false;false,10410/10465
baricitinib nmbr mg ( n = nmbr ),C4044947;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10411/10465
baricitinib nmbr mg qd ( n = nmbr ),C4044947;C0053917;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;true;false;false;false;false;false;false,10412/10465
alcohol consumption,C0001948,true,10413/10465
alcohol consumption !,C0001948,true,10414/10465
sri response  %,C1420401;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,10415/10465
acr response  %,C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,10416/10465
endpoint / baseline,C2349179;C0168634;C1442488;C2826544,false;true;false;false,10417/10465
endpoint / baselinec,C2349179;C2826544,false;false,10418/10465
ranozaline,,,10419/10465
ranolazine,C0073633,true,10420/10465
left anterior descending coronary artery,C0226032,false,10421/10465
l eft anterior descending coronary artery,C0439394;C0451214;C0226032;C1706495;C3642217,false;false;false;false;false,10422/10465
renal subgroup,C0022646;C1079230;C1515021,true;false;false,10423/10465
female subgroup,C0043210;C1079230;C1515021;C0086287;C1705497;C1705498,true;false;false;true;false;false,10424/10465
ss < nmbr ( n = nmbrvsnmbr ),C2699257;C0053917;C1334884;C3891295;C4551874,false;true;false;false;false,10425/10465
ss > nmbr ( n = nmbrvs nmbr ),C2699257;C0053917;C1334884;C3891295;C4551874,false;true;false;false;false,10426/10465
transient ischemic attack,C0007787;C0917805,true;true,10427/10465
transient ischaemic attack,C0007787;C0917805,true;true,10428/10465
nmbr mg ew n = nmbr,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,10429/10465
nmbr mg eow n = nmbr,C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,10430/10465
phgada ( mm ),C4330985;C4554674,false;false,10431/10465
ptgada ( mm ),C4330985;C4554674,false;false,10432/10465
patient ' s assessment of pain !,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,10433/10465
patient ' s assessment of pain,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,10434/10465
lama ( only monotherapy ),C0999593;C0205171;C1720467;C1416775,false;false;false;false,10435/10465
laba ( only monotherapy ),C0205171;C1720467,false;false,10436/10465
insulin glargine ( n = nmbr ),C0907402;C0053917;C1334884,true;true;false,10437/10465
insulin glargine ( n = nmbrll ),C0907402,true,10438/10465
secukinumab  nmbr mg ( n = nmbr ),C3179547;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10439/10465
secukinumab nmbr mg ( n = nmbr ),C3179547;C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;true;false;false;false;false;false;false,10440/10465
paroxysmal,C0205311,false,10441/10465
paroxysmal af,C0235480,true,10442/10465
history of major microvascular disease — no . ( % ),C0683519;C0205082;C0443258;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false;false,10443/10465
history of major macrovascular disease — no . ( % ),C0683519;C0205082;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false,10444/10465
non - hdl cholesterol,C0729627;C1535899,false;false,10445/10465
non - hdl choleslerol,C1518422;C3715113,false;false,10446/10465
insulin treated,C0021641;C1533581;C1579433;C3714501,true;false;false;false,10447/10465
insulin - treated,C0021641;C1533581;C1579433;C3714501,true;false;false;false,10448/10465
msdbp  mmhg ( sd ),C0439475;C2699239,false;false,10449/10465
mssbp  mmhg ( sd ),C0439475;C2699239,false;false,10450/10465
no prior statin ( n = nmbr  nmbr ),C0332152;C0360714;C0053917;C1334884;C2826257,false;true;true;false;false,10451/10465
prior statin ( n = nmbr  nmbr ),C0332152;C0360714;C0053917;C1334884;C2826257,false;true;true;false;false,10452/10465
fevnmbr ( liters ),C0475211,false,10453/10465
fevnmbr — liters,C0475211,false,10454/10465
systolic,C0039155,true,10455/10465
diastolic,C0012000,true,10456/10465
czp + mtx^mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,10457/10465
pbo + mtx^mtx,C0031962;C0025677;C1417487,true;true;false,10458/10465
history of paroxysmal af,C0019664;C0235480;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,10459/10465
no history of paroxysmal af,C0019664;C0235480;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,10460/10465
stage nmbr : > = nmbr,C0205390;C0053917;C1334884;C1300072;C1306673,false;true;false;false;false,10461/10465
stage nmbr : < nmbr,C0205390;C0053917;C1334884;C1300072;C1306673,false;true;false;false;false,10462/10465
ato nmbr mg and sim nmbr^nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,10463/10465
ato nmbr mg and sim nmbr - nmbr mg ( n = nmbr ),C0053917;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1334884,true;true;true;false;false;false;false;false;false,10464/10465
